{
    "56c8605b5795f9a73e000014_1": [
        {
            "start_logit": 11.734375,
            "end_logit": 10.828125,
            "text": "JAK1",
            "probability": 0.79296875
        },
        {
            "start_logit": 11.734375,
            "end_logit": 9.4921875,
            "text": "JAK1/2",
            "probability": 0.20703125
        },
        {
            "start_logit": 11.734375,
            "end_logit": -5.05078125,
            "text": "JAK",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 10.828125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 11.734375,
            "end_logit": -8.125,
            "text": "JAK1/",
            "probability": 0.0
        },
        {
            "start_logit": 11.734375,
            "end_logit": -8.453125,
            "text": "JAK1/2 Inhibitor Baricitinib.",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.4921875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.4921875,
            "text": "1/2",
            "probability": 0.0
        },
        {
            "start_logit": 11.734375,
            "end_logit": -9.265625,
            "text": "JAK1/2 Inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 11.734375,
            "end_logit": -9.7421875,
            "text": "JAK1/2 Inhibitor Baricitinib",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": 10.828125,
            "text": "Alopecia Areata Following Treatment With the JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": 9.4921875,
            "text": "Alopecia Areata Following Treatment With the JAK1/2",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": -5.05078125,
            "text": "Alopecia Areata Following Treatment With the JAK",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -8.125,
            "text": "1/",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -8.453125,
            "text": "2 Inhibitor Baricitinib.",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -8.453125,
            "text": "1/2 Inhibitor Baricitinib.",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": -6.99609375,
            "text": "Alopecia Areata",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -9.265625,
            "text": "2 Inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -9.265625,
            "text": "1/2 Inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -9.7421875,
            "text": "2 Inhibitor Baricitinib",
            "probability": 0.0
        }
    ],
    "56c8605b5795f9a73e000014_2": [
        {
            "start_logit": 11.0859375,
            "end_logit": 10.8125,
            "text": "JAK1",
            "probability": 0.87353515625
        },
        {
            "start_logit": 11.0859375,
            "end_logit": 8.875,
            "text": "JAK1/2",
            "probability": 0.1258544921875
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -5.3828125,
            "text": "JAK",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 10.8125,
            "text": "AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 10.8125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -7.81640625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -7.859375,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -7.984375,
            "text": "JAK1/",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -8.1875,
            "text": "JAK1/2 inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": 8.875,
            "text": "AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 0.0
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 8.875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -9.21875,
            "text": "JAK1/2 inhibitor, to treat concomitant CAND",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.875,
            "text": "1/2",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -9.5234375,
            "text": "JAK1/2 inhibitor, to",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -9.5703125,
            "text": "JAK1/2 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 11.0859375,
            "end_logit": -9.65625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 10.8125,
            "text": "baricitinib, a JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 10.8125,
            "text": "patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 10.8125,
            "text": "examine the efficacy of baricitinib, a JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 8.875,
            "text": "baricitinib, a JAK1/2",
            "probability": 0.0
        }
    ],
    "56c8605b5795f9a73e000014_3": [
        {
            "start_logit": 10.8046875,
            "end_logit": 12.0625,
            "text": "JAK2",
            "probability": 1.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 12.0625,
            "text": "JAK1 and JAK2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 12.0625,
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 12.0625,
            "text": "JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.0625,
            "text": "1 and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -9.3125,
            "text": "JAK2,",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.0625,
            "text": "selectivity for JAK1 and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -9.515625,
            "text": "JAK2, is currently in clinical development",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -3.546875,
            "text": "JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -3.546875,
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -3.546875,
            "text": "JAKs) with selectivity for JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -7.24609375,
            "text": "JAK",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -3.546875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -3.546875,
            "text": "INCB028050), a novel and potent small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -5.91796875,
            "text": "Janus kinase family of enzymes (JAKs",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": -3.546875,
            "text": "selectivity for JAK1",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": -5.91796875,
            "text": "LY3009104 or INCB028050), a novel and potent small molecule inhibitor of Janus kinase family of enzymes (JAKs",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -5.91796875,
            "text": "JAKs",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -9.0234375,
            "text": "JAK1 and",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.15625,
            "text": "Janus kinase",
            "probability": 0.0
        }
    ],
    "56c8605b5795f9a73e000014_4": [
        {
            "start_logit": 10.9609375,
            "end_logit": 10.3515625,
            "text": "JAK1",
            "probability": 0.6689453125
        },
        {
            "start_logit": 10.9609375,
            "end_logit": 9.6484375,
            "text": "JAK1/2",
            "probability": 0.3310546875
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -5.32421875,
            "text": "JAK",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -6.3984375,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse model",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 10.3515625,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 10.3515625,
            "text": "AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -7.69140625,
            "text": "JAK1/",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": 9.6484375,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -7.87109375,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -8.21875,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 9.6484375,
            "text": "1/2",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 9.6484375,
            "text": "AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -8.53125,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -8.53125,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -8.921875,
            "text": "JAK1/2 inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -9.0703125,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -9.3125,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -9.4609375,
            "text": "JAK1/2 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -9.6015625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/He",
            "probability": 0.0
        },
        {
            "start_logit": 10.9609375,
            "end_logit": -9.6015625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_1": [
        {
            "start_logit": 13.0078125,
            "end_logit": 12.7109375,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -5.1953125,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -5.484375,
            "text": "INO",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 12.7109375,
            "text": "80",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -7.0234375,
            "text": "INO80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -9.359375,
            "text": "INO80 promotes homologous",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.7109375,
            "text": "O80",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 12.7109375,
            "text": "Removal of H2A.Z by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.0234375,
            "text": "80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -9.359375,
            "text": "80 promotes homologous",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -5.484375,
            "text": "O",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -5.1953125,
            "text": "Removal of H2A.Z by IN",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -5.484375,
            "text": "Removal of H2A.Z by INO",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -7.0234375,
            "text": "homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -7.0234375,
            "text": "O80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": -7.0234375,
            "text": "promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -7.0234375,
            "text": "Removal of H2A.Z by INO80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -9.359375,
            "text": "homologous",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -9.359375,
            "text": "O80 promotes homologous",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": -9.359375,
            "text": "promotes homologous",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_2": [
        {
            "start_logit": 13.0703125,
            "end_logit": 13.296875,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -4.9609375,
            "text": "INO",
            "probability": 0.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 13.296875,
            "text": "80",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -5.13671875,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -8.015625,
            "text": "INO80 can remove H2A.Z/H2B",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -8.0625,
            "text": "INO80 can remove H2A.Z/H2B dimers",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -8.4375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.234375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.25,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.296875,
            "text": "Budding yeast INO80",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.328125,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.421875,
            "text": "INO80 can remove H2A.Z",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.5,
            "text": "INO80 can remove H2A.Z/H2",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.6640625,
            "text": "INO80 can",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.7734375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.8046875,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers.",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.8125,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 13.296875,
            "text": "yeast INO80",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.296875,
            "text": "O80",
            "probability": 0.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -8.015625,
            "text": "80 can remove H2A.Z/H2B",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_3": [
        {
            "start_logit": 13.0703125,
            "end_logit": 12.828125,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -5.1328125,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 12.828125,
            "text": "80",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -6.3515625,
            "text": "INO",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 12.828125,
            "text": "O80",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.609375,
            "text": "INO80.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.828125,
            "text": "H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 12.828125,
            "text": "flanking DNA damage by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 12.828125,
            "text": "DNA damage by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.828125,
            "text": "removed from chromatin flanking DNA damage by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.828125,
            "text": "rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -9.609375,
            "text": "80.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": -5.1328125,
            "text": "H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -6.3515625,
            "text": "O",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": -5.1328125,
            "text": "flanking DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -5.1328125,
            "text": "DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": -5.1328125,
            "text": "removed from chromatin flanking DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -5.1328125,
            "text": "rapidly removed from chromatin flanking DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": -6.3515625,
            "text": "H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": -6.3515625,
            "text": "flanking DNA damage by INO",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_4": [
        {
            "start_logit": 7.85546875,
            "end_logit": 9.421875,
            "text": "ANP32E",
            "probability": 0.71435546875
        },
        {
            "start_logit": 8.3984375,
            "end_logit": 7.5078125,
            "text": "INO80",
            "probability": 0.1807861328125
        },
        {
            "start_logit": 7.85546875,
            "end_logit": 7.5078125,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 0.1046142578125
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -4.44140625,
            "text": "ANP32E, which is implicated in removing H2AZ",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 9.421875,
            "text": "E",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -5.12890625,
            "text": "ANP32",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -6.2890625,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.421875,
            "text": "32E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -6.73046875,
            "text": "ANP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 7.5078125,
            "text": "E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.94921875,
            "text": "INO",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.5078125,
            "text": "H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.94921875,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 9.421875,
            "text": "histone chaperone ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 9.421875,
            "text": "chaperone ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.875,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -8.546875,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 7.5078125,
            "text": "32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 0.0
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -8.6171875,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly",
            "probability": 0.0
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -8.625,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_5": [
        {
            "start_logit": 12.3203125,
            "end_logit": 12.7265625,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -3.81640625,
            "text": "INO80 and ANP32E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.90625,
            "end_logit": 12.7265625,
            "text": "80",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -5.82421875,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -6.35546875,
            "text": "INO80 and ANP",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -6.828125,
            "text": "INO80 and ANP32",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -6.83203125,
            "text": "INO",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -8.0078125,
            "text": "INO80 and ANP32E in promoting homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": 12.7265625,
            "text": "O80",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -9.0078125,
            "text": "INO80 and",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -9.5703125,
            "text": "INO80 and ANP32E in promoting homologous recombination.",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -9.6171875,
            "text": "INO80 and ANP32E in",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -10.03125,
            "text": "INO80 and ANP32E in promoting homologous",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 12.7265625,
            "text": "H2A.Z removal from chromatin is the primary function of INO80",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -3.81640625,
            "text": "ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -3.81640625,
            "text": "80 and ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -6.35546875,
            "text": "ANP",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -6.828125,
            "text": "ANP32",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -8.0078125,
            "text": "ANP32E in promoting homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.35546875,
            "text": "80 and ANP",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_6": [
        {
            "start_logit": 9.4453125,
            "end_logit": 8.734375,
            "text": "Htz1",
            "probability": 0.50537109375
        },
        {
            "start_logit": 8.515625,
            "end_logit": 9.1484375,
            "text": "INO80 complex",
            "probability": 0.296875
        },
        {
            "start_logit": 8.515625,
            "end_logit": 8.734375,
            "text": "INO80 complex, which removes H2A.Z(Htz1",
            "probability": 0.1978759765625
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -2.263671875,
            "text": "Htz",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 8.515625,
            "end_logit": -2.263671875,
            "text": "INO80 complex, which removes H2A.Z(Htz",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 8.515625,
            "end_logit": -3.11328125,
            "text": "INO80",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -6.3203125,
            "text": "Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A(Cse4",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -6.87890625,
            "text": "Ht",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -5.96484375,
            "text": "INO",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -6.87890625,
            "text": "INO80 complex, which removes H2A.Z(Ht",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 9.1484375,
            "text": "complex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.734375,
            "text": "1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.734375,
            "text": "complex, which removes H2A.Z(Htz1",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.671875,
            "text": "Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A",
            "probability": 0.0
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.8828125,
            "text": "IN",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -9.1796875,
            "text": "Htz1)",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -9.3671875,
            "text": "Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A(Cse",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -9.453125,
            "text": "Htz1) from nucleosomes",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -9.484375,
            "text": "Htz1) from nucleosomes,",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -9.515625,
            "text": "Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A(",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_1": [
        {
            "start_logit": 13.9765625,
            "end_logit": 13.96875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -3.70703125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": 13.96875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -7.98046875,
            "text": "essential tremor, but how the brain network",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.7109375,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.9453125,
            "text": "essential tremor,",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.9453125,
            "text": "essential tremor, but how the brain network changes",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.9609375,
            "text": "essential tremor, but how the brain",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.0859375,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 13.96875,
            "text": "ventralis intermedius nucleus has been an effective treatment method for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.96875,
            "text": "Thalamotomy at the ventralis intermedius nucleus has been an effective treatment method for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.96875,
            "text": "at the ventralis intermedius nucleus has been an effective treatment method for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -7.98046875,
            "text": "tremor, but how the brain network",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -8.7109375,
            "text": "tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -8.9453125,
            "text": "tremor,",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -8.9453125,
            "text": "tremor, but how the brain network changes",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -8.9609375,
            "text": "tremor, but how the brain",
            "probability": 0.0
        },
        {
            "start_logit": -3.97265625,
            "end_logit": -9.0859375,
            "text": "tremor, but how the brain network changes immediately responding to this deliberate lesion",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -3.70703125,
            "text": "ventralis intermedius nucleus has been an effective treatment method for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -3.70703125,
            "text": "Thalamotomy at the ventralis intermedius nucleus has been an effective treatment method for essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_2": [
        {
            "start_logit": 13.7578125,
            "end_logit": 13.765625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -4.05078125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": 13.765625,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -8.8046875,
            "text": "essential tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 13.765625,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.765625,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -9.6796875,
            "text": "essential tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.0546875,
            "text": "essential tremor: practices",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.0546875,
            "text": "essential tremor: practices and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.125,
            "text": "essential tremor:",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.765625,
            "text": "thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.765625,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 13.765625,
            "text": "ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 13.765625,
            "text": "guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -8.8046875,
            "text": "tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": -4.05078125,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -4.05078125,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -9.6796875,
            "text": "tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -4.05078125,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -4.05078125,
            "text": "focused ultrasound thalamotomy for essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_3": [
        {
            "start_logit": 13.828125,
            "end_logit": 14.3359375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": 14.3359375,
            "text": "tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.94140625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -4.12890625,
            "text": "essential tremor (ET) or obsessive-compulsive disorder (OCD",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -4.6171875,
            "text": "essential tremor (ET) or obsessive-compulsive disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -5.65234375,
            "text": "essential tremor (ET",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.7890625,
            "text": "essential tremor (",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.94140625,
            "text": "essential tremor (ET) or obsessive-compulsive disorder (",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.36328125,
            "text": "essential tremor (ET)",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.6640625,
            "text": "essential tremor (ET) or obsessive",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.3046875,
            "text": "essential tremor (ET) or obsessive-compulsive disorder (OCD)",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.5546875,
            "text": "essential tremor (ET) or obsessive-compulsive",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.3828125,
            "text": "essential tremor (ET) or obsessive-",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 14.3359375,
            "text": ": The authors report different MRI patterns in patients with essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": -4.12890625,
            "text": "tremor (ET) or obsessive-compulsive disorder (OCD",
            "probability": 0.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": -4.6171875,
            "text": "tremor (ET) or obsessive-compulsive disorder",
            "probability": 0.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": -5.65234375,
            "text": "tremor (ET",
            "probability": 0.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": -6.7890625,
            "text": "tremor (",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -4.12890625,
            "text": "obsessive-compulsive disorder (OCD",
            "probability": 0.0
        },
        {
            "start_logit": -3.208984375,
            "end_logit": -6.94140625,
            "text": "tremor (ET) or obsessive-compulsive disorder (",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_4": [
        {
            "start_logit": 13.75,
            "end_logit": 14.1328125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": 14.1328125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -4.0390625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -8.421875,
            "text": "essential tremor,",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -8.921875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 0.0
        },
        {
            "start_logit": -9.5703125,
            "end_logit": 14.1328125,
            "text": "neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.7890625,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 14.1328125,
            "text": "neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.9453125,
            "text": "essential tremor, while measuring magnetoencephalogram",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.0234375,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.078125,
            "text": "essential tremor, while measuring magnetoencephalogram mu",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 14.1328125,
            "text": "applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 14.1328125,
            "text": "IFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.3125,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -8.421875,
            "text": "tremor,",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -8.921875,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -9.7890625,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -9.9453125,
            "text": "tremor, while measuring magnetoencephalogram",
            "probability": 0.0
        },
        {
            "start_logit": -9.5703125,
            "end_logit": -4.0390625,
            "text": "neurologic disorder, essential",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -10.0234375,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_5": [
        {
            "start_logit": 13.8671875,
            "end_logit": 13.9765625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": 13.9765625,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -3.8046875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.34375,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging.",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.3515625,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.3984375,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.3984375,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.703125,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 13.9765625,
            "text": "Thalamic connectivity in patients with essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.8515625,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.984375,
            "text": "essential tremor treated",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -10.0859375,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -10.0859375,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 13.9765625,
            "text": "connectivity in patients with essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.34375,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging.",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.3515625,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.3984375,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.3984375,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.703125,
            "text": "tremor treated with MR imaging-guided focused ultrasound",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.8515625,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_6": [
        {
            "start_logit": 14.0546875,
            "end_logit": 14.34375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.12109375,
            "end_logit": 14.34375,
            "text": "tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -3.494140625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.5859375,
            "text": "essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 14.34375,
            "text": "patients with essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.84375,
            "text": "essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the ventralis intermedius nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 14.34375,
            "text": ": To use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.12109375,
            "end_logit": -8.7578125,
            "text": "tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the ventralis intermedius nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -3.12109375,
            "end_logit": -9.5859375,
            "text": "tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity",
            "probability": 0.0
        },
        {
            "start_logit": -3.12109375,
            "end_logit": -9.84375,
            "text": "tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the ventralis intermedius nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -3.494140625,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.494140625,
            "text": ": To use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -6.61328125,
            "text": "patients with medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -6.61328125,
            "text": "essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.234375,
            "end_logit": -6.61328125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -6.61328125,
            "text": "15 patients with medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -6.61328125,
            "text": "With institutional review board approval, and with prospective informed consent, 15 patients with medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -6.61328125,
            "text": ": With institutional review board approval, and with prospective informed consent, 15 patients with medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -6.61328125,
            "text": "MATERIALS AND METHODS: With institutional review board approval, and with prospective informed consent, 15 patients with medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -6.61328125,
            "text": "medication-refractory essential tremor",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_7": [
        {
            "start_logit": 13.6484375,
            "end_logit": 13.40625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -4.171875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 13.40625,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -6.97265625,
            "text": "essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 13.40625,
            "text": "pilot study of focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 13.40625,
            "text": "thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 13.40625,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 13.40625,
            "text": "ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -6.97265625,
            "text": "tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -4.171875,
            "text": "pilot study of focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -4.171875,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -4.171875,
            "text": "focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -4.171875,
            "text": "ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -6.97265625,
            "text": "pilot study of focused ultrasound thalamotomy for essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -6.97265625,
            "text": "thalamotomy for essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -6.97265625,
            "text": "focused ultrasound thalamotomy for essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -6.97265625,
            "text": "ultrasound thalamotomy for essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -8.8046875,
            "text": "pilot study",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -9.3203125,
            "text": "pilot study of focused ultrasound thalamotomy for",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -9.359375,
            "text": "pilot study of focused ultrasound thalamotomy",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_8": [
        {
            "start_logit": 13.90625,
            "end_logit": 14.0,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.7109375,
            "end_logit": 14.0,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -3.650390625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -9.7421875,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study,",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 14.0,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.7109375,
            "end_logit": -9.7421875,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study,",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -3.650390625,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": -7.875,
            "text": "essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -7.875,
            "text": "unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -8.0078125,
            "text": "unilateral ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -8.109375,
            "text": "unilateral ventral intermediate nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -7.875,
            "text": "patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -7.875,
            "text": "15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -7.875,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -8.0078125,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": -7.875,
            "text": "ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -8.109375,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": -8.0078125,
            "text": "ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -7.875,
            "text": "transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": -8.109375,
            "text": "ventral intermediate nucleus",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_9": [
        {
            "start_logit": 13.65625,
            "end_logit": 13.7890625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": 13.7890625,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -4.09765625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.2890625,
            "text": "essential tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.6640625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.921875,
            "text": "essential tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.046875,
            "text": "essential tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.1171875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.171875,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.171875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalam",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.2265625,
            "text": "essential tremor improved in 15 patients treated with",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.375,
            "text": "essential tremor improved in 15 patients treated with MRI-",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.7890625,
            "text": ": In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 13.7890625,
            "text": "CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 13.7890625,
            "text": "pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -9.2890625,
            "text": "tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -9.6640625,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -9.921875,
            "text": "tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -10.046875,
            "text": "tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -10.1171875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_10": [
        {
            "start_logit": 13.8359375,
            "end_logit": 13.875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -3.908203125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": 13.875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -8.265625,
            "text": "essential tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -8.8671875,
            "text": "essential tremor: a proof-of-concept study.",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.09375,
            "text": "essential tremor: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.5703125,
            "text": "essential tremor: a proof-of-concept",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.828125,
            "text": "essential tremor: a proof-of-",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.9921875,
            "text": "essential tremor: a proof",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.078125,
            "text": "essential tremor: a proof-of",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.1640625,
            "text": "essential tremor: a proof-",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 13.875,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.28125,
            "text": "essential tremor:",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 13.875,
            "text": "MR-guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 13.875,
            "text": "thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.875,
            "text": "ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 13.875,
            "text": "for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 13.875,
            "text": "guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -8.265625,
            "text": "tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -8.8671875,
            "text": "tremor: a proof-of-concept study.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_11": [
        {
            "start_logit": 13.0625,
            "end_logit": 13.0078125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -4.76953125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": 13.0078125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.0078125,
            "text": "non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 13.0078125,
            "text": "focal lesions. We examined its application to the management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 13.0078125,
            "text": "examined its application to the management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 13.0078125,
            "text": "management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.0078125,
            "text": "focused ultrasound has been developed as a non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": 13.0078125,
            "text": "placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -4.76953125,
            "text": "non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -4.76953125,
            "text": "focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -4.76953125,
            "text": "examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.76953125,
            "text": "management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -4.76953125,
            "text": "MR-guided focused ultrasound has been developed as a non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -4.76953125,
            "text": "focused ultrasound has been developed as a non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -4.76953125,
            "text": "placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -8.9453125,
            "text": "non-invasive means of generating precisely placed focal lesions.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -8.9453125,
            "text": "focal lesions.",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -9.1015625,
            "text": "non-invasive means of generating precisely placed focal lesions",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -9.1015625,
            "text": "focal lesions",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_12": [
        {
            "start_logit": 14.015625,
            "end_logit": 14.21875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": 14.21875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -3.556640625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -8.9296875,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -9.6015625,
            "text": "essential tremor were",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -9.859375,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus.",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -9.875,
            "text": "essential tremor were treated with MR-guided focused ultrasound",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -9.90625,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 14.21875,
            "text": "Four patients with chronic and medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -10.0,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -10.0234375,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 14.21875,
            "text": "patients with chronic and medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -10.0703125,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-",
            "probability": 0.0
        },
        {
            "start_logit": 14.015625,
            "end_logit": -10.0703125,
            "text": "essential tremor were treated with MR-guided focused ultrasound to",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 14.21875,
            "text": "medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": -8.9296875,
            "text": "tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": -9.6015625,
            "text": "tremor were",
            "probability": 0.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": -9.859375,
            "text": "tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus.",
            "probability": 0.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": -9.875,
            "text": "tremor were treated with MR-guided focused ultrasound",
            "probability": 0.0
        },
        {
            "start_logit": -3.38671875,
            "end_logit": -9.90625,
            "text": "tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_13": [
        {
            "start_logit": 13.5234375,
            "end_logit": 13.5234375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.5234375,
            "end_logit": -4.33203125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 13.5234375,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.5234375,
            "end_logit": -9.90625,
            "text": "essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.5234375,
            "text": "intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.5234375,
            "text": "focal intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.5234375,
            "text": "medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 13.5234375,
            "text": ": MR-guided focused ultrasound might be a safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 13.5234375,
            "text": "management of disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 13.5234375,
            "text": "generation of focal intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 13.5234375,
            "text": ", medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.5234375,
            "text": "disabling, medication-resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 13.5234375,
            "text": "resistant essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -9.90625,
            "text": "tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -4.33203125,
            "text": "intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -4.33203125,
            "text": "focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -4.33203125,
            "text": "medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": -4.33203125,
            "text": ": MR-guided focused ultrasound might be a safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33203125,
            "text": "management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33203125,
            "text": "INTERPRETATION: MR-guided focused ultrasound might be a safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_14": [
        {
            "start_logit": 13.453125,
            "end_logit": 13.546875,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": 13.546875,
            "text": "chronic neuropathic pain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 13.453125,
            "end_logit": -3.521484375,
            "text": "neuropathic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 13.546875,
            "text": "pain",
            "probability": 0.0
        },
        {
            "start_logit": 13.453125,
            "end_logit": -7.8046875,
            "text": "neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": 13.546875,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 13.546875,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.546875,
            "text": "thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 13.546875,
            "text": "lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 13.546875,
            "text": "magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.546875,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 13.546875,
            "text": "central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -3.521484375,
            "text": "chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -7.8046875,
            "text": "chronic neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -9.0625,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -4.21484375,
            "end_logit": -7.8046875,
            "text": "pain.",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": -3.521484375,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": -3.521484375,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -3.521484375,
            "text": "thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": -3.521484375,
            "text": "lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_15": [
        {
            "start_logit": 14.421875,
            "end_logit": 14.0625,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -0.71484375,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 14.421875,
            "end_logit": -1.7470703125,
            "text": "neuropathic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.208984375,
            "end_logit": 14.0625,
            "text": "pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 14.0625,
            "text": "chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -7.234375,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.46875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.671875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain, tcMRgFUS CLT was proposed",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.6953125,
            "text": "neuropathic pain.METHODS: In 12 patients suffering",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.859375,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -10.0625,
            "text": "neuropathic pain.METHODS: In",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -10.203125,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -10.25,
            "text": "neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 14.0625,
            "text": "CLTs) as a treatment for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 14.0625,
            "text": "tcMRgFUS) technology to perform noninvasive central lateral thalamotomies (CLTs) as a treatment for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 14.0625,
            "text": "noninvasive central lateral thalamotomies (CLTs) as a treatment for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -2.208984375,
            "end_logit": -0.71484375,
            "text": "pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -0.71484375,
            "text": "chronic neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -0.71484375,
            "text": "neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -1.7470703125,
            "text": "chronic neuropathic",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_16": [
        {
            "start_logit": 13.6171875,
            "end_logit": 13.8359375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": 13.8359375,
            "text": "tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -4.1640625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.3359375,
            "text": "essential tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 13.8359375,
            "text": "37% to 11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -10.0390625,
            "text": "essential tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 13.8359375,
            "text": ": In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -10.078125,
            "text": "essential tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.8359375,
            "text": "P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.8359375,
            "text": "Quality-of-life scores improved from 37% to 11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -10.171875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -10.1796875,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 13.8359375,
            "text": "11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 13.8359375,
            "text": "CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 13.8359375,
            "text": "of-life scores improved from 37% to 11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -9.3359375,
            "text": "tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -10.0390625,
            "text": "tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -10.078125,
            "text": "tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -10.171875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -10.1796875,
            "text": "tremor improved in 15 patients treated",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_17": [
        {
            "start_logit": 13.4453125,
            "end_logit": 13.578125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.109375,
            "end_logit": 13.578125,
            "text": "Tremor and the Quality of Life in Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.00390625,
            "end_logit": 13.578125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -4.296875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 13.578125,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -7.57421875,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.1484375,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": 13.578125,
            "text": "Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.8671875,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vi",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.484375,
            "text": "essential tremor patients treated at the University of Virginia with bilateral",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.609375,
            "text": "essential tremor patients treated at the University of Virginia",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.7109375,
            "text": "essential tremor patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.109375,
            "end_logit": 1.6787109375,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.109375,
            "end_logit": -1.2060546875,
            "text": "Tremor and the Quality of Life in Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -1.2060546875,
            "text": "Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.109375,
            "end_logit": -4.296875,
            "text": "Tremor and the Quality of Life in Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -4.296875,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -1.2060546875,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.109375,
            "end_logit": -7.82421875,
            "text": "Tremor and the Quality of Life in Essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -7.57421875,
            "text": "tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_18": [
        {
            "start_logit": 13.59375,
            "end_logit": 13.6328125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": 13.6328125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -4.171875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.453125,
            "text": "essential tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.71875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.9609375,
            "text": "essential tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.0,
            "text": "essential tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.015625,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.09375,
            "text": "essential tremor improved in 15 patients treated with",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 13.6328125,
            "text": "37% to 11% (P=0.001).In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 13.6328125,
            "text": "P=0.001).In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.6328125,
            "text": "Quality-of-life scores improved from 37% to 11% (P=0.001).In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 13.6328125,
            "text": "11% (P=0.001).In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 13.6328125,
            "text": "of-life scores improved from 37% to 11% (P=0.001).In this pilot study, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -9.453125,
            "text": "tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -9.71875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -9.9609375,
            "text": "tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -10.0,
            "text": "tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -10.015625,
            "text": "tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": -3.912109375,
            "end_logit": -10.09375,
            "text": "tremor improved in 15 patients treated with",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_19": [
        {
            "start_logit": 13.625,
            "end_logit": 14.234375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": 14.234375,
            "text": "tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.625,
            "end_logit": -4.17578125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.2890625,
            "text": "essential tremor,",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": 14.234375,
            "text": "neurologic disorders. To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 14.234375,
            "text": "neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 14.234375,
            "text": "neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.5703125,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy beam",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 14.234375,
            "text": "applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 14.234375,
            "text": "disorder, essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.8671875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.890625,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.921875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy beam on the ventral",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -8.2890625,
            "text": "tremor,",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.5703125,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy beam",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.8671875,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.890625,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.921875,
            "text": "tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy beam on the ventral",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": -4.17578125,
            "text": "neurologic disorders. To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -4.17578125,
            "text": "neurologic disorder, essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_20": [
        {
            "start_logit": 13.9296875,
            "end_logit": 14.109375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.5390625,
            "end_logit": 14.109375,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -3.615234375,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.8671875,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 14.109375,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -9.8671875,
            "text": "tremor.METHODS: From February 2011 through December 2011, in",
            "probability": 0.0
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -10.0078125,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided focused ultrasound to target",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -3.615234375,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -7.4296875,
            "text": "unilateral ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": -7.90625,
            "text": "essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -7.4296875,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -7.90625,
            "text": "unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": -7.90625,
            "text": "patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -7.4296875,
            "text": "ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -7.90625,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -7.4296875,
            "text": "transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -8.296875,
            "text": "unilateral ventral intermediate nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -7.90625,
            "text": "ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -7.90625,
            "text": "15 patients with severe, medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -8.296875,
            "text": "used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_21": [
        {
            "start_logit": 13.5,
            "end_logit": 13.78125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": 13.78125,
            "text": "tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.5,
            "end_logit": -4.23046875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.34375,
            "text": "essential tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.546875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.859375,
            "text": "essential tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.046875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.0859375,
            "text": "essential tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.1015625,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.125,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalam",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.15625,
            "text": "essential tremor improved in 15 patients treated with",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -9.34375,
            "text": "tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -9.546875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -9.859375,
            "text": "tremor improved in 15 patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -10.046875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -10.0859375,
            "text": "tremor improved in",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -10.1015625,
            "text": "tremor improved in 15 patients treated",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -10.125,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalam",
            "probability": 0.0
        },
        {
            "start_logit": -3.462890625,
            "end_logit": -10.15625,
            "text": "tremor improved in 15 patients treated with",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": -9.546875,
            "text": "15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_22": [
        {
            "start_logit": 13.6796875,
            "end_logit": 13.5546875,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -4.125,
            "text": "Essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 13.5546875,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -6.72265625,
            "text": "Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 13.5546875,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 13.5546875,
            "text": "Focused Ultrasound Thalamotomy for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.5546875,
            "text": "Thalamotomy for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 13.5546875,
            "text": "Ultrasound Thalamotomy for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -6.72265625,
            "text": "Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -4.125,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -4.125,
            "text": "Focused Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -4.125,
            "text": "Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -4.125,
            "text": "Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -6.72265625,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -6.72265625,
            "text": "Focused Ultrasound Thalamotomy for Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -6.72265625,
            "text": "Thalamotomy for Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -6.72265625,
            "text": "Ultrasound Thalamotomy for Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -9.078125,
            "text": "Randomized Trial",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -9.390625,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -9.4140625,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_23": [
        {
            "start_logit": 13.8359375,
            "end_logit": 13.875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -3.908203125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": 13.875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -8.265625,
            "text": "essential tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -8.8671875,
            "text": "essential tremor: a proof-of-concept study.",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.09375,
            "text": "essential tremor: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.5703125,
            "text": "essential tremor: a proof-of-concept",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.828125,
            "text": "essential tremor: a proof-of-",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -9.9921875,
            "text": "essential tremor: a proof",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.078125,
            "text": "essential tremor: a proof-of",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.1640625,
            "text": "essential tremor: a proof-",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 13.875,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.8359375,
            "end_logit": -10.28125,
            "text": "essential tremor:",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 13.875,
            "text": "MR-guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 13.875,
            "text": "thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.875,
            "text": "ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 13.875,
            "text": "for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 13.875,
            "text": "guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -8.265625,
            "text": "tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -8.8671875,
            "text": "tremor: a proof-of-concept study.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_24": [
        {
            "start_logit": 13.7578125,
            "end_logit": 13.765625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -4.05078125,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": 13.765625,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -8.8046875,
            "text": "essential tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 13.765625,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.765625,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -9.6796875,
            "text": "essential tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.0546875,
            "text": "essential tremor: practices",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.0546875,
            "text": "essential tremor: practices and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -10.125,
            "text": "essential tremor:",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.765625,
            "text": "thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.765625,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 13.765625,
            "text": "ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 13.765625,
            "text": "guided focused ultrasound thalamotomy for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -8.8046875,
            "text": "tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": -4.05078125,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -4.05078125,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -9.6796875,
            "text": "tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -4.05078125,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -4.05078125,
            "text": "focused ultrasound thalamotomy for essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_25": [
        {
            "start_logit": 13.7890625,
            "end_logit": 13.8046875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -3.978515625,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": 13.8046875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.41015625,
            "text": "essential tremor with bilateral or unilateral DBS",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -8.9140625,
            "text": "essential tremor with bilateral or unilateral",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.0234375,
            "text": "essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.6953125,
            "text": "essential tremor with bilateral or unilateral DBS and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.734375,
            "text": "essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.7890625,
            "text": "essential tremor with bilateral",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.7890625,
            "text": "essential tremor with bilateral or",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.9296875,
            "text": "essential tremor with bilateral or unilateral DBS and focused ultrasound thalam",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -10.0390625,
            "text": "essential tremor with",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 13.8046875,
            "text": "quality of life in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 13.8046875,
            "text": "Functional assessment and quality of life in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 13.8046875,
            "text": "and quality of life in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": -7.41015625,
            "text": "tremor with bilateral or unilateral DBS",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": -8.9140625,
            "text": "tremor with bilateral or unilateral",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": -9.0234375,
            "text": "tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": -9.6953125,
            "text": "tremor with bilateral or unilateral DBS and",
            "probability": 0.0
        },
        {
            "start_logit": -4.08984375,
            "end_logit": -9.734375,
            "text": "tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_26": [
        {
            "start_logit": 13.453125,
            "end_logit": 13.546875,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": 13.546875,
            "text": "chronic neuropathic pain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 13.453125,
            "end_logit": -3.521484375,
            "text": "neuropathic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 13.546875,
            "text": "pain",
            "probability": 0.0
        },
        {
            "start_logit": 13.453125,
            "end_logit": -7.8046875,
            "text": "neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": 13.546875,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 13.546875,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.546875,
            "text": "thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 13.546875,
            "text": "lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 13.546875,
            "text": "magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.546875,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 13.546875,
            "text": "central lateral thalamotomy for chronic neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -3.521484375,
            "text": "chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -7.8046875,
            "text": "chronic neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -1.529296875,
            "end_logit": -9.0625,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -4.21484375,
            "end_logit": -7.8046875,
            "text": "pain.",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": -3.521484375,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": -3.521484375,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -3.521484375,
            "text": "thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": -3.521484375,
            "text": "lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_27": [
        {
            "start_logit": 13.9765625,
            "end_logit": 13.9453125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -3.69921875,
            "text": "essential",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": 13.9453125,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.8671875,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.8828125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.34375,
            "text": "essential tremor patients treated at the University of Virginia with bilateral",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.6171875,
            "text": "essential tremor patients",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.765625,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.78125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vi",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.8828125,
            "text": "essential tremor patients treated at the University of Virginia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 13.9453125,
            "text": "retrospective study of medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 13.9453125,
            "text": "medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -8.8671875,
            "text": "tremor patients treated at the University of Virginia with bilateral Vim",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -8.8828125,
            "text": "tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -9.34375,
            "text": "tremor patients treated at the University of Virginia with bilateral",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -9.6171875,
            "text": "tremor patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -9.765625,
            "text": "tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -9.78125,
            "text": "tremor patients treated at the University of Virginia with bilateral Vi",
            "probability": 0.0
        },
        {
            "start_logit": -3.88671875,
            "end_logit": -9.8828125,
            "text": "tremor patients treated at the University of Virginia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": -3.69921875,
            "text": "retrospective study of medication-refractory essential",
            "probability": 0.0
        }
    ],
    "515a7ffdd24251bc050000a5_1": [
        {
            "start_logit": 4.8203125,
            "end_logit": 1.5703125,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK",
            "probability": 0.7666015625
        },
        {
            "start_logit": 4.8203125,
            "end_logit": 0.33984375,
            "text": "inhibited TGF\u03b2-mediated activation of ERK",
            "probability": 0.2239990234375
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -3.095703125,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun",
            "probability": 0.007228851318359375
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -5.6875,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun promoter",
            "probability": 0.0005402565002441406
        },
        {
            "start_logit": -2.853515625,
            "end_logit": 1.5703125,
            "text": "activation of ERK and JNK",
            "probability": 0.00035691261291503906
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -6.49609375,
            "text": "inhibited TGF\u03b2-mediated",
            "probability": 0.0002416372299194336
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -6.62109375,
            "text": "inhibited TGF\u03b2-mediated activation of",
            "probability": 0.0002130270004272461
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -6.921875,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c",
            "probability": 0.0001571178436279297
        },
        {
            "start_logit": -3.9453125,
            "end_logit": 1.5703125,
            "text": "ERK and JNK",
            "probability": 0.00011962652206420898
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -7.3125,
            "text": "inhibited TGF\u03b2",
            "probability": 0.00010633468627929688
        },
        {
            "start_logit": -2.853515625,
            "end_logit": 0.33984375,
            "text": "activation of ERK",
            "probability": 0.00010389089584350586
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -7.54296875,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun, and",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.1640625,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun",
            "probability": 4.5359134674072266e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.203125,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun, and transactivation",
            "probability": 4.363059997558594e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.2109375,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and",
            "probability": 4.3332576751708984e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.40625,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": -3.9453125,
            "end_logit": 0.33984375,
            "text": "ERK",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.46875,
            "text": "inhibited TGF\u03b2-",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.515625,
            "text": "inhibited TGF\u03b2-mediated activation",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -8.8046875,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of",
            "probability": 2.390146255493164e-05
        }
    ],
    "515a7ffdd24251bc050000a5_2": [
        {
            "start_logit": 1.84765625,
            "end_logit": 8.421875,
            "text": "decreased RhoA activation",
            "probability": 1.0
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 8.421875,
            "text": "RhoA activation",
            "probability": 0.00020825862884521484
        },
        {
            "start_logit": -8.71875,
            "end_logit": 8.421875,
            "text": "activation",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -3.697265625,
            "text": "decreased RhoA",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -10.671875,
            "end_logit": 8.421875,
            "text": "km23-1 decreased RhoA activation",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 8.421875,
            "text": "of km23-1 decreased RhoA activation",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 8.421875,
            "text": "knockdown (KD) of km23-1 decreased RhoA activation",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -6.55078125,
            "text": "decreased RhoA activation in Mv1Lu epithelial cells",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -7.7890625,
            "text": "decreased RhoA activation in Mv1Lu epithelial",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -7.80078125,
            "text": "decreased RhoA activation in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -8.375,
            "text": "decreased RhoA activation in Mv1Lu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -8.953125,
            "text": "decreased",
            "probability": 0.0
        },
        {
            "start_logit": 1.84765625,
            "end_logit": -9.4765625,
            "text": "decreased RhoA activation in Mv1",
            "probability": 0.0
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -3.697265625,
            "text": "RhoA",
            "probability": 0.0
        },
        {
            "start_logit": -5.93359375,
            "end_logit": -6.55078125,
            "text": "Mv1Lu epithelial cells",
            "probability": 0.0
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -6.55078125,
            "text": "RhoA activation in Mv1Lu epithelial cells",
            "probability": 0.0
        },
        {
            "start_logit": -5.93359375,
            "end_logit": -7.7890625,
            "text": "Mv1Lu epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -5.93359375,
            "end_logit": -8.375,
            "text": "Mv1Lu",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -3.697265625,
            "text": "km23-1 decreased RhoA",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -3.697265625,
            "text": "of km23-1 decreased RhoA",
            "probability": 0.0
        }
    ],
    "515a7ffdd24251bc050000a5_3": [
        {
            "start_logit": 9.859375,
            "end_logit": 10.9921875,
            "text": "inhibition of cell growth",
            "probability": 1.0
        },
        {
            "start_logit": 1.6103515625,
            "end_logit": 10.9921875,
            "text": "cell growth",
            "probability": 0.000263214111328125
        },
        {
            "start_logit": 9.859375,
            "end_logit": -4.87890625,
            "text": "inhibition",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -5.31640625,
            "text": "inhibition of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 10.9921875,
            "text": "induction of fibronectin expression and inhibition of cell growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 10.9921875,
            "text": "fibronectin expression and inhibition of cell growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 10.9921875,
            "text": "TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": 10.9921875,
            "text": "growth",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.9921875,
            "text": "small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.15625,
            "text": "inhibition of cell",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 10.9921875,
            "text": "km23 using small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -9.234375,
            "text": "inhibition of cell growth.",
            "probability": 0.0
        },
        {
            "start_logit": 1.6103515625,
            "end_logit": -8.15625,
            "text": "cell",
            "probability": 0.0
        },
        {
            "start_logit": 1.6103515625,
            "end_logit": -9.234375,
            "text": "cell growth.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.0029296875,
            "text": "TGFbeta responses",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -1.0029296875,
            "text": "small interfering RNAs significantly decreased key TGFbeta responses",
            "probability": 0.0
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -4.0546875,
            "text": "induction of fibronectin expression",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -4.0546875,
            "text": "fibronectin expression",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -1.0029296875,
            "text": "km23 using small interfering RNAs significantly decreased key TGFbeta responses",
            "probability": 0.0
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -4.87890625,
            "text": "induction of fibronectin expression and inhibition",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_1": [
        {
            "start_logit": 14.359375,
            "end_logit": 13.609375,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -0.53466796875,
            "text": "uc",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.0078125,
            "end_logit": 13.609375,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -7.83984375,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -8.5859375,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -8.6796875,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.03125,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.140625,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.2421875,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.3828125,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.390625,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.4453125,
            "text": "uc.454 Inhibited Growth by",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.4921875,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.6328125,
            "text": "uc.454 Inhibited Growth",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.671875,
            "text": "uc.454 Inhibited Growth by Targeting",
            "probability": 0.0
        },
        {
            "start_logit": 14.359375,
            "end_logit": -9.75,
            "text": "uc.454 Inhibited",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 13.609375,
            "text": ".454",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -7.83984375,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -8.6796875,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -9.03125,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_2": [
        {
            "start_logit": 2.232421875,
            "end_logit": 12.5625,
            "text": "uc.454",
            "probability": 0.9580078125
        },
        {
            "start_logit": 2.232421875,
            "end_logit": 9.3515625,
            "text": "uc",
            "probability": 0.038604736328125
        },
        {
            "start_logit": -3.4453125,
            "end_logit": 12.5625,
            "text": "454",
            "probability": 0.0032711029052734375
        },
        {
            "start_logit": -7.15625,
            "end_logit": 12.5625,
            "text": "that uc.454",
            "probability": 7.998943328857422e-05
        },
        {
            "start_logit": -7.9375,
            "end_logit": 12.5625,
            "text": ".454",
            "probability": 3.6597251892089844e-05
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 12.5625,
            "text": "clinicopathologic significance and regulatory mechanism of T-UCRs in lung cancer (LC) remain largely unknown. We found that uc.454",
            "probability": 2.1338462829589844e-05
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 12.5625,
            "text": "found that uc.454",
            "probability": 1.5616416931152344e-05
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.3515625,
            "text": "that uc",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.3515625,
            "text": "clinicopathologic significance and regulatory mechanism of T-UCRs in lung cancer (LC) remain largely unknown. We found that uc",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 9.3515625,
            "text": "found that uc",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 2.232421875,
            "end_logit": -5.69140625,
            "text": "uc.454 was",
            "probability": 0.0
        },
        {
            "start_logit": 2.232421875,
            "end_logit": -8.0234375,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -3.6015625,
            "text": "Heat shock protein family A member 12B",
            "probability": 0.0
        },
        {
            "start_logit": -3.4453125,
            "end_logit": -5.69140625,
            "text": "454 was",
            "probability": 0.0
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -3.462890625,
            "text": "tumors with more advanced stages",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -5.00390625,
            "text": "Heat shock protein family A member 12",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -5.66015625,
            "text": "Heat shock protein family A member 12B (HSPA12B",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -3.462890625,
            "text": "tumor size and tumors with more advanced stages",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -3.462890625,
            "text": "NSCLC) tissues and LC cell lines, and the downregulated uc.454 is associated with tumor size and tumors with more advanced stages",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -7.0078125,
            "text": "Heat shock protein family A member",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_3": [
        {
            "start_logit": -1.6416015625,
            "end_logit": 8.96875,
            "text": "uc.339",
            "probability": 0.36083984375
        },
        {
            "start_logit": 3.703125,
            "end_logit": 3.5625,
            "text": "TP53",
            "probability": 0.3388671875
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": 8.3359375,
            "text": "uc",
            "probability": 0.191650390625
        },
        {
            "start_logit": -2.857421875,
            "end_logit": 8.96875,
            "text": "339",
            "probability": 0.106689453125
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.96875,
            "text": "expression of uc.339",
            "probability": 0.0006546974182128906
        },
        {
            "start_logit": -2.857421875,
            "end_logit": 3.5625,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 0.0004787445068359375
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.3359375,
            "text": "expression of uc",
            "probability": 0.0003476142883300781
        },
        {
            "start_logit": -8.90625,
            "end_logit": 8.96875,
            "text": "high expression of uc.339",
            "probability": 0.0002522468566894531
        },
        {
            "start_logit": -8.90625,
            "end_logit": 8.3359375,
            "text": "high expression of uc",
            "probability": 0.00013399124145507812
        },
        {
            "start_logit": -4.49609375,
            "end_logit": 3.5625,
            "text": "that TP53",
            "probability": 9.28044319152832e-05
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 3.5625,
            "text": "non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": -7.796875,
            "end_logit": 3.5625,
            "text": "NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 3.703125,
            "end_logit": -8.296875,
            "text": "TP53 directly regulates uc.339. We find that transcribed uc.339",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 3.5625,
            "text": "lower survival in 210 non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -6.7734375,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -7.046875,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -6.7734375,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -8.0859375,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -7.046875,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -3.98828125,
            "text": "miR-339-3p, -663b-3p, and -95-5p",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_4": [
        {
            "start_logit": 13.21875,
            "end_logit": 13.203125,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -2.986328125,
            "text": "uc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 13.203125,
            "text": "339",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -5.84765625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -9.5,
            "text": "uc.339 in",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -9.578125,
            "text": "uc.339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -10.2109375,
            "text": "uc.339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -9.5,
            "text": "339 in",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -9.578125,
            "text": "339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -10.2109375,
            "text": "339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -9.578125,
            "text": "lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -10.2109375,
            "text": "lung cancer",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_5": [
        {
            "start_logit": 13.578125,
            "end_logit": 12.9921875,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -2.392578125,
            "text": "uc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 12.9921875,
            "text": "339",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -6.9375,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -8.3359375,
            "text": "uc.339 correlates",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.234375,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.6171875,
            "text": "uc.339 correlates with lower survival",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.6796875,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.9453125,
            "text": "uc.339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -8.3359375,
            "text": "339 correlates",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.234375,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.6171875,
            "text": "339 correlates with lower survival",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.6796875,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.9453125,
            "text": "339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.234375,
            "text": "non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.6796875,
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.234375,
            "text": "210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -9.234375,
            "text": "NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -9.234375,
            "text": "lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.6796875,
            "text": "210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_6": [
        {
            "start_logit": 14.0234375,
            "end_logit": 13.375,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -1.4580078125,
            "text": "uc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -2.603515625,
            "text": "uc.454/HSPA12B",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 13.375,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -5.4609375,
            "text": "uc.454/HSP",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -6.1328125,
            "text": "uc.454/HSPA1",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -6.8359375,
            "text": "uc.454/HSPA12B axis",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -7.15625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.6796875,
            "text": "uc.454/HSPA12B axis furthers our understanding",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.7734375,
            "text": "uc.454/",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.8203125,
            "text": "uc.454/HSPA12B axis further",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.828125,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.015625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.1015625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.265625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.5390625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.5390625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 13.375,
            "text": ".454",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -2.603515625,
            "text": "454/HSPA12B",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -2.603515625,
            "text": "HSPA12B",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_7": [
        {
            "start_logit": 14.1484375,
            "end_logit": 13.421875,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -1.2841796875,
            "text": "uc",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.40625,
            "end_logit": 13.421875,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -7.53515625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -8.2890625,
            "text": "uc.454 played",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -8.578125,
            "text": "uc.454 played a suppressive role",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -8.71875,
            "text": "uc.454 played a suppressive role in LC",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.171875,
            "text": "uc.454 played a",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.234375,
            "text": "uc.454 played a suppressive role in LC.",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.6171875,
            "text": "uc.454 played a suppressive role in",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.7734375,
            "text": "uc.454 played a suppressive",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -8.2890625,
            "text": "454 played",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -8.578125,
            "text": "454 played a suppressive role",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -8.71875,
            "text": "454 played a suppressive role in LC",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -9.171875,
            "text": "454 played a",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -9.234375,
            "text": "454 played a suppressive role in LC.",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -9.6171875,
            "text": "454 played a suppressive role in",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -9.7734375,
            "text": "454 played a suppressive",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -8.71875,
            "text": "LC",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -9.234375,
            "text": "LC.",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_8": [
        {
            "start_logit": 14.0234375,
            "end_logit": 13.375,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -1.4580078125,
            "text": "uc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -2.603515625,
            "text": "uc.454/HSPA12B",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 13.375,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -5.4609375,
            "text": "uc.454/HSP",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -6.1328125,
            "text": "uc.454/HSPA1",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -6.8359375,
            "text": "uc.454/HSPA12B axis",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -7.15625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.6796875,
            "text": "uc.454/HSPA12B axis furthers our understanding",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.7734375,
            "text": "uc.454/",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.8203125,
            "text": "uc.454/HSPA12B axis further",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.828125,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.015625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.1015625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.265625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.5390625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -9.5390625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 13.375,
            "text": ".454",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -2.603515625,
            "text": "454/HSPA12B",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -2.603515625,
            "text": "HSPA12B",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_9": [
        {
            "start_logit": 14.515625,
            "end_logit": 13.3515625,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -1.798828125,
            "text": "uc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.37890625,
            "end_logit": 13.3515625,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -8.0546875,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -8.328125,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -8.65625,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -9.046875,
            "text": "uc.454 was downregulated",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -9.3359375,
            "text": "uc.454 was",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -9.34375,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454 is",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -9.5546875,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines,",
            "probability": 0.0
        },
        {
            "start_logit": 14.515625,
            "end_logit": -9.578125,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.3515625,
            "text": ".454",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -8.328125,
            "text": "454 was downregulated in both non-small-cell LC (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -8.65625,
            "text": "454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -9.046875,
            "text": "454 was downregulated",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -9.3359375,
            "text": "454 was",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -9.34375,
            "text": "454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454 is",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -9.5546875,
            "text": "454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines,",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -9.578125,
            "text": "454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -8.328125,
            "text": "non-small-cell LC (NSCLC",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_10": [
        {
            "start_logit": 14.390625,
            "end_logit": 13.78125,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -0.84228515625,
            "text": "uc",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.8359375,
            "end_logit": 13.78125,
            "text": "454",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.1015625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.4296875,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.8046875,
            "text": "uc.454 markedly induced apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.8125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.0546875,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.28125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.40625,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.8828125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines.",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.890625,
            "text": "uc.454 markedly",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.9453125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.984375,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -9.9921875,
            "text": "uc.454 markedly induced",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.78125,
            "text": "Transfection with uc.454",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 13.78125,
            "text": ".454",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -0.84228515625,
            "text": "Transfection with uc",
            "probability": 0.0
        },
        {
            "start_logit": -3.8359375,
            "end_logit": -8.4296875,
            "text": "454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2",
            "probability": 0.0
        },
        {
            "start_logit": -3.8359375,
            "end_logit": -8.8046875,
            "text": "454 markedly induced apoptosis",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_11": [
        {
            "start_logit": 13.21875,
            "end_logit": 13.203125,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -2.986328125,
            "text": "uc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 13.203125,
            "text": "339",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -5.84765625,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -9.5,
            "text": "uc.339 in",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -9.578125,
            "text": "uc.339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -10.2109375,
            "text": "uc.339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -9.5,
            "text": "339 in",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -9.578125,
            "text": "339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -10.2109375,
            "text": "339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -9.578125,
            "text": "lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -10.2109375,
            "text": "lung cancer",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_12": [
        {
            "start_logit": 13.578125,
            "end_logit": 12.9921875,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -2.392578125,
            "text": "uc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 12.9921875,
            "text": "339",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -6.9375,
            "text": "uc.",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -8.3359375,
            "text": "uc.339 correlates",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.234375,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.6171875,
            "text": "uc.339 correlates with lower survival",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.6796875,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": 13.578125,
            "end_logit": -9.9453125,
            "text": "uc.339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -8.3359375,
            "text": "339 correlates",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.234375,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.6171875,
            "text": "339 correlates with lower survival",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.6796875,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -9.9453125,
            "text": "339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.234375,
            "text": "non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.6796875,
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.234375,
            "text": "210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -9.234375,
            "text": "NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -9.234375,
            "text": "lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.6796875,
            "text": "210 non-small cell lung cancer (NSCLC)",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_1": [
        {
            "start_logit": 10.6875,
            "end_logit": 8.375,
            "text": "Lipid Mini-On",
            "probability": 0.9990234375
        },
        {
            "start_logit": 10.6875,
            "end_logit": 1.23046875,
            "text": "Lipid Mini-On: mining and ontology",
            "probability": 0.0007910728454589844
        },
        {
            "start_logit": 10.6875,
            "end_logit": -3.8828125,
            "text": "Lipid Mini-On: mining and ontology tool",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 10.6875,
            "end_logit": -4.8828125,
            "text": "Lipid",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 10.6875,
            "end_logit": -7.90234375,
            "text": "Lipid Mini-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.6875,
            "end_logit": -7.921875,
            "text": "Lipid Mini",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.6875,
            "end_logit": -8.296875,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.125,
            "text": "Lipid Mini-On: mining",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.1328125,
            "text": "Lipid Mini-On: mining and",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.2109375,
            "text": "Lipid Mini-On:",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.25,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic data",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.3125,
            "text": "Lipid Mini-On: mining and ontology tool for",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.421875,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.875,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.375,
            "text": "Mini-On",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.25,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.3828125,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic",
            "probability": 0.0
        },
        {
            "start_logit": -9.15625,
            "end_logit": 8.375,
            "text": "On",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 8.375,
            "text": "-On",
            "probability": 0.0
        },
        {
            "start_logit": -4.703125,
            "end_logit": 1.23046875,
            "text": "mining and ontology",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_2": [
        {
            "start_logit": 12.5,
            "end_logit": 13.7578125,
            "text": "LipidMaps",
            "probability": 1.0
        },
        {
            "start_logit": -4.1875,
            "end_logit": 13.7578125,
            "text": "s",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.5,
            "end_logit": -5.1328125,
            "text": "Lipid",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -5.6484375,
            "text": "LipidMap",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 13.7578125,
            "text": "Maps",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -7.74609375,
            "text": "LipidMaps) and other characteristics, such as chain length",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 13.7578125,
            "text": "classification (e.g. LipidMaps",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": 13.7578125,
            "text": "bin individual lipid names into multiple lipid ontology groups based on the classification (e.g. LipidMaps",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -8.4296875,
            "text": "LipidMaps) and other characteristics, such as chain length. Lipid Mini-On provides users with the capability to conduct enrichment analysis of the lipid ontology",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 13.7578125,
            "text": "e.g. LipidMaps",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -9.015625,
            "text": "LipidMaps)",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": 0.01336669921875,
            "text": "Lipid Mini-On",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -5.75,
            "text": "Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -9.3828125,
            "end_logit": 0.01336669921875,
            "text": "Mini-On",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -6.484375,
            "text": "Lipid Mini",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -7.65234375,
            "text": "Lipid Mini-",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -7.953125,
            "text": "Lipid Mini-On, an open-source tool",
            "probability": 0.0
        },
        {
            "start_logit": -4.1875,
            "end_logit": -7.74609375,
            "text": "s) and other characteristics, such as chain length",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -8.921875,
            "text": "Lipid Mini-On, an open-source tool that performs lipid",
            "probability": 0.0
        },
        {
            "start_logit": -3.4765625,
            "end_logit": -9.0234375,
            "text": "Lipid Mini-On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data. Lipid Mini-On",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_3": [
        {
            "start_logit": 13.484375,
            "end_logit": 14.0,
            "text": "lipidr",
            "probability": 1.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": 14.0,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -4.57421875,
            "text": "lipid",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.2109375,
            "text": "lipidr: A Software Tool",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.6328125,
            "text": "lipidr: A Software",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.671875,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets.",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.9765625,
            "text": "lipidr: A",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.0546875,
            "text": "lipidr: A Software Tool for Data Mining and Analysis",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.1640625,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.171875,
            "text": "lipidr:",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.296875,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.3046875,
            "text": "lipidr: A Software Tool for Data Mining",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.4140625,
            "text": "lipidr: A Software Tool for",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -10.4296875,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -9.2109375,
            "text": "r: A Software Tool",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -9.6328125,
            "text": "r: A Software",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -9.671875,
            "text": "r: A Software Tool for Data Mining and Analysis of Lipidomics Datasets.",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -9.9765625,
            "text": "r: A",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -10.0546875,
            "text": "r: A Software Tool for Data Mining and Analysis",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -10.1640625,
            "text": "r: A Software Tool for Data Mining and Analysis of Lipidomics Datasets",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_4": [
        {
            "start_logit": 14.1015625,
            "end_logit": 14.515625,
            "text": "lipidr",
            "probability": 1.0
        },
        {
            "start_logit": -2.99609375,
            "end_logit": 14.515625,
            "text": "r",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -3.580078125,
            "text": "lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 14.515625,
            "text": "molecular information such as lipid class, chain length, and unsaturation. To address this need, we developed lipidr",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -8.796875,
            "text": "lipidr, an open-source R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 14.515625,
            "text": "unsaturation. To address this need, we developed lipidr",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 14.515625,
            "text": "developed lipidr",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -3.580078125,
            "text": "molecular information such as lipid class, chain length, and unsaturation. To address this need, we developed lipid",
            "probability": 0.0
        },
        {
            "start_logit": -2.99609375,
            "end_logit": -8.796875,
            "text": "r, an open-source R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -3.580078125,
            "text": "unsaturation. To address this need, we developed lipid",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -3.580078125,
            "text": "developed lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.203125,
            "text": "molecular information",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.42578125,
            "text": "molecular information such as lipid class, chain length, and unsaturation",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": -6.62109375,
            "text": "unsaturation data, we also developed and implemented a novel lipid set enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -8.21875,
            "text": "molecular",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -8.3203125,
            "text": "molecular information such as lipid class",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": -7.21484375,
            "text": "unsaturation",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -7.42578125,
            "text": "unsaturation",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": -8.1171875,
            "text": "unsaturation data, we also developed and implemented a novel lipid set",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": -8.2421875,
            "text": "unsaturation data, we also developed and implemented a novel lipid set enrichment",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_5": [
        {
            "start_logit": 13.375,
            "end_logit": 14.1171875,
            "text": "LipidMS",
            "probability": 1.0
        },
        {
            "start_logit": -3.6875,
            "end_logit": 14.1171875,
            "text": "MS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.375,
            "end_logit": -4.58984375,
            "text": "Lipid",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.0546875,
            "text": "LipidMS: An R Package",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.2578125,
            "text": "LipidMS: An R Package for Lipid Annotation",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.3671875,
            "text": "LipidMS: An R Package for Lipid",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.8359375,
            "text": "LipidMS: An R",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.8515625,
            "text": "LipidMS: An",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.9921875,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.03125,
            "text": "LipidMS:",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.21875,
            "text": "LipidMS: An R Package for",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.234375,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.2734375,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.28125,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.375,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.5,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass",
            "probability": 0.0
        },
        {
            "start_logit": -3.6875,
            "end_logit": -9.0546875,
            "text": "MS: An R Package",
            "probability": 0.0
        },
        {
            "start_logit": -3.6875,
            "end_logit": -9.2578125,
            "text": "MS: An R Package for Lipid Annotation",
            "probability": 0.0
        },
        {
            "start_logit": -3.6875,
            "end_logit": -9.3671875,
            "text": "MS: An R Package for Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -3.6875,
            "end_logit": -9.8359375,
            "text": "MS: An R",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_6": [
        {
            "start_logit": 13.78125,
            "end_logit": 14.28125,
            "text": "LipidMS",
            "probability": 1.0
        },
        {
            "start_logit": -3.39453125,
            "end_logit": 14.28125,
            "text": "MS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.78125,
            "end_logit": -4.1015625,
            "text": "Lipid",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.7265625,
            "text": "LipidMS, an R package aimed to confidently identify lipid species",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.0234375,
            "text": "LipidMS, an R package",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.296875,
            "text": "LipidMS,",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 14.28125,
            "text": "dimensionality of DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 14.28125,
            "text": "DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 14.28125,
            "text": "combined with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 14.28125,
            "text": "feature annotation. Here, we present LipidMS",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 14.28125,
            "text": "precursor and the product ions combined with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.6953125,
            "text": "LipidMS, an R package aimed to confidently identify lipid",
            "probability": 0.0
        },
        {
            "start_logit": -3.39453125,
            "end_logit": -8.7265625,
            "text": "MS, an R package aimed to confidently identify lipid species",
            "probability": 0.0
        },
        {
            "start_logit": -3.39453125,
            "end_logit": -9.0234375,
            "text": "MS, an R package",
            "probability": 0.0
        },
        {
            "start_logit": -3.39453125,
            "end_logit": -9.296875,
            "text": "MS,",
            "probability": 0.0
        },
        {
            "start_logit": -3.39453125,
            "end_logit": -9.6953125,
            "text": "MS, an R package aimed to confidently identify lipid",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -4.1015625,
            "text": "dimensionality of DIA data sets hinder accurate feature annotation. Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -4.1015625,
            "text": "DIA data sets hinder accurate feature annotation. Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": -4.1015625,
            "text": "combined with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -4.1015625,
            "text": "feature annotation. Here, we present Lipid",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_1": [
        {
            "start_logit": 12.515625,
            "end_logit": 12.9609375,
            "text": "HDAC4",
            "probability": 1.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -3.859375,
            "text": "HDAC4 and HDAC5",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.28515625,
            "end_logit": 12.9609375,
            "text": "4",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -5.26953125,
            "text": "HDAC",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -6.87109375,
            "text": "HDAC4 and HDAC5,",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -7.0546875,
            "text": "HDAC4 and HDAC",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.2109375,
            "text": "HDAC4 and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": 12.9609375,
            "text": "targets salt-inducible kinases, HDAC4",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 12.9609375,
            "text": "PTHrP targets salt-inducible kinases, HDAC4",
            "probability": 0.0
        },
        {
            "start_logit": -11.0625,
            "end_logit": 12.9609375,
            "text": "inducible kinases, HDAC4",
            "probability": 0.0
        },
        {
            "start_logit": -11.09375,
            "end_logit": 12.9609375,
            "text": "salt-inducible kinases, HDAC4",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": 12.9609375,
            "text": "-inducible kinases, HDAC4",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -3.859375,
            "text": "4 and HDAC5",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -3.859375,
            "text": "HDAC5",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -6.87109375,
            "text": "4 and HDAC5,",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -7.0546875,
            "text": "4 and HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -6.87109375,
            "text": "HDAC5,",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -7.0546875,
            "text": "HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": -3.859375,
            "text": "5",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": -3.859375,
            "text": "targets salt-inducible kinases, HDAC4 and HDAC5",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_2": [
        {
            "start_logit": 11.609375,
            "end_logit": 10.0859375,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -0.6064453125,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SIK2",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 11.609375,
            "end_logit": -6.109375,
            "text": "SI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.609375,
            "end_logit": -7.2890625,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SI",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.46875,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SIK2, as",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 10.0859375,
            "text": "K1",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.1328125,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.15625,
            "text": "SIK1 has",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 10.0859375,
            "text": "SIKs) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.0859375,
            "text": "AMPK family kinases. SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 10.0859375,
            "text": "inducible kinases (SIKs) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 10.0859375,
            "text": "Salt-inducible kinases (SIKs) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -2.787109375,
            "end_logit": -0.6064453125,
            "text": "SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.6064453125,
            "text": "K1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -8.703125,
            "end_logit": -0.6064453125,
            "text": "K2",
            "probability": 0.0
        },
        {
            "start_logit": -2.787109375,
            "end_logit": -6.84375,
            "text": "SIK2, as an isoform of the SIK family",
            "probability": 0.0
        },
        {
            "start_logit": -2.787109375,
            "end_logit": -7.2890625,
            "text": "SI",
            "probability": 0.0
        },
        {
            "start_logit": -2.787109375,
            "end_logit": -8.1015625,
            "text": "SIK2, as an isoform of the SIK",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -0.6064453125,
            "text": "intracellular sodium in a variety of cell types. SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -2.787109375,
            "end_logit": -8.46875,
            "text": "SIK2, as",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_3": [
        {
            "start_logit": 13.0,
            "end_logit": 12.3125,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -5.2265625,
            "text": "SI",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -6.29296875,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. Type 2",
            "probability": 0.0
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 12.3125,
            "text": "K1",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -8.1171875,
            "text": "SIK1)",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -8.4296875,
            "text": "SIK1) has",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -8.875,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.21875,
            "text": "SIK1) has been shown to act as a",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.40625,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 12.3125,
            "text": "Type 1 salt-inducible kinases (SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": 12.3125,
            "text": "inducible kinases (SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -3.31640625,
            "end_logit": -1.5078125,
            "text": "SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -3.31640625,
            "end_logit": -6.87109375,
            "text": "SI",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -1.5078125,
            "text": "K2",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -1.5078125,
            "text": "SIK (SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -1.5078125,
            "text": "Type 2 SIK (SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -3.31640625,
            "end_logit": -8.734375,
            "text": "SIK2)",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -1.5078125,
            "text": "intracellular sodium in a variety of cell types. Type 2 SIK (SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -1.5078125,
            "text": "cellular adaptation to variations in intracellular sodium in a variety of cell types. Type 2 SIK (SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": -1.5078125,
            "text": "K (SIK2",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_4": [
        {
            "start_logit": 12.953125,
            "end_logit": 13.6015625,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 13.6015625,
            "text": "K1",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.0625,
            "text": "SIK1, SIK2 and SIK3",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.43359375,
            "text": "SI",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.6484375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -6.99609375,
            "text": "SIK1, SIK2",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.17578125,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.1953125,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.6171875,
            "text": "SIK1, SIK2 and",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.76171875,
            "text": "SIK1, SIK2 and SIK3, most closely resemble",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.93359375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK) and other AMPK",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.984375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK)",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.71875,
            "text": "SIK1, SI",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.78125,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK) and other AMPK-related",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.796875,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.8359375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK) and other AMPK-related kinases",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.8671875,
            "text": "SIK1, SIK2 and SIK3,",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 13.6015625,
            "text": "kinases, SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 13.6015625,
            "text": "inducible kinases, SIK1",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 13.6015625,
            "text": "salt-inducible kinases, SIK1",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_5": [
        {
            "start_logit": 11.78125,
            "end_logit": 9.71875,
            "text": "SIK2",
            "probability": 1.0
        },
        {
            "start_logit": 11.78125,
            "end_logit": 1.7705078125,
            "text": "SIK2 and SIK3",
            "probability": 0.0003542900085449219
        },
        {
            "start_logit": 11.78125,
            "end_logit": -5.69921875,
            "text": "SIK2 and SIK3) by Na+ stress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.78125,
            "end_logit": -6.3203125,
            "text": "SI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.78125,
            "end_logit": -7.44140625,
            "text": "SIK2 and SI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.78125,
            "end_logit": -7.62109375,
            "text": "SIK2 and",
            "probability": 0.0
        },
        {
            "start_logit": 11.78125,
            "end_logit": -8.140625,
            "text": "SIK2 and SIK3)",
            "probability": 0.0
        },
        {
            "start_logit": 11.78125,
            "end_logit": -8.40625,
            "text": "SIK2 and SIK3) by",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 9.71875,
            "text": "SIKs; SIK2",
            "probability": 0.0
        },
        {
            "start_logit": 11.78125,
            "end_logit": -8.8515625,
            "text": "SIK2 and SIK3) by Na+",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 9.71875,
            "text": "K2",
            "probability": 0.0
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": 1.7705078125,
            "text": "SIK3",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 9.71875,
            "text": "Ks; SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 9.71875,
            "text": "; SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 9.71875,
            "text": "inducible kinases (SIKs; SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -10.9296875,
            "end_logit": 9.71875,
            "text": "salt-inducible kinases (SIKs; SIK2",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 1.7705078125,
            "text": "SIKs; SIK2 and SIK3",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 1.7705078125,
            "text": "K2 and SIK3",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 1.7705078125,
            "text": "K3",
            "probability": 0.0
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": -5.69921875,
            "text": "SIK3) by Na+ stress",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_1": [
        {
            "start_logit": 10.25,
            "end_logit": 10.7578125,
            "text": "duodenum",
            "probability": 0.9990234375
        },
        {
            "start_logit": 2.943359375,
            "end_logit": 10.7578125,
            "text": "pancreatic duct and the duodenum",
            "probability": 0.0006771087646484375
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": 10.7578125,
            "text": "bile duct, the pancreatic duct and the duodenum",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 2.943359375,
            "end_logit": 3.15625,
            "text": "pancreatic duct",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.7578125,
            "text": "duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 10.7578125,
            "text": ", the pancreatic duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": 3.15625,
            "text": "bile duct, the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 10.7578125,
            "text": "duct, the pancreatic duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 10.7578125,
            "text": "and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -0.2427978515625,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -5.40625,
            "text": "pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -7.9609375,
            "text": "pancreatic duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 3.15625,
            "text": "duct",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -8.28125,
            "text": "pancreatic duct and",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 3.15625,
            "text": ", the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 3.15625,
            "text": "duct, the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -5.40625,
            "text": "bile duct, the pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -7.9609375,
            "text": "bile duct, the pancreatic duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -8.28125,
            "text": "bile duct, the pancreatic duct and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -0.2427978515625,
            "text": "duct",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_2": [
        {
            "start_logit": 10.6875,
            "end_logit": 11.5390625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 11.5390625,
            "text": "biliary tract and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -8.7578125,
            "text": "pancreas are",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 11.5390625,
            "text": "and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 11.5390625,
            "text": "of the biliary tract and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.3515625,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.4609375,
            "text": "pancreas are associated with disordered motility",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 11.5390625,
            "text": "functional disorders of the biliary tract and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.7578125,
            "text": "pancreas are associated",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.8359375,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO).",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.8828125,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.9296875,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO)",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.9375,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO). Th",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.0,
            "text": "pancreas are associated with",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.1171875,
            "text": "pancreas are associated with disordered motility of the",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -7.4375,
            "text": "biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.7578125,
            "text": "biliary tract and pancreas are",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -7.4375,
            "text": "of the biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -7.4375,
            "text": "functional disorders of the biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -9.3515625,
            "text": "biliary tract and pancreas are associated with disordered motility of the sphincter of Oddi (SO",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_3": [
        {
            "start_logit": 11.3359375,
            "end_logit": 11.4375,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -7.15625,
            "text": "duodenum and the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -7.75390625,
            "text": "duodenum and the sphincter of Oddi (SO).",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -7.90625,
            "text": "duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.6328125,
            "text": "duodenum and the sphincter of Oddi (SO)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.9375,
            "text": "duodenum and the",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.328125,
            "text": "duodenum and the sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.78125,
            "text": "duodenum and the sphincter of Odd",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.875,
            "text": "duodenum and the sphincter",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.953125,
            "text": "duodenum and the sphincter of Oddi (",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 11.4375,
            "text": "neural connections between the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -7.15625,
            "text": "sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -7.15625,
            "text": "SO",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -7.75390625,
            "text": "sphincter of Oddi (SO).",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": -7.15625,
            "text": "Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -7.15625,
            "text": "neural connections between the duodenum and the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -7.75390625,
            "text": "SO).",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": -7.75390625,
            "text": "Oddi (SO).",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -8.6328125,
            "text": "sphincter of Oddi (SO)",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -7.75390625,
            "text": "neural connections between the duodenum and the sphincter of Oddi (SO).",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_4": [
        {
            "start_logit": 1.8955078125,
            "end_logit": 10.015625,
            "text": "bile duct",
            "probability": 0.91650390625
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": 10.015625,
            "text": "common bile duct",
            "probability": 0.08331298828125
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 10.015625,
            "text": "duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 0.0001595020294189453
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.015625,
            "text": "duct",
            "probability": 3.701448440551758e-05
        },
        {
            "start_logit": -9.28125,
            "end_logit": 10.015625,
            "text": "and areas close to the common bile duct",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -9.453125,
            "end_logit": 10.015625,
            "text": "papilla (area I) and areas close to the common bile duct",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 1.8955078125,
            "end_logit": -6.640625,
            "text": "bile duct (area II). In the whole sph",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.8955078125,
            "end_logit": -8.8046875,
            "text": "bile duct (area II). In the whole",
            "probability": 0.0
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": -6.640625,
            "text": "common bile duct (area II). In the whole sph",
            "probability": 0.0
        },
        {
            "start_logit": 1.8955078125,
            "end_logit": -9.328125,
            "text": "bile",
            "probability": 0.0
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": -8.8046875,
            "text": "common bile duct (area II). In the whole",
            "probability": 0.0
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": -9.328125,
            "text": "common bile",
            "probability": 0.0
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": -9.5859375,
            "text": "common",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -4.62890625,
            "text": "duodenal papilla",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -6.18359375,
            "text": "duodenal",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -4.62890625,
            "text": "nd set of experiments, sphincter of Oddi was divided into two parts and the effects of field stimulation were studied separately on areas close to the duodenal papilla",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -6.640625,
            "text": "sph",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -6.640625,
            "text": "duodenal papilla (area I) and areas close to the common bile duct (area II). In the whole sph",
            "probability": 0.0
        },
        {
            "start_logit": -9.453125,
            "end_logit": -4.62890625,
            "text": "papilla",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": -4.62890625,
            "text": "sphincter of Oddi was divided into two parts and the effects of field stimulation were studied separately on areas close to the duodenal papilla",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_5": [
        {
            "start_logit": 5.3515625,
            "end_logit": 8.96875,
            "text": "gallbladder",
            "probability": 0.9990234375
        },
        {
            "start_logit": 5.3515625,
            "end_logit": 1.9365234375,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 0.0008831024169921875
        },
        {
            "start_logit": 1.2802734375,
            "end_logit": 1.9365234375,
            "text": "duodenum",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.96875,
            "text": "LTS: Two to 3 weeks after gallbladder",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -6.34765625,
            "text": "gallbladder injection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.140625,
            "end_logit": 8.96875,
            "text": ": Two to 3 weeks after gallbladder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -7.30078125,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.2802734375,
            "end_logit": -3.36328125,
            "text": "duodenum but were rare in the duodenum distal to the sphincter of Oddi. No",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -7.9140625,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but were rare",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.03125,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.0390625,
            "text": "gallbladder injection,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.0859375,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but were rare in the duodenum distal to the sphincter of Odd",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.234375,
            "text": "gallbladder injection, labeled nerve cell bodies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.5546875,
            "text": "gallbladder injection, labeled",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.6484375,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but were rare in the duodenum distal to the",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.65625,
            "text": "gallbladder injection, labeled nerve cell bodies were",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -8.7265625,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -9.0703125,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum but were rare in the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -9.34375,
            "text": "gallbladder injection, labeled nerve cell bodies were found in",
            "probability": 0.0
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -9.4453125,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_6": [
        {
            "start_logit": 10.7265625,
            "end_logit": 11.4921875,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": 11.4921875,
            "text": "bile duct and the duodenum",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -10.34375,
            "end_logit": 11.4921875,
            "text": "smooth muscle connection between the bile duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 11.4921875,
            "text": "duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -10.0078125,
            "text": "duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -0.6376953125,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -7.640625,
            "text": "bile duct and",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -0.6376953125,
            "text": "smooth muscle connection between the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -0.6376953125,
            "text": "duct",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -8.046875,
            "text": "bile duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -8.0546875,
            "text": "bile",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -10.0078125,
            "text": "bile duct and the duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -7.640625,
            "text": "smooth muscle connection between the bile duct and",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -7.640625,
            "text": "duct and",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.046875,
            "text": "smooth muscle connection between the bile duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.0546875,
            "text": "smooth muscle connection between the bile",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -8.046875,
            "text": "duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.6484375,
            "text": "smooth muscle connection between the",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.875,
            "text": "smooth muscle connection",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -9.140625,
            "text": "smooth muscle",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_7": [
        {
            "start_logit": 10.421875,
            "end_logit": 11.546875,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": 11.546875,
            "text": "pancreatic duct, and duodenum",
            "probability": 0.00020194053649902344
        },
        {
            "start_logit": -3.318359375,
            "end_logit": 11.546875,
            "text": "bile duct, pancreatic duct, and duodenum",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": 1.490234375,
            "text": "pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 11.546875,
            "text": ", pancreatic duct, and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 11.546875,
            "text": "duct, and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 11.546875,
            "text": "and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 11.546875,
            "text": "duct, pancreatic duct, and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 11.546875,
            "text": "smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 10.421875,
            "end_logit": -10.0,
            "text": "duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -3.318359375,
            "end_logit": 1.490234375,
            "text": "bile duct, pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": -4.6796875,
            "text": "pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": -3.318359375,
            "end_logit": -1.7490234375,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": -7.98046875,
            "text": "pancreatic duct, and",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 1.490234375,
            "text": ", pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 1.490234375,
            "text": "duct",
            "probability": 0.0
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": -9.53125,
            "text": "pancreatic duct,",
            "probability": 0.0
        },
        {
            "start_logit": -3.318359375,
            "end_logit": -4.6796875,
            "text": "bile duct, pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 1.9130859375,
            "end_logit": -10.0,
            "text": "pancreatic duct, and duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 1.490234375,
            "text": "duct, pancreatic duct",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_8": [
        {
            "start_logit": 11.9765625,
            "end_logit": 10.9921875,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 11.9765625,
            "end_logit": -4.03515625,
            "text": "duodenum and gall-bladder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 10.9921875,
            "text": "stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 11.9765625,
            "end_logit": -8.078125,
            "text": "duodenum and gall-bladder.",
            "probability": 0.0
        },
        {
            "start_logit": 11.9765625,
            "end_logit": -8.3828125,
            "text": "duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": 11.9765625,
            "end_logit": -8.4765625,
            "text": "duodenum and gall",
            "probability": 0.0
        },
        {
            "start_logit": 11.9765625,
            "end_logit": -9.2734375,
            "text": "duodenum and gall-",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 10.9921875,
            "text": ", duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 10.9921875,
            "text": "sphincter of Oddi to the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -2.9375,
            "text": "stomach",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -4.03515625,
            "text": "gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -4.03515625,
            "text": "stomach, duodenum and gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -2.9375,
            "text": "sphincter of Oddi to the stomach",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -8.078125,
            "text": "gall-bladder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -4.03515625,
            "text": ", duodenum and gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -8.4765625,
            "text": "gall",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -8.078125,
            "text": "stomach, duodenum and gall-bladder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -4.03515625,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -4.03515625,
            "text": "and gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -4.03515625,
            "text": "sphincter of Oddi to the stomach, duodenum and gall-bladder",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_9": [
        {
            "start_logit": 10.71875,
            "end_logit": 9.6484375,
            "text": "duodenum",
            "probability": 0.5830078125
        },
        {
            "start_logit": 9.09375,
            "end_logit": 10.625,
            "text": "stomach",
            "probability": 0.30224609375
        },
        {
            "start_logit": 9.09375,
            "end_logit": 9.6484375,
            "text": "stomach, duodenum",
            "probability": 0.11474609375
        },
        {
            "start_logit": 10.71875,
            "end_logit": -3.40234375,
            "text": "duodenum, or upper small bowel",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.09375,
            "end_logit": -3.40234375,
            "text": "stomach, duodenum, or upper small bowel",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.71875,
            "end_logit": -8.953125,
            "text": "duodenum, or",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -9.859375,
            "text": "duodenum, or upper small bowel influences the tone",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.0078125,
            "text": "duodenum, or upper small bowel influences",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.0390625,
            "text": "duodenum, or upper small bowel influences the tone of the sphincter of Odd",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.0546875,
            "text": "duodenum, or upper small bowel influences the tone of the sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.1484375,
            "text": "duodenum, or upper small bowel influences the tone of",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.1640625,
            "text": "duodenum, or upper small bowel influences the tone of the sphincter of Oddi.",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.21875,
            "text": "duodenum, or upper small bowel influences the tone of the",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.265625,
            "text": "duodenum, or upper small bowel influences the",
            "probability": 0.0
        },
        {
            "start_logit": 10.71875,
            "end_logit": -10.3046875,
            "text": "duodenum, or upper small",
            "probability": 0.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.953125,
            "text": "stomach, duodenum, or",
            "probability": 0.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -9.8125,
            "text": "stomach,",
            "probability": 0.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -9.859375,
            "text": "stomach, duodenum, or upper small bowel influences the tone",
            "probability": 0.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -10.0078125,
            "text": "stomach, duodenum, or upper small bowel influences",
            "probability": 0.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -10.0390625,
            "text": "stomach, duodenum, or upper small bowel influences the tone of the sphincter of Odd",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_10": [
        {
            "start_logit": 10.703125,
            "end_logit": 10.7265625,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -1.4990234375,
            "text": "duodenum, gallbladder",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.625,
            "end_logit": 10.7265625,
            "text": "stomach, descending duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": 10.7265625,
            "text": "descending duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.125,
            "text": "duodenum,",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.2734375,
            "text": "duodenum, gallbladder and sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.3828125,
            "text": "duodenum, gallbladder and",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.6796875,
            "text": "duodenum, gallbladder and sphincter of Odd",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 10.7265625,
            "text": "interdigestive motor activity in the stomach, descending duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -1.4990234375,
            "text": "gallbladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.4990234375,
            "text": "stomach, descending duodenum, gallbladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -1.4990234375,
            "text": "descending duodenum, gallbladder",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -1.4990234375,
            "text": "interdigestive motor activity in the stomach, descending duodenum, gallbladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -4.9375,
            "text": "stomach",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.2734375,
            "text": "gallbladder and sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.3828125,
            "text": "gallbladder and",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.6796875,
            "text": "gallbladder and sphincter of Odd",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -4.9375,
            "text": "interdigestive motor activity in the stomach",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -9.125,
            "text": "stomach, descending duodenum,",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -9.2734375,
            "text": "stomach, descending duodenum, gallbladder and sphincter of Oddi",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_11": [
        {
            "start_logit": 10.6875,
            "end_logit": 9.859375,
            "text": "pancreatic duct",
            "probability": 0.998046875
        },
        {
            "start_logit": 10.6875,
            "end_logit": 3.580078125,
            "text": "pancreatic duct with the duodenum",
            "probability": 0.0018672943115234375
        },
        {
            "start_logit": -3.2421875,
            "end_logit": 9.859375,
            "text": "bile duct and pancreatic duct",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 10.6875,
            "end_logit": -4.4140625,
            "text": "pancreatic",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.8583984375,
            "end_logit": 3.580078125,
            "text": "duodenum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.6875,
            "end_logit": -7.7578125,
            "text": "pancreatic duct with the",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.859375,
            "text": "duct",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -8.8359375,
            "text": "pancreatic duct with",
            "probability": 0.0
        },
        {
            "start_logit": -3.2421875,
            "end_logit": 3.580078125,
            "text": "bile duct and pancreatic duct with the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 9.859375,
            "text": "and pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 9.859375,
            "text": "small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 3.580078125,
            "text": "duct with the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -3.2421875,
            "end_logit": -0.72900390625,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": 3.580078125,
            "text": "with the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 3.580078125,
            "text": "and pancreatic duct with the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 3.580078125,
            "text": "small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct with the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -3.2421875,
            "end_logit": -4.4140625,
            "text": "bile duct and pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": -3.2421875,
            "end_logit": -7.7578125,
            "text": "bile duct and pancreatic duct with the",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -0.72900390625,
            "text": "small sphincter which is strategically placed at the junction of the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -3.2421875,
            "end_logit": -8.109375,
            "text": "bile",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_12": [
        {
            "start_logit": 4.08203125,
            "end_logit": 3.109375,
            "text": "pancreatic juice into the duodenum",
            "probability": 0.90283203125
        },
        {
            "start_logit": 4.08203125,
            "end_logit": 0.2308349609375,
            "text": "pancreatic",
            "probability": 0.05072021484375
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": 3.109375,
            "text": "duodenum",
            "probability": 0.04620361328125
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -6.296875,
            "text": "pancreatic juice into the duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic",
            "probability": 7.420778274536133e-05
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -6.3203125,
            "text": "pancreatic juice",
            "probability": 7.2479248046875e-05
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -8.3828125,
            "text": "pancreatic juice into the duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -9.109375,
            "text": "pancreatic juice into the duodenum, and",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -9.1328125,
            "text": "pancreatic juice into the duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal systems",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -9.203125,
            "text": "pancreatic juice into the duodenum,",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": -6.296875,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -9.359375,
            "text": "pancreatic juice into the duodenum, and equally",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 4.08203125,
            "end_logit": -9.4140625,
            "text": "pancreatic juice into the duodenum, and equally importantly helps",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -9.9375,
            "end_logit": 3.109375,
            "text": "juice into the duodenum",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 3.109375,
            "text": "Oddi's original description that the sphincter has a major role in the control of flow of bile and pancreatic juice into the duodenum",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 3.109375,
            "text": "into the duodenum",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -10.28125,
            "end_logit": 3.109375,
            "text": "flow of bile and pancreatic juice into the duodenum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 3.109375,
            "text": "control of flow of bile and pancreatic juice into the duodenum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": -8.3828125,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": -9.109375,
            "text": "duodenum, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": -9.1328125,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal systems",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292e661cb411341a000112_13": [
        {
            "start_logit": 4.14453125,
            "end_logit": 6.3359375,
            "text": "common bile duct",
            "probability": 0.459228515625
        },
        {
            "start_logit": 4.14453125,
            "end_logit": 5.73828125,
            "text": "common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 0.25146484375
        },
        {
            "start_logit": 3.892578125,
            "end_logit": 5.73828125,
            "text": "duodenum",
            "probability": 0.1959228515625
        },
        {
            "start_logit": 3.12109375,
            "end_logit": 5.73828125,
            "text": "pancreatic duct, and the duodenum",
            "probability": 0.09039306640625
        },
        {
            "start_logit": 4.14453125,
            "end_logit": 0.81640625,
            "text": "common bile duct (CBD), main pancreatic duct",
            "probability": 0.0018339157104492188
        },
        {
            "start_logit": 3.12109375,
            "end_logit": 0.81640625,
            "text": "pancreatic duct",
            "probability": 0.0006585121154785156
        },
        {
            "start_logit": 4.14453125,
            "end_logit": -1.5263671875,
            "text": "common bile duct (CBD), main pancreatic",
            "probability": 0.00017595291137695312
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 6.3359375,
            "text": "bile duct",
            "probability": 9.948015213012695e-05
        },
        {
            "start_logit": 3.12109375,
            "end_logit": -1.5263671875,
            "text": "pancreatic",
            "probability": 6.324052810668945e-05
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 5.73828125,
            "text": "bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 5.4955482482910156e-05
        },
        {
            "start_logit": 4.14453125,
            "end_logit": -4.11328125,
            "text": "common bile duct (CBD",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 5.73828125,
            "text": ", main pancreatic duct, and the duodenum",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 5.73828125,
            "text": "main pancreatic duct, and the duodenum",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -8.71875,
            "end_logit": 5.73828125,
            "text": "CBD), main pancreatic duct, and the duodenum",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -9.421875,
            "end_logit": 6.3359375,
            "text": "duct",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 5.73828125,
            "text": "duct, and the duodenum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.14453125,
            "end_logit": -7.48046875,
            "text": "common bile duct (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 0.81640625,
            "text": "bile duct (CBD), main pancreatic duct",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -9.421875,
            "end_logit": 5.73828125,
            "text": "duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.14453125,
            "end_logit": -7.890625,
            "text": "common bile duct (CBD)",
            "probability": 2.980232238769531e-07
        }
    ],
    "60292e661cb411341a000112_14": [
        {
            "start_logit": 10.25,
            "end_logit": 10.7578125,
            "text": "duodenum",
            "probability": 0.9990234375
        },
        {
            "start_logit": 2.943359375,
            "end_logit": 10.7578125,
            "text": "pancreatic duct and the duodenum",
            "probability": 0.0006771087646484375
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": 10.7578125,
            "text": "bile duct, the pancreatic duct and the duodenum",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 2.943359375,
            "end_logit": 3.15625,
            "text": "pancreatic duct",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.7578125,
            "text": "duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 10.7578125,
            "text": ", the pancreatic duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": 3.15625,
            "text": "bile duct, the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 10.7578125,
            "text": "duct, the pancreatic duct and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 10.7578125,
            "text": "and the duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -0.2427978515625,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -5.40625,
            "text": "pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -7.9609375,
            "text": "pancreatic duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 3.15625,
            "text": "duct",
            "probability": 0.0
        },
        {
            "start_logit": 2.943359375,
            "end_logit": -8.28125,
            "text": "pancreatic duct and",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 3.15625,
            "text": ", the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 3.15625,
            "text": "duct, the pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -5.40625,
            "text": "bile duct, the pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -7.9609375,
            "text": "bile duct, the pancreatic duct and the",
            "probability": 0.0
        },
        {
            "start_logit": -1.7900390625,
            "end_logit": -8.28125,
            "text": "bile duct, the pancreatic duct and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -0.2427978515625,
            "text": "duct",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_15": [
        {
            "start_logit": 10.734375,
            "end_logit": 11.703125,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": 11.703125,
            "text": "biliary tract and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -8.8671875,
            "text": "pancreas relates",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 11.703125,
            "text": "and pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.8984375,
            "text": "pancreas relates to the activity of the Sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.9921875,
            "text": "pancreas relates to the activity of the Sphincter of Oddi.",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -10.0078125,
            "text": "pancreas relates to the",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -10.0234375,
            "text": "pancreas relates to",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -10.0546875,
            "text": "pancreas relates to the activity of the",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -7.30859375,
            "text": "biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -8.8671875,
            "text": "biliary tract and pancreas relates",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -8.9921875,
            "text": "biliary",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -9.8984375,
            "text": "biliary tract and pancreas relates to the activity of the Sphincter of Oddi",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -9.9609375,
            "text": "biliary tract and",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -9.9921875,
            "text": "biliary tract and pancreas relates to the activity of the Sphincter of Oddi.",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -10.0078125,
            "text": "biliary tract and pancreas relates to the",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -10.0234375,
            "text": "biliary tract and pancreas relates to",
            "probability": 0.0
        },
        {
            "start_logit": -8.7734375,
            "end_logit": -10.0546875,
            "text": "biliary tract and pancreas relates to the activity of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -8.8671875,
            "text": "and pancreas relates",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -9.8984375,
            "text": "and pancreas relates to the activity of the Sphincter of Oddi",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_1": [
        {
            "start_logit": 14.4375,
            "end_logit": 14.375,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -2.84765625,
            "text": "Enterococcus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.91015625,
            "end_logit": 14.375,
            "text": "faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -5.34765625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -5.921875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -6.23828125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -6.29296875,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -6.3828125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -6.82421875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -7.48046875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -7.74609375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.3359375,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.6875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens in ventilator-associated pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.7109375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.8359375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE)",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -9.125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens",
            "probability": 0.0
        },
        {
            "start_logit": -2.91015625,
            "end_logit": -5.34765625,
            "text": "faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": -2.91015625,
            "end_logit": -5.921875,
            "text": "faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 0.0
        },
        {
            "start_logit": -2.91015625,
            "end_logit": -6.23828125,
            "text": "faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": -2.91015625,
            "end_logit": -6.29296875,
            "text": "faecium, Staphylococcus aureus",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_2": [
        {
            "start_logit": 14.3984375,
            "end_logit": 14.328125,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": -2.861328125,
            "end_logit": 14.328125,
            "text": "faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -2.998046875,
            "text": "Enterococcus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -4.6484375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -4.74609375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -4.94921875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -5.97265625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -6.43359375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -7.07421875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -7.1953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -7.3203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -7.515625,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -8.390625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (ESKAPE)",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -8.4140625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -8.7734375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.015625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.0234375,
            "text": "Enterococcus faecium, Staphylococcus aureus,",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.0234375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii,",
            "probability": 0.0
        },
        {
            "start_logit": -2.861328125,
            "end_logit": -4.6484375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": -2.861328125,
            "end_logit": -4.74609375,
            "text": "faecium, Staphylococcus aureus",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_3": [
        {
            "start_logit": 14.1328125,
            "end_logit": 14.046875,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -3.525390625,
            "text": "Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": -3.5234375,
            "end_logit": 14.046875,
            "text": "faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -6.81640625,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.1953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.3125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.328125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.65625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.6640625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.3203125,
            "text": "Enterococcus faecium,",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.4453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. -",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.5,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.640625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.671875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.7265625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.75,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.765625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 14.046875,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_4": [
        {
            "start_logit": 12.0546875,
            "end_logit": 11.9921875,
            "text": "A. baumannii",
            "probability": 1.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": 2.486328125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -2.900390625,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -3.12890625,
            "text": "A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -4.05859375,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 11.9921875,
            "text": "baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -5.46484375,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -5.828125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -6.86328125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -7.078125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -7.41015625,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -8.078125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -8.2421875,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -8.4140625,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -8.828125,
            "text": "A. baumannii (",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -9.0546875,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 0.469970703125,
            "end_logit": 2.486328125,
            "text": "Enterococcus faecium",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -9.6171875,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": 11.9921875,
            "text": ". baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 12.0546875,
            "end_logit": -9.765625,
            "text": "A.",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_5": [
        {
            "start_logit": 14.234375,
            "end_logit": 14.3671875,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": -2.841796875,
            "end_logit": 14.3671875,
            "text": "faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.234375,
            "end_logit": -3.318359375,
            "text": "Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.359375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.6953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.7578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.83203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.)",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -7.984375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -8.4375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -8.6484375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) pathogens play a major role",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.3671875,
            "text": "Enterococcus faecium,",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.484375,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.53125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 14.234375,
            "end_logit": -9.640625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) pathogens",
            "probability": 0.0
        },
        {
            "start_logit": -2.841796875,
            "end_logit": -7.359375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": -2.841796875,
            "end_logit": -7.6953125,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_6": [
        {
            "start_logit": 14.125,
            "end_logit": 14.2109375,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": -3.224609375,
            "end_logit": 14.2109375,
            "text": "faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -3.51953125,
            "text": "Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -5.328125,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -6.34375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -6.5234375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -6.59765625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -6.64453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -7.8515625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -8.140625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -8.625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -8.7890625,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -8.96875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -9.0546875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -9.2578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 14.2109375,
            "text": "bacteremias caused by the 6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 14.2109375,
            "text": "pathogens (Enterococcus faecium",
            "probability": 0.0
        },
        {
            "start_logit": -3.224609375,
            "end_logit": -5.328125,
            "text": "faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -3.224609375,
            "end_logit": -6.34375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": -3.224609375,
            "end_logit": -6.5234375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_7": [
        {
            "start_logit": 14.1328125,
            "end_logit": 14.0625,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -3.509765625,
            "text": "Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": 14.0625,
            "text": "faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -5.46875,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -6.74609375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -7.4609375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -7.7265625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -7.734375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -7.78125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.5234375,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.7109375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.921875,
            "text": "Enterococcus faecium,",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.0625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.25,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.421875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter",
            "probability": 0.0
        },
        {
            "start_logit": -9.40625,
            "end_logit": 14.0625,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.53125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.7421875,
            "text": "Enterococcus faecium, Staphylococcus aureus,",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -5.46875,
            "text": "faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -6.74609375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_8": [
        {
            "start_logit": 14.1328125,
            "end_logit": 14.046875,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -3.525390625,
            "text": "Enterococcus",
            "probability": 0.0
        },
        {
            "start_logit": -3.5234375,
            "end_logit": 14.046875,
            "text": "faecium",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -6.81640625,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.1953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.3125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.328125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.65625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -8.6640625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.3203125,
            "text": "Enterococcus faecium,",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.4453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. -",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.5,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.640625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.671875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.7265625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.75,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible",
            "probability": 0.0
        },
        {
            "start_logit": 14.1328125,
            "end_logit": -9.765625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 14.046875,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_1": [
        {
            "start_logit": 13.203125,
            "end_logit": 12.328125,
            "text": "VEGF-C",
            "probability": 1.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -2.4609375,
            "text": "VEGF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 13.203125,
            "end_logit": -4.08984375,
            "text": "VEGF-C and -D",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.515625,
            "end_logit": 12.328125,
            "text": "C",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -6.71875,
            "text": "VEGF-",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 12.328125,
            "text": "ur results demonstrate that NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.3203125,
            "text": "VEGF-C and",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.2421875,
            "text": "VEGF-C and -",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 12.328125,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 12.328125,
            "text": "that NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.328125,
            "text": "lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": 12.328125,
            "text": "stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -4.08984375,
            "text": "C and -D",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -2.4609375,
            "text": "ur results demonstrate that NHT stimulates lymphangiogenesis via upregulation of VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -2.4609375,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -4.08984375,
            "text": "ur results demonstrate that NHT stimulates lymphangiogenesis via upregulation of VEGF-C and -D",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -4.08984375,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C and -D",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -2.4609375,
            "text": "that NHT stimulates lymphangiogenesis via upregulation of VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -2.4609375,
            "text": "lymphangiogenesis via upregulation of VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": -2.4609375,
            "text": "stimulates lymphangiogenesis via upregulation of VEGF",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_2": [
        {
            "start_logit": 13.6328125,
            "end_logit": 13.28125,
            "text": "VEGF-C",
            "probability": 1.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -3.49609375,
            "text": "VEGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6640625,
            "end_logit": 13.28125,
            "text": "C",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -5.8828125,
            "text": "VEGF-C and its receptor VEGF-R3",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -6.4765625,
            "text": "VEGF-C and its receptor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.546875,
            "text": "VEGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.92578125,
            "text": "VEGF-C and its receptor VEGF",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.5390625,
            "text": "VEGF-C and its",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.8828125,
            "text": "VEGF-C and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.9609375,
            "text": "VEGF-C and its receptor VEGF-",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.28125,
            "text": "lymphangiogenesis, VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -10.8671875,
            "end_logit": 13.28125,
            "text": "-C",
            "probability": 0.0
        },
        {
            "start_logit": -11.171875,
            "end_logit": 13.28125,
            "text": "for lymphangiogenesis, VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": 13.28125,
            "text": ", VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -11.2421875,
            "end_logit": 13.28125,
            "text": "The signals for lymphangiogenesis, VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -5.8828125,
            "text": "C and its receptor VEGF-R3",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -6.4765625,
            "text": "C and its receptor",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.92578125,
            "text": "C and its receptor VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -8.5390625,
            "text": "C and its",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -8.8828125,
            "text": "C and",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_3": [
        {
            "start_logit": 7.05859375,
            "end_logit": 9.984375,
            "text": "VEGF",
            "probability": 0.986328125
        },
        {
            "start_logit": 2.740234375,
            "end_logit": 9.984375,
            "text": "Vascular endothelial growth factor (VEGF",
            "probability": 0.01311492919921875
        },
        {
            "start_logit": 2.740234375,
            "end_logit": 4.421875,
            "text": "Vascular endothelial growth factor",
            "probability": 5.030632019042969e-05
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -4.05078125,
            "text": "VEGF) members VEGF-C and VEGF-D",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -5.6328125,
            "text": "VEGF) members VEGF-C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -6.1796875,
            "text": "VEGF) members VEGF-C and VEGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 9.984375,
            "text": "growth factor (VEGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.609375,
            "end_logit": 9.984375,
            "text": "endothelial growth factor (VEGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -7.14453125,
            "text": "VEGF)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -7.625,
            "text": "VEGF) members VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 9.984375,
            "text": "factor (VEGF",
            "probability": 0.0
        },
        {
            "start_logit": 2.740234375,
            "end_logit": -4.05078125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.3828125,
            "text": "VEGF) members VEGF-C and VEGF-",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.578125,
            "text": "VEGF) members VEGF-C and VEGF-D are both potent candidates for stimulating lymphangiogenesis,",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -9.359375,
            "text": "VEGF) members VEGF-",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -9.671875,
            "text": "VEGF) members VEGF-C and VEGF-D are both potent candidates",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -9.6875,
            "text": "VEGF) members VEGF-C and VEGF-D are",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -9.8359375,
            "text": "VEGF) members VEGF-C and",
            "probability": 0.0
        },
        {
            "start_logit": 2.740234375,
            "end_logit": -5.6328125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -10.09375,
            "text": "VEGF) members VEGF-C and VEGF-D are both",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_1": [
        {
            "start_logit": 13.9375,
            "end_logit": 13.90625,
            "text": "Ascher's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -3.91015625,
            "text": "Asc",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": 13.90625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -4.171875,
            "text": "Ascher",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -5.89453125,
            "text": "Ascher's",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -8.0546875,
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -8.1015625,
            "text": "Ascher'",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.0390625,
            "text": "Ascher's syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": 13.90625,
            "text": "'s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.2890625,
            "text": "Ascher's syndrome associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.6171875,
            "text": "Ascher's syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 13.90625,
            "text": "s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 13.90625,
            "text": "her's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 13.90625,
            "text": "our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.90625,
            "text": "To our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -8.0546875,
            "text": "syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.0390625,
            "text": "syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.2890625,
            "text": "syndrome associated",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.6171875,
            "text": "syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -3.91015625,
            "text": "our knowledge, this is the first reported case of Asc",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_2": [
        {
            "start_logit": 13.046875,
            "end_logit": 10.921875,
            "text": "WS2",
            "probability": 1.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -4.33984375,
            "text": "WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 10.921875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -9.328125,
            "text": "WS2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 10.921875,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 10.921875,
            "text": "0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 10.921875,
            "text": "Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.921875,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 10.921875,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 10.921875,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -4.33984375,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -5.90234375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -4.33984375,
            "text": "0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33984375,
            "text": "Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -5.90234375,
            "text": "hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -4.33984375,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -4.33984375,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.33984375,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -9.328125,
            "text": "2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.90234375,
            "text": "loss",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_3": [
        {
            "start_logit": 13.4609375,
            "end_logit": 13.8359375,
            "text": "Waardenburg Syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -3.51171875,
            "text": "Wa",
            "probability": 0.0
        },
        {
            "start_logit": -4.18359375,
            "end_logit": 13.8359375,
            "text": "Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -4.41015625,
            "text": "Waardenburg Syndrome (WS",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -5.49609375,
            "text": "Waardenburg Syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -6.265625,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -6.3828125,
            "text": "Waardenburg",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -6.69921875,
            "text": "Waardenburg Syndrome (WS)",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -6.8046875,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -6.98828125,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -7.16015625,
            "text": "Waard",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 13.8359375,
            "text": "burg Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -7.7421875,
            "text": "Waardenburg Syndrome (WS) is an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -7.796875,
            "text": "Waarden",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -7.9765625,
            "text": "Waardenburg Syndrome (WS) is an",
            "probability": 0.0
        },
        {
            "start_logit": 13.4609375,
            "end_logit": -8.0,
            "text": "Waardenburg Syndrome (WS) is",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 13.8359375,
            "text": "ardenburg Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 13.8359375,
            "text": "enburg Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.18359375,
            "end_logit": -4.41015625,
            "text": "Syndrome (WS",
            "probability": 0.0
        },
        {
            "start_logit": -4.18359375,
            "end_logit": -5.49609375,
            "text": "Syndrome (",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_4": [
        {
            "start_logit": 14.3828125,
            "end_logit": 14.265625,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -2.966796875,
            "text": "Horn",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.408203125,
            "end_logit": 14.265625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -4.9765625,
            "text": "Horner's",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -5.1015625,
            "text": "Horner",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -5.578125,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -7.63671875,
            "text": "Horner'",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -8.640625,
            "text": "Horner's syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -8.703125,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -8.765625,
            "text": "Horner's syndrome and hypochromia iridum without an",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -8.8203125,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway injury",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -8.84375,
            "text": "Horner's syndrome and hypochromia iridum without anhidro",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 14.265625,
            "text": "'s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.15625,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway injury early in life",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.15625,
            "text": "Horner's syndrome and hypochromia iridum without",
            "probability": 0.0
        },
        {
            "start_logit": -9.0703125,
            "end_logit": 14.265625,
            "text": "congenital Horner's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.203125,
            "text": "Horner's syndrome and hypochromia iridum without anhi",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.234375,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway",
            "probability": 0.0
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.2578125,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 14.265625,
            "text": "s syndrome",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_5": [
        {
            "start_logit": 13.390625,
            "end_logit": 13.7265625,
            "text": "Waardenburg syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -3.73828125,
            "text": "Wa",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 13.7265625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -5.21484375,
            "text": "Waardenburg syndrome (WS) consists",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -5.4453125,
            "text": "Waardenburg syndrome (WS",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -5.578125,
            "text": "Waardenburg",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -6.12890625,
            "text": "Waardenburg syndrome (WS)",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -6.21875,
            "text": "Waardenburg syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.28515625,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders. WS Type I",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.44921875,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders. WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 13.7265625,
            "text": "burg syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.94921875,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.9609375,
            "text": "Waard",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.390625,
            "text": "Waarden",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.5625,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders. WS Type",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.6328125,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders. WS Type I has been mapped",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.703125,
            "text": "Waardenburg syndrome (WS) consists of",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.8671875,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": 13.7265625,
            "text": "enburg syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 13.7265625,
            "text": "ardenburg syndrome",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_6": [
        {
            "start_logit": 13.1015625,
            "end_logit": 6.6484375,
            "text": "WS",
            "probability": 0.97607421875
        },
        {
            "start_logit": 13.1015625,
            "end_logit": 2.935546875,
            "text": "WS Type II",
            "probability": 0.023681640625
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -6.26953125,
            "text": "WS Type",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -10.109375,
            "text": "WS Type II.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 6.6484375,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 6.6484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 6.6484375,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 6.6484375,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 6.6484375,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 6.6484375,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 6.6484375,
            "text": "(77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": 6.6484375,
            "text": "47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 2.935546875,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 2.935546875,
            "text": "Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 2.935546875,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 2.935546875,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 2.935546875,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 2.935546875,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 2.935546875,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 2.935546875,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_7": [
        {
            "start_logit": 13.9375,
            "end_logit": 13.90625,
            "text": "Ascher's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -3.91015625,
            "text": "Asc",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": 13.90625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -4.171875,
            "text": "Ascher",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -5.89453125,
            "text": "Ascher's",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -8.0546875,
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -8.1015625,
            "text": "Ascher'",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.0390625,
            "text": "Ascher's syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": 13.90625,
            "text": "'s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.2890625,
            "text": "Ascher's syndrome associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.6171875,
            "text": "Ascher's syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 13.90625,
            "text": "s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 13.90625,
            "text": "her's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 13.90625,
            "text": "our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.90625,
            "text": "To our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -8.0546875,
            "text": "syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.0390625,
            "text": "syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.2890625,
            "text": "syndrome associated",
            "probability": 0.0
        },
        {
            "start_logit": -4.0,
            "end_logit": -9.6171875,
            "text": "syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -3.91015625,
            "text": "our knowledge, this is the first reported case of Asc",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_8": [
        {
            "start_logit": 13.1015625,
            "end_logit": 6.6484375,
            "text": "WS",
            "probability": 0.97607421875
        },
        {
            "start_logit": 13.1015625,
            "end_logit": 2.935546875,
            "text": "WS Type II",
            "probability": 0.023681640625
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -6.26953125,
            "text": "WS Type",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -10.109375,
            "text": "WS Type II.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 6.6484375,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 6.6484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 6.6484375,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 6.6484375,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 6.6484375,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 6.6484375,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 6.6484375,
            "text": "(77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": 6.6484375,
            "text": "47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 2.935546875,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 2.935546875,
            "text": "Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 2.935546875,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 2.935546875,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 2.935546875,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 2.935546875,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 2.935546875,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 2.935546875,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_9": [
        {
            "start_logit": 13.046875,
            "end_logit": 10.921875,
            "text": "WS2",
            "probability": 1.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -4.33984375,
            "text": "WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 10.921875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -9.328125,
            "text": "WS2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 10.921875,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 10.921875,
            "text": "0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 10.921875,
            "text": "Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.921875,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 10.921875,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 10.921875,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -4.33984375,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -5.90234375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -4.33984375,
            "text": "0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33984375,
            "text": "Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -5.90234375,
            "text": "hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -4.33984375,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -4.33984375,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.33984375,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -9.328125,
            "text": "2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.90234375,
            "text": "loss",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_10": [
        {
            "start_logit": 13.3359375,
            "end_logit": 14.125,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -0.5009765625,
            "text": "Horner's syndrome due to paravertebral neurilemmoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.4375,
            "end_logit": 14.125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -3.6171875,
            "text": "Horn",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -3.986328125,
            "text": "Horner",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -5.265625,
            "text": "Horner's",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.0390625,
            "text": "Horner's syndrome due to",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.42578125,
            "text": "Horner's syndrome due to paravertebral",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.44140625,
            "text": "Horner's syndrome due to paravertebral neur",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.609375,
            "text": "Horner's syndrome due",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.73046875,
            "text": "Horner'",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.765625,
            "text": "Horner's syndrome due to paravertebral neurilemm",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -6.84375,
            "text": "Horner's syndrome due to paravertebral neurile",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -7.81640625,
            "text": "Horner's syndrome due to para",
            "probability": 0.0
        },
        {
            "start_logit": -8.78125,
            "end_logit": 14.125,
            "text": "s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 14.125,
            "text": "'s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -8.8203125,
            "text": "Horner's syndrome due to paravertebral neurilemmoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 14.125,
            "text": "Heterochromia iridis and Horner's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 14.125,
            "text": "er's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 14.125,
            "text": "iridis and Horner's syndrome",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_11": [
        {
            "start_logit": 13.4453125,
            "end_logit": 13.765625,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -3.62109375,
            "text": "Horn",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 13.765625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -5.17578125,
            "text": "Horner's",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -5.25,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemmoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -5.89453125,
            "text": "Horner",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -7.69921875,
            "text": "Horner'",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 13.765625,
            "text": "'s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.6484375,
            "text": "Horner's syndrome is reported",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.8828125,
            "text": "Horner's syndrome is reported in a",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.953125,
            "text": "Horner's syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.984375,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neur",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.03125,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.0625,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemm",
            "probability": 0.0
        },
        {
            "start_logit": -9.4609375,
            "end_logit": 13.765625,
            "text": "s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.2265625,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemmoma.",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.265625,
            "text": "Horner's syndrome is reported in",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 13.765625,
            "text": "er's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 13.765625,
            "text": "heterochromia iridis and Horner's syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -5.25,
            "text": "syndrome is reported in a 7-year old girl with paravertebral neurilemmoma",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_12": [
        {
            "start_logit": 13.328125,
            "end_logit": 12.84375,
            "text": "Aschers syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -4.43359375,
            "text": "Aschers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.328125,
            "end_logit": -4.58203125,
            "text": "Asc",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -5.1875,
            "text": "Ascher",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 12.84375,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -6.5859375,
            "text": "Aschers syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -8.03125,
            "text": "Aschers syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -8.859375,
            "text": "Aschers syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -8.984375,
            "text": "Aschers syndrome associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -9.0078125,
            "text": "Aschers syndrome associated with iris",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 12.84375,
            "text": "s syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.84375,
            "text": "hers syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.84375,
            "text": "our knowledge, this is the first reported case of Aschers syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 12.84375,
            "text": "To our knowledge, this is the first reported case of Aschers syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": -6.5859375,
            "text": "syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -4.43359375,
            "text": "s",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": -8.03125,
            "text": "syndrome associated with iris col",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -4.43359375,
            "text": "hers",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": -8.859375,
            "text": "syndrome associated with iris colob",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": -8.984375,
            "text": "syndrome associated",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_13": [
        {
            "start_logit": 12.890625,
            "end_logit": 10.7890625,
            "text": "WS2",
            "probability": 1.0
        },
        {
            "start_logit": 12.890625,
            "end_logit": -4.46875,
            "text": "WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 10.7890625,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 12.890625,
            "end_logit": -9.296875,
            "text": "WS2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 10.7890625,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 10.7890625,
            "text": "0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 10.7890625,
            "text": "Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 10.7890625,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 10.7890625,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 10.7890625,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 10.7890625,
            "text": "/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -4.46875,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -4.46875,
            "text": "0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": -4.46875,
            "text": "Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -4.46875,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -4.46875,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": -4.46875,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -4.46875,
            "text": "/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": -6.51953125,
            "text": "Sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -6.37109375,
            "end_logit": -9.296875,
            "text": "2 patients",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_14": [
        {
            "start_logit": 13.046875,
            "end_logit": 10.921875,
            "text": "WS2",
            "probability": 1.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -4.33984375,
            "text": "WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 10.921875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -9.328125,
            "text": "WS2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 10.921875,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 10.921875,
            "text": "0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 10.921875,
            "text": "Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.921875,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 10.921875,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 10.921875,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -4.33984375,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -5.90234375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -4.33984375,
            "text": "0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33984375,
            "text": "Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -5.90234375,
            "text": "hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -4.33984375,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -4.33984375,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.33984375,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -9.328125,
            "text": "2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.90234375,
            "text": "loss",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_15": [
        {
            "start_logit": 13.1015625,
            "end_logit": 6.6484375,
            "text": "WS",
            "probability": 0.97607421875
        },
        {
            "start_logit": 13.1015625,
            "end_logit": 2.935546875,
            "text": "WS Type II",
            "probability": 0.023681640625
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -6.26953125,
            "text": "WS Type",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 13.1015625,
            "end_logit": -10.109375,
            "text": "WS Type II.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 6.6484375,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 6.6484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 6.6484375,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 6.6484375,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 6.6484375,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 6.6484375,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 6.6484375,
            "text": "(77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": 6.6484375,
            "text": "47%) were the two most important diagnostic indicators for WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 2.935546875,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 2.935546875,
            "text": "Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 2.935546875,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 2.935546875,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 2.935546875,
            "text": "77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 2.935546875,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 2.935546875,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 2.935546875,
            "text": "heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_16": [
        {
            "start_logit": 13.046875,
            "end_logit": 10.921875,
            "text": "WS2",
            "probability": 1.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -4.33984375,
            "text": "WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 10.921875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.046875,
            "end_logit": -9.328125,
            "text": "WS2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 10.921875,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 10.921875,
            "text": "0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 10.921875,
            "text": "Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.921875,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 10.921875,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 10.921875,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -4.33984375,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -5.90234375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -4.33984375,
            "text": "0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.33984375,
            "text": "Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -5.90234375,
            "text": "hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -4.33984375,
            "text": "0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -4.33984375,
            "text": "heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.33984375,
            "text": "20/20, 100.0%) were the most commonly observed clinical features in Chinese WS",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -9.328125,
            "text": "2 patients",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.90234375,
            "text": "loss",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_1": [
        {
            "start_logit": 13.3125,
            "end_logit": 13.0703125,
            "text": "MLE4901",
            "probability": 1.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -4.625,
            "text": "ML",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": 13.0703125,
            "text": "01",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -6.4609375,
            "text": "MLE",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -7.671875,
            "text": "MLE49",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 13.0703125,
            "text": "4901",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 13.0703125,
            "text": "postmenopausal women were administered the NK3R antagonist MLE4901",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -9.640625,
            "text": "MLE4901 at 40 mg twice daily orally for 7 days.",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -10.0546875,
            "text": "MLE4901 at 40 mg twice daily orally for 7 days",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -10.15625,
            "text": "MLE4901 at 40 mg",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -10.2109375,
            "text": "MLE4901 at 40 mg twice daily orally",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 13.0703125,
            "text": "Eleven postmenopausal women were administered the NK3R antagonist MLE4901",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 13.0703125,
            "text": "E4901",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.0703125,
            "text": "administered the NK3R antagonist MLE4901",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 13.0703125,
            "text": "NK3R antagonist MLE4901",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 13.0703125,
            "text": "women were administered the NK3R antagonist MLE4901",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -4.625,
            "text": "postmenopausal women were administered the NK3R antagonist ML",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -4.625,
            "text": "Eleven postmenopausal women were administered the NK3R antagonist ML",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -4.625,
            "text": "administered the NK3R antagonist ML",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -4.625,
            "text": "NK3R antagonist ML",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_2": [
        {
            "start_logit": 13.4765625,
            "end_logit": 12.6796875,
            "text": "SB222200",
            "probability": 1.0
        },
        {
            "start_logit": 13.4765625,
            "end_logit": -2.369140625,
            "text": "SB22",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 13.4765625,
            "end_logit": -4.421875,
            "text": "SB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.4765625,
            "end_logit": -4.578125,
            "text": "SB2222",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 12.6796875,
            "text": "00",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": 12.6796875,
            "text": "2200",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": 12.6796875,
            "text": "NK3R antagonist SB222200",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 12.6796875,
            "text": "monkeys; and (3) the kisspeptin-induced GnRH release was blocked in the presence of the NK3R antagonist SB222200",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -2.869140625,
            "text": "senktide",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -2.869140625,
            "text": "kisspeptin-10), the NK3R agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -2.869140625,
            "text": "agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -2.869140625,
            "text": "KISS1R agonist (i.e., human kisspeptin-10), the NK3R agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -2.869140625,
            "text": "ide",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": -2.369140625,
            "text": "NK3R antagonist SB22",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -2.369140625,
            "text": "monkeys; and (3) the kisspeptin-induced GnRH release was blocked in the presence of the NK3R antagonist SB22",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -2.869140625,
            "text": "ktide",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -6.84375,
            "text": "senkt",
            "probability": 0.0
        },
        {
            "start_logit": -9.3125,
            "end_logit": -2.869140625,
            "text": "NK3R agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.6640625,
            "text": "sen",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": -4.421875,
            "text": "NK3R antagonist SB",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_3": [
        {
            "start_logit": 13.953125,
            "end_logit": 13.3359375,
            "text": "AZD4901",
            "probability": 1.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -4.02734375,
            "text": "AZ",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 13.3359375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -7.35546875,
            "text": "AZD4",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -7.51171875,
            "text": "AZD490",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 13.3359375,
            "text": "901",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 13.3359375,
            "text": "D4901",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.3984375,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.5625,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -10.078125,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -10.125,
            "text": "AZD4901 40 mg",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -10.2265625,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -10.2734375,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -10.3515625,
            "text": "AZD4901 40 mg twice daily",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 13.3359375,
            "text": "NK3R antagonist AZD4901",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -4.02734375,
            "text": "NK3R antagonist AZ",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -9.3984375,
            "text": "1 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -9.5625,
            "text": "1 40 mg twice daily orally was taken from cycle",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -9.9765625,
            "text": "1 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls)",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -10.078125,
            "text": "1 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_4": [
        {
            "start_logit": 14.3515625,
            "end_logit": 14.15625,
            "text": "ESN364",
            "probability": 1.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -3.248046875,
            "text": "ES",
            "probability": 0.0
        },
        {
            "start_logit": -3.625,
            "end_logit": 14.15625,
            "text": "64",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -5.4765625,
            "text": "ESN3",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -9.59375,
            "text": "ESN364,",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": 14.15625,
            "text": "N364",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.046875,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.0703125,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion,",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.09375,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.21875,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading to a restrained decrease",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.2265625,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.3046875,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading to a restrained",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.3046875,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of",
            "probability": 0.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -10.3125,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading to a",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 14.15625,
            "text": "NK3R antagonist, ESN364",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 14.15625,
            "text": "Oral administration of the NK3R antagonist, ESN364",
            "probability": 0.0
        },
        {
            "start_logit": -3.625,
            "end_logit": -9.59375,
            "text": "64,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -3.248046875,
            "text": "NK3R antagonist, ES",
            "probability": 0.0
        },
        {
            "start_logit": -3.625,
            "end_logit": -10.046875,
            "text": "64, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading",
            "probability": 0.0
        },
        {
            "start_logit": -3.625,
            "end_logit": -10.0703125,
            "text": "64, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion,",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_1": [
        {
            "start_logit": 14.1953125,
            "end_logit": 12.96875,
            "text": "H4K20me3",
            "probability": 1.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": 3.248046875,
            "text": "H4K20me3, H3K9me3",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -3.26953125,
            "text": "H4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -4.265625,
            "text": "H4K20me3, H3K9me3, and H3K79me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -5.40625,
            "text": "H4K20me3, H3K",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -5.8828125,
            "text": "H4K2",
            "probability": 0.0
        },
        {
            "start_logit": -5.09375,
            "end_logit": 12.96875,
            "text": "me3",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -6.3984375,
            "text": "H4K20me3, H3K9",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -6.40234375,
            "text": "H4K20",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -7.02734375,
            "text": "H4K20me3, H3K9me3, and H3K",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -7.34375,
            "text": "H4K20me3, H3K9me3, and H3K79",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.15625,
            "text": "H4K20me3, H3K9me3, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.65625,
            "text": "H4K20me3,",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.9765625,
            "text": "H4K20me3, H3K9me3,",
            "probability": 0.0
        },
        {
            "start_logit": 1.705078125,
            "end_logit": 3.248046875,
            "text": "H3K9me3",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 12.96875,
            "text": "K20me3",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 12.96875,
            "text": "potent transcription repressive mechanism, is uniformly enriched in histone methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 12.96875,
            "text": "0me3",
            "probability": 0.0
        },
        {
            "start_logit": -5.09375,
            "end_logit": 3.248046875,
            "text": "me3, H3K9me3",
            "probability": 0.0
        },
        {
            "start_logit": 1.705078125,
            "end_logit": -4.265625,
            "text": "H3K9me3, and H3K79me3",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_2": [
        {
            "start_logit": 13.6640625,
            "end_logit": 12.78125,
            "text": "H3K9me2",
            "probability": 1.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": 2.59375,
            "text": "H3K9me2, H3K27me1",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -2.408203125,
            "text": "H3K9me2, H3K27me1 and H3K27me2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -2.91796875,
            "text": "H3K9me2, H3K27me",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -3.927734375,
            "text": "H3K",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -5.4375,
            "text": "H3K9me2, H3K27me1 and H3K27me",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -5.50390625,
            "text": "H3K9",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -5.60546875,
            "text": "H3K9me",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -5.8046875,
            "text": "H3K9me2, H3K27",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.609375,
            "text": "H3K9me2, H3K27me1 and H3K",
            "probability": 0.0
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 12.78125,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.875,
            "text": "H3K9me2, H3K27me1 and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.9140625,
            "text": "H3K9me2, H3K27me1 and H3K27",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -7.06640625,
            "text": "H3K9me2, H3K",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -7.51953125,
            "text": "H3K9me2, H3K27me1 and H3K27me2, were distributed throughout both A and B chromosomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -8.765625,
            "text": "H3K9me2,",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -8.9609375,
            "text": "H3K9me2, H3K27me1 and H3K27me2, were distributed",
            "probability": 0.0
        },
        {
            "start_logit": 1.56640625,
            "end_logit": 2.59375,
            "text": "H3K27me1",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 12.78125,
            "text": "me2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.78125,
            "text": "9me2",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_3": [
        {
            "start_logit": 12.4296875,
            "end_logit": 11.5859375,
            "text": "H3K27me2",
            "probability": 1.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -4.53125,
            "text": "H3K",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -4.8359375,
            "text": "H3K27me",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -6.19140625,
            "text": "H3K27",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -6.74609375,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was not associated with some classes of constitutive heterochromatin",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 11.5859375,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -8.9921875,
            "text": "H3K27me2 showed a reduced level",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.015625,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.0703125,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.15625,
            "text": "H3K27me2 showed a reduced level on the B chromosome",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.1953125,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was not associated with some classes of",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.3046875,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.4296875,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was not associated",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.5,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was not associated with",
            "probability": 0.0
        },
        {
            "start_logit": 12.4296875,
            "end_logit": -9.59375,
            "text": "H3K27me2 showed a reduced level on the B",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 11.5859375,
            "text": "me2",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 11.5859375,
            "text": "27me2",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.74609375,
            "text": "2 showed a reduced level on the B chromosome compared with the A chromosomes and was not associated with some classes of constitutive heterochromatin",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -4.8359375,
            "text": "me",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -4.8359375,
            "text": "27me",
            "probability": 0.0
        }
    ],
    "5e6e5d1d51b80c9423000003_1": [
        {
            "start_logit": 11.0390625,
            "end_logit": 12.359375,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -7.77734375,
            "text": "schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -7.97265625,
            "text": "schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 12.359375,
            "text": "LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -8.6796875,
            "text": "schizophrenia and methamphetamine",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 12.359375,
            "text": "ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.359375,
            "text": "FABP5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 12.359375,
            "text": "RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 12.359375,
            "text": "SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 12.359375,
            "text": "5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -7.77734375,
            "text": "LDHA, which are related genes to schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -7.97265625,
            "text": "LDHA, which are related genes to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -7.77734375,
            "text": "methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -7.77734375,
            "text": "ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -7.97265625,
            "text": "methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": -7.77734375,
            "text": "FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -8.3984375,
            "text": "LDHA",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -7.77734375,
            "text": "RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -7.77734375,
            "text": "SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -7.97265625,
            "text": "ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        }
    ],
    "5e6e5d1d51b80c9423000003_2": [
        {
            "start_logit": 11.3046875,
            "end_logit": 12.109375,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -5.69921875,
            "text": "schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -8.1953125,
            "text": "schizophrenia, and attention-deficit/hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -8.7734375,
            "text": "schizophrenia, and attention",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -8.8515625,
            "text": "schizophrenia, and attention-deficit",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": 12.109375,
            "text": ", schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 12.109375,
            "text": "bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 12.109375,
            "text": "brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 12.109375,
            "text": "Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.4921875,
            "text": "schizophrenia, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.53125,
            "text": "schizophrenia, and attention-",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.5625,
            "text": "schizophrenia, and attention-deficit/",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.109375,
            "text": "psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.109375,
            "text": "diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 12.109375,
            "text": "SNAP25 and a variety of brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 12.109375,
            "text": "nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.046875,
            "end_logit": -5.69921875,
            "text": "attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": -5.69921875,
            "text": ", schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -5.69921875,
            "text": "bipolar, schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -5.69921875,
            "text": "Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        }
    ],
    "5e6e5d1d51b80c9423000003_3": [
        {
            "start_logit": 10.953125,
            "end_logit": 12.421875,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -7.515625,
            "text": "schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -8.9765625,
            "text": "schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.421875,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 12.421875,
            "text": "SNAP-25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 12.421875,
            "text": "psychiatric diseases including schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": 12.421875,
            "text": "25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 12.421875,
            "text": "key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -7.515625,
            "text": "ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -7.515625,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -7.515625,
            "text": "SNAP-25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -7.515625,
            "text": "psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": -7.515625,
            "text": "25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -7.515625,
            "text": "key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -8.9765625,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -8.9765625,
            "text": "SNAP-25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -8.9765625,
            "text": "psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": -8.9765625,
            "text": "25 is a key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -9.359375,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -8.9765625,
            "text": "key component of the synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_1": [
        {
            "start_logit": 8.484375,
            "end_logit": 4.1875,
            "text": "fibroblast growth factors",
            "probability": 0.97998046875
        },
        {
            "start_logit": 8.484375,
            "end_logit": 0.10821533203125,
            "text": "fibroblast growth factors (FGFs",
            "probability": 0.0166015625
        },
        {
            "start_logit": 8.484375,
            "end_logit": -1.484375,
            "text": "fibroblast growth factors (FGFs)",
            "probability": 0.0033721923828125
        },
        {
            "start_logit": 8.484375,
            "end_logit": -3.359375,
            "text": "fibroblast growth factors (FGF",
            "probability": 0.0005173683166503906
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.296875,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including FGFR1",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.6640625,
            "text": "fibroblast growth factors (",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.9296875,
            "text": "fibroblast",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -8.21875,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -8.234375,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -8.8984375,
            "text": "fibroblast growth factors (FGFs) exec",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -9.15625,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -9.15625,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -9.2578125,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -9.3984375,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -3.2734375,
            "end_logit": 0.10821533203125,
            "text": "FGFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.71875,
            "end_logit": 4.1875,
            "text": "growth factors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.734375,
            "end_logit": 4.1875,
            "text": ", fibroblast growth factors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.2734375,
            "end_logit": -1.484375,
            "text": "FGFs)",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 4.1875,
            "text": "soluble growth factors or cytokines. Among these factors, fibroblast growth factors",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 4.1875,
            "text": "Among these factors, fibroblast growth factors",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_2": [
        {
            "start_logit": 13.46875,
            "end_logit": 11.9921875,
            "text": "TGF-\u03b22",
            "probability": 1.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -3.25,
            "text": "TGF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.783203125,
            "end_logit": 11.9921875,
            "text": "Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.46875,
            "end_logit": -6.59375,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": -5.859375,
            "end_logit": 11.9921875,
            "text": "\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.3203125,
            "text": "TGF-\u03b22-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.46875,
            "text": "TGF-\u03b22-",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": 11.9921875,
            "text": "egulation of Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 11.9921875,
            "text": "ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.265625,
            "text": "TGF-\u03b22-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 11.9921875,
            "text": "\u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 11.9921875,
            "text": "K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.96875,
            "text": "TGF-\u03b22-mediated epithelial-to-mesenchymal transition in human retinal pigmented",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 11.9921875,
            "text": ",K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 11.9921875,
            "text": "subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 11.9921875,
            "text": "of Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -3.783203125,
            "end_logit": -3.25,
            "text": "Na,K-ATPase \u03b21-subunit in TGF",
            "probability": 0.0
        },
        {
            "start_logit": -3.783203125,
            "end_logit": -3.8125,
            "text": "Na,K-ATPase",
            "probability": 0.0
        },
        {
            "start_logit": -3.783203125,
            "end_logit": -4.45703125,
            "text": "Na,K-ATPase \u03b21-subunit",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -3.25,
            "text": "egulation of Na,K-ATPase \u03b21-subunit in TGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_3": [
        {
            "start_logit": 13.8671875,
            "end_logit": 13.0625,
            "text": "TGF-\u03b22",
            "probability": 1.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -2.7421875,
            "text": "TGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.828125,
            "end_logit": 13.0625,
            "text": "\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -6.8203125,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.6875,
            "text": "TGF-\u03b22.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.0625,
            "text": "vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 13.0625,
            "text": "growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 13.0625,
            "text": "EMT process is mediated via exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 13.0625,
            "text": "exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 13.0625,
            "text": "cytokines and growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.90625,
            "end_logit": 13.0625,
            "text": "mediated via exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -2.7421875,
            "text": "vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -2.7421875,
            "text": "growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": -2.7421875,
            "text": "EMT process is mediated via exposure to vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": -2.7421875,
            "text": "exposure to vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -2.7421875,
            "text": "cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.90625,
            "end_logit": -2.7421875,
            "text": "mediated via exposure to vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.828125,
            "end_logit": -9.6875,
            "text": "\u03b22.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -6.8203125,
            "text": "vitreous cytokines and growth factors such as TGF-",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -6.8203125,
            "text": "growth factors such as TGF-",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_4": [
        {
            "start_logit": 13.9921875,
            "end_logit": 12.921875,
            "text": "TGF-\u03b21",
            "probability": 1.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -2.513671875,
            "text": "TGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.05859375,
            "end_logit": 12.921875,
            "text": "\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 12.921875,
            "text": "ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -7.82421875,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.5546875,
            "text": "TGF-\u03b21-",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": 12.921875,
            "text": "K-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": 12.921875,
            "text": "Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.921875,
            "text": "ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 12.921875,
            "text": "K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 12.921875,
            "text": "subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.921875,
            "text": "-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.921875,
            "text": "decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.921875,
            "text": ",K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 0.0
        },
        {
            "start_logit": -5.265625,
            "end_logit": -2.513671875,
            "text": "Na,K-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -2.513671875,
            "text": "ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -5.265625,
            "end_logit": -4.1875,
            "text": "Na,K-ATPase",
            "probability": 0.0
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -4.1875,
            "text": "ATPase",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": -2.513671875,
            "text": "K-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": -2.513671875,
            "text": "Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_5": [
        {
            "start_logit": 7.95703125,
            "end_logit": 5.79296875,
            "text": "TGF-\u03b22",
            "probability": 0.779296875
        },
        {
            "start_logit": 6.6953125,
            "end_logit": 5.79296875,
            "text": "Na,K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 0.2197265625
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -0.0443115234375,
            "text": "Na,K-ATPase \u03b21",
            "probability": 0.0006442070007324219
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -2.029296875,
            "text": "Na,K-ATPase",
            "probability": 8.827447891235352e-05
        },
        {
            "start_logit": -4.515625,
            "end_logit": 5.79296875,
            "text": "\u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.90234375,
            "text": "TGF",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -5.66015625,
            "text": "Na",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -6.90234375,
            "text": "Na,K-ATPase \u03b21 is a potential contributor to TGF",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.9921875,
            "text": "TGF-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 5.79296875,
            "text": "ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -8.6796875,
            "text": "Na,K",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -10.0546875,
            "text": "TGF-\u03b22-mediated EMT in RPE",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -10.109375,
            "text": "TGF-\u03b22-mediated EMT in RPE cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -8.8828125,
            "text": "Na,K-ATPase \u03b21 is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -10.1875,
            "text": "TGF-\u03b22-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -8.9921875,
            "text": "Na,K-ATPase \u03b21 is a potential contributor to TGF-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -9.0625,
            "text": "Na,K-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -9.40625,
            "text": "Na,K-ATPase \u03b21 is a potential",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -9.578125,
            "text": "Na,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -9.578125,
            "text": "Na,K-ATPase \u03b21 is a",
            "probability": 5.960464477539063e-08
        }
    ],
    "5319abffb166e2b80600002f_6": [
        {
            "start_logit": 14.296875,
            "end_logit": 13.421875,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -2.45703125,
            "text": "TGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 13.421875,
            "text": "\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -6.01953125,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -7.80859375,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -8.2421875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -8.828125,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -8.875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.09375,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.2421875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology, expression of EMT markers",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.46875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.640625,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology, expression of",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.671875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology, expression of EMT",
            "probability": 0.0
        },
        {
            "start_logit": 14.296875,
            "end_logit": -9.7265625,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": 13.421875,
            "text": "MT (epithelial-mesenchymal transition) is crucial for cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.421875,
            "text": "epithelial-mesenchymal transition) is crucial for cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 13.421875,
            "text": "A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 13.421875,
            "text": "lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -6.01953125,
            "text": "\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -2.45703125,
            "text": "MT (epithelial-mesenchymal transition) is crucial for cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_7": [
        {
            "start_logit": 13.484375,
            "end_logit": 12.609375,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -3.041015625,
            "text": "TGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.484375,
            "end_logit": -3.408203125,
            "text": "TGF-\u03b2 and TNF-\u03b1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.484375,
            "end_logit": -6.59375,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM",
            "probability": 0.0
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 12.609375,
            "text": "\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -6.7734375,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -7.98828125,
            "text": "TGF-\u03b2 and TNF",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.015625,
            "text": "TGF-\u03b2 and TNF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.0625,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.15625,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.296875,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.3203125,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.3828125,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.5625,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.8203125,
            "text": "TGF-\u03b2 and TNF-\u03b1,",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.0390625,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines,",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.046875,
            "text": "TGF-\u03b2 and TNF-\u03b1, such",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.0859375,
            "text": "TGF-\u03b2 and",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -9.3984375,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices), suggesting",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 12.609375,
            "text": "Comprehensive expression analysis unraveled genes differentially regulated by TGF-\u03b2",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_8": [
        {
            "start_logit": 12.6953125,
            "end_logit": 12.1640625,
            "text": "CCN1",
            "probability": 1.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -5.3671875,
            "text": "CC",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -6.234375,
            "text": "CCN1 regulates the Sonic Hedgehog",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": 12.1640625,
            "text": "N1",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -6.5625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.14453125,
            "text": "CCN1 regulates the Sonic Hedgehog (",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.28125,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.44140625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.6328125,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway,",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.6875,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.6953125,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh)",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.7109375,
            "text": "CCN1 regulates the Sonic",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.796875,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.0625,
            "text": "CCN1 regulates",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.140625,
            "text": "CCN1 regulates the",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.4296875,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.4765625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression and poor prognosis",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -6.234375,
            "text": "N1 regulates the Sonic Hedgehog",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -6.5625,
            "text": "N1 regulates the Sonic Hedgehog (SHh",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -7.14453125,
            "text": "N1 regulates the Sonic Hedgehog (",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_9": [
        {
            "start_logit": 12.9921875,
            "end_logit": 12.4921875,
            "text": "CCN1",
            "probability": 1.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -4.3203125,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -5.12109375,
            "text": "CC",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -5.84375,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 0.0
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 12.4921875,
            "text": "N1",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -8.6796875,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.140625,
            "text": "CCN1 can provide a new treatment option",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.1484375,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.171875,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.2890625,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.2890625,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.328125,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.5546875,
            "text": "CCN1 can provide a",
            "probability": 0.0
        },
        {
            "start_logit": 12.9921875,
            "end_logit": -9.578125,
            "text": "CCN1 can",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 12.4921875,
            "text": "targeting CCN1",
            "probability": 0.0
        },
        {
            "start_logit": -5.90234375,
            "end_logit": -4.3203125,
            "text": "N1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -4.3203125,
            "text": "Notch1",
            "probability": 0.0
        },
        {
            "start_logit": -5.90234375,
            "end_logit": -5.84375,
            "text": "N1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -4.3203125,
            "text": "SHh and Notch1",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -4.3203125,
            "text": "pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_10": [
        {
            "start_logit": 11.8359375,
            "end_logit": 10.3828125,
            "text": "GF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -4.19140625,
            "text": "GF",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -5.21875,
            "text": "GF-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -7.54296875,
            "text": "GF-\u03b2-induced epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -8.5390625,
            "text": "GF-\u03b2-",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": 10.3828125,
            "text": "\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -9.109375,
            "text": "GF-\u03b2-induced",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -9.5390625,
            "text": "GF-\u03b2-induced epithelial-mesenchymal",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -9.609375,
            "text": "GF-\u03b2-induced epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.54296875,
            "text": "\u03b2-induced epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -8.5390625,
            "text": "\u03b2-",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -9.109375,
            "text": "\u03b2-induced",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -9.5390625,
            "text": "\u03b2-induced epithelial-mesenchymal",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -9.609375,
            "text": "\u03b2-induced epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": -7.54296875,
            "text": "epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -11.3828125,
            "end_logit": -7.54296875,
            "text": "mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -11.40625,
            "end_logit": -7.54296875,
            "text": "-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": -9.5390625,
            "text": "epithelial-mesenchymal",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": -9.609375,
            "text": "epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -11.3828125,
            "end_logit": -9.5390625,
            "text": "mesenchymal",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_11": [
        {
            "start_logit": 14.3984375,
            "end_logit": 13.765625,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -2.1640625,
            "text": "TGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.1796875,
            "end_logit": 13.765625,
            "text": "\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -7.76953125,
            "text": "TGF-",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.0078125,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.1484375,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.2109375,
            "text": "TGF-\u03b2,",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.2890625,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.71875,
            "text": "TGF-\u03b2, which is expressed",
            "probability": 0.0
        },
        {
            "start_logit": 14.3984375,
            "end_logit": -9.84375,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a master regulator of the pro-invasive tumor microenvironment",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 13.765625,
            "text": "cytokine TGF-\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -2.1640625,
            "text": "cytokine TGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.0078125,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.1484375,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.2109375,
            "text": "\u03b2,",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.2890625,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.71875,
            "text": "\u03b2, which is expressed",
            "probability": 0.0
        },
        {
            "start_logit": -4.1796875,
            "end_logit": -9.84375,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a master regulator of the pro-invasive tumor microenvironment",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": -7.171875,
            "text": "Wnt and Ras",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": -7.3671875,
            "text": "Wnt and Ras signaling",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_12": [
        {
            "start_logit": 13.2890625,
            "end_logit": 13.2578125,
            "text": "c-Myc",
            "probability": 1.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": 2.802734375,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 13.2890625,
            "end_logit": 0.0516357421875,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -2.9375,
            "text": "c",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.54296875,
            "end_logit": 13.2578125,
            "text": "Myc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -5.04296875,
            "text": "c-Myc and CDX2",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -6.87109375,
            "text": "c-Myc and CD",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -7.85546875,
            "text": "c-",
            "probability": 0.0
        },
        {
            "start_logit": 2.03515625,
            "end_logit": 2.802734375,
            "text": "EGF",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.59375,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.609375,
            "text": "c-Myc and",
            "probability": 0.0
        },
        {
            "start_logit": -8.8046875,
            "end_logit": 13.2578125,
            "text": "ranscription factors c-Myc",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.890625,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -9.3359375,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -9.484375,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -9.6796875,
            "text": "c-Myc and CDX2 mediate E-selectin",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -9.8671875,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 13.2578125,
            "text": "ption factors c-Myc",
            "probability": 0.0
        },
        {
            "start_logit": 2.03515625,
            "end_logit": 0.0516357421875,
            "text": "EGF/bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -3.54296875,
            "end_logit": 2.802734375,
            "text": "Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_13": [
        {
            "start_logit": 11.3125,
            "end_logit": 11.8515625,
            "text": "EGF",
            "probability": 1.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -2.8359375,
            "text": "EGF and/or basic FGF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 11.3125,
            "end_logit": -4.1875,
            "text": "EGF and/or basic FGF (bFGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.3125,
            "end_logit": -6.26171875,
            "text": "EGF and/or basic FGF (",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -6.8359375,
            "text": "EGF and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -7.40234375,
            "text": "EGF and/or",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -7.73046875,
            "text": "EGF and/or basic FGF (bFGF)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -8.03125,
            "text": "EGF and/or basic",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.2578125,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.3359375,
            "text": "EGF and/",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.34375,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.4453125,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.4921875,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 11.8515625,
            "text": "Treatment of HT29 and DLD-1 cells with EGF",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.546875,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 11.8515625,
            "text": "with EGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 11.8515625,
            "text": "DLD-1 cells with EGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 11.8515625,
            "text": "HT29 and DLD-1 cells with EGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": 11.8515625,
            "text": "1 cells with EGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -2.8359375,
            "text": "FGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_14": [
        {
            "start_logit": 9.3671875,
            "end_logit": 10.75,
            "text": "EGF",
            "probability": 1.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 10.75,
            "text": "cell migration induced by IGF-I or EGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 10.75,
            "text": "IGF-I or EGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.875,
            "end_logit": 10.75,
            "text": "enhanced cell migration induced by IGF-I or EGF",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 10.75,
            "text": "I or EGF",
            "probability": 0.0
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.9765625,
            "text": "EGF stimulation",
            "probability": 0.0
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -8.6484375,
            "text": "EGF stimulation. The phenotypic effects of Akt1 down-regulation were accompanied by enhanced extracellular signal-related kinase (ERK",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 10.75,
            "text": "EMT) and enhanced cell migration induced by IGF-I or EGF",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 10.75,
            "text": "or EGF",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -2.21875,
            "text": "Akt1",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -3.017578125,
            "text": "Akt1 down-regulation in IGF-IR",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -3.017578125,
            "text": "IGF-IR",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -4.921875,
            "text": "IGF-IR-stimulated cells promoted dramatic neomorphic effects characteristic of an epithelial-mesenchymal transition (EMT) and enhanced cell migration",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -4.3984375,
            "text": "cell migration induced by IGF-I",
            "probability": 0.0
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -4.3984375,
            "text": "IGF-I",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -4.921875,
            "text": "cell migration",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -8.171875,
            "text": "Akt1 down-regulation in IGF",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -8.8203125,
            "text": "Akt1 down-regulation in IGF-IR-",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -8.96875,
            "text": "Akt1 down-regulation in IGF-",
            "probability": 0.0
        },
        {
            "start_logit": -3.716796875,
            "end_logit": -9.0390625,
            "text": "Akt",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_15": [
        {
            "start_logit": 13.78125,
            "end_logit": 13.7578125,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -3.798828125,
            "text": "IGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.30859375,
            "end_logit": 13.7578125,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -6.2734375,
            "text": "IGF-II induces rapid beta-catenin",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -7.125,
            "text": "IGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.7734375,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.0234375,
            "text": "IGF-II induces rapid beta-",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.0703125,
            "text": "IGF-II induces rapid beta-catenin relocation",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.15625,
            "text": "IGF-II induces",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.171875,
            "text": "IGF-II induces rapid beta",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.34375,
            "text": "IGF-II induces rapid beta-catenin rel",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.53125,
            "text": "IGF-II induces rapid beta-catenin relocation to the",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.5390625,
            "text": "IGF-II induces rapid beta-catenin relocation to",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.6328125,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.640625,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.703125,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.71875,
            "text": "IGF-II induces rapid",
            "probability": 0.0
        },
        {
            "start_logit": -4.30859375,
            "end_logit": -6.2734375,
            "text": "II induces rapid beta-catenin",
            "probability": 0.0
        },
        {
            "start_logit": -4.30859375,
            "end_logit": -8.7734375,
            "text": "II induces rapid beta-catenin relocation to the nucleus",
            "probability": 0.0
        },
        {
            "start_logit": -4.30859375,
            "end_logit": -9.0234375,
            "text": "II induces rapid beta-",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_16": [
        {
            "start_logit": 13.5546875,
            "end_logit": 13.734375,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -3.9375,
            "text": "IGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 13.734375,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -6.62890625,
            "text": "IGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -8.4296875,
            "text": "IGF-II induces a rapid epithelium to mesenchymal transition;",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -8.59375,
            "text": "IGF-II induces",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 13.734375,
            "text": "1) IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -9.3359375,
            "text": "IGF-II induces a rapid epithelium to mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -9.390625,
            "text": "IGF-II induces a",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -9.53125,
            "text": "IGF-II induces a rapid epithelium",
            "probability": 0.0
        },
        {
            "start_logit": 13.5546875,
            "end_logit": -9.6640625,
            "text": "IGF-II induces a rapid",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 13.734375,
            "text": "(1) IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 13.734375,
            "text": ") IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 13.734375,
            "text": "We can show that (1) IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": 13.734375,
            "text": "show that (1) IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -8.4296875,
            "text": "II induces a rapid epithelium to mesenchymal transition;",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -8.59375,
            "text": "II induces",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": -3.9375,
            "text": "1) IGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.3359375,
            "text": "II induces a rapid epithelium to mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.390625,
            "text": "II induces a",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_17": [
        {
            "start_logit": 13.6953125,
            "end_logit": 13.6953125,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -3.34375,
            "text": "IGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 13.6953125,
            "text": "II",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -4.890625,
            "text": "IGF-II and E-cadherin/beta-catenin complex",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -6.59375,
            "text": "IGF-II and E-cadherin",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -6.91015625,
            "text": "IGF-",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -7.265625,
            "text": "IGF-II and E-cadherin/beta-catenin",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.5703125,
            "text": "IGF-II and E-cadherin/beta",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.609375,
            "text": "IGF-II and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.890625,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.8984375,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.9609375,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.0703125,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.078125,
            "text": "IGF-II and E-",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.2421875,
            "text": "IGF-II and E",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.5078125,
            "text": "IGF-II and E-cadherin/beta-",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": 13.6953125,
            "text": "given case of IGF-II",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -4.890625,
            "text": "II and E-cadherin/beta-catenin complex",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -6.59375,
            "text": "II and E-cadherin",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -7.265625,
            "text": "II and E-cadherin/beta-catenin",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_18": [
        {
            "start_logit": 12.1640625,
            "end_logit": 12.8203125,
            "text": "FGF-1",
            "probability": 1.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": 3.658203125,
            "text": "FGF-1 and EGF",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": -4.921875,
            "end_logit": 12.8203125,
            "text": "1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -4.75390625,
            "text": "FGF",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": 3.658203125,
            "text": "EGF",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -6.4140625,
            "text": "FGF-",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 12.8203125,
            "text": "NBT-II rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -7.95703125,
            "text": "FGF-1 and EGF, entering mitosis",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -8.34375,
            "text": "FGF-1 and",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -9.015625,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -9.21875,
            "text": "FGF-1 and EGF, entering mitosis at cell conflu",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -9.7265625,
            "text": "FGF-1 and EGF,",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.8203125,
            "text": "rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -9.8515625,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to-mesenchyme",
            "probability": 0.0
        },
        {
            "start_logit": 12.1640625,
            "end_logit": -9.859375,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.8203125,
            "text": "responses to FGF-1",
            "probability": 0.0
        },
        {
            "start_logit": -4.921875,
            "end_logit": 3.658203125,
            "text": "1 and EGF",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 3.658203125,
            "text": "NBT-II rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1 and EGF",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.95703125,
            "text": "EGF, entering mitosis",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -9.015625,
            "text": "EGF, entering mitosis at cell confluency",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_1": [
        {
            "start_logit": 13.8515625,
            "end_logit": 13.46875,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -4.0703125,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": 13.46875,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -6.8984375,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -7.3203125,
            "text": "ExTopoDB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -8.5546875,
            "text": "ExTopoDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -8.65625,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 13.46875,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.71875,
            "text": "ExTopoDB: a database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.7265625,
            "text": "ExTopoDB: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.7890625,
            "text": "ExTopoDB: a database of experimentally derived topological",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.921875,
            "text": "ExTopoDB:",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.984375,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -10.15625,
            "text": "ExTopoDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -7.3203125,
            "text": "DB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -8.5546875,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -8.65625,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.71875,
            "text": "DB: a database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.7265625,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.7890625,
            "text": "DB: a database of experimentally derived topological",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_2": [
        {
            "start_logit": 13.984375,
            "end_logit": 14.1328125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": 14.1328125,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -4.015625,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -7.953125,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": 14.1328125,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.84375,
            "text": "ExTopoDB is",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.984375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -9.09375,
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -9.1171875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -8.84375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -8.984375,
            "text": "DB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.09375,
            "text": "DB is a publicly accessible database",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -9.1171875,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -6.8828125,
            "text": "ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": -6.8828125,
            "text": "transmembrane topology prediction resulting in more reliable topological models. AVAILABILITY: http://bioinformatics.biol.uoa.gr/ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": -7.1640625,
            "text": "transmembrane topology prediction resulting in more reliable topological models. AVAILABILITY: http:/",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -9.390625,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -6.8828125,
            "text": "topological models. AVAILABILITY: http://bioinformatics.biol.uoa.gr/ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -6.8828125,
            "text": "http://bioinformatics.biol.uoa.gr/ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": -6.8828125,
            "text": "bioinformatics.biol.uoa.gr/ExTopoDB",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_3": [
        {
            "start_logit": 12.984375,
            "end_logit": 13.4609375,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 13.4609375,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -5.03515625,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -8.2421875,
            "text": "TMPDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -9.09375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -9.5546875,
            "text": "TMPDB: a",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -9.921875,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -9.984375,
            "text": "TMPDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -10.1328125,
            "text": "TMPDB:",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -10.203125,
            "text": "TMPDB: a database of experimentally-characterized transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -10.2734375,
            "text": "TMPDB: a database of experimentally-characterized",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -8.2421875,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -9.09375,
            "text": "DB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -9.5546875,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -9.921875,
            "text": "DB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -9.984375,
            "text": "DB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -10.1328125,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -10.203125,
            "text": "DB: a database of experimentally-characterized transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -10.2734375,
            "text": "DB: a database of experimentally-characterized",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -8.2421875,
            "text": ": a database",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_4": [
        {
            "start_logit": 13.6328125,
            "end_logit": 14.2578125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -3.416015625,
            "end_logit": 14.2578125,
            "text": "DB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -4.3203125,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -6.36328125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB release 6.2",
            "probability": 0.0
        },
        {
            "start_logit": -3.416015625,
            "end_logit": -6.36328125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB release 6.2",
            "probability": 0.0
        },
        {
            "start_logit": -3.416015625,
            "end_logit": -8.3046875,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB release 6.2 contains a total of 302 TM protein",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -6.85546875,
            "text": "are alpha-helical",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -7.66796875,
            "text": "are alpha-helical sequences, 17 beta",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -7.8125,
            "text": "are alpha-helical sequences, 17 beta-stranded, and 9 alpha-helical sequences with short pore-forming helices",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -8.109375,
            "text": "are alpha-helical sequences, 17 beta-stranded",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -8.21875,
            "text": "are alpha-helical sequences, 17 beta-stranded, and 9 alpha-helical sequences with short pore-forming helices buried",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -8.2578125,
            "text": "are",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -6.9609375,
            "text": "X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -6.85546875,
            "text": "alpha-helical",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.55078125,
            "text": "TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -8.9453125,
            "end_logit": -6.85546875,
            "text": "302 TM protein sequences, in which 276 are alpha-helical",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -6.36328125,
            "text": "TMPDB release 6.2",
            "probability": 0.0
        },
        {
            "start_logit": -9.53125,
            "end_logit": -6.36328125,
            "text": "experimentally-characterized transmembrane (TM) topologies. TMPDB release 6.2",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.953125,
            "text": "X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -6.85546875,
            "text": "276 are alpha-helical",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_5": [
        {
            "start_logit": 14.1015625,
            "end_logit": 13.828125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -3.796875,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 13.828125,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -7.80078125,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -8.453125,
            "text": "ExTopoDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 13.828125,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.4375,
            "text": "ExTopoDB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.6875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u0436\u2534-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.7421875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.8828125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.90625,
            "text": "ExTopoDB provides an up",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.953125,
            "text": "ExTopoDB provides an up to date, complete",
            "probability": 0.0
        },
        {
            "start_logit": 14.1015625,
            "end_logit": -9.9765625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 13.828125,
            "text": "topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 13.828125,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -8.453125,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -9.4375,
            "text": "DB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -9.6875,
            "text": "DB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u0436\u2534-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -9.7421875,
            "text": "DB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -9.8828125,
            "text": "DB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_6": [
        {
            "start_logit": 13.1171875,
            "end_logit": 13.515625,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": 13.515625,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -4.8984375,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -8.4765625,
            "text": "TMPDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.140625,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies.",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.71875,
            "text": "TMPDB: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.734375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -10.140625,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -10.265625,
            "text": "TMPDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -10.3671875,
            "text": "TMPDB: a database of experimentally-characterized transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -10.390625,
            "text": "TMPDB:",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -10.5234375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologi",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -8.4765625,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -9.140625,
            "text": "DB: a database of experimentally-characterized transmembrane topologies.",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -9.71875,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -9.734375,
            "text": "DB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -10.140625,
            "text": "DB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -10.265625,
            "text": "DB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -10.3671875,
            "text": "DB: a database of experimentally-characterized transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": -4.609375,
            "end_logit": -10.390625,
            "text": "DB:",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_7": [
        {
            "start_logit": 13.3046875,
            "end_logit": 13.7109375,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": 13.7109375,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -4.7421875,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.5859375,
            "text": "TMPDB is a database",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.7265625,
            "text": "TMPDB is",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.15625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM)",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.2890625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies.",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.3984375,
            "text": "TMPDB is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.5078125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.546875,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.5859375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.9453125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -10.2578125,
            "text": "TMPDB is a database of",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -10.2734375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologi",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -8.5859375,
            "text": "DB is a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -8.7265625,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -9.15625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM)",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -9.2890625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies.",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -9.3984375,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -9.5078125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_8": [
        {
            "start_logit": 13.625,
            "end_logit": 13.8125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": 13.8125,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -4.33203125,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.046875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.171875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.2265625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.265625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.2734375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.4375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.546875,
            "text": "TMPDB were determined experimentally by means of X-",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": 13.8125,
            "text": "TM topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.6953125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.7421875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.84375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.890625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.9453125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.8125,
            "text": "topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.8125,
            "text": "gies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": -9.046875,
            "text": "DB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": -9.171875,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_9": [
        {
            "start_logit": 14.078125,
            "end_logit": 13.75,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -3.83203125,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": 13.75,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -7.8359375,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -8.3046875,
            "text": "ExTopoDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 13.75,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.375,
            "text": "ExTopoDB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.6640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.8203125,
            "text": "ExTopoDB provides an up",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.859375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.9296875,
            "text": "ExTopoDB provides an up to date, complete",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -9.9609375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 14.078125,
            "end_logit": -10.0703125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 13.75,
            "text": "topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 13.75,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": -8.3046875,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": -9.375,
            "text": "DB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": -9.6640625,
            "text": "DB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": -9.8203125,
            "text": "DB provides an up",
            "probability": 0.0
        },
        {
            "start_logit": -4.125,
            "end_logit": -9.859375,
            "text": "DB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_10": [
        {
            "start_logit": 14.09375,
            "end_logit": 13.765625,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -3.798828125,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": 13.765625,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -7.83984375,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -8.3984375,
            "text": "ExTopoDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 13.765625,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.375,
            "text": "ExTopoDB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.6640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.765625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.8046875,
            "text": "ExTopoDB provides an up",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.8125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \ufffd-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -9.890625,
            "text": "ExTopoDB provides an up to date, complete",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -10.21875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 13.765625,
            "text": "topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 13.765625,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -8.3984375,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -9.375,
            "text": "DB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -9.6640625,
            "text": "DB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -9.765625,
            "text": "DB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -9.8046875,
            "text": "DB provides an up",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_11": [
        {
            "start_logit": 12.515625,
            "end_logit": 13.640625,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 13.640625,
            "text": "DB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.515625,
            "end_logit": -5.34765625,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -6.94921875,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 13.640625,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 13.640625,
            "text": ": ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -8.203125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 13.640625,
            "text": "UNLABELLED: ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -8.8671875,
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.0,
            "text": "ExTopoDB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.125,
            "text": "ExTopoDB is",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.7734375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.8359375,
            "text": "ExTopoDB is a",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.1171875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.1328125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.1796875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.25,
            "text": "ExTopoDB is a publicly",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.34375,
            "text": "ExTopoDB is a publicly accessible database of",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -10.4765625,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": -4.5390625,
            "end_logit": -8.203125,
            "text": "DB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_12": [
        {
            "start_logit": 13.625,
            "end_logit": 13.8125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": 13.8125,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -4.33203125,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.046875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.171875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.2265625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.265625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.2734375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.4375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.546875,
            "text": "TMPDB were determined experimentally by means of X-",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": 13.8125,
            "text": "TM topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.6953125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.7421875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.84375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.890625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.9453125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.8125,
            "text": "topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.8125,
            "text": "gies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": -9.046875,
            "text": "DB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -4.1015625,
            "end_logit": -9.171875,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_13": [
        {
            "start_logit": 14.0,
            "end_logit": 13.6171875,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -3.962890625,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 13.6171875,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -7.8984375,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -8.171875,
            "text": "ExTopoDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 13.6171875,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.3203125,
            "text": "ExTopoDB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.6640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.703125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.734375,
            "text": "ExTopoDB provides an up",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.8125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -9.921875,
            "text": "ExTopoDB provides an up to date, complete",
            "probability": 0.0
        },
        {
            "start_logit": 14.0,
            "end_logit": -10.0390625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 13.6171875,
            "text": "topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 13.6171875,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -8.171875,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -9.3203125,
            "text": "DB provides an up to date",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -9.6640625,
            "text": "DB provides an up to date, complete and comprehensive",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -9.703125,
            "text": "DB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -9.734375,
            "text": "DB provides an up",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_14": [
        {
            "start_logit": 13.59375,
            "end_logit": 13.7421875,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": 13.7421875,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -4.3671875,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.2578125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.265625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.2734375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.2734375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.3359375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.546875,
            "text": "TMPDB were determined experimentally by means of X-",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.6015625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.6484375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation experiment",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 13.7421875,
            "text": "TM topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.7421875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.8671875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.8984375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.9375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.953125,
            "text": "TMPDB were",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.7421875,
            "text": "topologies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 13.7421875,
            "text": "gies in TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -9.2578125,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_15": [
        {
            "start_logit": 13.0625,
            "end_logit": 13.5234375,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": 13.5234375,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -5.0078125,
            "text": "TMP",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -8.5234375,
            "text": "TMPDB is a database",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -8.7265625,
            "text": "TMPDB is",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -8.8984375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM)",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.15625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.1875,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.2890625,
            "text": "TMPDB is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.4609375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.875,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -10.140625,
            "text": "TMPDB is a database of",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -8.5234375,
            "text": "DB is a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -8.7265625,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -8.8984375,
            "text": "DB is a database of experimentally-characterized transmembrane (TM)",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -9.15625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -9.1875,
            "text": "DB is a database of experimentally-characterized transmembrane (TM",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -9.2890625,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -9.4609375,
            "text": "DB is a database of experimentally-characterized transmembrane (",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -9.875,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_16": [
        {
            "start_logit": 13.9609375,
            "end_logit": 13.6015625,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -3.9453125,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 13.6015625,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -6.90234375,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -7.7109375,
            "text": "ExTopoDB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -8.625,
            "text": "ExTopoDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 13.6015625,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -9.3359375,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -9.3828125,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -9.8203125,
            "text": "ExTopoDB: a database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -9.828125,
            "text": "ExTopoDB: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -9.890625,
            "text": "ExTopoDB: a database of experimentally derived topological",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -10.1640625,
            "text": "ExTopoDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -10.171875,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -10.171875,
            "text": "ExTopoDB:",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -7.7109375,
            "text": "DB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -8.625,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -9.3359375,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -9.3828125,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -9.8203125,
            "text": "DB: a database of experimentally derived topological models of",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_17": [
        {
            "start_logit": 14.0546875,
            "end_logit": 13.7421875,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -3.806640625,
            "text": "ExT",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": 13.7421875,
            "text": "DB",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -7.47265625,
            "text": "ExTopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -7.8203125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 13.7421875,
            "text": "opoDB",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -8.9140625,
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.25,
            "text": "ExTopoDB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.265625,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.375,
            "text": "ExTopoDB is",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.8515625,
            "text": "ExTopoDB is a",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.9375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.984375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -7.8203125,
            "text": "DB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -8.9140625,
            "text": "DB is a publicly accessible database",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.25,
            "text": "DB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.265625,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.8515625,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.9375,
            "text": "DB is a publicly accessible database of experimentally derived topological",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_1": [
        {
            "start_logit": 9.7265625,
            "end_logit": 11.4140625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -3.154296875,
            "text": "kidney tissues",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 11.4140625,
            "text": "renal cells/kidney",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 11.4140625,
            "text": "/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 11.4140625,
            "text": "murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.4140625,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.4140625,
            "text": "anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 11.4140625,
            "text": "Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.4140625,
            "text": "aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.4140625,
            "text": "\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -3.154296875,
            "text": "renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -3.154296875,
            "text": "/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -3.154296875,
            "text": "murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -3.154296875,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": -3.154296875,
            "text": "anti\u2011aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -3.154296875,
            "text": "Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -3.154296875,
            "text": "aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -3.154296875,
            "text": "\u2011aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -8.015625,
            "text": "renal",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -8.1796875,
            "text": "renal cells",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_2": [
        {
            "start_logit": 11.140625,
            "end_logit": 11.65625,
            "text": "Renal",
            "probability": 1.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -1.650390625,
            "text": "Renal expression of klotho is diminished in polycystic kidney",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.8203125,
            "end_logit": 11.65625,
            "text": "rming growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.6171875,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.6484375,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (PKD)",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.71875,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (PKD",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": 11.65625,
            "text": "ing growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 11.65625,
            "text": "TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.203125,
            "text": "Renal expression of klotho",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 11.65625,
            "text": "IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 11.65625,
            "text": "growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.640625,
            "text": "Renal expression of klotho is",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.6484375,
            "text": "Renal expression",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 11.65625,
            "text": "insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 11.65625,
            "text": "\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -1.650390625,
            "text": "kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -1.650390625,
            "text": "TGF-\u03b2) and insulin-like growth factor (IGF). Renal expression of klotho is diminished in polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -1.650390625,
            "text": "IGF). Renal expression of klotho is diminished in polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -1.650390625,
            "text": "growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal expression of klotho is diminished in polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -1.650390625,
            "text": "insulin-like growth factor (IGF). Renal expression of klotho is diminished in polycystic kidney",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_3": [
        {
            "start_logit": 10.671875,
            "end_logit": 12.4296875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 12.4296875,
            "text": "\u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 12.4296875,
            "text": "aging membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 12.4296875,
            "text": "antiaging membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -8.828125,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -8.875,
            "text": "kidney, and deletion of the Klotho gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 12.4296875,
            "text": "fortuitously discovered antiaging membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 12.4296875,
            "text": "Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 12.4296875,
            "text": "Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 12.4296875,
            "text": "membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -9.625,
            "text": "kidney, and deletion of the Klotho gene in mice",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -9.8984375,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -9.921875,
            "text": "kidney, and deletion of the Klotho",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -9.9375,
            "text": "kidney, and deletion of the Klotho gene in mice causes",
            "probability": 0.0
        },
        {
            "start_logit": 10.671875,
            "end_logit": -9.9765625,
            "text": "kidney,",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -7.9375,
            "text": "\u03b1Klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -7.9375,
            "text": "aging membrane protein \u03b1Klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -7.9375,
            "text": "antiaging membrane protein \u03b1Klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -7.9375,
            "text": "fortuitously discovered antiaging membrane protein \u03b1Klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -7.9375,
            "text": "Klotho",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_4": [
        {
            "start_logit": 9.5546875,
            "end_logit": 12.6171875,
            "text": "heart",
            "probability": 1.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": 12.6171875,
            "text": "myocardial levels of Klotho and protects the heart",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -4.515625,
            "text": "heart against ischaemia-reperfusion injury",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 12.6171875,
            "text": "High-intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 12.6171875,
            "text": "Klotho and protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.6171875,
            "text": "protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.6171875,
            "text": "intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 12.6171875,
            "text": "the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 12.6171875,
            "text": "interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 12.6171875,
            "text": "-intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.1484375,
            "text": "heart against ischaemia-reperfusion",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.859375,
            "text": "heart against",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.9609375,
            "text": "heart against ischaemia-reperfusion injury.",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.1875,
            "text": "heart against ischaemia",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.859375,
            "text": "heart against ischaemia-",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -4.515625,
            "text": "myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -4.8984375,
            "text": "myocardial",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -8.1484375,
            "text": "myocardial levels of Klotho and protects the heart against ischaemia-reperfusion",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -8.4921875,
            "text": "myocardial levels of Klotho",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -8.59375,
            "text": "myocardial levels of Klotho and protects the",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_5": [
        {
            "start_logit": 6.984375,
            "end_logit": 12.734375,
            "text": "cerebellum",
            "probability": 0.9873046875
        },
        {
            "start_logit": 2.640625,
            "end_logit": 12.734375,
            "text": "Purkinje cells of the cerebellum",
            "probability": 0.01282501220703125
        },
        {
            "start_logit": -10.671875,
            "end_logit": 12.734375,
            "text": "of the cerebellum",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 12.734375,
            "text": "anti-aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 12.734375,
            "text": "Klotho is an anti-aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 0.0
        },
        {
            "start_logit": -11.0234375,
            "end_logit": 12.734375,
            "text": "aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 0.0
        },
        {
            "start_logit": 2.640625,
            "end_logit": -3.111328125,
            "text": "Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": 6.984375,
            "end_logit": -9.34375,
            "text": "cerebellum.",
            "probability": 0.0
        },
        {
            "start_logit": 2.640625,
            "end_logit": -6.3828125,
            "text": "Purkinje cells of the",
            "probability": 0.0
        },
        {
            "start_logit": 2.640625,
            "end_logit": -6.86328125,
            "text": "Purkinje cells of",
            "probability": 0.0
        },
        {
            "start_logit": 2.640625,
            "end_logit": -7.046875,
            "text": "Purkinje",
            "probability": 0.0
        },
        {
            "start_logit": 2.640625,
            "end_logit": -9.34375,
            "text": "Purkinje cells of the cerebellum.",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -3.111328125,
            "text": "anti-aging protein expressed in Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -3.111328125,
            "text": "Klotho is an anti-aging protein expressed in Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": -11.0234375,
            "end_logit": -3.111328125,
            "text": "aging protein expressed in Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -6.3828125,
            "text": "of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -6.3828125,
            "text": "anti-aging protein expressed in Purkinje cells of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -6.3828125,
            "text": "Klotho is an anti-aging protein expressed in Purkinje cells of the",
            "probability": 0.0
        },
        {
            "start_logit": -11.0234375,
            "end_logit": -6.3828125,
            "text": "aging protein expressed in Purkinje cells of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -6.86328125,
            "text": "of",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_6": [
        {
            "start_logit": 10.6640625,
            "end_logit": 11.453125,
            "text": "lens",
            "probability": 1.0
        },
        {
            "start_logit": 10.6640625,
            "end_logit": -9.65625,
            "text": "lens.",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 11.453125,
            "text": "Klotho is expressed in limited tissues including the lens",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": 11.453125,
            "text": "tissues including the lens",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 11.453125,
            "text": "limited tissues including the lens",
            "probability": 0.0
        },
        {
            "start_logit": -11.046875,
            "end_logit": 11.453125,
            "text": "the lens",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -8.65625,
            "text": "Klotho is expressed in limited tissues including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": -8.65625,
            "text": "tissues including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -8.7265625,
            "text": "Klotho is expressed in limited tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": -8.7265625,
            "text": "tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -8.65625,
            "text": "limited tissues including the",
            "probability": 0.0
        },
        {
            "start_logit": -11.046875,
            "end_logit": -8.65625,
            "text": "the",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -8.7265625,
            "text": "limited tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -9.65625,
            "text": "Klotho is expressed in limited tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": -9.65625,
            "text": "tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.65625,
            "text": "limited tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -11.046875,
            "end_logit": -9.65625,
            "text": "the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -9.859375,
            "text": "Klotho is expressed in limited tissues including",
            "probability": 0.0
        },
        {
            "start_logit": -10.9140625,
            "end_logit": -9.859375,
            "text": "tissues including",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.859375,
            "text": "limited tissues including",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_7": [
        {
            "start_logit": 8.140625,
            "end_logit": 12.0078125,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -4.17578125,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.234375,
            "end_logit": 12.0078125,
            "text": "Klotho in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 12.0078125,
            "text": "ulating Klotho in the brain",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.3359375,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.5390625,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.671875,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.703125,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.75,
            "text": "brain may lead to novel therapeutics to people suffering or at risk",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -9.9375,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases",
            "probability": 0.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -10.015625,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -3.521484375,
            "text": "amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -4.17578125,
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -8.453125,
            "text": "amyotrophic lateral sclerosis, and demyelinating diseases such as multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -9.515625,
            "text": "amyotrophic lateral sclerosis, and demyelinating diseases such as",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -9.671875,
            "text": "amyotrophic lateral",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -9.96875,
            "text": "amyotrophic lateral sclerosis, and demyelinating",
            "probability": 0.0
        },
        {
            "start_logit": -2.859375,
            "end_logit": -10.015625,
            "text": "amyotrophic",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": -3.521484375,
            "text": "and amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": -3.521484375,
            "text": "multiple sclerosis",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_8": [
        {
            "start_logit": 9.7109375,
            "end_logit": 12.3984375,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -6.5859375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -6.66015625,
            "text": "kidneys, parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 12.3984375,
            "text": "Klotho, a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 12.3984375,
            "text": ": Klotho, a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 12.3984375,
            "text": "single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -7.8515625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.7109375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.765625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.015625,
            "text": "kidneys, parathyroid glands, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.453125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.671875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain,",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.703125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.7109375,
            "text": "kidneys, parathyroid glands, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.7265625,
            "text": "kidneys, parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -6.5859375,
            "text": "parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -6.66015625,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": -6.5859375,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -7.8515625,
            "text": "parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -6.5859375,
            "text": ", parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_9": [
        {
            "start_logit": 11.2265625,
            "end_logit": 12.109375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -7.01953125,
            "text": "kidney, parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -8.84375,
            "text": "kidney, parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.21875,
            "text": "kidney, parathyroid gland, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.375,
            "text": "kidney,",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.46875,
            "text": "kidney, parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.5390625,
            "text": "kidney, parathyroid gland, and choroid plexus.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 12.109375,
            "text": "Klotho is a transmembrane protein expressed primarily in kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.8125,
            "text": "kidney, parathyroid gland, and choroid",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -7.01953125,
            "text": "parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -8.84375,
            "text": "parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -7.01953125,
            "text": "Klotho is a transmembrane protein expressed primarily in kidney, parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -7.01953125,
            "text": ", parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -7.01953125,
            "text": "gland",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -9.21875,
            "text": "parathyroid gland, and",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -9.46875,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -9.5390625,
            "text": "parathyroid gland, and choroid plexus.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -9.8125,
            "text": "parathyroid gland, and choroid",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": -8.84375,
            "text": "choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": -9.5390625,
            "text": "choroid plexus.",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_10": [
        {
            "start_logit": 9.7109375,
            "end_logit": 10.7734375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -5.70703125,
            "text": "kidney tubules",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 10.7734375,
            "text": "Klotho, an antiaging gene with restricted organ distribution, is mainly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.3984375,
            "text": "kidney tubules; the mutant mice",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.5078125,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -9.84375,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -10.0,
            "text": "kidney tubules; the mutant",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -5.70703125,
            "text": "Klotho, an antiaging gene with restricted organ distribution, is mainly expressed in the kidney tubules",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -7.1796875,
            "text": "Klotho, an antiaging gene with restricted organ distribution",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -8.34375,
            "text": "Klotho, an antiaging gene with restricted organ distribution, is mainly expressed in the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -8.515625,
            "text": "Klotho, an antiaging gene with restricted organ distribution, is mainly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.171875,
            "text": "osteoporesis, features common to patients with chronic renal failure. Concei",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -8.765625,
            "text": "Klotho, an antiaging gene with restricted organ",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -9.171875,
            "text": "Concei",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -9.1328125,
            "text": "Klotho, an antiaging gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -9.2109375,
            "text": "Klotho, an antiaging gene with restricted organ distribution, is mainly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -9.7109375,
            "text": "osteoporesis, features common to patients with chronic renal failure. Conce",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -9.171875,
            "text": "life span, arteriosclerosis, anemia, and osteoporesis, features common to patients with chronic renal failure. Concei",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -9.171875,
            "text": "esis, features common to patients with chronic renal failure. Concei",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -9.171875,
            "text": "shortened life span, arteriosclerosis, anemia, and osteoporesis, features common to patients with chronic renal failure. Concei",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_11": [
        {
            "start_logit": 11.75,
            "end_logit": 11.265625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": 11.265625,
            "text": "parathyroid glands, kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.75,
            "end_logit": -6.57421875,
            "text": "kidney, and choroid plexus, counteracts aging and increases the life span. Accor",
            "probability": 0.0
        },
        {
            "start_logit": 11.75,
            "end_logit": -8.9765625,
            "text": "kidney, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 11.265625,
            "text": ", kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.75,
            "end_logit": -9.296875,
            "text": "kidney, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.75,
            "end_logit": -9.796875,
            "text": "kidney, and choroid plexus,",
            "probability": 0.0
        },
        {
            "start_logit": 11.75,
            "end_logit": -10.0390625,
            "text": "kidney, and choroid plexus, counteracts aging and increases the life span",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 11.265625,
            "text": "Klotho, a membrane protein mainly expressed in parathyroid glands, kidney",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -3.822265625,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -6.57421875,
            "text": "parathyroid glands, kidney, and choroid plexus, counteracts aging and increases the life span. Accor",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -8.9765625,
            "text": "parathyroid glands, kidney, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -9.296875,
            "text": "parathyroid glands, kidney, and",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -9.59375,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -3.822265625,
            "text": "Klotho, a membrane protein mainly expressed in parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -9.796875,
            "text": "parathyroid glands, kidney, and choroid plexus,",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -10.0390625,
            "text": "parathyroid glands, kidney, and choroid plexus, counteracts aging and increases the life span",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": -6.57421875,
            "text": ", kidney, and choroid plexus, counteracts aging and increases the life span. Accor",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": -6.57421875,
            "text": "Accor",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -6.57421875,
            "text": "choroid plexus, counteracts aging and increases the life span. Accor",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_12": [
        {
            "start_logit": 9.9296875,
            "end_logit": 12.96875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -4.9296875,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(OH)2D3 form",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -6.09375,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(OH)2D3",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 12.96875,
            "text": ": Klotho, a protein expressed mainly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 12.96875,
            "text": "Klotho, a protein expressed mainly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.96875,
            "text": "UNLABELLED: Klotho, a protein expressed mainly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.8515625,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(OH",
            "probability": 0.0
        },
        {
            "start_logit": -10.8984375,
            "end_logit": 12.96875,
            "text": "in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.0234375,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(OH)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.4296875,
            "text": "kidney, is required for the inhibitory effect of FGF23",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.640625,
            "text": "kidney, is required",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.640625,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.78125,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.828125,
            "text": "kidney,",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.875,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -9.0859375,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -9.203125,
            "text": "kidney, is required for the inhibitory effect of FGF23 on",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -9.375,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -4.9296875,
            "text": "1,25(OH)2D3 form",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -4.9296875,
            "text": "OH)2D3 form",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_13": [
        {
            "start_logit": 9.2890625,
            "end_logit": 13.1328125,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -2.947265625,
            "text": "kidney in the distal but not in the proximal tubule",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.203125,
            "end_logit": 13.1328125,
            "text": "FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.1328125,
            "text": "FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": 13.1328125,
            "text": "ing of FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -5.890625,
            "text": "kidney in the distal but not in the proximal tubule. The mech",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.1328125,
            "text": "Klotho that is expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 13.1328125,
            "text": "the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -8.3671875,
            "text": "kidney in the distal but not in the proximal",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -8.78125,
            "text": "kidney in the distal but not",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -8.9765625,
            "text": "kidney in the distal but not in the proximal tubule. The mec",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -9.078125,
            "text": "kidney in the distal but not in the proximal tubule. The",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -9.40625,
            "text": "kidney in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -9.4140625,
            "text": "kidney in the distal",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -2.947265625,
            "text": "proximal tubule",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -2.947265625,
            "text": "tubule",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -2.947265625,
            "text": "FGF receptor requires a protein named Klotho that is expressed in the kidney in the distal but not in the proximal tubule",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -2.947265625,
            "text": "FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney in the distal but not in the proximal tubule",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": -2.947265625,
            "text": "ing of FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney in the distal but not in the proximal tubule",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -2.947265625,
            "text": "Klotho that is expressed in the kidney in the distal but not in the proximal tubule",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_14": [
        {
            "start_logit": 11.125,
            "end_logit": 12.1171875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": 12.1171875,
            "text": "lotho, an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": 12.1171875,
            "text": "brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 12.1171875,
            "text": "ho, an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.765625,
            "text": "kidney. The",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 12.1171875,
            "text": "anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.9140625,
            "text": "kidney.",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -4.12109375,
            "text": "lotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -4.12109375,
            "text": "ho",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -7.1328125,
            "text": "lotho, an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": -7.1328125,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -8.75,
            "text": "lotho, an anti-aging gene, is mainly expressed in the brain and",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -7.1328125,
            "text": "ho, an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -8.859375,
            "text": "lotho, an anti-aging gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -7.1328125,
            "text": "anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -9.21875,
            "text": "lotho, an anti-aging gene, is mainly expressed in the",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -9.328125,
            "text": "lotho, an anti-aging gene, is mainly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -9.359375,
            "text": "lotho, an anti-aging gene, is mainly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": -8.75,
            "text": "brain and",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -9.71875,
            "text": "lot",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_15": [
        {
            "start_logit": 10.5859375,
            "end_logit": 12.5,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 12.5,
            "text": "membrane-bound protein predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.5,
            "text": "Klotho is a membrane-bound protein predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -8.9296875,
            "text": "kidney, where",
            "probability": 0.0
        },
        {
            "start_logit": -10.90625,
            "end_logit": 12.5,
            "text": "the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.0859375,
            "text": "kidney, where it acts as a permissive co-receptor",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.125,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor 23",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.515625,
            "text": "kidney,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.5546875,
            "text": "kidney, where it",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.671875,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.84375,
            "text": "kidney, where it acts as a permissive co-receptor for",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.9453125,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor 23.",
            "probability": 0.0
        },
        {
            "start_logit": 10.5859375,
            "end_logit": -9.9453125,
            "text": "kidney, where it acts",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -8.8046875,
            "text": "membrane-bound protein",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -8.9296875,
            "text": "membrane-bound protein predominantly expressed in the kidney, where",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -8.8046875,
            "text": "Klotho is a membrane-bound protein",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -9.0,
            "text": "membrane",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -8.9296875,
            "text": "Klotho is a membrane-bound protein predominantly expressed in the kidney, where",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -9.0859375,
            "text": "membrane-bound protein predominantly expressed in the kidney, where it acts as a permissive co-receptor",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -9.125,
            "text": "membrane-bound protein predominantly expressed in the kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor 23",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_16": [
        {
            "start_logit": 9.3203125,
            "end_logit": 7.4296875,
            "text": "stria vascularis",
            "probability": 0.97802734375
        },
        {
            "start_logit": 9.3203125,
            "end_logit": 3.58203125,
            "text": "stria vascularis and spiral ligament of the inner ear",
            "probability": 0.02093505859375
        },
        {
            "start_logit": 9.3203125,
            "end_logit": 0.9033203125,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 0.0014362335205078125
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -3.140625,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -4.234375,
            "text": "stria vascularis and spiral ligament",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -0.466064453125,
            "end_logit": 3.58203125,
            "text": "inner ear",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.05859375,
            "text": "stria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.7109375,
            "text": "str",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -8.203125,
            "text": "stria vascular",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -8.375,
            "text": "stria vascularis and spiral ligament of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -8.53125,
            "text": "stria vascularis and spiral ligament of the inner ear and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -8.640625,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.01171875,
            "end_logit": 3.58203125,
            "text": "spiral ligament of the inner ear",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.466064453125,
            "end_logit": 0.9033203125,
            "text": "inner ear and in the distal convoluted tubule of the kidney",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -9.171875,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney, likely",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -9.296875,
            "text": "stria vascularis and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -9.375,
            "text": "stria vascularis and spiral ligament of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -9.3984375,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -9.4921875,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.4296875,
            "text": "is",
            "probability": 5.960464477539063e-08
        }
    ],
    "6060996394d57fd879000045_17": [
        {
            "start_logit": 10.78125,
            "end_logit": 12.421875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -7.26171875,
            "text": "kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -8.109375,
            "text": "kidney, parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.421875,
            "text": "antiaging protein of Klotho is a transmembrane protein mainly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 12.421875,
            "text": "Klotho is a transmembrane protein mainly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.421875,
            "text": "of Klotho is a transmembrane protein mainly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 12.421875,
            "text": "the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 12.421875,
            "text": "transmembrane protein mainly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -9.171875,
            "text": "kidney, parathyroid glands and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -9.5859375,
            "text": "kidney, parathyroid glands and",
            "probability": 0.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -9.9453125,
            "text": "kidney, parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 10.78125,
            "end_logit": -10.0,
            "text": "kidney, parathyroid glands and choroid plexus of the brain.",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -7.26171875,
            "text": "parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": -7.26171875,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -7.26171875,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -7.26171875,
            "text": ", parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -8.109375,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": -7.26171875,
            "text": "antiaging protein of Klotho is a transmembrane protein mainly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -7.26171875,
            "text": "Klotho is a transmembrane protein mainly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -7.26171875,
            "text": "of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_18": [
        {
            "start_logit": 10.7578125,
            "end_logit": 12.484375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -6.73046875,
            "text": "kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -8.4140625,
            "text": "kidney and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 12.484375,
            "text": "hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.484375,
            "text": ": The hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 12.484375,
            "text": "klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 12.484375,
            "text": "klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 12.484375,
            "text": "BACKGROUND: The hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.8671875,
            "end_logit": 12.484375,
            "text": "encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.359375,
            "text": "kidney and choroid plexus of",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.453125,
            "text": "kidney and choroid",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.5703125,
            "text": "kidney and choroid plexus of the",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.6796875,
            "text": "kidney and",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": -6.73046875,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -6.73046875,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -6.73046875,
            "text": "hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -6.73046875,
            "text": ": The hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": -6.73046875,
            "text": "klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": -6.73046875,
            "text": "klotho, encoded by the gene klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": -6.73046875,
            "text": "of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_19": [
        {
            "start_logit": 11.34375,
            "end_logit": 11.96875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -7.45703125,
            "text": "kidney and expressed in a limited number of other organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -8.3515625,
            "text": "kidney and expressed in a limited number of other organs",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -8.9453125,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.40625,
            "text": "kidney and expressed in a limited number of",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.453125,
            "text": "kidney and expressed",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.5,
            "text": "kidney and expressed in a limited number of other organs, including the",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.5234375,
            "text": "kidney and expressed in a limited",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.5703125,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.6171875,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in choroid",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.625,
            "text": "kidney and expressed in a limited number of other organs, including",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.6875,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 11.96875,
            "text": "Klotho is most abundant in kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 11.96875,
            "text": "most abundant in kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -7.45703125,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -7.45703125,
            "text": "Klotho is most abundant in kidney and expressed in a limited number of other organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": -7.45703125,
            "text": "other organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": -7.45703125,
            "text": "most abundant in kidney and expressed in a limited number of other organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -7.45703125,
            "text": "organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -8.9453125,
            "text": "brain, where klotho levels are highest in choroid plexus",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_20": [
        {
            "start_logit": 9.609375,
            "end_logit": 12.3984375,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.74609375,
            "text": "kidneys, parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 12.3984375,
            "text": "Klotho, a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 12.3984375,
            "text": ": Klotho, a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.3984375,
            "text": "single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.8984375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 12.3984375,
            "text": "pass transmembrane protein primarily expressed in the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.5390625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -9.046875,
            "text": "kidneys, parathyroid glands, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -9.4453125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -9.5703125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain,",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -9.5859375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and released",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -6.375,
            "text": "parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -6.74609375,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -6.375,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": -6.375,
            "text": ", parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -6.375,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -6.375,
            "text": "Klotho, a single-pass transmembrane protein primarily expressed in the kidneys, parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_21": [
        {
            "start_logit": 13.9921875,
            "end_logit": 14.3828125,
            "text": "parathyroid gland",
            "probability": 1.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": 14.3828125,
            "text": "gland",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -3.83203125,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.5703125,
            "text": "parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.1171875,
            "text": "parathyroid gland, where FGF-23",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.453125,
            "text": "parathyroid gland, where FGF-23 decreases parathyroid hormone",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.765625,
            "text": "parathyroid gland, where",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 14.3828125,
            "text": "in the parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 14.3828125,
            "text": "Klotho also is expressed in the parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.9765625,
            "text": "parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -10.109375,
            "text": "parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -10.1953125,
            "text": "parathyroid gland,",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -8.5703125,
            "text": "gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -9.1171875,
            "text": "gland, where FGF-23",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -9.453125,
            "text": "gland, where FGF-23 decreases parathyroid hormone",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -9.765625,
            "text": "gland, where",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -9.9765625,
            "text": "gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -10.109375,
            "text": "gland, where FGF-23 decreases parathyroid hormone expression and secretion, further",
            "probability": 0.0
        },
        {
            "start_logit": -2.896484375,
            "end_logit": -10.1953125,
            "text": "gland,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -3.83203125,
            "text": "in the parathyroid",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_22": [
        {
            "start_logit": 9.9375,
            "end_logit": 11.0703125,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.046875,
            "text": "brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.234375,
            "text": "brain parenchyma from early postnatal development into adulthood",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.5,
            "text": "brain parenchyma from early postnatal development into adulthood.",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.1015625,
            "text": "brain parenchyma from",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.2265625,
            "text": "brain parenchyma from early postnatal development into",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 11.0703125,
            "text": "klotho mRNA and protein in rat brain",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.359375,
            "text": "brain parenchyma from early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 11.0703125,
            "text": "Expression of klotho mRNA and protein in rat brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": 11.0703125,
            "text": "rat brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -7.046875,
            "text": "klotho mRNA and protein in rat brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -7.046875,
            "text": "Expression of klotho mRNA and protein in rat brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": -7.046875,
            "text": "rat brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -8.1640625,
            "text": "klotho mRNA and protein in",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -8.234375,
            "text": "klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -8.5,
            "text": "klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood.",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -8.1640625,
            "text": "Expression of klotho mRNA and protein in",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": -8.234375,
            "text": "Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -8.7421875,
            "text": "klotho mRNA and protein",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": -8.234375,
            "text": "rat brain parenchyma from early postnatal development into adulthood",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_23": [
        {
            "start_logit": 6.16015625,
            "end_logit": 9.390625,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -4.63671875,
            "text": "brain parenchyma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -9.375,
            "end_logit": 9.390625,
            "text": "klotho is expressed within the brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -9.796875,
            "end_logit": 9.390625,
            "text": "where klotho is expressed within the brain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.96875,
            "end_logit": 9.390625,
            "text": "within the brain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -11.078125,
            "end_logit": 9.390625,
            "text": "otho is expressed within the brain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.109375,
            "text": "brain parenchyma, and no data is available",
            "probability": 0.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.2421875,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.5859375,
            "text": "brain parenchyma, and no data",
            "probability": 0.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.6328125,
            "text": "brain parenchyma, and no data is available as",
            "probability": 0.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.6640625,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across postnatal development.",
            "probability": 0.0
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -9.7890625,
            "text": "brain parenchyma,",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -4.63671875,
            "text": "klotho is expressed within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -4.63671875,
            "text": "where klotho is expressed within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -4.63671875,
            "text": "within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -11.078125,
            "end_logit": -4.63671875,
            "text": "otho is expressed within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -6.85546875,
            "text": "klotho is",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -6.85546875,
            "text": "where klotho is",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -7.859375,
            "text": "klotho is expressed",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -7.9453125,
            "text": "klotho",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_24": [
        {
            "start_logit": 8.96875,
            "end_logit": 12.59375,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 12.59375,
            "text": "klotho protein expressed widely throughout the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.59375,
            "text": "throughout the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.59375,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely throughout the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 12.59375,
            "text": "otho protein expressed widely throughout the brain",
            "probability": 0.0
        },
        {
            "start_logit": 8.96875,
            "end_logit": -9.984375,
            "text": "brain.",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -7.15234375,
            "text": "klotho protein expressed widely throughout the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -7.15234375,
            "text": "throughout the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -7.15234375,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely throughout the",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -7.15234375,
            "text": "otho protein expressed widely throughout the",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -8.8671875,
            "text": "klotho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -8.8671875,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.0390625,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.125,
            "text": "Immunohistochemistry",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.203125,
            "text": "Immunohistochemistry revealed a protein expression pattern",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -8.8671875,
            "text": "otho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -9.6328125,
            "text": "klotho protein expressed widely throughout",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -9.6796875,
            "text": "klotho protein expressed widely",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -9.6328125,
            "text": "throughout",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.6328125,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely throughout",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_25": [
        {
            "start_logit": 11.234375,
            "end_logit": 12.03125,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 12.03125,
            "text": "brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.8046875,
            "text": "kidney.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 12.03125,
            "text": "Klotho, an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 12.03125,
            "text": "anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": 12.03125,
            "text": "and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -7.08984375,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -7.08984375,
            "text": "Klotho, an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -7.08984375,
            "text": "anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -9.1328125,
            "text": "brain and",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -9.1328125,
            "text": "Klotho, an anti-aging gene, is mainly expressed in the brain and",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -9.1953125,
            "text": "Klotho, an anti-aging gene, is mainly expressed in the",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -9.296875,
            "text": "Klotho, an anti-aging gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -9.8046875,
            "text": "brain and kidney.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -9.4375,
            "text": "Klotho, an anti-aging gene, is mainly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -9.5078125,
            "text": "Klotho, an anti-aging gene, is mainly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.1328125,
            "text": "anti-aging gene, is mainly expressed in the brain and",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": -9.1328125,
            "text": "and",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.1953125,
            "text": "anti-aging gene, is mainly expressed in the",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.296875,
            "text": "anti-aging gene",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_26": [
        {
            "start_logit": 11.5859375,
            "end_logit": 11.734375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -7.5390625,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -8.34375,
            "text": "kidney, reproductive organs",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": 11.734375,
            "text": "brain, kidney",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.109375,
            "text": "kidney, reproductive organs, pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.203125,
            "text": "kidney, reproductive organs, pituitary gland, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.2890625,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.71875,
            "text": "kidney,",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.8828125,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid gland.",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -9.921875,
            "text": "kidney, reproductive organs, pituitary",
            "probability": 0.0
        },
        {
            "start_logit": 11.5859375,
            "end_logit": -10.0,
            "text": "kidney, reproductive",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 11.734375,
            "text": ", kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 11.734375,
            "text": "Klotho mRNA, however, is expressed only in brain, kidney",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -7.03125,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -7.5390625,
            "text": "brain, kidney, reproductive organs, pituitary gland, and parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": -7.5390625,
            "text": "parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -7.5390625,
            "text": "reproductive organs, pituitary gland, and parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -7.03125,
            "text": "Klotho mRNA, however, is expressed only in brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -8.34375,
            "text": "brain, kidney, reproductive organs",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -7.5390625,
            "text": "pituitary gland, and parathyroid gland",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_27": [
        {
            "start_logit": 10.8515625,
            "end_logit": 12.265625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.65625,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.5390625,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.609375,
            "text": "kidney, while RT-PCR detected low levels of expression",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 12.265625,
            "text": "single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.8828125,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine, and ovaries",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.265625,
            "text": "Northern blot analysis using the rat klotho cDNA probe identified a single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.265625,
            "text": "2 kb in size expressed predominantly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 12.265625,
            "text": "transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 12.265625,
            "text": "klotho cDNA probe identified a single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.2421875,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.7265625,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -5.7890625,
            "text": "single transcript of 5.2",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -5.7890625,
            "text": "Northern blot analysis using the rat klotho cDNA probe identified a single transcript of 5.2",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -5.7890625,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -5.7890625,
            "text": "transcript of 5.2",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -5.7890625,
            "text": "klotho cDNA probe identified a single transcript of 5.2",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -7.65625,
            "text": "lung",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": -7.65625,
            "text": "brain, lung",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -8.8828125,
            "text": "lung, intestine, and ovaries",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_28": [
        {
            "start_logit": 11.125,
            "end_logit": 10.9765625,
            "text": "choroid plexus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 4.3828125,
            "end_logit": 10.9765625,
            "text": "brain, Klotho proteins were localized at choroid plexus",
            "probability": 0.0011882781982421875
        },
        {
            "start_logit": 4.3828125,
            "end_logit": 5.9921875,
            "text": "brain",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 11.125,
            "end_logit": -5.0625,
            "text": "choroid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 10.9765625,
            "text": "plexus",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.9765625,
            "text": "at choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -8.421875,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -8.890625,
            "text": "choroid plexus,",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.203125,
            "text": "choroid plexus, where the proteins were",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.2734375,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of ependymal cells",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.5078125,
            "text": "choroid plexus, where the proteins were dominantly localized at",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.5234375,
            "text": "choroid plexus, where the proteins were dominantly localized",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.5703125,
            "text": "choroid plexus, where the proteins",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.796875,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.8046875,
            "text": "choroid plexus, where",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.8671875,
            "text": "choroid plexus, where the proteins were dominant",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 10.9765625,
            "text": "In brain, Klotho proteins were localized at choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 10.9765625,
            "text": "Klotho proteins were localized at choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 4.3828125,
            "end_logit": -5.0625,
            "text": "brain, Klotho proteins were localized at choroid",
            "probability": 0.0
        },
        {
            "start_logit": 4.3828125,
            "end_logit": -8.421875,
            "text": "brain, Klotho proteins were localized at choroid plexus, where the proteins were dominantly localized at the apical plasma membrane",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_29": [
        {
            "start_logit": 8.9453125,
            "end_logit": 13.15625,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -2.701171875,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -3.080078125,
            "text": "kidneys and brain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.6875,
            "end_logit": 13.15625,
            "text": "for the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": -9.078125,
            "end_logit": 13.15625,
            "text": "the kidneys",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.796875,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.87890625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.546875,
            "text": "kidneys and",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.7734375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.1328125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-kl",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.2890625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.390625,
            "text": "kidneys and brain, other tissues",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.5703125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.6015625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-kloth",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.734375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho,",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -9.7890625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter",
            "probability": 0.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -10.0,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-",
            "probability": 0.0
        },
        {
            "start_logit": -5.91015625,
            "end_logit": -2.701171875,
            "text": "\u03b1-klotho",
            "probability": 0.0
        },
        {
            "start_logit": -6.1796875,
            "end_logit": -2.701171875,
            "text": "brain, other tissues primarily expressed the shorter-form \u03b1-klotho",
            "probability": 0.0
        },
        {
            "start_logit": -6.1796875,
            "end_logit": -3.080078125,
            "text": "brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_30": [
        {
            "start_logit": 10.7578125,
            "end_logit": 12.4765625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -7.546875,
            "text": "kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -8.390625,
            "text": "kidney, parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 12.4765625,
            "text": "anti-aging protein predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.4765625,
            "text": "Klotho is an anti-aging protein predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 12.4765625,
            "text": "aging protein predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 12.4765625,
            "text": "the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.8984375,
            "end_logit": 12.4765625,
            "text": "in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.578125,
            "text": "kidney, parathyroid glands and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -9.9921875,
            "text": "kidney, parathyroid glands and",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -10.015625,
            "text": "kidney, parathyroid glands and choroid plexus of the brain.",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -10.1171875,
            "text": "kidney, parathyroid glands and choroid plexus of the",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -10.15625,
            "text": "kidney, parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 10.7578125,
            "end_logit": -10.2109375,
            "text": "kidney, parathyroid glands and choroid plexus of",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": -7.546875,
            "text": "parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -7.546875,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -7.546875,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -7.546875,
            "text": ", parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -7.546875,
            "text": "anti-aging protein predominantly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": -8.390625,
            "text": "parathyroid glands",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_31": [
        {
            "start_logit": 7.69921875,
            "end_logit": 13.2109375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": 0.72802734375,
            "text": "kidney, choroid plexus in the brain, and the main cells of the parathyroid gland",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -5.25390625,
            "end_logit": 13.2109375,
            "text": "distal tubule cells of the kidney",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -9.34375,
            "end_logit": 13.2109375,
            "text": "of the kidney",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.2109375,
            "text": "tubule cells of the kidney",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 13.2109375,
            "text": "tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 13.2109375,
            "text": "klotho gene is expressed principally in the important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.21484375,
            "text": "kidney, choroid plexus in the brain, and the main cells of the parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -0.399169921875,
            "end_logit": 0.72802734375,
            "text": "parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -8.5625,
            "text": "kidney, choroid plexus in the brain",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -8.6640625,
            "text": "kidney, choroid plexus in the brain, and the main cells",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -8.8359375,
            "text": "kidney, choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -8.9609375,
            "text": "kidney, choroid plexus in the brain, and the main cells of the",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -9.0234375,
            "text": "kidney, choroid plexus in the brain, and",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -9.1171875,
            "text": "kidney, choroid plexus in the brain, and the main cells of",
            "probability": 0.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -9.59375,
            "text": "kidney, choroid plexus in the brain, and the",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": 0.72802734375,
            "text": "distal tubule cells of the kidney, choroid plexus in the brain, and the main cells of the parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 0.72802734375,
            "text": "gland",
            "probability": 0.0
        },
        {
            "start_logit": -0.399169921875,
            "end_logit": -7.21484375,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": 0.72802734375,
            "text": "of the kidney, choroid plexus in the brain, and the main cells of the parathyroid gland",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_32": [
        {
            "start_logit": 10.46875,
            "end_logit": 12.671875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.671875,
            "text": "klotho gene is predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.46875,
            "end_logit": -10.0,
            "text": "kidney and",
            "probability": 0.0
        },
        {
            "start_logit": 10.46875,
            "end_logit": -10.03125,
            "text": "kidney and the expression level of klotho RNA",
            "probability": 0.0
        },
        {
            "start_logit": 10.46875,
            "end_logit": -10.1328125,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure (CRF",
            "probability": 0.0
        },
        {
            "start_logit": 10.46875,
            "end_logit": -10.25,
            "text": "kidney and the expression level",
            "probability": 0.0
        },
        {
            "start_logit": 10.46875,
            "end_logit": -10.3203125,
            "text": "kidney and the expression level of klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -6.890625,
            "text": "klotho gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.3671875,
            "text": "klotho gene is predominantly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.53125,
            "text": "klotho gene is predominantly expressed in the",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.75,
            "text": "klotho gene is",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.78125,
            "text": "klotho gene is predominantly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.9609375,
            "text": "klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.0,
            "text": "klotho gene is predominantly expressed in the kidney and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.03125,
            "text": "klotho gene is predominantly expressed in the kidney and the expression level of klotho RNA",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.1875,
            "text": "klotho gene is predominantly",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.25,
            "text": "klotho gene is predominantly expressed in the kidney and the expression level",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.3203125,
            "text": "klotho gene is predominantly expressed in the kidney and the expression level of klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -10.03125,
            "text": "klotho RNA",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": -10.1328125,
            "text": "CRF",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_33": [
        {
            "start_logit": 10.5625,
            "end_logit": 12.515625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.515625,
            "text": "klotho gene: a gene predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 12.515625,
            "text": ": a gene predominantly expressed in the kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.4921875,
            "text": "kidney is",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.515625,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus metabolism",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.8828125,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus metabolism.",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -10.15625,
            "text": "kidney is a fundamental regulator",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -10.21875,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -7.12890625,
            "text": "klotho gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -8.4765625,
            "text": "klotho gene: a gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -8.4765625,
            "text": ": a gene",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.4921875,
            "text": "klotho gene: a gene predominantly expressed in the kidney is",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.4921875,
            "text": "klotho",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.515625,
            "text": "klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.5546875,
            "text": "klotho gene: a gene predominantly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -9.515625,
            "text": "calcium/phosphorus metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -9.734375,
            "text": "klotho gene: a gene predominantly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -9.4921875,
            "text": ": a gene predominantly expressed in the kidney is",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -9.515625,
            "text": ": a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -9.515625,
            "text": "phosphorus metabolism",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_34": [
        {
            "start_logit": 10.9296875,
            "end_logit": 12.3515625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -8.8203125,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -8.828125,
            "text": "kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.3515625,
            "text": "Klotho mRNA and protein expression levels in rat brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 12.3515625,
            "text": "rat brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 12.3515625,
            "text": "brain and kidney",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -9.796875,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively.",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -9.84375,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -10.0703125,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -8.3671875,
            "text": "Klotho mRNA and protein expression levels in rat brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -8.3671875,
            "text": "rat brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": -8.3671875,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -8.8203125,
            "text": "tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -8.828125,
            "text": "tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -8.8203125,
            "text": "Klotho mRNA and protein expression levels in rat brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -8.828125,
            "text": "Klotho mRNA and protein expression levels in rat brain and kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -8.8203125,
            "text": "rat brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -8.828125,
            "text": "rat brain and kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": -8.8203125,
            "text": "reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": -8.8203125,
            "text": "brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_1": [
        {
            "start_logit": 14.2109375,
            "end_logit": 14.5234375,
            "text": "telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -2.177734375,
            "text": "telangiectasia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.78125,
            "end_logit": 14.5234375,
            "text": "s",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -5.46875,
            "text": "telangiectasias, erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -8.0625,
            "text": "telangiectasias, erythro",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -8.8125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -9.0234375,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -9.40625,
            "text": "telangiectasias, erythrocyt",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": 14.5234375,
            "text": "TEMPI (telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -9.796875,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting)",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -9.9140625,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -10.09375,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -10.109375,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gamm",
            "probability": 0.0
        },
        {
            "start_logit": 14.2109375,
            "end_logit": -10.109375,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting) syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -2.78125,
            "end_logit": -5.46875,
            "text": "s, erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.70703125,
            "end_logit": -5.46875,
            "text": "erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.78125,
            "end_logit": -8.0625,
            "text": "s, erythro",
            "probability": 0.0
        },
        {
            "start_logit": -2.78125,
            "end_logit": -8.8125,
            "text": "s, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -2.78125,
            "end_logit": -9.0234375,
            "text": "s, erythrocytosis with elevated erythropoietin, monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": -2.177734375,
            "text": "TEMPI (telangiectasia",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_2": [
        {
            "start_logit": 13.8515625,
            "end_logit": 14.21875,
            "text": "telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -1.0146484375,
            "text": "telangiectasia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.1875,
            "end_logit": 14.21875,
            "text": "s",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -7.37890625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -8.609375,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting)",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.1171875,
            "text": "telangiectasias, elevated erythropoietin level and erythro",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.21875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.578125,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.7265625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 14.21875,
            "text": "TEMPI syndrome (telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -9.890625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -10.0234375,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is a recently",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -10.046875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.0
        },
        {
            "start_logit": 13.8515625,
            "end_logit": -10.1875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is a",
            "probability": 0.0
        },
        {
            "start_logit": -3.1875,
            "end_logit": -7.37890625,
            "text": "s, elevated erythropoietin level and erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -1.0146484375,
            "text": "TEMPI syndrome (telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -3.1875,
            "end_logit": -8.609375,
            "text": "s, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting)",
            "probability": 0.0
        },
        {
            "start_logit": -3.1875,
            "end_logit": -9.1171875,
            "text": "s, elevated erythropoietin level and erythro",
            "probability": 0.0
        },
        {
            "start_logit": -3.1875,
            "end_logit": -9.21875,
            "text": "s, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -3.1875,
            "end_logit": -9.578125,
            "text": "s, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_3": [
        {
            "start_logit": 12.65625,
            "end_logit": 13.3828125,
            "text": "Telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -2.64453125,
            "text": "Telangiectasia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.90625,
            "end_logit": 13.3828125,
            "text": "s",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -5.80078125,
            "text": "Telangiectasias, Erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.1953125,
            "text": "Telangiectasias, Erythro",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.1953125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.3359375,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.3828125,
            "text": "TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.6328125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 13.3828125,
            "text": "constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.3828125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.78125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.0078125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.0859375,
            "text": "Telangiectasias, Erythrocyt",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.1875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.421875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric",
            "probability": 0.0
        },
        {
            "start_logit": -4.90625,
            "end_logit": -5.80078125,
            "text": "s, Erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -2.64453125,
            "text": "TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -2.64453125,
            "text": "constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -2.64453125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_4": [
        {
            "start_logit": 9.1484375,
            "end_logit": 12.6484375,
            "text": "teleangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -0.04986572265625,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 12.6484375,
            "text": "s",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -4.890625,
            "text": "teleangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 12.6484375,
            "text": "angiectasias",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.6484375,
            "text": "TEMPI syndrome is a recently described condition defined by teleangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.0078125,
            "text": "teleangiectasias, elevated erythropoietin and erythro",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.28125,
            "text": "teleangiect",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.375,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.46484375,
            "text": "tele",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -8.09375,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -8.7578125,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -8.8203125,
            "text": "teleangiectasias, elevated erythropoietin and erythrocyt",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.2421875,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.578125,
            "text": "teleangiectasias, elevated erythropoietin",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.75,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.8515625,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.875,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting.",
            "probability": 0.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -9.921875,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perineph",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -0.04986572265625,
            "text": "erythrocytosis",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_5": [
        {
            "start_logit": 12.65625,
            "end_logit": 13.3828125,
            "text": "Telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -2.64453125,
            "text": "Telangiectasia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.90625,
            "end_logit": 13.3828125,
            "text": "s",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -5.80078125,
            "text": "Telangiectasias, Erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.1953125,
            "text": "Telangiectasias, Erythro",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.1953125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.3359375,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.3828125,
            "text": "TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.6328125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 13.3828125,
            "text": "constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.3828125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.78125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.0078125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.0859375,
            "text": "Telangiectasias, Erythrocyt",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.1875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -10.421875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric",
            "probability": 0.0
        },
        {
            "start_logit": -4.90625,
            "end_logit": -5.80078125,
            "text": "s, Erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -2.64453125,
            "text": "TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -2.64453125,
            "text": "constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -2.64453125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasia",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_1": [
        {
            "start_logit": 10.5546875,
            "end_logit": 12.6796875,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -1.560546875,
            "text": "age, blood pressure, clinical features, duration and diabetes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 12.6796875,
            "text": "'accuracy' of age",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -8.1328125,
            "text": "age, blood pressure, clinical features, duration and",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -8.265625,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -8.578125,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.3046875,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2))",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.4453125,
            "text": "age, blood pressure, clinical features, duration and diabetes (",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.4609375,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.671875,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.7734375,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -9.9453125,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2)) scoring by non-stroke",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -10.078125,
            "text": "age, blood pressure, clinical features,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -10.0859375,
            "text": "age, blood pressure,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -10.1015625,
            "text": "age,",
            "probability": 0.0
        },
        {
            "start_logit": -3.65625,
            "end_logit": -1.560546875,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": -1.560546875,
            "text": "clinical features, duration and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": -1.560546875,
            "text": "and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -1.560546875,
            "text": ", clinical features, duration and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -1.560546875,
            "text": ", duration and diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_2": [
        {
            "start_logit": 10.3828125,
            "end_logit": 12.4296875,
            "text": "diabetes",
            "probability": 0.9990234375
        },
        {
            "start_logit": 2.974609375,
            "end_logit": 12.4296875,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.0006070137023925781
        },
        {
            "start_logit": 2.974609375,
            "end_logit": 3.271484375,
            "text": "age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 12.4296875,
            "text": "clinical features, duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.1875,
            "end_logit": 12.4296875,
            "text": "duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 12.4296875,
            "text": "low risk was based on an age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -7.90234375,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease, crescendo TIA, or atrial fibrillation",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.4296875,
            "text": "blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -7.96484375,
            "text": "diabetes (ABCD2) score <4",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.4296875,
            "text": "and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 12.4296875,
            "text": "an age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.53125,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease, crescendo TIA",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.671875,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.6328125,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.75,
            "text": "diabetes (ABCD2) score",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.8046875,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -10.0546875,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -10.1328125,
            "text": "diabetes (ABCD2)",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -10.1328125,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease, crescendo TIA, or atrial",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -10.140625,
            "text": "diabetes (ABCD2) score <4 and the absence of high risk features, including known carotid disease, crescendo TIA, or",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_3": [
        {
            "start_logit": 11.078125,
            "end_logit": 12.15625,
            "text": "age",
            "probability": 0.6728515625
        },
        {
            "start_logit": 11.078125,
            "end_logit": 11.1953125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.25927734375
        },
        {
            "start_logit": 9.75,
            "end_logit": 11.1953125,
            "text": "diabetes",
            "probability": 0.06768798828125
        },
        {
            "start_logit": 11.078125,
            "end_logit": -8.46875,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 12.15625,
            "text": "[age",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -8.765625,
            "text": "age, blood pressure, clinical features and duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.15625,
            "text": "compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 11.1953125,
            "text": "clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.453125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 11.1953125,
            "text": "[age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": 11.1953125,
            "text": ", ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 11.1953125,
            "text": "and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 11.1953125,
            "text": "ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.8984375,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.96875,
            "text": "age, blood pressure, clinical features and duration",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -10.21875,
            "text": "age, blood pressure, clinical features and duration of symptoms (",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -10.25,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 9.75,
            "end_logit": -9.9140625,
            "text": "diabetes (ABCD2) score, ABCD and brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA",
            "probability": 0.0
        },
        {
            "start_logit": 9.75,
            "end_logit": -10.0234375,
            "text": "diabetes (ABCD2) score, ABCD and brain infarction",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -8.46875,
            "text": "clinical features",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_4": [
        {
            "start_logit": 10.609375,
            "end_logit": 12.640625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": 0.1461181640625,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 10.609375,
            "end_logit": -7.390625,
            "text": "age, blood pressure, clinical features, duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -7.55859375,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -8.1875,
            "text": "age, blood pressure, clinical features, duration of symptoms and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.640625,
            "text": "examined the association of the age",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -8.5234375,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after TIA",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -8.9375,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.2265625,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.2578125,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.4140625,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.4609375,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.4921875,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2)",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.6328125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after TIA,",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.65625,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.75,
            "text": "age, blood pressure, clinical features, duration of",
            "probability": 0.0
        },
        {
            "start_logit": -1.0791015625,
            "end_logit": 0.1461181640625,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 0.1461181640625,
            "text": "and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.40625,
            "end_logit": 0.1461181640625,
            "text": ", duration of symptoms and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.53125,
            "end_logit": 0.1461181640625,
            "text": "clinical features, duration of symptoms and diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_5": [
        {
            "start_logit": 10.5234375,
            "end_logit": 12.7109375,
            "text": "Age",
            "probability": 1.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -4.1171875,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -7.546875,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -7.62890625,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 12.7109375,
            "text": ": The ABCD2 score (Age",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -8.046875,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.7109375,
            "text": "ABCD2 score (Age",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -8.1015625,
            "text": "Age, Blood pressure, Clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.046875,
            "text": "Age, Blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.1015625,
            "text": "Age, Blood pressure, Clinical features, Duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.3046875,
            "text": "Age, Blood pressure, Clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.5,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.6640625,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.7265625,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes)",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.7578125,
            "text": "Age, Blood pressure, Clinical features, Duration of",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.9453125,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack who are",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -9.9921875,
            "text": "Age,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -10.0,
            "text": "Age, Blood",
            "probability": 0.0
        },
        {
            "start_logit": 10.5234375,
            "end_logit": -10.078125,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack who",
            "probability": 0.0
        },
        {
            "start_logit": -6.15234375,
            "end_logit": -4.1171875,
            "text": "Diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_6": [
        {
            "start_logit": 10.7109375,
            "end_logit": 12.546875,
            "text": "age",
            "probability": 0.97900390625
        },
        {
            "start_logit": 10.7109375,
            "end_logit": 8.6640625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0203094482421875
        },
        {
            "start_logit": 7.2421875,
            "end_logit": 8.6640625,
            "text": "diabetes",
            "probability": 0.0006327629089355469
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.546875,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -8.578125,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.546875,
            "text": "TIA) can be predicted by scores incorporating age",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.078125,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.4453125,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.46875,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.9765625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.03125,
            "text": "age,",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.3125,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.4375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.6015625,
            "text": "age, blood",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 8.6640625,
            "text": "clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 8.6640625,
            "text": "ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 8.6640625,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.6640625,
            "text": ", clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.6640625,
            "text": ", duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 8.6640625,
            "text": "and diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_7": [
        {
            "start_logit": 10.65625,
            "end_logit": 12.6015625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -1.1025390625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 10.65625,
            "end_logit": -7.25,
            "text": "age, blood pressure, clinical symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -7.87890625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -8.203125,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 12.6015625,
            "text": ": Modifications to the age",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -8.4296875,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -8.6015625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -8.9140625,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -8.953125,
            "text": "age, blood pressure, clinical symptoms, duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -9.21875,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -9.3125,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -9.40625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -9.6015625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2)",
            "probability": 0.0
        },
        {
            "start_logit": 10.65625,
            "end_logit": -9.6484375,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms,",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -1.1025390625,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -7.06640625,
            "text": "diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia in addition to acute blood pressure (BP) elevation and history of diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -1.1025390625,
            "text": "clinical symptoms, duration of symptoms, and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -1.1025390625,
            "text": "blood pressure, clinical symptoms, duration of symptoms, and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -7.87890625,
            "text": "diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_8": [
        {
            "start_logit": 10.5078125,
            "end_logit": 12.7265625,
            "text": "Age",
            "probability": 1.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -1.5576171875,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -10.1875,
            "end_logit": 12.7265625,
            "text": "ABCD2 (Age",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -8.203125,
            "text": "Age, Blood pressure, Clinical features, Duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -8.3046875,
            "text": "Age, Blood pressure, Clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -8.8203125,
            "text": "Age, Blood pressure, Clinical features, Duration,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -9.359375,
            "text": "Age, Blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -9.5703125,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes)",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -9.5859375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -9.6953125,
            "text": "Age, Blood pressure, Clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -9.8359375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk of stroke",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.109375,
            "text": "Age, Blood pressure, Clinical features,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.15625,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.2109375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.2265625,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk of stroke.",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.2734375,
            "text": "Age, Blood pressure,",
            "probability": 0.0
        },
        {
            "start_logit": 10.5078125,
            "end_logit": -10.2734375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk",
            "probability": 0.0
        },
        {
            "start_logit": -3.16015625,
            "end_logit": -1.5576171875,
            "text": "Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": -1.5576171875,
            "text": "Clinical features, Duration, Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -1.5576171875,
            "text": ", Diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_9": [
        {
            "start_logit": 9.8828125,
            "end_logit": 13.140625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": 13.140625,
            "text": ": We prospectively calculated the ABCD(2) score (age",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.6171875,
            "text": "age [> or = 60 years: 1 point",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.6875,
            "text": "age [> or = 60 years: 1 point]",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -9.1875,
            "text": "age [> or = 60 years: 1 point]; blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -9.4453125,
            "text": "age [> or = 60",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -4.7578125,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -7.0703125,
            "text": "diabetes mellitus [yes: 1]) in consecutive TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian",
            "probability": 0.0
        },
        {
            "start_logit": -9.125,
            "end_logit": -4.7578125,
            "text": "0]; duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -7.50390625,
            "text": "diabetes mellitus [yes: 1]) in consecutive TIA",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -4.7578125,
            "text": "; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": -4.7578125,
            "text": "0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -4.7578125,
            "text": "<10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -4.7578125,
            "text": "; duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": -4.7578125,
            "text": "duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -8.6328125,
            "text": "diabetes mellitus",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.0703125,
            "text": "TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -6.78125,
            "text": "; clinical features [unilateral weakness: 2, speech disturbance without weakness: 1, other symptom: 0]; duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -9.03125,
            "text": "diabetes mellitus [yes: 1])",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.50390625,
            "text": "TIA",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_10": [
        {
            "start_logit": 9.953125,
            "end_logit": 13.015625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": 13.015625,
            "text": "A age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.578125,
            "end_logit": 13.015625,
            "text": "TIA patients with a high ABCD2 score of 4 or more (A age",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.46484375,
            "text": "age over 60 years",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.66015625,
            "text": "age over 60",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1640625,
            "text": "age over",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.25,
            "text": "age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.3125,
            "text": "age over 60 years [1 point]",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.6875,
            "text": "age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features, including unilateral weakness",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -9.40625,
            "text": "age over 60 years [1 point]: B blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -4.4296875,
            "end_logit": -3.94140625,
            "text": "atrial fibrillation",
            "probability": 0.0
        },
        {
            "start_logit": -4.4296875,
            "end_logit": -6.9765625,
            "text": "atrial",
            "probability": 0.0
        },
        {
            "start_logit": -6.46484375,
            "end_logit": -5.328125,
            "text": "Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -4.4296875,
            "end_logit": -8.265625,
            "text": "atrial fibrillation, or hypercoagulable states",
            "probability": 0.0
        },
        {
            "start_logit": -9.21875,
            "end_logit": -3.94140625,
            "text": "fibrillation",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -5.328125,
            "text": "D2: Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -5.328125,
            "text": ": Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -3.94140625,
            "text": "carotid stenosis, severe intracranial artery stenosis, microembolic signals on transcranial Doppler, atrial fibrillation",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -5.328125,
            "text": "C Clinical features, including unilateral weakness [2 points] and speech disturbance without weakness [1 point] D2: Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.46484375,
            "end_logit": -8.09375,
            "text": "Diabetes [1 point] and Duration of symptoms",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_11": [
        {
            "start_logit": 10.3828125,
            "end_logit": 12.796875,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 12.796875,
            "text": "transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.6640625,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance] [C], transient ischemic attack duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.7265625,
            "text": "age [A], blood pressure [B], clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.8359375,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance] [C], transient ischemic attack",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -8.921875,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.0859375,
            "text": "age [A], blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.1328125,
            "text": "age [A], blood pressure [B], clinical features [weakness",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.2265625,
            "text": "age [A]",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.2578125,
            "text": "age [A], blood pressure [B], clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.3203125,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech",
            "probability": 0.0
        },
        {
            "start_logit": 10.3828125,
            "end_logit": -9.5546875,
            "text": "age [A",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -5.06640625,
            "text": "diabetes history",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -5.71875,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": -5.06640625,
            "text": "transient ischemic attack duration [D], and diabetes history",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -5.06640625,
            "text": "history",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": -5.06640625,
            "text": ", transient ischemic attack duration [D], and diabetes history",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": -5.06640625,
            "text": "blood pressure [B], clinical features [weakness/speech disturbance] [C], transient ischemic attack duration [D], and diabetes history",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": -5.71875,
            "text": "transient ischemic attack duration [D], and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": -5.06640625,
            "text": "D], and diabetes history",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_12": [
        {
            "start_logit": 11.078125,
            "end_logit": 12.15625,
            "text": "age",
            "probability": 0.6728515625
        },
        {
            "start_logit": 11.078125,
            "end_logit": 11.1953125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.25927734375
        },
        {
            "start_logit": 9.75,
            "end_logit": 11.1953125,
            "text": "diabetes",
            "probability": 0.06768798828125
        },
        {
            "start_logit": 11.078125,
            "end_logit": -8.46875,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 12.15625,
            "text": "[age",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -8.765625,
            "text": "age, blood pressure, clinical features and duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.15625,
            "text": "compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 11.1953125,
            "text": "clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.453125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 11.1953125,
            "text": "[age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": 11.1953125,
            "text": ", ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 11.1953125,
            "text": "and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 11.1953125,
            "text": "ABCD and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.8984375,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.96875,
            "text": "age, blood pressure, clinical features and duration",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -10.21875,
            "text": "age, blood pressure, clinical features and duration of symptoms (",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -10.25,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 9.75,
            "end_logit": -9.9140625,
            "text": "diabetes (ABCD2) score, ABCD and brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA",
            "probability": 0.0
        },
        {
            "start_logit": 9.75,
            "end_logit": -10.0234375,
            "text": "diabetes (ABCD2) score, ABCD and brain infarction",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -8.46875,
            "text": "clinical features",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_13": [
        {
            "start_logit": 10.8671875,
            "end_logit": 12.421875,
            "text": "age",
            "probability": 0.9111328125
        },
        {
            "start_logit": 10.8671875,
            "end_logit": 9.9921875,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.08087158203125
        },
        {
            "start_logit": 8.5390625,
            "end_logit": 9.9921875,
            "text": "diabetes",
            "probability": 0.00788116455078125
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -8.2265625,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -8.515625,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.421875,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -9.484375,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -9.515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -9.890625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -9.9765625,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -10.0703125,
            "text": "age,",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -10.421875,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -10.4375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score).",
            "probability": 0.0
        },
        {
            "start_logit": 10.8671875,
            "end_logit": -10.515625,
            "text": "age, blood pressure, clinical features,",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 9.9921875,
            "text": "clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 9.9921875,
            "text": "ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 9.9921875,
            "text": "score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 9.9921875,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 9.9921875,
            "text": "blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 9.9921875,
            "text": ", clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_14": [
        {
            "start_logit": 10.7109375,
            "end_logit": 12.546875,
            "text": "age",
            "probability": 0.97900390625
        },
        {
            "start_logit": 10.7109375,
            "end_logit": 8.6640625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0203094482421875
        },
        {
            "start_logit": 7.2421875,
            "end_logit": 8.6640625,
            "text": "diabetes",
            "probability": 0.0006327629089355469
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.546875,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -8.578125,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.546875,
            "text": "TIA) can be predicted by scores incorporating age",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.078125,
            "text": "age, blood pressure, clinical features",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.4453125,
            "text": "age, blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.46875,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.9765625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.03125,
            "text": "age,",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.3125,
            "text": "age, blood pressure, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.4375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.6015625,
            "text": "age, blood",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 8.6640625,
            "text": "clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 8.6640625,
            "text": "ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 8.6640625,
            "text": "transient ischaemic attack (TIA) can be predicted by scores incorporating age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.6640625,
            "text": ", clinical features, duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.6640625,
            "text": ", duration (ABCD-score), and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 8.6640625,
            "text": "and diabetes",
            "probability": 0.0
        }
    ],
    "5c6585287c78d69471000004_1": [
        {
            "start_logit": 14.9609375,
            "end_logit": 14.7109375,
            "text": "acute myeloid leukemia",
            "probability": 1.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -1.58203125,
            "text": "acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.40234375,
            "end_logit": 14.7109375,
            "text": "leukemia",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -3.517578125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -3.58203125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -7.02734375,
            "text": "acute myeloid leukemia with activating FLT3",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -7.0859375,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mast",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -7.77734375,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (ASM",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -7.79296875,
            "text": "acute myeloid leukemia with activating FLT3 mutations",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -8.7109375,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -8.828125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -8.859375,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -8.875,
            "text": "acute myeloid",
            "probability": 0.0
        },
        {
            "start_logit": 14.9609375,
            "end_logit": -8.9453125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (ASM)",
            "probability": 0.0
        },
        {
            "start_logit": -8.765625,
            "end_logit": 14.7109375,
            "text": "myeloid leukemia",
            "probability": 0.0
        },
        {
            "start_logit": -2.40234375,
            "end_logit": -3.517578125,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.40234375,
            "end_logit": -3.58203125,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -3.517578125,
            "text": "as well as aggressive systemic mastocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -3.58203125,
            "text": "as",
            "probability": 0.0
        },
        {
            "start_logit": -2.40234375,
            "end_logit": -7.02734375,
            "text": "leukemia with activating FLT3",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_1": [
        {
            "start_logit": 1.6005859375,
            "end_logit": 10.28125,
            "text": "regulates transcription",
            "probability": 0.9990234375
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 10.28125,
            "text": "transcription",
            "probability": 0.000614166259765625
        },
        {
            "start_logit": 1.6005859375,
            "end_logit": -0.99267578125,
            "text": "regulates transcription, translation",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 10.28125,
            "text": "therapeutic research. Being present in key regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -10.109375,
            "end_logit": 10.28125,
            "text": "telomere, G-Quadruplex structure regulates transcription",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -10.125,
            "end_logit": 10.28125,
            "text": "oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 10.28125,
            "text": "regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -10.25,
            "end_logit": 10.28125,
            "text": ", G-Quadruplex structure regulates transcription",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 1.6005859375,
            "end_logit": -6.91796875,
            "text": "regulates transcription, translation, splicing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.6005859375,
            "end_logit": -8.25,
            "text": "regulates transcription, translation, splicing, etc",
            "probability": 0.0
        },
        {
            "start_logit": 1.6005859375,
            "end_logit": -8.265625,
            "text": "regulates transcription, translation, splicing, etc.",
            "probability": 0.0
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -0.99267578125,
            "text": "transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": 1.6005859375,
            "end_logit": -8.6171875,
            "text": "regulates transcription, translation, splicing,",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -0.99267578125,
            "text": ", translation",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -0.99267578125,
            "text": "translation",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -0.99267578125,
            "text": "therapeutic research. Being present in key regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -0.99267578125,
            "text": "telomere, G-Quadruplex structure regulates transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": -0.99267578125,
            "text": "oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -0.99267578125,
            "text": "regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -0.99267578125,
            "text": ", G-Quadruplex structure regulates transcription, translation",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_2": [
        {
            "start_logit": -0.57958984375,
            "end_logit": 6.359375,
            "text": "biological events",
            "probability": 0.9990234375
        },
        {
            "start_logit": -8.8125,
            "end_logit": 6.359375,
            "text": "various biological events",
            "probability": 0.0002651214599609375
        },
        {
            "start_logit": -9.21875,
            "end_logit": 6.359375,
            "text": "and those in gene regulatory regions. G4s regulate various biological events",
            "probability": 0.0001766681671142578
        },
        {
            "start_logit": -9.40625,
            "end_logit": 6.359375,
            "text": "G4s regulate various biological events",
            "probability": 0.00014638900756835938
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -3.556640625,
            "text": "replication, transcription, and translation",
            "probability": 6.598234176635742e-05
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -3.556640625,
            "text": "biological events, including replication, transcription, and translation",
            "probability": 4.9054622650146484e-05
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -5.55078125,
            "text": "replication",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -5.55078125,
            "text": "biological events, including replication",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -6.77734375,
            "text": "replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer and neurodegenerative diseases",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -6.984375,
            "text": "replication, transcription",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -6.77734375,
            "text": "biological events, including replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer and neurodegenerative diseases",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -6.984375,
            "text": "biological events, including replication, transcription",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -4.453125,
            "end_logit": -3.556640625,
            "text": "including replication, transcription, and translation",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -8.3125,
            "text": "biological events,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -8.859375,
            "text": "replication, transcription, and translation. Imbalanced G4 dynamics",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -8.9921875,
            "text": "replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.282470703125,
            "end_logit": -9.1171875,
            "text": "replication, transcription, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -8.859375,
            "text": "biological events, including replication, transcription, and translation. Imbalanced G4 dynamics",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -8.9609375,
            "text": "biological",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.57958984375,
            "end_logit": -8.9921875,
            "text": "biological events, including replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer",
            "probability": 2.384185791015625e-07
        }
    ],
    "6220ce4c3a8413c653000068_3": [
        {
            "start_logit": 13.1640625,
            "end_logit": 12.3984375,
            "text": "translational suppression",
            "probability": 1.0
        },
        {
            "start_logit": 13.1640625,
            "end_logit": -3.109375,
            "text": "translational suppression, splicing etc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.1640625,
            "end_logit": -4.12890625,
            "text": "translational",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1640625,
            "end_logit": -5.578125,
            "text": "translational suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 12.3984375,
            "text": "suppression",
            "probability": 0.0
        },
        {
            "start_logit": 13.1640625,
            "end_logit": -7.296875,
            "text": "translational suppression, splicing etc.",
            "probability": 0.0
        },
        {
            "start_logit": 13.1640625,
            "end_logit": -8.7734375,
            "text": "translational suppression,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.3984375,
            "text": "functions of RNA G-quadruplexes such as translational suppression",
            "probability": 0.0
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -3.109375,
            "text": "suppression, splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -3.109375,
            "text": "splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -5.578125,
            "text": "suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -5.578125,
            "text": "splicing",
            "probability": 0.0
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -7.296875,
            "text": "suppression, splicing etc.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -3.109375,
            "text": "functions of RNA G-quadruplexes such as translational suppression, splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -3.109375,
            "text": ", splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -7.296875,
            "text": "splicing etc.",
            "probability": 0.0
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -8.7734375,
            "text": "suppression,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -4.12890625,
            "text": "functions of RNA G-quadruplexes such as translational",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -5.578125,
            "text": "functions of RNA G-quadruplexes such as translational suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -5.578125,
            "text": ", splicing",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_4": [
        {
            "start_logit": 13.1484375,
            "end_logit": 13.1015625,
            "text": "inhibition of telomerase",
            "probability": 1.0
        },
        {
            "start_logit": -4.12109375,
            "end_logit": 13.1015625,
            "text": "telomerase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -5.078125,
            "text": "inhibition",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -5.9765625,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation",
            "probability": 0.0
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 13.1015625,
            "text": "biological functions, including inhibition of telomerase",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -6.72265625,
            "text": "inhibition of telomerase and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.6328125,
            "text": "inhibition of telomerase and the regulation of gene transcription",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.1484375,
            "text": "inhibition of telomerase and the regulation of gene",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 13.1015625,
            "text": "of telomerase",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.1328125,
            "text": "inhibition of telomerase and the regulation of",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.3515625,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.46875,
            "text": "inhibition of",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.515625,
            "text": "inhibition of telomerase and the",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.5546875,
            "text": "inhibition of telomerase and the regulation of gene transcription and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.5625,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development, particularly for",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.6171875,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.75,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation,",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -10.0703125,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.1015625,
            "text": "various biological functions, including inhibition of telomerase",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.1015625,
            "text": "including inhibition of telomerase",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_5": [
        {
            "start_logit": 9.453125,
            "end_logit": 10.1328125,
            "text": "transcription",
            "probability": 1.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -5.55859375,
            "text": "transcription, translation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -5.91015625,
            "text": "transcription, translation, regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.30859375,
            "text": "transcription, translation, regulation of telomere length",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 10.1328125,
            "text": "various processes such as transcription",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.796875,
            "end_logit": 10.1328125,
            "text": "as transcription",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -9.2890625,
            "text": "transcription, translation, regulation of telomere",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 10.1328125,
            "text": "processes such as transcription",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 10.1328125,
            "text": "Growing evidence indicates that RNA G-quadruplexes have important roles in various processes such as transcription",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -9.9296875,
            "text": "transcription, translation, regulation of telomere length, and formation of telomeric",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -9.9453125,
            "text": "transcription, translation, regulation of telomere length, and formation",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -9.953125,
            "text": "transcription, translation, regulation of telomere length, and formation of",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -10.0,
            "text": "transcription, translation, regulation of telomere length, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -10.2265625,
            "text": "transcription,",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -5.55859375,
            "text": "translation",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -5.91015625,
            "text": "translation, regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -6.30859375,
            "text": "translation, regulation of telomere length",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.55859375,
            "text": "various processes such as transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -5.91015625,
            "text": "regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.78125,
            "text": "various processes",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_6": [
        {
            "start_logit": 12.921875,
            "end_logit": 12.2734375,
            "text": "translational suppression",
            "probability": 1.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -4.4453125,
            "text": "translational",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.86328125,
            "end_logit": 12.2734375,
            "text": "suppression",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -6.5625,
            "text": "translational suppression, splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -7.05859375,
            "text": "translational suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -8.1875,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope for an extens",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -8.9140625,
            "text": "translational suppression,",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.4296875,
            "text": "translational suppression, splicing etc.",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.7421875,
            "text": "translational suppression, splicing etc. are",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.8125,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope for an",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.859375,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.875,
            "text": "translational suppression, splicing etc. are discussed",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -9.9765625,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope for",
            "probability": 0.0
        },
        {
            "start_logit": 12.921875,
            "end_logit": -10.046875,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.2734375,
            "text": "functions of RNA G-quadruplexes such as translational suppression",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 12.2734375,
            "text": "RNA G-quadruplexes such as translational suppression",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 12.2734375,
            "text": "of RNA G-quadruplexes such as translational suppression",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -6.5625,
            "text": "suppression, splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -7.05859375,
            "text": "suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -8.1875,
            "text": "suppression, splicing etc. are discussed in brief, suggesting scope for an extens",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_7": [
        {
            "start_logit": 14.21875,
            "end_logit": 12.796875,
            "text": "DNA replication",
            "probability": 1.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -3.048828125,
            "text": "DNA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.33203125,
            "end_logit": 12.796875,
            "text": "biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 12.796875,
            "text": "replication",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -8.5625,
            "text": "DNA replication, transcription",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -8.671875,
            "text": "DNA replication, transcription, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -8.90625,
            "text": "DNA replication,",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -8.9765625,
            "text": "DNA replication, transcription, and translation",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 12.796875,
            "text": "fundamental biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -9.265625,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability",
            "probability": 0.0
        },
        {
            "start_logit": 14.21875,
            "end_logit": -9.9765625,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability and cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": 12.796875,
            "text": "important regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": 12.796875,
            "text": "regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 12.796875,
            "text": "as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.796875,
            "text": "that G-quadruplexes serve important regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.796875,
            "text": "Accumulating evidence indicates that G-quadruplexes serve important regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -4.33203125,
            "end_logit": 0.262939453125,
            "text": "biological processes",
            "probability": 0.0
        },
        {
            "start_logit": -4.33203125,
            "end_logit": -3.048828125,
            "text": "biological processes such as DNA",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 0.262939453125,
            "text": "fundamental biological processes",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": 0.262939453125,
            "text": "important regulatory roles in fundamental biological processes",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_8": [
        {
            "start_logit": 7.66796875,
            "end_logit": 9.1796875,
            "text": "pre-mRNA processing (splicing and polyadenylation",
            "probability": 1.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": 1.4765625,
            "text": "pre-mRNA processing",
            "probability": 0.0004513263702392578
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -5.8203125,
            "text": "pre-mRNA processing (splicing",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 9.1796875,
            "text": "polyadenylation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -6.62109375,
            "text": "pre-mRNA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.1796875,
            "text": "regulators of pre-mRNA processing (splicing and polyadenylation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.1796875,
            "text": "(splicing and polyadenylation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -6.81640625,
            "text": "pre-mRNA processing (splicing and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.171875,
            "text": "pre-mRNA processing (splicing and polyaden",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.109375,
            "end_logit": 9.1796875,
            "text": "ylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.83203125,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 9.1796875,
            "text": "splicing and polyadenylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.015625,
            "text": "pre-mRNA processing (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.1875,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover, mRNA targeting and translation",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.5234375,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover, mRNA targeting and",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 9.1796875,
            "text": "of pre-mRNA processing (splicing and polyadenylation",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.828125,
            "text": "pre",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 9.1796875,
            "text": "mRNA processing (splicing and polyadenylation",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 9.1796875,
            "text": "RNA G-quadruplexes appear as important regulators of pre-mRNA processing (splicing and polyadenylation",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -9.2734375,
            "text": "pre-",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_9": [
        {
            "start_logit": 11.6953125,
            "end_logit": 12.375,
            "text": "inhibition of transcription",
            "probability": 1.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -1.1318359375,
            "text": "inhibition of transcription, translation, and DNA replication",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.60546875,
            "end_logit": 12.375,
            "text": "transcription",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.0625,
            "text": "inhibition of transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.6171875,
            "text": "inhibition",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 12.375,
            "text": "biological functions, such as the inhibition of transcription",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 12.375,
            "text": "of transcription",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.7265625,
            "text": "inhibition of transcription, translation, and DNA",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 12.375,
            "text": "their biological functions, such as the inhibition of transcription",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.5703125,
            "text": "inhibition of",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.375,
            "text": "different conformations of G-quadruplexes have certain influences on their biological functions, such as the inhibition of transcription",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.25,
            "text": "inhibition of transcription, translation, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.3125,
            "text": "inhibition of transcription,",
            "probability": 0.0
        },
        {
            "start_logit": -1.4775390625,
            "end_logit": -1.1318359375,
            "text": "DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -5.60546875,
            "end_logit": -1.1318359375,
            "text": "transcription, translation, and DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -1.1318359375,
            "text": "translation, and DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -1.1318359375,
            "text": "biological functions, such as the inhibition of transcription, translation, and DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -1.4775390625,
            "end_logit": -8.7265625,
            "text": "DNA",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -1.1318359375,
            "text": "of transcription, translation, and DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -1.1318359375,
            "text": ", translation, and DNA replication",
            "probability": 0.0
        }
    ],
    "5ad303970340b9f05800001a_1": [
        {
            "start_logit": 10.6484375,
            "end_logit": 12.5234375,
            "text": "inflammation",
            "probability": 1.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 12.5234375,
            "text": "Growth differentiation factor 15 (GDF-15) is expressed and secreted in response to inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 12.5234375,
            "text": "GDF-15) is expressed and secreted in response to inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 12.5234375,
            "text": "response to inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.5234375,
            "text": "secreted in response to inflammation",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -8.875,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.0859375,
            "text": "inflammation, oxidative stress",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.3359375,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.5703125,
            "text": "inflammation, oxidative stress, hypoxia",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.890625,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.953125,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation.",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -10.0078125,
            "text": "inflammation, oxidative",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -10.25,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -8.875,
            "text": "oxidative stress, hypoxia, telomere erosion, and oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -9.0859375,
            "text": "oxidative stress",
            "probability": 0.0
        },
        {
            "start_logit": -9.078125,
            "end_logit": -8.875,
            "text": "oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -9.3359375,
            "text": "oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -8.875,
            "text": "hypoxia, telomere erosion, and oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -9.5703125,
            "text": "oxidative stress, hypoxia",
            "probability": 0.0
        },
        {
            "start_logit": -9.078125,
            "end_logit": -9.3359375,
            "text": "oncogene activation",
            "probability": 0.0
        }
    ],
    "5ad303970340b9f05800001a_2": [
        {
            "start_logit": 12.734375,
            "end_logit": 11.4921875,
            "text": "tissue injury",
            "probability": 1.0
        },
        {
            "start_logit": 12.734375,
            "end_logit": -4.12109375,
            "text": "tissue",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 11.4921875,
            "text": "injury",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": 11.4921875,
            "text": "response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -9.453125,
            "end_logit": 11.4921875,
            "text": "induced in response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 11.4921875,
            "text": "GDF-15) is a member of the TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 11.4921875,
            "text": "cytokine superfamily that is widely expressed and may be induced in response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 11.4921875,
            "text": "TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 11.4921875,
            "text": "15) is a member of the TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue injury",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -4.12109375,
            "text": "response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -9.453125,
            "end_logit": -4.12109375,
            "text": "induced in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -4.12109375,
            "text": "GDF-15) is a member of the TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -4.12109375,
            "text": "cytokine superfamily that is widely expressed and may be induced in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -4.12109375,
            "text": "TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -4.12109375,
            "text": "15) is a member of the TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -7.25,
            "text": "Growth differentiation factor-15 (GDF-15) is",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -6.69140625,
            "text": "response to",
            "probability": 0.0
        },
        {
            "start_logit": -9.453125,
            "end_logit": -6.69140625,
            "text": "induced in response to",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -8.1328125,
            "text": "Growth differentiation factor-15",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -8.1796875,
            "text": "Growth differentiation factor-15 (GDF-15) is a",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_1": [
        {
            "start_logit": 11.8984375,
            "end_logit": 11.8203125,
            "text": "Long Interspersed Element-1",
            "probability": 1.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": 3.38671875,
            "text": "Long Interspersed Element-1 (LINE-1",
            "probability": 0.00021660327911376953
        },
        {
            "start_logit": 11.8984375,
            "end_logit": 2.8984375,
            "text": "Long Interspersed Element-1 (LINE-1)",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -3.544921875,
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -4.5234375,
            "text": "Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 11.8203125,
            "text": "1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -5.109375,
            "text": "Long Interspersed Element-1 (LINE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -5.37890625,
            "text": "Long",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -6.4140625,
            "text": "Long Interspersed Element",
            "probability": 0.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -7.46484375,
            "text": "Long Interspersed Element-1 (LINE-",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": 11.8203125,
            "text": "Interspersed Element-1",
            "probability": 0.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -7.66015625,
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA",
            "probability": 0.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -8.1953125,
            "text": "Long Interspersed Element-",
            "probability": 0.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -8.1953125,
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements)",
            "probability": 0.0
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -8.6640625,
            "text": "Long Interspersed Element-1 (LINE-1),",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 11.8203125,
            "text": "Element-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.8359375,
            "end_logit": 11.8203125,
            "text": "ersed Element-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": 11.8203125,
            "text": "retrotransposons). Despite their abundance, only a small fraction of them are currently active in our genome (Long Interspersed Element-1",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 11.8203125,
            "text": "their abundance, only a small fraction of them are currently active in our genome (Long Interspersed Element-1",
            "probability": 0.0
        },
        {
            "start_logit": -1.931640625,
            "end_logit": 3.38671875,
            "text": "LINE-1",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_2": [
        {
            "start_logit": 12.7109375,
            "end_logit": 9.0,
            "text": "Alu",
            "probability": 1.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -1.2080078125,
            "text": "Alu, L1",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -2.966796875,
            "text": "Alu, L1, and SVA families",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -7.21484375,
            "text": "Alu, L1, and SVA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -8.28125,
            "text": "Alu, L1, and SVA families,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.3359375,
            "text": "Alu, L1, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.3359375,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity/polymorphism",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.6875,
            "text": "Alu, L1, and SV",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.9609375,
            "text": "Alu,",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -10.3359375,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -10.484375,
            "text": "Alu, L1, and SVA families, are",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 9.0,
            "text": "of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": 1.171875,
            "end_logit": -1.2080078125,
            "text": "L1",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 9.0,
            "text": "members of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 9.0,
            "text": "types of retrotransposons, particularly members of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 9.0,
            "text": "Since certain types of retrotransposons, particularly members of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": 9.0,
            "text": "particularly members of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 9.0,
            "text": "retrotransposons, particularly members of the Alu",
            "probability": 0.0
        },
        {
            "start_logit": 1.171875,
            "end_logit": -2.966796875,
            "text": "L1, and SVA families",
            "probability": 0.0
        },
        {
            "start_logit": 1.171875,
            "end_logit": -7.21484375,
            "text": "L1, and SVA",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_3": [
        {
            "start_logit": 14.5,
            "end_logit": 11.296875,
            "text": "Alu elements",
            "probability": 1.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -1.9111328125,
            "text": "Alu",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 14.5,
            "end_logit": -5.90234375,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.5,
            "end_logit": -6.69140625,
            "text": "Alu elements are the most successful SINEs",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -7.640625,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000,000",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -8.1171875,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements)",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -8.2109375,
            "text": "Alu elements are the most successful SINEs (Short INterspersed",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -8.21875,
            "text": "Alu elements are",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -8.3671875,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -8.9921875,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000,000 copies",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.3203125,
            "text": "Alu elements are the most successful SIN",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.421875,
            "text": "Alu elements are the most successful SINEs (",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.59375,
            "text": "Alu elements are the",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.65625,
            "text": "Alu elements are the most successful SINEs (Short",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.7265625,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have",
            "probability": 0.0
        },
        {
            "start_logit": 14.5,
            "end_logit": -9.84375,
            "text": "Alu elements are the most successful SINEs (Short INtersp",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": 11.296875,
            "text": "elements",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": -5.90234375,
            "text": "elements are the most successful SINEs (Short INterspersed Elements",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -5.90234375,
            "text": "SINEs (Short INterspersed Elements",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.69140625,
            "text": "elements are the most successful SINEs",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_4": [
        {
            "start_logit": 10.3125,
            "end_logit": 8.0078125,
            "text": "Alu",
            "probability": 1.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -0.97900390625,
            "text": "Alu represent the most prolific human LINE",
            "probability": 0.00012636184692382812
        },
        {
            "start_logit": 10.3125,
            "end_logit": -1.3291015625,
            "text": "Alu represent the most prolific human LINE and SINE",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 10.3125,
            "end_logit": -5.98828125,
            "text": "Alu represent the most prolific human LINE and SINE families",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 10.3125,
            "end_logit": -7.140625,
            "text": "Alu represent the most prolific human LINE and SIN",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.3125,
            "end_logit": 8.0078125,
            "text": "1 and Alu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.3125,
            "end_logit": -7.9921875,
            "text": "Alu represent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 8.0078125,
            "text": "and Alu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3125,
            "end_logit": -9.6484375,
            "text": "Alu represent the most prolific",
            "probability": 0.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -10.1953125,
            "text": "Alu represent the",
            "probability": 0.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -10.203125,
            "text": "Alu represent the most",
            "probability": 0.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -10.234375,
            "text": "Alu represent the most prolific human LINE and SINE families, respectively",
            "probability": 0.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -10.28125,
            "text": "Alu represent the most prolific human LINE and SINE families, respectively.",
            "probability": 0.0
        },
        {
            "start_logit": 10.3125,
            "end_logit": -10.5390625,
            "text": "Alu represent the most prolific human LINE and",
            "probability": 0.0
        },
        {
            "start_logit": -1.3046875,
            "end_logit": -0.97900390625,
            "text": "LINE",
            "probability": 0.0
        },
        {
            "start_logit": -1.3046875,
            "end_logit": -1.3291015625,
            "text": "LINE and SINE",
            "probability": 0.0
        },
        {
            "start_logit": -3.12109375,
            "end_logit": -1.3291015625,
            "text": "SINE",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -0.97900390625,
            "text": "1 and Alu represent the most prolific human LINE",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -1.3291015625,
            "text": "1 and Alu represent the most prolific human LINE and SINE",
            "probability": 0.0
        },
        {
            "start_logit": -1.3046875,
            "end_logit": -5.98828125,
            "text": "LINE and SINE families",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_5": [
        {
            "start_logit": 15.046875,
            "end_logit": 4.390625,
            "text": "Alu",
            "probability": 0.640625
        },
        {
            "start_logit": 15.046875,
            "end_logit": 3.81640625,
            "text": "Alu elements",
            "probability": 0.359375
        },
        {
            "start_logit": 15.046875,
            "end_logit": -8.6015625,
            "text": "Alu elements are able to retropose",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.28125,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.4453125,
            "text": "Alu elements are",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.59375,
            "text": "Alu elements are able to retropose,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.6484375,
            "text": "Alu elements are able to retropose, and the factors",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.71875,
            "text": "Alu elements are able to retropo",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.8984375,
            "text": "Alu elements are able to retropose, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -9.921875,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -10.0,
            "text": "Alu elements are able",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -10.0234375,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -10.1953125,
            "text": "Alu elements are able to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -10.203125,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 15.046875,
            "end_logit": -10.265625,
            "text": "Alu elements are able to retropose, and the factors determining",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.515625,
            "end_logit": 4.390625,
            "text": "few Alu",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 4.390625,
            "text": "Only a few Alu",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 4.390625,
            "text": "a few Alu",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 3.81640625,
            "text": "few Alu elements",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 3.81640625,
            "text": "Only a few Alu elements",
            "probability": 0.0
        }
    ],
    "5aae6a86fcf456587200000e_1": [
        {
            "start_logit": 4.77734375,
            "end_logit": 8.6171875,
            "text": "UVC",
            "probability": 0.97314453125
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 4.32421875,
            "text": "UVC (200-280 nm), medium-wave UVB",
            "probability": 0.0133514404296875
        },
        {
            "start_logit": 0.462158203125,
            "end_logit": 8.6171875,
            "text": "short-wave UVC",
            "probability": 0.01303863525390625
        },
        {
            "start_logit": 0.462158203125,
            "end_logit": 4.32421875,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB",
            "probability": 0.00017750263214111328
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -0.78759765625,
            "text": "UVC (200-280 nm), medium-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 8.064508438110352e-05
        },
        {
            "start_logit": -0.484375,
            "end_logit": 4.32421875,
            "text": "UVB",
            "probability": 6.949901580810547e-05
        },
        {
            "start_logit": -1.3408203125,
            "end_logit": 4.32421875,
            "text": ", medium-wave UVB",
            "probability": 2.944469451904297e-05
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.6171875,
            "text": "C",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -5.01953125,
            "text": "UVC (200-280 nm",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 0.462158203125,
            "end_logit": -0.78759765625,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -0.484375,
            "end_logit": -0.78759765625,
            "text": "UVB (280-320 nm), and long-wave UVA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -6.25,
            "text": "UVC (200",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.3408203125,
            "end_logit": -0.78759765625,
            "text": ", medium-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -7.2109375,
            "text": "UVC (200-280",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -7.29296875,
            "text": "UVC (200-280 nm)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -7.96875,
            "text": "UVC (200-280 nm), medium-wave UVB (280-320 nm), and long-wave",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.3046875,
            "text": "UVC (200-280 nm), medium-wave",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.46875,
            "text": "UVC (200-280 nm), medium-wave UVB (280-320",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.5625,
            "text": "UV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 4.32421875,
            "text": "C (200-280 nm), medium-wave UVB",
            "probability": 0.0
        }
    ],
    "5aae6a86fcf456587200000e_2": [
        {
            "start_logit": 5.59765625,
            "end_logit": 8.4765625,
            "text": "UVC",
            "probability": 0.99609375
        },
        {
            "start_logit": 5.59765625,
            "end_logit": 2.654296875,
            "text": "UVC (200-280 nm), mid-wave UVB",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -1.396484375,
            "end_logit": 8.4765625,
            "text": "short-wave UVC",
            "probability": 0.0009083747863769531
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -1.267578125,
            "text": "UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 5.805492401123047e-05
        },
        {
            "start_logit": -1.396484375,
            "end_logit": 2.654296875,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -5.17578125,
            "text": "UVC (200-280 nm",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 2.654296875,
            "text": "UVB",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.4765625,
            "text": "C",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -6.4921875,
            "text": "UVC (200",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -7.4453125,
            "text": "UVC (200-280 nm)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -7.59765625,
            "text": "UVC (200-280",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.546875,
            "end_logit": 8.4765625,
            "text": "wave UVC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.1015625,
            "end_logit": 2.654296875,
            "text": ", mid-wave UVB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.396484375,
            "end_logit": -1.267578125,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -8.2890625,
            "text": "UV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -8.5625,
            "text": "UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -8.5859375,
            "text": "UVC (200-280 nm), mid-wave UVB (280-320",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -8.921875,
            "text": "UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA (320- 400 nm",
            "probability": 0.0
        },
        {
            "start_logit": 5.59765625,
            "end_logit": -8.96875,
            "text": "UVC (200-280 nm), mid-wave",
            "probability": 0.0
        },
        {
            "start_logit": -2.37109375,
            "end_logit": -1.267578125,
            "text": "UVB (280-320 nm), and long-wave UVA",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_1": [
        {
            "start_logit": 12.984375,
            "end_logit": 12.6171875,
            "text": "DVL-1",
            "probability": 1.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -1.8662109375,
            "text": "DVL-1 and DVL-3",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 12.984375,
            "end_logit": -2.48828125,
            "text": "DVL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 12.984375,
            "end_logit": -4.83984375,
            "text": "DV",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -5.859375,
            "text": "DVL-1 and DVL",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 12.6171875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -6.4140625,
            "text": "DVL-",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -6.6640625,
            "text": "DVL-1 and DVL-3 genes",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -6.73046875,
            "text": "DVL-1 and DV",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -7.2890625,
            "text": "DVL-1 and DVL-3 genes and their proteins in the aganglionic segment and the ganglionic segment of colon",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -7.625,
            "text": "DVL-1 and DVL-",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -8.0859375,
            "text": "DVL-1 and DVL-3 genes and their proteins",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -8.609375,
            "text": "DVL-1 and",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -8.6953125,
            "text": "DVL-1 and DVL-3 genes and their proteins in the aganglionic segment and the ganglionic",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -8.78125,
            "text": "DVL-1 and DVL-3 genes and their",
            "probability": 0.0
        },
        {
            "start_logit": 12.984375,
            "end_logit": -9.359375,
            "text": "DVL-1 and DVL-3 genes and their proteins in the aganglionic segment and the ganglion",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.6171875,
            "text": "L-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.6171875,
            "text": "studying the expression of DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -1.8662109375,
            "text": "DVL-3",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -1.8662109375,
            "text": "1 and DVL-3",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_2": [
        {
            "start_logit": 12.59375,
            "end_logit": 12.984375,
            "text": "DVL-1",
            "probability": 1.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": 2.4140625,
            "text": "DVL-1 and DVL-3",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": 12.59375,
            "end_logit": -2.12109375,
            "text": "DVL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -3.669921875,
            "text": "DVL-1 and DVL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 12.984375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -5.33203125,
            "text": "DV",
            "probability": 0.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -5.859375,
            "text": "DVL-1 and DVL-",
            "probability": 0.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -6.62890625,
            "text": "DVL-",
            "probability": 0.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -7.20703125,
            "text": "DVL-1 and DV",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 12.984375,
            "text": "neuroblast specification. We have isolated and characterized cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 12.984375,
            "text": "as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": 12.984375,
            "text": "dsh-homologous genes, designated as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.671875,
            "text": "DVL-1 and",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 12.984375,
            "text": "segmentation and neuroblast specification. We have isolated and characterized cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": 0.473388671875,
            "end_logit": 2.4140625,
            "text": "DVL-3",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.984375,
            "text": "clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 12.984375,
            "text": "from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 0.0
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 2.4140625,
            "text": "1 and DVL-3",
            "probability": 0.0
        },
        {
            "start_logit": 0.473388671875,
            "end_logit": -3.669921875,
            "text": "DVL",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 2.4140625,
            "text": "3",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_3": [
        {
            "start_logit": 10.3203125,
            "end_logit": 10.734375,
            "text": "Dvl-1",
            "probability": 1.0
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -1.9287109375,
            "text": "Dvl",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -5.17578125,
            "text": "Dvl-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 10.734375,
            "text": "1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 10.734375,
            "text": "dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -6.5703125,
            "text": "Dv",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -6.75390625,
            "text": "Dvl-1) shares 50% identity",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.734375,
            "text": "Drosophila dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.734375,
            "text": "dishevelled gene (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -7.7890625,
            "text": "Dvl-1) shares",
            "probability": 0.0
        },
        {
            "start_logit": 10.3203125,
            "end_logit": -8.015625,
            "text": "Dvl-1) shares 50% identity (65% similarity) with dsh",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": 10.734375,
            "text": "segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": 10.734375,
            "text": "mouse dishevelled gene (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 10.734375,
            "text": "h segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -1.9287109375,
            "text": "mouse homolog of the Drosophila dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl",
            "probability": 0.0
        },
        {
            "start_logit": -6.1953125,
            "end_logit": -2.609375,
            "text": "Wnt-1), demonstrating a role for dsh in Wnt signal transduction. We have isolated a mouse homolog of the Drosophila dsh segment polarity",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -1.9287109375,
            "text": "dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl",
            "probability": 0.0
        },
        {
            "start_logit": -6.1953125,
            "end_logit": -2.80078125,
            "text": "Wnt-1), demonstrating a role for dsh in Wnt signal transduction. We have isolated a mouse homolog of the Drosophila dsh",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -1.9287109375,
            "text": "Drosophila dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -2.609375,
            "text": "mouse homolog of the Drosophila dsh segment polarity",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_4": [
        {
            "start_logit": 12.265625,
            "end_logit": 12.1484375,
            "text": "Dvl-1",
            "probability": 1.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -3.31640625,
            "text": "Dvl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.265625,
            "end_logit": -5.515625,
            "text": "Dv",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 12.1484375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -7.47265625,
            "text": "Dvl-",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -7.77734375,
            "text": "Dvl-1 gene on chromosome 1p36",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -7.84375,
            "text": "Dvl-1 gene",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -7.8828125,
            "text": "Dvl-1 gene on chromosome 1p36 belongs to a family of highly conserved secreted proteins which regulates embryonic induction, generation of cell polarity",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -8.65625,
            "text": "Dvl-1 gene on chromosome 1p",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -8.9140625,
            "text": "Dvl-1 gene on chromosome 1p36 belongs to a family of highly conserved secreted proteins which regulates embryonic induction",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -9.109375,
            "text": "Dvl-1 gene on chromosome 1p36 belongs",
            "probability": 0.0
        },
        {
            "start_logit": 12.265625,
            "end_logit": -9.203125,
            "text": "Dvl-1 gene on chromosome 1p36 belongs to a family of highly conserved secreted proteins",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 12.1484375,
            "text": "-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.1484375,
            "text": "l-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.31640625,
            "text": "l",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -7.77734375,
            "text": "1 gene on chromosome 1p36",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -7.84375,
            "text": "1 gene",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -7.8828125,
            "text": "1 gene on chromosome 1p36 belongs to a family of highly conserved secreted proteins which regulates embryonic induction, generation of cell polarity",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -8.65625,
            "text": "1 gene on chromosome 1p",
            "probability": 0.0
        },
        {
            "start_logit": -8.859375,
            "end_logit": -6.0546875,
            "text": "DVL-1;",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_5": [
        {
            "start_logit": 9.4296875,
            "end_logit": 10.265625,
            "text": "Dvl-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.1875,
            "end_logit": 10.265625,
            "text": "Dishevelled-1 (Dvl-1",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -3.044921875,
            "text": "Dvl",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -3.283203125,
            "text": "Dvl-1) and Dishevelled-2",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 10.265625,
            "text": "mouse Dishevelled-1 (Dvl-1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -5.609375,
            "text": "Dvl-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 10.265625,
            "text": "1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -6.75,
            "text": "Dv",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -6.87890625,
            "text": "Dvl-1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.33984375,
            "text": "Dvl-1) and Dishevelled-2 genes",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.265625,
            "text": "(Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.1015625,
            "text": "Dvl-1) and Dishevelled",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 10.265625,
            "text": "1 (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.2109375,
            "text": "Dvl-1) and Dishevelled-2 genes encode",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.484375,
            "text": "Dvl-1) and Dishevelled-2 genes encode proteins that are differentially localized in Wnt",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.734375,
            "text": "Dvl-1) and Dishevelled-2 genes encode proteins that are differentially localized",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.875,
            "text": "Dvl-1) and Dishevelled-2 genes encode proteins that are differentially localized in Wnt-overexpressing PC12 cell lines (PC12/Wnt",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.8984375,
            "text": "Dvl-1) and Dishevel",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 10.265625,
            "text": "evelled-1 (Dvl-1",
            "probability": 0.0
        },
        {
            "start_logit": -1.1875,
            "end_logit": 1.03515625,
            "text": "Dishevelled-1",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_1": [
        {
            "start_logit": 13.78125,
            "end_logit": 13.390625,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -2.28125,
            "text": "DNMT1 and DNMT3a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.78125,
            "end_logit": -3.708984375,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.8359375,
            "end_logit": 13.390625,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -7.0625,
            "text": "DNMT1 and DNMT",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.1796875,
            "text": "DNMT1 and",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.34375,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic neurons.",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.0078125,
            "text": "DNMT1 and DNMT3a are",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.1875,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic neurons",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.1953125,
            "text": "DNMT1 and DNMT3a are most highly expressed",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.40625,
            "text": "DNMT1 and DNMT3a are most highly expressed in",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.5,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmito",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.5546875,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.65625,
            "text": "DNMT1 and DNMT3a are most highly",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": 13.390625,
            "text": "DNMTs, DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": 13.390625,
            "text": "Of the DNMTs, DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.90625,
            "end_logit": 13.390625,
            "text": ", DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -4.8359375,
            "end_logit": -2.28125,
            "text": "1 and DNMT3a",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -2.28125,
            "text": "DNMT3a",
            "probability": 0.0
        },
        {
            "start_logit": -9.1953125,
            "end_logit": -2.28125,
            "text": "3a",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_2": [
        {
            "start_logit": 13.4296875,
            "end_logit": 12.3359375,
            "text": "DNMT3",
            "probability": 1.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -3.7421875,
            "text": "DNMT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -4.37109375,
            "text": "DNMT3 family",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -6.578125,
            "text": "DNMT3 family proteins",
            "probability": 0.0
        },
        {
            "start_logit": -5.84375,
            "end_logit": 12.3359375,
            "text": "3",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.8515625,
            "text": "DNMT3 family proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 12.3359375,
            "text": "oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.3359375,
            "text": "Bovine DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.3359375,
            "text": "DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 12.3359375,
            "text": "imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.3359375,
            "text": "an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 0.0
        },
        {
            "start_logit": -5.84375,
            "end_logit": -4.37109375,
            "text": "3 family",
            "probability": 0.0
        },
        {
            "start_logit": -5.84375,
            "end_logit": -6.578125,
            "text": "3 family proteins",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": -3.7421875,
            "text": "oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": -4.37109375,
            "text": "oocyte size-specific manner, which are coordinated with the expression of the DNMT3 family",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.7421875,
            "text": "Bovine DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -3.7421875,
            "text": "DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -3.7421875,
            "text": "imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -3.7421875,
            "text": "an oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -4.37109375,
            "text": "Bovine DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3 family",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_3": [
        {
            "start_logit": 13.828125,
            "end_logit": 13.078125,
            "text": "Dnmt2",
            "probability": 1.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.60546875,
            "text": "Dnmt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 13.078125,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.9921875,
            "text": "Dnmt2 proteins are the most conserved",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.8203125,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.0078125,
            "text": "Dnmt2 proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.0546875,
            "text": "Dnmt2 proteins are",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.625,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family,",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.6328125,
            "text": "Dnmt2 proteins are the most conserved members of",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.671875,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.78125,
            "text": "Dnmt2 proteins are the most conserved members",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.796875,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.9453125,
            "text": "Dnmt2 proteins are the most",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.9765625,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have been a subject of controversy.",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.125,
            "text": "Dnmt2 proteins are the",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.328125,
            "text": "Dnmt2 proteins are the most conserved members of the",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.3671875,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.3671875,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have been a subject of controversy",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -9.484375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity",
            "probability": 0.0
        },
        {
            "start_logit": -5.23046875,
            "end_logit": -6.9921875,
            "text": "2 proteins are the most conserved",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_4": [
        {
            "start_logit": 11.03125,
            "end_logit": 10.2109375,
            "text": "Dnmt3a",
            "probability": 0.9091796875
        },
        {
            "start_logit": 11.03125,
            "end_logit": 7.8671875,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 0.0872802734375
        },
        {
            "start_logit": 7.8828125,
            "end_logit": 7.8671875,
            "text": "Dnmt1",
            "probability": 0.00371551513671875
        },
        {
            "start_logit": 11.03125,
            "end_logit": -5.859375,
            "text": "Dnmt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.03125,
            "end_logit": -6.1875,
            "text": "Dnmt3a and 3b",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.03125,
            "end_logit": -6.21875,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8125,
            "end_logit": 10.2109375,
            "text": "3a",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.4296875,
            "text": "Dnmt3a and",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.9453125,
            "text": "Dnmt3a and 3b establish methylation marks during early development",
            "probability": 0.0
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -6.21875,
            "text": "Dnmt",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.4296875,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1 maintains methylation patterns after DNA replication. The maintenance function of Dnmt1",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.453125,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1 maintains methylation patterns after DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.5703125,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1 maintains",
            "probability": 0.0
        },
        {
            "start_logit": -8.9140625,
            "end_logit": 10.2109375,
            "text": "Dnmts), Dnmt3a",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": 10.2109375,
            "text": "Within the family of DNA methyltransferases (Dnmts), Dnmt3a",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": 7.8671875,
            "text": "3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8671875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -7.67578125,
            "text": "Dnmt1 maintains methylation patterns after DNA replication. The maintenance function of Dnmt1 is regulated by its large regulatory N-terminal domain",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 10.2109375,
            "text": "family of DNA methyltransferases (Dnmts), Dnmt3a",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 10.2109375,
            "text": "DNA methyltransferases (Dnmts), Dnmt3a",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_5": [
        {
            "start_logit": 13.5625,
            "end_logit": 13.2265625,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -3.99609375,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.5625,
            "end_logit": -5.23828125,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 13.2265625,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -8.8125,
            "text": "DNMT1 is a widely expressed DNA methyltransferase",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -8.9140625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2.",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -8.953125,
            "text": "DNMT1 is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.0546875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.1171875,
            "text": "DNMT1 is",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.2265625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.34375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.5,
            "text": "DNMT1 is a widely expressed DNA",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.578125,
            "text": "DNMT1 is a widely expressed",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.671875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.7421875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.8203125,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.8671875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": -5.23828125,
            "text": "1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": -8.8125,
            "text": "1 is a widely expressed DNA methyltransferase",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": -8.9140625,
            "text": "1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2.",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_6": [
        {
            "start_logit": 14.15625,
            "end_logit": 13.578125,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -3.236328125,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 13.578125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.4765625,
            "text": "DNMT1 causes a widespread loss of imprinting.",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.7890625,
            "text": "DNMT1 causes a",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.890625,
            "text": "DNMT1 causes",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -9.0,
            "text": "DNMT1 causes a widespread loss of",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -9.0859375,
            "text": "DNMT1 causes a widespread loss of imprinting",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 13.578125,
            "text": "DNA methyltransferase DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.578125,
            "text": "methyltransferase DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -11.015625,
            "end_logit": 13.578125,
            "text": "imprinting; a reduction in the DNA methyltransferase DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -3.236328125,
            "text": "DNA methyltransferase DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -8.4765625,
            "text": "1 causes a widespread loss of imprinting.",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -8.7890625,
            "text": "1 causes a",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.236328125,
            "text": "methyltransferase DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -8.890625,
            "text": "1 causes",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.0,
            "text": "1 causes a widespread loss of",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.0859375,
            "text": "1 causes a widespread loss of imprinting",
            "probability": 0.0
        },
        {
            "start_logit": -11.015625,
            "end_logit": -3.236328125,
            "text": "imprinting; a reduction in the DNA methyltransferase DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -6.87109375,
            "text": "DNA methyltransferase",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_7": [
        {
            "start_logit": 13.5703125,
            "end_logit": 12.5,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": 0.67578125,
            "text": "DNMT1 and DNMT3B",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -3.869140625,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -5.3046875,
            "text": "DNMT1 and DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 12.5,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -7.6953125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.0,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethyl",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.125,
            "text": "DNMT1 and DNMT3B regulate BAG-1",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.390625,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethylation",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.3984375,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.4140625,
            "text": "DNMT1 and DNMT3B regulate BAG",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.671875,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.7890625,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -8.984375,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethylation.",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -9.0625,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -9.125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -9.1953125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -9.296875,
            "text": "DNMT1 and DNMT3B regulate BAG-",
            "probability": 0.0
        },
        {
            "start_logit": 13.5703125,
            "end_logit": -9.296875,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.5,
            "text": "that DNMT1",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_8": [
        {
            "start_logit": 13.265625,
            "end_logit": 12.3125,
            "text": "DNA methyltransferase 1",
            "probability": 1.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": 4.328125,
            "text": "DNA methyltransferase 1 (DNMT1",
            "probability": 0.0003407001495361328
        },
        {
            "start_logit": 13.265625,
            "end_logit": -3.744140625,
            "text": "DNA methyltransferase 1 (DNMT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.265625,
            "end_logit": -4.2890625,
            "text": "DNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.265625,
            "end_logit": -4.8984375,
            "text": "DNA methyltransferase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.859375,
            "end_logit": 12.3125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -6.07421875,
            "text": "DNA methyltransferase 1 (DNMT1)",
            "probability": 0.0
        },
        {
            "start_logit": 0.8603515625,
            "end_logit": 4.328125,
            "text": "DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.0859375,
            "text": "DNA methyltransferase 1 (",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.375,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety of factors",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.21875,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety of factors and to contain intrinsic transcriptional repressor activity.",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.359375,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety of",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.5546875,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.6328125,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety of factors and to contain intrinsic transcriptional repressor activity",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.65625,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety of factors and",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.6953125,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.703125,
            "text": "DNA methyltransferase 1 (DNMT1) has",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.8359375,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -9.8984375,
            "text": "DNA methyltransferase 1 (DNMT1) has been reported to interact with a wide variety",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": 12.3125,
            "text": "methyltransferase 1",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_9": [
        {
            "start_logit": 9.1875,
            "end_logit": 10.2109375,
            "text": "DNMT1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 2.080078125,
            "end_logit": 10.2109375,
            "text": "DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 0.0008101463317871094
        },
        {
            "start_logit": 0.44189453125,
            "end_logit": 10.2109375,
            "text": "enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 0.0001583099365234375
        },
        {
            "start_logit": 2.080078125,
            "end_logit": 8.0078125,
            "text": "DNMT3A",
            "probability": 8.952617645263672e-05
        },
        {
            "start_logit": 0.44189453125,
            "end_logit": 8.0078125,
            "text": "enzymes DNMT3A",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -6.265625,
            "end_logit": 10.2109375,
            "text": "1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 10.2109375,
            "text": "3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 10.2109375,
            "text": "DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.0703125,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.03125,
            "end_logit": 10.2109375,
            "text": "de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.0078125,
            "text": "3A",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": 10.2109375,
            "text": "enzyme DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 10.2109375,
            "text": "DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": 2.080078125,
            "end_logit": -1.708984375,
            "text": "DNMT3A and DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 10.2109375,
            "text": "and the maintenance enzyme DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.0078125,
            "text": "de novo enzymes DNMT3A",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 10.2109375,
            "text": "maintenance enzyme DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": 0.44189453125,
            "end_logit": -1.708984375,
            "text": "enzymes DNMT3A and DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 8.0078125,
            "text": "DNMTs), the de novo enzymes DNMT3A",
            "probability": 0.0
        },
        {
            "start_logit": 2.080078125,
            "end_logit": -6.0703125,
            "text": "DNMT3A and DNMT3B and the maintenance enzyme DNMT",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_10": [
        {
            "start_logit": 14.0078125,
            "end_logit": 13.421875,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -2.265625,
            "text": "DNMT1 and DNMT3B",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -3.400390625,
            "text": "DNMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 13.421875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -6.1875,
            "text": "DNMT1 and DNMT",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -8.2734375,
            "text": "DNMT1 and DNMT3B.",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -8.9296875,
            "text": "DNMT1 and",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 13.421875,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": 13.421875,
            "text": "DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 13.421875,
            "text": "murine H1 subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 13.421875,
            "text": "methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 13.421875,
            "text": "subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -2.265625,
            "text": "1 and DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -2.265625,
            "text": "DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -2.265625,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1 and DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -6.1875,
            "text": "1 and DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -3.400390625,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -2.265625,
            "text": "DNA methyltransferases DNMT1 and DNMT3B",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -6.1875,
            "text": "DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": -2.265625,
            "text": "3B",
            "probability": 0.0
        }
    ],
    "55031628e9bde69634000024_1": [
        {
            "start_logit": 13.6484375,
            "end_logit": 13.5078125,
            "text": "medullary thyroid carcinoma",
            "probability": 1.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -3.595703125,
            "text": "medullary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -4.78515625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.71484375,
            "end_logit": 13.5078125,
            "text": "carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": 13.5078125,
            "text": "thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -7.7890625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 13.5078125,
            "text": "pheochromocytoma-paraganglioma syndrome, and familial nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -8.15625,
            "text": "medullary thyroid",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 13.5078125,
            "text": "thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 13.5078125,
            "text": "nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -8.9609375,
            "end_logit": 13.5078125,
            "text": "familial nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 13.5078125,
            "text": "carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": 1.037109375,
            "text": "multiple endocrine neoplasia types 1",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -1.5517578125,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease, neurofibromatosis type 1",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -4.48828125,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.845703125,
            "end_logit": -1.5517578125,
            "text": "Von Hippel-Lindau disease, neurofibromatosis type 1",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -5.44140625,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease, neurofibromatosis type 1, Carney complex",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -6.5078125,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -6.6171875,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease, neurofibromatosis type 1, Carney complex, pheochromocytoma",
            "probability": 0.0
        },
        {
            "start_logit": 1.4287109375,
            "end_logit": -6.71484375,
            "text": "multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease, neurofibromatosis",
            "probability": 0.0
        }
    ],
    "55031628e9bde69634000024_2": [
        {
            "start_logit": 14.1875,
            "end_logit": 14.109375,
            "text": "medullary thyroid carcinoma",
            "probability": 1.0
        },
        {
            "start_logit": -3.09765625,
            "end_logit": 14.109375,
            "text": "thyroid carcinoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.1875,
            "end_logit": -3.185546875,
            "text": "medullary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.880859375,
            "end_logit": 14.109375,
            "text": "carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -4.18359375,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -5.66015625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -8.3671875,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -8.46875,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -8.8828125,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paragangli",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -8.921875,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.2890625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma, emphasizing specific histopathologic characteristics",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.3203125,
            "text": "medullary thyroid carcinoma, gastroenter",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.390625,
            "text": "medullary thyroid carcinoma, gastroenteropancre",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.3984375,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors,",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.5,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma, emphasizing",
            "probability": 0.0
        },
        {
            "start_logit": 14.1875,
            "end_logit": -9.5390625,
            "text": "medullary thyroid",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 14.109375,
            "text": "neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 14.109375,
            "text": "tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -3.09765625,
            "end_logit": -4.18359375,
            "text": "thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.0
        },
        {
            "start_logit": -3.880859375,
            "end_logit": -4.18359375,
            "text": "carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_1": [
        {
            "start_logit": 13.296875,
            "end_logit": 13.234375,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -4.625,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 13.234375,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -6.12109375,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -6.48828125,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -7.26953125,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 13.234375,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.2578125,
            "text": "istradefylline,",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.8203125,
            "text": "istradefylline, improve motor function in PD, but their effect",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.828125,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.9765625,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.984375,
            "text": "istradefylline, improve motor function in PD,",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -10.03125,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -10.1875,
            "text": "istradefylline, improve motor function",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -10.265625,
            "text": "istradefylline, improve",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 13.234375,
            "text": "Adenosine A2A antagonists, such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 13.234375,
            "text": "A2A antagonists, such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.234375,
            "text": "antagonists, such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.234375,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -9.2578125,
            "text": "ylline,",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_2": [
        {
            "start_logit": 13.6953125,
            "end_logit": 13.6171875,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -4.04296875,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -4.3203125,
            "text": "istradefylline and preladenant",
            "probability": 0.0
        },
        {
            "start_logit": -4.8359375,
            "end_logit": 13.6171875,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -6.0078125,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -6.49609375,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -6.53515625,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.5,
            "text": "istradefylline and prela",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -8.7734375,
            "text": "istradefylline and pre",
            "probability": 0.0
        },
        {
            "start_logit": -8.9296875,
            "end_logit": 13.6171875,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.0234375,
            "text": "istradefylline and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.09375,
            "text": "istradefylline and preladen",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.203125,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -9.46875,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time in PD patients with motor fluctuations",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -10.046875,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -10.1484375,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time in PD patients with motor fluctuations.",
            "probability": 0.0
        },
        {
            "start_logit": 13.6953125,
            "end_logit": -10.1640625,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.6171875,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.6171875,
            "text": "Both istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -4.8359375,
            "end_logit": -4.3203125,
            "text": "ylline and preladenant",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_3": [
        {
            "start_logit": 13.359375,
            "end_logit": 13.3203125,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -4.40234375,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 13.3203125,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -6.0390625,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -6.5625,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -6.8203125,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 13.3203125,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 13.3203125,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -8.65625,
            "text": "istradefylline reduces OFF time and dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.15625,
            "text": "istradefylline reduces OFF time and dyskinesia associated with standard 'dopamine",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.734375,
            "text": "istradefylline reduces OFF time and dyskinesia associated with standard 'dopamine replacement' treatments",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.765625,
            "text": "istradefylline reduces OFF time and dyskinesia associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.796875,
            "text": "istradefylline reduces OFF time",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.828125,
            "text": "istradefylline reduces OFF time and dyskinesia associated with standard 'dopamine replacement",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -9.953125,
            "text": "istradefylline reduces",
            "probability": 0.0
        },
        {
            "start_logit": 13.359375,
            "end_logit": -10.0234375,
            "text": "istradefylline reduces OFF time and dyskinesia associated with standard",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 13.3203125,
            "text": "adenosine A2A receptor antagonists such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.3203125,
            "text": "A2A receptor antagonists such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.3203125,
            "text": "motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.3203125,
            "text": "that caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_4": [
        {
            "start_logit": 13.7109375,
            "end_logit": 13.4140625,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -0.8408203125,
            "text": "Istradefylline (KW-6002",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -3.95703125,
            "text": "Is",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": 13.4140625,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.23046875,
            "text": "Istradefylline (KW",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.91796875,
            "text": "Istradefylline (KW-600",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.1875,
            "text": "Istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.28515625,
            "text": "Istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.50390625,
            "text": "Istradef",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.5703125,
            "text": "Istradefylline (",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.1171875,
            "text": "Istradefylline (KW-6002)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 13.4140625,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.4765625,
            "text": "Istradefylline (KW-",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.5859375,
            "text": "Istradefylline (KW-6002) is the first",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.875,
            "text": "Istradefylline (KW-6002) is",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.171875,
            "text": "Istradefylline (KW-6002) is the first of several adenosine A2A receptor antagonists in development for PD to",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.4140625,
            "text": "Istradefylline (KW-6002) is the first of several adenosine A2A receptor antagonists in",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.4140625,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -0.8408203125,
            "text": "KW-6002",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -0.8408203125,
            "text": "ylline (KW-6002",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_5": [
        {
            "start_logit": 11.3828125,
            "end_logit": 11.8125,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -5.1953125,
            "text": "istrade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -5.97265625,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 11.8125,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -6.2109375,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": 11.8125,
            "text": "fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -6.84375,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 11.8125,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -7.6015625,
            "text": "istradefylline), AMPA receptor antagonists (eg, talampanel",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": 11.8125,
            "text": ", adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": 11.8125,
            "text": "alpha2 adrenergic receptor antagonists (eg, fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 11.8125,
            "text": "adrenergic receptor antagonists (eg, fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.3984375,
            "text": "istradefylline), AMPA receptor antagonists (eg, talampanel), neuronal synchronization modulators (eg, levetiracetam",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 11.8125,
            "text": "zole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 11.8125,
            "text": "le), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 11.8125,
            "text": "adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -2.806640625,
            "text": "fipamezole",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -5.1953125,
            "text": "fipamezole), adenosine A2A receptor antagonists (eg, istrade",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -2.806640625,
            "text": "alpha2 adrenergic receptor antagonists (eg, fipamezole",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": -2.806640625,
            "text": "adrenergic receptor antagonists (eg, fipamezole",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_6": [
        {
            "start_logit": 13.671875,
            "end_logit": 13.59375,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -3.98046875,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 13.59375,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.42578125,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.546875,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.86328125,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -7.09765625,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 13.59375,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.4921875,
            "text": "istradefylline, a selective",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.859375,
            "text": "istradefylline, a",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.1640625,
            "text": "istradefylline,",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.2578125,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.6796875,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks in a double-blind",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.6875,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.9140625,
            "text": "istradefylline, a selective adenosine A2A",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.921875,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.9375,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -10.0234375,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 13.59375,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.59375,
            "text": "of istradefylline",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_7": [
        {
            "start_logit": 13.765625,
            "end_logit": 13.5625,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -3.96875,
            "text": "Is",
            "probability": 0.0
        },
        {
            "start_logit": -4.953125,
            "end_logit": 13.5625,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -6.72265625,
            "text": "Istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -6.86328125,
            "text": "Istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -7.2890625,
            "text": "Istradef",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 13.5625,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.0625,
            "text": "Istradefylline,",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.1171875,
            "text": "Istradefylline, a",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.40625,
            "text": "Istradefylline, a novel",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.546875,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist,",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.9375,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinsons disease.",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.015625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinsons disease",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.015625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.1796875,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.1953125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.2109375,
            "text": "Istradefylline, a novel adenosine A2A",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 13.5625,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -10.3359375,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.5625,
            "text": "defylline",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_8": [
        {
            "start_logit": 13.75,
            "end_logit": 13.546875,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -3.970703125,
            "text": "Is",
            "probability": 0.0
        },
        {
            "start_logit": -4.953125,
            "end_logit": 13.546875,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -6.73828125,
            "text": "Istrade",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -6.859375,
            "text": "Istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -7.359375,
            "text": "Istradef",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 13.546875,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.0625,
            "text": "Istradefylline, a",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.1328125,
            "text": "Istradefylline,",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.40625,
            "text": "Istradefylline, a novel",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.5234375,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist,",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.9140625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -9.9765625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.03125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.15625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.1953125,
            "text": "Istradefylline, a novel adenosine A2A",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.203125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.546875,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.75,
            "end_logit": -10.3671875,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 13.546875,
            "text": "defylline",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_9": [
        {
            "start_logit": 13.6015625,
            "end_logit": 12.5546875,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -4.015625,
            "text": "is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -6.80078125,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -6.8671875,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 12.5546875,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -7.8046875,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 12.5546875,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 12.5546875,
            "text": "A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 12.5546875,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.5546875,
            "text": "adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 12.5546875,
            "text": "receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 12.5546875,
            "text": "s disease through the evaluation of istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -4.015625,
            "text": "A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -4.015625,
            "text": "adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -4.015625,
            "text": "receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -4.015625,
            "text": "s disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -7.8046875,
            "text": "f",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -6.80078125,
            "text": "A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istra",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -6.8671875,
            "text": "A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istrade",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -6.80078125,
            "text": "tra",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_10": [
        {
            "start_logit": 13.3203125,
            "end_logit": 12.9296875,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -4.59765625,
            "text": "is",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -5.8203125,
            "text": "istrade",
            "probability": 0.0
        },
        {
            "start_logit": -5.80859375,
            "end_logit": 12.9296875,
            "text": "ylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -6.3046875,
            "text": "istra",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -7.21875,
            "text": "istradef",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.640625,
            "text": "istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 12.9296875,
            "text": "fylline",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.7890625,
            "text": "istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.3984375,
            "text": "istradefylline for",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.1640625,
            "text": "istradefylline for the treatment of Parkinson's disease: pharmacokinetic and",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.1796875,
            "text": "istradefylline for the treatment of Parkinson's disease",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.265625,
            "text": "istradefylline for the",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.390625,
            "text": "istradefylline for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.9296875,
            "text": "adenosine antagonist istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.9296875,
            "text": "tradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 12.9296875,
            "text": "of the adenosine antagonist istradefylline",
            "probability": 0.0
        },
        {
            "start_logit": -5.80859375,
            "end_logit": -8.640625,
            "text": "ylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations",
            "probability": 0.0
        },
        {
            "start_logit": -5.80859375,
            "end_logit": -8.7890625,
            "text": "ylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": -4.59765625,
            "text": "adenosine antagonist is",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_1": [
        {
            "start_logit": 7.61328125,
            "end_logit": 8.6796875,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": 8.6796875,
            "text": "parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 8.6796875,
            "text": "endocrine pancreas",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.6796875,
            "text": "pituitary glands and the endocrine pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -8.2734375,
            "text": "pancreas,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -8.484375,
            "text": "pancreas, along with numerous other characteristic tumors and features",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.265625,
            "end_logit": 8.6796875,
            "text": "and pituitary glands and the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 8.6796875,
            "text": "hyperplastic or neoplastic changes in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -9.75,
            "text": "pancreas, along",
            "probability": 0.0
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -9.7578125,
            "text": "pancreas, along with numerous other characteristic tumors",
            "probability": 0.0
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -9.921875,
            "text": "pancreas, along with numerous other",
            "probability": 0.0
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -9.9765625,
            "text": "pancreas, along with numerous other characteristic tumors and features.",
            "probability": 0.0
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -9.9921875,
            "text": "pancreas, along with",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -6.38671875,
            "text": "parathyroid and pituitary glands",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -6.56640625,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -8.0703125,
            "text": "parathyroid and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -8.2734375,
            "text": "parathyroid and pituitary glands and the endocrine pancreas,",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -8.2890625,
            "text": "parathyroid and pituitary glands and the",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -8.3671875,
            "text": "parathyroid and pituitary glands and the endocrine",
            "probability": 0.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": -8.484375,
            "text": "parathyroid and pituitary glands and the endocrine pancreas, along with numerous other characteristic tumors and features",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_2": [
        {
            "start_logit": 11.078125,
            "end_logit": 11.8828125,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -5.89453125,
            "text": "pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": 11.8828125,
            "text": "neuroendocrine tumors (NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 11.8828125,
            "text": "NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -9.109375,
            "end_logit": 11.8828125,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 11.8828125,
            "text": "adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.34375,
            "text": "pancreas and",
            "probability": 0.0
        },
        {
            "start_logit": 11.078125,
            "end_logit": -9.515625,
            "text": "pancreas and pituitary.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 11.8828125,
            "text": "of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 11.8828125,
            "text": "(NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 11.8828125,
            "text": "MEN1) is an autosomal dominant disorder characterized by the combined occurrence of parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.8984375,
            "end_logit": 11.8828125,
            "text": "and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -5.89453125,
            "text": "neuroendocrine tumors (NETs) of the pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.078125,
            "text": "neuroendocrine tumors",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.67578125,
            "text": "neuroendocrine tumors (NETs",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -5.89453125,
            "text": "NETs) of the pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -8.9296875,
            "end_logit": -5.89453125,
            "text": "pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.5,
            "text": "neuroendocrine tumors (",
            "probability": 0.0
        },
        {
            "start_logit": -9.109375,
            "end_logit": -5.89453125,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -9.109375,
            "end_logit": -6.078125,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_3": [
        {
            "start_logit": 11.03125,
            "end_logit": 12.265625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.28125,
            "text": "pancreas, the pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": 12.265625,
            "text": "endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.390625,
            "text": "pancreas, the pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.5390625,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows high penetrance",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -8.90625,
            "text": "pancreas, the pituitary",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.546875,
            "text": "pancreas, the pituitary gland, and the parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.5703125,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows high penetrance.",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.75,
            "text": "pancreas, the pituitary gland, and the",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.90625,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows",
            "probability": 0.0
        },
        {
            "start_logit": 11.03125,
            "end_logit": -9.9375,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -8.28125,
            "text": "endocrine pancreas, the pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -8.390625,
            "text": "endocrine pancreas, the pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -8.28125,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -8.5390625,
            "text": "endocrine pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows high penetrance",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -8.28125,
            "text": "pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -8.28125,
            "text": ", the pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -8.390625,
            "text": "pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -8.390625,
            "text": ", the pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -8.765625,
            "text": "endocrine",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_4": [
        {
            "start_logit": 11.28125,
            "end_logit": 10.6953125,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": 10.6953125,
            "text": "hyperparathyroidism, tumors of endocrine pancreas",
            "probability": 0.0004584789276123047
        },
        {
            "start_logit": 3.58984375,
            "end_logit": 3.23828125,
            "text": "hyperparathyroidism",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 11.28125,
            "end_logit": -5.01171875,
            "text": "pancreas and pituitary",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.28125,
            "end_logit": -8.3671875,
            "text": "pancreas and",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -9.078125,
            "text": "pancreas and pituitary.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 10.6953125,
            "text": "endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 10.6953125,
            "text": "tumors of endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -5.01171875,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -8.0546875,
            "text": "hyperparathyroidism, tumors",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -8.3671875,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -9.078125,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and pituitary.",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -9.0859375,
            "text": "hyperparathyroidism,",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -9.1953125,
            "text": "hyperparathyroidism, tumors of",
            "probability": 0.0
        },
        {
            "start_logit": 3.58984375,
            "end_logit": -9.203125,
            "text": "hyperparathyroidism, tumors of endocrine",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -5.01171875,
            "text": "pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -5.01171875,
            "text": "endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -5.01171875,
            "text": "tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -9.078125,
            "text": "pituitary.",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -8.3671875,
            "text": "endocrine pancreas and",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_5": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.96875,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 10.96875,
            "text": "endocrine pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 10.96875,
            "text": "parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 10.96875,
            "text": "anterior pituitary gland, the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.96875,
            "text": "nodular proliferation of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 10.96875,
            "text": "of the anterior pituitary gland, the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": 10.96875,
            "text": ", the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 10.96875,
            "text": "pituitary gland, the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.6875,
            "text": "pancreas, and the neuroendocrine cell system",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.8203125,
            "text": "pancreas, and the neuroendocrine cell system of the gut",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.9375,
            "text": "pancreas, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -9.1015625,
            "text": "pancreas, and the",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 10.96875,
            "text": "MEN1) is an autosomal dominant inherited disorder characterized by nodular proliferation of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -9.546875,
            "text": "pancreas, and the neuroendocrine cell",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -5.8671875,
            "text": "parathyroid glands and tumors of the anterior pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -5.8671875,
            "text": "anterior pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -6.78515625,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -5.54296875,
            "end_logit": -8.6875,
            "text": "endocrine pancreas, and the neuroendocrine cell system",
            "probability": 0.0
        },
        {
            "start_logit": -5.54296875,
            "end_logit": -8.8203125,
            "text": "endocrine pancreas, and the neuroendocrine cell system of the gut",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -5.8671875,
            "text": "nodular proliferation of the parathyroid glands and tumors of the anterior pituitary",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_6": [
        {
            "start_logit": 11.2265625,
            "end_logit": 13.109375,
            "text": "parathyroid glands",
            "probability": 1.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -1.583984375,
            "text": "parathyroid glands, pancreatic islet cells",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -2.75390625,
            "text": "parathyroid glands, pancreatic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 13.109375,
            "text": "glands",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -5.5546875,
            "text": "parathyroid glands, pancreatic islet",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -6.55078125,
            "text": "parathyroid glands, pancreatic islet cells, and anterior pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 13.109375,
            "text": "of the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -6.5859375,
            "text": "parathyroid",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -7.8046875,
            "text": "parathyroid glands, pancreatic islet cells, and anterior pituitary",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -8.640625,
            "text": "parathyroid glands, pancreatic islet cells, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 13.109375,
            "text": "MEN1) is defined clinically by the combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.109375,
            "text": "neoplasia type 1 (MEN1) is defined clinically by the combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.109375,
            "text": "Multiple endocrine neoplasia type 1 (MEN1) is defined clinically by the combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 13.109375,
            "text": "endocrine neoplasia type 1 (MEN1) is defined clinically by the combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.9921875,
            "text": "parathyroid glands, pancreatic islet cells, and anterior",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -10.234375,
            "text": "parathyroid glands, pancreatic islet cells,",
            "probability": 0.0
        },
        {
            "start_logit": 2.193359375,
            "end_logit": -1.583984375,
            "text": "pancreatic islet cells",
            "probability": 0.0
        },
        {
            "start_logit": 2.193359375,
            "end_logit": -2.75390625,
            "text": "pancreatic",
            "probability": 0.0
        },
        {
            "start_logit": 2.193359375,
            "end_logit": -5.5546875,
            "text": "pancreatic islet",
            "probability": 0.0
        },
        {
            "start_logit": 2.193359375,
            "end_logit": -6.55078125,
            "text": "pancreatic islet cells, and anterior pituitary gland",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_7": [
        {
            "start_logit": 11.53125,
            "end_logit": 11.65625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -7.7734375,
            "text": "pancreas, and duodenum",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -8.0,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -8.3125,
            "text": "pancreas, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -8.359375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angiofibromas",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -8.4375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.0546875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.21875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipo",
            "probability": 0.0
        },
        {
            "start_logit": -9.546875,
            "end_logit": 11.65625,
            "text": ", pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.4375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 11.65625,
            "text": "endocrine tumors of the parathyroid and pituitary glands, pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.4765625,
            "text": "pancreas, and duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.5234375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.53125,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 11.65625,
            "text": "pituitary glands, pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 11.65625,
            "text": "parathyroid and pituitary glands, pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 11.65625,
            "text": "of the parathyroid and pituitary glands, pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.65625,
            "text": "Multiple endocrine neoplasia type 1 (MEN1) is characterized by the development of endocrine tumors of the parathyroid and pituitary glands, pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": -6.9765625,
            "text": "endocrine tumors",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": -7.640625,
            "text": "endocrine tumors of the parathyroid and pituitary glands",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_8": [
        {
            "start_logit": 10.640625,
            "end_logit": 12.3828125,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 12.3828125,
            "text": "parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -8.1796875,
            "text": "pancreas and a hepatic neuroendocrine tumor metastasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 12.3828125,
            "text": "neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -8.3671875,
            "text": "pancreas and a hepatic neuroendocrine tumor",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.3828125,
            "text": "involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 12.3828125,
            "text": "deletions of the MEN1 gene were consistently detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 12.3828125,
            "text": "MEN1 gene was detected, and deletions of the MEN1 gene were consistently detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.3828125,
            "text": "and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 12.3828125,
            "text": "consistently detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 12.3828125,
            "text": "detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 12.3828125,
            "text": "of the MEN1 gene was detected, and deletions of the MEN1 gene were consistently detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -9.6875,
            "text": "pancreas and a hepatic neuroendocrine",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -9.703125,
            "text": "pancreas and a hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -7.2578125,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -7.2578125,
            "text": "neuroendocrine tumors involving the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -7.2578125,
            "text": "germline mutation of the MEN1 gene was detected, and deletions of the MEN1 gene were consistently detected in multiple neuroendocrine tumors involving the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -8.1796875,
            "text": "parathyroid glands and the pancreas and a hepatic neuroendocrine tumor metastasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -7.2578125,
            "text": "involving the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -8.3671875,
            "text": "parathyroid glands and the pancreas and a hepatic neuroendocrine tumor",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_1": [
        {
            "start_logit": 11.4609375,
            "end_logit": 11.9375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -5.1640625,
            "text": "thrombocytopenia, fever",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -8.703125,
            "text": "thrombocytopenia, fever, elevated creatinine, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -9.0703125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental status.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 11.9375,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -9.453125,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental status",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -9.6015625,
            "text": "thrombocytopenia, fever, elevated creatinine",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 11.9375,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -9.953125,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 11.9375,
            "text": "Our patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4609375,
            "end_logit": -10.046875,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 11.9375,
            "text": "pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 11.9375,
            "text": "presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.765625,
            "end_logit": -5.1640625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -5.1640625,
            "text": "anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -5.1640625,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.765625,
            "end_logit": -8.703125,
            "text": "fever, elevated creatinine, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -5.1640625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": -5.1640625,
            "text": "Our patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_2": [
        {
            "start_logit": 11.140625,
            "end_logit": 12.21875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 12.21875,
            "text": "fever, thrombocytopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.96875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.21875,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.21875,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.25,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 12.21875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.3125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.21875,
            "text": "thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 12.21875,
            "text": "TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.4921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure.",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.75,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.8828125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -3.6171875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.6171875,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -3.6171875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -3.6171875,
            "text": "thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -3.6171875,
            "text": "TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -8.8203125,
            "text": "fever,",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_3": [
        {
            "start_logit": 11.21875,
            "end_logit": 12.171875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -6.59375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -8.5390625,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 12.171875,
            "text": "MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 12.171875,
            "text": "hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 12.171875,
            "text": "pentad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 12.171875,
            "text": "microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.171875,
            "text": "anemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.734375,
            "text": "thrombocytopenia, neurological dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.7421875,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.8046875,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are seen only in 40 percent of the patients.",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.859375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.890625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.21875,
            "end_logit": -9.921875,
            "text": "thrombocytopenia, neurological dysfunction, kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -6.59375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": -6.59375,
            "text": "MAHA), thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -6.59375,
            "text": "neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": -6.59375,
            "text": "hemolytic anemia (MAHA), thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": -6.59375,
            "text": "kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -6.59375,
            "text": ", neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_4": [
        {
            "start_logit": 11.1953125,
            "end_logit": 12.203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -6.56640625,
            "text": "thrombocytopenia, hemolysis, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -8.5390625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -8.8203125,
            "text": "thrombocytopenia, hemolysis",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.0078125,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 12.203125,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.3984375,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.515625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.5234375,
            "text": "thrombocytopenia, hemolysis,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.5625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 12.203125,
            "text": "classical pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.6875,
            "text": "thrombocytopenia, hemolysis, fever,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.7265625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthrombi formation in the",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -10.03125,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.56640625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -6.56640625,
            "text": "hemolysis, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -8.5390625,
            "text": "fever, renal injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -9.0078125,
            "text": "fever, renal injury and neurological deficits",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -6.56640625,
            "text": ", fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_5": [
        {
            "start_logit": 11.3125,
            "end_logit": 12.0859375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -6.2890625,
            "text": "thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -8.234375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia, fever, altered mental status, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.0859375,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.4296875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 12.0859375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 12.0859375,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.5859375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.65625,
            "text": "thrombocytopenia, fever, altered mental status",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.0859375,
            "text": "disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.890625,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -6.2890625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -8.234375,
            "text": "fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -6.2890625,
            "text": "hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -6.2890625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -6.2890625,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -6.2890625,
            "text": "disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -9.1171875,
            "text": "fever, altered mental status, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -9.5859375,
            "text": "fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_6": [
        {
            "start_logit": 11.328125,
            "end_logit": 12.0390625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -8.1328125,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -8.71875,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -8.9140625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.2734375,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.3828125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 12.0390625,
            "text": "haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 12.0390625,
            "text": "onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.4921875,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers.",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.5859375,
            "text": "thrombocytopenia, neurological symptoms, renal impairment",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.0390625,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.0390625,
            "text": "acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.0390625,
            "text": "TTP) is a distinct, rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.0390625,
            "text": "anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.8125,
            "text": "thrombocytopenia, neurological",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.1328125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.9140625,
            "text": "fevers",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -9.4921875,
            "text": "fevers.",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": -8.1328125,
            "text": "neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -8.1328125,
            "text": "haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_7": [
        {
            "start_logit": 11.3828125,
            "end_logit": 11.9921875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -4.94140625,
            "text": "thrombocytopenia, fever",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -8.75,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -8.90625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.2734375,
            "text": "thrombocytopenia, fever neurologic, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.4609375,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 11.9921875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 11.9921875,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.828125,
            "text": "thrombocytopenia, fever neurologic",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 11.9921875,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 11.9921875,
            "text": "diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 11.9921875,
            "text": "opathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 11.9921875,
            "text": "pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 11.9921875,
            "text": "thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -4.94140625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -4.94140625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -4.94140625,
            "text": "hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -4.94140625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -4.94140625,
            "text": "diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": -4.94140625,
            "text": "opathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_8": [
        {
            "start_logit": 11.2109375,
            "end_logit": 12.1171875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": 12.1171875,
            "text": "fever, thrombocytopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.2109375,
            "end_logit": -8.9375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": 11.2109375,
            "end_logit": -9.109375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2109375,
            "end_logit": -9.3984375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.2109375,
            "end_logit": -9.5078125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.1171875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.1171875,
            "text": "thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.1171875,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -3.5,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -3.5,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -3.5,
            "text": "thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -3.5,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -8.9140625,
            "text": "fever,",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -8.9375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -9.109375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -9.3984375,
            "text": "fever, thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": -9.5078125,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -8.9375,
            "text": "microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -8.9375,
            "text": "mental status changes",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_9": [
        {
            "start_logit": 11.2578125,
            "end_logit": 12.1015625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -3.23828125,
            "end_logit": 12.1015625,
            "text": "fever, thrombocytopenia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.3046875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.9765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.2421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction.",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.265625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.2890625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.1015625,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 12.1015625,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.1015625,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is characterized by the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.1015625,
            "text": "TTP) is characterized by the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.1015625,
            "text": "thrombocytopenic purpura (TTP) is characterized by the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -3.23828125,
            "end_logit": -1.2724609375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.23828125,
            "end_logit": -8.3046875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -1.2724609375,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -1.2724609375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -1.2724609375,
            "text": "TTP) is characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -1.2724609375,
            "text": "thrombocytopenic purpura (TTP) is characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.23828125,
            "end_logit": -8.5546875,
            "text": "fever,",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_10": [
        {
            "start_logit": 11.140625,
            "end_logit": 12.21875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 12.21875,
            "text": "fever, thrombocytopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.96875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 12.21875,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.21875,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.25,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 12.21875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.3125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.21875,
            "text": "thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 12.21875,
            "text": "TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.4921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure.",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.75,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.8828125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -3.6171875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -3.6171875,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -3.6171875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -3.6171875,
            "text": "thrombocytopenic purpura (TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -3.6171875,
            "text": "TTP) is typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -8.8203125,
            "text": "fever,",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_11": [
        {
            "start_logit": 10.984375,
            "end_logit": 11.6484375,
            "text": "fever",
            "probability": 1.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": 11.6484375,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 11.6484375,
            "text": "hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 11.6484375,
            "text": "microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": 11.6484375,
            "text": "renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 11.6484375,
            "text": "neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": 11.6484375,
            "text": "anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": 11.6484375,
            "text": ", microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 11.6484375,
            "text": ", renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 11.6484375,
            "text": "dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 11.6484375,
            "text": ", neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 11.6484375,
            "text": "multisystem disorder characterized by a pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 11.6484375,
            "text": "TTP) is a multisystem disorder characterized by a pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -3.609375,
            "text": "thrombocytopenic",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -7.1796875,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -3.609375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a multisystem disorder characterized by a pentad consisting of thrombocytopenic",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -8.7578125,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": -3.609375,
            "text": "thrombocytopenic purpura (TTP) is a multisystem disorder characterized by a pentad consisting of thrombocytopenic",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -3.609375,
            "text": "multisystem disorder characterized by a pentad consisting of thrombocytopenic",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -9.0,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_12": [
        {
            "start_logit": 11.234375,
            "end_logit": 12.1484375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -6.6640625,
            "text": "thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.6328125,
            "text": "thrombocytopenia, neurological symptoms, renal involvement, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.6328125,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.203125,
            "text": "thrombocytopenia, neurological symptoms, renal involvement",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 12.1484375,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 12.1484375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.3828125,
            "text": "thrombocytopenia, neurological symptoms, renal involvement, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 12.1484375,
            "text": "thrombotic thrombocytopenic purpura (TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.1484375,
            "text": "Clinical thrombotic thrombocytopenic purpura (TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 12.1484375,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 12.1484375,
            "text": "TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 12.1484375,
            "text": "thrombocytopenic purpura (TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 12.1484375,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.71875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.859375,
            "text": "thrombocytopenia, neurological",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -6.6640625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -6.6640625,
            "text": "neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -6.6640625,
            "text": "hemolytic anemia, thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -6.6640625,
            "text": "renal involvement, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_13": [
        {
            "start_logit": 11.0625,
            "end_logit": 12.3203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -5.39453125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.3984375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.765625,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.8984375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.9296875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpu",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 12.3203125,
            "text": ": The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 12.3203125,
            "text": "UNLABELLED: The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 12.3203125,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -5.39453125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -5.39453125,
            "text": "mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -5.39453125,
            "text": "neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -5.39453125,
            "text": "haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -5.39453125,
            "text": ": The pentad of thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": -5.39453125,
            "text": "UNLABELLED: The pentad of thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -5.39453125,
            "text": "pentad of thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -5.39453125,
            "text": "anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": -5.39453125,
            "text": "renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -5.39453125,
            "text": ", neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -8.9296875,
            "text": "fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpu",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_14": [
        {
            "start_logit": 11.09375,
            "end_logit": 12.2890625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -5.8203125,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -8.0078125,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -8.828125,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpur",
            "probability": 0.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -9.1015625,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs",
            "probability": 0.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -9.21875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.2890625,
            "text": ": The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.2890625,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 12.2890625,
            "text": "BACKGROUND: The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.09375,
            "end_logit": -9.6171875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -5.8203125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": -5.8203125,
            "text": "mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -5.8203125,
            "text": "neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": -5.8203125,
            "text": "hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -5.8203125,
            "text": ": The pentad of thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -5.8203125,
            "text": "pentad of thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": -5.8203125,
            "text": "renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": -5.8203125,
            "text": ", neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -5.8203125,
            "text": "anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": -5.8203125,
            "text": "BACKGROUND: The pentad of thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_15": [
        {
            "start_logit": 11.3203125,
            "end_logit": 12.015625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": 12.015625,
            "text": "fever, thrombocytopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -8.71875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.0859375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.390625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.015625,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.015625,
            "text": "thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.015625,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.71875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes. How",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.7265625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.7734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -3.751953125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -3.751953125,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -3.751953125,
            "text": "thrombocytopenic purpura (TTP) is a disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -3.751953125,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -8.71875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -9.0234375,
            "text": "fever,",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -9.0859375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -9.390625,
            "text": "fever, thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -9.71875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes. How",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_16": [
        {
            "start_logit": 11.0,
            "end_logit": 12.1015625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": 12.1015625,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 12.1015625,
            "text": "botic thrombocytopenic purpura has classically been characterized by the pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 12.1015625,
            "text": "neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.1015625,
            "text": "microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0,
            "end_logit": -8.890625,
            "text": "thrombocytopenia. The pat",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 12.1015625,
            "text": "hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 12.1015625,
            "text": "thrombocytopenic purpura has classically been characterized by the pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.1015625,
            "text": "pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.1015625,
            "text": "renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.1015625,
            "text": "anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.1015625,
            "text": "dysfunction, and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0,
            "end_logit": -9.7734375,
            "text": "thrombocytopenia.",
            "probability": 0.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": 0.1634521484375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": -7.71484375,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 0.1634521484375,
            "text": "botic thrombocytopenic purpura has classically been characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": -8.7578125,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": -8.890625,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia. The pat",
            "probability": 0.0
        },
        {
            "start_logit": -0.8505859375,
            "end_logit": -8.984375,
            "text": "fever,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 0.1634521484375,
            "text": "thrombocytopenic purpura has classically been characterized by the pentad of fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_17": [
        {
            "start_logit": 11.234375,
            "end_logit": 12.1328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -6.54296875,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -7.69921875,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and fever. The a",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.3125,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 12.1328125,
            "text": "MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.1328125,
            "text": "haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 12.1328125,
            "text": "microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.1328125,
            "text": "pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.546875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.1328125,
            "text": "A), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.5859375,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.1328125,
            "text": "anaemia (MAHA), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -6.54296875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -7.69921875,
            "text": "fever. The a",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": -6.54296875,
            "text": "MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -6.54296875,
            "text": "fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -6.54296875,
            "text": "haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": -6.54296875,
            "text": "microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -6.54296875,
            "text": "pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": -6.54296875,
            "text": "neurologic signs, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_18": [
        {
            "start_logit": 11.171875,
            "end_logit": 12.1796875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -5.88671875,
            "text": "thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -8.96875,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.171875,
            "text": "thrombocytopenia, fever, hemiparesis",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 12.1796875,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.296875,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria)",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.1796875,
            "text": "thrombocytopenic purpura was first described in 1924 by Moschowitz as a disease presenting with a pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.3828125,
            "text": "thrombocytopenia, fever, hemiparesis and",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.1796875,
            "text": "Moschowitz as a disease presenting with a pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.1796875,
            "text": "pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.7890625,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria). Pr",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.8671875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.8828125,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria).",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -5.88671875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": -5.88671875,
            "text": "anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.88671875,
            "text": "Moschowitz as a disease presenting with a pentad of signs and symptoms (anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": -5.88671875,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": -5.88671875,
            "text": "pentad of signs and symptoms (anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -8.96875,
            "text": "fever, hemiparesis and hematuria",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -9.171875,
            "text": "fever, hemiparesis",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_19": [
        {
            "start_logit": 11.3671875,
            "end_logit": 12.0078125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -8.4765625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -8.8203125,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -9.296875,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 12.0078125,
            "text": "TTP) is a distinct, rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.0078125,
            "text": "haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -9.515625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -9.5703125,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -9.65625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 12.0078125,
            "text": "onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3671875,
            "end_logit": -9.703125,
            "text": "thrombocytopenia, neurological symptoms, renal impairment",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.0078125,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.0078125,
            "text": "anaemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -8.4765625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -8.734375,
            "text": "botic thrombocytopenic purpura (TTP",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -9.296875,
            "text": "fevers",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": -9.1171875,
            "text": "botic thrombocytopenic purpura (TTP)",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -9.65625,
            "text": "fevers.",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.4765625,
            "text": "neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": -8.734375,
            "text": "thrombocytopenic purpura (TTP",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_20": [
        {
            "start_logit": 10.7421875,
            "end_logit": 12.5859375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -5.34765625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.078125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological disturbances.",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.5859375,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.5859375,
            "text": "s clinically characterized by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.0703125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.3203125,
            "text": "thrombocytopenia, Coombs-",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.5078125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological disturbances",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.640625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.703125,
            "text": "thrombocytopenia, Coombs-negative",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.75,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia,",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.84375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.8515625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.875,
            "text": "thrombocytopenia, Coombs",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -5.34765625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -5.34765625,
            "text": "Coombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -8.078125,
            "text": "fever, renal abnormalities and neurological disturbances.",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -5.34765625,
            "text": "pentad of thrombocytopenia, Coombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -5.34765625,
            "text": "s clinically characterized by the pentad of thrombocytopenia, Coombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -9.5078125,
            "text": "fever, renal abnormalities and neurological disturbances",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_21": [
        {
            "start_logit": 11.296875,
            "end_logit": 12.0703125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -4.7265625,
            "text": "thrombocytopenia, fever",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.296875,
            "end_logit": -7.921875,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities. Magnetic reso",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": 12.0703125,
            "text": "t was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -8.7578125,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.0546875,
            "text": "thrombocytopenia, fever neurologic, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.09375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.2109375,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities. Magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 12.0703125,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 12.0703125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.0703125,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -4.7265625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": -4.7265625,
            "text": "t was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -7.921875,
            "text": "fever neurologic, and renal abnormalities. Magnetic reso",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": -4.7265625,
            "text": "hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": -4.7265625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -4.7265625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -8.7578125,
            "text": "fever neurologic, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -9.0546875,
            "text": "fever neurologic, and",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -9.2109375,
            "text": "fever neurologic, and renal abnormalities. Magnetic",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_22": [
        {
            "start_logit": 11.140625,
            "end_logit": 12.2421875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 12.2421875,
            "text": "fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 12.2421875,
            "text": "acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 12.2421875,
            "text": "kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 12.2421875,
            "text": "he presented with most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 12.2421875,
            "text": "with most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 12.2421875,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.2421875,
            "text": "that he presented with most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.2421875,
            "text": "mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.2421875,
            "text": "most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 12.2421875,
            "text": "altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.625,
            "text": "thrombocytopenia, and evidence of red cell fragmentation",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.7109375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior to therapy.",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.71875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior to therapy",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.7890625,
            "text": "thrombocytopenia, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.9296875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -10.0703125,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10%",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -6.62890625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": -6.62890625,
            "text": "he presented with most components of the TTP pentad (except for fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -6.62890625,
            "text": "with most components of the TTP pentad (except for fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_23": [
        {
            "start_logit": 11.3125,
            "end_logit": 12.0859375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -6.2890625,
            "text": "thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -8.234375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia, fever, altered mental status, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.0859375,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.4296875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 12.0859375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 12.0859375,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.5859375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.65625,
            "text": "thrombocytopenia, fever, altered mental status",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.0859375,
            "text": "disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3125,
            "end_logit": -9.890625,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -6.2890625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -8.234375,
            "text": "fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -6.2890625,
            "text": "hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -6.2890625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -6.2890625,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -6.2890625,
            "text": "disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -9.1171875,
            "text": "fever, altered mental status, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -9.5859375,
            "text": "fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_24": [
        {
            "start_logit": 10.859375,
            "end_logit": 12.484375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -6.49609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 12.484375,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.484375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.484375,
            "text": "thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.484375,
            "text": "TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 12.484375,
            "text": "rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.0,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.1796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.2421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction.",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.3359375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": 10.859375,
            "end_logit": -9.6015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -6.49609375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": -6.49609375,
            "text": "microangiopathic hemolytic anemia, neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": -6.49609375,
            "text": "neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": -6.49609375,
            "text": "hemolytic anemia, neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -6.49609375,
            "text": "anemia, neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": -6.49609375,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -6.49609375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_25": [
        {
            "start_logit": 11.7421875,
            "end_logit": 11.21875,
            "text": "thrombocytopenic purpura",
            "probability": 1.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": 1.12890625,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -4.984375,
            "text": "thrombocytopenic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 11.21875,
            "text": "purpura",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -6.49609375,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -8.90625,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -9.5859375,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -9.9140625,
            "text": "thrombocytopenic purpura,",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -10.0625,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities,",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 11.21875,
            "text": "hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": 11.21875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": 11.7421875,
            "end_logit": -10.1953125,
            "text": "thrombocytopenic purpura, neurologic and renal",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 11.21875,
            "text": ", thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 11.21875,
            "text": "clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -0.344970703125,
            "end_logit": 1.12890625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 11.21875,
            "text": "anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 11.21875,
            "text": "opathic hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 11.21875,
            "text": "pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 1.12890625,
            "text": "purpura, neurologic and renal abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 1.12890625,
            "text": "neurologic and renal abnormalities, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_26": [
        {
            "start_logit": 11.0390625,
            "end_logit": 12.3359375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -6.44921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -8.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -8.796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 12.3359375,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.15625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.28125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.5,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -6.44921875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": -6.44921875,
            "text": "microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -6.44921875,
            "text": "neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -6.44921875,
            "text": "hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -6.44921875,
            "text": "decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -6.44921875,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -6.44921875,
            "text": "anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -6.44921875,
            "text": "diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -6.44921875,
            "text": "and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": -6.44921875,
            "text": "nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -6.44921875,
            "text": "opathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -6.44921875,
            "text": "renal function, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_27": [
        {
            "start_logit": 11.6484375,
            "end_logit": 11.6875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -8.796875,
            "text": "thrombocytopenia and",
            "probability": 0.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -9.171875,
            "text": "thrombocytopenia and a haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -9.4140625,
            "text": "thrombocytopenia and a haemolytic",
            "probability": 0.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -9.5390625,
            "text": "thrombocytopenia and a haemolytic anaemia--the pentad of features seen in TTP.",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 11.6875,
            "text": "fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -9.7890625,
            "text": "thrombocytopenia and a",
            "probability": 0.0
        },
        {
            "start_logit": 11.6484375,
            "end_logit": -9.875,
            "text": "thrombocytopenia and a haemolytic anaemia-",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 11.6875,
            "text": "seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 11.6875,
            "text": "presenting a fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 11.6875,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 11.6875,
            "text": "dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.6875,
            "text": "systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 11.6875,
            "text": "Initially presenting a fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 11.6875,
            "text": "upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -7.828125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -7.828125,
            "text": "presenting a fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -7.828125,
            "text": "Initially presenting a fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -8.796875,
            "text": "fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia and",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -8.796875,
            "text": "seizures, thrombocytopenia and",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_28": [
        {
            "start_logit": 11.1171875,
            "end_logit": 12.2734375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.44921875,
            "text": "thrombocytopenia, hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -8.5234375,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and renal disease",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -8.609375,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -8.7734375,
            "text": "thrombocytopenia, hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.015625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.109375,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and renal disease.",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 12.2734375,
            "text": "TTP) consists of the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.1875,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.2734375,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 12.2734375,
            "text": "thrombocytopenic purpura (TTP) consists of the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.2734375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) consists of the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.515625,
            "text": "thrombocytopenia, hemolytic anemia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.5625,
            "text": "thrombocytopenia, hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -6.44921875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -6.44921875,
            "text": "hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -8.5234375,
            "text": "fever, neurologic abnormalities, and renal disease",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -8.609375,
            "text": "fever, neurologic abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -6.44921875,
            "text": "TTP) consists of the pentad of thrombocytopenia, hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -6.44921875,
            "text": "anemia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_29": [
        {
            "start_logit": 10.984375,
            "end_logit": 12.375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -5.5390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.828125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.9375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.375,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.1796875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.1796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 12.375,
            "text": "Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 12.375,
            "text": "thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -5.5390625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": -5.5390625,
            "text": "microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -5.5390625,
            "text": "hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -8.734375,
            "text": "fever, and renal and neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -8.828125,
            "text": "fever, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -5.5390625,
            "text": "anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -5.5390625,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -8.9375,
            "text": "fever, and renal and neurologic abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -5.5390625,
            "text": ", fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_30": [
        {
            "start_logit": 11.0703125,
            "end_logit": 12.328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -5.30078125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.0703125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.6875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.8203125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.9296875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpura (TTP)",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.328125,
            "text": ": The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.328125,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.328125,
            "text": "UNLABELLED: The pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.421875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpura (TTP",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.4375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpura (TTP).",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.4609375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.4765625,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.609375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.65625,
            "text": "thrombocytopenia, haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.671875,
            "text": "thrombocytopenia, haemolytic anaemia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.84375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -5.30078125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": -5.30078125,
            "text": "mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -5.30078125,
            "text": "neurological signs and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_31": [
        {
            "start_logit": 11.2578125,
            "end_logit": 12.1171875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -6.72265625,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.6484375,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.671875,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 12.1171875,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 12.1171875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.1171875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.5078125,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.1171875,
            "text": "thrombocytopenic purpura (TTP) is characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.1171875,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.1171875,
            "text": "TTP) is characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.6796875,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.1171875,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -10.015625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -6.72265625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -6.72265625,
            "text": "neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -6.72265625,
            "text": "hemolytic anemia, thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -6.72265625,
            "text": "renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -6.72265625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -6.72265625,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_32": [
        {
            "start_logit": 10.8515625,
            "end_logit": 12.4921875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -6.63671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.4453125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 12.4921875,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.078125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.21875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.453125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.5859375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.8125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -6.63671875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": -6.63671875,
            "text": "neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": -6.63671875,
            "text": "microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": -6.63671875,
            "text": "hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -9.015625,
            "text": "fever, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -6.63671875,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -9.078125,
            "text": "fever, and renal abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -6.63671875,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -6.63671875,
            "text": "anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": -6.63671875,
            "text": ", neurological symptoms, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_33": [
        {
            "start_logit": 11.28125,
            "end_logit": 12.109375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -6.265625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -8.1796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -8.6171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage)",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -8.7421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -9.0390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -9.09375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -9.2109375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.28125,
            "end_logit": -9.546875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage).",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 12.109375,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a rare disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.109375,
            "text": "thrombocytopenic purpura (TTP) is a rare disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.109375,
            "text": "TTP) is a rare disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.109375,
            "text": "pentad (thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.265625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -8.1796875,
            "text": "fever and renal damage",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": -6.265625,
            "text": "neurologic signs and symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -8.6171875,
            "text": "fever and renal damage)",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -6.265625,
            "text": "microangiopathic hemolytic anemia, neurologic signs and symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -6.265625,
            "text": "hemolytic anemia, neurologic signs and symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -9.0390625,
            "text": "fever and",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_34": [
        {
            "start_logit": 11.4453125,
            "end_logit": 11.9375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -6.94921875,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.140625,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 11.9375,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.5703125,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.640625,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 11.9375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.6953125,
            "text": "thrombocytopenia, renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 11.9375,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 11.9375,
            "text": "pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.9453125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 11.9375,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -10.1796875,
            "text": "thrombocytopenia, renal",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 11.9375,
            "text": "TTP is characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -6.94921875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -6.94921875,
            "text": "hemolytic anemia, thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -6.94921875,
            "text": "renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -6.94921875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": -6.94921875,
            "text": "neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -6.94921875,
            "text": ", thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_35": [
        {
            "start_logit": 11.0703125,
            "end_logit": 12.3046875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -5.078125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.578125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.6171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.8125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.828125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -8.875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.0703125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs and symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.3046875,
            "text": "pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 12.3046875,
            "text": "While the pentad of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.25,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs and symptoms.",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.6796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -9.7734375,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -5.078125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": -5.078125,
            "text": "hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -5.078125,
            "text": "microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -8.578125,
            "text": "fever, and",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -8.6171875,
            "text": "fever, and renal and neurologic abnormalities",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_36": [
        {
            "start_logit": 11.3203125,
            "end_logit": 12.0546875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -5.54296875,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -7.88671875,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -8.875,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -8.9453125,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.0625,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 12.0546875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.0546875,
            "text": "congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.0546875,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.0546875,
            "text": "opathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.0546875,
            "text": "pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 12.0546875,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.890625,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": 11.3203125,
            "end_logit": -9.9140625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -5.54296875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": -5.54296875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": -5.54296875,
            "text": "congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -5.54296875,
            "text": "hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": -5.54296875,
            "text": "neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -5.54296875,
            "text": "renal dysfunction and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_37": [
        {
            "start_logit": 11.2421875,
            "end_logit": 12.1328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -5.77734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -8.078125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 12.1328125,
            "text": "Moschcowitz's pentad: thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -9.078125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -9.1171875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -9.2265625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.1328125,
            "text": "pentad: thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 12.1328125,
            "text": "witz's pentad: thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -9.5390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 11.2421875,
            "end_logit": -9.734375,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -5.77734375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -5.77734375,
            "text": "fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -5.77734375,
            "text": "Moschcowitz's pentad: thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -5.77734375,
            "text": "microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": -5.77734375,
            "text": "hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -5.77734375,
            "text": "neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -5.77734375,
            "text": "anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -5.77734375,
            "text": "pentad: thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -5.77734375,
            "text": "witz's pentad: thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_38": [
        {
            "start_logit": 10.75,
            "end_logit": 12.5234375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": 12.5234375,
            "text": "severe thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.75,
            "end_logit": -7.8359375,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": 12.5234375,
            "text": "1 This case presented with the pentad of thrombotic thrombocytopenic purpura: severe thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -8.3203125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L)",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -8.875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.078125,
            "text": "thrombocytopenia (platelets",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.171875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.328125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.5078125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20-110)), LDH",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.5078125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.6328125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L),",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.6484375,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20-110))",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.8046875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -9.8125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -5.77734375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -7.8359375,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -8.3203125,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L)",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -8.875,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -9.078125,
            "text": "severe thrombocytopenia (platelets",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_39": [
        {
            "start_logit": 11.4765625,
            "end_logit": 11.8984375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -6.03515625,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -7.96875,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 11.8984375,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 11.8984375,
            "text": "31 patients had diagnostic criteria for TTP; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.59375,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.6171875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.6875,
            "text": "thrombocytopenia, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 11.8984375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 11.8984375,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.84375,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 11.8984375,
            "text": "All 31 patients had diagnostic criteria for TTP; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.890625,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 11.8984375,
            "text": "; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 11.8984375,
            "text": "16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -6.03515625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": -6.03515625,
            "text": "hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -6.03515625,
            "text": "renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -6.03515625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": -6.03515625,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_40": [
        {
            "start_logit": 11.234375,
            "end_logit": 12.125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -6.203125,
            "text": "thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 12.125,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.1328125,
            "text": "thrombocytopenia, renal dysfunction, fever, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.3203125,
            "text": "thrombocytopenia, renal dysfunction, fever, and a fluctuating neurologic syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.3359375,
            "text": "thrombocytopenia, renal dysfunction, fever, and a fluctuating neurologic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.125,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.125,
            "text": "thrombocytopenic purpura (TTP) is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.125,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.125,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 12.125,
            "text": "TTP) is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.6640625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.703125,
            "text": "thrombocytopenia, renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.203125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -6.203125,
            "text": "hemolytic anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -6.203125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": -6.203125,
            "text": "renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -6.203125,
            "text": "anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -6.203125,
            "text": "thrombocytopenic purpura (TTP) is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_41": [
        {
            "start_logit": 11.3046875,
            "end_logit": 12.03125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -7.3046875,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -8.765625,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 12.03125,
            "text": "Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.25,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 12.03125,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 12.03125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.4921875,
            "text": "thrombocytopenia, neurological symptoms, renal injury",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.03125,
            "text": "thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.03125,
            "text": ": Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 12.03125,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.03125,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.7109375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.03125,
            "text": "thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -9.9375,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal if left untreated.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3046875,
            "end_logit": -10.2578125,
            "text": "thrombocytopenia, neurological",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -7.3046875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": -7.3046875,
            "text": "neurological symptoms, renal injury, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -7.3046875,
            "text": "hemolytic anemia, thrombocytopenia, neurological symptoms, renal injury, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -7.3046875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal injury, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_42": [
        {
            "start_logit": 11.3515625,
            "end_logit": 12.0390625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -6.2265625,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -8.1484375,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.046875,
            "text": "thrombocytopenia, renal disease",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.2734375,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.4453125,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.578125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.0390625,
            "text": "anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.0390625,
            "text": "pentad of anemia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.765625,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities,",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 12.0390625,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -6.2265625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -6.2265625,
            "text": "renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -6.2265625,
            "text": "neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -6.2265625,
            "text": "anemia, thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -6.2265625,
            "text": "pentad of anemia, thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -6.2265625,
            "text": ", renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": -6.2265625,
            "text": ", neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -6.2265625,
            "text": ", thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -6.2265625,
            "text": "disease, neurologic abnormalities, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_43": [
        {
            "start_logit": 11.2578125,
            "end_logit": 12.1328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -5.6796875,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.375,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.6484375,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -8.875,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.1015625,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 12.1328125,
            "text": "e., thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 12.1328125,
            "text": "pentad of thrombocytopenic purpura, i.e., thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.609375,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.671875,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 12.1328125,
            "text": "., thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2578125,
            "end_logit": -9.921875,
            "text": "thrombocytopenia, micro-angiopathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -5.6796875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -5.6796875,
            "text": "encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": -5.6796875,
            "text": "micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": -5.6796875,
            "text": ", micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -5.6796875,
            "text": "hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": -5.6796875,
            "text": "e., thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -5.6796875,
            "text": "renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -5.6796875,
            "text": ", renal failure, encephalopathy, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_44": [
        {
            "start_logit": 11.2265625,
            "end_logit": 11.8984375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 11.8984375,
            "text": "fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 11.8984375,
            "text": "microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": 11.8984375,
            "text": "neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.2265625,
            "end_logit": -9.46875,
            "text": "thrombocytopenia.",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 11.8984375,
            "text": "hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 11.8984375,
            "text": "renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 11.8984375,
            "text": "young adults. It is characterized by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 11.8984375,
            "text": "pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 11.8984375,
            "text": "anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.8984375,
            "text": "dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -5.1640625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -8.0390625,
            "text": "fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -5.1640625,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is an uncommon disorder which usually occurs in young adults. It is characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -5.1640625,
            "text": "thrombocytopenic purpura (TTP) is an uncommon disorder which usually occurs in young adults. It is characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -5.1640625,
            "text": "young adults. It is characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": -5.1640625,
            "text": "pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -9.46875,
            "text": "fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia.",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -9.4921875,
            "text": "fever, neurological abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -9.5234375,
            "text": "fever,",
            "probability": 0.0
        }
    ],
    "606a23c694d57fd87900004d_1": [
        {
            "start_logit": 10.90625,
            "end_logit": 12.234375,
            "text": "CYP2C9",
            "probability": 1.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": 12.234375,
            "text": "VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": 12.234375,
            "text": "507 adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 12.234375,
            "text": "(VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.046875,
            "end_logit": 12.234375,
            "text": "7 adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.234375,
            "text": "dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.234375,
            "text": "genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 12.234375,
            "text": "initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 12.234375,
            "text": "adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 12.234375,
            "text": "and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.234375,
            "text": "an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -9.2421875,
            "text": "CYP2C9) plus clinical information",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -10.3203125,
            "text": "CYP2C9) plus clinical information or only clinical information",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -10.3359375,
            "text": "CYP2C9) plus clinical information or only clinical information.",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -10.375,
            "text": "CYP2C9)",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -10.40625,
            "text": "CYP2C9) plus",
            "probability": 0.0
        },
        {
            "start_logit": 10.90625,
            "end_logit": -10.59375,
            "text": "CYP2C9) plus clinical",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -8.7421875,
            "text": "VKORC1",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -8.7421875,
            "text": "507 adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -9.2421875,
            "text": "VKORC1 and CYP2C9) plus clinical information",
            "probability": 0.0
        }
    ],
    "620c01ae3a8413c653000005_1": [
        {
            "start_logit": 11.1953125,
            "end_logit": 11.984375,
            "text": "CYP1A2",
            "probability": 1.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -4.4609375,
            "text": "CYP1A2 and CYP3A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.8125,
            "end_logit": 11.984375,
            "text": "as well as the expression of CYP1A2",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 11.984375,
            "text": "CYP content as well as the expression of CYP1A2",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.484375,
            "text": "CYP1A2 and",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 11.984375,
            "text": "total hepatic CYP content as well as the expression of CYP1A2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 11.984375,
            "text": "hepatic CYP content as well as the expression of CYP1A2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 11.984375,
            "text": "pomegranate juice consumption decreased total hepatic CYP content as well as the expression of CYP1A2",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.84375,
            "text": "CYP1A2 and CYP3A.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -4.4609375,
            "text": "CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": -4.4609375,
            "text": "as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -4.4609375,
            "text": "CYP content as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -4.4609375,
            "text": "total hepatic CYP content as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -4.4609375,
            "text": "hepatic CYP content as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -4.4609375,
            "text": "pomegranate juice consumption decreased total hepatic CYP content as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": -6.640625,
            "text": "CYP",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -6.640625,
            "text": "total hepatic CYP",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -6.640625,
            "text": "hepatic CYP",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -6.640625,
            "text": "pomegranate juice consumption decreased total hepatic CYP",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -9.84375,
            "text": "CYP3A.",
            "probability": 0.0
        }
    ],
    "5c6e146a7c78d6947100004c_1": [
        {
            "start_logit": 13.46875,
            "end_logit": 13.5078125,
            "text": "glecaprevir",
            "probability": 1.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -4.359375,
            "text": "gle",
            "probability": 0.0
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 13.5078125,
            "text": "vir",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -5.97265625,
            "text": "glecapre",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -6.17578125,
            "text": "glecap",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.10546875,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": 13.5078125,
            "text": "hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 13.5078125,
            "text": "NS3/4A protease inhibitor (PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 13.5078125,
            "text": "PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.2421875,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrentasvir",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.8359375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrent",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.9375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentas",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.953125,
            "text": "glecaprevir and the HCV NS5A inhibitor pibre",
            "probability": 0.0
        },
        {
            "start_logit": -9.0,
            "end_logit": 13.5078125,
            "text": "HCV) NS3/4A protease inhibitor (PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.9921875,
            "text": "glecaprevir and the HCV NS5A inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.015625,
            "text": "glecaprevir and the HCV NS5A inhibitor pi",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.0390625,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -9.5703125,
            "end_logit": 13.5078125,
            "text": "(PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": 13.5078125,
            "text": "tablet of the hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.5078125,
            "text": "protease inhibitor (PI) glecaprevir",
            "probability": 0.0
        }
    ],
    "5c6e146a7c78d6947100004c_2": [
        {
            "start_logit": 12.875,
            "end_logit": 13.109375,
            "text": "glecaprevir",
            "probability": 1.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -3.388671875,
            "text": "glecaprevir/pibrentasvir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.875,
            "end_logit": -4.21484375,
            "text": "glecap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.90625,
            "end_logit": 13.109375,
            "text": "vir",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -4.8828125,
            "text": "gle",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -6.66015625,
            "text": "glecapre",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 13.109375,
            "text": "delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -7.515625,
            "text": "glecaprevir/pibrentasvir (Mavyret) for chronic HCV",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -8.3515625,
            "text": "glecaprevir/pi",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -8.484375,
            "text": "glecaprevir/pibre",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -8.71875,
            "text": "glecaprevir/",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -8.828125,
            "text": "glecaprevir/pibrentasvir (Mavyret) for chronic HCV infection",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -9.171875,
            "text": "glecaprevir/pibrent",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.109375,
            "text": "afloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": 12.875,
            "end_logit": -9.2578125,
            "text": "glecaprevir/pibrentasvir (Mavyret)",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": 13.109375,
            "text": "revir",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.109375,
            "text": "bacterial skin infections; and glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 13.109375,
            "text": "loxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 0.0
        },
        {
            "start_logit": -4.90625,
            "end_logit": -3.388671875,
            "text": "vir/pibrentasvir",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -3.388671875,
            "text": "pibrentasvir",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_1": [
        {
            "start_logit": 14.15625,
            "end_logit": 14.3203125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": 14.3203125,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -3.64453125,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -7.765625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -7.92578125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.703125,
            "text": "tmVar, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.796875,
            "text": "tmVar, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": 14.3203125,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.9921875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": -7.765625,
            "text": "r, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": -8.703125,
            "text": "r, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": -8.796875,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": -8.9921875,
            "text": "r, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.703125,
            "text": "Human Genome Variation Society",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.1796875,
            "text": "Human Genome Variation Society. By doing so, we cover several important types of mutations that were not considered in past studies. Using a novel CRF label model",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.46875,
            "text": "Human Genome Variation Society. By doing so, we cover several important types of mutations that were not considered in past studies. Using a novel CRF",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.7421875,
            "text": "Human Genome Variation Society. By doing so, we cover several important types of mutations",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.8984375,
            "text": "Human Genome Variation",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": -7.765625,
            "text": "Var, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -7.703125,
            "text": "extracting a wide range of sequence variants described at protein, DNA and RNA levels according to a standard nomenclature developed by the Human Genome Variation Society",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_2": [
        {
            "start_logit": 13.0703125,
            "end_logit": 13.546875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": 13.546875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -4.90625,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -6.03125,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -7.73828125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -7.8125,
            "text": "tmVar 2.0",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -7.8828125,
            "text": "tmVar 2",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -7.89453125,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -7.94140625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -8.8046875,
            "text": "tmVar 2.0: integrating genomic variant",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 13.546875,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -8.90625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbS",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.21875,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and Clin",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.2890625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine.",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.40625,
            "text": "tmVar 2.0: integrating genomic variant information from literature",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.6171875,
            "text": "tmVar 2.0: integrating genomic variant information",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.671875,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.7578125,
            "text": "tmVar 2.",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.78125,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.984375,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_3": [
        {
            "start_logit": 12.9296875,
            "end_logit": 13.0,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -5.0234375,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 13.0,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -6.99609375,
            "text": "tmVar: a text mining",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -7.375,
            "text": "tmVar: a text mining approach for extracting sequence variants",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -7.77734375,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -8.1015625,
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -8.3359375,
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature.",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -8.71875,
            "text": "tmVar: a text mining approach",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.59375,
            "text": "tmVar:",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.71875,
            "text": "tmVar: a text",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.7421875,
            "text": "tmVar: a text mining approach for extracting sequence",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.8203125,
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.8203125,
            "text": "tmVar: a text mining approach for extracting sequence variants in",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.0,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -10.3125,
            "text": "tmVar: a text mining approach for",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -10.4140625,
            "text": "tmVar: a text mining approach for extracting",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -10.65625,
            "text": "tmVar: a",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -6.99609375,
            "text": "r: a text mining",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -7.375,
            "text": "r: a text mining approach for extracting sequence variants",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_4": [
        {
            "start_logit": 13.65625,
            "end_logit": 13.265625,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -3.87890625,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.65625,
            "end_logit": -4.5546875,
            "text": "tmVar 2",
            "probability": 0.0
        },
        {
            "start_logit": -4.80859375,
            "end_logit": 13.265625,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -6.18359375,
            "text": "tmVar 2.0",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -6.5,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -7.4140625,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -7.94140625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.015625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.09375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.2578125,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.4609375,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.640625,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.75,
            "text": "tmVar 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 13.265625,
            "text": "genomic research.Availability and implementation: The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 13.265625,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 13.265625,
            "text": "human efforts in evaluating/prioritizing variants in genomic research.Availability and implementation: The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 13.265625,
            "text": ": The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -4.80859375,
            "end_logit": -4.5546875,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -4.80859375,
            "end_logit": -6.18359375,
            "text": "r 2.0",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_5": [
        {
            "start_logit": 13.65625,
            "end_logit": 13.7421875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 13.7421875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -4.41015625,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -7.546875,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.4375,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.1953125,
            "text": "tmVar, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.3828125,
            "text": "tmVar, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 13.7421875,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.546875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.5859375,
            "text": "tmVar, a text",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.5859375,
            "text": "tmVar,",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.7421875,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a wide range of sequence variants described",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.7734375,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a wide range of sequence variants",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 13.7421875,
            "text": "RESULTS Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -8.4375,
            "text": "r, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.1953125,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.3828125,
            "text": "r, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.546875,
            "text": "r, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.5859375,
            "text": "r, a text",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.5859375,
            "text": "r,",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_6": [
        {
            "start_logit": 10.84375,
            "end_logit": 10.1328125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -6.59765625,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.84375,
            "end_logit": -7.7109375,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.59375,
            "text": "tmVar is a high-performance method for mutation extraction",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.6796875,
            "text": "tmVar is a high-performance method",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.7421875,
            "text": "tmVar is a high-performance method for mutation",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.0625,
            "text": "tmVar is a high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.1328125,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.46875,
            "text": "tmVar is",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.546875,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.59375,
            "text": "tmVar is a high-performance method for mutation extraction from",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.84375,
            "text": "tmVar is a",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.0625,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.171875,
            "text": "tmVar is a high-performance",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.2421875,
            "text": "tmVar is a high-performance method for",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.1328125,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.7109375,
            "text": "r is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -8.59375,
            "text": "r is a high-performance method for mutation extraction",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -8.6796875,
            "text": "r is a high-performance method",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_7": [
        {
            "start_logit": 13.1328125,
            "end_logit": 13.046875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -5.0703125,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": 13.046875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -5.97265625,
            "text": "tmVar software",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.6796875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.828125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.875,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.90625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 13.046875,
            "text": "AVAILABILITY tmVar",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.6796875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.859375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.0078125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.390625,
            "text": "tmVar software and its corpus of 500 manually curated",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": 13.046875,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -5.97265625,
            "text": "r software",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.6796875,
            "text": "r software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.828125,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -5.0703125,
            "text": "AVAILABILITY tm",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.90625,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -8.21875,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.nih",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_8": [
        {
            "start_logit": 13.265625,
            "end_logit": 12.5703125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -3.8515625,
            "text": "tmVar 2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.265625,
            "end_logit": -4.3125,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.265625,
            "end_logit": -5.8515625,
            "text": "tmVar 2.0",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -6.44140625,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 12.5703125,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.3671875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.5,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.51171875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.625,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.63671875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.890625,
            "text": "tmVar 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.375,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.6484375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.7265625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -3.8515625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -5.8515625,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.37109375,
            "text": "bionlp",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.79296875,
            "text": "bionlp/Tools/tmvar/",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.90625,
            "text": "bionl",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_9": [
        {
            "start_logit": 13.65625,
            "end_logit": 13.7421875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 13.7421875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -4.41015625,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -7.546875,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.4375,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.1953125,
            "text": "tmVar, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.3828125,
            "text": "tmVar, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 13.7421875,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.546875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.5859375,
            "text": "tmVar, a text",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.5859375,
            "text": "tmVar,",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.7421875,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a wide range of sequence variants described",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.7734375,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a wide range of sequence variants",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 13.7421875,
            "text": "RESULTS Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -8.4375,
            "text": "r, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.1953125,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.3828125,
            "text": "r, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.546875,
            "text": "r, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.5859375,
            "text": "r, a text",
            "probability": 0.0
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -9.5859375,
            "text": "r,",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_10": [
        {
            "start_logit": 13.1328125,
            "end_logit": 13.046875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -5.0703125,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": 13.046875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -5.97265625,
            "text": "tmVar software",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.6796875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.828125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.875,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.90625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 13.046875,
            "text": "AVAILABILITY tmVar",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.6796875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.859375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.0078125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.390625,
            "text": "tmVar software and its corpus of 500 manually curated",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": 13.046875,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -5.97265625,
            "text": "r software",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.6796875,
            "text": "r software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.828125,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -5.0703125,
            "text": "AVAILABILITY tm",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -7.90625,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -8.21875,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.nih",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_11": [
        {
            "start_logit": 13.265625,
            "end_logit": 12.5703125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -3.8515625,
            "text": "tmVar 2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.265625,
            "end_logit": -4.3125,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.265625,
            "end_logit": -5.8515625,
            "text": "tmVar 2.0",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -6.44140625,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 12.5703125,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.3671875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.5,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.51171875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.625,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.63671875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -7.890625,
            "text": "tmVar 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.375,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.6484375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 13.265625,
            "end_logit": -8.7265625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -3.8515625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -5.8515625,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.37109375,
            "text": "bionlp",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.79296875,
            "text": "bionlp/Tools/tmvar/",
            "probability": 0.0
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -7.90625,
            "text": "bionl",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_12": [
        {
            "start_logit": 13.859375,
            "end_logit": 13.984375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": 13.984375,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -4.0859375,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.4140625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.72265625,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -8.7578125,
            "text": "tmVar, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -8.890625,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 13.984375,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.296875,
            "text": "tmVar, a text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 13.984375,
            "text": "b>RESULTS</b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.4140625,
            "text": "tmVar, a text",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": 13.984375,
            "text": "<br><b>RESULTS</b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.4453125,
            "text": "tmVar, a text-mining approach based on conditional random field (",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 13.984375,
            "text": "br><b>RESULTS</b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 13.984375,
            "text": "b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 13.984375,
            "text": "extracting different kinds of mutations with high accuracy.<br><b>RESULTS</b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 13.984375,
            "text": "kinds of mutations with high accuracy.<br><b>RESULTS</b>: Here, we report tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": -7.4140625,
            "text": "r, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": -8.7578125,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": -8.890625,
            "text": "r, a text-mining approach based on conditional random field",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_13": [
        {
            "start_logit": 0.93994140625,
            "end_logit": 4.8125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -9.21875,
            "end_logit": 4.8125,
            "text": "mutation extraction from biomedical literature.<br><b>AVAILABILITY</b>: tmVar",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -5.35546875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -5.56640625,
            "text": "tmVar software",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 4.8125,
            "text": "Var",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -9.796875,
            "end_logit": 4.8125,
            "text": "<br><b>AVAILABILITY</b>: tmVar",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -10.046875,
            "end_logit": 4.8125,
            "text": ": tmVar",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -10.09375,
            "end_logit": 4.8125,
            "text": "Var is a high-performance method for mutation extraction from biomedical literature.<br><b>AVAILABILITY</b>: tmVar",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -10.125,
            "end_logit": 4.8125,
            "text": "/b>: tmVar",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -6.43359375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -6.515625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -7.78515625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nl",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -8.234375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 0.93994140625,
            "end_logit": -8.3828125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -9.296875,
            "end_logit": -5.35546875,
            "text": "and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -5.44921875,
            "text": "and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": -9.21875,
            "end_logit": -5.56640625,
            "text": "mutation extraction from biomedical literature.<br><b>AVAILABILITY</b>: tmVar software",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -5.35546875,
            "text": "Var software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -5.35546875,
            "text": "ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -5.56640625,
            "text": "Var software",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_14": [
        {
            "start_logit": 12.6796875,
            "end_logit": 12.046875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": 3.43359375,
            "text": "tmVar 2",
            "probability": 0.0001823902130126953
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -2.294921875,
            "text": "tmVar 2.0",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -4.328125,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -6.14453125,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -6.7578125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 12.046875,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -7.2421875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -7.30859375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -7.9375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -8.1171875,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -8.4296875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": 12.046875,
            "text": ": The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 12.046875,
            "text": "/b>: The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 12.046875,
            "text": "human efforts in evaluating/prioritizing variants in genomic research.<br><b>Availability and implementation</b>: The tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 3.43359375,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": 3.43359375,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": 3.43359375,
            "text": ": The tmVar 2",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 3.43359375,
            "text": "/b>: The tmVar 2",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -2.294921875,
            "text": "r 2.0",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_15": [
        {
            "start_logit": 13.2109375,
            "end_logit": 13.34375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 13.34375,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -4.8359375,
            "text": "tm",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.3515625,
            "text": "tmVar software",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.43359375,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.5859375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.7734375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.87890625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -8.7421875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -8.8984375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.0546875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.3984375,
            "text": "tmVar software and its corpus of",
            "probability": 0.0
        },
        {
            "start_logit": -9.7890625,
            "end_logit": 13.34375,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -6.3515625,
            "text": "r software",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -7.5859375,
            "text": "r software and its corpus of 500 manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -7.7734375,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -7.87890625,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -8.2578125,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -8.7421875,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -4.9140625,
            "end_logit": -8.8984375,
            "text": "r software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.nl",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_16": [
        {
            "start_logit": 12.953125,
            "end_logit": 12.2734375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -3.625,
            "text": "tmVar 2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.953125,
            "end_logit": -4.6796875,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.8515625,
            "text": "tmVar 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 12.2734375,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -6.828125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.39453125,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.7578125,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.76171875,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.765625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.953125,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.nih.gov",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.0703125,
            "text": "tmVar 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.40625,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.84375,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nl",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.9140625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi.nlm.",
            "probability": 0.0
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -3.625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -5.8515625,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -5.41015625,
            "end_logit": -7.18359375,
            "text": "bionlp",
            "probability": 0.0
        },
        {
            "start_logit": -9.1328125,
            "end_logit": -3.625,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": -5.41015625,
            "end_logit": -7.9296875,
            "text": "bionl",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_17": [
        {
            "start_logit": 10.84375,
            "end_logit": 10.1328125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -6.59765625,
            "text": "tm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.84375,
            "end_logit": -7.7109375,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.125,
            "text": "tmVa",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.59375,
            "text": "tmVar is a high-performance method for mutation extraction",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.6796875,
            "text": "tmVar is a high-performance method",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -8.7421875,
            "text": "tmVar is a high-performance method for mutation",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.0625,
            "text": "tmVar is a high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.1328125,
            "text": "r",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.46875,
            "text": "tmVar is",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.546875,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.59375,
            "text": "tmVar is a high-performance method for mutation extraction from",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -9.84375,
            "text": "tmVar is a",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.0625,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.171875,
            "text": "tmVar is a high-performance",
            "probability": 0.0
        },
        {
            "start_logit": 10.84375,
            "end_logit": -10.2421875,
            "text": "tmVar is a high-performance method for",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.1328125,
            "text": "Var",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.7109375,
            "text": "r is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -8.59375,
            "text": "r is a high-performance method for mutation extraction",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -8.6796875,
            "text": "r is a high-performance method",
            "probability": 0.0
        }
    ],
    "5a736f0c3b9d13c708000007_1": [
        {
            "start_logit": 5.30078125,
            "end_logit": 12.0546875,
            "text": "thalassemia",
            "probability": 0.9951171875
        },
        {
            "start_logit": 9.625,
            "end_logit": 2.224609375,
            "text": "mean corpuscular volume (MCV)",
            "probability": 0.00403594970703125
        },
        {
            "start_logit": 9.625,
            "end_logit": 0.30029296875,
            "text": "mean corpuscular volume (MCV",
            "probability": 0.0005860328674316406
        },
        {
            "start_logit": 9.625,
            "end_logit": -0.176513671875,
            "text": "mean corpuscular volume",
            "probability": 0.0003638267517089844
        },
        {
            "start_logit": -3.62109375,
            "end_logit": 12.0546875,
            "text": "for thalassemia",
            "probability": 0.0001327991485595703
        },
        {
            "start_logit": 9.625,
            "end_logit": -5.9296875,
            "text": "mean corpuscular volume (MCV) and red blood cell count",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.01171875,
            "text": "mean corpuscular volume (MCV) and red blood cell count (RBC",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 12.0546875,
            "text": "screened for thalassemia",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -9.21875,
            "end_logit": 12.0546875,
            "text": "determined through a receiver operating characteristic (ROC) curve on the first subset, and screened for thalassemia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.625,
            "end_logit": -7.13671875,
            "text": "mean corpuscular volume (MCV) and red blood cell count (RBC)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.625,
            "end_logit": -7.1875,
            "text": "mean",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.625,
            "end_logit": -7.3046875,
            "text": "mean corpuscular volume (MCV) and red blood cell count (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.625,
            "end_logit": -7.58203125,
            "text": "mean corpuscular volume (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.625,
            "end_logit": -7.8515625,
            "text": "mean corpuscular volume (MCV) and red blood cell",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.24609375,
            "end_logit": 2.224609375,
            "text": "MCV)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.625,
            "end_logit": -9.2890625,
            "text": "mean corpuscular volume (MCV) and red blood",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.625,
            "end_logit": -9.3515625,
            "text": "mean corpuscular volume (MCV) and red",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.625,
            "end_logit": -9.4453125,
            "text": "mean corpus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.625,
            "end_logit": -9.5546875,
            "text": "mean corpuscular volume (MCV) and red blood cell count (RBC) can be automatically calculated with any of the newer hematology analyzer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.625,
            "end_logit": -9.640625,
            "text": "mean corpuscu",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_1": [
        {
            "start_logit": 13.703125,
            "end_logit": 12.140625,
            "text": "skin reactions",
            "probability": 1.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": 2.11328125,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 13.703125,
            "end_logit": -2.24609375,
            "text": "skin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.796875,
            "end_logit": 12.140625,
            "text": "reactions",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.703125,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.2109375,
            "text": "skin reactions to gabapentin are considered uncommon",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.2578125,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash possibly",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.65625,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash possibly related to gabapentin range from 1% to 10%",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.765625,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash possibly related",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 12.140625,
            "text": ", skin reactions",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 12.140625,
            "text": "antiepileptic drugs, skin reactions",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": 2.11328125,
            "text": "rash",
            "probability": 0.0
        },
        {
            "start_logit": -5.796875,
            "end_logit": 2.11328125,
            "text": "reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 2.11328125,
            "text": "prevalence of rash",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 2.11328125,
            "text": ", skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -5.39453125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 2.11328125,
            "text": "antiepileptic drugs, skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -9.1953125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -9.2578125,
            "text": "rash possibly",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -9.2734375,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_2": [
        {
            "start_logit": 7.6484375,
            "end_logit": 10.0546875,
            "text": "drowsiness/sedation",
            "probability": 0.927734375
        },
        {
            "start_logit": 7.6484375,
            "end_logit": 6.98828125,
            "text": "drowsiness/sedation, dizziness",
            "probability": 0.04339599609375
        },
        {
            "start_logit": 7.12890625,
            "end_logit": 6.98828125,
            "text": "dizziness",
            "probability": 0.02569580078125
        },
        {
            "start_logit": 7.6484375,
            "end_logit": 4.4375,
            "text": "drowsiness",
            "probability": 0.0033721923828125
        },
        {
            "start_logit": -0.7431640625,
            "end_logit": 6.98828125,
            "text": ", dizziness",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 10.0546875,
            "text": "sedation",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 6.98828125,
            "text": "sedation, dizziness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.78125,
            "end_logit": 10.0546875,
            "text": "ess/sedation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.41796875,
            "text": "drowsin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.94140625,
            "text": "drowsiness/sedation, dizziness, and malaise",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.359375,
            "end_logit": 10.0546875,
            "text": ", drowsiness/sedation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.5,
            "end_logit": 10.0546875,
            "text": "adverse events reported during the first month of treatment, drowsiness/sedation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.1171875,
            "text": "drow",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.15234375,
            "text": "drowsiness/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -6.94140625,
            "text": "dizziness, and malaise",
            "probability": 0.0
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.84765625,
            "text": "drowsiness/sedation, dizziness, and malaise/lassitude",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 10.0546875,
            "text": "siness/sedation",
            "probability": 0.0
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.84765625,
            "text": "dizziness, and malaise/lassitude",
            "probability": 0.0
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -8.671875,
            "text": "drowsiness/sedation,",
            "probability": 0.0
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -9.0703125,
            "text": "drowsiness/sedation, dizziness, and",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_3": [
        {
            "start_logit": 14.4375,
            "end_logit": 14.1875,
            "text": "somnolence",
            "probability": 1.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -2.60546875,
            "text": "som",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.4375,
            "end_logit": -3.408203125,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 0.0
        },
        {
            "start_logit": -3.373046875,
            "end_logit": 14.1875,
            "text": "ce",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -4.9453125,
            "text": "somno",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -5.80859375,
            "text": "somnolen",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -6.75390625,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -7.4453125,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -7.46875,
            "text": "somnolence, fainting, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.0703125,
            "text": "somnolence, fainting",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.109375,
            "text": "somnolence, fainting, ataxia, nystagmus",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -8.765625,
            "text": "somnolence, fa",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -9.234375,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and headache. However, their incidence was low and intensity",
            "probability": 0.0
        },
        {
            "start_logit": 14.4375,
            "end_logit": -9.3046875,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and headache. However, their incidence",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": 14.1875,
            "text": "adverse effects seen were somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 14.1875,
            "text": "lence",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 14.1875,
            "text": "were somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -3.373046875,
            "end_logit": -3.408203125,
            "text": "ce, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 0.0
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -3.408203125,
            "text": "headache",
            "probability": 0.0
        },
        {
            "start_logit": -3.373046875,
            "end_logit": -6.75390625,
            "text": "ce, fainting, ataxia, nystagmus, tremor",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_4": [
        {
            "start_logit": 14.0390625,
            "end_logit": 13.7890625,
            "text": "somnolence",
            "probability": 1.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -2.765625,
            "text": "somnolence, dizziness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -2.970703125,
            "text": "som",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.1171875,
            "end_logit": 13.7890625,
            "text": "ce",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -4.58203125,
            "text": "somno",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -4.94921875,
            "text": "somnolence, dizziness, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -5.26953125,
            "text": "somnolen",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -5.7890625,
            "text": "somnolence, dizziness, ataxia, fatigue",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -8.796875,
            "text": "somnolence, dizziness, ataxia, fatigue), only one, dizziness",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.296875,
            "text": "somnolence,",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.5078125,
            "text": "somnolence, dizziness,",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": 13.7890625,
            "text": "adverse events (somnolence",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.703125,
            "text": "somnolence, dizziness, ataxia, fatigue)",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.8125,
            "text": "somnolence, dizziness, ataxia, fatigue), only one, dizziness,",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.9921875,
            "text": "somnolence, dizziness, ataxia, fatigue), only one,",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 13.7890625,
            "text": "lence",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.7890625,
            "text": "nolence",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 13.7890625,
            "text": "Of the four most common adverse events (somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -3.900390625,
            "end_logit": -2.765625,
            "text": "dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -2.765625,
            "text": "ce, dizziness",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_5": [
        {
            "start_logit": 14.6796875,
            "end_logit": 14.1015625,
            "text": "Somnolence",
            "probability": 1.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -2.146484375,
            "text": "Som",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -2.201171875,
            "text": "Somnolence and dizziness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.60546875,
            "end_logit": 14.1015625,
            "text": "ce",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -5.796875,
            "text": "Somno",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -6.01171875,
            "text": "Somnolen",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -9.09375,
            "text": "Somnolence and dizziness were the only adverse events",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -9.4453125,
            "text": "Somnolence and",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 14.1015625,
            "text": "nolence",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.046875,
            "text": "Somnolence and dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.09375,
            "text": "Somnolence and dizziness were the only adverse events reported by at least two patients during gabapentin treatment.",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.1015625,
            "text": "Somnolence and dizziness were the only",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.140625,
            "text": "Somnolence and dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.140625,
            "text": "Somnolence and dizziness were the only adverse events reported by at least two",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.15625,
            "text": "Somnolence and dizziness were the only adverse events reported",
            "probability": 0.0
        },
        {
            "start_logit": 14.6796875,
            "end_logit": -10.21875,
            "text": "Somnolence and dizziness were the",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 14.1015625,
            "text": "lence",
            "probability": 0.0
        },
        {
            "start_logit": -2.4453125,
            "end_logit": -2.201171875,
            "text": "dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -2.201171875,
            "text": "ce and dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -2.4453125,
            "end_logit": -9.09375,
            "text": "dizziness were the only adverse events",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_6": [
        {
            "start_logit": 11.5703125,
            "end_logit": 11.6796875,
            "text": "hyperactivity",
            "probability": 1.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -7.375,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -7.9453125,
            "text": "hyperactivity, irritability",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -8.75,
            "text": "hyperactivity, irritability, and agitation",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -9.2265625,
            "text": "hyperactivity, irritability, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -9.6328125,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -9.8515625,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 11.6796875,
            "text": "side effects were behavioral. These consisted of hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -10.234375,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -10.359375,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.5703125,
            "end_logit": -10.421875,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit.",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.375,
            "text": "irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.9453125,
            "text": "irritability",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -8.75,
            "text": "irritability, and agitation",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -9.2265625,
            "text": "irritability, and",
            "probability": 0.0
        },
        {
            "start_logit": -8.953125,
            "end_logit": -7.375,
            "text": "agitation that occurred in patients with baseline mental retardation with attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": -9.2109375,
            "end_logit": -7.375,
            "text": ", irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -9.6328125,
            "text": "irritability, and agitation that occurred in patients with baseline mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -7.375,
            "text": "mental retardation with attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -9.8515625,
            "text": "irritability, and agitation that occurred in patients with baseline mental retardation with attention",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_7": [
        {
            "start_logit": 14.5234375,
            "end_logit": 13.6484375,
            "text": "attention deficit hyperactivity disorder",
            "probability": 1.0
        },
        {
            "start_logit": 14.5234375,
            "end_logit": -2.677734375,
            "text": "attention",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6875,
            "end_logit": 13.6484375,
            "text": "disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.5234375,
            "end_logit": -7.53515625,
            "text": "attention deficit hyperactivity disorder and developmental delays",
            "probability": 0.0
        },
        {
            "start_logit": 14.5234375,
            "end_logit": -8.0,
            "text": "attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": 14.5234375,
            "end_logit": -8.765625,
            "text": "attention deficit hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 13.6484375,
            "text": "hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.5234375,
            "end_logit": -9.4296875,
            "text": "attention deficit hyperactivity disorder and developmental",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": 13.6484375,
            "text": "defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -3.923828125,
            "end_logit": -2.677734375,
            "text": "hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention",
            "probability": 0.0
        },
        {
            "start_logit": -3.923828125,
            "end_logit": -3.341796875,
            "text": "hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": -2.677734375,
            "text": "defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -3.341796875,
            "text": "as well as new behavioral problems. Behaviors that parents considered most troublesome were tantrums, aggression directed toward others, hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": -3.923828125,
            "end_logit": -8.0,
            "text": "hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -3.341796875,
            "text": "tantrums, aggression directed toward others, hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": -4.6875,
            "end_logit": -7.53515625,
            "text": "disorder and developmental delays",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": -2.677734375,
            "text": ", hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention",
            "probability": 0.0
        },
        {
            "start_logit": -3.923828125,
            "end_logit": -8.7109375,
            "text": "hyperactivity, and",
            "probability": 0.0
        },
        {
            "start_logit": -3.923828125,
            "end_logit": -8.765625,
            "text": "hyperactivity, and defiance. All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit hyperactivity",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -3.341796875,
            "text": "aggression directed toward others, hyperactivity",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_8": [
        {
            "start_logit": 9.703125,
            "end_logit": 7.75,
            "text": "hyperactive",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.1083984375,
            "end_logit": 8.3828125,
            "text": "intractable partial seizures",
            "probability": 0.0003485679626464844
        },
        {
            "start_logit": 1.1083984375,
            "end_logit": 7.75,
            "text": "intractable partial seizures who developed severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 0.0001850128173828125
        },
        {
            "start_logit": -0.8193359375,
            "end_logit": 7.75,
            "text": "severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": 9.703125,
            "end_logit": -6.65625,
            "text": "hyper",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.703125,
            "end_logit": -6.98046875,
            "text": "hyperactive and had explosive outburst",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.140625,
            "end_logit": 7.75,
            "text": "became hyperactive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 1.1083984375,
            "end_logit": 1.412109375,
            "text": "intractable partial seizures who developed severe behavioral problems",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 8.3828125,
            "text": "partial seizures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 8.3828125,
            "text": "seizures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.6484375,
            "text": "hyperactive and had explosive outburst consisting of aggressive and oppositional behavior",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 7.75,
            "text": "partial seizures who developed severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 7.75,
            "text": "seizures who developed severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.8046875,
            "text": "hyperactive and had explosive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.75,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.8515625,
            "text": "hyperactive and had",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.90625,
            "text": "hyperactive and had explosive outbur",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.9453125,
            "text": "hyperactive and had explosive outburst consisting of aggressive and oppositional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -9.0546875,
            "text": "hyperactive and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.8193359375,
            "end_logit": 1.412109375,
            "text": "severe behavioral problems",
            "probability": 5.960464477539063e-08
        }
    ],
    "57090784cf1c325851000011_1": [
        {
            "start_logit": 14.625,
            "end_logit": 14.6875,
            "text": "myelodysplastic syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 14.6875,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.625,
            "end_logit": -2.46484375,
            "text": "myelodysplastic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.625,
            "end_logit": -5.97265625,
            "text": "myelodysplastic syndrome (MDS",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -7.5546875,
            "text": "myelodysplastic syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -8.046875,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -8.7421875,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -8.7890625,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML)",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -8.859375,
            "text": "myelodysplastic syndrome (MDS)",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -9.2890625,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": 14.6875,
            "text": "n10% of patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -9.5859375,
            "text": "myelodysplastic syndrome (MDS), but are rare",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": 14.6875,
            "text": "\\n10% of patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 14.6875,
            "text": "~\\n10% of patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": 14.6875,
            "text": "patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 14.6875,
            "text": "0% of patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -9.859375,
            "text": "myelodysplastic syndrome (MDS),",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 14.6875,
            "text": "PRC2), are observed in ~\\n10% of patients with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -9.9375,
            "text": "myelodysplastic syndrome (MDS), but are rare in",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 14.6875,
            "text": "polycomb repressive complex 2 (PRC2), are observed in ~\\n10% of patients with myelodysplastic syndrome",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_2": [
        {
            "start_logit": 14.875,
            "end_logit": 14.671875,
            "text": "myelodysplastic syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -1.7744140625,
            "text": "myelodysplastic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.521484375,
            "end_logit": 14.671875,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -5.2421875,
            "text": "myelodysplastic syndrome (MDS",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -7.32421875,
            "text": "myelodysplastic syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -8.125,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype and FISH",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -8.2734375,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype and FISH result",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -8.7578125,
            "text": "myelodysplastic syndrome (MDS)",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": 14.671875,
            "text": "cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -9.1796875,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype",
            "probability": 0.0
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 14.671875,
            "text": "aCNA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 14.875,
            "end_logit": -9.5546875,
            "text": "myelodysplastic syndrome (MDS) presenting with normal",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 14.671875,
            "text": "LOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 14.671875,
            "text": "NA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 14.671875,
            "text": "profiling of aCNA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -5.2421875,
            "text": "syndrome (MDS",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -7.32421875,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -1.7744140625,
            "text": "cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -8.125,
            "text": "syndrome (MDS) presenting with normal karyotype and FISH",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -8.2734375,
            "text": "syndrome (MDS) presenting with normal karyotype and FISH result",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_3": [
        {
            "start_logit": 12.8046875,
            "end_logit": 13.140625,
            "text": "aplastic anemia",
            "probability": 1.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -4.3984375,
            "text": "aplastic anemia (AA)",
            "probability": 0.0
        },
        {
            "start_logit": -5.17578125,
            "end_logit": 13.140625,
            "text": "anemia",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -4.94140625,
            "text": "aplastic",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 13.140625,
            "text": "Acquired aplastic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -6.56640625,
            "text": "aplastic anemia (AA",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -6.6015625,
            "text": "aplastic anemia (",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -6.75390625,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow (BM) failure syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -6.83203125,
            "text": "aplastic anemia (AA) is",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -7.703125,
            "text": "aplastic anemia (AA) is a",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -8.90625,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow (BM)",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -9.078125,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow (BM",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -9.1171875,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow (BM) failure",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -9.9453125,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow (",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -9.96875,
            "text": "aplastic anemia (AA) is a potentially fatal",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -10.109375,
            "text": "aplastic anemia (AA) is a potentially fatal bone marrow",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -10.21875,
            "text": "aplastic anemia (AA) is a potentially",
            "probability": 0.0
        },
        {
            "start_logit": 12.8046875,
            "end_logit": -10.390625,
            "text": "aplastic anemia (AA) is a potentially fatal bone",
            "probability": 0.0
        },
        {
            "start_logit": -5.17578125,
            "end_logit": -4.3984375,
            "text": "anemia (AA)",
            "probability": 0.0
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -4.3984375,
            "text": "Acquired aplastic anemia (AA)",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_4": [
        {
            "start_logit": 12.515625,
            "end_logit": 13.28125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": 13.28125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.515625,
            "end_logit": -5.16796875,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -5.5234375,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 13.28125,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -8.703125,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date are",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.1875,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date are in the last exon,",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.2578125,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date are in the last exon",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.3671875,
            "text": "Weaver syndrome are primarily missense variants and",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.421875,
            "text": "Weaver syndrome are",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.5078125,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date are in the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 13.28125,
            "text": "EZH2 mutations that cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 13.28125,
            "text": "mutations that cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.7421875,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.8515625,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date",
            "probability": 0.0
        },
        {
            "start_logit": 12.515625,
            "end_logit": -9.9375,
            "text": "Weaver syndrome are primarily missense variants and the rare",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -8.703125,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported to date are",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -9.1875,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported to date are in the last exon,",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -9.2578125,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported to date are in the last exon",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -9.3671875,
            "text": "syndrome are primarily missense variants and",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_5": [
        {
            "start_logit": 13.15625,
            "end_logit": 14.03125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -3.740234375,
            "end_logit": 14.03125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.15625,
            "end_logit": -3.400390625,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": 13.15625,
            "end_logit": -4.64453125,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.15625,
            "end_logit": -8.0234375,
            "text": "Weaver syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": 13.15625,
            "end_logit": -8.5625,
            "text": "Weaver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 14.03125,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.15625,
            "end_logit": -9.7578125,
            "text": "Weaver syndrome and EZH2",
            "probability": 0.0
        },
        {
            "start_logit": -3.740234375,
            "end_logit": -8.0234375,
            "text": "syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -3.740234375,
            "end_logit": -8.5625,
            "text": "syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -3.740234375,
            "end_logit": -9.7578125,
            "text": "syndrome and EZH2",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -3.400390625,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -8.0234375,
            "text": "aver syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -8.0234375,
            "text": "EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -8.5625,
            "text": "aver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -11.3359375,
            "end_logit": -8.0234375,
            "text": "H2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -9.7578125,
            "text": "aver syndrome and EZH2",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -9.7578125,
            "text": "EZH2",
            "probability": 0.0
        },
        {
            "start_logit": -11.3359375,
            "end_logit": -9.7578125,
            "text": "H2",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_6": [
        {
            "start_logit": 13.0859375,
            "end_logit": 13.625,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 13.625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.0859375,
            "end_logit": -4.65234375,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.0859375,
            "end_logit": -5.31640625,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -9.53125,
            "end_logit": 13.625,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 13.625,
            "text": "EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 13.625,
            "text": "histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 13.625,
            "text": "2011, mutations in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": 13.625,
            "text": "mutations in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": 13.625,
            "text": "in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.046875,
            "end_logit": 13.625,
            "text": "methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.0859375,
            "end_logit": 13.625,
            "text": "shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.53125,
            "end_logit": -5.31640625,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": -4.65234375,
            "text": "EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -4.65234375,
            "text": "histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -4.65234375,
            "text": "2011, mutations in the histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -4.65234375,
            "text": "mutations in the histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": -4.65234375,
            "text": "in the histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.046875,
            "end_logit": -4.65234375,
            "text": "methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.0859375,
            "end_logit": -4.65234375,
            "text": "shown to cause We",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_7": [
        {
            "start_logit": 13.2109375,
            "end_logit": 13.828125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": 0.505859375,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -2.6328125,
            "text": "Weaver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.984375,
            "end_logit": 13.828125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -4.6328125,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -5.23046875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Soto",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.24609375,
            "text": "Weaver syndrome and/or distinguishing Weaver and So",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.15625,
            "text": "Weaver syndrome and/or",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.4609375,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.6171875,
            "text": "Weaver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.65625,
            "text": "Weaver syndrome and/or distinguishing Weaver and",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.6640625,
            "text": "Weaver syndrome and/or distinguishing Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.828125,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.921875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes.",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.828125,
            "text": "subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -10.1015625,
            "text": "Weaver syndrome and/or distinguishing",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 13.828125,
            "text": "confirming a subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.828125,
            "text": "EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -3.91796875,
            "end_logit": 0.505859375,
            "text": "Sotos",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": 0.505859375,
            "text": "syndrome and/or distinguishing Weaver and Sotos",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_8": [
        {
            "start_logit": 12.3359375,
            "end_logit": 13.34375,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 13.34375,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -5.06640625,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -5.2421875,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 13.34375,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": 13.34375,
            "text": "EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": 13.34375,
            "text": "Mutations in EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.3515625,
            "end_logit": 13.34375,
            "text": "in EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.3671875,
            "end_logit": 13.34375,
            "text": "H2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -5.06640625,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": -5.06640625,
            "text": "EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": -5.2421875,
            "text": "EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": -5.06640625,
            "text": "Mutations in EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": -5.2421875,
            "text": "Mutations in EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.3515625,
            "end_logit": -5.06640625,
            "text": "in EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -11.3671875,
            "end_logit": -5.06640625,
            "text": "H2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -11.3515625,
            "end_logit": -5.2421875,
            "text": "in EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.3671875,
            "end_logit": -5.2421875,
            "text": "H2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": -9.2578125,
            "text": "EZH2 cause",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": -9.2578125,
            "text": "Mutations in EZH2 cause",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_9": [
        {
            "start_logit": 12.8671875,
            "end_logit": 13.4765625,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 13.4765625,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -4.5078125,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -4.78125,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 13.4765625,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": 13.4765625,
            "text": "EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": 13.4765625,
            "text": "mutations in EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.171875,
            "end_logit": 13.4765625,
            "text": "in EZH2 cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -4.5078125,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": -4.5078125,
            "text": "EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": -4.5078125,
            "text": "mutations in EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -11.171875,
            "end_logit": -4.5078125,
            "text": "in EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": -4.78125,
            "text": "EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": -4.78125,
            "text": "mutations in EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -11.171875,
            "end_logit": -4.78125,
            "text": "in EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": -9.4765625,
            "text": "EZH2 cause",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": -9.4765625,
            "text": "mutations in EZH2 cause",
            "probability": 0.0
        },
        {
            "start_logit": -11.171875,
            "end_logit": -9.4765625,
            "text": "in EZH2 cause",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_10": [
        {
            "start_logit": 13.0234375,
            "end_logit": 13.7109375,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": 13.7109375,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -4.1484375,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -4.765625,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -8.1953125,
            "text": "Weaver syndrome shows considerable overlap",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -8.96875,
            "text": "Weaver syndrome shows",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -8.9765625,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in myeloid malignancies",
            "probability": 0.0
        },
        {
            "start_logit": -10.046875,
            "end_logit": 13.7109375,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -9.453125,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -9.6171875,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.7109375,
            "text": "EZH2 mutation spectrum in Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -9.828125,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -9.9140625,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -9.9296875,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in myeloid",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.0234375,
            "text": "Weaver syndrome shows considerable",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.0703125,
            "text": "Weaver syndrome shows considerable overlap with",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": 13.7109375,
            "text": "mutation spectrum in Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": 13.7109375,
            "text": "H2 mutation spectrum in Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": -8.1953125,
            "text": "syndrome shows considerable overlap",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": -8.96875,
            "text": "syndrome shows",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_11": [
        {
            "start_logit": 13.125,
            "end_logit": 13.875,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": 13.875,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.125,
            "end_logit": -4.7890625,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -5.703125,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 13.875,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.21875,
            "text": "Weaver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 13.875,
            "text": "EZH2 mutations as the cause of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.6640625,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of human growth.",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.8828125,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.90625,
            "text": "Weaver syndrome and provide",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 13.875,
            "text": "as the cause of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 13.875,
            "text": "mutations as the cause of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -10.0859375,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of human growth",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.21875,
            "text": "syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.6640625,
            "text": "syndrome and provide further links between histone modifications and regulation of human growth.",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.8828125,
            "text": "syndrome and provide further links between histone modifications and regulation of",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -9.90625,
            "text": "syndrome and provide",
            "probability": 0.0
        },
        {
            "start_logit": -4.04296875,
            "end_logit": -10.0859375,
            "text": "syndrome and provide further links between histone modifications and regulation of human growth",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": -4.7890625,
            "text": "EZH2 mutations as the cause of We",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -4.7890625,
            "text": "as the cause of We",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_12": [
        {
            "start_logit": 2.1171875,
            "end_logit": 6.484375,
            "text": "non-Hodgkin lymphoma",
            "probability": 1.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -2.75,
            "text": "non-Hodgkin lymphoma (NHL)",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.484375,
            "text": "subtypes of non-Hodgkin lymphoma",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.484375,
            "text": "lymphoma",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 6.484375,
            "text": "H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -4.13671875,
            "text": "non-Hodgkin lymphoma (NHL",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -8.7421875,
            "end_logit": 6.484375,
            "text": "and Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 6.484375,
            "text": "Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 6.484375,
            "text": "1H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -9.546875,
            "end_logit": 6.484375,
            "text": "Hodgkin lymphoma",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 6.484375,
            "text": "Y641S and Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -10.3125,
            "end_logit": 6.484375,
            "text": "certain subtypes of non-Hodgkin lymphoma",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -6.37109375,
            "text": "non-Hodgkin lymphoma (",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -8.03125,
            "text": "non",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -9.703125,
            "text": "non-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -2.75,
            "text": "NHL)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -4.13671875,
            "text": "NHL",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -2.75,
            "text": "subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -2.75,
            "text": "lymphoma (NHL)",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -2.634765625,
            "text": "H",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_13": [
        {
            "start_logit": 13.0703125,
            "end_logit": 13.8046875,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": 13.8046875,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -4.7421875,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -4.76171875,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 13.8046875,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.0703125,
            "end_logit": -9.5625,
            "text": "Weaver syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 13.8046875,
            "text": "EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.8046875,
            "text": "histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.8046875,
            "text": "2011, mutations in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 13.8046875,
            "text": "mutations in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.90625,
            "end_logit": 13.8046875,
            "text": "in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 13.8046875,
            "text": "shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -11.03125,
            "end_logit": 13.8046875,
            "text": "methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": -9.5625,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -4.76171875,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -4.7421875,
            "text": "EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -4.76171875,
            "text": "EZH2, were shown to cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -4.7421875,
            "text": "histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -4.76171875,
            "text": "histone methyltransferase, EZH2, were shown to cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": -4.7421875,
            "text": "2011, mutations in the histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_14": [
        {
            "start_logit": 12.703125,
            "end_logit": 13.7578125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -2.240234375,
            "text": "Weaver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.927734375,
            "end_logit": 13.7578125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.703125,
            "end_logit": -5.1015625,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.421875,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.890625,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 13.7578125,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.3046875,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.3828125,
            "text": "Weaver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.5703125,
            "text": "Weaver syndrome and EZH2 mutations:",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.6328125,
            "text": "Weaver syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.9140625,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -10.0625,
            "text": "Weaver syndrome and EZH2",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -10.0703125,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": -2.240234375,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -8.421875,
            "text": "syndrome and EZH2 mutations: Clarifying the clinical phenotype",
            "probability": 0.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -8.890625,
            "text": "syndrome and EZH2 mutations: Clarifying the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -9.3046875,
            "text": "syndrome and EZH2 mutations: Clarifying the",
            "probability": 0.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -9.3828125,
            "text": "syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -9.5703125,
            "text": "syndrome and EZH2 mutations:",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_15": [
        {
            "start_logit": 13.2109375,
            "end_logit": 13.828125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": 0.505859375,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -2.6328125,
            "text": "Weaver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.984375,
            "end_logit": 13.828125,
            "text": "syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -4.6328125,
            "text": "We",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -5.23046875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Soto",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.24609375,
            "text": "Weaver syndrome and/or distinguishing Weaver and So",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.15625,
            "text": "Weaver syndrome and/or",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.4609375,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.6171875,
            "text": "Weaver syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.65625,
            "text": "Weaver syndrome and/or distinguishing Weaver and",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.6640625,
            "text": "Weaver syndrome and/or distinguishing Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.828125,
            "text": "aver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.921875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes.",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.828125,
            "text": "subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -10.1015625,
            "text": "Weaver syndrome and/or distinguishing",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 13.828125,
            "text": "confirming a subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.828125,
            "text": "EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of Weaver syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -3.91796875,
            "end_logit": 0.505859375,
            "text": "Sotos",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": 0.505859375,
            "text": "syndrome and/or distinguishing Weaver and Sotos",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_16": [
        {
            "start_logit": 14.46875,
            "end_logit": 14.1171875,
            "text": "Sotos",
            "probability": 1.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -2.970703125,
            "text": "So",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.87109375,
            "end_logit": 14.1171875,
            "text": "s",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -4.50390625,
            "text": "Sotos and Weaver",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -6.6875,
            "text": "Soto",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -7.5546875,
            "text": "Sotos and We",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -8.3671875,
            "text": "Sotos and Weaver syndromes",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.125,
            "text": "Sotos and Weaver syndromes is also evident",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.1328125,
            "text": "Sotos and Weaver syndromes is also evident.",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.5625,
            "text": "Sotos and",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.59375,
            "text": "Sotos and Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide an",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": 14.1171875,
            "text": "tos",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.7421875,
            "text": "Sotos and Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide an objective means",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.796875,
            "text": "Sotos and Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide",
            "probability": 0.0
        },
        {
            "start_logit": 14.46875,
            "end_logit": -9.8125,
            "text": "Sotos and Weaver syndromes is also evident. The identification of an EZH2 mutation can",
            "probability": 0.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": -4.50390625,
            "text": "s and Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -4.50390625,
            "text": "Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": -7.5546875,
            "text": "s and We",
            "probability": 0.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": -8.3671875,
            "text": "s and Weaver syndromes",
            "probability": 0.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -7.5546875,
            "text": "We",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_1": [
        {
            "start_logit": 13.0546875,
            "end_logit": 12.8359375,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -1.861328125,
            "text": "uvrA, uvrB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -3.330078125,
            "text": "uvrA, uvrB, uvrC or uvrAC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -4.859375,
            "text": "uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -4.8828125,
            "text": "uvrA, uvrB, uvrC",
            "probability": 0.0
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 12.8359375,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -5.98046875,
            "text": "uvrA, uvrB, uvrC or uvrAC genes",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -6.125,
            "text": "uvrA, uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -7.765625,
            "text": "uvrA, uvrB, uvrC or uvr",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 12.8359375,
            "text": "of wild-type E. coli K12 and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 12.8359375,
            "text": "for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -8.3828125,
            "text": "uvrA, uvrB, uvrC or",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -8.5859375,
            "text": "uvrA, uvrB, uvr",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 12.8359375,
            "text": "Cultures of wild-type E. coli K12 and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.0703125,
            "end_logit": 12.8359375,
            "text": "wild-type E. coli K12 and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 12.8359375,
            "text": "mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": 12.8359375,
            "text": "and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 12.8359375,
            "text": "E. coli K12 and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": 12.8359375,
            "text": "E. coli. Cultures of wild-type E. coli K12 and mutants for uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -1.861328125,
            "text": "uvrB",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_2": [
        {
            "start_logit": 13.2109375,
            "end_logit": 12.9453125,
            "text": "UvrA",
            "probability": 0.9990234375
        },
        {
            "start_logit": 13.2109375,
            "end_logit": 5.39453125,
            "text": "UvrA, UvrB, UvrC, the UvrD",
            "probability": 0.0005273818969726562
        },
        {
            "start_logit": 13.2109375,
            "end_logit": 2.515625,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": 13.2109375,
            "end_logit": 0.181884765625,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -1.271484375,
            "text": "UvrA, UvrB, UvrC",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -1.400390625,
            "text": "UvrA, UvrB",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.10546875,
            "end_logit": 5.39453125,
            "text": "UvrD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -4.75,
            "text": "Uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -5.08984375,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase",
            "probability": 0.0
        },
        {
            "start_logit": -5.265625,
            "end_logit": 12.9453125,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.10546875,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase",
            "probability": 0.0
        },
        {
            "start_logit": 4.10546875,
            "end_logit": 2.515625,
            "text": "UvrD helicase, DNA polymerase I",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.921875,
            "text": "UvrA, Uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.3125,
            "text": "UvrA, UvrB, Uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.48046875,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.71484375,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase,",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -7.97265625,
            "text": "UvrA, UvrB, UvrC, the Uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -8.0859375,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -8.25,
            "text": "UvrA, UvrB, UvrC, the",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -8.5078125,
            "text": "UvrA,",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_3": [
        {
            "start_logit": 13.7109375,
            "end_logit": 13.7578125,
            "text": "UvrD",
            "probability": 1.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -3.04296875,
            "text": "UvrD, a superfamily 1A helicase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.18359375,
            "end_logit": 13.7578125,
            "text": "D",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -4.21484375,
            "text": "Uvr",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": 13.7578125,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.54296875,
            "text": "UvrD,",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.296875,
            "text": "UvrD, a",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 13.7578125,
            "text": "nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.63671875,
            "text": "UvrD, a superfamily 1A",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.75,
            "text": "UvrD, a superfamily",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": 13.7578125,
            "text": "C nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 13.7578125,
            "text": "and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 13.7578125,
            "text": "short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 13.7578125,
            "text": "post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 13.7578125,
            "text": "NER) in bacteria the UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 13.7578125,
            "text": "incision complex by UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -4.18359375,
            "end_logit": -3.04296875,
            "text": "D, a superfamily 1A helicase",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": -3.04296875,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD, a superfamily 1A helicase",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": -3.255859375,
            "text": "UvrC",
            "probability": 0.0
        },
        {
            "start_logit": -4.3203125,
            "end_logit": -3.5390625,
            "text": "UvrC nuclease",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_4": [
        {
            "start_logit": 13.6328125,
            "end_logit": 12.859375,
            "text": "UvrD",
            "probability": 1.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": 3.646484375,
            "text": "UvrD interacts with UvrB",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -4.21875,
            "text": "Uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -5.15234375,
            "text": "UvrD interacts with UvrB, a component of the post-incision complex",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -5.859375,
            "text": "UvrD interacts with Uvr",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": 12.859375,
            "text": "D",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.125,
            "text": "UvrD interacts with UvrB,",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.1875,
            "text": "UvrD interacts with UvrB, a",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.515625,
            "text": "UvrD interacts with UvrB, a component",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -7.7890625,
            "text": "UvrD interacts",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.2578125,
            "text": "UvrD interacts with UvrB, a component of",
            "probability": 0.0
        },
        {
            "start_logit": 1.6044921875,
            "end_logit": 3.646484375,
            "text": "UvrB",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.4140625,
            "text": "UvrD interacts with UvrB, a component of the",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.4921875,
            "text": "UvrD interacts with",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.6875,
            "text": "UvrD interacts with UvrB, a component of the post-incision",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -8.921875,
            "text": "UvrD interacts with UvrB, a component of the post-incision complex.",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -9.1171875,
            "text": "UvrD interacts with UvrB, a component of the post",
            "probability": 0.0
        },
        {
            "start_logit": 13.6328125,
            "end_logit": -9.3671875,
            "text": "UvrD interacts with UvrB, a component of the post-",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": 3.646484375,
            "text": "D interacts with UvrB",
            "probability": 0.0
        },
        {
            "start_logit": 1.6044921875,
            "end_logit": -5.15234375,
            "text": "UvrB, a component of the post-incision complex",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_5": [
        {
            "start_logit": 12.546875,
            "end_logit": 12.0703125,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": 2.349609375,
            "text": "uvrA and uvrB",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 12.546875,
            "end_logit": -2.58984375,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 12.546875,
            "end_logit": -4.98828125,
            "text": "uvrA and uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.546875,
            "end_logit": -5.30078125,
            "text": "uvr",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -6.06640625,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 12.0703125,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 12.0703125,
            "text": "nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.203125,
            "text": "uvrA and uvrB mutants are",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.390625,
            "text": "uvrA and uvrB mutants",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.3984375,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvr",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.5625,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.671875,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain as the wild type",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -8.734375,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain as the wild type strain",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 12.0703125,
            "text": "Escherichia coli K12 mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 0.0
        },
        {
            "start_logit": 12.546875,
            "end_logit": -9.3828125,
            "text": "uvrA and",
            "probability": 0.0
        },
        {
            "start_logit": -9.2109375,
            "end_logit": 12.0703125,
            "text": "NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 12.0703125,
            "text": "that uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 12.0703125,
            "text": "K12 mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": 2.349609375,
            "text": "uvrB",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_6": [
        {
            "start_logit": 12.5078125,
            "end_logit": 11.9140625,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": 12.5078125,
            "end_logit": -0.46728515625,
            "text": "uvrA and uvrB",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 12.5078125,
            "end_logit": -5.1015625,
            "text": "uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.53125,
            "end_logit": 11.9140625,
            "text": "uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA",
            "probability": 0.0
        },
        {
            "start_logit": 12.5078125,
            "end_logit": -6.36328125,
            "text": "uvrA and uvr",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 11.9140625,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 12.5078125,
            "end_logit": -8.984375,
            "text": "uvrA and",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": 11.9140625,
            "text": "of uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.078125,
            "end_logit": 11.9140625,
            "text": "Inactivation of any of the four uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -9.25,
            "end_logit": 11.9140625,
            "text": "Inactivation of uvrA",
            "probability": 0.0
        },
        {
            "start_logit": -1.3486328125,
            "end_logit": 1.271484375,
            "text": "uvrD",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -0.46728515625,
            "text": "uvrB",
            "probability": 0.0
        },
        {
            "start_logit": -5.53125,
            "end_logit": -0.46728515625,
            "text": "uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA and uvrB",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -0.46728515625,
            "text": "A and uvrB",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": 1.271484375,
            "text": "D",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -5.43359375,
            "text": "uvrB significantly decreased mutation frequencies whereas only the uvrA deficient mutant exhibited a significant decrease of the recombination frequency after natural transformation. A uvrC",
            "probability": 0.0
        },
        {
            "start_logit": -1.3486328125,
            "end_logit": -7.51171875,
            "text": "uvr",
            "probability": 0.0
        },
        {
            "start_logit": -5.53125,
            "end_logit": -3.357421875,
            "text": "uvr",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -6.36328125,
            "text": "uvr",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -0.46728515625,
            "text": "of uvrA and uvrB",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_7": [
        {
            "start_logit": 13.6640625,
            "end_logit": 13.640625,
            "text": "Mfd",
            "probability": 1.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": 13.640625,
            "text": "UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -4.01953125,
            "text": "Mf",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 13.640625,
            "text": "UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 13.640625,
            "text": "d",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -5.66015625,
            "text": "Mfd protein",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -7.47265625,
            "text": "Mfd protein, a DNA translocase",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -7.78125,
            "text": "Mfd protein, a DNA translocase that removes the stalled transcription complexes",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -8.71875,
            "text": "Mfd protein,",
            "probability": 0.0
        },
        {
            "start_logit": -8.765625,
            "end_logit": 13.640625,
            "text": "A, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 13.640625,
            "text": "loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": 13.640625,
            "text": "B onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": 13.640625,
            "text": "NER depends upon UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.640625,
            "text": "Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": -1.0615234375,
            "text": "UvrA",
            "probability": 0.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": -1.9052734375,
            "text": "UvrA, which binds to the damage and loads UvrB",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -1.9052734375,
            "text": "UvrB",
            "probability": 0.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": -4.01953125,
            "text": "UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mf",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -4.01953125,
            "text": "UvrB onto the DNA. Bacterial TCR additionally requires the Mf",
            "probability": 0.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": -5.66015625,
            "text": "UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_1": [
        {
            "start_logit": 13.84375,
            "end_logit": 11.1171875,
            "text": "Increased serum ferritin",
            "probability": 1.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -2.732421875,
            "text": "Increased",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 13.84375,
            "end_logit": -5.04296875,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.9609375,
            "end_logit": 11.1171875,
            "text": "serum ferritin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.84375,
            "end_logit": -7.30078125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -7.484375,
            "text": "Increased serum ferritin (74.2%)",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -7.59375,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate",
            "probability": 0.0
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 11.1171875,
            "text": "ferritin",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.1328125,
            "text": "Increased serum ferritin (74.2%",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.421875,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.9609375,
            "text": "Increased serum ferritin (74.2",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.1015625,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.5078125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.59375,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.6953125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.859375,
            "text": "Increased serum ferritin (74.2%), high C",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.9453125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.953125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -5.04296875,
            "text": "serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR",
            "probability": 0.0
        },
        {
            "start_logit": -3.06640625,
            "end_logit": -5.04296875,
            "text": ", high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_2": [
        {
            "start_logit": 11.4296875,
            "end_logit": 13.265625,
            "text": "leucocytosis",
            "probability": 1.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 13.265625,
            "text": "ocytosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -5.9140625,
            "text": "leucocytosis, lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -6.0234375,
            "text": "leucocytosis, lymphopenia, platelet",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -6.125,
            "text": "leuc",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -8.53125,
            "text": "leucocytosis, lympho",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -8.6015625,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.1328125,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT)",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.1484375,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, creatinine, creatine kinase",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.2265625,
            "text": "leucocytosis,",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.40625,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, creatinine, creatine kinase (CK",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.65625,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": 11.4296875,
            "end_logit": -9.890625,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -5.9140625,
            "text": "ocytosis, lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -6.0234375,
            "text": "ocytosis, lymphopenia, platelet",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -6.0234375,
            "text": "platelet",
            "probability": 0.0
        },
        {
            "start_logit": -6.125,
            "end_logit": -5.9140625,
            "text": "lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.125,
            "end_logit": -6.0234375,
            "text": "lymphopenia, platelet",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -8.53125,
            "text": "ocytosis, lympho",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -8.6015625,
            "text": "ocytosis, lymphopenia, platelet, alanine aminotransferase (ALT",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_3": [
        {
            "start_logit": 10.9453125,
            "end_logit": 12.359375,
            "text": "fever",
            "probability": 1.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -2.875,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -5.328125,
            "text": "fever and cough with lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -6.85546875,
            "text": "fever and cough with lymphopenia and increased inflammatory indices",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -7.265625,
            "text": "fever and cough",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.0390625,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.1640625,
            "text": "fever and cough with lympho",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.3125,
            "text": "fever and cough with lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.4296875,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GG",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 12.359375,
            "text": "COVID-19 patients have fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.7578125,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved bilateral lung",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -8.8203125,
            "text": "fever and cough with lymphopenia and increased inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 12.359375,
            "text": "Most COVID-19 patients have fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -9.171875,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -9.2109375,
            "text": "fever and cough with lymphopenia and",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -9.265625,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved bilateral",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -9.390625,
            "text": "fever and",
            "probability": 0.0
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -9.5390625,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is",
            "probability": 0.0
        },
        {
            "start_logit": -6.15234375,
            "end_logit": -2.875,
            "text": "cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -2.875,
            "text": "lymphopenia and increased inflammatory indices, and the main CT feature is GGO",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_4": [
        {
            "start_logit": 12.5859375,
            "end_logit": 13.3359375,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": 0.08502197265625,
            "text": "lymphopenia, elevated level of d-dimer",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -3.982421875,
            "end_logit": 13.3359375,
            "text": "nia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -4.74609375,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -5.1640625,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -5.33203125,
            "text": "lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -5.953125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -6.3359375,
            "text": "lymphopenia, elevated level of d",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.22265625,
            "text": "lymphopenia, elevated level of",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.4453125,
            "text": "lymphopenia, elevated level of d-",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.48828125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.50390625,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and high sensitivity C-reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.546875,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.83203125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI)",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -7.9296875,
            "text": "lymphopenia, elevated",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -9.03125,
            "text": "lymphopenia, elevated level",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -9.1953125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and high sensitivity C",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -9.28125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs",
            "probability": 0.0
        },
        {
            "start_logit": 12.5859375,
            "end_logit": -9.296875,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and high sensitivity C-reactive protein (hs",
            "probability": 0.0
        },
        {
            "start_logit": 2.625,
            "end_logit": 0.08502197265625,
            "text": "elevated level of d-dimer",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_5": [
        {
            "start_logit": 12.9375,
            "end_logit": 13.6796875,
            "text": "Lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": 3.927734375,
            "text": "Lymphopenia, elevated level of d-dimer",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 12.9375,
            "end_logit": -2.791015625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.587890625,
            "end_logit": 13.6796875,
            "text": "nia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.9375,
            "end_logit": -4.484375,
            "text": "Lympho",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -4.71484375,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -5.26171875,
            "text": "Lymphopenia, elevated level of d",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -6.328125,
            "text": "Lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 2.427734375,
            "end_logit": 3.927734375,
            "text": "d-dimer",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -6.984375,
            "text": "Lymphopenia, elevated level of d-",
            "probability": 0.0
        },
        {
            "start_logit": 1.3603515625,
            "end_logit": 3.927734375,
            "text": "elevated level of d-dimer",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.09375,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.09375,
            "text": "Lymphopenia, elevated level of d-dimer, hs",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.421875,
            "text": "Lymphopenia, elevated level of",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.640625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.8046875,
            "text": "Lymphopenia, elevated level",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.8828125,
            "text": "Lymphopenia, elevated",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.1171875,
            "text": "Lymphopenia, elevated level of d-dimer,",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.28125,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.8359375,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_6": [
        {
            "start_logit": 11.140625,
            "end_logit": 12.0390625,
            "text": "Hyponatremia",
            "probability": 1.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -6.28515625,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.1171875,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.3125,
            "text": "Hyponatremia (50%)",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.5390625,
            "text": "Hyponatremia (50%), elevated C-reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.6015625,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -8.6875,
            "text": "Hyponatremia (50",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.0546875,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.5,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.5390625,
            "text": "Hyponatremia (50%), elevated C-reactive protein (",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.578125,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.625,
            "text": "Hyponatremia (50%), elevated",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -6.28515625,
            "text": "elevated C-reactive protein (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -6.37109375,
            "text": "renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -6.37109375,
            "text": "elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -6.28515625,
            "text": ", elevated C-reactive protein (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -6.37109375,
            "text": ", elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -8.0234375,
            "text": "renal failure, myocardial injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -8.078125,
            "text": "renal",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -8.0234375,
            "text": "elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure, myocardial injury",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_7": [
        {
            "start_logit": 11.296875,
            "end_logit": 11.7578125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": 11.7578125,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 11.7578125,
            "text": "decreased lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -8.2734375,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 11.7578125,
            "text": "lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.453125,
            "text": "thrombocytopenia (17%-36.2",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.6328125,
            "text": "thrombocytopenia (17%-36",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 11.7578125,
            "text": "\u201119 include decreased lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 11.7578125,
            "text": "35%-82.1%), thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.8828125,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93%), lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.984375,
            "text": "thrombocytopenia (17%-36.2%",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.9921875,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93%)",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -8.2734375,
            "text": ", thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -7.8671875,
            "text": "decreased lymphocyte count",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -8.2734375,
            "text": "decreased lymphocyte count (35%-82.1%), thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -9.453125,
            "text": ", thrombocytopenia (17%-36.2",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -9.6328125,
            "text": ", thrombocytopenia (17%-36",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -7.8671875,
            "text": "lymphocyte count",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -8.9765625,
            "text": "decreased lymphocyte count (35%-82.1",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -9.0859375,
            "text": "decreased lymphocyte count (35%-82.1%)",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_8": [
        {
            "start_logit": 11.1875,
            "end_logit": 11.390625,
            "text": "thrombocytopenia",
            "probability": 0.59765625
        },
        {
            "start_logit": 9.71875,
            "end_logit": 12.046875,
            "text": "pneumonia",
            "probability": 0.26513671875
        },
        {
            "start_logit": 9.71875,
            "end_logit": 11.390625,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 0.1375732421875
        },
        {
            "start_logit": 11.1875,
            "end_logit": -8.0390625,
            "text": "thrombocytopenia, and prolonged prothrombin time",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.140625,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.1875,
            "end_logit": 11.390625,
            "text": "lymphopenia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.21875,
            "text": "thrombocytopenia, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0390625,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 12.046875,
            "text": "COVID-19 related pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.8203125,
            "text": "thrombocytopenia, and prolonged prothrombin time.",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.046875,
            "text": "Clinical observations demonstrated that COVID-19 related pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -10.1015625,
            "text": "thrombocytopenia, and prolonged",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -10.1875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 11.390625,
            "text": ", thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 11.390625,
            "text": "COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 11.390625,
            "text": "coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 11.390625,
            "text": "Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.390625,
            "text": "nia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 11.390625,
            "text": "and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -9.21875,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_9": [
        {
            "start_logit": 13.7109375,
            "end_logit": 13.5078125,
            "text": "Lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -3.693359375,
            "text": "Lympho",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.359375,
            "end_logit": 13.5078125,
            "text": "nia",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -5.6640625,
            "text": "Lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.3984375,
            "text": "Lymphopenia is",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.6796875,
            "text": "Lymphopenia is the mostly commonly reported",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.7578125,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.9453125,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50% of COVID-19 patients.",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.984375,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.015625,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50%",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.1171875,
            "text": "Lymphopenia is the",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.15625,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.2109375,
            "text": "Lymphopenia is the mostly",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.21875,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -10.2734375,
            "text": "Lymphopenia is the mostly commonly",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 13.5078125,
            "text": "penia",
            "probability": 0.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": -9.3984375,
            "text": "nia is",
            "probability": 0.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": -9.6796875,
            "text": "nia is the mostly commonly reported",
            "probability": 0.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": -9.7578125,
            "text": "nia is the mostly commonly reported laboratory abnormality and occurs",
            "probability": 0.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": -9.9453125,
            "text": "nia is the mostly commonly reported laboratory abnormality and occurs in over 50% of COVID-19 patients.",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_10": [
        {
            "start_logit": 13.1328125,
            "end_logit": 12.9296875,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -4.1875,
            "text": "lymphopenia, elevated of LDH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -4.37109375,
            "text": "lympho",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.3125,
            "end_logit": 12.9296875,
            "text": "nia",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -5.6015625,
            "text": "lymphopenia, elevated of LDH, CPK",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -6.3828125,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -6.47265625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -6.59765625,
            "text": "lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.29296875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.45703125,
            "text": "lymphopenia, elevated of LDH, CP",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -7.55859375,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte sedimentation rate",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.3515625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -8.8828125,
            "text": "lymphopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.15625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritin",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.5390625,
            "text": "lymphopenia, elevated of LDH,",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.734375,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.84375,
            "text": "lymphopenia, elevated of LDH, CPK and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.84375,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte",
            "probability": 0.0
        },
        {
            "start_logit": 13.1328125,
            "end_logit": -9.9296875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.9296875,
            "text": "COVID-19 patients; laboratory abnormalities include lymphopenia",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_11": [
        {
            "start_logit": 13.875,
            "end_logit": 13.6640625,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -3.3046875,
            "text": "lympho",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.5703125,
            "end_logit": 13.6640625,
            "text": "nia",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -5.39453125,
            "text": "lymphope",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -5.67578125,
            "text": "lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -7.37890625,
            "text": "lymphopenia, elevated levels of C-reactive proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -9.046875,
            "text": "lymphopenia, elevated levels of C-reactive proteins and",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -9.234375,
            "text": "lymphopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -9.390625,
            "text": "lymphopenia, elevated levels of",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -9.6875,
            "text": "lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase.",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -9.7421875,
            "text": "lymphopenia, elevated",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -10.0,
            "text": "lymphopenia, elevated levels of C",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -10.0078125,
            "text": "lymphopenia, elevated levels of C-reactive",
            "probability": 0.0
        },
        {
            "start_logit": 13.875,
            "end_logit": -10.03125,
            "text": "lymphopenia, elevated levels",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.6640625,
            "text": "penia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 13.6640625,
            "text": "laboratory features reported include lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -3.5703125,
            "end_logit": -5.67578125,
            "text": "nia, elevated levels of C-reactive proteins and lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": -3.5703125,
            "end_logit": -7.37890625,
            "text": "nia, elevated levels of C-reactive proteins",
            "probability": 0.0
        },
        {
            "start_logit": -5.67578125,
            "end_logit": -5.67578125,
            "text": "lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": -6.75,
            "end_logit": -5.67578125,
            "text": "elevated levels of C-reactive proteins and lactate dehydrogenase",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_1": [
        {
            "start_logit": 12.25,
            "end_logit": 11.40625,
            "text": "Lichen sclerosus",
            "probability": 1.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -3.8984375,
            "text": "Lichen",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 12.25,
            "end_logit": -5.109375,
            "text": "Lichen sclerosus has been reported at sites of injury",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.25,
            "end_logit": -6.2265625,
            "text": "Lichen scler",
            "probability": 0.0
        },
        {
            "start_logit": -5.46875,
            "end_logit": 11.40625,
            "text": "osus",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -7.77734375,
            "text": "Lichen sclerosus has been reported at sites of",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -8.6875,
            "text": "Lichen sclerosus has been reported at sites of injury as a",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -8.7421875,
            "text": "Lichen sclerosus has been reported at",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -8.8203125,
            "text": "Lichen sclerosus has been reported at sites of injury as a Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -8.8828125,
            "text": "Lichen sclerosus has",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -8.953125,
            "text": "Lichen sclerosus has been reported",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -9.3203125,
            "text": "Lichen sclerosus has been reported at sites",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -9.5078125,
            "text": "Lichen sclerosus has been reported at sites of injury as",
            "probability": 0.0
        },
        {
            "start_logit": -8.734375,
            "end_logit": 11.40625,
            "text": "sclerosus",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -9.921875,
            "text": "Lichen sclerosus has been reported at sites of injury as a Koebner phenomenon",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.2265625,
            "text": "Lichen sclerosus has been",
            "probability": 0.0
        },
        {
            "start_logit": -5.46875,
            "end_logit": -5.109375,
            "text": "osus has been reported at sites of injury",
            "probability": 0.0
        },
        {
            "start_logit": -5.46875,
            "end_logit": -7.77734375,
            "text": "osus has been reported at sites of",
            "probability": 0.0
        },
        {
            "start_logit": -8.734375,
            "end_logit": -5.109375,
            "text": "sclerosus has been reported at sites of injury",
            "probability": 0.0
        },
        {
            "start_logit": -5.46875,
            "end_logit": -8.6875,
            "text": "osus has been reported at sites of injury as a",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_2": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.93359375,
            "text": "physical trauma",
            "probability": 1.0
        },
        {
            "start_logit": -0.30615234375,
            "end_logit": 7.93359375,
            "text": "following physical trauma",
            "probability": 0.0002613067626953125
        },
        {
            "start_logit": -2.32421875,
            "end_logit": 7.93359375,
            "text": "apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.66796875,
            "text": "physical",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.71875,
            "text": "physical trauma, even if this is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.93359375,
            "text": "melanocytes. Vitiligo often develops following physical trauma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.359375,
            "text": "physical trauma, even if this",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 7.93359375,
            "text": "trauma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.6484375,
            "text": "physical trauma,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.7734375,
            "end_logit": 7.93359375,
            "text": "Deprivation of survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.609375,
            "end_logit": 7.93359375,
            "text": "survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 0.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -9.8203125,
            "text": "physical trauma, even if this is minor",
            "probability": 0.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -9.8984375,
            "text": "physical trauma, even if this is minor. The exact mechanism",
            "probability": 0.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -9.9375,
            "text": "physical trauma, even if this is minor. The exact mechanism of the Koebner phenomenon in vitiligo is unclear",
            "probability": 0.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -9.9375,
            "text": "physical trauma, even if this is minor.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 7.93359375,
            "text": "Vitiligo often develops following physical trauma",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 7.93359375,
            "text": "causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 7.93359375,
            "text": "of survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 0.0
        },
        {
            "start_logit": -2.32421875,
            "end_logit": -3.134765625,
            "text": "apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.32421875,
            "end_logit": -3.46484375,
            "text": "apoptosis of melanocytes",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_3": [
        {
            "start_logit": 9.5703125,
            "end_logit": 8.7578125,
            "text": "lichen sclerosus",
            "probability": 0.89599609375
        },
        {
            "start_logit": 9.5703125,
            "end_logit": 6.6015625,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 0.10369873046875
        },
        {
            "start_logit": 3.94921875,
            "end_logit": 6.6015625,
            "text": "sexual abuse",
            "probability": 0.00037407875061035156
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -2.373046875,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -3.478515625,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -5.01171875,
            "text": "lichen sclerosus occurs in skin already scarred or damaged",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -5.90625,
            "text": "lichen sclerosus occurs in skin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -6.2890625,
            "text": "lichen scler",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -6.42578125,
            "text": "lichen",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.697265625,
            "end_logit": 6.6015625,
            "text": "trauma, injury, and sexual abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -6.84375,
            "text": "lichen sclerosus occurs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 6.6015625,
            "text": "injury, and sexual abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.23828125,
            "text": "lichen sclerosus occurs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.421875,
            "text": "lichen sclerosus occurs in skin already scarred or damaged)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.60546875,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.90234375,
            "text": "lichen sclerosus occurs in skin already scar",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.328125,
            "text": "lichen sclerosus occurs in skin already scarred",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.7578125,
            "text": "osus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.375,
            "text": "lichen sclerosus occurs in skin already",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -9.1484375,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma,",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_4": [
        {
            "start_logit": 12.65625,
            "end_logit": 11.0546875,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -1.6142578125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 12.65625,
            "end_logit": -2.64453125,
            "text": "physical",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 12.65625,
            "end_logit": -5.578125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.77734375,
            "end_logit": 11.0546875,
            "text": "stress",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -7.88671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon,",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.7109375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.015625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.09375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.3359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.453125,
            "text": "physical stress is seen",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.4921875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.5,
            "text": "physical stress is",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.53125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis,",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.6953125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enth",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.75,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": 11.0546875,
            "text": "triggering role of physical stress",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 11.0546875,
            "text": "of physical stress",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_5": [
        {
            "start_logit": 12.65625,
            "end_logit": 11.0546875,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -1.6142578125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 12.65625,
            "end_logit": -2.64453125,
            "text": "physical",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 12.65625,
            "end_logit": -5.578125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.77734375,
            "end_logit": 11.0546875,
            "text": "stress",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -7.88671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon,",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.7109375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.015625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.09375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.3359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.453125,
            "text": "physical stress is seen",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.4921875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.5,
            "text": "physical stress is",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.53125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis,",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.6953125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enth",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.75,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which",
            "probability": 0.0
        },
        {
            "start_logit": -9.375,
            "end_logit": 11.0546875,
            "text": "triggering role of physical stress",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 11.0546875,
            "text": "of physical stress",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_6": [
        {
            "start_logit": 5.36328125,
            "end_logit": 12.5859375,
            "text": "psoriasis",
            "probability": 1.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 12.5859375,
            "text": "skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.5859375,
            "text": "koebner phenomenon in psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 12.5859375,
            "text": "Two patients with unusual skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 12.5859375,
            "text": "ner phenomenon in psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.890625,
            "end_logit": 12.5859375,
            "text": "ebner phenomenon in psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.36328125,
            "end_logit": -9.484375,
            "text": "psoriasis are reported",
            "probability": 0.0
        },
        {
            "start_logit": 5.36328125,
            "end_logit": -9.6484375,
            "text": "psoriasis are",
            "probability": 0.0
        },
        {
            "start_logit": 5.36328125,
            "end_logit": -9.7109375,
            "text": "psoriasis are reported.",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -6.015625,
            "text": "skin stimuli",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -6.015625,
            "text": "Two patients with unusual skin stimuli",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -8.3671875,
            "text": "skin stimuli causing koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": -8.3671875,
            "text": "koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -9.1953125,
            "text": "skin",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": -8.3671875,
            "text": "Two patients with unusual skin stimuli causing koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -8.3671875,
            "text": "ner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -8.3671875,
            "text": "ebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -9.484375,
            "text": "skin stimuli causing koebner phenomenon in psoriasis are reported",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -9.6484375,
            "text": "skin stimuli causing koebner phenomenon in psoriasis are",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -9.7109375,
            "text": "skin stimuli causing koebner phenomenon in psoriasis are reported.",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_7": [
        {
            "start_logit": 12.3515625,
            "end_logit": 10.4296875,
            "text": "striae distensae",
            "probability": 1.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -1.5615234375,
            "text": "striae distensae and striae gravidarum",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -3.20703125,
            "text": "striae",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -3.673828125,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -4.73046875,
            "text": "striae distens",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.296875,
            "text": "str",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.41015625,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.48828125,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen plan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.48828125,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.56640625,
            "text": "striae dist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -6.30859375,
            "text": "striae distensae and striae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -6.5546875,
            "text": "striae distensae and striae gravida",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 10.4296875,
            "text": "ae",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -7.8125,
            "text": "striae distensae and str",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -8.1171875,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -8.1640625,
            "text": "striae distensae and striae grav",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -8.4765625,
            "text": "striae distensae and",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -9.046875,
            "text": "striae distensae and striae gravidarum in",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 10.4296875,
            "text": "distensae",
            "probability": 0.0
        },
        {
            "start_logit": -1.5166015625,
            "end_logit": -1.5615234375,
            "text": "striae gravidarum",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_8": [
        {
            "start_logit": 7.2109375,
            "end_logit": 11.4453125,
            "text": "psoriasis",
            "probability": 0.99609375
        },
        {
            "start_logit": 7.2109375,
            "end_logit": 5.77734375,
            "text": "psoriasis can be caused by a local cutaneus trauma",
            "probability": 0.0034275054931640625
        },
        {
            "start_logit": -2.783203125,
            "end_logit": 5.77734375,
            "text": "local cutaneus trauma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -5.984375,
            "text": "psoriasis can be caused by a local cutaneus",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.4453125,
            "text": ", psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -6.56640625,
            "text": "psoriasis can be caused by a local cutane",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.53515625,
            "text": "psoriasis can be caused by a",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.63671875,
            "text": "psoriasis can be caused by a local cutaneus trauma,",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.8671875,
            "text": "psoriasis can be",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -8.1640625,
            "text": "psoriasis can be caused by",
            "probability": 0.0
        },
        {
            "start_logit": -7.109375,
            "end_logit": 5.77734375,
            "text": "caused by a local cutaneus trauma",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -8.734375,
            "text": "psoriasis can be caused by a local cut",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.0078125,
            "text": "psoriasis can",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.1015625,
            "text": "psoriasis can be caused",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.4765625,
            "text": "psoriasis can be caused by a local cutaneus trauma, known",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.53125,
            "text": "psoriasis can be caused by a local",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.734375,
            "text": "psoriasis can be caused by a local cutaneus trauma, known as",
            "probability": 0.0
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -9.734375,
            "text": "psoriasis can be caused by a local cutaneus trauma, known as Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 5.77734375,
            "text": "cutaneus trauma",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 5.77734375,
            "text": "aneus trauma",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_9": [
        {
            "start_logit": 9.765625,
            "end_logit": 8.859375,
            "text": "vitiligo",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.765625,
            "end_logit": 2.201171875,
            "text": "vitiligo, psoriasis",
            "probability": 0.0012826919555664062
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 8.859375,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.000385284423828125
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 4.25,
            "text": "Striae",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.765625,
            "end_logit": -3.6328125,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 2.201171875,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.765625,
            "end_logit": -6.84765625,
            "text": "vitiligo, psoriasis and lichen plan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.765625,
            "end_logit": -8.796875,
            "text": "vitiligo, psoriasis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.7431640625,
            "end_logit": 2.201171875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -9.359375,
            "text": "vitiligo, psoriasis and lichen",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -9.953125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.1484375,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Nelder",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.1796875,
            "text": "vitiligo, psoriasis and lichen planus,",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.2734375,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Neld",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.390625,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Ne",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 8.859375,
            "text": "iae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.859375,
            "text": "preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": 1.904296875,
            "end_logit": -3.6328125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.0
        },
        {
            "start_logit": 1.904296875,
            "end_logit": -6.84765625,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen plan",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": 2.201171875,
            "text": ", psoriasis",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_10": [
        {
            "start_logit": 6.0234375,
            "end_logit": 12.109375,
            "text": "psoriasis",
            "probability": 1.0
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 2.7578125,
            "text": "psoriasis caused by varicella",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 1.8642578125,
            "end_logit": 2.7578125,
            "text": "varicella",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -4.17578125,
            "text": "psoriasis caused by varicella and UVB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 12.109375,
            "text": "[Unusual Koebner phenomenon in psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.109375,
            "text": "Koebner phenomenon in psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.796875,
            "end_logit": 12.109375,
            "text": "ner phenomenon in psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 12.109375,
            "text": "ebner phenomenon in psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -6.734375,
            "text": "psoriasis caused by varicella and UVB]",
            "probability": 0.0
        },
        {
            "start_logit": 1.8642578125,
            "end_logit": -4.17578125,
            "text": "varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -8.5390625,
            "text": "psoriasis caused by",
            "probability": 0.0
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -8.5390625,
            "text": "psoriasis caused by varicella and",
            "probability": 0.0
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -9.265625,
            "text": "psoriasis caused by varicella and UVB].",
            "probability": 0.0
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -9.4921875,
            "text": "psoriasis caused",
            "probability": 0.0
        },
        {
            "start_logit": 1.8642578125,
            "end_logit": -6.734375,
            "text": "varicella and UVB]",
            "probability": 0.0
        },
        {
            "start_logit": 1.8642578125,
            "end_logit": -8.5390625,
            "text": "varicella and",
            "probability": 0.0
        },
        {
            "start_logit": 1.8642578125,
            "end_logit": -9.265625,
            "text": "varicella and UVB].",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 2.7578125,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 2.7578125,
            "text": "Koebner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 2.7578125,
            "text": "caused by varicella",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_11": [
        {
            "start_logit": 8.4296875,
            "end_logit": 11.8046875,
            "text": "Borrelia afzelii infection",
            "probability": 1.0
        },
        {
            "start_logit": 8.4296875,
            "end_logit": 3.818359375,
            "text": "Borrelia afze",
            "probability": 0.0003407001495361328
        },
        {
            "start_logit": -3.255859375,
            "end_logit": 11.8046875,
            "text": "infection",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -0.1123046875,
            "text": "Borrelia afzeli",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 11.8046875,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -3.2265625,
            "text": "Borrelia afzelii",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 11.8046875,
            "text": "migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -4.8671875,
            "text": "Borrelia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -4.9375,
            "text": "Borrelia af",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 11.8046875,
            "text": "i infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 11.8046875,
            "text": "latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 11.8046875,
            "text": "48 year-old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 11.8046875,
            "text": "erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 11.8046875,
            "text": "caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 11.8046875,
            "text": "woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 3.818359375,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afze",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 3.818359375,
            "text": "migrating erythema caused by Borrelia afze",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 1.888671875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 3.818359375,
            "text": "latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afze",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -0.1123046875,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzeli",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_12": [
        {
            "start_logit": 11.53125,
            "end_logit": 7.8125,
            "text": "psoriasis vulgaris",
            "probability": 1.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -1.896484375,
            "text": "psoriasis",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 11.53125,
            "end_logit": -3.06640625,
            "text": "psoriasis vulgaris]",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 11.53125,
            "end_logit": -6.26171875,
            "text": "psoriasis vulgaris].",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.90625,
            "end_logit": 7.8125,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 7.8125,
            "text": "vulgaris",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 7.8125,
            "text": "Koebner phenomenon in patients with psoriasis vulgaris",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 7.8125,
            "text": "patients with psoriasis vulgaris",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -1.896484375,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -3.06640625,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris]",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -3.06640625,
            "text": "vulgaris]",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -1.896484375,
            "text": "Koebner phenomenon in patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -1.896484375,
            "text": "patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -3.06640625,
            "text": "Koebner phenomenon in patients with psoriasis vulgaris]",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -3.06640625,
            "text": "patients with psoriasis vulgaris]",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -6.26171875,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -6.26171875,
            "text": "vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -6.26171875,
            "text": "Koebner phenomenon in patients with psoriasis vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -6.26171875,
            "text": "patients with psoriasis vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -8.0859375,
            "text": "[Characteristics of the Koebner phenomenon in patients with",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_13": [
        {
            "start_logit": 10.2890625,
            "end_logit": 10.6015625,
            "text": "Vitiligo",
            "probability": 1.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -3.62890625,
            "text": "Vitiligo appearing in striae distensae",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -4.61328125,
            "text": "Vitiligo appearing in striae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -6.75,
            "text": "Vitiligo appearing in striae dist",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -6.7890625,
            "text": "Vitiligo appearing in striae distens",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -7.9296875,
            "text": "Vitiligo appearing in",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -8.6171875,
            "text": "Vitiligo appearing in striae distensae as a Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -9.125,
            "text": "Vitiligo appearing in str",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -9.53125,
            "text": "Vitiligo appearing in striae distensae as",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -9.5703125,
            "text": "Vitiligo appearing in striae distensae as a",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -10.0078125,
            "text": "Vitiligo appearing",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -10.0234375,
            "text": "Vitiligo appearing in striae distensae as a Koebner phenomenon",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -10.5234375,
            "text": "Vitiligo appearing in striae distensae as a Koebner",
            "probability": 0.0
        },
        {
            "start_logit": 10.2890625,
            "end_logit": -10.5625,
            "text": "Vitiligo appearing in striae distensae as a Koeb",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -3.62890625,
            "text": "striae distensae",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -4.61328125,
            "text": "striae",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -6.75,
            "text": "striae dist",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -6.7890625,
            "text": "striae distens",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -8.6171875,
            "text": "striae distensae as a Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -9.125,
            "text": "str",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_14": [
        {
            "start_logit": 7.84765625,
            "end_logit": 8.4375,
            "text": "vitiligo",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -0.68017578125,
            "text": "vitiligo in striae distensae",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -3.00390625,
            "text": "vitiligo in striae",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -5.54296875,
            "text": "vitiligo in striae distens",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -5.5703125,
            "text": "vitiligo in striae dist",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 2.044921875,
            "end_logit": -0.68017578125,
            "text": "striae distensae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -6.62890625,
            "text": "vitiligo in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.62890625,
            "text": "vitiligo in striae distensae as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.0625,
            "text": "vitiligo in striae distensae as a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.421875,
            "text": "vitiligo in str",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.044921875,
            "end_logit": -3.00390625,
            "text": "striae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.8671875,
            "text": "vitiligo in striae distensae as a form",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -9.0234375,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported rarely",
            "probability": 0.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -9.2265625,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported",
            "probability": 0.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -9.6796875,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has",
            "probability": 0.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -10.03125,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported rarely.",
            "probability": 0.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -10.03125,
            "text": "vitiligo in striae distensae as a form of",
            "probability": 0.0
        },
        {
            "start_logit": 2.044921875,
            "end_logit": -5.54296875,
            "text": "striae distens",
            "probability": 0.0
        },
        {
            "start_logit": 2.044921875,
            "end_logit": -5.5703125,
            "text": "striae dist",
            "probability": 0.0
        },
        {
            "start_logit": 2.044921875,
            "end_logit": -7.62890625,
            "text": "striae distensae as",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_15": [
        {
            "start_logit": 4.046875,
            "end_logit": 11.1796875,
            "text": "trauma",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 11.1796875,
            "text": "psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 0.0006046295166015625
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 11.1796875,
            "text": "a consequence of trauma",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -8.34375,
            "end_logit": 11.1796875,
            "text": "as a consequence of trauma",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -8.71875,
            "end_logit": 11.1796875,
            "text": "psoriasis as a consequence of trauma",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -9.328125,
            "end_logit": 11.1796875,
            "text": "patients with psoriasis as a consequence of trauma",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -9.609375,
            "end_logit": 11.1796875,
            "text": "of trauma",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 11.1796875,
            "text": "uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -10.34375,
            "end_logit": 11.1796875,
            "text": "consequence of trauma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -10.71875,
            "end_logit": 11.1796875,
            "text": "Koebner phenomenon originally described the appearance of psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 11.1796875,
            "text": "of psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 0.302001953125,
            "text": "psoriatic lesions in the uninvolved skin of patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -1.4443359375,
            "text": "psoriatic lesions",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -4.5625,
            "text": "psoriatic",
            "probability": 0.0
        },
        {
            "start_logit": -8.71875,
            "end_logit": 0.302001953125,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -5.484375,
            "text": "psoriatic lesions in the uninvolved skin",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 0.302001953125,
            "text": "patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 0.302001953125,
            "text": "uninvolved skin of patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 0.302001953125,
            "text": "Koebner phenomenon originally described the appearance of psoriatic lesions in the uninvolved skin of patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 0.302001953125,
            "text": "of psoriatic lesions in the uninvolved skin of patients with psoriasis",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_16": [
        {
            "start_logit": 11.609375,
            "end_logit": 10.046875,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": 0.73193359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": 11.609375,
            "end_logit": -2.3203125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 11.609375,
            "end_logit": -3.064453125,
            "text": "physical",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -5.41796875,
            "end_logit": 10.046875,
            "text": "stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.609375,
            "end_logit": -7.7421875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.09375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.28125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon,",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.453125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.65625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.9375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.0625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis,",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.3046875,
            "text": "physical stress is seen",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.3046875,
            "text": "physical stress is",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.4140625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.484375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.734375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enth",
            "probability": 0.0
        },
        {
            "start_logit": -9.53125,
            "end_logit": 10.046875,
            "text": "triggering role of physical stress",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 10.046875,
            "text": "of physical stress",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": 0.73193359375,
            "text": "stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_17": [
        {
            "start_logit": 10.9453125,
            "end_logit": 6.18359375,
            "text": "striae distensae",
            "probability": 0.9990234375
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -1.310546875,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo",
            "probability": 0.00055694580078125
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -2.482421875,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis",
            "probability": 0.00017261505126953125
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -2.701171875,
            "text": "striae",
            "probability": 0.0001386404037475586
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -4.68359375,
            "text": "striae distens",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -4.70703125,
            "text": "striae distensae and striae gravidarum",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -5.80078125,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -6.19921875,
            "text": "striae dist",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -6.39453125,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen plan",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -6.5546875,
            "text": "str",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -7.7578125,
            "text": "striae distensae and striae gravida",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 10.9453125,
            "end_logit": -7.93359375,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus.Striae",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.5517578125,
            "end_logit": 2.90234375,
            "text": "blunt trauma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.18359375,
            "text": "ae",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -1.310546875,
            "text": "vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -2.482421875,
            "text": "vitiligo, psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.45703125,
            "end_logit": -1.310546875,
            "text": "striae gravidarum in causing Koebner phenomenon in cases of vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -5.80078125,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -5.984375,
            "text": "vitiligo, psoriasis and lichen planus.Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 2.90234375,
            "text": "Striae distensae and striae gravidarum are examples of blunt trauma",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_18": [
        {
            "start_logit": 4.60546875,
            "end_logit": 10.65625,
            "text": "psoriasis",
            "probability": 0.85693359375
        },
        {
            "start_logit": 6.17578125,
            "end_logit": 7.11328125,
            "text": "varicella",
            "probability": 0.11871337890625
        },
        {
            "start_logit": 4.60546875,
            "end_logit": 7.11328125,
            "text": "psoriasis caused by varicella",
            "probability": 0.024688720703125
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -3.33203125,
            "text": "varicella and UVB",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -4.74609375,
            "text": "varicella and UVB]",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 4.60546875,
            "end_logit": -3.33203125,
            "text": "psoriasis caused by varicella and UVB",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -10.25,
            "end_logit": 10.65625,
            "text": "[Unusual Koebner phenomenon in psoriasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.390625,
            "end_logit": 10.65625,
            "text": "Koebner phenomenon in psoriasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.60546875,
            "end_logit": -4.74609375,
            "text": "psoriasis caused by varicella and UVB]",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.828125,
            "end_logit": 10.65625,
            "text": "ner phenomenon in psoriasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.859375,
            "end_logit": 10.65625,
            "text": "ebner phenomenon in psoriasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -8.6953125,
            "text": "varicella and",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 7.11328125,
            "text": "caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 7.11328125,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 7.11328125,
            "text": "Koebner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 7.11328125,
            "text": "ner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": 7.11328125,
            "text": "ebner phenomenon in psoriasis caused by varicella",
            "probability": 0.0
        },
        {
            "start_logit": 4.60546875,
            "end_logit": -8.4921875,
            "text": "psoriasis caused by",
            "probability": 0.0
        },
        {
            "start_logit": 4.60546875,
            "end_logit": -8.6953125,
            "text": "psoriasis caused by varicella and",
            "probability": 0.0
        },
        {
            "start_logit": 4.60546875,
            "end_logit": -9.5390625,
            "text": "psoriasis caused",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_19": [
        {
            "start_logit": 7.80078125,
            "end_logit": 11.140625,
            "text": "Borrelia afzelii infection",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.80078125,
            "end_logit": 3.74609375,
            "text": "Borrelia afze",
            "probability": 0.0006165504455566406
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -0.309814453125,
            "text": "Borrelia afzeli",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -4.640625,
            "end_logit": 11.140625,
            "text": "infection",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 11.140625,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.962890625,
            "text": "Borrelia afzelii",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 11.140625,
            "text": "migrating erythema caused by Borrelia afzelii infection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -4.921875,
            "text": "Borrelia af",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -5.3046875,
            "text": "Borrelia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.71875,
            "end_logit": 11.140625,
            "text": "i infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 11.140625,
            "text": "latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 11.140625,
            "text": "48 year-old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 11.140625,
            "text": "erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 11.140625,
            "text": "caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 11.140625,
            "text": "zelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.140625,
            "text": "woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.140625,
            "text": "Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 11.140625,
            "text": "exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 0.0
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 3.74609375,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afze",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 3.74609375,
            "text": "migrating erythema caused by Borrelia afze",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_20": [
        {
            "start_logit": -7.7421875,
            "end_logit": 9.1796875,
            "text": "Intradermal antigen tests and the Koebner phenomenon in psoriasis",
            "probability": 0.64453125
        },
        {
            "start_logit": -9.265625,
            "end_logit": 9.1796875,
            "text": "psoriasis",
            "probability": 0.1405029296875
        },
        {
            "start_logit": -9.8203125,
            "end_logit": 9.1796875,
            "text": "Koebner phenomenon in psoriasis",
            "probability": 0.08062744140625
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 9.1796875,
            "text": "ebner phenomenon in psoriasis",
            "probability": 0.034698486328125
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 9.1796875,
            "text": "ner phenomenon in psoriasis",
            "probability": 0.034698486328125
        },
        {
            "start_logit": -10.6875,
            "end_logit": 9.1796875,
            "text": "tests and the Koebner phenomenon in psoriasis",
            "probability": 0.03387451171875
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 9.1796875,
            "text": "and the Koebner phenomenon in psoriasis",
            "probability": 0.031097412109375
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.87109375,
            "text": "Intradermal antigen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -8.03125,
            "text": "Intradermal antigen tests and the Koebner phenomenon in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -8.59375,
            "text": "Intradermal antigen tests",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -9.6484375,
            "text": "Intradermal antigen tests and the",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": -8.03125,
            "text": "Koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -8.03125,
            "text": "ebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -8.03125,
            "text": "ner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -8.03125,
            "text": "tests and the Koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -8.03125,
            "text": "and the Koebner phenomenon in",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -8.59375,
            "text": "tests",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -9.6484375,
            "text": "tests and the",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -9.6484375,
            "text": "and the",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_21": [
        {
            "start_logit": 10.28125,
            "end_logit": 9.3203125,
            "text": "vitiligo",
            "probability": 0.9990234375
        },
        {
            "start_logit": 10.28125,
            "end_logit": 2.3828125,
            "text": "vitiligo, psoriasis",
            "probability": 0.0009775161743164062
        },
        {
            "start_logit": -1.8984375,
            "end_logit": 9.3203125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 10.28125,
            "end_logit": -4.62890625,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 10.28125,
            "end_logit": -6.65234375,
            "text": "vitiligo, psoriasis and lichen plan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.42578125,
            "end_logit": 2.3828125,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -9.328125,
            "text": "vitiligo, psoriasis and lichen",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -9.359375,
            "text": "vitiligo, psoriasis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.8984375,
            "end_logit": 2.3828125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -9.8515625,
            "text": "vitiligo, psoriasis and lichen planus,",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -10.1484375,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -10.3125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Neld",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -10.3125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Nelder",
            "probability": 0.0
        },
        {
            "start_logit": 10.28125,
            "end_logit": -10.3828125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Ne",
            "probability": 0.0
        },
        {
            "start_logit": -1.8984375,
            "end_logit": 1.6787109375,
            "text": "Striae",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 9.3203125,
            "text": ": Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 9.3203125,
            "text": "preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 9.3203125,
            "text": "RESULTS: Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 2.3828125,
            "text": ", psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -4.62890625,
            "text": "psoriasis and lichen planus",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_22": [
        {
            "start_logit": 0.658203125,
            "end_logit": 12.5546875,
            "text": "psoriasis",
            "probability": 0.9951171875
        },
        {
            "start_logit": -4.61328125,
            "end_logit": 12.5546875,
            "text": "severe psoriasis",
            "probability": 0.00511932373046875
        },
        {
            "start_logit": -8.46875,
            "end_logit": 12.5546875,
            "text": "actively spreading, severe psoriasis",
            "probability": 0.00010836124420166016
        },
        {
            "start_logit": -9.6875,
            "end_logit": 12.5546875,
            "text": "control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be more frequent in actively spreading, severe psoriasis",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -9.828125,
            "end_logit": 12.5546875,
            "text": "spreading, severe psoriasis",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.5546875,
            "text": "RESULTS AND DISCUSSION: The Koebner reaction is often thought to be more frequent in actively spreading, severe psoriasis",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.5546875,
            "text": ", severe psoriasis",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 12.5546875,
            "text": "Koebner reaction is often thought to be more frequent in actively spreading, severe psoriasis",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": -4.61328125,
            "end_logit": -9.484375,
            "text": "severe",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -9.484375,
            "text": "actively spreading, severe",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -9.734375,
            "text": "actively spreading",
            "probability": 0.0
        },
        {
            "start_logit": -9.5703125,
            "end_logit": -8.8359375,
            "text": "Koebner phenomenon which presented the control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -8.8359375,
            "text": "control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -8.8359375,
            "text": "presented the control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -10.515625,
            "text": "actively spreading,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -8.8359375,
            "text": "negative Koebner phenomenon which presented the control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -8.8359375,
            "text": "with negative Koebner phenomenon which presented the control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -8.8359375,
            "text": "RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -8.8359375,
            "text": "Koebner reaction is often thought to be",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -8.8359375,
            "text": "phenomenon which presented the control group at the same time.RESULTS AND DISCUSSION: The Koebner reaction is often thought to be",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_23": [
        {
            "start_logit": 13.625,
            "end_logit": 13.28125,
            "text": "lichen planus",
            "probability": 1.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -2.109375,
            "text": "lichen planus and sarcoidosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.625,
            "end_logit": -3.845703125,
            "text": "lichen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.703125,
            "end_logit": 13.28125,
            "text": "us",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -5.34375,
            "text": "lichen plan",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -7.73046875,
            "text": "lichen planus and sarcoidosis in the auditory canal",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -7.8125,
            "text": "lichen planus and sarcoidosis in the auditory canal, which represents",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.1328125,
            "text": "lichen planus and",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.6171875,
            "text": "lichen planus and sarcoidosis in",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.015625,
            "text": "lichen planus and sarcoidosis in the auditory canal,",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.265625,
            "text": "lichen planus and sarcoidosis in the",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.5859375,
            "text": "lichen planus and sarcoidosis in the auditory canal, which represents an unusual",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.625,
            "text": "lichen planus and sarcoidosis in the auditory",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.6484375,
            "text": "lichen planus and sarcoidosis in the auditory canal, which",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.7421875,
            "text": "lichen planus and sarcoidosis in the auditory canal, which represents an",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 13.28125,
            "text": "concurrent lichen planus",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -10.28125,
            "text": "lichen planus and sarcoidosis in the auditory canal, which represents an unusual manifestation",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.28125,
            "text": "planus",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -2.109375,
            "text": "sarcoidosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.703125,
            "end_logit": -2.109375,
            "text": "us and sarcoidosis",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_24": [
        {
            "start_logit": 9.765625,
            "end_logit": 8.859375,
            "text": "vitiligo",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.765625,
            "end_logit": 2.201171875,
            "text": "vitiligo, psoriasis",
            "probability": 0.0012826919555664062
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 8.859375,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.000385284423828125
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 4.25,
            "text": "Striae",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.765625,
            "end_logit": -3.6328125,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 1.904296875,
            "end_logit": 2.201171875,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.765625,
            "end_logit": -6.84765625,
            "text": "vitiligo, psoriasis and lichen plan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.765625,
            "end_logit": -8.796875,
            "text": "vitiligo, psoriasis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.7431640625,
            "end_logit": 2.201171875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -9.359375,
            "text": "vitiligo, psoriasis and lichen",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -9.953125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.1484375,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Nelder",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.1796875,
            "text": "vitiligo, psoriasis and lichen planus,",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.2734375,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Neld",
            "probability": 0.0
        },
        {
            "start_logit": 9.765625,
            "end_logit": -10.390625,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Ne",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 8.859375,
            "text": "iae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.859375,
            "text": "preexisting vitiligo",
            "probability": 0.0
        },
        {
            "start_logit": 1.904296875,
            "end_logit": -3.6328125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.0
        },
        {
            "start_logit": 1.904296875,
            "end_logit": -6.84765625,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen plan",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": 2.201171875,
            "text": ", psoriasis",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_1": [
        {
            "start_logit": 11.9140625,
            "end_logit": 11.171875,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -8.3671875,
            "text": "deafness (sensorineural), onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -8.4609375,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -8.921875,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.1171875,
            "text": "deafness (sensorineural)",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.25,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.28125,
            "text": "deafness (sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.65625,
            "text": "deafness (",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.734375,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation.",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.765625,
            "text": "deafness (sensorineural), onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -9.875,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -10.0,
            "text": "deafness (sensorineural), onychodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": 11.9140625,
            "end_logit": -10.0,
            "text": "deafness (sensorineural),",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 11.171875,
            "text": "multisystem genetic disorder, consisting of deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 11.171875,
            "text": "DOOR syndrome is a rare multisystem genetic disorder, consisting of deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 11.171875,
            "text": "rare multisystem genetic disorder, consisting of deafness",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -8.4609375,
            "text": "mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": -8.3671875,
            "text": "onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": -8.4609375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -9.40625,
            "end_logit": -8.4609375,
            "text": "osteodystrophy, and mental retardation",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_2": [
        {
            "start_logit": 11.421875,
            "end_logit": 11.859375,
            "text": "Deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -5.71484375,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -6.32421875,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy and cerebral palsy",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -6.91796875,
            "text": "Deafness, Onycho-Osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -7.39453125,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -7.75390625,
            "text": "Deafness, Onycho",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.0546875,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.640625,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy and",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.8046875,
            "text": "Deafness, Onycho-Osteodystrophy and mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.859375,
            "text": "Deafness, Onycho-Oste",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.046875,
            "text": "Deafness, Onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.046875,
            "text": "Deafness, On",
            "probability": 0.0
        },
        {
            "start_logit": -9.5,
            "end_logit": 11.859375,
            "text": "male patient with Deafness",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.078125,
            "text": "Deafness, Onycho-Osteodystrophy and",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.2578125,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy and cerebral",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 11.859375,
            "text": "48-year-old male patient with Deafness",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.4921875,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.5,
            "text": "Deafness, Onycho-",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.6875,
            "text": "Deafness,",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.8125,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy and cerebral palsy who",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_3": [
        {
            "start_logit": 13.5625,
            "end_logit": 13.9765625,
            "text": "congenital deafness",
            "probability": 1.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": 13.9765625,
            "text": "deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.5625,
            "end_logit": -3.404296875,
            "text": "congenital",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -7.796875,
            "text": "congenital deafness, nail and bone abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -8.6953125,
            "text": "congenital deafness, nail and bone abnormalities, and mild mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": 13.9765625,
            "text": "delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.3125,
            "text": "congenital deafness, nail and bone abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.484375,
            "text": "congenital deafness, nail",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -9.5078125,
            "text": "congenital deafness, nail and bone",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.9765625,
            "text": "speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.9765625,
            "text": "development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 0.0
        },
        {
            "start_logit": 13.5625,
            "end_logit": -10.1015625,
            "text": "congenital deafness, nail and bone abnormalities, and mild mental retardation.",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.9765625,
            "text": "DOOR syndrome recognized in the first year of his life because of a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 13.9765625,
            "text": "of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -7.796875,
            "text": "deafness, nail and bone abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -8.6953125,
            "text": "deafness, nail and bone abnormalities, and mild mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -9.3125,
            "text": "deafness, nail and bone abnormalities, and",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -9.484375,
            "text": "deafness, nail",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -9.5078125,
            "text": "deafness, nail and bone",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -10.1015625,
            "text": "deafness, nail and bone abnormalities, and mild mental retardation.",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_4": [
        {
            "start_logit": 11.6015625,
            "end_logit": 11.7734375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.203125,
            "text": "deafness, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.203125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.4375,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.609375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.2109375,
            "text": "deafness, onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.3359375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.5234375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.5859375,
            "text": "deafness, onychodystrophy, osteodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.6328125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.7421875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.7890625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.796875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.828125,
            "text": "deafness,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 11.7734375,
            "text": "DOOR syndrome (deafness",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.203125,
            "text": "onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.203125,
            "text": "onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -8.765625,
            "end_logit": -8.203125,
            "text": "mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.4375,
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.609375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_5": [
        {
            "start_logit": 11.421875,
            "end_logit": 11.9453125,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -7.60546875,
            "text": "deafness, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.2578125,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.8203125,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -8.90625,
            "text": "deafness, onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.1015625,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome]",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": 11.9453125,
            "text": "DOOR (deafness",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.640625,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation)",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.71875,
            "text": "deafness, onychodystrophy, osteodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.7890625,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome].",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.859375,
            "text": "deafness, onychodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -9.9609375,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -10.0078125,
            "text": "deafness, on",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -10.015625,
            "text": "deafness, onychodystrophy, oste",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -10.1796875,
            "text": "deafness, onychodystrophy, osteodystrophy, mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.421875,
            "end_logit": -10.2578125,
            "text": "deafness,",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -7.60546875,
            "text": "onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -8.2578125,
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": -7.60546875,
            "text": "DOOR (deafness, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -8.8203125,
            "text": "onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_6": [
        {
            "start_logit": 11.6015625,
            "end_logit": 11.7734375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.203125,
            "text": "deafness, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.203125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.4375,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -8.609375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.2109375,
            "text": "deafness, onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.3359375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.5234375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.5859375,
            "text": "deafness, onychodystrophy, osteodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.6328125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.7421875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.7890625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.796875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature",
            "probability": 0.0
        },
        {
            "start_logit": 11.6015625,
            "end_logit": -9.828125,
            "text": "deafness,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 11.7734375,
            "text": "DOOR syndrome (deafness",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.203125,
            "text": "onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.203125,
            "text": "onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -8.765625,
            "end_logit": -8.203125,
            "text": "mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.4375,
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": -8.609375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_7": [
        {
            "start_logit": 13.78125,
            "end_logit": 14.0703125,
            "text": "hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": -0.458740234375,
            "end_logit": 14.0703125,
            "text": "sensorineural hearing loss",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -3.71484375,
            "end_logit": 14.0703125,
            "text": "loss",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -3.728515625,
            "text": "hearing",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -6.765625,
            "text": "hearing loss, hypoplastic or absent",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -7.31640625,
            "text": "hearing loss, hypoplastic or absent nails",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -7.87890625,
            "text": "hearing loss, hypoplastic",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.6484375,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the hands and feet, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -8.875,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.015625,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the hands and feet, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.3515625,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.4375,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.4453125,
            "text": "hearing loss, hypoplastic or absent nails on",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.515625,
            "text": "hearing loss, hypoplastic or absent nails on the hands",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -9.6953125,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the hands and feet, and mental",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 14.0703125,
            "text": "DOOR acronym, include sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": 13.78125,
            "end_logit": -10.0625,
            "text": "hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the hands and feet",
            "probability": 0.0
        },
        {
            "start_logit": -0.458740234375,
            "end_logit": -3.728515625,
            "text": "sensorineural hearing",
            "probability": 0.0
        },
        {
            "start_logit": -0.458740234375,
            "end_logit": -6.765625,
            "text": "sensorineural hearing loss, hypoplastic or absent",
            "probability": 0.0
        },
        {
            "start_logit": -0.458740234375,
            "end_logit": -7.31640625,
            "text": "sensorineural hearing loss, hypoplastic or absent nails",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_8": [
        {
            "start_logit": 4.77734375,
            "end_logit": 5.625,
            "text": "sensorineural deafness",
            "probability": 0.67919921875
        },
        {
            "start_logit": 3.67578125,
            "end_logit": 5.625,
            "text": "dystrophic thumbs, sensorineural deafness",
            "probability": 0.2239990234375
        },
        {
            "start_logit": 2.203125,
            "end_logit": 5.625,
            "text": "onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 0.051544189453125
        },
        {
            "start_logit": 3.67578125,
            "end_logit": 3.7265625,
            "text": "dystrophic thumbs",
            "probability": 0.033660888671875
        },
        {
            "start_logit": 2.203125,
            "end_logit": 3.7265625,
            "text": "onycho-osteodystrophy, dystrophic thumbs",
            "probability": 0.007724761962890625
        },
        {
            "start_logit": 2.203125,
            "end_logit": 3.005859375,
            "text": "onycho-osteodystrophy",
            "probability": 0.0037631988525390625
        },
        {
            "start_logit": -3.1953125,
            "end_logit": 5.625,
            "text": "deafness",
            "probability": 0.00023317337036132812
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -5.8671875,
            "text": "sensorineural",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -5.8671875,
            "text": "dystrophic thumbs, sensorineural",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -8.125,
            "end_logit": 5.625,
            "text": "ycho-osteodystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 5.625,
            "text": "osteodystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -8.421875,
            "end_logit": 5.625,
            "text": "thumbs, sensorineural deafness",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -8.7578125,
            "end_logit": 5.625,
            "text": "odystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.2578125,
            "text": "dystrophic",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.30859375,
            "text": "dystrophic thumb",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 2.203125,
            "end_logit": -5.8671875,
            "text": "onycho-osteodystrophy, dystrophic thumbs, sensorineural",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.484375,
            "text": "sensorineural deafness, and increased urinary levels of 2-oxoglutarate)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 2.203125,
            "end_logit": -6.1171875,
            "text": "onycho",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.7265625,
            "text": "sensorineural deafness, and increased urinary levels of 2-oxoglutarate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -8.78125,
            "text": "sensorineural deafness, and",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c73ace67c78d69471000083_9": [
        {
            "start_logit": 13.7890625,
            "end_logit": 13.6953125,
            "text": "sensorineural deafness",
            "probability": 1.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -3.69921875,
            "text": "sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": 13.6953125,
            "text": "deafness",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.546875,
            "text": "sensorineural deafness, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.921875,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -8.0546875,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -8.7421875,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.28125,
            "text": "sensorineural deafness, osteodystrophy, onych",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.3359375,
            "text": "sensorineural deafness, oste",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.3984375,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation.",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.6171875,
            "text": "sensorineural deafness,",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.65625,
            "text": "sensorineural deafness, osteodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.703125,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 13.6953125,
            "text": "Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 13.6953125,
            "text": "DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -7.546875,
            "text": "deafness, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -7.921875,
            "text": "deafness, osteodystrophy, onychodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -8.0546875,
            "text": "deafness, osteodystrophy, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -8.7421875,
            "text": "deafness, osteodystrophy, onychodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -9.28125,
            "text": "deafness, osteodystrophy, onych",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_10": [
        {
            "start_logit": 11.4453125,
            "end_logit": 11.953125,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -7.64453125,
            "text": "deafness, onycho-osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -8.140625,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -8.3046875,
            "text": "deafness, onycho-osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -8.59375,
            "text": "deafness, onycho-osteodystrophy, and mental retardation)",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -8.84375,
            "text": "deafness, onycho",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.0390625,
            "text": "deafness, onycho-osteodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.359375,
            "text": "deafness, onych",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.4453125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive cases.",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.453125,
            "text": "deafness, onycho-",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.4921875,
            "text": "deafness, onycho-oste",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.625,
            "text": "deafness, onycho-osteodystrophy, and mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.6640625,
            "text": "deafness, on",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.703125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive cases",
            "probability": 0.0
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.71875,
            "text": "deafness, onycho-osteodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 11.953125,
            "text": "DOOR syndrome (deafness",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -7.64453125,
            "text": "onycho-osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -8.140625,
            "text": "onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -8.3046875,
            "text": "onycho-osteodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -8.140625,
            "text": "mental retardation): a new patient and delineation of neurologic variability among recessive",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_11": [
        {
            "start_logit": 11.1953125,
            "end_logit": 10.3515625,
            "text": "sensorineural deafness",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.28515625,
            "end_logit": 7.99609375,
            "text": "Congenital heart disease",
            "probability": 0.0006985664367675781
        },
        {
            "start_logit": -0.90185546875,
            "end_logit": 7.99609375,
            "text": "heart disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -5.03125,
            "text": "sensorineural",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 10.3515625,
            "text": "deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -7.453125,
            "text": "sensorineural deafness, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -6.734375,
            "end_logit": 10.3515625,
            "text": "urinary tract abnormalities in two siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -8.3125,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -8.4453125,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.15625,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.421875,
            "text": "sensorineural deafness,",
            "probability": 0.0
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -4.94921875,
            "text": "Congenital heart disease and urinary tract abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.890625,
            "text": "sensorineural deafness, oste",
            "probability": 0.0
        },
        {
            "start_logit": 11.1953125,
            "end_logit": -9.90625,
            "text": "sensorineural deafness, osteodystrophy,",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.99609375,
            "text": "disease",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 10.3515625,
            "text": "Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 10.3515625,
            "text": "DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 10.3515625,
            "text": "DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -6.6875,
            "text": "Congenital heart",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 10.3515625,
            "text": "tract abnormalities in two siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_1": [
        {
            "start_logit": 10.1875,
            "end_logit": 11.90625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 11.90625,
            "text": "oculomotor disturbance and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 11.90625,
            "text": "confusion, oculomotor disturbance and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 11.90625,
            "text": ", oculomotor disturbance and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 10.1875,
            "end_logit": -10.265625,
            "text": "ataxia), however, in the majority of the cases only confusion is present",
            "probability": 0.0
        },
        {
            "start_logit": 10.1875,
            "end_logit": -10.3515625,
            "text": "ataxia), however, in the majority of the cases",
            "probability": 0.0
        },
        {
            "start_logit": 10.1875,
            "end_logit": -10.375,
            "text": "ataxia),",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -8.28125,
            "text": "oculomotor disturbance",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -8.28125,
            "text": "confusion, oculomotor disturbance",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.28125,
            "text": ", oculomotor disturbance",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -8.75,
            "text": "oculomotor disturbance and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -8.75,
            "text": "confusion, oculomotor disturbance and",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.75,
            "text": ", oculomotor disturbance and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -9.2421875,
            "text": "confusion",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -9.7890625,
            "text": "oculomotor",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -9.7890625,
            "text": "confusion, oculomotor",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -9.7890625,
            "text": ", oculomotor",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -10.265625,
            "text": "oculomotor disturbance and ataxia), however, in the majority of the cases only confusion is present",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -10.3515625,
            "text": "oculomotor disturbance and ataxia), however, in the majority of the cases",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": -10.265625,
            "text": "confusion, oculomotor disturbance and ataxia), however, in the majority of the cases only confusion is present",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_2": [
        {
            "start_logit": 9.203125,
            "end_logit": 11.109375,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.109375,
            "text": "mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 11.109375,
            "text": "oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 11.109375,
            "text": "Wernicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 11.109375,
            "text": "confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 11.109375,
            "text": "neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 11.109375,
            "text": ", oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 11.109375,
            "text": "rnicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 11.109375,
            "text": "nicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -10.171875,
            "text": "ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.46875,
            "text": "mental confusion, oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.78125,
            "text": "mental confusion, oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.9453125,
            "text": "mental confusion",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -8.46875,
            "text": "oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": -8.46875,
            "text": "Wernicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -8.46875,
            "text": "confusion, oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": -8.46875,
            "text": "neurological disorder characterized by mental confusion, oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -8.78125,
            "text": "oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -8.46875,
            "text": ", oculomotor dysfunction, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -8.46875,
            "text": "rnicke's encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_3": [
        {
            "start_logit": -2.69921875,
            "end_logit": 8.078125,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 0.81396484375
        },
        {
            "start_logit": -4.6796875,
            "end_logit": 8.078125,
            "text": "gait ataxia",
            "probability": 0.11236572265625
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 8.078125,
            "text": "ataxia",
            "probability": 0.068115234375
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.078125,
            "text": "oculomotor dysfunction and gait ataxia",
            "probability": 0.004512786865234375
        },
        {
            "start_logit": -10.046875,
            "end_logit": 8.078125,
            "text": ", oculomotor dysfunction and gait ataxia",
            "probability": 0.0005245208740234375
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 8.078125,
            "text": "dysfunction and gait ataxia",
            "probability": 0.00034117698669433594
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -2.705078125,
            "text": "encephalopathy",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -6.0703125,
            "text": "encephalopathy, oculomotor dysfunction",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -7.8125,
            "text": "encephalopathy, oculomotor dysfunction and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -8.5234375,
            "text": "encephalopathy, oculomotor dysfunction and gait",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -8.71875,
            "text": "encephalopathy, oculomotor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -9.1796875,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia but",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -10.203125,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia but is not seen",
            "probability": 0.0
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -10.21875,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a majority of patients.",
            "probability": 0.0
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -10.3671875,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a majority of patients",
            "probability": 0.0
        },
        {
            "start_logit": -2.69921875,
            "end_logit": -10.3671875,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia but is not seen in a",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -8.5234375,
            "text": "gait",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -9.1796875,
            "text": "gait ataxia but",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -6.0703125,
            "text": "oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -9.1796875,
            "text": "ataxia but",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_4": [
        {
            "start_logit": 4.4765625,
            "end_logit": 10.2109375,
            "text": "truncal ataxia",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.859375,
            "end_logit": 10.2109375,
            "text": "ataxia",
            "probability": 0.0006513595581054688
        },
        {
            "start_logit": -9.765625,
            "end_logit": 10.2109375,
            "text": "ocular abnormalities, and truncal ataxia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 10.2109375,
            "text": "mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 10.2109375,
            "text": "vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 10.2109375,
            "text": "with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 10.2109375,
            "text": ", he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 10.2109375,
            "text": "status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 10.2109375,
            "text": ", ocular abnormalities, and truncal ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.546875,
            "end_logit": 10.2109375,
            "text": "he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.609375,
            "end_logit": 10.2109375,
            "text": "frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 10.2109375,
            "text": "presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.703125,
            "end_logit": 10.2109375,
            "text": "After frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -6.33984375,
            "text": "truncal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -6.91015625,
            "text": "trunc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -9.5859375,
            "text": "truncal ataxia (the classic",
            "probability": 0.0
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -9.828125,
            "text": "truncal ataxia (the classic triad",
            "probability": 0.0
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -10.0234375,
            "text": "truncal ataxia (",
            "probability": 0.0
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -10.1484375,
            "text": "truncal ataxia (the classic triad)",
            "probability": 0.0
        },
        {
            "start_logit": 4.4765625,
            "end_logit": -10.2734375,
            "text": "truncal ataxia (the classic triad).",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_5": [
        {
            "start_logit": 13.9765625,
            "end_logit": 13.8671875,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -3.19140625,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.673828125,
            "end_logit": 13.8671875,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -5.046875,
            "text": "ophthalmoplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.3671875,
            "text": "ophthalmoplegia, ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.5859375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.734375,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.015625,
            "text": "ophthalmoplegia, ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.203125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.515625,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine)",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.734375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.7734375,
            "text": "ophthalmoplegia, ataxia and confusion seen",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -9.8203125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency.",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -5.046875,
            "text": "oplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -8.3671875,
            "text": "oplegia, ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -8.5859375,
            "text": "oplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -8.734375,
            "text": "oplegia,",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -9.015625,
            "text": "oplegia, ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -5.046875,
            "text": "ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -9.203125,
            "text": "oplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_6": [
        {
            "start_logit": 9.5703125,
            "end_logit": 11.3515625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": 11.3515625,
            "text": "confusional symptoms, ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 11.3515625,
            "text": "ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 11.3515625,
            "text": ", ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 11.3515625,
            "text": "ke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 11.3515625,
            "text": "encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 11.3515625,
            "text": "nicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -10.3359375,
            "text": "ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -6.8515625,
            "text": "confusional symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -6.8515625,
            "text": "ke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -6.8515625,
            "text": "Wernicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -6.8515625,
            "text": "encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -6.8515625,
            "text": "nicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -7.8515625,
            "text": "confusional symptoms, ocular alterations and",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -7.8515625,
            "text": "ocular alterations and",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -7.8515625,
            "text": ", ocular alterations and",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -7.8515625,
            "text": "ke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -7.8515625,
            "text": "Wernicke encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -8.65625,
            "text": "confusional symptoms, ocular alterations",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -7.8515625,
            "text": "encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_7": [
        {
            "start_logit": 14.0546875,
            "end_logit": 14.0546875,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -3.39453125,
            "text": "ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": 14.0546875,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.0859375,
            "text": "ophthalmoplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.4140625,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.4453125,
            "text": "ophthalmoplegia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.625,
            "text": "ophthalmoplegia, and confusion)",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -9.8984375,
            "text": "ophthalmoplegia, and confusion) are found in only a third",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 14.0546875,
            "text": "gait ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -10.0546875,
            "text": "ophthalmoplegia, and confusion) are found in only a third of patients upon initial examination.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 14.0546875,
            "text": "ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -10.28125,
            "text": "ophthalmoplegia, and confusion) are found in only a third of patients",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -9.0859375,
            "text": "oplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -9.4140625,
            "text": "oplegia,",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -9.4453125,
            "text": "oplegia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -9.625,
            "text": "oplegia, and confusion)",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -3.39453125,
            "text": "gait ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -9.8984375,
            "text": "oplegia, and confusion) are found in only a third",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -3.39453125,
            "text": "ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -10.0546875,
            "text": "oplegia, and confusion) are found in only a third of patients upon initial examination.",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_8": [
        {
            "start_logit": 13.6015625,
            "end_logit": 13.65625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -3.525390625,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.984375,
            "end_logit": 13.65625,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -3.962890625,
            "text": "ophthalmoplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -7.3125,
            "text": "ophthalmoplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.2890625,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 13.65625,
            "text": "confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": 13.65625,
            "text": "0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 13.65625,
            "text": ", ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 13.65625,
            "text": "4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 13.65625,
            "text": "of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 13.65625,
            "text": "only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 13.65625,
            "text": ".4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.7578125,
            "end_logit": 13.65625,
            "text": "namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 13.65625,
            "text": "Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": -3.962890625,
            "text": "oplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": -7.3125,
            "text": "oplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -3.962890625,
            "text": "ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": -3.525390625,
            "text": "confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": -8.2890625,
            "text": "oplegia,",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_9": [
        {
            "start_logit": 13.796875,
            "end_logit": 13.7734375,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -3.4921875,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.904296875,
            "end_logit": 13.7734375,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -5.796875,
            "text": "ophthalmoplegia and nystagmus, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -7.578125,
            "text": "ophthalmoplegia and nystagmus",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -8.3359375,
            "text": "ophthalmoplegia and nystagmus, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -8.9453125,
            "text": "ophthalmoplegia and",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.0859375,
            "text": "ophthalmoplegia and nystagmus,",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.71875,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.8203125,
            "text": "ophthalmoplegia and nystagmus, and ataxia-",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.828125,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment.",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.984375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics",
            "probability": 0.0
        },
        {
            "start_logit": 13.796875,
            "end_logit": -9.984375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 13.7734375,
            "text": "global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.7734375,
            "text": "confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 13.7734375,
            "text": "-global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 13.7734375,
            "text": "Wernicke's encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.7734375,
            "text": ", ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.7734375,
            "text": "al state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -3.904296875,
            "end_logit": -5.796875,
            "text": "oplegia and nystagmus, and ataxia",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_10": [
        {
            "start_logit": 8.5859375,
            "end_logit": 11.171875,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 11.171875,
            "text": "mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 11.171875,
            "text": "ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 11.171875,
            "text": ", ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 11.171875,
            "text": "Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 11.171875,
            "text": "Only six presented with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 11.171875,
            "text": "with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -9.53125,
            "text": "ataxia) at neurologic onset",
            "probability": 0.0
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -10.3828125,
            "text": "ataxia) at neurologic onset; nine eventually",
            "probability": 0.0
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -10.40625,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad.",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -7.83984375,
            "text": "mental status changes, ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -7.83984375,
            "text": "ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -8.078125,
            "text": "mental status changes, ocular signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -8.1484375,
            "text": "mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -8.078125,
            "text": "ocular signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -7.83984375,
            "text": ", ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -7.83984375,
            "text": "Wernicke's encephalopathy clinical triad (mental status changes, ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -7.83984375,
            "text": "Only six presented with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -8.078125,
            "text": ", ocular signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.078125,
            "text": "Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_11": [
        {
            "start_logit": 13.71875,
            "end_logit": 13.1796875,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -3.62890625,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.7890625,
            "end_logit": 13.1796875,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": -5.6171875,
            "end_logit": 13.1796875,
            "text": "ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 13.1796875,
            "text": "confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.421875,
            "text": "ophthalmoplegia.",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 13.1796875,
            "text": ", ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 13.1796875,
            "text": "Wernicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 13.1796875,
            "text": "rnicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.1796875,
            "text": "nicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 13.1796875,
            "text": "encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 13.1796875,
            "text": "s encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -5.6171875,
            "end_logit": -2.833984375,
            "text": "ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -5.6171875,
            "end_logit": -3.62890625,
            "text": "ataxia, and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -2.833984375,
            "text": "confusion, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -3.62890625,
            "text": "confusion, ataxia, and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -2.833984375,
            "text": ", ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -3.62890625,
            "text": ", ataxia, and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -2.833984375,
            "text": "Wernicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -2.833984375,
            "text": "rnicke's encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_12": [
        {
            "start_logit": 13.7421875,
            "end_logit": 13.515625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -3.31640625,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.15234375,
            "end_logit": 13.515625,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -5.375,
            "text": "ophthalmoplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -7.23046875,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -8.421875,
            "text": "ophthalmoplegia, ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -8.8828125,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -8.9453125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -9.0546875,
            "text": "ophthalmoplegia, ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -9.4453125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -9.484375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine)",
            "probability": 0.0
        },
        {
            "start_logit": 13.7421875,
            "end_logit": -9.84375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 13.515625,
            "text": "apos;s encephalopathy is a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 13.515625,
            "text": ";s encephalopathy is a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 13.515625,
            "text": "&apos;s encephalopathy is a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 13.515625,
            "text": "s encephalopathy is a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -4.15234375,
            "end_logit": -5.375,
            "text": "oplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -4.15234375,
            "end_logit": -7.23046875,
            "text": "oplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 0.0
        },
        {
            "start_logit": -4.15234375,
            "end_logit": -8.421875,
            "text": "oplegia, ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": -4.15234375,
            "end_logit": -8.8828125,
            "text": "oplegia,",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_13": [
        {
            "start_logit": 14.0078125,
            "end_logit": 13.828125,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -3.185546875,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.896484375,
            "end_logit": 13.828125,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -4.35546875,
            "text": "ophthalmoplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -7.484375,
            "text": "ophthalmoplegia, ataxia, and mental confusion",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -8.5703125,
            "text": "ophthalmoplegia, ataxia, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -8.75,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -9.09375,
            "text": "ophthalmoplegia, ataxia,",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -9.2265625,
            "text": "ophthalmoplegia, ataxia, and mental",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 13.828125,
            "text": "WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.828125,
            "text": "Wernicke encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 13.828125,
            "text": "neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 13.828125,
            "text": "ke encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 13.828125,
            "text": "rnicke encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 13.828125,
            "text": "nicke encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.828125,
            "text": "encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -3.896484375,
            "end_logit": -4.35546875,
            "text": "oplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -3.896484375,
            "end_logit": -7.484375,
            "text": "oplegia, ataxia, and mental confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -4.35546875,
            "text": "ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -3.896484375,
            "end_logit": -8.5703125,
            "text": "oplegia, ataxia, and",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_14": [
        {
            "start_logit": 11.7890625,
            "end_logit": 12.0546875,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 11.7890625,
            "end_logit": -4.29296875,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 12.0546875,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 11.7890625,
            "end_logit": -7.69921875,
            "text": "ophthalmoplegia, and altered mental status",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": 12.0546875,
            "text": "ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": 11.7890625,
            "end_logit": -8.765625,
            "text": "ophthalmoplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.7890625,
            "end_logit": -9.2578125,
            "text": "ophthalmoplegia, and altered mental",
            "probability": 0.0
        },
        {
            "start_logit": 11.7890625,
            "end_logit": -9.640625,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.0546875,
            "text": "nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 12.0546875,
            "text": "vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.0546875,
            "text": "patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 12.0546875,
            "text": "alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -4.29296875,
            "text": "ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -4.88671875,
            "text": "ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -7.69921875,
            "text": "oplegia, and altered mental status",
            "probability": 0.0
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -8.765625,
            "text": "oplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -4.29296875,
            "text": "nonalcoholic patients, classically presenting with a triad of ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -9.2578125,
            "text": "oplegia, and altered mental",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -4.29296875,
            "text": "vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -4.29296875,
            "text": "patients, classically presenting with a triad of ataxia, ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_15": [
        {
            "start_logit": -7.8203125,
            "end_logit": 10.6796875,
            "text": "ataxia",
            "probability": 0.60400390625
        },
        {
            "start_logit": -9.703125,
            "end_logit": 10.6796875,
            "text": "mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.09197998046875
        },
        {
            "start_logit": -9.90625,
            "end_logit": 10.6796875,
            "text": ", oculomotor dysfunction and ataxia",
            "probability": 0.07501220703125
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 10.6796875,
            "text": "oculomotor dysfunction and ataxia",
            "probability": 0.059814453125
        },
        {
            "start_logit": -10.3125,
            "end_logit": 10.6796875,
            "text": "status changes, oculomotor dysfunction and ataxia",
            "probability": 0.049957275390625
        },
        {
            "start_logit": -10.484375,
            "end_logit": 10.6796875,
            "text": "s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.042083740234375
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 10.6796875,
            "text": "neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.03924560546875
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 10.6796875,
            "text": ";s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.03802490234375
        },
        {
            "start_logit": -9.703125,
            "end_logit": -6.48046875,
            "text": "mental status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -6.48046875,
            "text": "apos;s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -6.48046875,
            "text": ", oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -6.48046875,
            "text": "oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": -6.48046875,
            "text": "status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": -6.48046875,
            "text": "s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -6.48046875,
            "text": "neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -6.48046875,
            "text": ";s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": -8.03125,
            "text": "mental status changes, oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -8.03125,
            "text": "apos;s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -8.03125,
            "text": ", oculomotor dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -8.03125,
            "text": "oculomotor dysfunction",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_16": [
        {
            "start_logit": 13.25,
            "end_logit": 13.3515625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -3.8125,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.421875,
            "end_logit": 13.3515625,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -6.3046875,
            "text": "ophthalmoplegia and nystagmus, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -7.40625,
            "text": "ophthalmoplegia and nystagmus",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -8.3125,
            "text": "ophthalmoplegia and nystagmus, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -8.6796875,
            "text": "ophthalmoplegia and nystagmus,",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -8.71875,
            "text": "ophthalmoplegia and",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -9.1796875,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -9.328125,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -9.6484375,
            "text": "ophthalmoplegia and nystagmus, and ataxia-",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -9.9296875,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 13.3515625,
            "text": "apos;s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 13.3515625,
            "text": "global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3515625,
            "end_logit": 13.3515625,
            "text": "confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 13.3515625,
            "text": ", ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 13.3515625,
            "text": ";s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.3515625,
            "text": "&apos;s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.3515625,
            "text": "-global confusional state, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 13.3515625,
            "text": "Wernicke&apos;s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_17": [
        {
            "start_logit": 10.640625,
            "end_logit": 11.421875,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 11.421875,
            "text": "25/73 (35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -8.8046875,
            "text": "ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 11.421875,
            "text": "apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 11.421875,
            "text": "Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 11.421875,
            "text": "35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -9.515625,
            "text": "ataxia and confusion,",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -9.6875,
            "text": "ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -9.6875,
            "text": "ataxia and confusion, was found",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 11.421875,
            "text": ";s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 11.421875,
            "text": "&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 11.421875,
            "text": "of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 11.421875,
            "text": ", ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 11.421875,
            "text": "s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 11.421875,
            "text": "ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 11.421875,
            "text": "73 (35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 10.640625,
            "end_logit": -10.1796875,
            "text": "ataxia and confusion, was",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -6.9765625,
            "text": "25/73 (35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": -6.9765625,
            "text": "apos;s encephalopathy with ocular symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -6.9765625,
            "text": "Wernicke&apos;s encephalopathy with ocular symptoms",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_18": [
        {
            "start_logit": 13.1796875,
            "end_logit": 13.3515625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": 13.1796875,
            "end_logit": -2.912109375,
            "text": "ophthalmoplegia, and ataxia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1796875,
            "end_logit": -3.92578125,
            "text": "ophthalm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.41015625,
            "end_logit": 13.3515625,
            "text": "oplegia",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 13.3515625,
            "text": "confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": 13.1796875,
            "end_logit": -7.4375,
            "text": "ophthalmoplegia, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1796875,
            "end_logit": -8.0390625,
            "text": "ophthalmoplegia,",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 13.3515625,
            "text": "apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": 13.3515625,
            "text": "0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.3515625,
            "text": ";s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 13.3515625,
            "text": "of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.3515625,
            "text": ", ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.3515625,
            "text": "4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 13.3515625,
            "text": "&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 13.3515625,
            "text": "only 0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 13.3515625,
            "text": "s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.3515625,
            "text": "Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -2.912109375,
            "text": "oplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -2.912109375,
            "text": "confusion, ophthalmoplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -3.92578125,
            "text": "confusion, ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_19": [
        {
            "start_logit": 10.828125,
            "end_logit": 11.65625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": 10.828125,
            "end_logit": -7.9609375,
            "text": "ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": 10.828125,
            "end_logit": -9.2109375,
            "text": "ataxia, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.828125,
            "end_logit": -9.5078125,
            "text": "ataxia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 11.65625,
            "text": "neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.65625,
            "text": "1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": -7.9609375,
            "text": "confusion",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -7.9609375,
            "text": "neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": -7.9609375,
            "text": "1)), classically described as presenting with a triad of ocular abnormalities, ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": -8.6015625,
            "text": "neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": -8.6015625,
            "text": "1)), classically described as presenting with a triad of ocular abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -9.8203125,
            "text": "WE)",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -9.8828125,
            "text": "WE",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -9.9765625,
            "text": "WE) is a serious, potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -10.0,
            "text": "WE) is a serious, potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -9.8203125,
            "text": "apos;s encephalopathy (WE)",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -10.0234375,
            "text": "WE) is a",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -10.03125,
            "text": "WE) is a serious, potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -10.0703125,
            "text": "WE) is a serious, potentially fatal, neurologic disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -9.8828125,
            "text": "apos;s encephalopathy (WE",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_20": [
        {
            "start_logit": 8.4609375,
            "end_logit": 11.390625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 11.390625,
            "text": "mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": 11.390625,
            "text": "ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 11.390625,
            "text": "Wernicke&apos;s encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 11.390625,
            "text": "apos;s encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 11.390625,
            "text": ", ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 11.390625,
            "text": "Only six presented with the Wernicke&apos;s encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -8.3046875,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -8.640625,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9%) confirms",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -9.359375,
            "text": "ataxia) at neurologic onset",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -9.578125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -9.9609375,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9%",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -10.0546875,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -10.0703125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed",
            "probability": 0.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -10.2109375,
            "text": "ataxia) at neurologic onset; nine eventually",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -7.52734375,
            "text": "mental status changes, ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": -7.52734375,
            "text": "ocular signs",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -7.671875,
            "text": "mental status changes, ocular signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": -7.671875,
            "text": "ocular signs, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -7.93359375,
            "text": "mental status changes",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_1": [
        {
            "start_logit": 14.2421875,
            "end_logit": 13.84375,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -0.256103515625,
            "text": "Cdc6/Cdc18",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -1.2333984375,
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -3.30859375,
            "text": "Cdc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -3.568359375,
            "text": "Cdc6/Cdc18, MCM",
            "probability": 0.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -3.763671875,
            "text": "Cdc6/Cdc18, MCM, ORC",
            "probability": 0.0
        },
        {
            "start_logit": -3.86328125,
            "end_logit": 13.84375,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -4.359375,
            "text": "Cdc6/Cdc",
            "probability": 0.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -6.01953125,
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -6.89453125,
            "text": "Cdc6/Cdc18, MCM, ORC and",
            "probability": 0.0
        },
        {
            "start_logit": 14.2421875,
            "end_logit": -7.14453125,
            "text": "Cdc6/Cdc18, MCM, OR",
            "probability": 0.0
        },
        {
            "start_logit": -3.86328125,
            "end_logit": -0.256103515625,
            "text": "6/Cdc18",
            "probability": 0.0
        },
        {
            "start_logit": -3.86328125,
            "end_logit": -1.2333984375,
            "text": "6/Cdc18, MCM, ORC and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -4.890625,
            "end_logit": -1.2333984375,
            "text": "MCM, ORC and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -1.2333984375,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -0.256103515625,
            "text": "Cdc18",
            "probability": 0.0
        },
        {
            "start_logit": -3.86328125,
            "end_logit": -3.568359375,
            "text": "6/Cdc18, MCM",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -1.2333984375,
            "text": "Cdc18, MCM, ORC and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -1.2333984375,
            "text": "ORC and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -3.86328125,
            "end_logit": -3.763671875,
            "text": "6/Cdc18, MCM, ORC",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_2": [
        {
            "start_logit": 14.375,
            "end_logit": 13.8671875,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -3.01171875,
            "text": "Cdc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.375,
            "end_logit": -4.1953125,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -3.744140625,
            "end_logit": 13.8671875,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -5.83984375,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -6.17578125,
            "text": "Cdc6 and the MCM replicative helicase",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -6.875,
            "text": "Cdc6 and the MCM",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -7.10546875,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 13.8671875,
            "text": "ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -7.796875,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -7.84375,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Or",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -8.1015625,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1-6",
            "probability": 0.0
        },
        {
            "start_logit": 14.375,
            "end_logit": -8.2421875,
            "text": "Cdc6 and",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": 13.8671875,
            "text": ", Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 13.8671875,
            "text": "Origin Recognition Complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 13.8671875,
            "text": "Complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.046875,
            "end_logit": 13.8671875,
            "text": "(ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 13.8671875,
            "text": "C), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -3.744140625,
            "end_logit": -4.1953125,
            "text": "6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -3.744140625,
            "end_logit": -5.83984375,
            "text": "6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_3": [
        {
            "start_logit": 14.3359375,
            "end_logit": 14.234375,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": 14.3359375,
            "end_logit": -3.126953125,
            "text": "Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -3.60546875,
            "end_logit": 14.234375,
            "text": "45",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 14.234375,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": 14.3359375,
            "end_logit": -7.5078125,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": 14.234375,
            "text": "DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": 14.234375,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 14.234375,
            "text": "1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": 14.234375,
            "text": "e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -3.203125,
            "text": "MCM",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -3.126953125,
            "text": "Cdt1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -3.203125,
            "text": "minichromosome maintenance complex (MCM",
            "probability": 0.0
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.5078125,
            "text": "45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -4.2734375,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -6.609375,
            "text": "MCM) that plays a key role in the transition of pre-RC to the RC. Similar to other eukaryotes, the Plasmodium genome encodes six MCM subunits",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -3.126953125,
            "text": "DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -3.203125,
            "text": "(MCM",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": -3.126953125,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": -3.126953125,
            "text": "1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -7.2421875,
            "text": "MCM) that plays a key role in the transition of pre-RC to the RC. Similar to other eukaryotes, the Plasmodium genome encodes six MCM",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_4": [
        {
            "start_logit": 14.5859375,
            "end_logit": 13.953125,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -2.572265625,
            "text": "Cdc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -4.078125,
            "text": "Cdc6, and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -3.46484375,
            "end_logit": 13.953125,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -5.1796875,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -5.203125,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2",
            "probability": 0.0
        },
        {
            "start_logit": -4.92578125,
            "end_logit": 13.953125,
            "text": "origin recognition complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -5.68359375,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -6.65234375,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -6.6875,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7) complex",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.07421875,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.14453125,
            "text": "Cdc6, and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.2890625,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.30078125,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.390625,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7)",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 13.953125,
            "text": "ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 13.953125,
            "text": ", Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.0078125,
            "end_logit": 13.953125,
            "text": "C), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": 13.953125,
            "text": "complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": 13.953125,
            "text": "(ORC), Cdc6",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_5": [
        {
            "start_logit": 13.3359375,
            "end_logit": 12.8984375,
            "text": "Cdt1",
            "probability": 1.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -4.4296875,
            "text": "Cdt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 12.8984375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -7.9296875,
            "text": "Cdt1 is",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -8.984375,
            "text": "Cdt1 is the major regulator",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.0859375,
            "text": "Cdt1 is the",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.1640625,
            "text": "Cdt1 is the major",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.40625,
            "text": "Cdt1 is the major regulator in",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.546875,
            "text": "Cdt1 is the major regulator in licensing control",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.7578125,
            "text": "Cdt1 is the major regulator in licensing control for DNA replication.",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -9.7734375,
            "text": "Cdt1 is the major regulator in licensing control for DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -10.0234375,
            "text": "Cdt1 is the major regulator in licensing control for",
            "probability": 0.0
        },
        {
            "start_logit": 13.3359375,
            "end_logit": -10.125,
            "text": "Cdt1 is the major regulator in licensing",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.8984375,
            "text": "pre-replication complex (pre-RC) component Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 12.8984375,
            "text": "higher eukaryotes, the pre-replication complex (pre-RC) component Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 12.8984375,
            "text": "pre-RC) component Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.8984375,
            "text": "replication complex (pre-RC) component Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.8984375,
            "text": "RC) component Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.9296875,
            "text": "1 is",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -8.984375,
            "text": "1 is the major regulator",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_6": [
        {
            "start_logit": 14.09375,
            "end_logit": 14.015625,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -3.578125,
            "text": "Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": 14.015625,
            "text": "45",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 14.015625,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -6.62890625,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -7.2109375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -7.65234375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -8.203125,
            "text": "Cdc45)",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -8.4296875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -8.5078125,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC)",
            "probability": 0.0
        },
        {
            "start_logit": 14.09375,
            "end_logit": -8.5234375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": 14.015625,
            "text": "DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 14.015625,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.4921875,
            "end_logit": 14.015625,
            "text": "1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 14.015625,
            "text": "e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": 14.015625,
            "text": "K and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 14.015625,
            "text": ", DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -3.181640625,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -3.578125,
            "text": "Cdt1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -6.62890625,
            "text": "45) of the eukaryotic cell cycle",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_7": [
        {
            "start_logit": 14.390625,
            "end_logit": 14.1328125,
            "text": "CDC6",
            "probability": 1.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -3.041015625,
            "text": "CDC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.390625,
            "end_logit": -3.44140625,
            "text": "CDC6, CDT1, and MCM2",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": 14.1328125,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -5.62109375,
            "text": "CDC6, CDT1, and MCM2-7",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -6.0,
            "text": "CDC6, CDT1",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -6.04296875,
            "text": "CDC6, CDT1, and MCM",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -7.484375,
            "text": "CDC6, CDT1, and MCM2-",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.078125,
            "text": "CDC6, CDT1, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.46875,
            "text": "CDC6,",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.546875,
            "text": "CDC6, CDT",
            "probability": 0.0
        },
        {
            "start_logit": 14.390625,
            "end_logit": -8.6875,
            "text": "CDC6, CDT1,",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 14.1328125,
            "text": "pre-replication complex (Pre-RC), CDC6",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 14.1328125,
            "text": "RC), CDC6",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 14.1328125,
            "text": "mRNA expression of the components of pre-replication complex (Pre-RC), CDC6",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -3.44140625,
            "text": "6, CDT1, and MCM2",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -5.62109375,
            "text": "6, CDT1, and MCM2-7",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -6.0,
            "text": "6, CDT1",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -6.04296875,
            "text": "6, CDT1, and MCM",
            "probability": 0.0
        },
        {
            "start_logit": -6.3515625,
            "end_logit": -3.44140625,
            "text": "MCM2",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_8": [
        {
            "start_logit": 14.15625,
            "end_logit": 14.1015625,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -3.47265625,
            "text": "Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -3.859375,
            "end_logit": 14.1015625,
            "text": "45",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": 14.1015625,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -6.52734375,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -7.109375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -7.69140625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.1640625,
            "text": "Cdc45)",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.3359375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 0.0
        },
        {
            "start_logit": 14.15625,
            "end_logit": -8.4453125,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 14.1015625,
            "text": "DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.109375,
            "end_logit": 14.1015625,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.2890625,
            "end_logit": 14.1015625,
            "text": "1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": 14.1015625,
            "text": "e.g. Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 14.1015625,
            "text": "K and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 14.1015625,
            "text": ", DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": -2.830078125,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": -3.47265625,
            "text": "Cdt1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -3.859375,
            "end_logit": -6.52734375,
            "text": "45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": -3.859375,
            "end_logit": -7.109375,
            "text": "45) of the eukaryotic cell cycle machinery",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_9": [
        {
            "start_logit": 14.1953125,
            "end_logit": 14.1640625,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -3.4375,
            "text": "Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": 14.1640625,
            "text": "45",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -5.53125,
            "text": "Cdc45)",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 14.1640625,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -6.94921875,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -7.06640625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.0390625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.34375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.546875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -9.046875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC)",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -9.171875,
            "text": "Cdc45) of",
            "probability": 0.0
        },
        {
            "start_logit": -9.15625,
            "end_logit": 14.1640625,
            "text": "DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -9.2421875,
            "text": "Cdc45) of the",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -9.34375,
            "text": "Cdc45) of the eukaryotic cell",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -9.484375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC).",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 14.1640625,
            "text": ", DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 14.1640625,
            "text": "1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 14.1640625,
            "text": "and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 14.1640625,
            "text": "K and Cdc45",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_10": [
        {
            "start_logit": 14.6875,
            "end_logit": 14.234375,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 14.6875,
            "end_logit": -2.3359375,
            "text": "Cdc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 14.234375,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.6875,
            "end_logit": -5.390625,
            "text": "Cdc6, and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": 14.6875,
            "end_logit": -8.3359375,
            "text": "Cdc6, and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": 14.6875,
            "end_logit": -8.3359375,
            "text": "Cdc6, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 14.234375,
            "text": "origin recognition complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 14.234375,
            "text": "prereplicative complex (pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 14.234375,
            "text": "pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 14.234375,
            "text": "plicative complex (pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 14.234375,
            "text": "complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 14.234375,
            "text": "RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -5.390625,
            "text": "6, and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -4.55078125,
            "text": "MCM2-7",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -4.92578125,
            "text": "MCM2",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -8.3359375,
            "text": "6, and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": -3.36328125,
            "end_logit": -8.3359375,
            "text": "6, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": -2.3359375,
            "text": "origin recognition complex, Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -5.97265625,
            "text": "MCM",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -2.3359375,
            "text": "prereplicative complex (pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_11": [
        {
            "start_logit": 14.5078125,
            "end_logit": 14.046875,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -2.78125,
            "text": "Cdc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -3.58203125,
            "text": "Cdc6, Cdt1, and the Mcm2",
            "probability": 0.0
        },
        {
            "start_logit": -3.552734375,
            "end_logit": 14.046875,
            "text": "6",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -4.390625,
            "text": "Cdc6, Cdt1, and the Mcm",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -4.63671875,
            "text": "Cdc6, Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -5.30859375,
            "text": "Cdc6, Cdt1, and the Mcm2-7",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -5.3671875,
            "text": "Cdc6, Cdt1, and the Mcm2-7 complex",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -7.17578125,
            "text": "Cdc6, Cdt",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -7.515625,
            "text": "Cdc6, Cdt1, and the Mcm2-",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 14.046875,
            "text": "ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -8.1953125,
            "text": "Cdc6, Cdt1, and the",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -8.21875,
            "text": "Cdc6, Cdt1, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.5078125,
            "end_logit": -8.484375,
            "text": "Cdc6,",
            "probability": 0.0
        },
        {
            "start_logit": -8.78125,
            "end_logit": 14.046875,
            "text": "origin recognition complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 14.046875,
            "text": ", Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 14.046875,
            "text": "(ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": 14.046875,
            "text": "replicative complex (pre-RC) is formed at all potential origins of replication through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -3.552734375,
            "end_logit": -3.58203125,
            "text": "6, Cdt1, and the Mcm2",
            "probability": 0.0
        },
        {
            "start_logit": -4.23828125,
            "end_logit": -3.58203125,
            "text": "Mcm2",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_1": [
        {
            "start_logit": 11.1875,
            "end_logit": 12.203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -3.11328125,
            "text": "thrombocytopenia, fever",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 11.1875,
            "end_logit": -7.8671875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -8.75,
            "text": "thrombocytopenia, fever,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -8.8046875,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.203125,
            "text": "neurological symptoms, thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.046875,
            "text": "thrombocytopenia, fever, renal failure and",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.2109375,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP.",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.234375,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine points",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.375,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.578125,
            "text": "thrombocytopenia, fever, renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.65625,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a",
            "probability": 0.0
        },
        {
            "start_logit": 11.1875,
            "end_logit": -9.78125,
            "text": "thrombocytopenia, fever, renal failure and hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -3.11328125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -3.11328125,
            "text": "neurological symptoms, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -3.11328125,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -8.75,
            "text": "fever,",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -8.8046875,
            "text": "fever, renal failure and hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -9.046875,
            "text": "fever, renal failure and",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -9.2109375,
            "text": "fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP.",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_2": [
        {
            "start_logit": 11.15625,
            "end_logit": 12.203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -1.759765625,
            "text": "thrombocytopenia, haemolysis, fever",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.1640625,
            "text": "thrombocytopenia, haemolysis, fever, coma",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.296875,
            "text": "thrombocytopenia, haemolysis",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.4765625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.6171875,
            "text": "thrombocytopenia, haemolysis, fever, coma and",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.6953125,
            "text": "thrombocytopenia, haemolysis,",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.8046875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 12.203125,
            "text": "like thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.203125,
            "text": "thrombocytopenia, haemolysis, fever,",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 12.203125,
            "text": "thrombocytopenic purpura like thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.5234375,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a patient after abdominal surgery",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.59375,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure,",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.6171875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a patient after abdominal surgery.",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.796875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -1.759765625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -8.1640625,
            "text": "fever, coma",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": -1.759765625,
            "text": "haemolysis, fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -8.6171875,
            "text": "fever, coma and",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -8.8046875,
            "text": "fever, coma and renal failure",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_3": [
        {
            "start_logit": 11.140625,
            "end_logit": 12.203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -7.1796875,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -7.8671875,
            "text": "thrombocytopenia, neurologic symptoms and renal disease",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 12.203125,
            "text": "microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 12.203125,
            "text": "hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.15625,
            "text": "thrombocytopenia, neurologic symptoms and",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 12.203125,
            "text": "thrombotic thrombocytopenic purpura is a rare disorder with a poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.296875,
            "text": "thrombocytopenia, neurologic",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.203125,
            "text": "thrombocytopenic purpura is a rare disorder with a poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.203125,
            "text": "This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.453125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 12.203125,
            "text": "witz syndrome or thrombotic thrombocytopenic purpura is a rare disorder with a poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.140625,
            "end_logit": -9.546875,
            "text": "thrombocytopenia, neurologic symptoms and renal disease.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.203125,
            "text": "anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 12.203125,
            "text": "poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -7.1796875,
            "text": "neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -7.8671875,
            "text": "neurologic symptoms and renal disease",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -7.1796875,
            "text": "microangiopathic hemolytic anemia with thrombocytopenia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": -7.1796875,
            "text": "hemolytic anemia with thrombocytopenia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -9.15625,
            "text": "neurologic symptoms and",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_4": [
        {
            "start_logit": 11.109375,
            "end_logit": 12.1953125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -7.99609375,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -8.703125,
            "text": "thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.1953125,
            "text": "haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 12.1953125,
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -9.234375,
            "text": "thrombocytopenia, neurological symptoms and renal involvement.",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -9.3984375,
            "text": "thrombocytopenia, neurological symptoms and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 12.1953125,
            "text": "Moschcowitz's syndrome is a rare condition with poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 12.1953125,
            "text": "anaemia associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -9.5,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 12.1953125,
            "text": "witz's syndrome is a rare condition with poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -7.99609375,
            "text": "neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -7.99609375,
            "text": "haemolytic anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -8.703125,
            "text": "neurological symptoms and renal involvement",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": -7.99609375,
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -7.99609375,
            "text": "anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.234375,
            "text": "neurological symptoms and renal involvement.",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": -8.703125,
            "text": "haemolytic anaemia associated with thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.3984375,
            "text": "neurological symptoms and",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -7.99609375,
            "text": "witz's syndrome is a rare condition with poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_5": [
        {
            "start_logit": 11.0390625,
            "end_logit": 12.296875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -2.330078125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -7.8671875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.296875,
            "text": "Thrombotic thrombocytopenic purpura (TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.296875,
            "text": "TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 12.296875,
            "text": "thrombocytopenic purpura (TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.296875,
            "text": "clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.7109375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.75,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.7734375,
            "text": "thrombocytopenia, Coombs-",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.828125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.9765625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -10.0,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -10.0703125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -4.0625,
            "end_logit": -2.330078125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": -2.330078125,
            "text": "neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": -2.330078125,
            "text": "Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -2.330078125,
            "text": "renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -2.330078125,
            "text": "hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -2.330078125,
            "text": "ombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_6": [
        {
            "start_logit": 11.0390625,
            "end_logit": 12.28125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -2.263671875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -8.015625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.28125,
            "text": "Thrombotic thrombocytopenic purpura (TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 12.28125,
            "text": "thrombocytopenic purpura (TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.28125,
            "text": "TTP), in 1924 first described by Moschcowitz, is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.296875,
            "text": "thrombocytopenia, Coombs-",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.8671875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.921875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -9.9296875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes",
            "probability": 0.0
        },
        {
            "start_logit": 11.0390625,
            "end_logit": -10.046875,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -2.263671875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -2.263671875,
            "text": "neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -2.263671875,
            "text": "Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -2.263671875,
            "text": "renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -2.263671875,
            "text": "hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -2.263671875,
            "text": "ombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": -2.263671875,
            "text": "anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": -8.015625,
            "text": "neurologic changes, renal impairment, and",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -8.015625,
            "text": "Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_7": [
        {
            "start_logit": -5.59765625,
            "end_logit": 7.68359375,
            "text": "brain",
            "probability": 0.927734375
        },
        {
            "start_logit": -9.0859375,
            "end_logit": 7.68359375,
            "text": "Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.0283355712890625
        },
        {
            "start_logit": -10.4375,
            "end_logit": 7.68359375,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.0073394775390625
        },
        {
            "start_logit": -10.46875,
            "end_logit": 7.68359375,
            "text": "(TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.007106781005859375
        },
        {
            "start_logit": -10.546875,
            "end_logit": 7.68359375,
            "text": "witz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.006572723388671875
        },
        {
            "start_logit": -10.546875,
            "end_logit": 7.68359375,
            "text": "various organs including the brain",
            "probability": 0.006572723388671875
        },
        {
            "start_logit": -10.65625,
            "end_logit": 7.68359375,
            "text": "purpura (TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.005893707275390625
        },
        {
            "start_logit": -10.703125,
            "end_logit": 7.68359375,
            "text": "the brain",
            "probability": 0.005626678466796875
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 7.68359375,
            "text": "disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.0050811767578125
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -7.59765625,
            "text": "Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -7.84375,
            "text": "Moschcowitz disease)",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -8.3359375,
            "text": "Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic",
            "probability": 0.0
        },
        {
            "start_logit": -9.9140625,
            "end_logit": -7.84375,
            "text": "Thrombotic thrombocytopenic purpura (TTP, Moschcowitz disease)",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": -7.59765625,
            "text": "thrombocytopenic purpura (TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -7.59765625,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -7.59765625,
            "text": "(TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": -7.84375,
            "text": "thrombocytopenic purpura (TTP, Moschcowitz disease)",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -9.0390625,
            "text": "Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -7.59765625,
            "text": "witz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": -7.59765625,
            "text": "various organs including the",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_8": [
        {
            "start_logit": 11.1015625,
            "end_logit": 12.2265625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -3.9609375,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -7.65234375,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 12.2265625,
            "text": "thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 12.2265625,
            "text": "thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.2265625,
            "text": "TTP), a disorder presenting with thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -9.578125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -9.6953125,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -9.78125,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -9.84375,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -10.0,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -10.0078125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 11.1015625,
            "end_logit": -10.015625,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -3.9609375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": -3.9609375,
            "text": "microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": -3.9609375,
            "text": "haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -3.9609375,
            "text": "neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -3.9609375,
            "text": "anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -3.9609375,
            "text": "TTP), a disorder presenting with thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": -3.9609375,
            "text": "renal failure, and fever",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_9": [
        {
            "start_logit": 10.9765625,
            "end_logit": 12.3671875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -5.76171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -8.1640625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -8.90625,
            "text": "thrombocytopenia,",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.3671875,
            "text": "Thrombotic thrombocytopenic purpura (TTP) is a syndrome that occurs mainly in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.3671875,
            "text": "TTP) is a syndrome that occurs mainly in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.3671875,
            "text": "thrombocytopenic purpura (TTP) is a syndrome that occurs mainly in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.1328125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.3125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.4140625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.6640625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.9296875,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.953125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -5.76171875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -5.76171875,
            "text": "neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -5.76171875,
            "text": "microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -5.76171875,
            "text": "hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -5.76171875,
            "text": "renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -9.3125,
            "text": "fever.",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_1": [
        {
            "start_logit": 13.0625,
            "end_logit": 12.5859375,
            "text": "rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -4.265625,
            "text": "ro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.0625,
            "end_logit": -5.78515625,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": 12.5859375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -6.421875,
            "text": "rofecox",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -7.859375,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -8.078125,
            "text": "rofe",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -8.4453125,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valde",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 12.5859375,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.1484375,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.1640625,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.2109375,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecox",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.421875,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, val",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.640625,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 12.5859375,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.7265625,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib was",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.796875,
            "text": "rofecoxib was voluntarily removed from the",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.796875,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005,",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.8984375,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.921875,
            "text": "rofecoxib was voluntarily removed from the market",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_2": [
        {
            "start_logit": 14.109375,
            "end_logit": 14.109375,
            "text": "clobutinol",
            "probability": 1.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -3.4453125,
            "text": "clo",
            "probability": 0.0
        },
        {
            "start_logit": -3.447265625,
            "end_logit": 14.109375,
            "text": "inol",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -6.92578125,
            "text": "clobut",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 14.109375,
            "text": "non-opioid antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -8.03125,
            "text": "clobutinol,",
            "probability": 0.0
        },
        {
            "start_logit": -9.21875,
            "end_logit": 14.109375,
            "text": "over-the-counter (OTC) non-opioid antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -9.2890625,
            "end_logit": 14.109375,
            "text": "antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 14.109375,
            "text": "butinol",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -9.3671875,
            "text": "clobutinol, was recently",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -9.40625,
            "text": "clobutinol, was recently withdrawn from the market due to its",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -9.5078125,
            "text": "clobutinol, was",
            "probability": 0.0
        },
        {
            "start_logit": -9.7734375,
            "end_logit": 14.109375,
            "text": "ussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 14.109375,
            "text": "OTC) non-opioid antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 14.109375,
            "text": "opioid antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 14.109375,
            "text": "common over-the-counter (OTC) non-opioid antitussive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 14.109375,
            "text": "ive drug, clobutinol",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -3.4453125,
            "text": "non-opioid antitussive drug, clo",
            "probability": 0.0
        },
        {
            "start_logit": -3.447265625,
            "end_logit": -8.03125,
            "text": "inol,",
            "probability": 0.0
        },
        {
            "start_logit": -9.21875,
            "end_logit": -3.4453125,
            "text": "over-the-counter (OTC) non-opioid antitussive drug, clo",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_3": [
        {
            "start_logit": 12.3515625,
            "end_logit": 12.6875,
            "text": "sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": 12.6875,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 12.6875,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -5.52734375,
            "text": "sib",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 12.6875,
            "text": "at (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -7.61328125,
            "text": "sibutr",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 12.6875,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 12.6875,
            "text": "listat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -8.90625,
            "text": "sibutramine having",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.6875,
            "text": "; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 12.3515625,
            "end_logit": -9.5546875,
            "text": "sibutramine having recently",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 12.6875,
            "text": "obesity, with sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": -0.55322265625,
            "text": "orlistat",
            "probability": 0.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": -5.52734375,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sib",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -0.55322265625,
            "text": "at",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -0.55322265625,
            "text": "listat",
            "probability": 0.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": -6.5,
            "text": "or",
            "probability": 0.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": -6.58984375,
            "text": "orlist",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -0.55322265625,
            "text": "this, at the time of writing orlistat",
            "probability": 0.0
        },
        {
            "start_logit": -2.650390625,
            "end_logit": -7.52734375,
            "text": "orlistat (Europe; USA)",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_4": [
        {
            "start_logit": 11.1171875,
            "end_logit": 10.7109375,
            "text": "rofecoxib",
            "probability": 0.9990234375
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 10.7109375,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0014333724975585938
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 4.07421875,
            "text": "Diclofenac",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -5.05859375,
            "text": "ro",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.36328125,
            "text": "rofecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.88671875,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -7.34375,
            "text": "rofe",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 10.7109375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.1328125,
            "text": "rofecoxib,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.46875,
            "text": "rofecoxib, which was withdrawn from worldwide markets",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.5703125,
            "text": "rofecoxib, which was withdrawn from worldwide",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6171875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6953125,
            "text": "rofecoxib, which was",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.75,
            "text": "rofecoxib, which",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.7734375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.9375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 10.7109375,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -10.1640625,
            "text": "rofecoxib, which was withdrawn",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 10.7109375,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 10.7109375,
            "text": "coxib",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_5": [
        {
            "start_logit": 13.0,
            "end_logit": 13.0703125,
            "text": "Sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": 13.0703125,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -5.2109375,
            "text": "Sib",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -7.80859375,
            "text": "Sibutr",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 13.0703125,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -8.71875,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and it",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -8.8828125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.2890625,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.484375,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT)",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.75,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.78125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.921875,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and it was",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -9.984375,
            "text": "Sibutramine was",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -10.1015625,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sib",
            "probability": 0.0
        },
        {
            "start_logit": 13.0,
            "end_logit": -10.1796875,
            "text": "Sibutramine was associated with an",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -8.71875,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and it",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -8.8828125,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -9.2890625,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -9.484375,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT)",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -9.75,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_6": [
        {
            "start_logit": 14.3515625,
            "end_logit": 13.921875,
            "text": "aprotinin",
            "probability": 1.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -3.34375,
            "text": "apr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.6796875,
            "end_logit": 13.921875,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 13.921875,
            "text": "otinin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -6.08203125,
            "text": "aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -6.9921875,
            "text": "Cochrane Injuries Groups",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.23046875,
            "text": "Cochrane Injuries Groups Specialised Register",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": -6.08203125,
            "text": "anti-fibrinolytic drugs aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.30859375,
            "text": "Cochrane Injuries Groups Specialised Register (July 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 3",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -7.86328125,
            "text": "tranexamic acid",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -6.08203125,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.1484375,
            "text": "tranexamic acid (TXA), and epsilon aminocaproic acid (EAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.81640625,
            "text": "Cochrane Injuries Groups Specialised Register (July 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 3), MEDLINE",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.8671875,
            "text": "Cochrane Injuries",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.3671875,
            "text": "tranexamic acid (TXA",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -6.08203125,
            "text": "drugs aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.515625,
            "text": "trane",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.5625,
            "text": "tra",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.609375,
            "text": "tranexamic",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": -6.9921875,
            "text": "renal dysfunction, and death.We searched: the Cochrane Injuries Groups",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_7": [
        {
            "start_logit": 14.3515625,
            "end_logit": 13.921875,
            "text": "aprotinin",
            "probability": 1.0
        },
        {
            "start_logit": 14.3515625,
            "end_logit": -3.34375,
            "text": "apr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.6796875,
            "end_logit": 13.921875,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 13.921875,
            "text": "otinin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -6.08203125,
            "text": "aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -6.9921875,
            "text": "Cochrane Injuries Groups",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.23046875,
            "text": "Cochrane Injuries Groups Specialised Register",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": -6.08203125,
            "text": "anti-fibrinolytic drugs aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.30859375,
            "text": "Cochrane Injuries Groups Specialised Register (July 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 3",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -7.86328125,
            "text": "tranexamic acid",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -6.08203125,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.1484375,
            "text": "tranexamic acid (TXA), and epsilon aminocaproic acid (EAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.81640625,
            "text": "Cochrane Injuries Groups Specialised Register (July 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 3), MEDLINE",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.8671875,
            "text": "Cochrane Injuries",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.3671875,
            "text": "tranexamic acid (TXA",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -6.08203125,
            "text": "drugs aprotinin",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.515625,
            "text": "trane",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.5625,
            "text": "tra",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -8.609375,
            "text": "tranexamic",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": -6.9921875,
            "text": "renal dysfunction, and death.We searched: the Cochrane Injuries Groups",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_8": [
        {
            "start_logit": 13.078125,
            "end_logit": 12.9375,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -4.3828125,
            "text": "Ro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 12.9375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -6.80859375,
            "text": "Rofecoxib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -7.62890625,
            "text": "Rofecox",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -7.87109375,
            "text": "Rofe",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -8.203125,
            "text": "Rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -9.1015625,
            "text": "Rofecoxib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events)",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 12.9375,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -9.2109375,
            "end_logit": 12.9375,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -9.3984375,
            "text": "Rofecoxib and valdeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -9.421875,
            "text": "Rofecoxib and valde",
            "probability": 0.0
        },
        {
            "start_logit": 13.078125,
            "end_logit": -9.65625,
            "text": "Rofecoxib and valdecoxib have been withdrawn from the market worldwide",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 12.9375,
            "text": "coxib",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -6.80859375,
            "text": "ib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -8.28125,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumira",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -6.0,
            "text": "lumiracoxib",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -6.4140625,
            "text": "lumiracoxib has been withdrawn in many countries due to liver toxicity",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -9.1015625,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events)",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -9.3984375,
            "text": "ib and valdeco",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_9": [
        {
            "start_logit": 13.5,
            "end_logit": 12.7109375,
            "text": "Sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -4.19140625,
            "text": "Sib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.5,
            "end_logit": -4.390625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.5,
            "end_logit": -5.66796875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 12.7109375,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -7.05078125,
            "text": "Sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -7.48046875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -7.57421875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -8.296875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -8.6484375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.359375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and was",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.4921875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial",
            "probability": 0.0
        },
        {
            "start_logit": -8.8203125,
            "end_logit": 12.7109375,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.6953125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -9.8125,
            "text": "Sibutramine Cardiovascular OUTcomes)",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 12.7109375,
            "text": "SCOUT (Sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.046875,
            "text": "Sibutramine Cardiovascular OUTcomes) study,",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.0546875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo,",
            "probability": 0.0
        },
        {
            "start_logit": 13.5,
            "end_logit": -10.078125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -4.390625,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_10": [
        {
            "start_logit": 11.1171875,
            "end_logit": 10.7109375,
            "text": "rofecoxib",
            "probability": 0.9990234375
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 10.7109375,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0014333724975585938
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 4.07421875,
            "text": "Diclofenac",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -5.05859375,
            "text": "ro",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.36328125,
            "text": "rofecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.88671875,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -7.34375,
            "text": "rofe",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 10.7109375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.1328125,
            "text": "rofecoxib,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.46875,
            "text": "rofecoxib, which was withdrawn from worldwide markets",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.5703125,
            "text": "rofecoxib, which was withdrawn from worldwide",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6171875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6953125,
            "text": "rofecoxib, which was",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.75,
            "text": "rofecoxib, which",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.7734375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.9375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 10.7109375,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -10.1640625,
            "text": "rofecoxib, which was withdrawn",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 10.7109375,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 10.7109375,
            "text": "coxib",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_11": [
        {
            "start_logit": 13.421875,
            "end_logit": 13.21875,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -4.06640625,
            "text": "Ro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 13.21875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -6.03515625,
            "text": "Rofecoxib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -7.48046875,
            "text": "Rofecox",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -7.6484375,
            "text": "Rofe",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -8.1796875,
            "text": "Rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -9.0234375,
            "text": "Rofecoxib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events)",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -9.0859375,
            "text": "Rofecoxib and valde",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 13.21875,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -9.1875,
            "text": "Rofecoxib and valdeco",
            "probability": 0.0
        },
        {
            "start_logit": -9.2734375,
            "end_logit": 13.21875,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -9.5546875,
            "text": "Rofecoxib and val",
            "probability": 0.0
        },
        {
            "start_logit": 13.421875,
            "end_logit": -9.6015625,
            "text": "Rofecoxib and valdecoxib have been withdrawn from the market worldwide",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 13.21875,
            "text": "coxib",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -6.03515625,
            "text": "ib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -5.15625,
            "text": "lumiracoxib",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -7.7578125,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumira",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -5.15625,
            "text": "valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumiracoxib",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -9.0234375,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events)",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_12": [
        {
            "start_logit": 13.2421875,
            "end_logit": 13.9921875,
            "text": "Sertindole",
            "probability": 1.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": 13.9921875,
            "text": "indole",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -4.87109375,
            "text": "Sert",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.1640625,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns,",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.296875,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.34375,
            "text": "Sertindole ,",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.359375,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.578125,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.6015625,
            "text": "Sertindole , first withdrawn from the",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.734375,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries.",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.7578125,
            "text": "Sertindole , first withdrawn from the market",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -9.7734375,
            "text": "Sertindole , first",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -10.109375,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -10.265625,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is",
            "probability": 0.0
        },
        {
            "start_logit": 13.2421875,
            "end_logit": -10.3046875,
            "text": "Sertindole , first withdrawn",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -9.1640625,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns,",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -9.296875,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -9.34375,
            "text": "indole ,",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -9.359375,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -9.578125,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_13": [
        {
            "start_logit": 12.609375,
            "end_logit": 12.484375,
            "text": "Sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -0.9228515625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 12.609375,
            "end_logit": -4.03125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.609375,
            "end_logit": -4.98046875,
            "text": "Sib",
            "probability": 0.0
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 12.484375,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -6.7109375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -7.3203125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -7.41796875,
            "text": "Sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -7.71875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -8.125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo",
            "probability": 0.0
        },
        {
            "start_logit": 12.609375,
            "end_logit": -9.1484375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": 12.484375,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 12.484375,
            "text": "SCOUT (Sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -4.91015625,
            "end_logit": -0.9228515625,
            "text": "sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -5.16015625,
            "end_logit": -0.9228515625,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -0.9228515625,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": -4.91015625,
            "end_logit": -4.03125,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": -5.16015625,
            "end_logit": -4.03125,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -0.9228515625,
            "text": "utramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -4.03125,
            "text": "myocardial infarction",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_14": [
        {
            "start_logit": 11.390625,
            "end_logit": 11.6796875,
            "text": "rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": -4.234375,
            "end_logit": 11.6796875,
            "text": "non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.390625,
            "end_logit": -4.65234375,
            "text": "ro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 11.6796875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -5.859375,
            "text": "rofecox",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -7.05078125,
            "text": "rofe",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -7.140625,
            "text": "rofecoxib [Vioxx]) increase the risk of heart attack and stroke",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -7.57421875,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 11.6796875,
            "text": "NSAIDs) (e.g., rofecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -8.0546875,
            "text": "rofecoxib [Vioxx",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -8.078125,
            "text": "rofecoxib [Vioxx]) increase the risk of heart attack",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -8.125,
            "text": "rofecoxib [Vioxx])",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -8.421875,
            "text": "rofecoxib [Vioxx]",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -9.0,
            "text": "rofecoxib [Vioxx]) increase",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -9.046875,
            "text": "rofecoxib [Vi",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": 11.6796875,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 11.390625,
            "end_logit": -9.3515625,
            "text": "rofecoxib [Vioxx]) increase the risk of heart attack and stroke and should be avoided in patients at high risk",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": 11.6796875,
            "text": "e.g., rofecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": 11.6796875,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 11.6796875,
            "text": "steroidal anti-inflammatory drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_15": [
        {
            "start_logit": 13.71875,
            "end_logit": 12.9921875,
            "text": "Sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -3.666015625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.71875,
            "end_logit": -3.98828125,
            "text": "Sib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.71875,
            "end_logit": -5.22265625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": -5.08203125,
            "end_logit": 12.9921875,
            "text": "amine",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -6.92578125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -6.96875,
            "text": "Sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -7.015625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -8.03125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -8.25,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutr",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.2421875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.3515625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and was",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 12.9921875,
            "text": "SCOUT (Sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -8.8359375,
            "end_logit": 12.9921875,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.7109375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.8984375,
            "text": "Sibutramine Cardiovascular OUTcomes)",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -9.921875,
            "text": "Sibutramine Cardiovascular OUTcomes) study,",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -10.015625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -10.0625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or",
            "probability": 0.0
        },
        {
            "start_logit": 13.71875,
            "end_logit": -10.078125,
            "text": "Sibutramine Cardiovascular OUTcomes) study",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_16": [
        {
            "start_logit": 11.1171875,
            "end_logit": 10.7109375,
            "text": "rofecoxib",
            "probability": 0.9990234375
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 10.7109375,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0014333724975585938
        },
        {
            "start_logit": 4.56640625,
            "end_logit": 4.07421875,
            "text": "Diclofenac",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -5.05859375,
            "text": "ro",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.36328125,
            "text": "rofecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -6.88671875,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -7.34375,
            "text": "rofe",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 10.7109375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.1328125,
            "text": "rofecoxib,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.46875,
            "text": "rofecoxib, which was withdrawn from worldwide markets",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.5703125,
            "text": "rofecoxib, which was withdrawn from worldwide",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6171875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.6953125,
            "text": "rofecoxib, which was",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.75,
            "text": "rofecoxib, which",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.7734375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -9.9375,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 10.7109375,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 11.1171875,
            "end_logit": -10.1640625,
            "text": "rofecoxib, which was withdrawn",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": 10.7109375,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 10.7109375,
            "text": "coxib",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_17": [
        {
            "start_logit": 13.390625,
            "end_logit": 12.90625,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -3.9296875,
            "text": "Ro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 12.90625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -6.90625,
            "text": "Rofecox",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.52734375,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.1015625,
            "text": "Rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.2578125,
            "text": "Rofe",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.3125,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.40625,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.609375,
            "text": "Rofecoxib, a selective",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.671875,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.046875,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor, was a widely marketed drug",
            "probability": 0.0
        },
        {
            "start_logit": -8.765625,
            "end_logit": 12.90625,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.2578125,
            "text": "Rofecoxib, a",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": 12.90625,
            "text": "xib",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.578125,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor, was a widely marketed drug that was used for relief of pain",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.59375,
            "text": "Rofecoxib,",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 12.90625,
            "text": "coxib",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -7.52734375,
            "text": "ib, a selective cyclo-oxygenase (COX)-2 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -8.3125,
            "text": "ib, a selective cyclo-oxygenase (COX)-2",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_1": [
        {
            "start_logit": 10.875,
            "end_logit": 9.9609375,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 0.8271484375
        },
        {
            "start_logit": 9.078125,
            "end_logit": 9.9609375,
            "text": "lymphoedema",
            "probability": 0.135009765625
        },
        {
            "start_logit": 10.875,
            "end_logit": 6.77734375,
            "text": "lymphoedema cholestasis",
            "probability": 0.03411865234375
        },
        {
            "start_logit": 10.875,
            "end_logit": 4.55078125,
            "text": "lymphoedema",
            "probability": 0.00365447998046875
        },
        {
            "start_logit": 10.875,
            "end_logit": -4.984375,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.203125,
            "end_logit": 9.9609375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.875,
            "end_logit": -5.78515625,
            "text": "lympho",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.875,
            "end_logit": -5.83203125,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lympho",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.875,
            "end_logit": -7.41796875,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1)",
            "probability": 0.0
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.83203125,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -7.64453125,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 9.9609375,
            "text": "chronic lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 9.9609375,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.3359375,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.9609375,
            "text": "severe chronic lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.46875,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.8203125,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic",
            "probability": 0.0
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.3046875,
            "text": "lymphoedema, mainly affecting the lower extremities",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.15625,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and",
            "probability": 0.0
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.2109375,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1),",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_2": [
        {
            "start_logit": 9.1015625,
            "end_logit": 7.1875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.93505859375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": 4.515625,
            "text": "neonatal intrahepatic cholestasis",
            "probability": 0.06512451171875
        },
        {
            "start_logit": -0.150390625,
            "end_logit": 7.1875,
            "text": "severe chronic lymphedema",
            "probability": 9.059906005859375e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 7.1875,
            "text": "lymphedema",
            "probability": 3.7729740142822266e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.76171875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.25,
            "text": "neonatal",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.73046875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -4.54296875,
            "end_logit": 7.1875,
            "text": "chronic lymphedema",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.96875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.62109375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.68359375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.140625,
            "text": "neonatal intrahepatic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.4140625,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.609375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.1875,
            "text": "cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.921875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 7.1875,
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 4.515625,
            "text": "Lymphedema-cholestasis syndrome (LCS; Aagenaes syndrome) is a rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.265625,
            "end_logit": 7.1875,
            "text": ") neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 7.1875,
            "text": "2) severe chronic lymphedema",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_3": [
        {
            "start_logit": 12.703125,
            "end_logit": 12.6484375,
            "text": "lymphoedema cholestasis",
            "probability": 1.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": 2.91796875,
            "text": "lymphoedema",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 12.703125,
            "end_logit": -3.8359375,
            "text": "lympho",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.7890625,
            "end_logit": 12.6484375,
            "text": "cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -7.63671875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -7.64453125,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.34375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes?",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.7578125,
            "text": "lymphoedema cholestasis syndrome 1",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 12.6484375,
            "text": "Do patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.203125,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.2109375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.234375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholest",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.34375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 12.6484375,
            "text": "edema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.5859375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.9375,
            "text": "lymphoedema cholestasis syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -10.046875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 12.6484375,
            "text": "patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 2.91796875,
            "text": "Do patients with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 2.91796875,
            "text": "edema",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_4": [
        {
            "start_logit": 13.296875,
            "end_logit": 11.9609375,
            "text": "lymphoedema cholestasis",
            "probability": 0.9990234375
        },
        {
            "start_logit": 13.296875,
            "end_logit": 5.0234375,
            "text": "lymphoedema",
            "probability": 0.0009698867797851562
        },
        {
            "start_logit": 13.296875,
            "end_logit": -3.521484375,
            "text": "lympho",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.16796875,
            "end_logit": 11.9609375,
            "text": "cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -7.3125,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -7.8671875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -8.6484375,
            "text": "lymphoedema cholestasis syndrome 1",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -8.71875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.0625,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholest",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.1015625,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic.",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.3046875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.46875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.6875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.734375,
            "text": "lymphoedema cholestasis syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -9.9375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when",
            "probability": 0.0
        },
        {
            "start_logit": 13.296875,
            "end_logit": -10.1328125,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": 11.9609375,
            "text": "edema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 11.9609375,
            "text": "BACKGROUND & AIMS: Patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 11.9609375,
            "text": ": Patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.9375,
            "end_logit": 11.9609375,
            "text": "Patients with lymphoedema cholestasis",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_5": [
        {
            "start_logit": 13.828125,
            "end_logit": 13.3515625,
            "text": "Lymphedema Cholestasis",
            "probability": 1.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -1.568359375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.15625,
            "text": "Lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.611328125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 13.3515625,
            "text": "Cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.5234375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.921875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1)",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.9296875,
            "text": "Lymphedema Cholestasis Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.6796875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.6953125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1),",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.7421875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.84765625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.94140625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.1015625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.4140625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.53125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.734375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.7421875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.75,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.8671875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_6": [
        {
            "start_logit": 13.828125,
            "end_logit": 13.3515625,
            "text": "Lymphedema Cholestasis",
            "probability": 1.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -1.568359375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.15625,
            "text": "Lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.828125,
            "end_logit": -3.611328125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 13.3515625,
            "text": "Cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.5234375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.921875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1)",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -6.9296875,
            "text": "Lymphedema Cholestasis Syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.6796875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.6953125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1),",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.7421875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.84765625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -7.94140625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.1015625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.4140625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.53125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.734375,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.7421875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.75,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic",
            "probability": 0.0
        },
        {
            "start_logit": 13.828125,
            "end_logit": -8.8671875,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_7": [
        {
            "start_logit": 13.1484375,
            "end_logit": 12.5234375,
            "text": "infantile cholestasis",
            "probability": 0.984375
        },
        {
            "start_logit": 13.1484375,
            "end_logit": 8.3515625,
            "text": "infantile cholestasis with lymphoedema",
            "probability": 0.01519012451171875
        },
        {
            "start_logit": 6.25,
            "end_logit": 8.3515625,
            "text": "lymphoedema",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -4.15625,
            "text": "infantile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -5.34375,
            "text": "infantile cholestasis with lympho",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 12.5234375,
            "text": "cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -6.4609375,
            "text": "infantile cholestasis with",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.40625,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.62109375,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.984375,
            "text": "infantile cholestasis with lymphoedema (",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 8.3515625,
            "text": "cholestasis with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 8.3515625,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -5.34375,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.40625,
            "text": "lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.62109375,
            "text": "lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -8.984375,
            "text": "lymphoedema (",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -5.34375,
            "text": "cholestasis with lympho",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -6.4609375,
            "text": "cholestasis with",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -7.40625,
            "text": "cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -7.62109375,
            "text": "cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_8": [
        {
            "start_logit": 9.7421875,
            "end_logit": 6.84765625,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lymphoedema",
            "probability": 0.578125
        },
        {
            "start_logit": 9.7421875,
            "end_logit": 6.46484375,
            "text": "neonatal cholestasis",
            "probability": 0.391357421875
        },
        {
            "start_logit": 6.875,
            "end_logit": 6.46484375,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1)), which is an autosomal recessive inherited syndrome consisting of neonatal cholestasis",
            "probability": 0.022430419921875
        },
        {
            "start_logit": 6.875,
            "end_logit": 5.08984375,
            "text": "lymphoedema",
            "probability": 0.00566864013671875
        },
        {
            "start_logit": 4.31640625,
            "end_logit": 6.84765625,
            "text": "lymphoedema",
            "probability": 0.0025348663330078125
        },
        {
            "start_logit": 6.875,
            "end_logit": 0.2137451171875,
            "text": "lymphoedema cholestasis",
            "probability": 4.3272972106933594e-05
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -5.18359375,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lympho",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -5.73828125,
            "text": "neonatal",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -5.8125,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.875,
            "end_logit": -4.625,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1))",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.875,
            "end_logit": -5.73828125,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1)), which is an autosomal recessive inherited syndrome consisting of neonatal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.875,
            "end_logit": -6.06640625,
            "text": "lympho",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.9765625,
            "text": "neonatal cholestasis with intermittent cholestatic episodes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -9.0625,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -9.28125,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.875,
            "end_logit": -6.48046875,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -9.46875,
            "text": "neonatal cholestasis with intermittent cholestatic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.31640625,
            "end_logit": -5.18359375,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.84765625,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 6.875,
            "end_logit": -8.2265625,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_9": [
        {
            "start_logit": 9.1015625,
            "end_logit": 7.1875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.93505859375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": 4.515625,
            "text": "neonatal intrahepatic cholestasis",
            "probability": 0.06512451171875
        },
        {
            "start_logit": -0.150390625,
            "end_logit": 7.1875,
            "text": "severe chronic lymphedema",
            "probability": 9.059906005859375e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 7.1875,
            "text": "lymphedema",
            "probability": 3.7729740142822266e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.76171875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.25,
            "text": "neonatal",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.73046875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -4.54296875,
            "end_logit": 7.1875,
            "text": "chronic lymphedema",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.96875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.62109375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.68359375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.140625,
            "text": "neonatal intrahepatic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.4140625,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.609375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.1875,
            "text": "cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -9.921875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 7.1875,
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 4.515625,
            "text": "Lymphedema-cholestasis syndrome (LCS; Aagenaes syndrome) is a rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.265625,
            "end_logit": 7.1875,
            "text": ") neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 7.1875,
            "text": "2) severe chronic lymphedema",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_10": [
        {
            "start_logit": 13.1484375,
            "end_logit": 12.5234375,
            "text": "infantile cholestasis",
            "probability": 0.984375
        },
        {
            "start_logit": 13.1484375,
            "end_logit": 8.3515625,
            "text": "infantile cholestasis with lymphoedema",
            "probability": 0.01519012451171875
        },
        {
            "start_logit": 6.25,
            "end_logit": 8.3515625,
            "text": "lymphoedema",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -4.15625,
            "text": "infantile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -5.34375,
            "text": "infantile cholestasis with lympho",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 12.5234375,
            "text": "cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -6.4609375,
            "text": "infantile cholestasis with",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.40625,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.62109375,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.984375,
            "text": "infantile cholestasis with lymphoedema (",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 8.3515625,
            "text": "cholestasis with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 8.3515625,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -5.34375,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.40625,
            "text": "lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.62109375,
            "text": "lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -8.984375,
            "text": "lymphoedema (",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -5.34375,
            "text": "cholestasis with lympho",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -6.4609375,
            "text": "cholestasis with",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -7.40625,
            "text": "cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -7.62109375,
            "text": "cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 0.0
        }
    ],
    "5536554abc4f83e828000008_1": [
        {
            "start_logit": 13.6796875,
            "end_logit": 12.9453125,
            "text": "D22S1",
            "probability": 1.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -1.0322265625,
            "text": "D22S1 and D22S15",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -3.029296875,
            "text": "D2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -5.8984375,
            "text": "D22S1 and D2",
            "probability": 0.0
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 12.9453125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -6.34375,
            "text": "D22S1 and D22S",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -6.875,
            "text": "D22S",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -7.70703125,
            "text": "D22S1 and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -8.4765625,
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -9.03125,
            "text": "D22S1 and D22S15,",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 12.9453125,
            "text": "2S1",
            "probability": 0.0
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -9.8046875,
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.9453125,
            "text": "recurrent translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 12.9453125,
            "text": "neuroepithelioma has been localized between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 12.9453125,
            "text": "between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -1.0322265625,
            "text": "D22S15",
            "probability": 0.0
        },
        {
            "start_logit": -5.56640625,
            "end_logit": -1.0322265625,
            "text": "1 and D22S15",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -5.8984375,
            "text": "D2",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -6.34375,
            "text": "D22S",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -1.0322265625,
            "text": "2S1 and D22S15",
            "probability": 0.0
        }
    ],
    "5536554abc4f83e828000008_2": [
        {
            "start_logit": 13.7109375,
            "end_logit": 13.015625,
            "text": "D22S1",
            "probability": 1.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -1.1337890625,
            "text": "D22S1 and D22S15",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -3.09765625,
            "text": "D2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.015625,
            "text": "D22S1 and D2",
            "probability": 0.0
        },
        {
            "start_logit": -5.484375,
            "end_logit": 13.015625,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.375,
            "text": "D22S1 and D22S",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -6.90234375,
            "text": "D22S",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -7.6484375,
            "text": "D22S1 and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -8.3984375,
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.015625,
            "text": "D22S1 and D22S15,",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 13.015625,
            "text": "2S1",
            "probability": 0.0
        },
        {
            "start_logit": 13.7109375,
            "end_logit": -9.734375,
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 13.015625,
            "text": "recurrent translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 13.015625,
            "text": "between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 13.015625,
            "text": "22 of neuroepithelioma has been localized between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.015625,
            "text": "neuroepithelioma has been localized between two probes, D22S1",
            "probability": 0.0
        },
        {
            "start_logit": -1.7255859375,
            "end_logit": -1.1337890625,
            "text": "D22S15",
            "probability": 0.0
        },
        {
            "start_logit": -5.484375,
            "end_logit": -1.1337890625,
            "text": "1 and D22S15",
            "probability": 0.0
        },
        {
            "start_logit": -1.7255859375,
            "end_logit": -6.015625,
            "text": "D2",
            "probability": 0.0
        },
        {
            "start_logit": -1.7255859375,
            "end_logit": -6.375,
            "text": "D22S",
            "probability": 0.0
        }
    ],
    "535d69177d100faa09000003_1": [
        {
            "start_logit": 12.3203125,
            "end_logit": 11.4296875,
            "text": "duodenal ulcer",
            "probability": 1.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -4.5625,
            "text": "duodenal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -6.140625,
            "text": "duodenal ulcer (DU",
            "probability": 0.0
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 11.4296875,
            "text": "ulcer",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -7.83984375,
            "text": "duodenal ulcer (DU)",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": 11.4296875,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": 12.3203125,
            "end_logit": -8.65625,
            "text": "duodenal ulcer (",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 11.4296875,
            "text": "electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.4296875,
            "text": "103 patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 11.4296875,
            "text": "patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 11.4296875,
            "text": "modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 11.4296875,
            "text": "SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -4.5625,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -4.5625,
            "text": "electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal",
            "probability": 0.0
        },
        {
            "start_logit": -6.7890625,
            "end_logit": -6.140625,
            "text": "ulcer (DU",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.140625,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (DU",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.140625,
            "text": "DU",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.74609375,
            "text": "low-frequency modulated electric current",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -4.5625,
            "text": "103 patients with duodenal",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -6.140625,
            "text": "electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (DU",
            "probability": 0.0
        }
    ],
    "535d69177d100faa09000003_2": [
        {
            "start_logit": 3.390625,
            "end_logit": 9.03125,
            "text": "nocturnal enuresis",
            "probability": 0.98291015625
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": 9.03125,
            "text": "enuresis",
            "probability": 0.016510009765625
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 9.03125,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 0.00016582012176513672
        },
        {
            "start_logit": -5.65625,
            "end_logit": 9.03125,
            "text": "neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 0.0001157522201538086
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 9.03125,
            "text": "children with nocturnal enuresis",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.03125,
            "text": "uresis",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -9.515625,
            "end_logit": 9.03125,
            "text": "bladder in children with nocturnal enuresis",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -9.609375,
            "end_logit": 9.03125,
            "text": "with nocturnal enuresis",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 9.03125,
            "text": "of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 9.03125,
            "text": "SCENAR) as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 3.390625,
            "end_logit": -7.734375,
            "text": "nocturnal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.390625,
            "end_logit": -7.7890625,
            "text": "nocturnal en",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": -7.7890625,
            "text": "en",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -3.421875,
            "text": "as",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -6.8671875,
            "text": "as effective in the treatment of neurogenic",
            "probability": 0.0
        },
        {
            "start_logit": -5.65625,
            "end_logit": -6.8671875,
            "text": "neurogenic",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.734375,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.7890625,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal en",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.84765625,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.94140625,
            "text": "as effective",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_1": [
        {
            "start_logit": 8.90625,
            "end_logit": 7.98046875,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -4.98046875,
            "text": "physical activity (PAL",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.90625,
            "end_logit": -7.08984375,
            "text": "physical activity (PAL), constant strain postures (CSP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -7.63671875,
            "text": "physical activity (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -7.6796875,
            "text": "physical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -7.84375,
            "text": "physical activity (PAL), constant strain postures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -8.1328125,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time (LT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -8.234375,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -8.4375,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.90625,
            "end_logit": -8.84375,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.25,
            "text": "physical activity (PAL)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.3203125,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.3515625,
            "text": "physical activity (PAL), constant strain postures (CSP)",
            "probability": 0.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.40625,
            "text": "physical activity (PAL), constant strain postures (CSP), standing",
            "probability": 0.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.421875,
            "text": "physical activity (PAL), constant strain postures (",
            "probability": 0.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.4921875,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST",
            "probability": 0.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -9.703125,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (",
            "probability": 0.0
        },
        {
            "start_logit": -8.8203125,
            "end_logit": 7.98046875,
            "text": "overall physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 7.98046875,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 7.98046875,
            "text": "measuring overall physical activity",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_2": [
        {
            "start_logit": 12.9296875,
            "end_logit": 10.15625,
            "text": "Physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -4.5859375,
            "text": "Physical",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -5.67578125,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an RT3 accelerometer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -7.4609375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an RT3",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -8.3984375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -8.4453125,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.234375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.4921875,
            "text": "Physical activity was measured for 7 days",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.6015625,
            "text": "Physical activity was measured for 7 days at both baseline",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -9.9609375,
            "text": "Physical activity was",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -10.1328125,
            "text": "Physical activity was measured for 7 days at both baseline and",
            "probability": 0.0
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -10.234375,
            "text": "Physical activity was measured for",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 10.15625,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -5.67578125,
            "text": "activity was measured for 7 days at both baseline and at 3 months with an RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -5.67578125,
            "text": "RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -7.4609375,
            "text": "activity was measured for 7 days at both baseline and at 3 months with an RT3",
            "probability": 0.0
        },
        {
            "start_logit": -9.3828125,
            "end_logit": -5.67578125,
            "text": "3 months with an RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -7.4609375,
            "text": "RT3",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -8.3984375,
            "text": "activity was measured for 7 days at both baseline and at 3",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -8.4453125,
            "text": "activity was measured for 7 days at both baseline and at 3 months",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_3": [
        {
            "start_logit": 13.7578125,
            "end_logit": 11.84375,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -3.595703125,
            "text": "physical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -3.65625,
            "text": "physical activity in daily life",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 11.84375,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -8.5859375,
            "text": "physical activity in",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -9.0703125,
            "text": "physical activity in daily",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 11.84375,
            "text": "wearing an accelerometer to assess physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 11.84375,
            "text": "an accelerometer to assess physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -11.0546875,
            "end_logit": 11.84375,
            "text": "accelerometer to assess physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": 11.84375,
            "text": "assess physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -6.265625,
            "end_logit": -3.65625,
            "text": "activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -3.595703125,
            "text": "wearing an accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -3.65625,
            "text": "wearing an accelerometer to assess physical activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -3.595703125,
            "text": "an accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -3.65625,
            "text": "an accelerometer to assess physical activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -10.875,
            "end_logit": -3.65625,
            "text": "daily life",
            "probability": 0.0
        },
        {
            "start_logit": -11.0546875,
            "end_logit": -3.595703125,
            "text": "accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -11.0546875,
            "end_logit": -3.65625,
            "text": "accelerometer to assess physical activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": -3.595703125,
            "text": "assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -11.15625,
            "end_logit": -3.65625,
            "text": "assess physical activity in daily life",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_4": [
        {
            "start_logit": 12.25,
            "end_logit": 8.609375,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 12.25,
            "end_logit": 0.202392578125,
            "text": "physical activity in daily life",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": 12.25,
            "end_logit": -5.60546875,
            "text": "physical",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 12.25,
            "end_logit": -6.50390625,
            "text": "physical activity in daily life was measured, with both an electronic diary and an accelerometer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 12.25,
            "end_logit": -7.328125,
            "text": "physical activity in daily life was measured, with both an electronic diary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.25,
            "end_logit": -9.453125,
            "text": "physical activity in",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.03125,
            "text": "physical activity in daily life was",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.1953125,
            "text": "physical activity in daily life was measured, with both an electronic diary and an",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.3359375,
            "text": "physical activity in daily life was measured, with both an electronic diary and",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.421875,
            "text": "physical activity in daily life was measured, with both an electronic",
            "probability": 0.0
        },
        {
            "start_logit": 12.25,
            "end_logit": -10.4296875,
            "text": "physical activity in daily life was measured",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": 8.609375,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 8.609375,
            "text": "14days physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 0.202392578125,
            "text": "daily life",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": 0.202392578125,
            "text": "activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 0.202392578125,
            "text": "14days physical activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -6.50390625,
            "text": "daily life was measured, with both an electronic diary and an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": -5.60546875,
            "text": "14days physical",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -6.50390625,
            "text": "activity in daily life was measured, with both an electronic diary and an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -7.328125,
            "text": "daily life was measured, with both an electronic diary",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_5": [
        {
            "start_logit": 13.0546875,
            "end_logit": 9.7265625,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -2.046875,
            "text": "physical activity in daily life",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -4.5078125,
            "text": "physical",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -7.5078125,
            "text": "physical activity in daily life was measured with an accelerometer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -9.0390625,
            "text": "physical activity in daily life was",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -9.1796875,
            "text": "physical activity in",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -9.65625,
            "text": "physical activity in daily",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -9.734375,
            "text": "physical activity in daily life was measured with an",
            "probability": 0.0
        },
        {
            "start_logit": 13.0546875,
            "end_logit": -10.0703125,
            "text": "physical activity in daily life was measured",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.7265625,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -2.046875,
            "text": "activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": -2.046875,
            "text": "daily life",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -2.046875,
            "text": "in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.5078125,
            "text": "activity in daily life was measured with an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -9.0390625,
            "text": "activity in daily life was",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -9.1796875,
            "text": "activity in",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": -7.5078125,
            "text": "daily life was measured with an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -9.65625,
            "text": "activity in daily",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -9.734375,
            "text": "activity in daily life was measured with an",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -10.0703125,
            "text": "activity in daily life was measured",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_6": [
        {
            "start_logit": 8.90625,
            "end_logit": 7.18359375,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 8.90625,
            "end_logit": -7.90234375,
            "text": "physical",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -8.9609375,
            "text": "physical activity (PA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.9609375,
            "end_logit": 7.18359375,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -5.2265625,
            "end_logit": 1.8359375,
            "text": "walking",
            "probability": 0.0
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 1.8359375,
            "text": "time upright (standing or walking",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 1.8359375,
            "text": "activPAL activity monitor) over a one week period. The following parameters of physical activity were recorded: time upright (standing or walking",
            "probability": 0.0
        },
        {
            "start_logit": -2.509765625,
            "end_logit": -2.6953125,
            "text": "step count",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 1.8359375,
            "text": "physical activity were recorded: time upright (standing or walking",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -2.6953125,
            "text": "time standing, time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -5.2265625,
            "end_logit": -2.6953125,
            "text": "walking), time standing, time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -2.6953125,
            "text": "time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -6.12109375,
            "end_logit": -2.6953125,
            "text": "time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -2.509765625,
            "end_logit": -7.546875,
            "text": "step",
            "probability": 0.0
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -5.8515625,
            "text": "time standing, time walking",
            "probability": 0.0
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -4.125,
            "text": "time upright",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -2.6953125,
            "text": ", time standing, time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": -4.125,
            "text": "activPAL activity monitor) over a one week period. The following parameters of physical activity were recorded: time upright",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -2.6953125,
            "text": "physical activity were recorded: time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0
        },
        {
            "start_logit": -5.2265625,
            "end_logit": -5.8515625,
            "text": "walking), time standing, time walking",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_7": [
        {
            "start_logit": 10.4453125,
            "end_logit": 7.50390625,
            "text": "Physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -1.546875,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial accelerometer",
            "probability": 0.00011682510375976562
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -6.24609375,
            "text": "Physical activity levels will be measured by self report",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -6.79296875,
            "text": "Physical activity levels will be measured by self report, RT3",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -6.9453125,
            "text": "Physical",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -7.12890625,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial accelerometer,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -8.03125,
            "text": "Physical activity levels",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -8.2109375,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -8.3125,
            "text": "Physical activity levels will",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -8.375,
            "text": "Physical activity levels will be measured by self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -8.7109375,
            "text": "Physical activity levels will be measured by self report, RT3 tri",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -9.6640625,
            "text": "Physical activity levels will be measured by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -9.921875,
            "text": "Physical activity levels will be measured by self report, RT",
            "probability": 0.0
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -10.078125,
            "text": "Physical activity levels will be measured by self report,",
            "probability": 0.0
        },
        {
            "start_logit": 10.4453125,
            "end_logit": -10.203125,
            "text": "Physical activity levels will be measured",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 7.50390625,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -1.546875,
            "text": "RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.546875,
            "text": "triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -1.546875,
            "text": "activity levels will be measured by self report, RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -1.546875,
            "text": "self report, RT3 triaxial accelerometer",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_8": [
        {
            "start_logit": 12.4765625,
            "end_logit": 4.9140625,
            "text": "physical activity",
            "probability": 0.9921875
        },
        {
            "start_logit": 12.4765625,
            "end_logit": 0.07904052734375,
            "text": "physical activity level",
            "probability": 0.00788116455078125
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -4.49609375,
            "text": "physical activity level (PAL), number of constant postures (CP",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -5.33203125,
            "text": "physical",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -6.52734375,
            "text": "physical activity level (PAL",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -7.7265625,
            "text": "physical activity level (PAL), number of constant postures",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -8.296875,
            "text": "physical activity level (PAL), number of constant postures (CP)",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -8.71875,
            "text": "physical activity level (PAL)",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -8.75,
            "text": "physical activity level (PAL), number of constant",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -8.75,
            "text": "physical activity level (",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -9.15625,
            "text": "physical activity level (PAL), number of constant postures (",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -9.234375,
            "text": "physical activity level (PAL), number of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 12.4765625,
            "end_logit": -10.21875,
            "text": "physical activity level (PAL), number",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 4.9140625,
            "text": "(physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 4.9140625,
            "text": "-h accelerometer assessment in their daily life (physical activity",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 0.07904052734375,
            "text": "(physical activity level",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 0.07904052734375,
            "text": "-h accelerometer assessment in their daily life (physical activity level",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -4.49609375,
            "text": ", number of constant postures (CP",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -4.49609375,
            "text": "CP",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -4.49609375,
            "text": "PAL), number of constant postures (CP",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_9": [
        {
            "start_logit": 12.3828125,
            "end_logit": 9.2578125,
            "text": "Physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -1.3623046875,
            "text": "Physical activity in daily life, expressed as whole-body acceleration",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -3.029296875,
            "text": "Physical activity in daily life",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -5.2734375,
            "text": "Physical",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -5.3046875,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -6.4609375,
            "text": "Physical activity in daily life, expressed as whole-body",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -7.2890625,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -7.30859375,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmor),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -8.90625,
            "text": "Physical activity in daily life, expressed as",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.03125,
            "text": "Physical activity in daily life, expressed as whole",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.3359375,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.46875,
            "text": "Physical activity in",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.59375,
            "text": "Physical activity in daily life, expressed",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.6640625,
            "text": "Physical activity in daily life,",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.828125,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmo",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.921875,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Trac",
            "probability": 0.0
        },
        {
            "start_logit": 12.3828125,
            "end_logit": -9.953125,
            "text": "Physical activity in daily life, expressed as whole-",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.2578125,
            "text": "activity",
            "probability": 0.0
        },
        {
            "start_logit": -6.375,
            "end_logit": -1.3623046875,
            "text": "whole-body acceleration",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -1.3623046875,
            "text": "activity in daily life, expressed as whole-body acceleration",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_1": [
        {
            "start_logit": 9.859375,
            "end_logit": 12.8046875,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": -5.078125,
            "end_logit": 12.8046875,
            "text": "fibrates and statins",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.90625,
            "end_logit": 12.8046875,
            "text": "and statins",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 12.8046875,
            "text": "which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": 12.8046875,
            "text": "(fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": 12.8046875,
            "text": "cardiovascular (CV) diseases. This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.8046875,
            "text": "lipid-lowering drugs (fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 12.8046875,
            "text": "CV) diseases. This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 12.8046875,
            "text": "of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -9.1953125,
            "text": "statins) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -9.40625,
            "text": "statins)",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -9.5625,
            "text": "statins) is more effective in patients with remnant lipoproteinemia",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -10.2265625,
            "text": "statins) is more effective in patients with remnant lipoproteinemia and if lowering remnant lipoprotein levels can reduce CV risk.",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -10.3203125,
            "text": "statins) is more effective in patients with remnant lipoproteinemia and if",
            "probability": 0.0
        },
        {
            "start_logit": -5.078125,
            "end_logit": -1.408203125,
            "text": "fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -1.408203125,
            "text": "which of 2 common lipid-lowering drugs (fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": -1.408203125,
            "text": "(fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": -1.408203125,
            "text": "cardiovascular (CV) diseases. This study examined which of 2 common lipid-lowering drugs (fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -1.408203125,
            "text": "lipid-lowering drugs (fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -1.408203125,
            "text": "CV) diseases. This study examined which of 2 common lipid-lowering drugs (fibrates",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_2": [
        {
            "start_logit": 10.6171875,
            "end_logit": 12.296875,
            "text": "Statins",
            "probability": 1.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -8.25,
            "text": "Statins are",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -9.40625,
            "text": "Statins are powerful lipid-lowering drugs",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.0625,
            "text": "Statins are powerful lipid-lowering drugs,",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.078125,
            "text": "Statins are powerful lipid-lowering drugs, widely",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.109375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease.",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.1328125,
            "text": "Statins are powerful lipid-lowering drugs, widely used",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.265625,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.34375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.3984375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.4453125,
            "text": "Statins are powerful",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.4921875,
            "text": "Statins are powerful lipid-",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.515625,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.6953125,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery",
            "probability": 0.0
        },
        {
            "start_logit": 10.6171875,
            "end_logit": -10.7265625,
            "text": "Statins are powerful lipid-lowering",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -9.40625,
            "text": "lipid-lowering drugs",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -9.40625,
            "text": "powerful lipid-lowering drugs",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -10.0625,
            "text": "lipid-lowering drugs,",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -10.078125,
            "text": "lipid-lowering drugs, widely",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -10.109375,
            "text": "lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease.",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_3": [
        {
            "start_logit": 9.59375,
            "end_logit": 9.34375,
            "text": "statins",
            "probability": 0.9990234375
        },
        {
            "start_logit": 2.36328125,
            "end_logit": 9.34375,
            "text": "fibrates, niacin, statins",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": 0.40087890625,
            "end_logit": 9.34375,
            "text": "niacin, statins",
            "probability": 0.00010138750076293945
        },
        {
            "start_logit": 9.59375,
            "end_logit": -0.99951171875,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimibe",
            "probability": 3.212690353393555e-05
        },
        {
            "start_logit": 2.36328125,
            "end_logit": 4.0078125,
            "text": "fibrates",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.25390625,
            "text": "statins and cholesterol absorption-inhibiting drugs (ez",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.36328125,
            "end_logit": -0.1417236328125,
            "text": "fibrates, niacin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.671875,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.36328125,
            "end_logit": -0.99951171875,
            "text": "fibrates, niacin, statins and cholesterol absorption-inhibiting drugs (ezetimibe",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.265625,
            "text": "statins and cholesterol absorption-inhibiting drugs",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.2890625,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezeti",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 9.34375,
            "text": "resins, fibrates, niacin, statins",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": 9.34375,
            "text": ", fibrates, niacin, statins",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": 9.34375,
            "text": ", niacin, statins",
            "probability": 0.0
        },
        {
            "start_logit": 0.40087890625,
            "end_logit": -0.1417236328125,
            "text": "niacin",
            "probability": 0.0
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 9.34375,
            "text": "acin, statins",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -9.390625,
            "text": "statins and",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -9.84375,
            "text": "statins and cholesterol absorption",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -10.1484375,
            "text": "statins and cholesterol absorption-inhibiting drugs (",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 9.34375,
            "text": ", statins",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_4": [
        {
            "start_logit": 6.8828125,
            "end_logit": 9.7421875,
            "text": "low-density lipoprotein cholesterol",
            "probability": 0.82373046875
        },
        {
            "start_logit": 6.8828125,
            "end_logit": 8.1328125,
            "text": "low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin",
            "probability": 0.164794921875
        },
        {
            "start_logit": 4.19921875,
            "end_logit": 8.1328125,
            "text": "statin",
            "probability": 0.0112152099609375
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 9.7421875,
            "text": "cholesterol",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 8.1328125,
            "text": "cholesterol level was &lt;120 mg/dl under statin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.7421875,
            "text": "whose low-density lipoprotein cholesterol",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.984375,
            "end_logit": 9.7421875,
            "text": "patients who were referred for percutaneous coronary intervention and whose low-density lipoprotein cholesterol",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -6.1640625,
            "text": "low-density lipoprotein cholesterol level was &lt;120 mg/dl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -6.27734375,
            "text": "low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin treatment or &lt;100 mg/dl without statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.1875,
            "end_logit": 9.7421875,
            "text": "lipoprotein cholesterol",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -6.5859375,
            "text": "low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 8.1328125,
            "text": "under statin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 8.1328125,
            "text": "whose low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -7.1328125,
            "text": "low-density lipoprotein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.984375,
            "end_logit": 8.1328125,
            "text": "patients who were referred for percutaneous coronary intervention and whose low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin",
            "probability": 0.0
        },
        {
            "start_logit": -9.1875,
            "end_logit": 8.1328125,
            "text": "lipoprotein cholesterol level was &lt;120 mg/dl under statin",
            "probability": 0.0
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -7.9921875,
            "text": "low-density lipoprotein cholesterol level",
            "probability": 0.0
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -8.0859375,
            "text": "low-density lipoprotein cholesterol level was &lt;120",
            "probability": 0.0
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -8.109375,
            "text": "low-density",
            "probability": 0.0
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -8.25,
            "text": "low-density lipoprotein cholesterol level was &lt;",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_5": [
        {
            "start_logit": 9.546875,
            "end_logit": 12.9765625,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 12.9765625,
            "text": "using statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.9765625,
            "text": "lipid-lowering therapy using statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.9765625,
            "text": "that lipid-lowering therapy using statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 12.9765625,
            "text": "clinical trials have elucidated that lipid-lowering therapy using statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.9765625,
            "text": "Large clinical trials have elucidated that lipid-lowering therapy using statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.5234375,
            "end_logit": 12.9765625,
            "text": "lowering therapy using statins",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -9.171875,
            "text": "statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -10.078125,
            "text": "statins reduces",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -10.109375,
            "text": "statins reduces cardiovascular events in patients with coronary artery disease (CAD",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -10.3125,
            "text": "statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -10.484375,
            "text": "statins reduces cardiovascular events in",
            "probability": 0.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -10.6015625,
            "text": "statins reduces cardiovascular events in patients with coronary artery disease",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": -9.171875,
            "text": "cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": -9.171875,
            "text": "using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.171875,
            "text": "lipid-lowering therapy using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -9.171875,
            "text": "that lipid-lowering therapy using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -9.171875,
            "text": "coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": -9.171875,
            "text": "clinical trials have elucidated that lipid-lowering therapy using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -9.171875,
            "text": "Large clinical trials have elucidated that lipid-lowering therapy using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_6": [
        {
            "start_logit": 9.5234375,
            "end_logit": 13.046875,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 13.046875,
            "text": "with statins",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 13.046875,
            "text": "LLT (lipid-lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 13.046875,
            "text": "lipid-lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 13.046875,
            "text": "investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.046875,
            "text": "whether LLT (lipid-lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 13.046875,
            "text": "lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 13.046875,
            "text": "T (lipid-lowering therapy) with statins",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -8.5390625,
            "text": "statins could",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -9.09375,
            "text": "statins could attenuate EPC telomere erosion in patients with CAD (coronary artery disease)",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -9.3671875,
            "text": "statins could attenuate EPC",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -9.4375,
            "text": "statins could attenuate EPC telomere",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -9.5,
            "text": "statins could attenuate EPC telomere erosion",
            "probability": 0.0
        },
        {
            "start_logit": 9.5234375,
            "end_logit": -10.046875,
            "text": "statins could attenuate EPC telomere erosion in",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": -8.5390625,
            "text": "with statins could",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -8.5390625,
            "text": "LLT (lipid-lowering therapy) with statins could",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": -9.09375,
            "text": "with statins could attenuate EPC telomere erosion in patients with CAD (coronary artery disease)",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -8.84375,
            "text": "LLT",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": -9.3671875,
            "text": "with statins could attenuate EPC",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": -9.09375,
            "text": "LLT (lipid-lowering therapy) with statins could attenuate EPC telomere erosion in patients with CAD (coronary artery disease)",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_7": [
        {
            "start_logit": 10.7265625,
            "end_logit": 12.2109375,
            "text": "pravastatin",
            "probability": 1.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": 3.9765625,
            "text": "pravastatin (+/-colestyramine/niacin",
            "probability": 0.00026535987854003906
        },
        {
            "start_logit": 10.7265625,
            "end_logit": 0.76708984375,
            "text": "pravastatin (+/-colestyramine",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 2.23046875,
            "end_logit": 3.9765625,
            "text": "niacin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -5.43359375,
            "text": "pravastatin (+/-cole",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -6.171875,
            "text": "pravastatin (+/-colestyr",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -6.48828125,
            "text": "pravastatin (+",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -7.09765625,
            "text": "pravastatin (+/-colestyramine/ni",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -7.32421875,
            "text": "pravastatin (+/-colest",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -7.46484375,
            "text": "pravastatin (+/-",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -8.1640625,
            "text": "pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -8.3515625,
            "text": "pravastatin (+/-colestyramine/",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -8.78125,
            "text": "pravastatin (+/-colestyramine/niacin)",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 3.9765625,
            "text": "colestyramine/niacin",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -9.09375,
            "text": "pravastatin (",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -9.4609375,
            "text": "pravastatin (+/-colestyramine/niacin) initiated",
            "probability": 0.0
        },
        {
            "start_logit": 10.7265625,
            "end_logit": -9.734375,
            "text": "pravastatin (+/",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 0.76708984375,
            "text": "colestyramine",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 3.9765625,
            "text": "amine/niacin",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": 3.9765625,
            "text": "+/-colestyramine/niacin",
            "probability": 0.0
        }
    ],
    "55072c803b8a5dc045000001_1": [
        {
            "start_logit": 8.0078125,
            "end_logit": 11.4140625,
            "text": "Notch-1",
            "probability": 1.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": 11.4140625,
            "text": "1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -3.626953125,
            "text": "Notch-1 to -4",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 11.4140625,
            "text": "Notch receptors have been identified in man (Notch-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -5.01171875,
            "text": "Notch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 11.4140625,
            "text": "Four Notch receptors have been identified in man (Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 11.4140625,
            "text": "cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.4140625,
            "text": "receptors have been identified in man (Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 11.4140625,
            "text": "(Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 11.4140625,
            "text": "Notch signaling is an evolutionarily conserved mechanism, used to regulate cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -8.109375,
            "text": "Notch-",
            "probability": 0.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -8.3203125,
            "text": "Notch-1 to",
            "probability": 0.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -9.5546875,
            "text": "Notch-1 to -4)",
            "probability": 0.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -9.921875,
            "text": "Notch-1 to -",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -3.626953125,
            "text": "1 to -4",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -3.626953125,
            "text": "Notch receptors have been identified in man (Notch-1 to -4",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -5.01171875,
            "text": "Notch receptors have been identified in man (Notch",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": -3.626953125,
            "text": "Four Notch receptors have been identified in man (Notch-1 to -4",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -3.626953125,
            "text": "to -4",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -3.626953125,
            "text": "cell fate decisions. Four Notch receptors have been identified in man (Notch-1 to -4",
            "probability": 0.0
        }
    ],
    "55072c803b8a5dc045000001_2": [
        {
            "start_logit": 11.7109375,
            "end_logit": 12.109375,
            "text": "Notch-1",
            "probability": 1.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -4.65234375,
            "text": "Notch-1, -2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -4.66796875,
            "text": "Notch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -5.4609375,
            "text": "Notch-1, -2, and -4",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 12.109375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -5.90625,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -7.09375,
            "text": "Notch-",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -8.71875,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA)",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -9.5703125,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -9.625,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However,",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -9.640625,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA",
            "probability": 0.0
        },
        {
            "start_logit": 11.7109375,
            "end_logit": -9.765625,
            "text": "Notch-1, -2, and -",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 12.109375,
            "text": "levels of Notch-1",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -4.65234375,
            "text": "1, -2",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -5.4609375,
            "text": "1, -2, and -4",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -5.90625,
            "text": "1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3",
            "probability": 0.0
        },
        {
            "start_logit": -8.875,
            "end_logit": -4.65234375,
            "text": ", -2",
            "probability": 0.0
        },
        {
            "start_logit": -8.875,
            "end_logit": -5.4609375,
            "text": ", -2, and -4",
            "probability": 0.0
        },
        {
            "start_logit": -8.875,
            "end_logit": -5.90625,
            "text": ", -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -8.71875,
            "text": "1, -2, and -4 messenger RNA (mRNA)",
            "probability": 0.0
        }
    ],
    "601d6ec61cb411341a000032_1": [
        {
            "start_logit": 13.6171875,
            "end_logit": 14.0234375,
            "text": "Focal segmental glomerulosclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": 14.0234375,
            "text": "glomerulosclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -3.732421875,
            "text": "Focal",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -6.3359375,
            "text": "Focal segmental",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -6.8359375,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.859375,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation.",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.1953125,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.359375,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.4140625,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.421875,
            "text": "Focal segmental glomerulosclerosis and mild",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.4921875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.609375,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 14.0234375,
            "text": "segmental glomerulosclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.859375,
            "text": "Focal segmental glomerulosclerosis and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.921875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8",
            "probability": 0.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -6.8359375,
            "text": "glomerulosclerosis and mild intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -8.859375,
            "text": "glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation.",
            "probability": 0.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -9.1953125,
            "text": "glomerulosclerosis and mild intellectual disability in",
            "probability": 0.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -9.359375,
            "text": "glomerulosclerosis and mild intellectual disability in a patient",
            "probability": 0.0
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -9.4140625,
            "text": "glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation",
            "probability": 0.0
        }
    ],
    "601d6ec61cb411341a000032_2": [
        {
            "start_logit": 13.1484375,
            "end_logit": 13.5,
            "text": "nephrotic syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 7.1171875,
            "text": "focal segmental glomerulosclerosis",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -3.908203125,
            "text": "nephrotic",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 13.5,
            "text": "syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": 13.5,
            "text": "epileptic encephalopathy was reported to have nephrotic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.5,
            "text": "encephalopathy was reported to have nephrotic syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.1171875,
            "text": "glomerulosclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.91796875,
            "text": "focal segmental",
            "probability": 0.0
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.93359375,
            "text": "focal",
            "probability": 0.0
        },
        {
            "start_logit": -8.78125,
            "end_logit": 7.1171875,
            "text": "epilepsy. The patient was found to have proteinuria at 2 years of age. Renal biopsy findings were suggestive of focal segmental glomerulosclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -4.32421875,
            "text": "severe developmental delay",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -5.953125,
            "text": "severe developmental delay, intellectual disability and epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -4.421875,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": -5.1171875,
            "end_logit": -5.953125,
            "text": "epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": -3.521484375,
            "end_logit": -7.578125,
            "text": "severe developmental delay, intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -4.32421875,
            "text": "developmental delay",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": -3.908203125,
            "text": "epileptic encephalopathy was reported to have nephrotic",
            "probability": 0.0
        },
        {
            "start_logit": -8.859375,
            "end_logit": -4.421875,
            "text": "del, p.(Tyr400ArgfsTer2",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.85546875,
            "text": "2). This patient is",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -3.908203125,
            "text": "encephalopathy was reported to have nephrotic",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_1": [
        {
            "start_logit": 14.1484375,
            "end_logit": 14.3125,
            "text": "type 2 diabetes",
            "probability": 1.0
        },
        {
            "start_logit": 3.505859375,
            "end_logit": 14.3125,
            "text": "diabetes",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 14.1484375,
            "end_logit": 0.2281494140625,
            "text": "type",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -2.142578125,
            "end_logit": 14.3125,
            "text": "Apolipoprotein E4 (E4) and type 2 diabetes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -2.7265625,
            "text": "type 2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.16015625,
            "end_logit": 14.3125,
            "text": "and type 2 diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -8.484375,
            "text": "type 2 diabetes are major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -8.8359375,
            "text": "type 2 diabetes are",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.6640625,
            "text": "type 2 diabetes are major",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 14.3125,
            "text": "E4) and type 2 diabetes",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.984375,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.9921875,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -10.4375,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -10.53125,
            "text": "type 2 diabetes are major risk",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -10.5390625,
            "text": "type 2 diabetes are major risk factors for cognitive decline",
            "probability": 0.0
        },
        {
            "start_logit": -2.142578125,
            "end_logit": 0.2281494140625,
            "text": "Apolipoprotein E4 (E4) and type",
            "probability": 0.0
        },
        {
            "start_logit": -4.16015625,
            "end_logit": 0.2281494140625,
            "text": "and type",
            "probability": 0.0
        },
        {
            "start_logit": -2.142578125,
            "end_logit": -2.7265625,
            "text": "Apolipoprotein E4 (E4) and type 2",
            "probability": 0.0
        },
        {
            "start_logit": 3.505859375,
            "end_logit": -8.484375,
            "text": "diabetes are major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": 3.505859375,
            "end_logit": -8.8359375,
            "text": "diabetes are",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_2": [
        {
            "start_logit": 10.703125,
            "end_logit": 12.453125,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 12.453125,
            "text": "Cardiovascular risk factors, especially hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 12.453125,
            "text": "risk factors, especially hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -8.90625,
            "text": "hypertension, are",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.3125,
            "text": "hypertension, are also major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.375,
            "text": "hypertension,",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.578125,
            "text": "hypertension, are also",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -9.8671875,
            "text": "hypertension, are also major",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -10.2890625,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD).",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -10.3671875,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -10.65625,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (",
            "probability": 0.0
        },
        {
            "start_logit": 10.703125,
            "end_logit": -10.703125,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.9921875,
            "text": "Cardiovascular risk factors",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -8.90625,
            "text": "Cardiovascular risk factors, especially hypertension, are",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.2578125,
            "text": "Cardiovascular",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.3125,
            "text": "Cardiovascular risk factors, especially hypertension, are also major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.375,
            "text": "Cardiovascular risk factors, especially hypertension,",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.578125,
            "text": "Cardiovascular risk factors, especially hypertension, are also",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.59375,
            "text": "Cardiovascular risk factors,",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -9.6015625,
            "text": "Cardiovascular risk factors, especially",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_3": [
        {
            "start_logit": 12.8984375,
            "end_logit": 13.4296875,
            "text": "Clusterin",
            "probability": 1.0
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 13.4296875,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -4.421875,
            "text": "Clusterin (Apo J",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -5.328125,
            "text": "Clusterin (Apo",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -5.49609375,
            "text": "Cluster",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -7.14453125,
            "text": "Clusterin (Apo J)",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -7.58984375,
            "text": "Clusterin (",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -8.84375,
            "text": "Clusterin (Apo J) is one",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -8.875,
            "text": "Clusterin (Apo J) is",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -8.96875,
            "text": "Clusterin (Apo J) is one of the major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -9.515625,
            "text": "Clusterin (Apo J) is one of the",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -9.578125,
            "text": "Clusterin (Apo J) is one of",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -9.7265625,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form of AD.",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -9.8359375,
            "text": "Clusterin (Apo J) is one of the major",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -10.375,
            "text": "Clusterin (Apo J) is one of the major risk",
            "probability": 0.0
        },
        {
            "start_logit": 12.8984375,
            "end_logit": -10.375,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form",
            "probability": 0.0
        },
        {
            "start_logit": -2.796875,
            "end_logit": -4.421875,
            "text": "Apo J",
            "probability": 0.0
        },
        {
            "start_logit": -2.796875,
            "end_logit": -5.328125,
            "text": "Apo",
            "probability": 0.0
        },
        {
            "start_logit": -4.59765625,
            "end_logit": -4.421875,
            "text": "in (Apo J",
            "probability": 0.0
        },
        {
            "start_logit": -4.59765625,
            "end_logit": -5.328125,
            "text": "in (Apo",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_4": [
        {
            "start_logit": 10.7109375,
            "end_logit": 12.484375,
            "text": "Hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -6.46484375,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -8.359375,
            "text": "Hypertension is one of the major risk factors",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.4765625,
            "text": "Hypertension is one",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.515625,
            "text": "Hypertension is",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.640625,
            "text": "Hypertension is one of the",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.7109375,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.90625,
            "text": "Hypertension is one of the major",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -9.9453125,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.015625,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD).",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.0234375,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.1015625,
            "text": "Hypertension is one of the major risk",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.1328125,
            "text": "Hypertension is one of",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.1796875,
            "text": "Hypertension is one of the major risk factors for central nervous system (",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.1953125,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.25,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS)",
            "probability": 0.0
        },
        {
            "start_logit": 10.7109375,
            "end_logit": -10.3359375,
            "text": "Hypertension is one of the major risk factors for",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -6.46484375,
            "text": "stroke",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -6.46484375,
            "text": "CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": -6.46484375,
            "text": "risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_5": [
        {
            "start_logit": 10.59375,
            "end_logit": 12.578125,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -1.79296875,
            "text": "age and diabetes",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 10.59375,
            "end_logit": -4.2265625,
            "text": "age and diabetes. Lately, obesity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.34375,
            "end_logit": 12.578125,
            "text": "advancing age",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.578125,
            "text": "risk factors for AD are advancing age",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 12.578125,
            "text": "AD are advancing age",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -9.6953125,
            "text": "age and",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -9.78125,
            "text": "age and diabetes. Lately,",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.1015625,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk of dementia.",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.1796875,
            "text": "age and diabetes. Lately",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.3359375,
            "text": "age and diabetes.",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.390625,
            "text": "age and diabetes. Lately, obesity has",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.4609375,
            "text": "age and diabetes. Lately, obesity has been associated",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.4765625,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.515625,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk of",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.515625,
            "text": "age and diabetes. Late",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.5390625,
            "text": "age and diabetes. Lately, obesity has been",
            "probability": 0.0
        },
        {
            "start_logit": 10.59375,
            "end_logit": -10.5625,
            "text": "age and diabetes. Lately, obesity has been associated with an",
            "probability": 0.0
        },
        {
            "start_logit": -2.9296875,
            "end_logit": -1.79296875,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -2.9296875,
            "end_logit": -4.2265625,
            "text": "diabetes. Lately, obesity",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_1": [
        {
            "start_logit": 12.9453125,
            "end_logit": 12.9453125,
            "text": "SCDRHA",
            "probability": 1.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": 4.97265625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder",
            "probability": 0.00034618377685546875
        },
        {
            "start_logit": 3.47265625,
            "end_logit": 4.97265625,
            "text": "Hierarchical Autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -4.70703125,
            "text": "SCD",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -5.1796875,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencode",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -5.28125,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoenc",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": 12.9453125,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -5.90625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -6.11328125,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Auto",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -6.8125,
            "text": "SCDRH",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -7.48828125,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.2890625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.5859375,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder.",
            "probability": 0.0
        },
        {
            "start_logit": -8.9609375,
            "end_logit": 12.9453125,
            "text": "RHA",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.2890625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.3515625,
            "text": "SCDRHA: A scRNA-Seq Data",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.9296875,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -10.0078125,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": 4.97265625,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 4.97265625,
            "text": "Autoencoder",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_2": [
        {
            "start_logit": 13.9765625,
            "end_logit": 13.5,
            "text": "SCDRHA",
            "probability": 1.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -3.494140625,
            "text": "SCD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -4.6796875,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder (DCA",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -4.8828125,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -4.89453125,
            "end_logit": 13.5,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -6.13671875,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder (",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -6.9765625,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count auto",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -7.1640625,
            "text": "SCDRH",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -7.1875,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -7.69921875,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoenc",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 13.5,
            "text": "hierarchical autoencoder, termed SCDRHA",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": 13.5,
            "text": "dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA",
            "probability": 0.0
        },
        {
            "start_logit": -9.0703125,
            "end_logit": 13.5,
            "text": "RHA",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 13.5,
            "text": "autoencoder, termed SCDRHA",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 0.43603515625,
            "text": "cell clustering",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -1.3271484375,
            "text": "graph autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -6.125,
            "end_logit": -1.3271484375,
            "text": "deep count autoencoder (DCA) that is used to denoise data, and the second module is a graph autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -9.2109375,
            "end_logit": 0.43603515625,
            "text": "noise reduction in five real scRNA-seq datasets. Besides, SCDRHA can also dramatically improve the performance of data visualization and cell clustering",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -1.3271484375,
            "text": "DCA) that is used to denoise data, and the second module is a graph autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -1.3271484375,
            "text": "autoencoder",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_3": [
        {
            "start_logit": 13.65625,
            "end_logit": 13.0546875,
            "text": "CellVGAE",
            "probability": 1.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -4.21484375,
            "text": "Cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 13.0546875,
            "text": "GAE",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -5.6171875,
            "text": "CellV",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.3828125,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.8671875,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -8.9375,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.15625,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.2890625,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks.",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.3203125,
            "text": "CellVGAE: an unsupervised",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.515625,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -9.625,
            "text": "CellVGAE: an unsupervised scRNA-seq",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.0078125,
            "text": "CellVGAE: an unsupervised scRNA-",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.2109375,
            "text": "CellVGAE: an",
            "probability": 0.0
        },
        {
            "start_logit": 13.65625,
            "end_logit": -10.28125,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.0546875,
            "text": "VGAE",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -8.3828125,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph attention networks",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -8.8671875,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -8.9375,
            "text": "GAE: an unsupervised scRNA-seq analysis",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -9.15625,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph attention",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_4": [
        {
            "start_logit": 14.1484375,
            "end_logit": 13.6171875,
            "text": "CellVGAE",
            "probability": 1.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -3.63671875,
            "text": "Cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.453125,
            "end_logit": 13.6171875,
            "text": "GAE",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -5.48046875,
            "text": "CellV",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.1015625,
            "text": "CellVGAE, can be effectively used for exploratory analysis even on challenging datasets, by extracting meaningful features from the data",
            "probability": 0.0
        },
        {
            "start_logit": 14.1484375,
            "end_logit": -9.6953125,
            "text": "CellVGAE,",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 13.6171875,
            "text": "VGAE",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.6171875,
            "text": "model, named CellVGAE",
            "probability": 0.0
        },
        {
            "start_logit": -4.453125,
            "end_logit": -9.1015625,
            "text": "GAE, can be effectively used for exploratory analysis even on challenging datasets, by extracting meaningful features from the data",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -3.63671875,
            "text": "model, named Cell",
            "probability": 0.0
        },
        {
            "start_logit": -4.453125,
            "end_logit": -9.6953125,
            "text": "GAE,",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -5.48046875,
            "text": "V",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -5.48046875,
            "text": "model, named CellV",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.015625,
            "text": "variational architectures by analysing the graph attention",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.0625,
            "text": "variational",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -6.296875,
            "text": "model",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.1484375,
            "text": "variational architectures by analysing the graph",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.625,
            "text": "variational architectures",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.7734375,
            "text": "variational architectures by analysing the graph attention coefficients",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": -8.015625,
            "text": "scRNA-seq variational architectures by analysing the graph attention",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_1": [
        {
            "start_logit": 14.484375,
            "end_logit": 13.328125,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -2.228515625,
            "text": "c",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.13671875,
            "end_logit": 13.328125,
            "text": "Abl",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -5.9296875,
            "text": "c-Abl in cell senescence and spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -6.97265625,
            "text": "c-",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -9.515625,
            "text": "c-Abl in",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -9.7109375,
            "text": "c-Abl in cell senescence and spontaneous",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -9.828125,
            "text": "c-Abl in cell senescence and spontaneous immortal",
            "probability": 0.0
        },
        {
            "start_logit": 14.484375,
            "end_logit": -9.859375,
            "text": "c-Abl in cell senescence and",
            "probability": 0.0
        },
        {
            "start_logit": -4.13671875,
            "end_logit": -5.9296875,
            "text": "Abl in cell senescence and spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -4.13671875,
            "end_logit": -9.515625,
            "text": "Abl in",
            "probability": 0.0
        },
        {
            "start_logit": -4.13671875,
            "end_logit": -9.7109375,
            "text": "Abl in cell senescence and spontaneous",
            "probability": 0.0
        },
        {
            "start_logit": -4.13671875,
            "end_logit": -9.828125,
            "text": "Abl in cell senescence and spontaneous immortal",
            "probability": 0.0
        },
        {
            "start_logit": -4.13671875,
            "end_logit": -9.859375,
            "text": "Abl in cell senescence and",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -5.9296875,
            "text": "immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -5.9296875,
            "text": "spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": -5.9296875,
            "text": "cell senescence and spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -11.03125,
            "end_logit": -5.9296875,
            "text": "senescence and spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -9.828125,
            "text": "immortal",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -9.7109375,
            "text": "spontaneous",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_2": [
        {
            "start_logit": 14.65625,
            "end_logit": 13.75,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -2.138671875,
            "text": "c",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.822265625,
            "end_logit": 13.75,
            "text": "Abl",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -6.74609375,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -7.4765625,
            "text": "c-",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -7.63671875,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -8.1875,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.0390625,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a)",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.515625,
            "text": "c-Abl in replicative senescence and immortalization",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.53125,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.5390625,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.578125,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.6953125,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.7109375,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression",
            "probability": 0.0
        },
        {
            "start_logit": 14.65625,
            "end_logit": -9.8359375,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of",
            "probability": 0.0
        },
        {
            "start_logit": -3.822265625,
            "end_logit": -6.74609375,
            "text": "Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53",
            "probability": 0.0
        },
        {
            "start_logit": -3.822265625,
            "end_logit": -7.63671875,
            "text": "Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16",
            "probability": 0.0
        },
        {
            "start_logit": -3.822265625,
            "end_logit": -8.1875,
            "text": "Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a",
            "probability": 0.0
        },
        {
            "start_logit": -3.822265625,
            "end_logit": -9.0390625,
            "text": "Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a)",
            "probability": 0.0
        },
        {
            "start_logit": -3.822265625,
            "end_logit": -9.515625,
            "text": "Abl in replicative senescence and immortalization",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_3": [
        {
            "start_logit": 13.921875,
            "end_logit": 12.5234375,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -2.431640625,
            "text": "c",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.046875,
            "end_logit": 12.5234375,
            "text": "Abl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.515625,
            "text": "c-",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.1484375,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice and how BCR",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.6484375,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.7734375,
            "text": "c-Abl in regulating cell senescence and immortalization",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.96875,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.1171875,
            "text": "c-Abl in regulating cell senescence and immortalization might",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.21875,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.703125,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice and",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.7421875,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-)",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.78125,
            "text": "c-Abl in regulating cell senescence and immortalization might explain",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.828125,
            "text": "c-Abl in regulating cell senescence and immortal",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -7.2265625,
            "text": "Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice and how BCR-ABL",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -8.1484375,
            "text": "Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice and how BCR",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -8.6484375,
            "text": "Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -8.7734375,
            "text": "Abl in regulating cell senescence and immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -8.96875,
            "text": "Abl in regulating cell senescence and immortalization might explain some of the developmental defects",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -9.1171875,
            "text": "Abl in regulating cell senescence and immortalization might",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_4": [
        {
            "start_logit": 11.890625,
            "end_logit": 10.2578125,
            "text": "Ras",
            "probability": 1.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -7.42578125,
            "text": "Ras/Raf",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -7.84765625,
            "text": "Ras/Raf-proto",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -8.03125,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safeguard program",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -8.453125,
            "text": "Ras/Raf-prototypic oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -8.9296875,
            "text": "Ras/Raf-prototy",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.1328125,
            "text": "Ras/Raf-prototypic",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.140625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.3125,
            "text": "Ras/Raf-",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.5625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest,",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.6328125,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safeguard",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.65625,
            "text": "Ras/",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.8359375,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.8515625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -9.96875,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -10.015625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle",
            "probability": 0.0
        },
        {
            "start_logit": 11.890625,
            "end_logit": -10.078125,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence,",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -7.42578125,
            "text": "Raf",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -7.84765625,
            "text": "Raf-proto",
            "probability": 0.0
        },
        {
            "start_logit": -10.375,
            "end_logit": -8.03125,
            "text": "Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safeguard program",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_5": [
        {
            "start_logit": -4.83984375,
            "end_logit": 10.71875,
            "text": "Myc",
            "probability": 0.98193359375
        },
        {
            "start_logit": -9.921875,
            "end_logit": 10.71875,
            "text": ", Myc",
            "probability": 0.006092071533203125
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 10.71875,
            "text": "senescence, Myc",
            "probability": 0.0036678314208984375
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 10.71875,
            "text": "induced senescence, Myc",
            "probability": 0.0036106109619140625
        },
        {
            "start_logit": -10.8359375,
            "end_logit": 10.71875,
            "text": "oncogene-induced senescence, Myc",
            "probability": 0.0024433135986328125
        },
        {
            "start_logit": -10.953125,
            "end_logit": 10.71875,
            "text": "-induced senescence, Myc",
            "probability": 0.0021724700927734375
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -5.10546875,
            "text": "Myc style",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.921875,
            "end_logit": -5.10546875,
            "text": ", Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -5.10546875,
            "text": "style",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -5.10546875,
            "text": "senescence, Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -5.10546875,
            "text": "induced senescence, Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": -5.10546875,
            "text": "oncogene-induced senescence, Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": -5.10546875,
            "text": "-induced senescence, Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -10.25,
            "text": ",",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": -10.25,
            "text": "senescence,",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -10.25,
            "text": "induced senescence,",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": -10.25,
            "text": "oncogene-induced senescence,",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": -10.25,
            "text": "-induced senescence,",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": -10.40625,
            "text": "oncogene",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_6": [
        {
            "start_logit": 11.6953125,
            "end_logit": 9.96875,
            "text": "Myc",
            "probability": 1.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.0546875,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a cell-autonomous, direct response to Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.890625,
            "text": "Myc-",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.953125,
            "text": "Myc-induced senescence - which is detectable",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.96875,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.984375,
            "text": "Myc-induced senescence - which is detectable to a limited degree",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": -6.0546875,
            "text": "Myc",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": -6.4921875,
            "text": "proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": -6.4921875,
            "text": "namely cells of the host immune system, prompting them to release pro-senescent cytokines that strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -6.4921875,
            "text": "of the host immune system, prompting them to release pro-senescent cytokines that strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": -6.61328125,
            "text": "namely cells of the host immune system",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": -6.4921875,
            "text": "strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -6.61328125,
            "text": "of the host immune system",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -6.4921875,
            "text": "that strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -6.61328125,
            "text": "non-neoplastic bystanders, namely cells of the host immune system",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -6.4921875,
            "text": "host immune system, prompting them to release pro-senescent cytokines that strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -6.61328125,
            "text": "host immune system",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -6.4921875,
            "text": "tumor",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": -6.4921875,
            "text": "bystanders, namely cells of the host immune system, prompting them to release pro-senescent cytokines that strike back onto adjacent proliferating tumor",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -6.61328125,
            "text": "crosstalk of the oncogene-driven cell population with non-neoplastic bystanders, namely cells of the host immune system",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_7": [
        {
            "start_logit": 4.82421875,
            "end_logit": 6.90234375,
            "text": "Skp2",
            "probability": 1.0
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -2.5078125,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -3.509765625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.90234375,
            "text": "p2",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -6.34765625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -6.63671875,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -9.078125,
            "end_logit": 6.90234375,
            "text": "genetic Skp2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -7.7734375,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -7.875,
            "text": "Skp2 inactivation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -8.5625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -8.5703125,
            "text": "Sk",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.0625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.1953125,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.2265625,
            "text": "Skp2 inactivation evokes cellular senescence even in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.296875,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.4921875,
            "text": "Skp2 inactivation evokes cellular senescence even",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -9.5390625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -2.451171875,
            "text": "p19(Arf)-p53 response is impaired, whereas a Skp2-SCF complex inhibitor can trigger cellular senescence in p53/Pten",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -2.5078125,
            "text": "p19(Arf",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -2.5078125,
            "text": "p2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_8": [
        {
            "start_logit": 10.546875,
            "end_logit": 12.1953125,
            "text": "RAS",
            "probability": 1.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -5.640625,
            "text": "RAS/BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 12.1953125,
            "text": "Activated RAS",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -8.890625,
            "text": "RAS/BRAF oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -9.2109375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -9.453125,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -9.828125,
            "text": "RAS/",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -9.9921875,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -10.0078125,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -10.0390625,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -10.2265625,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development,",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -10.3359375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in",
            "probability": 0.0
        },
        {
            "start_logit": 10.546875,
            "end_logit": -10.3359375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -5.640625,
            "text": "Activated RAS/BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": -5.640625,
            "text": "BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -5.640625,
            "text": "/BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -8.890625,
            "text": "Activated RAS/BRAF oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -9.453125,
            "text": "Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -9.828125,
            "text": "Activated RAS/",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -9.9921875,
            "text": "Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_9": [
        {
            "start_logit": 11.953125,
            "end_logit": 11.1484375,
            "text": "Myc",
            "probability": 1.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -7.859375,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -9.4609375,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -9.8515625,
            "text": "Myc also causes senescence in cells lacking the",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -9.875,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein Wrn.",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -9.9140625,
            "text": "Myc also causes senescence in cells lacking the DNA repair",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -10.0390625,
            "text": "Myc also causes senescence in cells lacking",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -10.140625,
            "text": "Myc also",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -10.15625,
            "text": "Myc also causes senescence in cells",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -10.1953125,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein Wr",
            "probability": 0.0
        },
        {
            "start_logit": 11.953125,
            "end_logit": -10.234375,
            "text": "Myc also causes senescence in",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": -7.859375,
            "text": "Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -7.859375,
            "text": "DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -7.859375,
            "text": "causes senescence in cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": -7.859375,
            "text": "senescence in cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": -7.859375,
            "text": "repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -7.859375,
            "text": "lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -11.0703125,
            "end_logit": -7.859375,
            "text": "cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -11.1640625,
            "end_logit": -7.859375,
            "text": "protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": -9.875,
            "text": "Wrn.",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_10": [
        {
            "start_logit": 11.5625,
            "end_logit": 10.4140625,
            "text": "Akt",
            "probability": 1.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -9.0546875,
            "text": "Akt,",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -9.6953125,
            "text": "Akt, causes senescence in primary mouse hepatoblasts",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -9.9453125,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in vitro",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -10.203125,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in vitro.",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -10.203125,
            "text": "Akt, causes",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -10.3125,
            "text": "Akt, causes senescence in",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -10.3203125,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -10.3671875,
            "text": "Akt, causes senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 10.4140625,
            "text": "expression of such an oncogene, Akt",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": 10.4140625,
            "text": "such an oncogene, Akt",
            "probability": 0.0
        },
        {
            "start_logit": -10.9296875,
            "end_logit": 10.4140625,
            "text": "oncogene, Akt",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": 10.4140625,
            "text": "found that expression of such an oncogene, Akt",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": -9.6953125,
            "text": "hepatoblasts",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": -8.4296875,
            "text": "expression of such an oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -8.4296875,
            "text": "such an oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": -9.9453125,
            "text": "hepatoblasts in vitro",
            "probability": 0.0
        },
        {
            "start_logit": -10.9296875,
            "end_logit": -8.4296875,
            "text": "oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": -8.4296875,
            "text": "found that expression of such an oncogene",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": -10.203125,
            "text": "hepatoblasts in vitro.",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_11": [
        {
            "start_logit": -2.693359375,
            "end_logit": 2.54296875,
            "text": "AKT",
            "probability": 0.9990234375
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 2.54296875,
            "text": "signaling through AKT",
            "probability": 0.0003917217254638672
        },
        {
            "start_logit": -10.78125,
            "end_logit": 2.54296875,
            "text": "through AKT",
            "probability": 0.0003075599670410156
        },
        {
            "start_logit": -11.0,
            "end_logit": 2.54296875,
            "text": "hyperproliferative signaling through AKT",
            "probability": 0.00024700164794921875
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -5.96484375,
            "text": "AKT might be a",
            "probability": 0.00020170211791992188
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -6.37109375,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate cells",
            "probability": 0.00013434886932373047
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -8.0234375,
            "text": "AKT might",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -8.5,
            "text": "AKT might be",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -8.9921875,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate cells.",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -9.0078125,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -9.5546875,
            "text": "AKT might be a driving force of the senescence in",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -9.75,
            "text": "AKT might be a driving force",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -10.2578125,
            "text": "AKT might be a driving force of the",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -6.37109375,
            "text": "hepatic stellate cells",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -6.37109375,
            "text": "activated hepatic stellate cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -9.859375,
            "end_logit": -5.96484375,
            "text": "a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -9.859375,
            "end_logit": -6.37109375,
            "text": "a driving force of the senescence in activated hepatic stellate cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.5390625,
            "end_logit": -5.96484375,
            "text": "signaling through AKT might be a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -6.37109375,
            "text": "stellate cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.78125,
            "end_logit": -5.96484375,
            "text": "through AKT might be a",
            "probability": 5.960464477539063e-08
        }
    ],
    "5309f8f5970c65fa6b000001_12": [
        {
            "start_logit": 11.46875,
            "end_logit": 11.4375,
            "text": "RAS",
            "probability": 1.0
        },
        {
            "start_logit": -6.875,
            "end_logit": 11.4375,
            "text": "oncogenic RAS",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.09375,
            "text": "RAS expression, which causes genotoxic stress and senescence in normal cells,",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.6328125,
            "text": "RAS expression",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.859375,
            "text": "RAS expression, which causes genotoxic stress",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.7578125,
            "text": "RAS expression, which causes",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.828125,
            "text": "RAS expression,",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.9375,
            "text": "RAS expression, which",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.0078125,
            "text": "RAS expression, which causes genotoxic",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.1015625,
            "text": "RAS expression, which causes genotoxic stress and senescence",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.1015625,
            "text": "RAS expression, which causes genotoxic stress and senescence in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.171875,
            "text": "RAS expression, which causes genotoxic stress and senescence in normal",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.265625,
            "text": "RAS expression, which causes genotoxic stress and",
            "probability": 0.0
        },
        {
            "start_logit": 11.46875,
            "end_logit": -10.3515625,
            "text": "RAS expression, which causes genotoxic stress and senescence in",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -8.09375,
            "text": "oncogenic RAS expression, which causes genotoxic stress and senescence in normal cells,",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -8.6328125,
            "text": "oncogenic RAS expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -8.859375,
            "text": "oncogenic RAS expression, which causes genotoxic stress",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -9.7578125,
            "text": "oncogenic RAS expression, which causes",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -9.828125,
            "text": "oncogenic RAS expression,",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -9.921875,
            "text": "oncogenic",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_13": [
        {
            "start_logit": 13.6171875,
            "end_logit": 12.3671875,
            "text": "c-Myc",
            "probability": 1.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -3.197265625,
            "text": "c",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -4.28125,
            "text": "c-Myc (MYC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.375,
            "end_logit": 12.3671875,
            "text": "Myc",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.16015625,
            "text": "c-Myc (MYC)",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.5,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.015625,
            "text": "c-Myc (",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.1953125,
            "text": "c-Myc (MYC) oncogene",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.3046875,
            "text": "c-",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.7578125,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.1171875,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and hepatocellular carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.234375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.5390625,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.6484375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -10.0703125,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and hepatocellular carcinoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.3671875,
            "text": "suppression of the c-Myc",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 12.3671875,
            "text": "of the c-Myc",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -4.28125,
            "text": "Myc (MYC",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -4.28125,
            "text": "MYC",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -7.16015625,
            "text": "Myc (MYC)",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_14": [
        {
            "start_logit": 11.4765625,
            "end_logit": 11.5546875,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.4921875,
            "text": "MYC inactivation was associated with prototypical markers of senescence",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.6171875,
            "text": "MYC inactivation was associated with prototypical markers",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.6953125,
            "text": "MYC inactivation was associated with prototypical markers of",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -9.9296875,
            "text": "MYC inactivation was associated with",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -10.0859375,
            "text": "MYC inactivation",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -10.1875,
            "text": "MYC inactivation was associated with prototypical",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -10.21875,
            "text": "MYC inactivation was associated",
            "probability": 0.0
        },
        {
            "start_logit": 11.4765625,
            "end_logit": -10.2578125,
            "text": "MYC inactivation was associated with prototy",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -9.4921875,
            "text": "inactivation was associated with prototypical markers of senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": -9.4921875,
            "text": "prototypical markers of senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": -9.4921875,
            "text": "senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -9.6171875,
            "text": "inactivation was associated with prototypical markers",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": -9.6171875,
            "text": "prototypical markers",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -9.6953125,
            "text": "inactivation was associated with prototypical markers of",
            "probability": 0.0
        },
        {
            "start_logit": -11.109375,
            "end_logit": -9.4921875,
            "text": "pical markers of senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": -9.6953125,
            "text": "prototypical markers of",
            "probability": 0.0
        },
        {
            "start_logit": -11.109375,
            "end_logit": -9.6171875,
            "text": "pical markers",
            "probability": 0.0
        },
        {
            "start_logit": -11.234375,
            "end_logit": -9.4921875,
            "text": "associated with prototypical markers of senescence",
            "probability": 0.0
        },
        {
            "start_logit": -11.265625,
            "end_logit": -9.4921875,
            "text": "typical markers of senescence",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_15": [
        {
            "start_logit": 10.765625,
            "end_logit": 11.0078125,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -8.828125,
            "text": "MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 11.0078125,
            "text": "after lymphomas were repaired for p53 expression did MYC",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -9.296875,
            "text": "MYC inactivation induce robust senescence and sustained tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.0078125,
            "text": "did MYC",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.0078125,
            "text": "lymphomas were repaired for p53 expression did MYC",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 11.0078125,
            "text": "p53 expression did MYC",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -9.8359375,
            "text": "MYC inactivation induce robust senescence and sustained tumor regression.",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -9.859375,
            "text": "MYC inactivation",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -9.90625,
            "text": "MYC inactivation induce robust senescence and",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -10.578125,
            "text": "MYC inactivation induce",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -7.05078125,
            "text": "after lymphomas were repaired for p53",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -7.05078125,
            "text": "lymphomas were repaired for p53",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -7.05078125,
            "text": "p53",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -8.828125,
            "text": "after lymphomas were repaired for p53 expression did MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -9.296875,
            "text": "after lymphomas were repaired for p53 expression did MYC inactivation induce robust senescence and sustained tumor",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -9.328125,
            "text": "after lymphomas",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.828125,
            "text": "did MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -8.828125,
            "text": "lymphomas were repaired for p53 expression did MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -8.828125,
            "text": "p53 expression did MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_16": [
        {
            "start_logit": 10.6875,
            "end_logit": 10.6796875,
            "text": "ras",
            "probability": 1.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": 10.6796875,
            "text": "oncogenic ras",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.6875,
            "end_logit": -7.95703125,
            "text": "ras, or p16",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -9.7109375,
            "text": "ras, or",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": 10.6796875,
            "text": ", premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 10.6796875,
            "text": "induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 10.6796875,
            "text": "Replicative senescence due to telomere shortening can, for example, be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 10.6796875,
            "text": "senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 10.6796875,
            "text": "overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.171875,
            "text": "ras,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 10.6796875,
            "text": "premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 10.6796875,
            "text": "senescence due to telomere shortening can, for example, be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 10.6796875,
            "text": "dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 10.6796875,
            "text": "negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": 10.6875,
            "end_logit": -10.5546875,
            "text": "ras, or p16.",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -7.95703125,
            "text": "oncogenic ras, or p16",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -9.390625,
            "text": "oncogenic",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -9.7109375,
            "text": "oncogenic ras, or",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -10.171875,
            "text": "oncogenic ras,",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -10.5546875,
            "text": "oncogenic ras, or p16.",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_17": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.75,
            "text": "HDAC2",
            "probability": 1.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 8.75,
            "text": "knockdown of HDAC2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.671875,
            "text": "HDAC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 8.75,
            "text": "2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.203125,
            "end_logit": -9.9140625,
            "text": "HDAC2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -10.6875,
            "text": "HDAC2 induced",
            "probability": 0.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -10.765625,
            "text": "HDAC2 induced cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -6.671875,
            "text": "knockdown of HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -9.75,
            "text": "knockdown of",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -9.9140625,
            "text": "knockdown of HDAC2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -10.6875,
            "text": "knockdown of HDAC2 induced",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -10.7265625,
            "text": "knockdown",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -10.765625,
            "text": "knockdown of HDAC2 induced cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -9.9140625,
            "text": "2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -10.6875,
            "text": "2 induced",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -10.765625,
            "text": "2 induced cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -9.9140625,
            "text": "cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -10.765625,
            "text": "cellular senescence",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_18": [
        {
            "start_logit": 11.34375,
            "end_logit": 11.6640625,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.609375,
            "text": "MYC overexpression",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -9.9453125,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.046875,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.171875,
            "text": "MYC overexpression is thought",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.1875,
            "text": "MYC overexpression is",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.2578125,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.3359375,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.34375,
            "text": "MYC overexpression is thought to initiate tumorigenesis",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.4453125,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.46875,
            "text": "MYC overexpression is thought to",
            "probability": 0.0
        },
        {
            "start_logit": 11.34375,
            "end_logit": -10.46875,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": -9.0390625,
            "text": "inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": -9.0390625,
            "text": "causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -9.0390625,
            "text": "cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": -9.0390625,
            "text": "proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -9.0390625,
            "text": "growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -9.0390625,
            "text": "initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -9.0390625,
            "text": "cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": -9.0390625,
            "text": "restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_19": [
        {
            "start_logit": 11.6953125,
            "end_logit": 11.5546875,
            "text": "Ras",
            "probability": 1.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.05078125,
            "text": "Ras over-expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 11.5546875,
            "text": "oncogenic Ras",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.0703125,
            "text": "Ras over-expression and inappropriate culture conditions",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.8671875,
            "text": "Ras over",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.9296875,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.703125,
            "text": "Ras over-",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.7421875,
            "text": "Ras over-expression and",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.75,
            "text": "Ras over-expression and inappropriate culture conditions,",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.0,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening.",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.0390625,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.296875,
            "text": "Ras over-expression and inappropriate",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.3046875,
            "text": "Ras over-expression and inappropriate culture conditions, also",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -10.3515625,
            "text": "Ras over-expression and inappropriate culture",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -6.05078125,
            "text": "oncogenic Ras over-expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -8.0703125,
            "text": "oncogenic Ras over-expression and inappropriate culture conditions",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": -6.05078125,
            "text": "over-expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -8.8671875,
            "text": "oncogenic Ras over",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -8.9296875,
            "text": "oncogenic Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening",
            "probability": 0.0
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -9.1015625,
            "text": "oncogenic",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_20": [
        {
            "start_logit": 13.0234375,
            "end_logit": 12.5703125,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -3.701171875,
            "text": "caveolin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.375,
            "end_logit": 12.5703125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -7.13671875,
            "text": "caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -8.8125,
            "text": "caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.015625,
            "text": "caveolin-1 induces premature cellular senescence in primary cultures of",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.203125,
            "text": "caveolin-1 induces premature cellular senescence in",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.234375,
            "text": "caveolin-1 induces",
            "probability": 0.0
        },
        {
            "start_logit": 13.0234375,
            "end_logit": -10.4375,
            "text": "caveolin-1 induces premature cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 12.5703125,
            "text": "Expression of caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -8.8125,
            "text": "1 induces premature cellular senescence in primary cultures of murine fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -3.701171875,
            "text": "Expression of caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -10.015625,
            "text": "1 induces premature cellular senescence in primary cultures of",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -10.203125,
            "text": "1 induces premature cellular senescence in",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -10.234375,
            "text": "1 induces",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -10.4375,
            "text": "1 induces premature cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -7.13671875,
            "text": "Expression of caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -8.8125,
            "text": "fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -8.8125,
            "text": "murine fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": -8.8125,
            "text": "primary cultures of murine fibroblasts",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_21": [
        {
            "start_logit": 13.4296875,
            "end_logit": 13.296875,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -3.65234375,
            "text": "caveolin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.8125,
            "end_logit": 13.296875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -7.5,
            "text": "caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -8.6015625,
            "text": "caveolin-1 show: 1) a reduced proliferative lifespan; 2) senescence-like cell morphology",
            "probability": 0.0
        },
        {
            "start_logit": -8.9609375,
            "end_logit": 13.296875,
            "text": "mouse embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.265625,
            "text": "caveolin-1 show",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.5859375,
            "text": "caveolin-1 show: 1) a reduced proliferative lifespan",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 13.296875,
            "text": "overexpressing caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 13.296875,
            "text": "transgenically overexpressing caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 13.296875,
            "text": "embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -10.2578125,
            "text": "caveolin-1 show: 1) a reduced proliferative lifespan; 2) senescence-like cell morphology; and 3) a senescence-associated increase",
            "probability": 0.0
        },
        {
            "start_logit": -8.9609375,
            "end_logit": -3.65234375,
            "text": "mouse embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -3.65234375,
            "text": "overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -8.6015625,
            "text": "1 show: 1) a reduced proliferative lifespan; 2) senescence-like cell morphology",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -3.65234375,
            "text": "transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -3.65234375,
            "text": "embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -9.1796875,
            "text": "1 show: 1) a reduced proliferative lifespan; 2) senescence-like cell morphology; and 3) a senescence-associated increase in beta-galactosidase",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -9.265625,
            "text": "1 show",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -9.5859375,
            "text": "1 show: 1) a reduced proliferative lifespan",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_22": [
        {
            "start_logit": 12.3359375,
            "end_logit": 12.125,
            "text": "caveolin-1",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 12.125,
            "text": "hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0025501251220703125
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 5.32421875,
            "text": "hydrogen peroxide",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -4.01171875,
            "text": "caveolin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 12.125,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -6.3046875,
            "text": "caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -7.9453125,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 12.125,
            "text": "antisense caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 12.125,
            "text": "NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -8.890625,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin-1 levels are restored",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.4453125,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin-1 levels are",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.4609375,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.5,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin-1 levels",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.5078125,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.8203125,
            "text": "caveolin-1. Importantly, induction of premature senescence is",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 12.125,
            "text": "peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.01171875,
            "text": "hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 12.125,
            "text": "induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 12.125,
            "text": "premature senescence induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.125,
            "text": "senescence induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_23": [
        {
            "start_logit": 13.2109375,
            "end_logit": 12.7734375,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -3.486328125,
            "text": "caveolin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.140625,
            "end_logit": 12.7734375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -6.8359375,
            "text": "caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -9.9453125,
            "text": "caveolin-1 in",
            "probability": 0.0
        },
        {
            "start_logit": 13.2109375,
            "end_logit": -10.296875,
            "text": "caveolin-1 in promoting cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -11.0703125,
            "end_logit": 12.7734375,
            "text": "-1",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": 12.7734375,
            "text": "these results clearly indicate a central role for caveolin-1",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -3.486328125,
            "text": "these results clearly indicate a central role for caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -5.140625,
            "end_logit": -9.9453125,
            "text": "1 in",
            "probability": 0.0
        },
        {
            "start_logit": -5.140625,
            "end_logit": -10.296875,
            "text": "1 in promoting cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -11.0703125,
            "end_logit": -6.8359375,
            "text": "-",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -6.8359375,
            "text": "these results clearly indicate a central role for caveolin-",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.0,
            "text": "these results clearly indicate a central role",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.234375,
            "text": "these results clearly indicate",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.2421875,
            "text": "these results clearly indicate a central role for",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.515625,
            "text": "these results clearly indicate a",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.6875,
            "text": "these results clearly indicate a central",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.703125,
            "text": "these results",
            "probability": 0.0
        },
        {
            "start_logit": -11.2109375,
            "end_logit": -9.7734375,
            "text": "these results clearly",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_24": [
        {
            "start_logit": 11.3515625,
            "end_logit": 11.9375,
            "text": "ras",
            "probability": 1.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": 11.9375,
            "text": "oncogenic ras",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -6.46484375,
            "text": "ras or activated mek1",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -7.90625,
            "text": "ras or activated mek1 with p53",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -7.98828125,
            "text": "ras or activated mek",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -8.375,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -8.6640625,
            "text": "ras or activated mek1 with p53 enhanced both p53",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -8.796875,
            "text": "ras or activated",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.265625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.421875,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.546875,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.640625,
            "text": "ras or",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.640625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest that",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.6640625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.7890625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.796875,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity",
            "probability": 0.0
        },
        {
            "start_logit": 11.3515625,
            "end_logit": -9.8203125,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels",
            "probability": 0.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": -6.46484375,
            "text": "oncogenic ras or activated mek1",
            "probability": 0.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": -7.90625,
            "text": "oncogenic ras or activated mek1 with p53",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_25": [
        {
            "start_logit": 11.15625,
            "end_logit": 11.7109375,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -8.265625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.546875,
            "text": "MYC is sufficient to induce sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.6796875,
            "text": "MYC is sufficient to induce sustained tumor",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.8125,
            "text": "MYC is sufficient",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 11.7109375,
            "text": "suppression of oncogenic levels of MYC",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.9296875,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis,",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.9375,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.9453125,
            "text": "MYC is sufficient to",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.96875,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known as oncogene addiction",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.984375,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -9.9921875,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -10.0078125,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -10.0546875,
            "text": "MYC is",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -10.0625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -10.109375,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation",
            "probability": 0.0
        },
        {
            "start_logit": 11.15625,
            "end_logit": -10.1171875,
            "text": "MYC is sufficient to induce sustained tumor regression associated",
            "probability": 0.0
        },
        {
            "start_logit": -10.9296875,
            "end_logit": 11.7109375,
            "text": "levels of MYC",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -8.140625,
            "text": "suppression of oncogenic levels of",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -8.265625,
            "text": "apoptosis",
            "probability": 0.0
        }
    ],
    "6206b8c2c9dfcb9c0900003c_1": [
        {
            "start_logit": 5.70703125,
            "end_logit": 11.5234375,
            "text": "MEK/ERK",
            "probability": 0.99609375
        },
        {
            "start_logit": 0.1514892578125,
            "end_logit": 11.5234375,
            "text": ") MEK/ERK",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": 5.70703125,
            "end_logit": 2.572265625,
            "text": "MEK",
            "probability": 0.00012886524200439453
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 11.5234375,
            "text": "ERK",
            "probability": 2.4974346160888672e-05
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -1.095703125,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS-MMP2",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -1.2041015625,
            "text": "MEK/ERK, 2) PI3K/AKT",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.03125,
            "end_logit": 11.5234375,
            "text": "1) MEK/ERK",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 11.5234375,
            "text": "migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.9375,
            "end_logit": 11.5234375,
            "text": "EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -2.19140625,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS-MMP2/9, 3) RHO-GTPases, 4) integrin",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -2.689453125,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.1514892578125,
            "end_logit": 2.572265625,
            "text": ") MEK",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -9.234375,
            "end_logit": 11.5234375,
            "text": "/ERK",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -4.0078125,
            "text": "MEK/ERK, 2) PI3K",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -4.7734375,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS-MMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -4.7734375,
            "text": "MEK/ERK,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -5.29296875,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS-MMP2/9",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -6.20703125,
            "text": "MEK/ERK, 2) PI3K/AKT/eNOS-MMP2/9, 3) RHO-GTPases",
            "probability": 0.0
        },
        {
            "start_logit": 0.1514892578125,
            "end_logit": -1.095703125,
            "text": ") MEK/ERK, 2) PI3K/AKT/eNOS-MMP2",
            "probability": 0.0
        },
        {
            "start_logit": 0.1514892578125,
            "end_logit": -1.2041015625,
            "text": ") MEK/ERK, 2) PI3K/AKT",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_1": [
        {
            "start_logit": 13.9375,
            "end_logit": 12.9140625,
            "text": "Mannose 6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -1.84375,
            "text": "Mannose 6-phosphate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 13.9375,
            "end_logit": -3.517578125,
            "text": "Mannose",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.9375,
            "end_logit": -4.69140625,
            "text": "Mannose 6-phosphate receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -5.53125,
            "text": "Mannose 6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 12.9140625,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -6.07421875,
            "text": "Mannose 6-phosphate receptors (MPR",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -6.77734375,
            "text": "Mannose 6-phosphate receptors (MPRs) are known",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -6.96875,
            "text": "Mannose 6",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -7.46875,
            "text": "Mannose 6-phosphate receptors (",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -7.8046875,
            "text": "Mannose 6-",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -7.87109375,
            "text": "Mannose 6-phosphate receptors (MPRs) are",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -8.7890625,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.1171875,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.328125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and endosomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.53125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and endosomes,",
            "probability": 0.0
        },
        {
            "start_logit": 13.9375,
            "end_logit": -9.6875,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttle",
            "probability": 0.0
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.69140625,
            "text": "receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -5.53125,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -6.07421875,
            "text": "receptors (MPR",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_2": [
        {
            "start_logit": 13.7734375,
            "end_logit": 13.7109375,
            "text": "sortilin",
            "probability": 1.0
        },
        {
            "start_logit": 13.7734375,
            "end_logit": -4.15234375,
            "text": "sort",
            "probability": 0.0
        },
        {
            "start_logit": -4.2578125,
            "end_logit": 13.7109375,
            "text": "ilin",
            "probability": 0.0
        },
        {
            "start_logit": 13.7734375,
            "end_logit": -9.265625,
            "text": "sortilin.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.7109375,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.7109375,
            "text": "hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 13.7109375,
            "text": "sorted and trafficked to the lysosomes by sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 13.7109375,
            "text": "lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 13.7109375,
            "text": "trafficked to the lysosomes by sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -4.2578125,
            "end_logit": -9.265625,
            "text": "ilin.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -4.15234375,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -4.15234375,
            "text": "hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": -4.15234375,
            "text": "sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -4.15234375,
            "text": "lysosomal hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": -4.15234375,
            "text": "trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -8.0234375,
            "text": "soluble lysosomal hydrolases",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -8.4140625,
            "text": "soluble lysosomal hydrolases,",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -8.0234375,
            "text": "hydrolases",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -8.578125,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": -8.0234375,
            "text": "lysosomal hydrolases",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_3": [
        {
            "start_logit": 10.75,
            "end_logit": 11.8359375,
            "text": "sortilin",
            "probability": 1.0
        },
        {
            "start_logit": 3.5390625,
            "end_logit": 3.1953125,
            "text": "Mannose-6-phosphate receptors",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 11.8359375,
            "text": "ilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.75,
            "end_logit": -5.09375,
            "text": "sortilin has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.75,
            "end_logit": -6.41015625,
            "text": "sortilin has also been implicated",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -6.515625,
            "text": "sortilin has also",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -6.74609375,
            "text": "sort",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -7.125,
            "text": "sortilin has also been",
            "probability": 0.0
        },
        {
            "start_logit": 10.75,
            "end_logit": -7.375,
            "text": "sortilin has also been implicated in this transport",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 11.8359375,
            "text": "receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 11.8359375,
            "text": "endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 11.8359375,
            "text": "(MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 11.8359375,
            "text": "MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 11.8359375,
            "text": "s) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.8359375,
            "text": "trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 11.8359375,
            "text": "multi-ligand receptor sortilin",
            "probability": 0.0
        },
        {
            "start_logit": 3.5390625,
            "end_logit": -3.19921875,
            "text": "Mannose-6-phosphate",
            "probability": 0.0
        },
        {
            "start_logit": 3.5390625,
            "end_logit": -3.634765625,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": 3.5390625,
            "end_logit": -5.39453125,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 0.0
        },
        {
            "start_logit": 3.5390625,
            "end_logit": -5.64453125,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_4": [
        {
            "start_logit": 13.25,
            "end_logit": 13.0546875,
            "text": "sortilin",
            "probability": 1.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -4.75,
            "text": "sort",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 13.0546875,
            "text": "ilin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 13.0546875,
            "text": "LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": 13.25,
            "end_logit": -7.54296875,
            "text": "sortilin,",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 13.0546875,
            "text": "M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -9.5,
            "end_logit": 13.0546875,
            "text": "lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 13.0546875,
            "text": "2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.0546875,
            "text": "P-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 13.0546875,
            "text": "protein (LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 13.0546875,
            "text": "receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.3125,
            "end_logit": 13.0546875,
            "text": "integral membrane protein (LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 13.0546875,
            "text": "(LIMP-2) and sortilin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -4.75,
            "text": "LIMP-2) and sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -5.1953125,
            "text": "LIMP-2",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -7.54296875,
            "text": "ilin,",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -4.75,
            "text": "M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sort",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -5.1953125,
            "text": "M6P alternative receptors, lysosomal integral membrane protein (LIMP-2",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -6.62890625,
            "text": "LIMP",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -6.0390625,
            "text": "M6P alternative receptors, lysosomal integral membrane protein",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_5": [
        {
            "start_logit": 12.6953125,
            "end_logit": 11.8203125,
            "text": "cation-independent mannose 6-phosphate receptor",
            "probability": 1.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": 2.119140625,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -2.798828125,
            "text": "cation-independent mannose 6-phosphate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -3.48046875,
            "text": "cation-independent mannose 6-phosphate receptor (CI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -4.31640625,
            "text": "cation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -5.984375,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR)",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -6.47265625,
            "text": "cation-independent mannose 6",
            "probability": 0.0
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 11.8203125,
            "text": "receptor",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.3828125,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.6484375,
            "text": "cation-independent mannose",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.8046875,
            "text": "cation-independent",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.21875,
            "text": "cation-independent mannose 6-phosphate receptor (",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.234375,
            "text": "cation-independent mannose 6-phosphate receptor (CI-",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": 11.8203125,
            "text": "mannose 6-phosphate receptor",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.4921875,
            "text": "cation-independent mannose 6-",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.9375,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.2578125,
            "text": "cation-",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.390625,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors from the TGN to endosomes",
            "probability": 0.0
        },
        {
            "start_logit": -9.5,
            "end_logit": 11.8203125,
            "text": "independent mannose 6-phosphate receptor",
            "probability": 0.0
        },
        {
            "start_logit": 0.126953125,
            "end_logit": 2.119140625,
            "text": "CI-MPR",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_6": [
        {
            "start_logit": 13.390625,
            "end_logit": 12.671875,
            "text": "Mannose-6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -1.2548828125,
            "text": "Mannose-6-phosphate",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 13.390625,
            "end_logit": -3.458984375,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.390625,
            "end_logit": -3.96484375,
            "text": "Mannose",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.390625,
            "end_logit": -4.4453125,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.390625,
            "end_logit": -5.73046875,
            "text": "Mannose-6",
            "probability": 0.0
        },
        {
            "start_logit": -5.5390625,
            "end_logit": 12.671875,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -6.4765625,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -6.62109375,
            "text": "Mannose-6-",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -7.59375,
            "text": "Mannose-",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.1484375,
            "text": "Mannose-6-phosphate receptors (",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -8.6796875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.0625,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.0859375,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.296875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.421875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes.",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.734375,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN)",
            "probability": 0.0
        },
        {
            "start_logit": 13.390625,
            "end_logit": -9.96875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from",
            "probability": 0.0
        },
        {
            "start_logit": -5.5390625,
            "end_logit": -3.458984375,
            "text": "receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -5.5390625,
            "end_logit": -4.4453125,
            "text": "receptors (MPR",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_7": [
        {
            "start_logit": 12.90625,
            "end_logit": 8.890625,
            "text": "mannose 6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -2.474609375,
            "text": "mannose 6-phosphate",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 12.90625,
            "end_logit": -3.78125,
            "text": "mannose 6-phosphate receptors (MPRs",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 12.90625,
            "end_logit": -4.875,
            "text": "mannose 6-phosphate receptors (MPR",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 12.90625,
            "end_logit": -4.9296875,
            "text": "mannose",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 12.90625,
            "end_logit": -6.20703125,
            "text": "mannose 6-phosphate receptors (MPRs)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 12.90625,
            "end_logit": -7.10546875,
            "text": "mannose 6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.90625,
            "end_logit": -7.9453125,
            "text": "mannose 6-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.90625,
            "end_logit": -8.25,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.90625,
            "end_logit": -8.71875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the late endos",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -8.78125,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -8.8125,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -8.9453125,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -9.125,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -9.15625,
            "text": "mannose 6-phosphate receptors (",
            "probability": 0.0
        },
        {
            "start_logit": 12.90625,
            "end_logit": -9.5859375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 8.890625,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 8.890625,
            "text": "Two related mannose 6-phosphate receptors",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -3.78125,
            "text": "receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -2.474609375,
            "text": "Two related mannose 6-phosphate",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_8": [
        {
            "start_logit": 12.953125,
            "end_logit": 11.9609375,
            "text": "Mannose-6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -1.392578125,
            "text": "Mannose-6-phosphate",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 12.953125,
            "end_logit": -4.015625,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.953125,
            "end_logit": -4.31640625,
            "text": "Mannose",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.953125,
            "end_logit": -4.375,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.86328125,
            "text": "Mannose-6",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -5.921875,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -6.71484375,
            "text": "Mannose-6-",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 11.9609375,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.60546875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.609375,
            "text": "Mannose-",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -7.94921875,
            "text": "Mannose-6-phosphate receptors (",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.3984375,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.578125,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -8.875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN)",
            "probability": 0.0
        },
        {
            "start_logit": 12.953125,
            "end_logit": -9.1796875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -4.015625,
            "text": "receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -4.375,
            "text": "receptors (MPR",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -5.921875,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -9.2109375,
            "end_logit": -4.015625,
            "text": "MPRs",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_9": [
        {
            "start_logit": 13.7890625,
            "end_logit": 12.59375,
            "text": "Mannose 6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -1.802734375,
            "text": "Mannose 6-phosphate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -3.693359375,
            "text": "Mannose",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -4.8515625,
            "text": "Mannose 6-phosphate receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -5.27734375,
            "text": "Mannose 6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -5.9375,
            "text": "Mannose 6-phosphate receptors (MPR",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": 12.59375,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -6.70703125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.03515625,
            "text": "Mannose 6",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.44140625,
            "text": "Mannose 6-phosphate receptors (",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.73828125,
            "text": "Mannose 6-phosphate receptors (MPRs) are",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.8515625,
            "text": "Mannose 6-",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -8.78125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.203125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.453125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and endosomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.5546875,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be shuttled between the trans-Golgi network (TGN) and endosomes,",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.6796875,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -4.8515625,
            "text": "receptors (MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -5.27734375,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -5.9375,
            "text": "receptors (MPR",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_10": [
        {
            "start_logit": 12.59375,
            "end_logit": 7.55859375,
            "text": "mannose 6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 12.59375,
            "end_logit": -2.169921875,
            "text": "mannose 6-phosphate",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 12.59375,
            "end_logit": -4.453125,
            "text": "mannose 6-phosphate receptors (MPRs",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 12.59375,
            "end_logit": -4.7578125,
            "text": "mannose 6-phosphate receptors (MPR",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 12.59375,
            "end_logit": -5.28125,
            "text": "mannose",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 12.59375,
            "end_logit": -5.7421875,
            "text": "mannose 6-phosphate receptors (MPRs)",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 12.59375,
            "end_logit": -7.12109375,
            "text": "mannose 6",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -7.5703125,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the late endos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -7.94140625,
            "text": "mannose 6-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.1875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.4296875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.7109375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.75,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the late",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.75,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.59375,
            "end_logit": -8.859375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.59375,
            "end_logit": -9.0625,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.75,
            "end_logit": 7.55859375,
            "text": "receptors",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 7.55859375,
            "text": "Two related mannose 6-phosphate receptors",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -2.169921875,
            "text": "Two related mannose 6-phosphate",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -4.453125,
            "text": "receptors (MPRs",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_1": [
        {
            "start_logit": 12.9296875,
            "end_logit": 11.0625,
            "text": "congenital toxoplasmosis",
            "probability": 1.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": 11.0625,
            "text": "Retinochoroiditis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 3.166015625,
            "end_logit": 5.0859375,
            "text": "Retinochoroiditis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.9296875,
            "end_logit": -4.82421875,
            "text": "congenital",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 11.0625,
            "text": "toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 11.0625,
            "text": "itis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 11.0625,
            "text": "ochoroiditis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 11.0625,
            "text": "oiditis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 11.0625,
            "text": "oroiditis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -4.82421875,
            "text": "Retinochoroiditis is the most frequent manifestation of congenital",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 5.0859375,
            "text": "itis",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -7.0546875,
            "text": "Retinochor",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 5.0859375,
            "text": "ochoroiditis",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -7.6484375,
            "text": "Retin",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -7.6875,
            "text": "Retinoch",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -8.1484375,
            "text": "Retinochoroid",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 5.0859375,
            "text": "oiditis",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -8.4609375,
            "text": "Retinochoroiditis is the most frequent manifestation",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -8.640625,
            "text": "Retinochoroiditis is the",
            "probability": 0.0
        },
        {
            "start_logit": 3.166015625,
            "end_logit": -8.7109375,
            "text": "Retinochoroiditis is the most frequent manifestation of",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_2": [
        {
            "start_logit": 0.845703125,
            "end_logit": 2.66796875,
            "text": "toxoplasmosis",
            "probability": 0.9990234375
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 2.66796875,
            "text": "Infectious uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis",
            "probability": 0.0010986328125
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 2.66796875,
            "text": "posterior uveitis cases of which toxoplasmosis",
            "probability": 0.00010460615158081055
        },
        {
            "start_logit": -9.6484375,
            "end_logit": 2.66796875,
            "text": "uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -8.0546875,
            "text": "toxoplasmosis was",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": -9.90625,
            "end_logit": 2.66796875,
            "text": "of which toxoplasmosis",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -8.2265625,
            "text": "toxoplasmosis was the",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": -10.0625,
            "end_logit": 2.66796875,
            "text": "37% of posterior uveitis cases of which toxoplasmosis",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -8.578125,
            "text": "toxoplasmosis was the most common cause.",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -8.7421875,
            "text": "toxoplasmosis was the most common cause",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -10.640625,
            "end_logit": 2.66796875,
            "text": "which toxoplasmosis",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -8.828125,
            "text": "toxoplasmosis was the most common",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -10.78125,
            "end_logit": 2.66796875,
            "text": "uveitis cases of which toxoplasmosis",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": -10.8125,
            "end_logit": 2.66796875,
            "text": "of posterior uveitis cases of which toxoplasmosis",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 0.845703125,
            "end_logit": -9.21875,
            "text": "toxoplasmosis was the most",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -2.58203125,
            "text": "Infectious uveitis",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -4.96875,
            "text": "Infectious uveitis accounted for 37% of posterior uveitis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -9.6484375,
            "end_logit": -2.58203125,
            "text": "uveitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -7.08984375,
            "text": "Infectious uveitis accounted for 37% of posterior uveitis cases of which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -4.96875,
            "text": "posterior uveitis",
            "probability": 5.960464477539063e-08
        }
    ],
    "601d72181cb411341a000034_3": [
        {
            "start_logit": -5.99609375,
            "end_logit": -1.3759765625,
            "text": "posterior uveitis",
            "probability": 0.78955078125
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -1.3759765625,
            "text": "Toxoplasmosis was the most common cause of posterior uveitis",
            "probability": 0.09320068359375
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -3.625,
            "text": "posterior uveitis (60%)",
            "probability": 0.0828857421875
        },
        {
            "start_logit": -10.09375,
            "end_logit": -1.3759765625,
            "text": "uveitis",
            "probability": 0.01312255859375
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -3.625,
            "text": "Toxoplasmosis was the most common cause of posterior uveitis (60%)",
            "probability": 0.00982666015625
        },
        {
            "start_logit": -11.2890625,
            "end_logit": -1.3759765625,
            "text": "of posterior uveitis",
            "probability": 0.003971099853515625
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -7.58203125,
            "text": "posterior uveitis (60",
            "probability": 0.0015916824340820312
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -7.609375,
            "text": "posterior",
            "probability": 0.0015420913696289062
        },
        {
            "start_logit": -10.09375,
            "end_logit": -3.625,
            "text": "uveitis (60%)",
            "probability": 0.0013828277587890625
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -8.359375,
            "text": "posterior uveitis (60%",
            "probability": 0.000728607177734375
        },
        {
            "start_logit": -11.1171875,
            "end_logit": -3.625,
            "text": "60%)",
            "probability": 0.0004963874816894531
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -8.90625,
            "text": "posterior uveitis (",
            "probability": 0.00042176246643066406
        },
        {
            "start_logit": -11.2890625,
            "end_logit": -3.625,
            "text": "of posterior uveitis (60%)",
            "probability": 0.0004181861877441406
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -7.58203125,
            "text": "Toxoplasmosis was the most common cause of posterior uveitis (60",
            "probability": 0.00018775463104248047
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -7.609375,
            "text": "Toxoplasmosis was the most common cause of posterior",
            "probability": 0.00018203258514404297
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -8.203125,
            "text": "Toxoplasmosis",
            "probability": 0.0001004934310913086
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -8.359375,
            "text": "Toxoplasmosis was the most common cause of posterior uveitis (60%",
            "probability": 8.594989776611328e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -8.4375,
            "text": "Toxoplasmosis was the most common cause of",
            "probability": 8.07642936706543e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -8.46875,
            "text": "Toxoplasmosis was the most common",
            "probability": 7.832050323486328e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -8.5859375,
            "text": "Toxoplasmosis was the",
            "probability": 6.908178329467773e-05
        }
    ],
    "601d72181cb411341a000034_4": [
        {
            "start_logit": 3.7734375,
            "end_logit": 6.79296875,
            "text": "syphilis",
            "probability": 0.9970703125
        },
        {
            "start_logit": -2.70703125,
            "end_logit": 6.79296875,
            "text": "ocular syphilis",
            "probability": 0.0015344619750976562
        },
        {
            "start_logit": -3.1484375,
            "end_logit": 6.79296875,
            "text": "toxoplasmosis, ocular syphilis",
            "probability": 0.0009870529174804688
        },
        {
            "start_logit": -4.24609375,
            "end_logit": 6.79296875,
            "text": "herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 0.0003292560577392578
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 6.79296875,
            "text": "itis, ocular toxoplasmosis, ocular syphilis",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 3.7734375,
            "end_logit": -5.52734375,
            "text": "syphilis, and bacterial endophthalmitis increased",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -8.984375,
            "end_logit": 6.79296875,
            "text": "infectious uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 6.79296875,
            "text": "ocular toxoplasmosis, ocular syphilis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -9.78125,
            "end_logit": 6.79296875,
            "text": "iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 6.79296875,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 3.7734375,
            "end_logit": -7.31640625,
            "text": "syphilis, and bacterial endophthalmitis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -10.453125,
            "end_logit": 6.79296875,
            "text": ", ocular syphilis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -3.1484375,
            "end_logit": -1.1318359375,
            "text": "toxoplasmosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 3.7734375,
            "end_logit": -8.65625,
            "text": "syphilis, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -1.1318359375,
            "text": "herpetic iridocyclitis, ocular toxoplasmosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.7734375,
            "end_logit": -9.3984375,
            "text": "syphilis,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -1.9794921875,
            "text": "herpetic iridocyclitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.70703125,
            "end_logit": -5.52734375,
            "text": "ocular syphilis, and bacterial endophthalmitis increased",
            "probability": 0.0
        },
        {
            "start_logit": -3.1484375,
            "end_logit": -5.52734375,
            "text": "toxoplasmosis, ocular syphilis, and bacterial endophthalmitis increased",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": -1.1318359375,
            "text": "itis, ocular toxoplasmosis",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_5": [
        {
            "start_logit": -1.9267578125,
            "end_logit": 0.3681640625,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis",
            "probability": 0.49560546875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": 0.3681640625,
            "text": "posterior uveitis",
            "probability": 0.465087890625
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -2.232421875,
            "text": "Toxoplasmosis",
            "probability": 0.0367431640625
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -6.31640625,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and congenital toxoplasmosis",
            "probability": 0.0006203651428222656
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.31640625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis",
            "probability": 0.0005826950073242188
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -7.34765625,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission",
            "probability": 0.00022113323211669922
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -7.34765625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission",
            "probability": 0.00020778179168701172
        },
        {
            "start_logit": -10.4375,
            "end_logit": 0.3681640625,
            "text": "uveitis",
            "probability": 9.924173355102539e-05
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 0.3681640625,
            "text": "cause of posterior uveitis",
            "probability": 8.487701416015625e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -8.921875,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was",
            "probability": 4.547834396362305e-05
        },
        {
            "start_logit": -4.58203125,
            "end_logit": -6.31640625,
            "text": "congenital toxoplasmosis",
            "probability": 4.3392181396484375e-05
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -8.921875,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -8.9921875,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -8.9921875,
            "text": "posterior uveitis in immunocompetent subjects and",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -9.2734375,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -9.2734375,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite",
            "probability": 3.0279159545898438e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -9.390625,
            "text": "Toxoplasmosis is the most common",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -9.6640625,
            "text": "Toxoplasmosis is the most common cause of",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -9.7109375,
            "text": "Toxoplasmosis is the most common cause of posterior",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -9.7421875,
            "text": "Toxoplasmosis is the",
            "probability": 2.0205974578857422e-05
        }
    ],
    "601d72181cb411341a000034_6": [
        {
            "start_logit": 9.515625,
            "end_logit": 10.4375,
            "text": "Retinochoroiditis",
            "probability": 1.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -3.427734375,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 10.4375,
            "text": "itis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -5.9296875,
            "text": "Retin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -6.609375,
            "text": "Retinochor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.59765625,
            "text": "Retinoch",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.4375,
            "text": "ochoroiditis",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.1171875,
            "text": "Retinochoroid",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 10.4375,
            "text": "oiditis",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.609375,
            "text": "Retinochoroiditis is",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.984375,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis,",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.0078125,
            "text": "Retinochoroiditis is the",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.3359375,
            "text": "Retinochoroiditis is the most common",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 10.4375,
            "text": "oroiditis",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.7734375,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.796875,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.796875,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.8046875,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur.",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.8828125,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -9.921875,
            "text": "Retinochoroiditis is the most common ocular manifestation",
            "probability": 0.0
        }
    ],
    "5162e44f298dcd4e5100004a_1": [
        {
            "start_logit": 3.125,
            "end_logit": -4.21875,
            "text": "Convection-enhanced delivery",
            "probability": 0.90234375
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.296875,
            "text": "Convection-enhanced delivery of neprilysin:",
            "probability": 0.01528167724609375
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.3671875,
            "text": "Convection-enhanced delivery of neprilysin",
            "probability": 0.014251708984375
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.4609375,
            "text": "Convection-enhanced",
            "probability": 0.012969970703125
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.5546875,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2",
            "probability": 0.011810302734375
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.8984375,
            "text": "Convection-enhanced delivery of",
            "probability": 0.0083770751953125
        },
        {
            "start_logit": 3.125,
            "end_logit": -8.953125,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy",
            "probability": 0.00792694091796875
        },
        {
            "start_logit": 3.125,
            "end_logit": -9.15625,
            "text": "Convection-enhanced delivery of neprilysin: a",
            "probability": 0.0064697265625
        },
        {
            "start_logit": 3.125,
            "end_logit": -9.3359375,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy.",
            "probability": 0.005405426025390625
        },
        {
            "start_logit": 3.125,
            "end_logit": -9.421875,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid",
            "probability": 0.004962921142578125
        },
        {
            "start_logit": 3.125,
            "end_logit": -9.484375,
            "text": "Conve",
            "probability": 0.00466156005859375
        },
        {
            "start_logit": 3.125,
            "end_logit": -9.9453125,
            "text": "Convection-enhanced delivery of neprilysin: a novel",
            "probability": 0.0029392242431640625
        },
        {
            "start_logit": 3.125,
            "end_logit": -10.1015625,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading",
            "probability": 0.002513885498046875
        },
        {
            "start_logit": -9.921875,
            "end_logit": -4.21875,
            "text": "ction-enhanced delivery",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -10.46875,
            "end_logit": -4.21875,
            "text": "ion-enhanced delivery",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -10.609375,
            "end_logit": -4.21875,
            "text": "enhanced delivery",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -8.6796875,
            "end_logit": -8.5546875,
            "text": "amyloid-\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -8.296875,
            "text": "neprilysin:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -8.3671875,
            "text": "neprilysin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6796875,
            "end_logit": -8.953125,
            "text": "amyloid-\u03b2-degrading therapeutic strategy",
            "probability": 5.960464477539063e-08
        }
    ],
    "6025a1e91cb411341a0000b4_1": [
        {
            "start_logit": 11.3828125,
            "end_logit": 10.71875,
            "text": "methotrexate",
            "probability": 1.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -6.78125,
            "text": "methotrexate (MTX",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -7.3515625,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": 10.71875,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.6015625,
            "text": "methotrexate (MTX), leflunomide",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.703125,
            "text": "methotrexate (MTX), lefluno",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.765625,
            "text": "methotrexate (MTX), leflu",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -6.78125,
            "text": "MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -7.3515625,
            "text": "MTX), leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": -6.78125,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate (MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": -7.6953125,
            "text": "task force",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": -7.3515625,
            "text": ", leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -8.625,
            "text": "(tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -7.3515625,
            "text": "leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -7.3515625,
            "text": ", sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": -8.625,
            "text": "tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -8.625,
            "text": "ol, etanercept, golimumab, infliximab",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -9.421875,
            "text": "(tumour necrosis factor inhibitors (adalimumab, certolizumab pegol",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -9.5234375,
            "text": "MTX), leflunomide, sulfasalazine); glucocorticoids (GCs); biological (b) DMARDs (tumour necrosis factor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -9.6015625,
            "text": "MTX), leflunomide",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_2": [
        {
            "start_logit": 11.328125,
            "end_logit": 10.4296875,
            "text": "methotrexate",
            "probability": 1.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -7.17578125,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -7.4453125,
            "text": "methotrexate (MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.4296875,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": 11.328125,
            "end_logit": -9.8046875,
            "text": "methotrexate (MTX), leflunomide",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 10.4296875,
            "text": "(methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -7.17578125,
            "text": "MTX), leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -7.4453125,
            "text": "MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -7.4453125,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate (MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -7.640625,
            "text": "task force",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -8.1796875,
            "text": "tofacitinib",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": -7.17578125,
            "text": ", leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -7.17578125,
            "text": "(methotrexate (MTX), leflunomide, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -7.17578125,
            "text": "sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -7.17578125,
            "text": ", sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -7.4453125,
            "text": "(methotrexate (MTX",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -8.7734375,
            "text": "tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -8.7734375,
            "text": "(tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab",
            "probability": 0.0
        },
        {
            "start_logit": -9.1484375,
            "end_logit": -8.1796875,
            "text": "and biosimilar (bs) DMARDs) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -9.0703125,
            "text": "tofacitinib, baricitinib",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_3": [
        {
            "start_logit": 11.046875,
            "end_logit": 12.21875,
            "text": "methotrexate",
            "probability": 1.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -6.24609375,
            "text": "methotrexate, sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -6.34765625,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -7.296875,
            "text": "methotrexate, sulfasalazine, leflunomide",
            "probability": 0.0
        },
        {
            "start_logit": -9.546875,
            "end_logit": 12.21875,
            "text": "DMARDs such as methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -8.8515625,
            "text": "methotrexate, sulfasal",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 12.21875,
            "text": "synthetic DMARDs such as methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -8.9453125,
            "text": "methotrexate, sulfasalazine, lefluno",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.0390625,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxych",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.109375,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 12.21875,
            "text": "RDs such as methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 12.21875,
            "text": "Conventional synthetic DMARDs such as methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.328125,
            "text": "methotrexate, sulfasalazine, leflu",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.359375,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.375,
            "text": "methotrexate, sulf",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.3984375,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative period",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.4453125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychlor",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.46875,
            "text": "methotrexate, sulfasalazine, leflunomi",
            "probability": 0.0
        },
        {
            "start_logit": 11.046875,
            "end_logit": -9.6953125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -6.34765625,
            "text": "hydroxychloroquine",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_4": [
        {
            "start_logit": 13.015625,
            "end_logit": 13.359375,
            "text": "tofacitinib",
            "probability": 1.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": 13.359375,
            "text": "tinib",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -4.8984375,
            "text": "tof",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -5.7890625,
            "text": "tofacitinib, fostamatinib",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -7.40625,
            "text": "tofacitinib, fostamatinib, baricitinib or apremilast",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -7.67578125,
            "text": "tofacitinib, fostamatinib, baricitinib",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -7.96484375,
            "text": "tofaci",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -8.015625,
            "text": "tofacitinib, fos",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -8.6015625,
            "text": "tofacitinib, fostama",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -8.765625,
            "text": "tofacitinib, fosta",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.1953125,
            "text": "tofacitinib, fostamatinib, baricitinib or apremilast, or agents not focused primarily on rheumatic diseases, such as imatinib",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 13.359375,
            "text": "tsDMARDs would then constitute only those that were specifically developed to target a particular molecular structure (such as tofacitinib",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 13.359375,
            "text": "acitinib",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.5546875,
            "text": "tofacitinib, fostamatinib, barici",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -5.7890625,
            "text": "tinib, fostamatinib",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -7.40625,
            "text": "tinib, fostamatinib, baricitinib or apremilast",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -7.67578125,
            "text": "tinib, fostamatinib, baricitinib",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -8.015625,
            "text": "tinib, fos",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -8.6015625,
            "text": "tinib, fostama",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -8.765625,
            "text": "tinib, fosta",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_1": [
        {
            "start_logit": 5.73046875,
            "end_logit": 6.828125,
            "text": "lambdoid",
            "probability": 0.96533203125
        },
        {
            "start_logit": 5.73046875,
            "end_logit": 3.419921875,
            "text": "lambdoid sutures",
            "probability": 0.03173828125
        },
        {
            "start_logit": -0.07684326171875,
            "end_logit": 6.828125,
            "text": "sagittal and both lambdoid",
            "probability": 0.0028858184814453125
        },
        {
            "start_logit": -0.07684326171875,
            "end_logit": 3.419921875,
            "text": "sagittal and both lambdoid sutures",
            "probability": 9.572505950927734e-05
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.828125,
            "text": "trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.73046875,
            "end_logit": -6.89453125,
            "text": "lambd",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -8.6875,
            "end_logit": 6.828125,
            "text": "both lambdoid",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.8125,
            "end_logit": 6.828125,
            "text": "oid",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.73046875,
            "end_logit": -8.1484375,
            "text": "lamb",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.07684326171875,
            "end_logit": -2.48828125,
            "text": "sagittal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 6.828125,
            "text": "doid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 6.828125,
            "text": "utural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 6.828125,
            "text": "\" involving the sagittal and both lambdoid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.609375,
            "end_logit": 6.828125,
            "text": "Mercedes Benz pattern,\" involving the sagittal and both lambdoid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 3.419921875,
            "text": "trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid sutures",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 3.419921875,
            "text": "sutures",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": 3.419921875,
            "text": "both lambdoid sutures",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 3.419921875,
            "text": "oid sutures",
            "probability": 0.0
        },
        {
            "start_logit": -0.07684326171875,
            "end_logit": -6.89453125,
            "text": "sagittal and both lambd",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 3.419921875,
            "text": "doid sutures",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_2": [
        {
            "start_logit": 12.2734375,
            "end_logit": 12.6484375,
            "text": "sagittal suture",
            "probability": 1.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -4.9921875,
            "text": "sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 12.6484375,
            "text": "suture",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -8.375,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -8.6875,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -9.2890625,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -9.5859375,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 12.6484375,
            "text": "CONCLUSIONS: Despite fusion of the sagittal suture",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 12.6484375,
            "text": ": Despite fusion of the sagittal suture",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.1953125,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening,",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.21875,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.2734375,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.3203125,
            "text": "sagittal suture, the surgical",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.390625,
            "text": "sagittal suture, the surgical treatment",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.4140625,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -10.453125,
            "text": "sagittal suture,",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -8.375,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -8.6875,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -9.2890625,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -9.5859375,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_3": [
        {
            "start_logit": 8.4296875,
            "end_logit": 8.3125,
            "text": "bilateral lambdoid",
            "probability": 0.958984375
        },
        {
            "start_logit": 8.4296875,
            "end_logit": 5.1640625,
            "text": "bilateral lambdoid and sagittal synostosis",
            "probability": 0.04083251953125
        },
        {
            "start_logit": 1.0380859375,
            "end_logit": 5.1640625,
            "text": "sagittal synostosis",
            "probability": 2.5212764739990234e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -5.62890625,
            "text": "bilateral lambdoid and sagittal syn",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.40234375,
            "text": "bilateral lambdoid and sagittal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.51953125,
            "text": "bilateral lambd",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.046875,
            "text": "bilateral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.13671875,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.48828125,
            "text": "bilateral lamb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.3125,
            "text": "lambdoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.984375,
            "text": "bilateral lambdoid and sagittal synostosis (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -8.125,
            "text": "bilateral lambdoid and sagittal synostosis (BL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -8.2578125,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -8.46875,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS) results in a very characteristic head shape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -8.515625,
            "text": "bilateral lambdoid and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 8.3125,
            "text": "oid",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": 8.3125,
            "text": "craniosynostosis that includes bilateral lambdoid",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": 5.1640625,
            "text": "lambdoid and sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 5.1640625,
            "text": "synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 5.1640625,
            "text": "oid and sagittal synostosis",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_4": [
        {
            "start_logit": 11.984375,
            "end_logit": 8.2734375,
            "text": "posterior sagittal synostosis",
            "probability": 0.8759765625
        },
        {
            "start_logit": 11.984375,
            "end_logit": 6.3125,
            "text": "posterior sagittal",
            "probability": 0.124267578125
        },
        {
            "start_logit": 11.984375,
            "end_logit": -5.796875,
            "text": "posterior",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 11.984375,
            "end_logit": -7.03515625,
            "text": "posterior sagittal syn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.517578125,
            "end_logit": 8.2734375,
            "text": "Bilambdoid and posterior sagittal synostosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.517578125,
            "end_logit": 6.3125,
            "text": "Bilambdoid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -9.2265625,
            "text": "posterior sagittal synostosis:",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -9.7890625,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -10.3828125,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -10.4375,
            "text": "posterior sagittal synostosis: the",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 8.2734375,
            "text": "synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.2734375,
            "text": "sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.2734375,
            "text": "ostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": 8.2734375,
            "text": "oid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 8.2734375,
            "text": "ambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 8.2734375,
            "text": "doid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 6.3125,
            "text": "sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": 6.3125,
            "text": "oid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 6.3125,
            "text": "ambdoid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 6.3125,
            "text": "doid and posterior sagittal",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_5": [
        {
            "start_logit": 5.25390625,
            "end_logit": 8.96875,
            "text": "lambdoid sutures",
            "probability": 0.9580078125
        },
        {
            "start_logit": 2.095703125,
            "end_logit": 8.96875,
            "text": "sagittal and bilateral lambdoid sutures",
            "probability": 0.040771484375
        },
        {
            "start_logit": -1.865234375,
            "end_logit": 8.96875,
            "text": "bilateral lambdoid sutures",
            "probability": 0.0007767677307128906
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -0.6796875,
            "text": "lambdoid",
            "probability": 6.22868537902832e-05
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 8.96875,
            "text": "sutures",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 2.095703125,
            "end_logit": -0.6796875,
            "text": "sagittal and bilateral lambdoid",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.96875,
            "text": "craniosynostosis in the sagittal and bilateral lambdoid sutures",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -6.2109375,
            "text": "lambd",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.5,
            "end_logit": 8.96875,
            "text": "oid sutures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 8.96875,
            "text": "in the sagittal and bilateral lambdoid sutures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -7.78515625,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -0.6796875,
            "text": "bilateral lambdoid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -8.421875,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces a characteristic triradiate",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -8.484375,
            "text": "lamb",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -8.609375,
            "text": "lambdoid sutures is described in three patients. The external cranial rid",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -8.9375,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -8.9453125,
            "text": "lambdoid sutures is",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -9.0234375,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces",
            "probability": 0.0
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -9.03125,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated",
            "probability": 0.0
        },
        {
            "start_logit": 2.095703125,
            "end_logit": -6.2109375,
            "text": "sagittal and bilateral lambd",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_6": [
        {
            "start_logit": 11.984375,
            "end_logit": 8.2734375,
            "text": "posterior sagittal synostosis",
            "probability": 0.8759765625
        },
        {
            "start_logit": 11.984375,
            "end_logit": 6.3125,
            "text": "posterior sagittal",
            "probability": 0.124267578125
        },
        {
            "start_logit": 11.984375,
            "end_logit": -5.796875,
            "text": "posterior",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 11.984375,
            "end_logit": -7.03515625,
            "text": "posterior sagittal syn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.517578125,
            "end_logit": 8.2734375,
            "text": "Bilambdoid and posterior sagittal synostosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.517578125,
            "end_logit": 6.3125,
            "text": "Bilambdoid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -9.2265625,
            "text": "posterior sagittal synostosis:",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -9.7890625,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -10.3828125,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 11.984375,
            "end_logit": -10.4375,
            "text": "posterior sagittal synostosis: the",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 8.2734375,
            "text": "synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.2734375,
            "text": "sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.2734375,
            "text": "ostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": 8.2734375,
            "text": "oid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 8.2734375,
            "text": "ambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 8.2734375,
            "text": "doid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 6.3125,
            "text": "sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": 6.3125,
            "text": "oid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 6.3125,
            "text": "ambdoid and posterior sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 6.3125,
            "text": "doid and posterior sagittal",
            "probability": 0.0
        }
    ],
    "553f7a71ab98a37113000009_1": [
        {
            "start_logit": 14.421875,
            "end_logit": 14.546875,
            "text": "nucleotide excision repair",
            "probability": 1.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -0.53271484375,
            "text": "nucleotide excision repair (NER",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 14.421875,
            "end_logit": -2.51171875,
            "text": "nucleotide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.826171875,
            "end_logit": 14.546875,
            "text": "repair",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.421875,
            "end_logit": -5.64453125,
            "text": "nucleotide excision",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -7.078125,
            "text": "nucleotide excision repair (",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -7.359375,
            "text": "nucleotide excision repair (NER)",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.234375,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.2890625,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed genes",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 14.546875,
            "text": "TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.5625,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed genes.",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.578125,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed",
            "probability": 0.0
        },
        {
            "start_logit": 14.421875,
            "end_logit": -9.6015625,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 14.546875,
            "text": "subpathway of nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 14.546875,
            "text": "excision repair",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 14.546875,
            "text": "Transcription-coupled repair (TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 14.546875,
            "text": "of nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": -2.826171875,
            "end_logit": -0.53271484375,
            "text": "repair (NER",
            "probability": 0.0
        },
        {
            "start_logit": -3.787109375,
            "end_logit": -0.53271484375,
            "text": "NER",
            "probability": 0.0
        },
        {
            "start_logit": -2.826171875,
            "end_logit": -7.078125,
            "text": "repair (",
            "probability": 0.0
        }
    ],
    "553f7a71ab98a37113000009_2": [
        {
            "start_logit": 13.703125,
            "end_logit": 14.453125,
            "text": "nucleotide excision repair",
            "probability": 1.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -1.8310546875,
            "text": "nucleotide excision repair (NER",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.78515625,
            "end_logit": 14.453125,
            "text": "repair",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.703125,
            "end_logit": -3.435546875,
            "text": "nucleotide",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -5.3515625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -5.90625,
            "text": "nucleotide excision repair (",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -6.0859375,
            "text": "nucleotide excision",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -7.0,
            "text": "nucleotide excision repair (NER)",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -7.51171875,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC endonuclease",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -7.78515625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts",
            "probability": 0.0
        },
        {
            "start_logit": -8.84375,
            "end_logit": 14.453125,
            "text": "Escherichia coli nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.859375,
            "text": "nucleotide excision repair (NER) is",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.0625,
            "text": "nucleotide excision repair (NER) is responsible",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.5,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the Uvr",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.515625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC endonuclease.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 14.453125,
            "text": "excision repair",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.609375,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrAB",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.640625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 14.453125,
            "text": "coli nucleotide excision repair",
            "probability": 0.0
        },
        {
            "start_logit": -2.78515625,
            "end_logit": -1.8310546875,
            "text": "repair (NER",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_1": [
        {
            "start_logit": 13.6796875,
            "end_logit": 13.0234375,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": 13.0234375,
            "text": "metastatic castration-resistant prostate cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.6796875,
            "end_logit": -3.583984375,
            "text": "prostate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 13.0234375,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": 13.0234375,
            "text": "castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 13.0234375,
            "text": "prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 13.0234375,
            "text": "\u03b1\u03bd integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.0234375,
            "text": "patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 13.0234375,
            "text": "with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 13.0234375,
            "text": "first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 13.0234375,
            "text": "combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 13.0234375,
            "text": "intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.0234375,
            "text": "docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": -3.583984375,
            "text": "metastatic castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": -3.583984375,
            "text": "castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": -8.578125,
            "text": "metastatic castration-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": -8.6953125,
            "text": "metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": -8.859375,
            "text": "metastatic castration",
            "probability": 0.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": -9.375,
            "text": "metastatic castration-",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": -3.583984375,
            "text": "prednisone for the first-line treatment of patients with metastatic castration-resistant prostate",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_2": [
        {
            "start_logit": 14.53125,
            "end_logit": 14.578125,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -2.443359375,
            "text": "prostate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.755859375,
            "end_logit": 14.578125,
            "text": "cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.31640625,
            "end_logit": 14.578125,
            "text": "castration-resistant prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -7.54296875,
            "text": "prostate cancer (CRPC)",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -8.15625,
            "text": "prostate cancer (CRPC",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -8.5703125,
            "text": "prostate cancer (",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -8.65625,
            "text": "prostate cancer (CRPC) patients. PATIENTS AND METHODS: In a phase 2, randomized, double-blind, multicenter study, men with metastatic",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -9.0390625,
            "text": "prostate cancer (CRP",
            "probability": 0.0
        },
        {
            "start_logit": 14.53125,
            "end_logit": -9.3203125,
            "text": "prostate cancer (CRPC) patients. PATIENTS AND METHODS: In a",
            "probability": 0.0
        },
        {
            "start_logit": -4.31640625,
            "end_logit": -2.443359375,
            "text": "castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -7.54296875,
            "text": "cancer (CRPC)",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -8.15625,
            "text": "cancer (CRPC",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -8.2421875,
            "text": "cancer (CRPC) patients. PATIENTS AND METHODS: In a phase 2, randomized, double-blind, multicenter study, men with metastatic CRPC",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -8.5703125,
            "text": "cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -8.65625,
            "text": "cancer (CRPC) patients. PATIENTS AND METHODS: In a phase 2, randomized, double-blind, multicenter study, men with metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -9.0390625,
            "text": "cancer (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -4.31640625,
            "end_logit": -7.54296875,
            "text": "castration-resistant prostate cancer (CRPC)",
            "probability": 0.0
        },
        {
            "start_logit": -2.755859375,
            "end_logit": -9.3203125,
            "text": "cancer (CRPC) patients. PATIENTS AND METHODS: In a",
            "probability": 0.0
        },
        {
            "start_logit": -6.02734375,
            "end_logit": -6.328125,
            "text": "docetaxel",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_3": [
        {
            "start_logit": 10.0703125,
            "end_logit": 11.140625,
            "text": "Melanoma",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.546875,
            "end_logit": 8.3984375,
            "text": "metastatic melanoma",
            "probability": 0.0018815994262695312
        },
        {
            "start_logit": 3.021484375,
            "end_logit": 8.3984375,
            "text": "melanoma",
            "probability": 5.549192428588867e-05
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -4.4921875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -5.58984375,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.8984375,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 8.3984375,
            "text": "Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.046875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer",
            "probability": 0.0
        },
        {
            "start_logit": 6.546875,
            "end_logit": -5.23046875,
            "text": "metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 11.140625,
            "text": "Data from the Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.21875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.2421875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.3984375,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.6875,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.71875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 8.3984375,
            "text": "dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 8.3984375,
            "text": "intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 8.3984375,
            "text": "BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 8.3984375,
            "text": "with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_4": [
        {
            "start_logit": 11.0703125,
            "end_logit": 12.125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 12.125,
            "text": "dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": 12.125,
            "text": "stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 12.125,
            "text": "of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 12.125,
            "text": "with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 12.125,
            "text": "alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 12.125,
            "text": "intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 12.125,
            "text": "randomised, phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 12.125,
            "text": "IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 12.125,
            "text": "and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.125,
            "text": "\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.125,
            "text": "arbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 12.125,
            "text": "phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.125,
            "text": "anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -10.0703125,
            "text": "melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.078125,
            "text": "dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.7890625,
            "text": "dacarbazine in stage IV",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -8.078125,
            "text": "of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -8.7890625,
            "text": "stage IV",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -8.078125,
            "text": "with dacarbazine",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_5": [
        {
            "start_logit": 11.0703125,
            "end_logit": 12.171875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": 12.171875,
            "text": "advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 12.171875,
            "text": "With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 12.171875,
            "text": "intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 12.171875,
            "text": "favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.171875,
            "text": "OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.171875,
            "text": "nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.171875,
            "text": ": With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.171875,
            "text": "tumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 12.171875,
            "text": "CONCLUSION: With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 12.171875,
            "text": "improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 12.171875,
            "text": "umumab merits further investigation in advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.0703125,
            "end_logit": -10.015625,
            "text": "melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -8.765625,
            "text": "With its favourable safety profile and a nonsignificant trend towards improved OS",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": -9.7734375,
            "text": "advanced",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -8.765625,
            "text": "favourable safety profile and a nonsignificant trend towards improved OS",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -8.765625,
            "text": "OS",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": -10.015625,
            "text": "advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -8.765625,
            "text": "nonsignificant trend towards improved OS",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": -8.765625,
            "text": ": With its favourable safety profile and a nonsignificant trend towards improved OS",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_6": [
        {
            "start_logit": 10.8984375,
            "end_logit": 12.171875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 12.171875,
            "text": "stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.09375,
            "end_logit": 12.171875,
            "text": ", stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -7.94140625,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -8.1796875,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": 12.171875,
            "text": "IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -9.3671875,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -9.703125,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarb",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -10.0703125,
            "text": "melanoma patients",
            "probability": 0.0
        },
        {
            "start_logit": 10.8984375,
            "end_logit": -10.1484375,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2)",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -7.94140625,
            "text": "placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -7.94140625,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -7.94140625,
            "text": "dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -8.1796875,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -8.1796875,
            "text": "dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -7.94140625,
            "text": "+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -8.390625,
            "text": "stage IV",
            "probability": 0.0
        },
        {
            "start_logit": -9.09375,
            "end_logit": -7.94140625,
            "text": ", stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -9.09375,
            "end_logit": -8.1796875,
            "text": ", stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.4609375,
            "end_logit": -7.94140625,
            "text": "patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_7": [
        {
            "start_logit": 11.125,
            "end_logit": 12.078125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 12.078125,
            "text": "CNTO 95) in patients with melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.125,
            "end_logit": -6.22265625,
            "text": "melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -8.6796875,
            "text": "melanoma or angiosarcom",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -8.734375,
            "text": "melanoma or angiosa",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -8.90625,
            "text": "melanoma or angiosar",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.0390625,
            "text": "melanoma or",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.0703125,
            "text": "melanoma or angio",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 12.078125,
            "text": "intetumumab (CNTO 95) in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 12.078125,
            "text": "dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 12.078125,
            "text": "Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.125,
            "end_logit": -9.8828125,
            "text": "melanoma or angiosarcoma.",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": 12.078125,
            "text": "patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 12.078125,
            "text": "of two dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.84375,
            "end_logit": 12.078125,
            "text": "two dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": -6.22265625,
            "text": "CNTO 95) in patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": -6.87109375,
            "text": "CNTO 95",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": -7.96484375,
            "text": "CNTO",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": -8.4375,
            "text": "CNT",
            "probability": 0.0
        },
        {
            "start_logit": -5.8359375,
            "end_logit": -8.6796875,
            "text": "CNTO 95) in patients with melanoma or angiosarcom",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_8": [
        {
            "start_logit": 11.2734375,
            "end_logit": 11.9609375,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -5.8515625,
            "text": "melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 11.9609375,
            "text": "CNTO 95), a fully human anti-\u03b1v integrin monoclonal antibody was evaluated for safety, pharmacokinetics, and pharmacodynamic activity in patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -8.5703125,
            "text": "melanoma or angiosa",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -8.6875,
            "text": "melanoma or angiosarcom",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -8.734375,
            "text": "melanoma or angio",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -8.765625,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -8.796875,
            "text": "melanoma or",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -9.140625,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 11.9609375,
            "text": "patients with melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -9.1953125,
            "text": "melanoma or angiosar",
            "probability": 0.0
        },
        {
            "start_logit": 11.2734375,
            "end_logit": -9.640625,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosa",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -5.8515625,
            "text": "angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -5.8515625,
            "text": "patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -5.8515625,
            "text": "coma",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -8.5703125,
            "text": "angiosa",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -8.6875,
            "text": "angiosarcom",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -8.734375,
            "text": "angio",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -8.765625,
            "text": "angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -9.140625,
            "text": "angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_9": [
        {
            "start_logit": 13.890625,
            "end_logit": 14.875,
            "text": "malignant melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 1.96875,
            "end_logit": 14.875,
            "text": "melanoma",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 13.890625,
            "end_logit": -2.6640625,
            "text": "malignant",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 14.875,
            "text": "metastatic malignant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -6.9765625,
            "text": "malignant melanoma and angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 14.875,
            "text": ": In patients with metastatic malignant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 14.875,
            "text": "patients with metastatic malignant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 14.875,
            "text": "CONCLUSIONS: In patients with metastatic malignant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -9.6796875,
            "text": "malignant melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity, was well tolerated",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -9.8046875,
            "text": "malignant melanoma and angiosa",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -9.8359375,
            "text": "malignant melanoma and angiosarcom",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -9.8671875,
            "text": "malignant melanoma and",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -10.0078125,
            "text": "malignant melanoma and angiosarcoma in",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -10.0703125,
            "text": "malignant melanoma and angio",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -10.1015625,
            "text": "malignant melanoma and angiosarcoma in this study, intetumumab",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -10.109375,
            "text": "malignant melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 1.96875,
            "end_logit": -6.9765625,
            "text": "melanoma and angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": 1.96875,
            "end_logit": -9.6796875,
            "text": "melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity, was well tolerated",
            "probability": 0.0
        },
        {
            "start_logit": 1.96875,
            "end_logit": -9.8046875,
            "text": "melanoma and angiosa",
            "probability": 0.0
        },
        {
            "start_logit": 1.96875,
            "end_logit": -9.828125,
            "text": "melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity, was well tolerated, and presented approximately dose-proportional",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_10": [
        {
            "start_logit": 13.9609375,
            "end_logit": 9.90625,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 13.9609375,
            "end_logit": -1.1201171875,
            "text": "prostate",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 9.90625,
            "text": "metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.328125,
            "end_logit": 9.90625,
            "text": "castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.90625,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 9.90625,
            "text": "prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 9.90625,
            "text": "docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": 9.90625,
            "text": "with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 9.90625,
            "text": "patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 9.90625,
            "text": "\u03b1(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 9.90625,
            "text": "combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 9.90625,
            "text": "intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -5.01953125,
            "end_logit": -1.1201171875,
            "text": "metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -6.328125,
            "end_logit": -1.1201171875,
            "text": "castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -1.1201171875,
            "text": "prednisone in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": -1.1201171875,
            "text": "docetaxel and prednisone in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -10.125,
            "end_logit": -1.1201171875,
            "text": "with docetaxel and prednisone in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -1.1201171875,
            "text": "patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": -1.1201171875,
            "text": "\u03b1(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": -1.1201171875,
            "text": "combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_11": [
        {
            "start_logit": 14.2578125,
            "end_logit": 14.0078125,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -2.37890625,
            "text": "prostate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.703125,
            "end_logit": 14.0078125,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 14.0078125,
            "text": "metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -8.609375,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m\u00b2 docetaxel",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 14.0078125,
            "text": "castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -9.75,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m",
            "probability": 0.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -9.859375,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study",
            "probability": 0.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -9.9296875,
            "text": "prostate cancer. Patients and methods In this phase 1",
            "probability": 0.0
        },
        {
            "start_logit": 14.2578125,
            "end_logit": -9.984375,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study,",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 14.0078125,
            "text": ": We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 14.0078125,
            "text": "intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -2.37890625,
            "text": "metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -2.37890625,
            "text": "castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -3.703125,
            "end_logit": -8.609375,
            "text": "cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m\u00b2 docetaxel",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -2.37890625,
            "text": ": We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": -2.37890625,
            "text": "intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -3.703125,
            "end_logit": -9.75,
            "text": "cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m",
            "probability": 0.0
        },
        {
            "start_logit": -3.703125,
            "end_logit": -9.859375,
            "text": "cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study",
            "probability": 0.0
        },
        {
            "start_logit": -3.703125,
            "end_logit": -9.9296875,
            "text": "cancer. Patients and methods In this phase 1",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_12": [
        {
            "start_logit": 10.953125,
            "end_logit": 12.140625,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": 12.140625,
            "text": "stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -7.953125,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 12.140625,
            "text": ", stage IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -8.046875,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.75,
            "end_logit": 12.140625,
            "text": "IV melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.3359375,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.578125,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarb",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.8828125,
            "text": "melanoma patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -7.953125,
            "text": "placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -7.953125,
            "text": "dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -8.046875,
            "text": "dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": -7.953125,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": -7.953125,
            "text": "+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": -8.046875,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -7.953125,
            "text": ", stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -8.046875,
            "text": ", stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": -7.953125,
            "text": "patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -8.8671875,
            "end_logit": -8.65625,
            "text": "stage IV",
            "probability": 0.0
        },
        {
            "start_logit": -9.4765625,
            "end_logit": -8.046875,
            "text": "patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_13": [
        {
            "start_logit": 11.546875,
            "end_logit": 11.65625,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -5.9765625,
            "text": "melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 11.65625,
            "text": "inoperable melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -8.9296875,
            "text": "melanoma or",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -8.9921875,
            "text": "melanoma or angiosarcom",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.0234375,
            "text": "melanoma or angio",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.046875,
            "text": "melanoma or angiosa",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 11.65625,
            "text": "Patients with histologically-confirmed inoperable melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.4140625,
            "text": "melanoma or angiosarcoma refractory",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.484375,
            "text": "melanoma or angiosarcoma refractory to standard treatment were allocated to treatment with 10 mg/kg or 20",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.546875,
            "text": "melanoma or angiosar",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.8203125,
            "text": "melanoma or angiosarcoma refractory to standard treatment were allocated to treatment with 10 mg/kg or 20 mg/kg intetumumab",
            "probability": 0.0
        },
        {
            "start_logit": 11.546875,
            "end_logit": -9.859375,
            "text": "melanoma or angiosarcoma refractory to standard treatment were",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 11.65625,
            "text": "with histologically-confirmed inoperable melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 11.65625,
            "text": "histologically-confirmed inoperable melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.9765625,
            "text": "angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -5.9765625,
            "text": "inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -5.9765625,
            "text": "Patients with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": -5.9765625,
            "text": "coma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -5.9765625,
            "text": "with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_14": [
        {
            "start_logit": 10.0703125,
            "end_logit": 11.140625,
            "text": "Melanoma",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.546875,
            "end_logit": 8.3984375,
            "text": "metastatic melanoma",
            "probability": 0.0018815994262695312
        },
        {
            "start_logit": 3.021484375,
            "end_logit": 8.3984375,
            "text": "melanoma",
            "probability": 5.549192428588867e-05
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -4.4921875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -5.58984375,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.8984375,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 8.3984375,
            "text": "Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.046875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer",
            "probability": 0.0
        },
        {
            "start_logit": 6.546875,
            "end_logit": -5.23046875,
            "text": "metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 11.140625,
            "text": "Data from the Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.21875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.2421875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.3984375,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.6875,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.71875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 8.3984375,
            "text": "dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 8.3984375,
            "text": "intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 8.3984375,
            "text": "BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 8.3984375,
            "text": "with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_15": [
        {
            "start_logit": 9.890625,
            "end_logit": 11.015625,
            "text": "Melanoma",
            "probability": 0.994140625
        },
        {
            "start_logit": 7.43359375,
            "end_logit": 8.3515625,
            "text": "metastatic melanoma",
            "probability": 0.00591278076171875
        },
        {
            "start_logit": 1.0732421875,
            "end_logit": 8.3515625,
            "text": "melanoma",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 9.890625,
            "end_logit": -4.625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.890625,
            "end_logit": -6.296875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -4.984375,
            "text": "metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": 8.3515625,
            "text": "Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.5,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.765625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 11.015625,
            "text": "Data from the Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.28125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.34375,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.734375,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.8125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 8.3515625,
            "text": "dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 8.3515625,
            "text": "intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 8.3515625,
            "text": "BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 8.3515625,
            "text": "with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 8.3515625,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 8.3515625,
            "text": "evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_16": [
        {
            "start_logit": 9.890625,
            "end_logit": 11.015625,
            "text": "Melanoma",
            "probability": 0.994140625
        },
        {
            "start_logit": 7.43359375,
            "end_logit": 8.3515625,
            "text": "metastatic melanoma",
            "probability": 0.00591278076171875
        },
        {
            "start_logit": 1.0732421875,
            "end_logit": 8.3515625,
            "text": "melanoma",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 9.890625,
            "end_logit": -4.625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.890625,
            "end_logit": -6.296875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -4.984375,
            "text": "metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": 8.3515625,
            "text": "Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.5,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.765625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 11.015625,
            "text": "Data from the Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.28125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.34375,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.734375,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -9.8125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 8.3515625,
            "text": "dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 8.3515625,
            "text": "intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 8.3515625,
            "text": "BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 8.3515625,
            "text": "with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 8.3515625,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 8.3515625,
            "text": "evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 0.0
        }
    ],
    "5c34a761da8336e21a000005_1": [
        {
            "start_logit": 10.265625,
            "end_logit": 7.21484375,
            "text": "amino acid metabolism",
            "probability": 0.51171875
        },
        {
            "start_logit": 10.265625,
            "end_logit": 7.171875,
            "text": "amino acid metabolism pathway",
            "probability": 0.48828125
        },
        {
            "start_logit": -0.9638671875,
            "end_logit": 7.21484375,
            "text": "unsaturated fatty acid and amino acid metabolism",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -0.9638671875,
            "end_logit": 7.171875,
            "text": "unsaturated fatty acid and amino acid metabolism pathway",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 10.265625,
            "end_logit": -6.4296875,
            "text": "amino acid",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.0234375,
            "text": "amino",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 7.21484375,
            "text": "fatty acid and amino acid metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 7.171875,
            "text": "fatty acid and amino acid metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 7.21484375,
            "text": "metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 7.171875,
            "text": "metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 7.171875,
            "text": "pathway",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 7.21484375,
            "text": "According to the analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 7.171875,
            "text": "According to the analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 7.21484375,
            "text": "SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 7.21484375,
            "text": "and amino acid metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 7.171875,
            "text": "SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 7.171875,
            "text": "and amino acid metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": 7.21484375,
            "text": "cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": 7.171875,
            "text": "cause significant changes in unsaturated fatty acid and amino acid metabolism pathway",
            "probability": 0.0
        },
        {
            "start_logit": -0.9638671875,
            "end_logit": -6.4296875,
            "text": "unsaturated fatty acid and amino acid",
            "probability": 0.0
        }
    ],
    "5c34a761da8336e21a000005_2": [
        {
            "start_logit": 2.458984375,
            "end_logit": 1.8466796875,
            "text": "glycosphingolipid metabolism",
            "probability": 0.97314453125
        },
        {
            "start_logit": 2.458984375,
            "end_logit": -1.7880859375,
            "text": "glycosphingolipid",
            "probability": 0.0257415771484375
        },
        {
            "start_logit": 2.458984375,
            "end_logit": -5.27734375,
            "text": "glycosphing",
            "probability": 0.0007834434509277344
        },
        {
            "start_logit": 2.458984375,
            "end_logit": -6.58984375,
            "text": "glycosphi",
            "probability": 0.00021088123321533203
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 1.8466796875,
            "text": "IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 8.720159530639648e-05
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 1.8466796875,
            "text": "T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 4.6312808990478516e-05
        },
        {
            "start_logit": 2.458984375,
            "end_logit": -9.09375,
            "text": "glycos",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -4.0546875,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -4.296875,
            "text": "FLI1",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -9.8125,
            "end_logit": 1.8466796875,
            "text": "modulation of glycosphingolipid metabolism",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -10.34375,
            "end_logit": 1.8466796875,
            "text": "of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -1.7880859375,
            "text": "IL-4 production in part through the modulation of glycosphingolipid",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -5.27734375,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphing",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -10.609375,
            "end_logit": 1.8466796875,
            "text": "decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 1.8466796875,
            "text": "pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 1.8466796875,
            "text": "lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -1.7880859375,
            "text": "T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -6.58984375,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphi",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -4.0546875,
            "text": "IL-4",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -7.48046875,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c34a761da8336e21a000005_3": [
        {
            "start_logit": 2.9296875,
            "end_logit": 6.92578125,
            "text": "estrogen metabolism",
            "probability": 1.0
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -5.890625,
            "text": "estrogen",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 6.92578125,
            "text": "genetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 6.92578125,
            "text": "of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 6.92578125,
            "text": "the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -10.34375,
            "end_logit": 6.92578125,
            "text": "metabolism",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 6.92578125,
            "text": "xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -10.8359375,
            "end_logit": 6.92578125,
            "text": "polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 6.92578125,
            "text": "metabolic pathway involved in estrogen metabolism",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -8.8203125,
            "text": "estrogen metabolism might",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -9.3125,
            "text": "estrogen metabolism might contribute towards pathophysiology of systemic lupus erythematosus (SLE)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -9.484375,
            "text": "estrogen metabolism might contribute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -10.4140625,
            "text": "estrogen metabolism might contribute towards",
            "probability": 0.0
        },
        {
            "start_logit": 2.9296875,
            "end_logit": -10.5,
            "text": "estrogen metabolism might contribute towards pathophysiology of systemic lupus erythematosus (",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": -5.890625,
            "text": "genetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -5.890625,
            "text": "of the xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -5.890625,
            "text": "the xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -5.890625,
            "text": "xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": -5.890625,
            "text": "polymorphisms of the xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": -5.890625,
            "text": "metabolic pathway involved in estrogen",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_1": [
        {
            "start_logit": 12.7890625,
            "end_logit": 13.15625,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -3.416015625,
            "text": "Dabrafenib) and MEK inhibition (Trametinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 13.15625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -5.03125,
            "text": "Dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -6.203125,
            "text": "Dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -6.578125,
            "text": "Dabrafenib) and MEK inhibition (Tram",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.09765625,
            "text": "Dabrafenib) and MEK inhibition (Trametini",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.171875,
            "text": "Dabrafenib) and MEK inhibition (Trameti",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.36328125,
            "text": "Dabrafenib) and MEK",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.96484375,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.9921875,
            "text": "Dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.2265625,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.3046875,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.5390625,
            "text": "Dabrafenib) and MEK inhibition (",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": 13.15625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.71875,
            "text": "Dabrafenib)",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.84375,
            "text": "Dabrafenib) and",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.890625,
            "text": "Dabrafenib) and MEK inhibition",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.9921875,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 13.15625,
            "text": "Combined BRAF (Dabrafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_2": [
        {
            "start_logit": 12.1484375,
            "end_logit": 11.8671875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.1484375,
            "end_logit": -5.33984375,
            "text": "dab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.1484375,
            "end_logit": -5.5078125,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 11.8671875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.1484375,
            "end_logit": -7.6796875,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 11.8671875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.1484375,
            "end_logit": -9.0859375,
            "text": "dabrafenib monotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 11.8671875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.8671875,
            "text": "BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 11.8671875,
            "text": "B; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.8671875,
            "text": "before study enrollment (part B; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 11.8671875,
            "text": "; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -6.11328125,
            "end_logit": -9.0859375,
            "text": "ib monotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -5.33984375,
            "text": "BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": -5.5078125,
            "text": "ra",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -5.33984375,
            "text": "B; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -5.5078125,
            "text": "BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dabra",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -5.33984375,
            "text": "before study enrollment (part B; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": -5.5078125,
            "text": "B; n = 26) or after cross-over at progression with dabra",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": -5.33984375,
            "text": "; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_3": [
        {
            "start_logit": 13.703125,
            "end_logit": 13.578125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -3.951171875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.765625,
            "end_logit": 13.578125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -5.1328125,
            "text": "vemurafenib and the MEK inhibitor cobimetinib",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -6.9375,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.359375,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.5703125,
            "text": "vemurafenib and the MEK",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.796875,
            "text": "vemurafenib and the MEK inhibitor cobime",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -8.8984375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.0,
            "text": "vemurafenib and the MEK inhibitor cob",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.0625,
            "text": "vemurafenib and",
            "probability": 0.0
        },
        {
            "start_logit": -9.046875,
            "end_logit": 13.578125,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.203125,
            "text": "vemurafenib and the MEK inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 13.578125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": 13.578125,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.703125,
            "end_logit": -9.8203125,
            "text": "vemurafenib and the",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.578125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.765625,
            "end_logit": -5.1328125,
            "text": "ib and the MEK inhibitor cobimetinib",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -5.1328125,
            "text": "cobimetinib",
            "probability": 0.0
        },
        {
            "start_logit": -4.765625,
            "end_logit": -8.5703125,
            "text": "ib and the MEK",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_4": [
        {
            "start_logit": 12.9609375,
            "end_logit": 13.3203125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -5.08203125,
            "end_logit": 13.3203125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -4.8203125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -6.45703125,
            "text": "vemurafenib or dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -6.80078125,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.3203125,
            "text": "vemurafenib or dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.40625,
            "text": "vemurafenib or dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.421875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.5625,
            "text": "vemurafenib or dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.5703125,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -8.6015625,
            "text": "vemurafenib or dabrafenib or combination BRAF inhibitor and mitogen-activated protein kinase kinase (MEK",
            "probability": 0.0
        },
        {
            "start_logit": -9.25,
            "end_logit": 13.3203125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.3203125,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -9.171875,
            "text": "vemurafenib or",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -9.3125,
            "text": "vemurafenib or dabrafenib or",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -9.34375,
            "text": "vemurafenib or dabrafenib or combination BRAF inhibitor and mitogen-activated protein kinase kinase (MEK)",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.3203125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9609375,
            "end_logit": -9.4375,
            "text": "vemurafenib or dabrafenib or combination BRAF inhibitor and mitogen-activated protein kinase kinase (MEK) inhibitor therapy",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 13.3203125,
            "text": ": All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 13.3203125,
            "text": "BRAF inhibitors vemurafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_5": [
        {
            "start_logit": 13.1484375,
            "end_logit": 13.25,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -2.9296875,
            "text": "vemurafenib and MEK inhibition with cobimetinib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -4.61328125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 13.25,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -6.484375,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.859375,
            "text": "vemurafenib and MEK inhibition with cobime",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.9296875,
            "text": "vemurafenib and MEK inhibition with cob",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.03125,
            "text": "vemurafenib and MEK",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.3125,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.5859375,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.8203125,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF-mutated melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.9296875,
            "text": "vemurafenib and MEK inhibition with",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.0234375,
            "text": "vemurafenib and",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.109375,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.2890625,
            "text": "vemurafenib and MEK inhibition",
            "probability": 0.0
        },
        {
            "start_logit": -9.4296875,
            "end_logit": 13.25,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 13.25,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.390625,
            "text": "vemurafenib and MEK inhibition with cobimetinib in",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.484375,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF-",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 13.25,
            "text": "murafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_6": [
        {
            "start_logit": 13.203125,
            "end_logit": 12.796875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -4.3671875,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 12.796875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -6.94140625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -7.94921875,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.6171875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.9921875,
            "text": "vemurafenib or never received a BRAF inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.0546875,
            "text": "vemurafenib or never received a BRAF inhibitor.",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.09375,
            "text": "vemurafenib or never received a",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.109375,
            "text": "vemurafenib or never",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.125,
            "text": "vemurafenib or never received a BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.328125,
            "text": "vemurafenib or never received",
            "probability": 0.0
        },
        {
            "start_logit": -9.1328125,
            "end_logit": 12.796875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.6796875,
            "text": "vemurafenib or",
            "probability": 0.0
        },
        {
            "start_logit": -9.2734375,
            "end_logit": 12.796875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 12.796875,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -8.9921875,
            "text": "ib or never received a BRAF inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -9.0546875,
            "text": "ib or never received a BRAF inhibitor.",
            "probability": 0.0
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -9.09375,
            "text": "ib or never received a",
            "probability": 0.0
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -9.109375,
            "text": "ib or never",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_7": [
        {
            "start_logit": 13.8984375,
            "end_logit": 13.5390625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -3.75390625,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.94921875,
            "end_logit": 13.5390625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -5.48046875,
            "text": "vemurafenib with ipilimumab",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -7.30859375,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -8.21875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -8.4296875,
            "text": "vemurafenib with ipilimumab (anti-CTLA4), with significant liver toxicities",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -8.4453125,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -8.8828125,
            "text": "vemurafenib with ipilimumab (anti-CTLA4",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -9.0546875,
            "text": "vemurafenib with ipilimuma",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 13.5390625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -9.3125,
            "text": "vemurafenib with ipilimu",
            "probability": 0.0
        },
        {
            "start_logit": 13.8984375,
            "end_logit": -9.609375,
            "text": "vemurafenib with ipili",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": 13.5390625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.5390625,
            "end_logit": 13.5390625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 13.5390625,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3984375,
            "end_logit": 13.5390625,
            "text": "testing a combination of the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.94921875,
            "end_logit": -5.48046875,
            "text": "ib with ipilimumab",
            "probability": 0.0
        },
        {
            "start_logit": -4.94921875,
            "end_logit": -8.4296875,
            "text": "ib with ipilimumab (anti-CTLA4), with significant liver toxicities",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -3.75390625,
            "text": "BRAF inhibitor ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_8": [
        {
            "start_logit": 13.2578125,
            "end_logit": 13.484375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 13.484375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -4.78515625,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -7.1171875,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -8.3671875,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -8.46875,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 13.484375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -8.53125,
            "text": "dabrafenib recently",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -8.640625,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -8.7578125,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -9.375,
            "text": "dabrafenib recently was approved",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -9.3828125,
            "text": "dabrafenib recently was approved for use in patients with BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -9.484375,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated metastatic",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -9.6796875,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-",
            "probability": 0.0
        },
        {
            "start_logit": 13.2578125,
            "end_logit": -9.703125,
            "text": "dabrafenib recently was approved for use in patients with BRAF V",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 13.484375,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 13.484375,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.46875,
            "text": "ib recently was approved for use in patients with BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.53125,
            "text": "ib recently",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.640625,
            "text": "ib recently was approved for use in patients with BRAF V600-mutated",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_9": [
        {
            "start_logit": 13.9921875,
            "end_logit": 13.8671875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -3.80078125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 13.8671875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -6.87890625,
            "text": "vemurafenib (PLX-4032",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -7.1015625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -7.5234375,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.3671875,
            "text": "vemurafenib (PLX-4032)",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 13.8671875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.6015625,
            "text": "vemurafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.671875,
            "text": "vemurafenib (PLX-40",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 13.8671875,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.765625,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -8.8984375,
            "text": "vemurafenib (PL",
            "probability": 0.0
        },
        {
            "start_logit": -8.96875,
            "end_logit": 13.8671875,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.1171875,
            "text": "vemurafenib (PLX",
            "probability": 0.0
        },
        {
            "start_logit": 13.9921875,
            "end_logit": -9.171875,
            "text": "vemurafenib (PLX-4032), clinical trial with combination BRAF plus MEK",
            "probability": 0.0
        },
        {
            "start_logit": -9.3125,
            "end_logit": 13.8671875,
            "text": "with the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 13.8671875,
            "text": "adjuvant radiotherapy, and interferon, metastasectomies, granulocyte-macrophage colony-stimulating factors, a clinical trial with the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 13.8671875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.8671875,
            "text": "granulocyte-macrophage colony-stimulating factors, a clinical trial with the BRAF inhibitor vemurafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_10": [
        {
            "start_logit": 12.7109375,
            "end_logit": 12.7265625,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -5.171875,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.66015625,
            "end_logit": 12.7265625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -6.33203125,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -7.90625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -8.4453125,
            "text": "dabrafenib therapy including six individuals who had progressed",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -8.5,
            "text": "dabrafenib therapy including six individuals who had",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 12.7265625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.1171875,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF-inhibitor treatment",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.140625,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF-inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.2109375,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.265625,
            "text": "dabrafenib therapy including six individuals who had progressed on a",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.3125,
            "text": "dabrafenib therapy",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.375,
            "text": "dabrafenib therapy including",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.5,
            "text": "dabrafenib therapy including six individuals who had progressed on",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.515625,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.7109375,
            "end_logit": -9.515625,
            "text": "dabrafenib therapy including six individuals who",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 12.7265625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 12.7265625,
            "text": "Thirty-one patients commenced dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": 12.7265625,
            "text": "commenced dabrafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_11": [
        {
            "start_logit": 12.6171875,
            "end_logit": 12.7109375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -5.5078125,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 12.7109375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -6.84765625,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.5703125,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.6015625,
            "text": "dabrafenib,",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 12.7109375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.609375,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.6796875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.75,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -8.9765625,
            "text": "dabrafenib, a",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 12.7109375,
            "text": "Population pharmacokinetics of dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.1796875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.3203125,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.46875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.59375,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites.",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.7890625,
            "text": "dabrafenib, a BRAF inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.828125,
            "text": "dabrafenib, a BRAF inhibitor: effect",
            "probability": 0.0
        },
        {
            "start_logit": 12.6171875,
            "end_logit": -9.8984375,
            "text": "dabrafenib, a BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 12.7109375,
            "text": "rafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_12": [
        {
            "start_logit": 12.84375,
            "end_logit": 13.015625,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -5.1171875,
            "text": "Dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": 13.015625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -7.21484375,
            "text": "Dabra",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 13.015625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.2578125,
            "text": "Dabrafenib is a BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.4296875,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.5,
            "text": "Dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.546875,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.6640625,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.78125,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.828125,
            "text": "Dabrafenib is a BRAF kinase inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.953125,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.984375,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.203125,
            "text": "Dabrafenib is a",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.2890625,
            "text": "Dabrafenib is a BRAF kinase",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.3671875,
            "text": "Dabrafenib is",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": 13.015625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.703125,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.7109375,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_13": [
        {
            "start_logit": 12.328125,
            "end_logit": 12.3046875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -4.75390625,
            "text": "dabrafenib) or as part of an expanded access program (vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.328125,
            "end_logit": -5.2578125,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 12.3046875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -7.12890625,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -7.984375,
            "text": "dabrafenib) or as part of an expanded access program (ve",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -8.359375,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -8.484375,
            "text": "dabrafenib) or as part of an expanded access program (vemu",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -8.8203125,
            "text": "dabrafenib) or as part of an expanded access program (vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": -8.828125,
            "end_logit": 12.3046875,
            "text": "V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -9.2890625,
            "text": "dabrafenib) or as part of an expanded access program (vemura",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -9.34375,
            "text": "dabrafenib) or as part of an expanded access program",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": 12.3046875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 12.3046875,
            "text": "iBRAF within a clinical trial (dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.328125,
            "end_logit": -9.4296875,
            "text": "dabrafenib)",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 12.3046875,
            "text": "harboring the BRAF V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 12.3046875,
            "text": "BRAF V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.3046875,
            "text": "F within a clinical trial (dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.3046875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 12.3046875,
            "text": "patients harboring the BRAF V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_14": [
        {
            "start_logit": 13.9453125,
            "end_logit": 13.78125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -3.6796875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.515625,
            "end_logit": 13.78125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -6.796875,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -7.45703125,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain metastases",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -8.140625,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -8.546875,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 13.78125,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 13.78125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.1640625,
            "text": "vemurafenib in patients with advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.171875,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain metastases.",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.2109375,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.2265625,
            "text": "vemurafenib in",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.5703125,
            "text": "vemurafenib in patients with advanced",
            "probability": 0.0
        },
        {
            "start_logit": 13.9453125,
            "end_logit": -9.609375,
            "text": "vemurafenib in patients with advanced melanoma with",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 13.78125,
            "text": "BRAF kinase inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.78125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.515625,
            "end_logit": 13.78125,
            "text": "kinase inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 13.78125,
            "text": "investigated the BRAF kinase inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.515625,
            "end_logit": -7.45703125,
            "text": "ib in patients with advanced melanoma with symptomatic brain metastases",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_15": [
        {
            "start_logit": 13.3125,
            "end_logit": 13.484375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -4.5546875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 13.484375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -5.97265625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -6.15234375,
            "text": "vemurafenib and dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -7.98828125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -8.3359375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -8.4453125,
            "text": "vemurafenib and dab",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -8.625,
            "text": "vemurafenib and",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -8.640625,
            "text": "vemurafenib and dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -9.1328125,
            "text": "vemurafenib and dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 13.484375,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 13.484375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 13.484375,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.484375,
            "text": "BRAF kinase inhibitors like vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 13.484375,
            "text": "like vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -6.15234375,
            "text": "ib and dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.4453125,
            "text": "ib and dab",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.625,
            "text": "ib and",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -8.640625,
            "text": "ib and dabra",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_16": [
        {
            "start_logit": 12.421875,
            "end_logit": 12.2421875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 0.59716796875,
            "end_logit": 12.2421875,
            "text": "Dabrafenib joins vemurafenib",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 12.421875,
            "end_logit": -5.046875,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.421875,
            "end_logit": -5.05859375,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 12.2421875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -6.88671875,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -8.1875,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarb",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -8.21875,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine in patients with BRAF(V600",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 12.2421875,
            "text": "ib joins vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -8.5234375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -8.7578125,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine in patients with BRAF(V600E",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -8.78125,
            "text": "vemurafenib to",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.0546875,
            "text": "vemurafenib to confirm the superior clinical outcome",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.140625,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine in patients with BRAF(V600E)",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.1796875,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine in patients with BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.203125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 0.59716796875,
            "end_logit": 2.603515625,
            "text": "Dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.234375,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dac",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": 12.2421875,
            "text": "rafenib joins vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.421875,
            "end_logit": -9.46875,
            "text": "vemurafenib to confirm the superior clinical outcome of the BRAF",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_17": [
        {
            "start_logit": 13.46875,
            "end_logit": 13.4140625,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -4.5078125,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 13.4140625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.015625,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.3828125,
            "text": "dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.15625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.640625,
            "text": "dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.765625,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": -8.734375,
            "end_logit": 13.4140625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.796875,
            "text": "dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.921875,
            "text": "dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.03125,
            "text": "dabrafenib (GSK2118436).",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.5,
            "text": "dabrafenib (GSK",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -9.515625,
            "text": "dabrafenib (GSK211843",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 13.4140625,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 13.4140625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 13.4140625,
            "text": "Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 13.4140625,
            "text": "genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": -7.3828125,
            "text": "ib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": -5.00390625,
            "end_logit": -8.640625,
            "text": "ib (GSK2118436)",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_18": [
        {
            "start_logit": 12.6796875,
            "end_logit": 13.0546875,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -5.40625,
            "end_logit": 13.0546875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -5.37890625,
            "text": "Dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -7.1328125,
            "text": "Dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -7.35546875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -8.21875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 13.0546875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -8.390625,
            "text": "Dabrafenib is a selective inhibitor of V600",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -8.7265625,
            "text": "Dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.0625,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.0859375,
            "text": "Dabrafenib is a selective",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.28125,
            "text": "Dabrafenib is",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.4609375,
            "text": "Dabrafenib is a",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.640625,
            "text": "Dabrafenib is a selective inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.6796875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS)",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 13.0546875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.71875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently",
            "probability": 0.0
        },
        {
            "start_logit": 12.6796875,
            "end_logit": -9.8828125,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase,",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 13.0546875,
            "text": ": Dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.40625,
            "end_logit": -7.265625,
            "text": "ib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS) as compared with dacarbazine",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_19": [
        {
            "start_logit": 13.234375,
            "end_logit": 13.125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -4.8046875,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.390625,
            "end_logit": 13.125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -6.6796875,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -7.27734375,
            "text": "dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.125,
            "text": "dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.2265625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.40625,
            "text": "dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.4296875,
            "text": "dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.59375,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.8125,
            "text": "dabrafenib (GSK2118436) in patients with metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -8.8203125,
            "text": "dabrafenib (GSK2118436) in",
            "probability": 0.0
        },
        {
            "start_logit": -8.7578125,
            "end_logit": 13.125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.234375,
            "end_logit": -9.171875,
            "text": "dabrafenib (GSK2118436) in patients with metastatic",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": 13.125,
            "text": "BREAK-2) of the BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 13.125,
            "text": "Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.125,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 13.125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 13.125,
            "text": "of the BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.390625,
            "end_logit": -7.27734375,
            "text": "ib (GSK2118436",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_20": [
        {
            "start_logit": 12.5625,
            "end_logit": 12.6015625,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -5.3046875,
            "text": "Dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.796875,
            "end_logit": 12.6015625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.51953125,
            "text": "Dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.86328125,
            "text": "Dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.48046875,
            "text": "Dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.734375,
            "text": "Dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.98046875,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.0390625,
            "text": "Dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.2578125,
            "text": "Dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.3359375,
            "text": "Dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 12.6015625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.859375,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF kinase",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.1171875,
            "text": "Dabrafenib (GSK",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.1328125,
            "text": "Dabrafenib (GSK2118436) is",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.1484375,
            "text": "Dabrafenib (GSK211843",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.421875,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.5546875,
            "text": "Dabrafenib (GSK2118436) is a",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.640625,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.7265625,
            "text": "Dabrafenib (GSK2118436) is a potent",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_21": [
        {
            "start_logit": 12.7890625,
            "end_logit": 13.234375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -4.3671875,
            "text": "vemurafenib, and dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 13.234375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -5.328125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -7.26953125,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.1484375,
            "text": "vemurafenib, and dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.1875,
            "text": "vemurafenib, and dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.2578125,
            "text": "vemurafenib, and dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.328125,
            "text": "vemurafenib,",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.328125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 13.234375,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -8.9609375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 13.234375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -9.1640625,
            "text": "vemurafenib, and dabrafenib,",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 13.234375,
            "text": "cSCC) is a concerning toxicity with BRAF inhibitors in the treatment for melanoma. While the two drugs shown to improve survival, vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7890625,
            "end_logit": -9.390625,
            "text": "vemurafenib, and dabrafenib, have similar efficacy, the reported rates of cSCC",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 13.234375,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 13.234375,
            "text": "While the two drugs shown to improve survival, vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.38671875,
            "end_logit": -4.3671875,
            "text": "ib, and dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -6.796875,
            "end_logit": -4.3671875,
            "text": "dabrafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_22": [
        {
            "start_logit": 13.84375,
            "end_logit": 13.6015625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -3.814453125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 13.6015625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -6.74609375,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.109375,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.234375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.3046875,
            "text": "vemurafenib in BRAF(V600",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.6875,
            "text": "vemurafenib in BRAF(V600)-mutant",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.0625,
            "text": "vemurafenib in BRAF(V600)",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.1328125,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 13.6015625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.3828125,
            "text": "vemurafenib in BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.4140625,
            "text": "vemurafenib in",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.4921875,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma,",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.6328125,
            "text": "vemurafenib in BRAF(V600)-",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 13.6015625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 13.6015625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 13.6015625,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.453125,
            "end_logit": 13.6015625,
            "text": "intrinsic and acquired resistance mechanisms of the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 13.6015625,
            "text": "PURPOSE To assess pharmacodynamic effects and intrinsic and acquired resistance mechanisms of the BRAF inhibitor vemurafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_23": [
        {
            "start_logit": 14.0234375,
            "end_logit": 13.4453125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -3.509765625,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 13.4453125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -6.51953125,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.2109375,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 14.0234375,
            "end_logit": -8.7109375,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.9609375,
            "end_logit": 13.4453125,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 13.4453125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 13.4453125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 13.4453125,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 13.4453125,
            "text": "selective BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": 13.4453125,
            "text": "select patients with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 13.4453125,
            "text": "CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -3.509765625,
            "text": "BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -3.509765625,
            "text": "selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -3.509765625,
            "text": "Mutation Test is a CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.21875,
            "end_logit": -3.509765625,
            "text": "select patients with metastatic melanoma for treatment with the selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -3.509765625,
            "text": "Test is a CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -3.509765625,
            "text": "CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -7.6171875,
            "text": "V600 Mutation",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_24": [
        {
            "start_logit": 12.9375,
            "end_logit": 12.8125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -5.09375,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 12.8125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -6.62109375,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -7.48046875,
            "text": "dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.2734375,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.375,
            "text": "dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.5625,
            "text": "dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.5625,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -8.6796875,
            "text": "dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.0,
            "text": "dabrafenib (GSK",
            "probability": 0.0
        },
        {
            "start_logit": -8.8984375,
            "end_logit": 12.8125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.1484375,
            "text": "dabrafenib (GSK2118436) and the evolving role of dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.1953125,
            "text": "dabrafenib (GSK211843",
            "probability": 0.0
        },
        {
            "start_logit": 12.9375,
            "end_logit": -9.625,
            "text": "dabrafenib (GSK2118436) and",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.8125,
            "text": "BRAF inhibitors, with emphasis on the trials conducted with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 12.8125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.703125,
            "end_logit": 12.8125,
            "text": "with emphasis on the trials conducted with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": -7.48046875,
            "text": "ib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": -8.375,
            "text": "ib (GSK2118436)",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_25": [
        {
            "start_logit": 12.6875,
            "end_logit": 12.8671875,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -5.2421875,
            "text": "Dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.53125,
            "end_logit": 12.8671875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -7.05078125,
            "text": "Dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -7.16796875,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V600K",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -7.41796875,
            "text": "Dabrafenib inhibits the mutant BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -7.6484375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 12.8671875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.1328125,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V600",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.4453125,
            "text": "Dabrafenib inhibits the mutant",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.46875,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut))",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.515625,
            "text": "Dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.8125,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.9375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -8.984375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -9.2265625,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -9.375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V",
            "probability": 0.0
        },
        {
            "start_logit": 12.6875,
            "end_logit": -9.3984375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 12.8671875,
            "text": "rafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_26": [
        {
            "start_logit": 12.7265625,
            "end_logit": 12.9375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -4.00390625,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.48046875,
            "end_logit": 12.9375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -5.296875,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -6.625,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -7.10546875,
            "text": "dabrafenib, a selective BRAF inhibitor, and tram",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -7.1171875,
            "text": "dabrafenib, a selective BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -7.4609375,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -7.47265625,
            "text": "dabrafenib, a selective BRAF inhibitor, and trameti",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -7.67578125,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametini",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.2421875,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.3046875,
            "text": "dabrafenib, a selective BRAF inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.3125,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.421875,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.484375,
            "text": "dabrafenib, a selective",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.6640625,
            "text": "dabrafenib, a selective BRAF inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": -8.890625,
            "end_logit": 12.9375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.6875,
            "text": "dabrafenib, a selective BRAF inhibitor, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -8.6953125,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a",
            "probability": 0.0
        },
        {
            "start_logit": 12.7265625,
            "end_logit": -9.0,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_27": [
        {
            "start_logit": 12.6953125,
            "end_logit": 13.0546875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 13.0546875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -5.2265625,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -6.78125,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.484375,
            "text": "dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.56640625,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 13.0546875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -7.9453125,
            "text": "dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.0546875,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.0703125,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.1640625,
            "text": "dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.203125,
            "text": "dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.578125,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.7890625,
            "text": "dabrafenib (GSK2118436): a selective",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.796875,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -8.8984375,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.0234375,
            "text": "dabrafenib (GSK",
            "probability": 0.0
        },
        {
            "start_logit": 12.6953125,
            "end_logit": -9.1640625,
            "text": "dabrafenib (GSK2118436): a",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 13.0546875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.0546875,
            "text": "Cutaneous manifestations of dabrafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_28": [
        {
            "start_logit": 13.28125,
            "end_logit": 13.125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -4.765625,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 13.125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -6.9921875,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.140625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.4453125,
            "text": "dabrafenib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.6953125,
            "text": "dabrafenib (GSK2118436)",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.8359375,
            "text": "dabrafenib (GSK21",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.8671875,
            "text": "dabrafenib (GSK2118",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.890625,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": -8.9375,
            "end_logit": 13.125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -9.3125,
            "text": "dabrafenib (GSK",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 13.125,
            "text": "mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 13.125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 13.125,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 13.125,
            "text": "single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.125,
            "text": "clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.125,
            "text": "enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 13.125,
            "text": "dermatological review of all patients enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -8.4453125,
            "text": "ib (GSK2118436",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_29": [
        {
            "start_logit": 13.2265625,
            "end_logit": 13.28125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -4.6953125,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.265625,
            "end_logit": 13.28125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -6.6171875,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -7.9921875,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -8.1640625,
            "text": "dabrafenib is associated with induction of keratinocytic",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -8.28125,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -8.375,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low-grade malignancy",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 13.28125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -8.6484375,
            "text": "dabrafenib is associated with induction of keratin",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -8.765625,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.3828125,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.4609375,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.28125,
            "text": "mutant BRAF inhibitor dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.46875,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation,",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.5078125,
            "text": "dabrafenib is",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.5234375,
            "text": "dabrafenib is associated with induction of",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.5390625,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low-grade",
            "probability": 0.0
        },
        {
            "start_logit": 13.2265625,
            "end_logit": -9.5703125,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 13.28125,
            "text": "rafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_30": [
        {
            "start_logit": 12.8671875,
            "end_logit": 13.0546875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -5.0,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": 13.0546875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -6.05078125,
            "text": "dabrafenib (a V600EBRAF inhibitor): a case report",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -6.55078125,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -6.984375,
            "text": "dabrafenib (a V600EBRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -7.84765625,
            "text": "dabrafenib (a V600EBRAF inhibitor)",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -8.046875,
            "text": "dabrafenib (a V600",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 13.0546875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -8.1640625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -8.2265625,
            "text": "dabrafenib (a V600EBRAF inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -8.640625,
            "text": "dabrafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -8.9375,
            "text": "dabrafenib (a V600EB",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -9.0,
            "text": "dabrafenib (a",
            "probability": 0.0
        },
        {
            "start_logit": 12.8671875,
            "end_logit": -9.1328125,
            "text": "dabrafenib (a V600EBRAF inhibitor): a case report.",
            "probability": 0.0
        },
        {
            "start_logit": -9.40625,
            "end_logit": 13.0546875,
            "text": "Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 13.0546875,
            "text": "leptomeningitis presenting in a melanoma patient treated with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 13.0546875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 13.0546875,
            "text": "melanoma patient treated with dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -6.05078125,
            "text": "ib (a V600EBRAF inhibitor): a case report",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_31": [
        {
            "start_logit": 13.328125,
            "end_logit": 13.4296875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -4.6640625,
            "text": "dab",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": 13.4296875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -6.74609375,
            "text": "dabra",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 13.4296875,
            "text": "GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -8.265625,
            "text": "dabrafen",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 13.4296875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -8.59375,
            "text": "dabrafenib,",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -9.078125,
            "text": "dabrafenib, as a second line of therapy",
            "probability": 0.0
        },
        {
            "start_logit": 13.328125,
            "end_logit": -9.3515625,
            "text": "dabrafenib, as a second line",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.4296875,
            "text": "6 BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0546875,
            "end_logit": 13.4296875,
            "text": "BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.4296875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 13.4296875,
            "text": "436 BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.4296875,
            "text": "she was enrolled into another clinical trial with the GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 13.4296875,
            "text": "18436 BRAF inhibitor, dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -4.6640625,
            "text": "GSK2118436 BRAF inhibitor, dab",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -5.7421875,
            "text": "GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -8.59375,
            "text": "ib,",
            "probability": 0.0
        },
        {
            "start_logit": -5.046875,
            "end_logit": -9.078125,
            "text": "ib, as a second line of therapy",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_32": [
        {
            "start_logit": 13.484375,
            "end_logit": 13.1953125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -4.29296875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.40625,
            "end_logit": 13.1953125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -7.28515625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.296875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.484375,
            "end_logit": -8.421875,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.78125,
            "end_logit": 13.1953125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": 13.1953125,
            "text": "KAs) and well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 13.1953125,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 13.1953125,
            "text": "squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 13.1953125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 13.1953125,
            "text": "SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.1953125,
            "text": "well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 13.1953125,
            "text": "adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 13.1953125,
            "text": "BRAF inhibitors such as vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.015625,
            "end_logit": -4.29296875,
            "text": "KAs) and well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": -4.29296875,
            "text": "squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -4.29296875,
            "text": "SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -4.29296875,
            "text": "well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": -4.29296875,
            "text": "adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_33": [
        {
            "start_logit": 13.765625,
            "end_logit": 13.3984375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -3.876953125,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.98046875,
            "end_logit": 13.3984375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -7.47265625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -8.1328125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -8.1640625,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 13.3984375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -8.9765625,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.25,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse",
            "probability": 0.0
        },
        {
            "start_logit": -8.9140625,
            "end_logit": 13.3984375,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.390625,
            "text": "vemurafenib (recently",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -9.40625,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration)",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 13.3984375,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 13.3984375,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -8.1640625,
            "text": "ib (recently approved by the US Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -8.3671875,
            "text": "ib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse, pathology-proven KAs and SCC",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -8.7265625,
            "text": "ib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse, pathology-proven KAs",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -8.7890625,
            "text": "ib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse, pathology-proven KA",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -3.876953125,
            "text": "BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -9.046875,
            "text": "ib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse, pathology-proven KAs and",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_34": [
        {
            "start_logit": 13.203125,
            "end_logit": 12.9765625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -4.44140625,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 12.9765625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -7.6015625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -7.84375,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report on the effective use of PDT",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.1875,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.21875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 12.9765625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.5390625,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -8.5546875,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": 12.9765625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.0,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration,",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.6328125,
            "text": "vemurafenib's recent approval",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.671875,
            "text": "vemurafenib's",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.7109375,
            "text": "vemurafenib's recent",
            "probability": 0.0
        },
        {
            "start_logit": 13.203125,
            "end_logit": -9.75,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 12.9765625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.9765625,
            "text": "CONCLUSIONS: Given vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 12.9765625,
            "text": ": Given vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -7.84375,
            "text": "ib's recent approval by the US Food and Drug Administration, we provide a timely case report on the effective use of PDT",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_35": [
        {
            "start_logit": 13.515625,
            "end_logit": 13.640625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -4.2578125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.74609375,
            "end_logit": 13.640625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -7.41015625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -7.8046875,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600E",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.0703125,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600E mutation",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.2734375,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.328125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.578125,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.7265625,
            "text": "vemurafenib,",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.7265625,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 13.640625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -8.9609375,
            "text": "vemurafenib, has shown up to 78% objective response rates",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -9.1328125,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 13.640625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": 13.640625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -9.6484375,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600E mutation but not",
            "probability": 0.0
        },
        {
            "start_logit": 13.515625,
            "end_logit": -9.7421875,
            "text": "vemurafenib, has shown up to 78%",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 13.640625,
            "text": "BRAF inhibitor, vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -4.74609375,
            "end_logit": -7.8046875,
            "text": "ib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600E",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_36": [
        {
            "start_logit": 13.6015625,
            "end_logit": 13.40625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -4.109375,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 13.40625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -6.078125,
            "text": "vemurafenib (PLX4032",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -7.6953125,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -7.93359375,
            "text": "vemurafenib (PLX40",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -7.953125,
            "text": "vemurafenib (PL",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.34375,
            "text": "vemurafenib (PLX4032)",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.3515625,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.3828125,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600-mutant",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.6875,
            "text": "vemurafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.7421875,
            "text": "vemurafenib (PLX",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.765625,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 13.40625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.9765625,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -8.984375,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": 13.6015625,
            "end_logit": -9.1484375,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600-mutant metastatic melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.046875,
            "end_logit": 13.40625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 13.40625,
            "text": "oral BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.40625,
            "text": "rafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_37": [
        {
            "start_logit": 14.0546875,
            "end_logit": 13.5,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -3.34765625,
            "text": "ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.8828125,
            "end_logit": 13.5,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -6.5625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -8.2890625,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 14.0546875,
            "end_logit": -8.5546875,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": -9.03125,
            "end_logit": 13.5,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": 13.5,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 13.5,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 13.5,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 13.5,
            "text": "BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 13.5,
            "text": "mutant metastatic melanoma for treatment with the BRAF inhibitor vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -3.34765625,
            "text": "BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": -3.34765625,
            "text": "BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": -3.34765625,
            "text": "mutant metastatic melanoma for treatment with the BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": -3.34765625,
            "text": "Mutation Test) was recently approved by the US Food and Drug Administration to select patients with BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.6796875,
            "text": "cobas 4800 BRAF V600 Mutation",
            "probability": 0.0
        },
        {
            "start_logit": -9.03125,
            "end_logit": -6.5625,
            "text": "murafen",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -6.5625,
            "text": "fen",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -6.5625,
            "text": "BRAF inhibitor vemurafen",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_38": [
        {
            "start_logit": 12.84375,
            "end_logit": 13.046875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -4.76953125,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.48046875,
            "end_logit": 13.046875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -7.09765625,
            "text": "vemurafenib (PLX4032",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -7.609375,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.0703125,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 13.046875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.546875,
            "text": "vemurafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.5625,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.5703125,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.7578125,
            "text": "vemurafenib (PLX40",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.8359375,
            "text": "vemurafenib (PLX4032)",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.84375,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.875,
            "text": "vemurafenib (PL",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -8.953125,
            "text": "vemurafenib (PLX",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": 13.046875,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.2109375,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E mutant",
            "probability": 0.0
        },
        {
            "start_logit": 12.84375,
            "end_logit": -9.2734375,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E mutant melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": 13.046875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 13.046875,
            "text": "BRAF inhibitor, vemurafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_39": [
        {
            "start_logit": 12.2421875,
            "end_logit": 12.7578125,
            "text": "Vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -5.59375,
            "end_logit": 12.7578125,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -5.33984375,
            "text": "Ve",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -6.39453125,
            "text": "Vemurafenib (RG7204",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -7.45703125,
            "text": "Vemurafenib (RG7204/PLX4032",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -7.4609375,
            "text": "Vemurafenib (RG720",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -7.546875,
            "text": "Vemurafenib (RG7204/PLX4032), a small-molecule inhibitor of mutant BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -7.65234375,
            "text": "Vemurafenib (RG7204/PLX4032)",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -7.96484375,
            "text": "Vemurafenib (RG",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 12.7578125,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.078125,
            "text": "Vemurafenib (RG7204/",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.1015625,
            "text": "Vemurafenib (RG7204/PLX40",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.1171875,
            "text": "Vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.1484375,
            "text": "Vemurafenib (RG7204/PLX",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.1640625,
            "text": "Vemurafenib (RG7204/PL",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.46875,
            "text": "Vemurafenib (",
            "probability": 0.0
        },
        {
            "start_logit": -9.0546875,
            "end_logit": 12.7578125,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.5859375,
            "text": "Vemurafenib (RG7204/PLX4032), a small-molecule",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.625,
            "text": "Vemurafenib (RG7204/PLX4032), a small-molecule inhibitor of mutant BRAF,",
            "probability": 0.0
        },
        {
            "start_logit": 12.2421875,
            "end_logit": -8.7421875,
            "text": "Vemurafenib (RG72",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_40": [
        {
            "start_logit": 13.28125,
            "end_logit": 13.234375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -4.23046875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -4.6953125,
            "text": "vemurafenib (PLX4032",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 13.234375,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -7.03515625,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -7.140625,
            "text": "vemurafenib (PLX40",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -7.70703125,
            "text": "vemurafenib (PL",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -7.890625,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.078125,
            "text": "vemurafenib (PLX4032)",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.2109375,
            "text": "vemurafenib (PLX",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.265625,
            "text": "vemurafenib (",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.375,
            "text": "vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma with the BRAF",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.4453125,
            "text": "vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma with the BRAF V600",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.7421875,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.796875,
            "text": "vemurafenib (PLX4032) have shown response rates of more than 50%",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": 13.234375,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.28125,
            "end_logit": -8.8515625,
            "text": "vemurafenib (PLX4032) have shown response rates",
            "probability": 0.0
        },
        {
            "start_logit": -9.234375,
            "end_logit": 13.234375,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 13.234375,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.703125,
            "end_logit": 13.234375,
            "text": "BRAF kinase inhibitor vemurafenib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_41": [
        {
            "start_logit": 13.1171875,
            "end_logit": 13.1796875,
            "text": "Vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -4.4453125,
            "text": "Ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 13.1796875,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -7.078125,
            "text": "Vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -8.3359375,
            "text": "Vemura",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -8.359375,
            "text": "Vemu",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 13.1796875,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -8.7421875,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe for treatment of advanced melanoma",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -8.9921875,
            "text": "Vemurafenib is",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 13.1796875,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.3125,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe",
            "probability": 0.0
        },
        {
            "start_logit": -9.3828125,
            "end_logit": 13.1796875,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.359375,
            "text": "Vemurafenib is the first",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.484375,
            "text": "Vemurafenib is the first molecularly targeted therapy",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.578125,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.6171875,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe for treatment of advanced",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.6328125,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe for",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.6640625,
            "text": "Vemurafenib is the",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.6640625,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -8.7421875,
            "text": "ib is the first molecularly targeted therapy to be licensed in the US and Europe for treatment of advanced melanoma",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_42": [
        {
            "start_logit": 13.3046875,
            "end_logit": 13.2890625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -4.32421875,
            "text": "ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 13.2890625,
            "text": "ib",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -5.51953125,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -7.26171875,
            "text": "vemurafen",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.203125,
            "text": "vemu",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.5546875,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.6171875,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK) inhibitors, such as GD",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.765625,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimuma",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -8.8671875,
            "text": "vemura",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 13.2890625,
            "text": "fenib",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.0625,
            "text": "vemurafenib in combination with immunomodulatory agents",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.078125,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimu",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.0859375,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipili",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.3671875,
            "text": "vemurafenib in",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.390625,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK)",
            "probability": 0.0
        },
        {
            "start_logit": 13.3046875,
            "end_logit": -9.40625,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab,",
            "probability": 0.0
        },
        {
            "start_logit": -9.40625,
            "end_logit": 13.2890625,
            "text": "rafenib",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 13.2890625,
            "text": "murafenib",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 13.2890625,
            "text": "test the efficacy of vemurafenib",
            "probability": 0.0
        }
    ],
    "5314c7afdae131f84700000a_1": [
        {
            "start_logit": 11.0625,
            "end_logit": 10.921875,
            "text": "periodic hypothermia",
            "probability": 0.9931640625
        },
        {
            "start_logit": 11.0625,
            "end_logit": 5.96875,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.00701141357421875
        },
        {
            "start_logit": 11.0625,
            "end_logit": -1.02734375,
            "text": "periodic hypothermia and hyperhidrosis",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 3.95703125,
            "end_logit": 5.96875,
            "text": "agenesis of the corpus callosum",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 11.0625,
            "end_logit": -4.078125,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 11.0625,
            "end_logit": -4.8046875,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.0625,
            "end_logit": -4.94921875,
            "text": "periodic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.0625,
            "end_logit": -5.140625,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.49609375,
            "end_logit": 10.921875,
            "text": "hypothermia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.0625,
            "end_logit": -7.26171875,
            "text": "periodic hypothermia and hyper",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -7.2890625,
            "text": "periodic hypothermia and hyperhidro",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -7.6953125,
            "text": "periodic hypothermia and hyperhidrosis along with",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -7.80859375,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.1484375,
            "text": "periodic hypothermia and hyperhi",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -8.2734375,
            "text": "periodic hypothermia and",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -9.3125,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro et al.",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -9.34375,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro et al. in",
            "probability": 0.0
        },
        {
            "start_logit": 11.0625,
            "end_logit": -9.484375,
            "text": "periodic hypothermia and hyperhidrosis along",
            "probability": 0.0
        },
        {
            "start_logit": -4.69921875,
            "end_logit": 5.96875,
            "text": "corpus callosum",
            "probability": 0.0
        },
        {
            "start_logit": -5.49609375,
            "end_logit": 5.96875,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.0
        }
    ],
    "5314c7afdae131f84700000a_2": [
        {
            "start_logit": 11.3828125,
            "end_logit": 12.2734375,
            "text": "hyperhidrosis",
            "probability": 1.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": 3.166015625,
            "text": "hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -2.19921875,
            "text": "hyperhidrosis and congenital agenesis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 12.2734375,
            "text": "sis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -5.01171875,
            "text": "hyper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -6.37890625,
            "text": "hyperhidrosis and congenital agenesis of the corpus",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -6.78515625,
            "text": "hyperhidrosis and congenital agenesis of the",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -7.16015625,
            "text": "hyperhidro",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 12.2734375,
            "text": "hypothermia, hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -7.9296875,
            "text": "hyperhi",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 12.2734375,
            "text": "drosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -8.421875,
            "text": "hyperhidrosis and congenital agenesis of",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -8.59375,
            "text": "hyperhidrosis and congenital",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -8.9453125,
            "text": "hyperhidrosis and",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 12.2734375,
            "text": "hidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.3828125,
            "end_logit": -9.359375,
            "text": "hyperhidrosis and congenital agenesis of the corpus callosum.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 12.2734375,
            "text": "recurrent hypothermia, hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.2734375,
            "text": "Shapiro syndrome is a rare entity, comprising a triad of recurrent hypothermia, hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 12.2734375,
            "text": ", hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.732421875,
            "end_logit": 3.166015625,
            "text": "agenesis of the corpus callosum",
            "probability": 0.0
        }
    ],
    "5314c7afdae131f84700000a_3": [
        {
            "start_logit": 11.5546875,
            "end_logit": 11.8515625,
            "text": "hyperhidrosis",
            "probability": 1.0
        },
        {
            "start_logit": -4.01171875,
            "end_logit": 11.8515625,
            "text": "periodic hypothermia and hyperhidrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -4.96875,
            "text": "hyper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 11.8515625,
            "text": "sis",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -6.2265625,
            "text": "hyperhidro",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -6.98828125,
            "text": "hyperhi",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 11.8515625,
            "text": "hypothermia and hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 11.8515625,
            "text": "drosis",
            "probability": 0.0
        },
        {
            "start_logit": -9.2734375,
            "end_logit": 11.8515625,
            "text": "hidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.1484375,
            "text": "hyperhidrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.8515625,
            "text": "Hypermelatoninemia should be considered in patients with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.5859375,
            "text": "hyperhidrosis, and also",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.796875,
            "text": "hyperhidrosis, and also in patients with Shapiro's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.8125,
            "text": "hyperhidrosis, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 11.8515625,
            "text": "spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.984375,
            "text": "hyperhidrosis, and also in",
            "probability": 0.0
        },
        {
            "start_logit": -4.01171875,
            "end_logit": -1.724609375,
            "text": "periodic hypothermia",
            "probability": 0.0
        },
        {
            "start_logit": -4.01171875,
            "end_logit": -4.96875,
            "text": "periodic hypothermia and hyper",
            "probability": 0.0
        },
        {
            "start_logit": -4.01171875,
            "end_logit": -6.2265625,
            "text": "periodic hypothermia and hyperhidro",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -1.724609375,
            "text": "hypothermia",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_1": [
        {
            "start_logit": 14.625,
            "end_logit": 14.7265625,
            "text": "lung cancer",
            "probability": 1.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": 14.7265625,
            "text": "non-small cell lung cancer",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 14.625,
            "end_logit": -2.28125,
            "text": "lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.421875,
            "end_logit": 14.7265625,
            "text": "cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.421875,
            "end_logit": 14.7265625,
            "text": "Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 14.7265625,
            "text": "small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -9.8203125,
            "text": "lung cancer both in vitro and in vivo",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 14.7265625,
            "text": "electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -10.0,
            "text": "lung cancer both",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 14.7265625,
            "text": "chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 14.625,
            "end_logit": -10.1796875,
            "text": "lung cancer both in vitro and in vivo.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 14.7265625,
            "text": "treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": 14.7265625,
            "text": "tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 14.7265625,
            "text": "improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -2.28125,
            "text": "non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -6.625,
            "text": "non-small cell",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -8.328125,
            "text": "non",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -8.609375,
            "text": "non-",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -8.640625,
            "text": "non-small",
            "probability": 0.0
        },
        {
            "start_logit": 2.1171875,
            "end_logit": -9.8203125,
            "text": "non-small cell lung cancer both in vitro and in vivo",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_2": [
        {
            "start_logit": 14.25,
            "end_logit": 13.46875,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -3.033203125,
            "text": "glioblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.42578125,
            "end_logit": 13.46875,
            "text": "multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -8.703125,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A system",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.1171875,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A system.",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.140625,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.2265625,
            "text": "glioblastoma multiforme response",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.4140625,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.6796875,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.75,
            "text": "glioblastoma multiforme response in patients treated with the Novo",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.8515625,
            "text": "glioblastoma multiforme response in patients treated with the",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.96875,
            "text": "glioblastoma multiforme response in",
            "probability": 0.0
        },
        {
            "start_logit": 14.25,
            "end_logit": -9.96875,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": 13.46875,
            "text": "field strength on glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -8.703125,
            "text": "multiforme response in patients treated with the NovoTTF\u2122-100A system",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.1171875,
            "text": "multiforme response in patients treated with the NovoTTF\u2122-100A system.",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.140625,
            "text": "multiforme response in patients treated with the NovoTTF\u2122-100A",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.2265625,
            "text": "multiforme response",
            "probability": 0.0
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -9.4140625,
            "text": "multiforme response in patients treated with the NovoTTF\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": -3.033203125,
            "text": "field strength on glioblastoma",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_3": [
        {
            "start_logit": 14.5859375,
            "end_logit": 14.4296875,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -2.41015625,
            "text": "glioblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.9453125,
            "end_logit": 14.4296875,
            "text": "multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -5.1015625,
            "text": "glioblastoma multiforme (GBM",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -7.3671875,
            "text": "glioblastoma multiforme (",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -8.84375,
            "text": "glioblastoma multiforme (GBM)",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -9.1171875,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for recurrent GBM",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 14.4296875,
            "text": "newly diagnosed glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 14.4296875,
            "text": "diagnosed glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.3046875,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.359375,
            "text": "glioblastoma multiforme (GBM) and",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 14.4296875,
            "text": "assessing its efficacy for newly diagnosed glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.46875,
            "text": "glioblastoma multiforme (GBM) and it",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.578125,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for recurrent GBM.",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.6171875,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for",
            "probability": 0.0
        },
        {
            "start_logit": 14.5859375,
            "end_logit": -10.703125,
            "text": "glioblastoma multiforme (GBM) and it has been",
            "probability": 0.0
        },
        {
            "start_logit": -2.9453125,
            "end_logit": -5.1015625,
            "text": "multiforme (GBM",
            "probability": 0.0
        },
        {
            "start_logit": -2.9453125,
            "end_logit": -7.3671875,
            "text": "multiforme (",
            "probability": 0.0
        },
        {
            "start_logit": -2.9453125,
            "end_logit": -8.84375,
            "text": "multiforme (GBM)",
            "probability": 0.0
        },
        {
            "start_logit": -2.9453125,
            "end_logit": -9.1171875,
            "text": "multiforme (GBM) and it has been FDA-approved for recurrent GBM",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_4": [
        {
            "start_logit": 14.7890625,
            "end_logit": 14.140625,
            "text": "non-small cell lung",
            "probability": 1.0
        },
        {
            "start_logit": 14.7890625,
            "end_logit": -1.869140625,
            "text": "non",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 14.7890625,
            "end_logit": -3.8125,
            "text": "non-small cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": 14.140625,
            "text": "lung",
            "probability": 0.0
        },
        {
            "start_logit": 14.7890625,
            "end_logit": -7.3515625,
            "text": "non-small cell",
            "probability": 0.0
        },
        {
            "start_logit": 14.7890625,
            "end_logit": -7.78125,
            "text": "non-small",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": 14.140625,
            "text": "pemetrexed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": 14.7890625,
            "end_logit": -8.6640625,
            "text": "non-",
            "probability": 0.0
        },
        {
            "start_logit": -8.9296875,
            "end_logit": 14.140625,
            "text": "advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -9.09375,
            "end_logit": 14.140625,
            "text": "small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 14.140625,
            "text": "cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 14.140625,
            "text": "TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 14.140625,
            "text": "phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 14.140625,
            "text": "exed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 14.140625,
            "text": "etrexed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 14.140625,
            "text": "Fields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -3.8125,
            "text": "lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.869140625,
            "text": "pemetrexed for advanced non",
            "probability": 0.0
        },
        {
            "start_logit": -8.9296875,
            "end_logit": -1.869140625,
            "text": "advanced non",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -3.8125,
            "text": "pemetrexed for advanced non-small cell lung cancer",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_5": [
        {
            "start_logit": 10.7421875,
            "end_logit": 12.421875,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 12.421875,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 12.421875,
            "text": "treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 12.421875,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 12.421875,
            "text": "Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.421875,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.421875,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.421875,
            "text": "fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.8984375,
            "text": "glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.0390625,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.1015625,
            "text": "glioblastoma by the U.S. FDA and has a",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.2421875,
            "text": "glioblastoma by the U.S. FDA and has a CE mark",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.3046875,
            "text": "glioblastoma by the U.S. FDA and has",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.328125,
            "text": "glioblastoma by the U.S. FDA and",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -8.8984375,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -8.8984375,
            "text": "recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.8984375,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -8.8984375,
            "text": ". FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -8.8984375,
            "text": "U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": -9.6484375,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_6": [
        {
            "start_logit": 10.53125,
            "end_logit": 12.203125,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": 6.05859375,
            "text": "TTFields",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 12.203125,
            "text": "TTFields monotherapy compared to active chemotherapy in recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 12.203125,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 12.203125,
            "text": "compared to active chemotherapy in recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.53125,
            "end_logit": -9.4765625,
            "text": "glioblastoma patients established",
            "probability": 0.0
        },
        {
            "start_logit": 10.53125,
            "end_logit": -9.671875,
            "text": "glioblastoma patients",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": 0.29296875,
            "text": "nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -8.34375,
            "text": "TT",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -8.3515625,
            "text": "TTField",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -8.375,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -9.1953125,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -9.4140625,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized. A phase III trial of TTFields",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -9.5546875,
            "text": "TTFields therapy has been demonstrated in multiple cell lines",
            "probability": 0.0
        },
        {
            "start_logit": 4.6484375,
            "end_logit": -9.59375,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized.",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -5.3671875,
            "text": "nonsmall cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 0.29296875,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 0.29296875,
            "text": "lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 0.29296875,
            "text": "brain metastases, nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -7.5546875,
            "text": "nonsmall cell lung cancer, and ovarian and pancreatic",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_7": [
        {
            "start_logit": 13.859375,
            "end_logit": 13.1171875,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -3.654296875,
            "text": "glioblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 13.1171875,
            "text": "multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -6.5,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 13.1171875,
            "text": "NovoTTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -8.34375,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -8.9375,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.4921875,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer types",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.828125,
            "text": "glioblastoma multiforme after standard therapies have failed",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.953125,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -10.0078125,
            "text": "glioblastoma multiforme after standard therapies have",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 13.1171875,
            "text": "progressive glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 13.1171875,
            "text": "TTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 13.1171875,
            "text": "100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -4.69140625,
            "end_logit": -6.5,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -3.654296875,
            "text": "NovoTTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.69140625,
            "end_logit": -8.34375,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": -3.654296875,
            "text": "progressive glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": -3.654296875,
            "text": "TTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.69140625,
            "end_logit": -8.9375,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_8": [
        {
            "start_logit": 14.0390625,
            "end_logit": 13.546875,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -3.4765625,
            "text": "glioblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.38671875,
            "end_logit": 13.546875,
            "text": "multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.265625,
            "text": "glioblastoma multiforme treated",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.296875,
            "text": "glioblastoma multiforme treated with tumor-treating fields.",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -10.2890625,
            "text": "glioblastoma multiforme treated with",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -10.296875,
            "text": "glioblastoma multiforme treated with tumor-treating fields",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 13.546875,
            "text": "Long-term survival of patients suffering from glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 13.546875,
            "text": "suffering from glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 13.546875,
            "text": "term survival of patients suffering from glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -11.015625,
            "end_logit": 13.546875,
            "text": "-term survival of patients suffering from glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -3.4765625,
            "text": "Long-term survival of patients suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.38671875,
            "end_logit": -9.265625,
            "text": "multiforme treated",
            "probability": 0.0
        },
        {
            "start_logit": -4.38671875,
            "end_logit": -9.296875,
            "text": "multiforme treated with tumor-treating fields.",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -3.4765625,
            "text": "suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": -3.4765625,
            "text": "term survival of patients suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -11.015625,
            "end_logit": -3.4765625,
            "text": "-term survival of patients suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.38671875,
            "end_logit": -10.2890625,
            "text": "multiforme treated with",
            "probability": 0.0
        },
        {
            "start_logit": -4.38671875,
            "end_logit": -10.296875,
            "text": "multiforme treated with tumor-treating fields",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": -9.046875,
            "text": "Long-term survival of patients suffering from",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_9": [
        {
            "start_logit": 13.9296875,
            "end_logit": 13.46875,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -3.326171875,
            "text": "glioblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 13.46875,
            "text": "multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": 13.46875,
            "text": "TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.625,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.140625,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy)",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.765625,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 13.46875,
            "text": "recurrent glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.8515625,
            "text": "glioblastoma multiforme: in a",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.90625,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.46875,
            "text": "in recurrent glioblastoma multiforme",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -3.326171875,
            "text": "TTFields, mainly in two indications: one in recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -5.3828125,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": -3.326171875,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -8.625,
            "text": "multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -3.326171875,
            "text": "in recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.140625,
            "text": "multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy)",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.765625,
            "text": "multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.8515625,
            "text": "multiforme: in a",
            "probability": 0.0
        },
        {
            "start_logit": -4.33984375,
            "end_logit": -9.90625,
            "text": "multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_10": [
        {
            "start_logit": 13.5859375,
            "end_logit": 12.078125,
            "text": "non-small cell lung",
            "probability": 0.97265625
        },
        {
            "start_logit": 13.5859375,
            "end_logit": 8.5,
            "text": "non-small cell lung cancer",
            "probability": 0.027587890625
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -3.498046875,
            "text": "non",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 12.078125,
            "text": "lung",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -8.1171875,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetrexed",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -8.2109375,
            "text": "non-small cell lung cancer, where TTFields",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -8.6484375,
            "text": "non-small",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -8.671875,
            "text": "non-",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -8.6796875,
            "text": "non-small cell",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -9.125,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetr",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -9.5234375,
            "text": "non-small cell lung cancer, where",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -9.6640625,
            "text": "non-small cell lung cancer,",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 12.078125,
            "text": "small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -9.765625,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetrex",
            "probability": 0.0
        },
        {
            "start_logit": 13.5859375,
            "end_logit": -9.8359375,
            "text": "non-small cell lung cancer, where TTFields was",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 8.5,
            "text": "lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": 12.078125,
            "text": "second-line non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 12.078125,
            "text": "Phase II study in second-line non-small cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.078125,
            "text": "cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 8.5,
            "text": "cancer",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_11": [
        {
            "start_logit": 11.8984375,
            "end_logit": 9.671875,
            "text": "pancreatic cancer",
            "probability": 0.96337890625
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 9.671875,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0241241455078125
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.9765625,
            "text": "glioblastoma",
            "probability": 0.01212310791015625
        },
        {
            "start_logit": 11.8984375,
            "end_logit": -1.2568359375,
            "text": "pancreatic",
            "probability": 1.7404556274414062e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2568359375,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 9.671875,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 9.671875,
            "text": "TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -8.625,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 9.671875,
            "text": "preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 9.671875,
            "text": "recurrent glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 8.9765625,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 8.9765625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 8.9765625,
            "text": ": Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 8.9765625,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 8.9765625,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -9.6484375,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of",
            "probability": 0.0
        },
        {
            "start_logit": -10.546875,
            "end_logit": 8.9765625,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -9.875,
            "text": "glioblastoma. The present study",
            "probability": 0.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -9.8828125,
            "text": "glioblastoma. The present study determined the",
            "probability": 0.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -9.8828125,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_12": [
        {
            "start_logit": 10.765625,
            "end_logit": 12.3984375,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 12.3984375,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 12.3984375,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.3984375,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.3984375,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.3984375,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.3984375,
            "text": "Fields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 12.3984375,
            "text": "treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.3984375,
            "text": "(TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -10.5859375,
            "text": "glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.0625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.0625,
            "text": "non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.421875,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.4296875,
            "text": "TTFields) are",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -9.0625,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.0625,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.421875,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.65625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.65625,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -9.421875,
            "text": "Treating Fields (TTFields) are a non-invasive",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_13": [
        {
            "start_logit": 10.7421875,
            "end_logit": 12.421875,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 12.421875,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 12.421875,
            "text": "treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": 12.421875,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 12.421875,
            "text": "Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.421875,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 12.421875,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.421875,
            "text": "fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.8984375,
            "text": "glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.0390625,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.1015625,
            "text": "glioblastoma by the U.S. FDA and has a",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.2421875,
            "text": "glioblastoma by the U.S. FDA and has a CE mark",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.3046875,
            "text": "glioblastoma by the U.S. FDA and has",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -10.328125,
            "text": "glioblastoma by the U.S. FDA and",
            "probability": 0.0
        },
        {
            "start_logit": -10.140625,
            "end_logit": -8.8984375,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -8.8984375,
            "text": "recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.8984375,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.4453125,
            "end_logit": -8.8984375,
            "text": ". FDA",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": -8.8984375,
            "text": "U.S. FDA",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": -9.6484375,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_14": [
        {
            "start_logit": 10.828125,
            "end_logit": 12.3359375,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 12.3359375,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 12.3359375,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 12.3359375,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 12.3359375,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 12.3359375,
            "text": ": Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.3359375,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 12.3359375,
            "text": "Fields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 12.3359375,
            "text": "treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.828125,
            "end_logit": -10.6953125,
            "text": "glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -9.1484375,
            "text": "TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -9.1484375,
            "text": "non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -9.1484375,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": -9.1484375,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -9.6015625,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": -9.1484375,
            "text": ": Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -9.6875,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -9.6015625,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": -9.890625,
            "text": "TTFields) are",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": -9.6875,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_15": [
        {
            "start_logit": 10.765625,
            "end_logit": 12.3984375,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 12.3984375,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 12.3984375,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.3984375,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 12.3984375,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 12.3984375,
            "text": "recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 12.3984375,
            "text": "Fields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.65625,
            "end_logit": 12.3984375,
            "text": "treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 12.3984375,
            "text": "(TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": 10.765625,
            "end_logit": -10.5859375,
            "text": "glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.0625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.0625,
            "text": "non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.421875,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.4296875,
            "text": "TTFields) are",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -9.0625,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.0625,
            "text": "Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.421875,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -9.65625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -9.65625,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -9.421875,
            "text": "Treating Fields (TTFields) are a non-invasive",
            "probability": 0.0
        }
    ],
    "61f81a2d882a024a10000042_1": [
        {
            "start_logit": 14.140625,
            "end_logit": 13.7890625,
            "text": "intellectual disability",
            "probability": 1.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -3.509765625,
            "text": "intellectual",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.25,
            "end_logit": 13.7890625,
            "text": "disability",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -5.29296875,
            "text": "intellectual disability, speech delay, and dysmorphism",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -5.875,
            "text": "intellectual disability, speech delay",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -7.99609375,
            "text": "intellectual disability, speech delay, and dysm",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -8.21875,
            "text": "intellectual disability, speech delay, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -8.3359375,
            "text": "intellectual disability, speech",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -8.671875,
            "text": "intellectual disability, speech delay,",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -9.390625,
            "text": "intellectual disability, speech delay, and dysmorphism.",
            "probability": 0.0
        },
        {
            "start_logit": 14.140625,
            "end_logit": -9.453125,
            "text": "intellectual disability,",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 13.7890625,
            "text": "syndrome with intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.7890625,
            "text": "Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -5.29296875,
            "text": "disability, speech delay, and dysmorphism",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -5.875,
            "text": "disability, speech delay",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -7.99609375,
            "text": "disability, speech delay, and dysm",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -8.21875,
            "text": "disability, speech delay, and",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -8.3359375,
            "text": "disability, speech",
            "probability": 0.0
        },
        {
            "start_logit": -4.25,
            "end_logit": -8.671875,
            "text": "disability, speech delay,",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -5.29296875,
            "text": "dysmorphism",
            "probability": 0.0
        }
    ],
    "61f81a2d882a024a10000042_2": [
        {
            "start_logit": 13.171875,
            "end_logit": 11.046875,
            "text": "developmental delay/intellectual disability",
            "probability": 0.94384765625
        },
        {
            "start_logit": 10.34375,
            "end_logit": 11.046875,
            "text": "intellectual disability",
            "probability": 0.0557861328125
        },
        {
            "start_logit": 13.171875,
            "end_logit": 2.220703125,
            "text": "developmental delay",
            "probability": 0.00013828277587890625
        },
        {
            "start_logit": -2.17578125,
            "end_logit": 11.046875,
            "text": "variable degree of developmental delay/intellectual disability",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.171875,
            "end_logit": -4.41015625,
            "text": "developmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.171875,
            "end_logit": -6.5,
            "text": "developmental delay/intellectual",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -7.35546875,
            "text": "developmental delay/intellectual disability, particularly affecting speech, while additional features include growth failure, feeding difficulties, non-specific MRI abnormalities, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -7.42578125,
            "text": "developmental delay/intellectual disability, particularly affecting speech",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -8.1015625,
            "text": "developmental delay/intellectual disability, particularly affecting speech, while additional features include growth failure",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -8.5234375,
            "text": "developmental delay/",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -8.65625,
            "text": "developmental delay/intellectual disability, particularly affecting speech, while additional features include growth failure, feeding difficulties, non-specific MRI",
            "probability": 0.0
        },
        {
            "start_logit": 13.171875,
            "end_logit": -8.890625,
            "text": "developmental delay/intellectual disability,",
            "probability": 0.0
        },
        {
            "start_logit": 10.34375,
            "end_logit": -6.5,
            "text": "intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 11.046875,
            "text": "disability",
            "probability": 0.0
        },
        {
            "start_logit": 10.34375,
            "end_logit": -7.35546875,
            "text": "intellectual disability, particularly affecting speech, while additional features include growth failure, feeding difficulties, non-specific MRI abnormalities, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": 10.34375,
            "end_logit": -7.42578125,
            "text": "intellectual disability, particularly affecting speech",
            "probability": 0.0
        },
        {
            "start_logit": 10.34375,
            "end_logit": -8.1015625,
            "text": "intellectual disability, particularly affecting speech, while additional features include growth failure",
            "probability": 0.0
        },
        {
            "start_logit": -8.875,
            "end_logit": 11.046875,
            "text": "/intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": 11.046875,
            "text": "is a variable degree of developmental delay/intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": 10.34375,
            "end_logit": -8.65625,
            "text": "intellectual disability, particularly affecting speech, while additional features include growth failure, feeding difficulties, non-specific MRI",
            "probability": 0.0
        }
    ],
    "620997e9c9dfcb9c09000042_1": [
        {
            "start_logit": 13.671875,
            "end_logit": 13.484375,
            "text": "intellectual disability",
            "probability": 1.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -4.203125,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -4.2890625,
            "text": "intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": 13.484375,
            "text": "disability",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.15234375,
            "text": "intellectual disability, spastic-dystonic cerebral palsy",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.7578125,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.0390625,
            "text": "intellectual disability, spastic-dystonic",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.3046875,
            "text": "intellectual disability, spastic-dystonic cerebral",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.453125,
            "text": "intellectual disability, spastic-dyst",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.6484375,
            "text": "intellectual disability, spastic",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.7265625,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.765625,
            "text": "intellectual disability, spastic-",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.8671875,
            "text": "intellectual disability, spastic-dystonic cerebral palsy,",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.484375,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy,",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.5078125,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.609375,
            "text": "intellectual disability,",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.484375,
            "text": "Bi-allelic variants in SPATA5L1 lead to intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -4.203125,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -4.203125,
            "text": "epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -6.15234375,
            "text": "disability, spastic-dystonic cerebral palsy",
            "probability": 0.0
        }
    ],
    "620997e9c9dfcb9c09000042_2": [
        {
            "start_logit": 13.3984375,
            "end_logit": 12.515625,
            "text": "sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": 12.515625,
            "text": "hearing loss",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -3.37109375,
            "text": "sensorineural",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 12.515625,
            "text": "loss",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -7.125,
            "text": "sensorineural hearing",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -8.0859375,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microc",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -8.1796875,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -8.4453125,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microcephal",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -9.2578125,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -9.578125,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented",
            "probability": 0.0
        },
        {
            "start_logit": 13.3984375,
            "end_logit": -9.7421875,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": 12.515625,
            "text": "with sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 12.515625,
            "text": "bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 12.515625,
            "text": "variants in SPATA5L1 associated with sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -3.18359375,
            "text": "hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -7.125,
            "text": "hearing",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -8.0859375,
            "text": "hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microc",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -8.1796875,
            "text": "hearing loss in 47 individuals from 28 (26 unrelated) families",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -8.4453125,
            "text": "hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microcephal",
            "probability": 0.0
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -9.2578125,
            "text": "hearing loss in 47 individuals from 28 (26 unrelated",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_1": [
        {
            "start_logit": 11.8203125,
            "end_logit": 11.515625,
            "text": "CD44",
            "probability": 1.0
        },
        {
            "start_logit": 11.8203125,
            "end_logit": -3.21875,
            "text": "CD44 and PARP1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 11.8203125,
            "end_logit": -7.44140625,
            "text": "CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": 11.8203125,
            "end_logit": -8.453125,
            "text": "CD44 and",
            "probability": 0.0
        },
        {
            "start_logit": 11.8203125,
            "end_logit": -9.3203125,
            "text": "CD44 and PARP1.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 11.515625,
            "text": "biology and clinical management of this disease, such as CD44",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 11.515625,
            "text": "and clinical management of this disease, such as CD44",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 11.515625,
            "text": "of this disease, such as CD44",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -3.21875,
            "text": "PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -3.21875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -3.21875,
            "text": "biology and clinical management of this disease, such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": -3.21875,
            "text": "and clinical management of this disease, such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -3.21875,
            "text": "of this disease, such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.44140625,
            "text": "PARP",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -9.3203125,
            "text": "PARP1.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -7.44140625,
            "text": "biology and clinical management of this disease, such as CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": -7.44140625,
            "text": "and clinical management of this disease, such as CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -7.44140625,
            "text": "of this disease, such as CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": -7.85546875,
            "text": "biology and clinical management of this disease, such as",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": -9.3203125,
            "text": "1.",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_2": [
        {
            "start_logit": 10.796875,
            "end_logit": 12.0546875,
            "text": "Mage-A4",
            "probability": 1.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -2.41796875,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 12.0546875,
            "text": "A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.796875,
            "end_logit": -4.578125,
            "text": "Mage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.796875,
            "end_logit": -7.09765625,
            "text": "Mage-",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -7.66015625,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive/ER",
            "probability": 0.0
        },
        {
            "start_logit": -9.5859375,
            "end_logit": 12.0546875,
            "text": "TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -8.375,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 12.0546875,
            "text": "large cumulative database of proteins based on the analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 12.0546875,
            "text": "analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -10.1875,
            "end_logit": 12.0546875,
            "text": "of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.0546875,
            "text": "78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -9.265625,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive/ER negative",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -9.4140625,
            "text": "Mage-A4,",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -9.4296875,
            "text": "Mage-A4, which was expressed",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -9.46875,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-",
            "probability": 0.0
        },
        {
            "start_logit": 10.796875,
            "end_logit": -9.6953125,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC",
            "probability": 0.0
        },
        {
            "start_logit": -2.873046875,
            "end_logit": -2.41796875,
            "text": "Her2",
            "probability": 0.0
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -2.41796875,
            "text": "A4, which was expressed in a significant fraction of TNBC and Her2",
            "probability": 0.0
        },
        {
            "start_logit": -2.873046875,
            "end_logit": -7.66015625,
            "text": "Her2-positive/ER",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_3": [
        {
            "start_logit": 11.6953125,
            "end_logit": 12.2890625,
            "text": "Mage-A4",
            "probability": 1.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": 0.11376953125,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -4.046875,
            "text": "Mage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 12.2890625,
            "text": "A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -5.828125,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.59375,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative breast",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.6953125,
            "text": "Mage-",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -7.66015625,
            "text": "Mage-A4 as potential therapeutic target",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -7.859375,
            "text": "Mage-A4 as",
            "probability": 0.0
        },
        {
            "start_logit": -9.421875,
            "end_logit": 12.2890625,
            "text": "breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.953125,
            "text": "Mage-A4 as potential therapeutic target in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.1171875,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.34375,
            "text": "Mage-A4 as potential therapeutic target in",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.3828125,
            "text": "Mage-A4 as potential",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.4375,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 12.2890625,
            "text": "profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 12.2890625,
            "text": "triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -10.5390625,
            "end_logit": 12.2890625,
            "text": "of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 0.0
        },
        {
            "start_logit": -0.875,
            "end_logit": 0.11376953125,
            "text": "breast cancer",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": 0.11376953125,
            "text": "estrogen receptor negative breast cancer",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_4": [
        {
            "start_logit": 5.03515625,
            "end_logit": 7.84375,
            "text": "RAB25",
            "probability": 0.92578125
        },
        {
            "start_logit": 5.03515625,
            "end_logit": 5.2265625,
            "text": "RAB25, S100A14 and mucin 1 (MUC1",
            "probability": 0.06817626953125
        },
        {
            "start_logit": 1.3984375,
            "end_logit": 5.2265625,
            "text": "MUC1",
            "probability": 0.0017871856689453125
        },
        {
            "start_logit": -1.2763671875,
            "end_logit": 7.84375,
            "text": "breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25",
            "probability": 0.0016851425170898438
        },
        {
            "start_logit": 1.0146484375,
            "end_logit": 5.2265625,
            "text": "S100A14 and mucin 1 (MUC1",
            "probability": 0.0012187957763671875
        },
        {
            "start_logit": 5.03515625,
            "end_logit": 0.79443359375,
            "text": "RAB25, S100A14",
            "probability": 0.0008058547973632812
        },
        {
            "start_logit": -2.775390625,
            "end_logit": 7.84375,
            "text": "lipolysis-stimulated lipoprotein receptor (LSR), RAB25",
            "probability": 0.000377655029296875
        },
        {
            "start_logit": 5.03515625,
            "end_logit": -0.32421875,
            "text": "RAB25, S100A14 and mucin 1",
            "probability": 0.00026345252990722656
        },
        {
            "start_logit": -1.0048828125,
            "end_logit": 5.2265625,
            "text": "mucin 1 (MUC1",
            "probability": 0.00016117095947265625
        },
        {
            "start_logit": -2.775390625,
            "end_logit": 5.2265625,
            "text": "lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14 and mucin 1 (MUC1",
            "probability": 2.759695053100586e-05
        },
        {
            "start_logit": 1.0146484375,
            "end_logit": 0.79443359375,
            "text": "S100A14",
            "probability": 1.4543533325195312e-05
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 7.84375,
            "text": "25",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 1.0146484375,
            "end_logit": -0.32421875,
            "text": "S100A14 and mucin 1",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.84375,
            "text": ", RAB25",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 5.03515625,
            "end_logit": -5.29296875,
            "text": "RAB25, S100A14 and mucin",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -1.2763671875,
            "end_logit": 0.79443359375,
            "text": "breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -1.0048828125,
            "end_logit": -0.32421875,
            "text": "mucin 1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -9.234375,
            "end_logit": 7.84375,
            "text": "stimulated lipoprotein receptor (LSR), RAB25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -9.359375,
            "end_logit": 7.84375,
            "text": "LSR), RAB25",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.2763671875,
            "end_logit": -0.32421875,
            "text": "breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14 and mucin 1",
            "probability": 4.76837158203125e-07
        }
    ],
    "51595fb0d24251bc0500009c_5": [
        {
            "start_logit": 11.828125,
            "end_logit": 11.546875,
            "text": "Hsp90",
            "probability": 1.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -7.3671875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -8.515625,
            "text": "Hsp90 as a critical and multimodal target",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -8.7265625,
            "text": "Hsp90 as a",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.296875,
            "text": "Hsp90 as a critical and multimodal target in this",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.375,
            "text": "Hsp90 as",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.5234375,
            "text": "Hsp90 as a critical",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 11.546875,
            "text": "he results identify Hsp90",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.6484375,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.703125,
            "text": "Hsp90 as a critical and multimodal",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.7265625,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.7265625,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor PU-H71 for",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.7421875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.796875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.8515625,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.859375,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor PU-",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the",
            "probability": 0.0
        },
        {
            "start_logit": 11.828125,
            "end_logit": -9.96875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor PU-H71",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.3671875,
            "text": "breast cancer",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": -7.3671875,
            "text": "he results identify Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_6": [
        {
            "start_logit": 3.1640625,
            "end_logit": 4.00390625,
            "text": "MDH2",
            "probability": 0.927734375
        },
        {
            "start_logit": 3.1640625,
            "end_logit": 1.384765625,
            "text": "MDH2, PGK1, TKT, Aldolase1",
            "probability": 0.06744384765625
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -1.81640625,
            "text": "MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 0.002750396728515625
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -2.8359375,
            "text": "MDH2, PGK1",
            "probability": 0.0009927749633789062
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -3.486328125,
            "text": "MDH2, PGK1, TKT",
            "probability": 0.0005168914794921875
        },
        {
            "start_logit": -3.22265625,
            "end_logit": 1.384765625,
            "text": "Aldolase1",
            "probability": 0.00011354684829711914
        },
        {
            "start_logit": -3.625,
            "end_logit": 1.384765625,
            "text": "1",
            "probability": 7.623434066772461e-05
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -5.61328125,
            "text": "MDH2, PGK1, TKT, Aldolase",
            "probability": 6.175041198730469e-05
        },
        {
            "start_logit": -3.9609375,
            "end_logit": 1.384765625,
            "text": "PGK1, TKT, Aldolase1",
            "probability": 5.453824996948242e-05
        },
        {
            "start_logit": -2.12890625,
            "end_logit": -1.142578125,
            "text": "cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -6.921875,
            "text": "MDH2, PGK1, TKT, Aldolase1), cytokeratins (CK7, 8, 9, 14, 17, 19",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -2.12890625,
            "end_logit": -1.81640625,
            "text": "cytokeratins",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": -2.12890625,
            "end_logit": -2.130859375,
            "text": "cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin, fibronectin, L-plastin",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -3.22265625,
            "end_logit": -1.142578125,
            "text": "Aldolase1), cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin",
            "probability": 9.119510650634766e-06
        },
        {
            "start_logit": -5.921875,
            "end_logit": 1.384765625,
            "text": "TKT, Aldolase1",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 3.1640625,
            "end_logit": -7.9296875,
            "text": "MDH2, PGK1, TKT, Aldolase1), cytokeratin",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -3.625,
            "end_logit": -1.142578125,
            "text": "1), cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -3.75390625,
            "end_logit": -1.142578125,
            "text": "vimentin",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 4.00390625,
            "text": "H2",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -3.22265625,
            "end_logit": -1.81640625,
            "text": "Aldolase1), cytokeratins",
            "probability": 4.649162292480469e-06
        }
    ],
    "51595fb0d24251bc0500009c_7": [
        {
            "start_logit": 10.9296875,
            "end_logit": 12.1796875,
            "text": "Stat1",
            "probability": 1.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -3.921875,
            "text": "Stat1, Mx1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -5.21484375,
            "text": "Stat1, Mx1, and CD74",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -6.7578125,
            "text": "Stat1, Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -8.1796875,
            "text": "Stat1, Mx",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -8.65625,
            "text": "Stat1, Mx1, and",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -9.1953125,
            "text": "Stat1,",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": 12.1796875,
            "text": "The first is characterized by high expression of Stat1",
            "probability": 0.0
        },
        {
            "start_logit": 10.9296875,
            "end_logit": -9.703125,
            "text": "Stat1, Mx1, and CD74.",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -3.921875,
            "text": "Mx1",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -5.21484375,
            "text": "CD74",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -5.21484375,
            "text": "Mx1, and CD74",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -6.7578125,
            "text": "CD",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -6.7578125,
            "text": "Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -3.921875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -8.1796875,
            "text": "Mx",
            "probability": 0.0
        },
        {
            "start_logit": -10.671875,
            "end_logit": -3.921875,
            "text": "The first is characterized by high expression of Stat1, Mx1",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -9.703125,
            "text": "CD74.",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -8.65625,
            "text": "Mx1, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -5.21484375,
            "text": "1, and CD74",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_8": [
        {
            "start_logit": 9.6796875,
            "end_logit": 3.822265625,
            "text": "MUC18",
            "probability": 0.90380859375
        },
        {
            "start_logit": 9.6796875,
            "end_logit": 1.560546875,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1",
            "probability": 0.094482421875
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -2.546875,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD74",
            "probability": 0.0015516281127929688
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -5.02734375,
            "text": "MUC1",
            "probability": 0.0001304149627685547
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -5.41796875,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.19140625,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis",
            "probability": 4.0411949157714844e-05
        },
        {
            "start_logit": -1.3544921875,
            "end_logit": 3.822265625,
            "text": "beta-catenin, MUC18",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.56640625,
            "text": "MUC18, plexins, integrins, and other proteins",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.97265625,
            "text": "MUC18, plexins, integrins",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.28125,
            "text": "MUC18, plexins",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.53125,
            "text": "MUC18, plexins, integrins, and",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.7265625,
            "text": "MUC18, plexins, integrins, and other proteins involved",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.9296875,
            "text": "MUC18, plexins, integrins, and other",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -1.5146484375,
            "end_logit": 1.560546875,
            "text": "Stat1",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -1.3544921875,
            "end_logit": 0.443359375,
            "text": "beta-catenin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.5146484375,
            "end_logit": -2.546875,
            "text": "Stat1/CD74",
            "probability": 0.0
        },
        {
            "start_logit": -8.9453125,
            "end_logit": 3.822265625,
            "text": "catenin, MUC18",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": 3.822265625,
            "text": "8",
            "probability": 0.0
        },
        {
            "start_logit": -1.5146484375,
            "end_logit": -4.63671875,
            "text": "Stat1/CD74 positive triple-negative tumors are more aggressive and suggest an approach for development of better diagnostics and more targeted therapies for triple negative breast cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.3544921875,
            "end_logit": -5.02734375,
            "text": "beta-catenin, MUC1",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_9": [
        {
            "start_logit": 9.71875,
            "end_logit": 10.2265625,
            "text": "IDH2",
            "probability": 0.96435546875
        },
        {
            "start_logit": 9.71875,
            "end_logit": 6.90625,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2",
            "probability": 0.035125732421875
        },
        {
            "start_logit": 4.97265625,
            "end_logit": 6.90625,
            "text": "SEC14L2",
            "probability": 0.0003039836883544922
        },
        {
            "start_logit": 9.71875,
            "end_logit": -0.394775390625,
            "text": "IDH2 and CRABP2",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 9.71875,
            "end_logit": -0.76611328125,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer",
            "probability": 1.6391277313232422e-05
        },
        {
            "start_logit": 9.71875,
            "end_logit": -4.96875,
            "text": "IDH2 and CRABP2 and low levels of SEC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -0.76611328125,
            "text": "SEC14L2 to be prognostic markers for overall breast cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.71875,
            "end_logit": -5.66796875,
            "text": "IDH2 and CRABP2 and low levels of SEC14",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 10.2265625,
            "text": "H2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -6.78125,
            "text": "IDH2 and CRAB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -6.89453125,
            "text": "ID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 6.90625,
            "text": "CRABP2 and low levels of SEC14L2",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.671875,
            "text": "IDH2 and CRABP2 and low levels of",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.6953125,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.9296875,
            "text": "IDH2 and",
            "probability": 0.0
        },
        {
            "start_logit": -5.3828125,
            "end_logit": 6.90625,
            "text": "L2",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.4453125,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.6328125,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer survival",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -9.015625,
            "text": "IDH2 and CRABP2 and",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -9.1015625,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_10": [
        {
            "start_logit": 11.8359375,
            "end_logit": 10.7109375,
            "text": "CD44",
            "probability": 1.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -1.544921875,
            "text": "CD44, and EGFR",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -4.59375,
            "end_logit": 10.7109375,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -7.5078125,
            "text": "CD44, and EGFR from the breast cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": 10.7109375,
            "text": "vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -7.81640625,
            "text": "CD44, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.8359375,
            "end_logit": -8.5625,
            "text": "CD44, and EGFR from the breast cancer cell lines",
            "probability": 0.0
        },
        {
            "start_logit": -8.84375,
            "end_logit": 10.7109375,
            "text": "galectin-3 binding protein, cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": -9.0390625,
            "end_logit": 10.7109375,
            "text": "D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 10.7109375,
            "text": "thromobospondin 1, galectin-3 binding protein, cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 10.7109375,
            "text": "zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": -9.953125,
            "end_logit": 10.7109375,
            "text": "biomarkers including thromobospondin 1, galectin-3 binding protein, cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 10.7109375,
            "text": ", CD44",
            "probability": 0.0
        },
        {
            "start_logit": -4.22265625,
            "end_logit": -1.544921875,
            "text": "EGFR",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -1.544921875,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -2.89453125,
            "text": "cathepsin D",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": -1.544921875,
            "text": "vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -3.984375,
            "text": "cathepsin D, vimentin",
            "probability": 0.0
        },
        {
            "start_logit": -8.84375,
            "end_logit": -1.544921875,
            "text": "galectin-3 binding protein, cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR",
            "probability": 0.0
        },
        {
            "start_logit": -9.0390625,
            "end_logit": -1.544921875,
            "text": "D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_1": [
        {
            "start_logit": 11.171875,
            "end_logit": 12.1484375,
            "text": "1",
            "probability": 1.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -6.48046875,
            "text": "1 (LOD = 3",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -7.01953125,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 12.1484375,
            "text": "PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -8.4921875,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -8.546875,
            "text": "1 (LOD",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": 12.1484375,
            "text": "OSA, including regions on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -8.84375,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 12.1484375,
            "text": "CMI, much of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 12.1484375,
            "text": "Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 12.1484375,
            "text": "genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 12.1484375,
            "text": "on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.1484375,
            "text": "much of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.453125,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.5703125,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22 (LOD = 3",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.6015625,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.7734375,
            "text": "1 (LOD = 3.07, p = 3",
            "probability": 0.0
        },
        {
            "start_logit": 11.171875,
            "end_logit": -9.859375,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3)",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -6.48046875,
            "text": "PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1 (LOD = 3",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -7.01953125,
            "text": "22",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_2": [
        {
            "start_logit": 10.3359375,
            "end_logit": 9.1484375,
            "text": "Chr8",
            "probability": 0.9990234375
        },
        {
            "start_logit": 10.3359375,
            "end_logit": 2.123046875,
            "text": "Chr8, Max LOD = 3",
            "probability": 0.0008897781372070312
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -2.2265625,
            "text": "Chr8, Max LOD = 3.04; Chr12",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -3.65234375,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -7.18359375,
            "text": "Chr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -7.7890625,
            "text": "Chr8, Max LOD = 3.04; Chr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -7.8203125,
            "text": "Chr8, Max LOD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -7.93359375,
            "text": "Chr8, Max LOD = 3.04;",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.046875,
            "text": "Chr8, Max LOD = 3.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.1484375,
            "text": "8",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.2890625,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09) identified within the subset of \"CTD",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.4140625,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.4375,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09) identified",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.5859375,
            "text": "Chr8, Max LOD =",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.8046875,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09)",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -9.953125,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09",
            "probability": 0.0
        },
        {
            "start_logit": 10.3359375,
            "end_logit": -10.0,
            "text": "Chr8, Max LOD = 3.04",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 9.1484375,
            "text": "regions (Chr8",
            "probability": 0.0
        },
        {
            "start_logit": -10.03125,
            "end_logit": 9.1484375,
            "text": "(Chr8",
            "probability": 0.0
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 2.123046875,
            "text": "3",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_3": [
        {
            "start_logit": 10.734375,
            "end_logit": 12.3671875,
            "text": "5",
            "probability": 1.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -7.28515625,
            "text": "5 (5q35.1",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 12.3671875,
            "text": "interstitial duplication in chromosome 5",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -8.1953125,
            "text": "5 (5q",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 12.3671875,
            "text": "chromosome 5",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -8.6953125,
            "text": "5 (5q35",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 12.3671875,
            "text": "performed DNA analysis showed interstitial duplication in chromosome 5",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -8.7890625,
            "text": "5 (",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.171875,
            "text": "5 (5q35.1)",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.3125,
            "text": "5 (5q35.",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.7578125,
            "text": "5 (5q35.1).",
            "probability": 0.0
        },
        {
            "start_logit": 10.734375,
            "end_logit": -9.921875,
            "text": "5 (5",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -6.19140625,
            "text": "interstitial duplication",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -6.19140625,
            "text": "performed DNA analysis showed interstitial duplication",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -7.28515625,
            "text": "5q35.1",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": -7.28515625,
            "text": "interstitial duplication in chromosome 5 (5q35.1",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": -7.28515625,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -7.28515625,
            "text": "chromosome 5 (5q35.1",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -7.28515625,
            "text": "performed DNA analysis showed interstitial duplication in chromosome 5 (5q35.1",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -8.1953125,
            "text": "5q",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_4": [
        {
            "start_logit": 9.6875,
            "end_logit": 9.828125,
            "text": "SRL",
            "probability": 0.998046875
        },
        {
            "start_logit": 3.3515625,
            "end_logit": 9.828125,
            "text": "3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0017681121826171875
        },
        {
            "start_logit": 3.3515625,
            "end_logit": 6.4765625,
            "text": "3",
            "probability": 6.192922592163086e-05
        },
        {
            "start_logit": -4.578125,
            "end_logit": 9.828125,
            "text": "ADCY9, and SRL",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 9.828125,
            "text": "7 kb microdeletion on 16p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.6875,
            "end_logit": -4.859375,
            "text": "SRL genes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.6875,
            "end_logit": -6.37890625,
            "text": "SR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.828125,
            "text": "3.3 involving CREBBP, ADCY9, and SRL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.828125,
            "text": "L",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.3515625,
            "end_logit": -0.98876953125,
            "text": "3 involving CREBBP, ADCY9",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.828125,
            "text": "CREBBP, ADCY9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 6.4765625,
            "text": "7 kb microdeletion on 16p13.3",
            "probability": 0.0
        },
        {
            "start_logit": -8.9765625,
            "end_logit": 9.828125,
            "text": "9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 9.828125,
            "text": "Y9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": 9.828125,
            "text": "microdeletion on 16p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 9.828125,
            "text": "approximately 520.7 kb microdeletion on 16p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": 9.828125,
            "text": "520.7 kb microdeletion on 16p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 9.828125,
            "text": "16p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0
        },
        {
            "start_logit": 3.3515625,
            "end_logit": -3.583984375,
            "text": "3 involving CREBBP",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 9.828125,
            "text": "p13.3 involving CREBBP, ADCY9, and SRL",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_5": [
        {
            "start_logit": 11.609375,
            "end_logit": 11.546875,
            "text": "49,XXXXY",
            "probability": 1.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -3.76171875,
            "text": "49",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 11.546875,
            "text": "XXXXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.734375,
            "end_logit": 11.546875,
            "text": "Pentasomy 49,XXXXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 11.546875,
            "text": "XY",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.1484375,
            "text": "49,XX",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 11.546875,
            "text": "XXY",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -8.171875,
            "text": "49,XXX",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 11.546875,
            "text": ",XXXXY",
            "probability": 0.0
        },
        {
            "start_logit": -9.3125,
            "end_logit": 11.546875,
            "text": "somy 49,XXXXY",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.6796875,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and cervical syrinx",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -9.8125,
            "text": "49,XXXXY associated",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.234375,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and cervical syrinx.",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.2734375,
            "text": "49,",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.3203125,
            "text": "49,XXXXY associated with a Chiari type 1 malformation",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.3984375,
            "text": "49,XXXXY associated with a",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 11.546875,
            "text": "my 49,XXXXY",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.5625,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.59375,
            "text": "49,XXXXY associated with",
            "probability": 0.0
        },
        {
            "start_logit": 11.609375,
            "end_logit": -10.6015625,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and cervical",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_6": [
        {
            "start_logit": 5.38671875,
            "end_logit": 10.0234375,
            "text": "49,XXXXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.59375,
            "end_logit": 10.0234375,
            "text": "pentasomy 49,XXXXY",
            "probability": 0.00034332275390625
        },
        {
            "start_logit": -3.62109375,
            "end_logit": 10.0234375,
            "text": "XXXXY",
            "probability": 0.0001233816146850586
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -1.974609375,
            "text": "49",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 10.0234375,
            "text": "XY",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 10.0234375,
            "text": "XXY",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.0234375,
            "text": "with pentasomy 49,XXXXY",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.0234375,
            "text": ",XXXXY",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 10.0234375,
            "text": "somy 49,XXXXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 10.0234375,
            "text": "13-year-old with pentasomy 49,XXXXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.046875,
            "end_logit": 10.0234375,
            "text": "my 49,XXXXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -7.4296875,
            "text": "49,XX",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -8.6484375,
            "text": "49,XXX",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -8.71875,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -9.28125,
            "text": "49,",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -9.703125,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syr",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -9.90625,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrin",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -9.9296875,
            "text": "49,XXXXY and a Chiari type 1 malformation",
            "probability": 0.0
        },
        {
            "start_logit": -2.59375,
            "end_logit": -1.974609375,
            "text": "pentasomy 49",
            "probability": 0.0
        },
        {
            "start_logit": 5.38671875,
            "end_logit": -10.203125,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx is presented",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_7": [
        {
            "start_logit": 11.0546875,
            "end_logit": 11.25,
            "text": "9",
            "probability": 0.380859375
        },
        {
            "start_logit": 11.4453125,
            "end_logit": 10.8359375,
            "text": "15",
            "probability": 0.369140625
        },
        {
            "start_logit": 11.0546875,
            "end_logit": 10.8359375,
            "text": "9 and 15",
            "probability": 0.249755859375
        },
        {
            "start_logit": 11.4453125,
            "end_logit": -9.9140625,
            "text": "15.",
            "probability": 0.0
        },
        {
            "start_logit": 11.0546875,
            "end_logit": -9.875,
            "text": "9 and",
            "probability": 0.0
        },
        {
            "start_logit": 11.0546875,
            "end_logit": -9.9140625,
            "text": "9 and 15.",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 11.25,
            "text": "Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 11.25,
            "text": "on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 11.25,
            "text": "with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.25,
            "text": "definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 11.25,
            "text": "Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.25,
            "text": "density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 11.25,
            "text": "SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 10.8359375,
            "text": "Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.5,
            "end_logit": 10.8359375,
            "text": "on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 10.8359375,
            "text": "with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 10.8359375,
            "text": "definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.7109375,
            "end_logit": 10.8359375,
            "text": "Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 10.8359375,
            "text": "density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 10.8359375,
            "text": "SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_8": [
        {
            "start_logit": 10.2578125,
            "end_logit": 12.765625,
            "text": "15",
            "probability": 1.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -6.71875,
            "text": "15 reached 3",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": 12.765625,
            "text": "Two-point LOD scores on chromosome 15",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 12.765625,
            "text": "chromosome 15",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -8.046875,
            "text": "15 reached 3.3",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 12.765625,
            "text": "LOD scores on chromosome 15",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -8.640625,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -8.84375,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -8.8671875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -9.0546875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21.1-22",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -9.3203125,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -9.390625,
            "text": "15 reached 3.3 and multipoint scores in this region",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -9.5546875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD",
            "probability": 0.0
        },
        {
            "start_logit": 10.2578125,
            "end_logit": -9.671875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -6.71875,
            "text": "3",
            "probability": 0.0
        },
        {
            "start_logit": -10.203125,
            "end_logit": -6.71875,
            "text": "Two-point LOD scores on chromosome 15 reached 3",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -6.71875,
            "text": "reached 3",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -6.71875,
            "text": "chromosome 15 reached 3",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": -6.71875,
            "text": "LOD scores on chromosome 15 reached 3",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": -8.046875,
            "text": "3.3",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_9": [
        {
            "start_logit": 10.375,
            "end_logit": 12.5703125,
            "text": "9",
            "probability": 1.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 12.5703125,
            "text": "chromosome 9",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 12.5703125,
            "text": "Multipoint LOD scores on chromosome 9",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -8.7578125,
            "text": "9 maximized at 3.05, identifying a 40 cM",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -8.8828125,
            "text": "9 maximized at 3",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -8.921875,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.0703125,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.21875,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.46875,
            "text": "9 maximized at 3.05, identifying a 40",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.6328125,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33.1",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.6875,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.7109375,
            "text": "9 maximized at 3.05, identifying a 40 cM region",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.75,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-",
            "probability": 0.0
        },
        {
            "start_logit": 10.375,
            "end_logit": -9.8125,
            "text": "9 maximized at 3.05, identifying a",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -8.7578125,
            "text": "chromosome 9 maximized at 3.05, identifying a 40 cM",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": -9.109375,
            "text": "that",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -8.8828125,
            "text": "chromosome 9 maximized at 3",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -8.921875,
            "text": "chromosome 9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21",
            "probability": 0.0
        },
        {
            "start_logit": -9.6171875,
            "end_logit": -8.921875,
            "text": "9q21",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": -9.0703125,
            "text": "chromosome 9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_10": [
        {
            "start_logit": 11.3359375,
            "end_logit": 11.390625,
            "text": "1",
            "probability": 1.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -7.2734375,
            "text": "1)(q23q31.2",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.0703125,
            "text": "1)(q23q31.2)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.2109375,
            "text": "1)(",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.2734375,
            "text": "1)(q23q31",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 11.390625,
            "text": "del(1",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.5546875,
            "text": "1)(q23q",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.6015625,
            "text": "1)",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.65625,
            "text": "1)(q",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -8.7421875,
            "text": "1)(q23",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.9921875,
            "text": "1)(q23q31.",
            "probability": 0.0
        },
        {
            "start_logit": 11.3359375,
            "end_logit": -9.9921875,
            "text": "1)(q23q31.2).",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 11.390625,
            "text": "46, XY, del(1",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 11.390625,
            "text": ", del(1",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 11.390625,
            "text": "XY, del(1",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 11.390625,
            "text": "karyotype showed 46, XY, del(1",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -6.296875,
            "text": "del",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -7.2734375,
            "text": "del(1)(q23q31.2",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -6.296875,
            "text": "46, XY, del",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -8.0703125,
            "text": "del(1)(q23q31.2)",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_11": [
        {
            "start_logit": 14.3828125,
            "end_logit": 2.1875,
            "text": "Y chromosome",
            "probability": 0.75341796875
        },
        {
            "start_logit": 14.3828125,
            "end_logit": 1.0615234375,
            "text": "Y",
            "probability": 0.2464599609375
        },
        {
            "start_logit": 14.3828125,
            "end_logit": -9.03125,
            "text": "Y chromosome.",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 2.1875,
            "text": "inversion of Y chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 2.1875,
            "text": "Karyotype analysis showed inversion of Y chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": 1.0615234375,
            "text": "inversion of Y",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": 1.0615234375,
            "text": "Karyotype analysis showed inversion of Y",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -5.65234375,
            "text": "inversion",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -5.65234375,
            "text": "Karyotype analysis showed inversion",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -9.03125,
            "text": "inversion of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.03125,
            "text": "Karyotype analysis showed inversion of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1640625,
            "end_logit": -9.2578125,
            "text": "inversion of",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.21875,
            "text": "Karyotype analysis showed",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.2578125,
            "text": "Karyotype analysis showed inversion of",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -9.8125,
            "text": "Karyotype",
            "probability": 0.0
        },
        {
            "start_logit": -10.2578125,
            "end_logit": -10.4765625,
            "text": "Karyotype analysis",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_12": [
        {
            "start_logit": 5.453125,
            "end_logit": 14.515625,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": 14.515625,
            "text": "trisomy 18",
            "probability": 0.0002453327178955078
        },
        {
            "start_logit": -9.3125,
            "end_logit": 14.515625,
            "text": "infants with trisomy 18",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.453125,
            "end_logit": -9.140625,
            "text": "18 are presented. The majority were small-for-date infants. There was no sex predominance",
            "probability": 0.0
        },
        {
            "start_logit": 5.453125,
            "end_logit": -9.96875,
            "text": "18 are presented. The majority were small-for-date infants. There was no sex predominance in our series, as",
            "probability": 0.0
        },
        {
            "start_logit": 5.453125,
            "end_logit": -9.9765625,
            "text": "18 are presented. The majority were small-for-date",
            "probability": 0.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -6.8359375,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -9.140625,
            "text": "trisomy 18 are presented. The majority were small-for-date infants. There was no sex predominance",
            "probability": 0.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -9.96875,
            "text": "trisomy 18 are presented. The majority were small-for-date infants. There was no sex predominance in our series, as",
            "probability": 0.0
        },
        {
            "start_logit": -2.857421875,
            "end_logit": -9.9765625,
            "text": "trisomy 18 are presented. The majority were small-for-date",
            "probability": 0.0
        },
        {
            "start_logit": -9.3125,
            "end_logit": -6.8359375,
            "text": "infants with trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": -8.78125,
            "text": "Cardiovascular anomalies were consistently present; ventricular septar defect",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": -8.78125,
            "text": "ventricular septar defect",
            "probability": 0.0
        },
        {
            "start_logit": -9.3125,
            "end_logit": -9.140625,
            "text": "infants with trisomy 18 are presented. The majority were small-for-date infants. There was no sex predominance",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.140625,
            "text": "sex predominance",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.4609375,
            "text": "sex predominance in our series, as opposed to male:female ratios of 1:3 reported",
            "probability": 0.0
        },
        {
            "start_logit": -9.46875,
            "end_logit": -9.390625,
            "text": "Cardiovascular anomalies were consistently present; ventricular septar defect and patent ductus arteriosus",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -9.53125,
            "text": "sex predominance in our series, as opposed to male:female ratios of 1:3",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": -9.4609375,
            "text": "ratios of 1:3 reported",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": -8.78125,
            "text": "average age at death was greater in females than in males. Cardiovascular anomalies were consistently present; ventricular septar defect",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_13": [
        {
            "start_logit": 8.9765625,
            "end_logit": 13.2109375,
            "text": "13",
            "probability": 1.0
        },
        {
            "start_logit": -5.4375,
            "end_logit": 13.2109375,
            "text": "trisomy 13",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 13.2109375,
            "text": "stillborn male showing feature of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": 13.2109375,
            "text": "pontine meninges of a stillborn male showing feature of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 13.2109375,
            "text": "male showing feature of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.2109375,
            "text": "meninges of a stillborn male showing feature of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.2109375,
            "text": "of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 13.2109375,
            "text": "born male showing feature of trisomy 13",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.2421875,
            "text": "13 and an Arnold-Chiari malformation",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.875,
            "text": "13 and an Arnold-Chiari malformation.",
            "probability": 0.0
        },
        {
            "start_logit": -5.4375,
            "end_logit": -8.125,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -5.4375,
            "end_logit": -9.2421875,
            "text": "trisomy 13 and an Arnold-Chiari malformation",
            "probability": 0.0
        },
        {
            "start_logit": -5.4375,
            "end_logit": -9.875,
            "text": "trisomy 13 and an Arnold-Chiari malformation.",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -8.125,
            "text": "stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0234375,
            "end_logit": -8.125,
            "text": "pontine meninges of a stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": -8.125,
            "text": "male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -8.125,
            "text": "meninges of a stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -8.125,
            "text": "of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": -8.125,
            "text": "born male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -9.0234375,
            "text": "stillborn male showing feature",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_14": [
        {
            "start_logit": 9.78125,
            "end_logit": 13.0546875,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 13.0546875,
            "text": "trisomy 18",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.625,
            "end_logit": 13.0546875,
            "text": "Arnold-Chiari malformation with normal spine in trisomy 18",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 13.0546875,
            "text": "Type II Arnold-Chiari malformation with normal spine in trisomy 18",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.0546875,
            "text": "normal spine in trisomy 18",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": 13.0546875,
            "text": "nold-Chiari malformation with normal spine in trisomy 18",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -9.484375,
            "text": "18.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -7.80859375,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -9.484375,
            "text": "trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": -7.80859375,
            "text": "Arnold-Chiari malformation with normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": -7.80859375,
            "text": "Type II Arnold-Chiari malformation with normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -7.80859375,
            "text": "normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -7.80859375,
            "text": "nold-Chiari malformation with normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": -9.3203125,
            "text": "Arnold-Chiari malformation with normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": -9.3203125,
            "text": "Type II Arnold-Chiari malformation with normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": -9.4609375,
            "text": "Arnold-Chiari malformation with normal spine in",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -9.3203125,
            "text": "normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -10.78125,
            "end_logit": -9.3203125,
            "text": "nold-Chiari malformation with normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": -9.484375,
            "text": "Arnold-Chiari malformation with normal spine in trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": -9.4609375,
            "text": "Type II Arnold-Chiari malformation with normal spine in",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_15": [
        {
            "start_logit": 8.9765625,
            "end_logit": 13.3515625,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 13.3515625,
            "text": "trisomy 18",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.37109375,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.7578125,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifid",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.3046875,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.4921875,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spin",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.625,
            "text": "18. The present case",
            "probability": 0.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -9.6640625,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida. One previous case",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -7.37109375,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -8.5546875,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -8.7578125,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifid",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -9.3046875,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -9.4921875,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spin",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -9.625,
            "text": "trisomy 18. The present case",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -9.6640625,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida. One previous case",
            "probability": 0.0
        },
        {
            "start_logit": -8.96875,
            "end_logit": -7.37109375,
            "text": "spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": -9.1875,
            "end_logit": -7.37109375,
            "text": "infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.4921875,
            "text": "that infant also had a lumbar meningomyelocoele",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.6484375,
            "text": "that infant also had a lumbar meningomyel",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": -8.4921875,
            "text": "meningomyelocoele",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_16": [
        {
            "start_logit": 11.1328125,
            "end_logit": 11.5703125,
            "text": "FOXP1",
            "probability": 1.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": 11.5703125,
            "text": "P1",
            "probability": 0.0
        },
        {
            "start_logit": 11.1328125,
            "end_logit": -6.33984375,
            "text": "FOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": 11.5703125,
            "text": "3p13-14.1 deletion of four genes, including FOXP1",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": 11.5703125,
            "text": "1 deletion of four genes, including FOXP1",
            "probability": 0.0
        },
        {
            "start_logit": 11.1328125,
            "end_logit": -8.8359375,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study, we report the case of a patient with a single deletion",
            "probability": 0.0
        },
        {
            "start_logit": 11.1328125,
            "end_logit": -8.875,
            "text": "FOXP1, and a constellation of deficits that included speech delay",
            "probability": 0.0
        },
        {
            "start_logit": 11.1328125,
            "end_logit": -9.15625,
            "text": "FOXP1,",
            "probability": 0.0
        },
        {
            "start_logit": 11.1328125,
            "end_logit": -9.296875,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study, we report the case",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": 11.5703125,
            "text": "child was reported who presented with a 3p13-14.1 deletion of four genes, including FOXP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -5.02734375,
            "text": "3p13-14.1",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -5.62109375,
            "text": "3p13-14.1 deletion of four genes",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -5.02734375,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -6.33984375,
            "text": "3p13-14.1 deletion of four genes, including FOX",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -5.62109375,
            "text": "1 deletion of four genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -8.8359375,
            "text": "P1, and a constellation of deficits that included speech delay. In this study, we report the case of a patient with a single deletion",
            "probability": 0.0
        },
        {
            "start_logit": -10.3046875,
            "end_logit": -5.02734375,
            "text": "child was reported who presented with a 3p13-14.1",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -8.8671875,
            "text": "P1, and a constellation of deficits that included speech delay. In this study, we report the case of a patient with a single deletion of FOX",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -8.875,
            "text": "P1, and a constellation of deficits that included speech delay",
            "probability": 0.0
        },
        {
            "start_logit": -9.203125,
            "end_logit": -6.33984375,
            "text": "1 deletion of four genes, including FOX",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_1": [
        {
            "start_logit": 13.84375,
            "end_logit": 12.453125,
            "text": "peripheral neuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -3.2109375,
            "text": "peripheral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.84375,
            "end_logit": -4.21484375,
            "text": "peripheral neuropathy, organomegaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.84375,
            "end_logit": -4.89453125,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 0.0
        },
        {
            "start_logit": -3.619140625,
            "end_logit": 12.453125,
            "text": "neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -7.5390625,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.65625,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.84375,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -8.953125,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.0,
            "text": "peripheral neuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.1484375,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.21875,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.84375,
            "end_logit": -9.59375,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papill",
            "probability": 0.0
        },
        {
            "start_logit": -9.3671875,
            "end_logit": 12.453125,
            "text": "plasma cell dyscrasia. Recognition of a combination of peripheral neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.453125,
            "text": "paraneoplastic syndrome secondary to a plasma cell dyscrasia. Recognition of a combination of peripheral neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": 1.1005859375,
            "end_logit": 1.31640625,
            "text": "thrombocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 1.31640625,
            "text": "monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 1.1005859375,
            "end_logit": -7.21875,
            "text": "thrombocytosis, and Castleman disease",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 1.31640625,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis",
            "probability": 0.0
        },
        {
            "start_logit": 1.1005859375,
            "end_logit": -7.66015625,
            "text": "thrombocyt",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_2": [
        {
            "start_logit": 9.2421875,
            "end_logit": 7.15625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.955078125
        },
        {
            "start_logit": 9.2421875,
            "end_logit": 4.09765625,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.044677734375
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -4.35546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.05859375,
            "text": "polyneuropathy",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.31640625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -8.2109375,
            "text": "polyneuropathy, organ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -8.25,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 7.15625,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -8.9375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.140625,
            "text": "polyneuropathy, organomegaly,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.15625,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.265625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.3046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.40625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome should be directed at the underlying plasma cell clone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.5546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.6328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.15625,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -9.8359375,
            "text": "polyneuropathy, organomegaly, endocrin",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a67afb7b750ff445500000d_3": [
        {
            "start_logit": 7.99609375,
            "end_logit": 8.3984375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.99609375,
            "end_logit": 1.67578125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.0012063980102539062
        },
        {
            "start_logit": 7.99609375,
            "end_logit": 0.2318115234375,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.0002841949462890625
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 8.3984375,
            "text": "endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 8.3984375,
            "text": "organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 8.3984375,
            "text": "skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.16015625,
            "text": "Polyneuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.19921875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.3984375,
            "text": "monoclonal plasma cell disorder, skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.92578125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.578125,
            "end_logit": 8.3984375,
            "text": ", organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -8.734375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -8.7734375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -8.8828125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -9.03125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -9.046875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -9.125,
            "text": "Polyneuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -9.171875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS)",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 8.3984375,
            "text": "changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_4": [
        {
            "start_logit": 11.46875,
            "end_logit": -1.34765625,
            "text": "Polyneuropathy",
            "probability": 0.87353515625
        },
        {
            "start_logit": 11.46875,
            "end_logit": -3.884765625,
            "text": "Polyneuropathy, Organomegaly",
            "probability": 0.0689697265625
        },
        {
            "start_logit": 11.46875,
            "end_logit": -4.65234375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy",
            "probability": 0.031951904296875
        },
        {
            "start_logit": 11.46875,
            "end_logit": -5.68359375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.01139068603515625
        },
        {
            "start_logit": 11.46875,
            "end_logit": -5.72265625,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein",
            "probability": 0.010955810546875
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.3046875,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M",
            "probability": 0.0008287429809570312
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.7109375,
            "text": "Polyneuropathy, Organ",
            "probability": 0.0005521774291992188
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.765625,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin",
            "probability": 0.000522613525390625
        },
        {
            "start_logit": 11.46875,
            "end_logit": -8.875,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and",
            "probability": 0.00046825408935546875
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.1015625,
            "text": "Polyneuropathy, Organomegaly,",
            "probability": 0.00037360191345214844
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.5859375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy,",
            "probability": 0.00022995471954345703
        },
        {
            "start_logit": 11.46875,
            "end_logit": -9.6875,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities.",
            "probability": 0.00020778179168701172
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -3.884765625,
            "text": "Organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -4.65234375,
            "text": "Organomegaly, Endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -1.34765625,
            "text": "POEMS is an acronym for the main clinical features of the syndrome, namely, Polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -4.65234375,
            "text": "Endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.8203125,
            "end_logit": -1.34765625,
            "text": "clinical features of the syndrome, namely, Polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": -1.34765625,
            "text": "acronym for the main clinical features of the syndrome, namely, Polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -5.68359375,
            "text": "Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -5.72265625,
            "text": "Organomegaly, Endocrinopathy, M protein",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_5": [
        {
            "start_logit": 10.6953125,
            "end_logit": 0.443115234375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.93359375
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -2.865234375,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.034027099609375
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -3.24609375,
            "text": "polyneuropathy",
            "probability": 0.0232696533203125
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -4.49609375,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.0066680908203125
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -6.27734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.0011234283447265625
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -7.21875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes)",
            "probability": 0.0004382133483886719
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -7.703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 0.00026988983154296875
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -8.71875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 9.775161743164062e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -8.7265625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 9.703636169433594e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -8.8515625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 8.565187454223633e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -8.9921875,
            "text": "polyneuropathy, organ",
            "probability": 7.43865966796875e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.125,
            "text": "polyneuropathy, organomegaly,",
            "probability": 6.514787673950195e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.40625,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 4.9173831939697266e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.46875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem disorder with a good long-term prognosis",
            "probability": 4.6193599700927734e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem disorder",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.7265625,
            "text": "polyneuropathy,",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.8125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem disorder with a good long-term prognosis.",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": 10.6953125,
            "end_logit": -9.90625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 0.443115234375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 0.443115234375,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_6": [
        {
            "start_logit": 13.9296875,
            "end_logit": 4.7265625,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -3.427734375,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.0002868175506591797
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -5.3359375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -5.91015625,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -6.4765625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.265625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.7109375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem syndrome, Crow-Fukase",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.7578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.8046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.015625,
            "text": "polyneuropathy, organ",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.125,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.140625,
            "text": "polyneuropathy, organomegaly,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.234375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem syndrome, Crow-Fukase syndrome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.5,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.5546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.5703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem syndrome, Crow-Fukase syndrome,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -3.427734375,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -5.3359375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -5.91015625,
            "text": "organomegaly, endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -5.3359375,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_7": [
        {
            "start_logit": 8.6640625,
            "end_logit": 10.921875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 1.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": 2.853515625,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.0003101825714111328
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 10.921875,
            "text": "skin changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -4.046875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 10.921875,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 10.921875,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 10.921875,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -5.265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.921875,
            "text": "changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.56640625,
            "text": "Polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": 10.921875,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.3515625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 0.0
        },
        {
            "start_logit": -9.7734375,
            "end_logit": 10.921875,
            "text": "opathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 10.921875,
            "text": "gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -10.046875,
            "end_logit": 10.921875,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.453125,
            "text": "Polyneuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.71875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -9.0703125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -9.109375,
            "text": "Polyneuropathy, organomegaly,",
            "probability": 0.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -9.3515625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS)",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_8": [
        {
            "start_logit": 9.1640625,
            "end_logit": 7.8203125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.94140625
        },
        {
            "start_logit": 9.1640625,
            "end_logit": 5.05078125,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.059234619140625
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -4.22265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.140625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.1640625,
            "text": "Polyneuropathy",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.1953125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -8.375,
            "text": "Polyneuropathy, organ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.8203125,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.8203125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.0234375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.8203125,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.1015625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is an uncommon condition related to a paraneoplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.8203125,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.1640625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.2265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.4375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is an uncommon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.484375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -9.5078125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a67afb7b750ff445500000d_9": [
        {
            "start_logit": 9.3125,
            "end_logit": 1.677734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.79638671875
        },
        {
            "start_logit": 9.3125,
            "end_logit": 0.303955078125,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.201416015625
        },
        {
            "start_logit": 9.3125,
            "end_logit": -4.70703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.0013408660888671875
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.140625,
            "text": "polyneuropathy",
            "probability": 0.0003197193145751953
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.2265625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.00010794401168823242
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.79296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 6.151199340820312e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -8.703125,
            "text": "polyneuropathy, organ",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -8.75,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -8.921875,
            "text": "polyneuropathy, organomegaly,",
            "probability": 1.9788742065429688e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.46875,
            "text": "polyneuropathy, organomegaly, endocrin",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.5703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome,",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.5703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.6328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": 9.3125,
            "end_logit": -9.703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS)",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 1.677734375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 1.677734375,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 1.677734375,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 0.303955078125,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 1.677734375,
            "text": "Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_10": [
        {
            "start_logit": 8.71875,
            "end_logit": 9.1484375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 1.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": 1.376953125,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.00041747093200683594
        },
        {
            "start_logit": 8.71875,
            "end_logit": -2.29296875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.11328125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 9.1484375,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.72265625,
            "text": "Polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.1484375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.36328125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 9.1484375,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.1484375,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.1484375,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -8.8125,
            "text": "Polyneuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": -9.296875,
            "end_logit": 9.1484375,
            "text": "changes",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -8.890625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.0546875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.2578125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.3515625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS)",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.4765625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.4765625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare disorder",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -9.625,
            "text": "Polyneuropathy, organomegaly,",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_11": [
        {
            "start_logit": 10.0703125,
            "end_logit": 10.609375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.9677734375
        },
        {
            "start_logit": 10.0703125,
            "end_logit": 7.21484375,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.0321044921875
        },
        {
            "start_logit": -4.56640625,
            "end_logit": 10.609375,
            "text": "skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -5.51953125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -5.765625,
            "text": "Polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 10.609375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -6.4140625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 10.609375,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 10.609375,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.3984375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.609375,
            "text": "changes",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.609375,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.1640625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome, a plasma cell dyscrasia associated with pulmonary hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.2265625,
            "text": "Polyneuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": -9.2421875,
            "end_logit": 10.609375,
            "text": "omegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.9765625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 10.609375,
            "text": "opathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.0859375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -9.8046875,
            "end_logit": 10.609375,
            "text": "gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -9.28125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_12": [
        {
            "start_logit": 8.8125,
            "end_logit": 5.08203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.97412109375
        },
        {
            "start_logit": 8.8125,
            "end_logit": 0.84521484375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 0.0141143798828125
        },
        {
            "start_logit": 8.8125,
            "end_logit": 0.6376953125,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.0115203857421875
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.55859375,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.76171875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.9453125,
            "text": "polyneuropathy",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.39453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema (ODE)",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.6796875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.86328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema (ODE",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -8.5625,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -9.28125,
            "text": "polyneuropathy, organomegaly,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -9.2890625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 5.08203125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 5.08203125,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 5.08203125,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.59375,
            "end_logit": 5.08203125,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 5.08203125,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 0.84521484375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 0.6376953125,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 0.84521484375,
            "text": "optic disc edema",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_13": [
        {
            "start_logit": 12.4609375,
            "end_logit": 6.99609375,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -4.38671875,
            "text": "polyneuropathy, hepatomegaly",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -5.05859375,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -5.7265625,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -7.05859375,
            "text": "polyneuropathy, hepatomegaly, splenomegaly",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -7.76171875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -8.1875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -8.546875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -8.921875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.40625,
            "text": "polyneuropathy, hepat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.6015625,
            "text": "polyneuropathy,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.65625,
            "text": "polyneuropathy, hepatomegaly,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.7578125,
            "text": "polyneuropathy, hepatomegaly, splenomegaly,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.796875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -9.828125,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.4609375,
            "end_logit": -10.046875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features of the recently described POEMS syndrome.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.7890625,
            "end_logit": 6.99609375,
            "text": "39-year-old woman presented with polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 6.99609375,
            "text": "woman presented with polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.2421875,
            "end_logit": -4.38671875,
            "text": "hepatomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -5.05859375,
            "text": "monoclonal protein and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_14": [
        {
            "start_logit": 10.875,
            "end_logit": -1.654296875,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.53515625
        },
        {
            "start_logit": 10.875,
            "end_logit": -2.55859375,
            "text": "polyneuropathy",
            "probability": 0.2161865234375
        },
        {
            "start_logit": 10.875,
            "end_logit": -2.630859375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.2015380859375
        },
        {
            "start_logit": 10.875,
            "end_logit": -4.70703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.02532958984375
        },
        {
            "start_logit": 10.875,
            "end_logit": -5.0078125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.01873779296875
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.4921875,
            "text": "polyneuropathy, organ",
            "probability": 0.0005750656127929688
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.65625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 0.0004878044128417969
        },
        {
            "start_logit": 10.875,
            "end_logit": -8.71875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions'",
            "probability": 0.0004582405090332031
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.03125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 0.0003352165222167969
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.171875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 0.0002913475036621094
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.3203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 0.0002510547637939453
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.4375,
            "text": "polyneuropathy, organomegaly,",
            "probability": 0.00022339820861816406
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.5546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.00019860267639160156
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.7265625,
            "text": "polyneuropathy, organomegaly, endocrin",
            "probability": 0.0001672506332397461
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.75,
            "text": "polyneuropathy,",
            "probability": 0.0001634359359741211
        },
        {
            "start_logit": 10.875,
            "end_logit": -9.828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions'.",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -1.654296875,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -2.630859375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -2.630859375,
            "text": "endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -2.630859375,
            "text": "monoclonal gammopathy and skin lesions",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_15": [
        {
            "start_logit": 12.65625,
            "end_logit": 8.78125,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -4.58984375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 12.65625,
            "end_logit": -5.79296875,
            "text": "polyneuropathy, organomegaly",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 12.65625,
            "end_logit": -7.0859375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.65625,
            "end_logit": -7.25390625,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.0625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.5625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -8.8671875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M",
            "probability": 0.0
        },
        {
            "start_logit": 12.65625,
            "end_logit": -9.078125,
            "text": "polyneuropathy, organ",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.78125,
            "text": "Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 8.78125,
            "text": "multisystem syndrome characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 8.78125,
            "text": "POEMS syndrome, also known as Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 8.78125,
            "text": "Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 8.78125,
            "text": "as Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -4.58984375,
            "text": "Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -4.58984375,
            "text": "organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -4.58984375,
            "text": "M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -5.08203125,
            "text": "Crow-Fukase syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -5.79296875,
            "text": "Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy, organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -5.79296875,
            "text": "organomegaly",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_16": [
        {
            "start_logit": 9.9375,
            "end_logit": 10.15625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.9375,
            "end_logit": 3.77734375,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.0017004013061523438
        },
        {
            "start_logit": 9.9375,
            "end_logit": -3.92578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.0,
            "end_logit": 10.15625,
            "text": "organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.27734375,
            "end_logit": 10.15625,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 10.15625,
            "text": "M protein and skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.9375,
            "end_logit": -5.59375,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.328125,
            "end_logit": 10.15625,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9375,
            "end_logit": -6.203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed as chronic inflammatory demyelinating polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9375,
            "end_logit": -6.34375,
            "text": "polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 10.15625,
            "text": "endocrinopathy, M protein and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.19140625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.15625,
            "text": "changes",
            "probability": 0.0
        },
        {
            "start_logit": -8.9453125,
            "end_logit": 10.15625,
            "text": ", organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.7890625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.0,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.0078125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.2734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed as chronic inflammatory demyelinating",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -9.6640625,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": 3.77734375,
            "text": "organomegaly",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_17": [
        {
            "start_logit": 11.5546875,
            "end_logit": 10.6953125,
            "text": "distal polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -1.21875,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -5.28125,
            "text": "distal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 10.6953125,
            "text": "progressive distal polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -6.2890625,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.484375,
            "end_logit": 10.6953125,
            "text": "polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -7.15625,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites, erythro",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -7.5859375,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -7.66015625,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -7.91796875,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -8.6953125,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites, erythrocyt",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -8.7421875,
            "text": "distal polyneuropathy and a monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.0546875,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.0859375,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 11.5546875,
            "end_logit": -9.1328125,
            "text": "distal polyneuropathy and a monoclonal plasma cell",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.6953125,
            "text": "that manifests with progressive distal polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.6953125,
            "text": "Castleman disease, that manifests with progressive distal polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 10.6953125,
            "text": "with progressive distal polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 10.6953125,
            "text": "manifests with progressive distal polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.46875,
            "end_logit": 10.6953125,
            "text": "leman disease, that manifests with progressive distal polyneuropathy",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_18": [
        {
            "start_logit": 13.4453125,
            "end_logit": 8.140625,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -5.1171875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -5.98046875,
            "text": "polyneuropathy, organomegaly",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -7.48828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -7.52734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -8.4765625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.03125,
            "text": "polyneuropathy, organ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.1328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.34375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes.",
            "probability": 0.0
        },
        {
            "start_logit": 13.4453125,
            "end_logit": -9.5546875,
            "text": "polyneuropathy,",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": 8.140625,
            "text": "osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.1953125,
            "end_logit": 8.140625,
            "text": "multisystem disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 8.140625,
            "text": "POEMS syndrome, a rare multisystem disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.921875,
            "end_logit": 8.140625,
            "text": "variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -5.1171875,
            "text": "organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -5.98046875,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -5.1171875,
            "text": "monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": -5.1171875,
            "text": "endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": -5.1171875,
            "text": "osteosclerotic myeloma and is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_19": [
        {
            "start_logit": 7.6328125,
            "end_logit": 4.87109375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.98291015625
        },
        {
            "start_logit": 7.6328125,
            "end_logit": 0.80419921875,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.0169219970703125
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -3.548828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.00021791458129882812
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -4.796875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 6.246566772460938e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -5.6953125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as systemic sclerosis",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.30078125,
            "text": "polyneuropathy",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.33203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -8.1640625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes)",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -8.8671875,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -8.9765625,
            "text": "polyneuropathy, organomegaly,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.078125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.1328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.2421875,
            "text": "polyneuropathy, organ",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.4296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 4.87109375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.8515625,
            "text": "polyneuropathy, organomegaly, endocrin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.8515625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as systemic",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -9.8828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 4.87109375,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 4.87109375,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a67afb7b750ff445500000d_20": [
        {
            "start_logit": 13.9296875,
            "end_logit": 4.34375,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -4.12109375,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.00020992755889892578
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -5.5546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -5.8828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -6.3359375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -7.88671875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.484375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.5859375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.171875,
            "text": "polyneuropathy, organ",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.2265625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.3125,
            "text": "polyneuropathy, organomegaly,",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.3203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.3828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein,",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.5390625,
            "text": "polyneuropathy,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 4.34375,
            "text": "plasma cell dyscrasia characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 4.34375,
            "text": "POEMS syndrome is a rare plasma cell dyscrasia characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": 4.34375,
            "text": "rare plasma cell dyscrasia characterized by polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -4.12109375,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -5.5546875,
            "text": "organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -5.8828125,
            "text": "organomegaly, endocrinopathy",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_21": [
        {
            "start_logit": 9.8671875,
            "end_logit": 2.404296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes",
            "probability": 0.9873046875
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.126953125,
            "text": "polyneuropathy, organomegaly",
            "probability": 0.01062774658203125
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -4.296875,
            "text": "polyneuropathy",
            "probability": 0.0012121200561523438
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -5.65625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy",
            "probability": 0.00031113624572753906
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.46484375,
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 5.078315734863281e-05
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.75390625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.5078125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.5703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapath",
            "probability": 1.6868114471435547e-05
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.9296875,
            "text": "polyneuropathy, organ",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes)",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.28125,
            "text": "polyneuropathy, organomegaly,",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes) syndrome is a rare variant of plasma cell dyscrasia",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes) syndrome is",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.4296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy,",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.65625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -9.765625,
            "text": "polyneuropathy,",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 2.404296875,
            "text": "organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 2.404296875,
            "text": "monoclonal gammapathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 2.404296875,
            "text": "endocrinopathy, monoclonal gammapathy, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_22": [
        {
            "start_logit": 10.96875,
            "end_logit": 11.65625,
            "text": "ascites",
            "probability": 0.9990234375
        },
        {
            "start_logit": 3.453125,
            "end_logit": 11.65625,
            "text": "castleman s disease angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0005440711975097656
        },
        {
            "start_logit": 3.453125,
            "end_logit": 4.234375,
            "text": "castleman s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 11.65625,
            "text": "disease angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 11.65625,
            "text": "leman s disease angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 11.65625,
            "text": "lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -10.078125,
            "end_logit": 11.65625,
            "text": "an s disease angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 11.65625,
            "text": "s disease angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 11.65625,
            "text": "angiofollicular lymph node hyperplasia in this case ascites",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": 4.234375,
            "text": "disease",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -7.390625,
            "text": "castleman",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -7.8515625,
            "text": "cast",
            "probability": 0.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": -3.359375,
            "text": "polyneuropathy hepatomegaly splenomegaly endocrinopathy monoclonal protein and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -8.0546875,
            "text": "castleman s disease angiofollicular lymph node hyperplasia",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -8.1640625,
            "text": "castlem",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 4.234375,
            "text": "leman s disease",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -8.3125,
            "text": "castleman s",
            "probability": 0.0
        },
        {
            "start_logit": -9.3203125,
            "end_logit": 4.234375,
            "text": "monoclonal protein and skin changes several of the many clinical features of the recently described poems syndrome in addition she had a castleman s disease",
            "probability": 0.0
        },
        {
            "start_logit": 3.453125,
            "end_logit": -8.6171875,
            "text": "castleman s disease angiofollicular lymph node",
            "probability": 0.0
        },
        {
            "start_logit": -9.5703125,
            "end_logit": 4.234375,
            "text": "skin changes several of the many clinical features of the recently described poems syndrome in addition she had a castleman s disease",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_23": [
        {
            "start_logit": 9.578125,
            "end_logit": 0.331298828125,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes",
            "probability": 0.92578125
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.9140625,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites",
            "probability": 0.03619384765625
        },
        {
            "start_logit": 9.578125,
            "end_logit": -3.240234375,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms",
            "probability": 0.02606201171875
        },
        {
            "start_logit": 9.578125,
            "end_logit": -4.85546875,
            "text": "polyneuropathy organomegaly",
            "probability": 0.005191802978515625
        },
        {
            "start_logit": 9.578125,
            "end_logit": -5.0078125,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.00445556640625
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.70703125,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin",
            "probability": 0.0008149147033691406
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.09375,
            "text": "polyneuropathy organomegaly endocrinopathy of various",
            "probability": 0.0005536079406738281
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.4453125,
            "text": "polyneuropathy",
            "probability": 0.0003895759582519531
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.4921875,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and",
            "probability": 0.00037169456481933594
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.4375,
            "text": "polyneuropathy organ",
            "probability": 0.00014448165893554688
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -1.9912109375,
            "text": "ascites one year after the onset of peripheral neuropathy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 0.331298828125,
            "text": "skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -2.9140625,
            "text": "ascites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 0.331298828125,
            "text": "endocrinopathy of various forms production of monoclonal m component and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.01953125,
            "end_logit": -1.9912109375,
            "text": "peripheral neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 0.331298828125,
            "text": "organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -1.9912109375,
            "text": "skin changes we describe a 46 year old man who developed ascites one year after the onset of peripheral neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": 0.331298828125,
            "text": "m component and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": 0.331298828125,
            "text": "with polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -5.625,
            "text": "ascites one year after the onset of peripheral neuropathy with accompanying muscle atrophies and increasing weakness extensive evaluation revealed that the patient had no underlying liver disease",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_24": [
        {
            "start_logit": 11.71875,
            "end_logit": 11.0078125,
            "text": "polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 1.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": 1.5166015625,
            "text": "polyneuropathy organomegaly",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 11.71875,
            "end_logit": -2.94140625,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -3.46484375,
            "end_logit": 11.0078125,
            "text": "protein",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 11.71875,
            "end_logit": -4.703125,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomeruloid hemangiomas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.71875,
            "end_logit": -5.94140625,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.71875,
            "end_logit": -5.94140625,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.71875,
            "end_logit": -5.953125,
            "text": "polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.4375,
            "end_logit": 11.0078125,
            "text": "m protein",
            "probability": 0.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": -7.19921875,
            "text": "polyneuropathy organ",
            "probability": 0.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 11.0078125,
            "text": "endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": -8.3984375,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and",
            "probability": 0.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": -8.5703125,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomerul",
            "probability": 0.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": -8.6015625,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomeruloid",
            "probability": 0.0
        },
        {
            "start_logit": 11.71875,
            "end_logit": -8.7109375,
            "text": "polyneuropathy organomegaly endocrinopathy m",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 11.0078125,
            "text": "opathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": 11.0078125,
            "text": "multiple myeloma and castleman disease poems is an acronym for the main clinical features of the syndrome namely polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.5546875,
            "end_logit": 11.0078125,
            "text": "organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.796875,
            "end_logit": 11.0078125,
            "text": "namely polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.828125,
            "end_logit": 11.0078125,
            "text": "castleman disease poems is an acronym for the main clinical features of the syndrome namely polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_25": [
        {
            "start_logit": 11.640625,
            "end_logit": 2.916015625,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy",
            "probability": 0.89599609375
        },
        {
            "start_logit": 11.640625,
            "end_logit": -0.1849365234375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease",
            "probability": 0.040313720703125
        },
        {
            "start_logit": 11.640625,
            "end_logit": -0.364013671875,
            "text": "polyneuropathy organomegaly",
            "probability": 0.033660888671875
        },
        {
            "start_logit": 11.640625,
            "end_logit": -0.505859375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions",
            "probability": 0.0292510986328125
        },
        {
            "start_logit": 11.640625,
            "end_logit": -4.2578125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease papilledema",
            "probability": 0.0006875991821289062
        },
        {
            "start_logit": 11.640625,
            "end_logit": -4.84375,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.0003829002380371094
        },
        {
            "start_logit": 11.640625,
            "end_logit": -6.25390625,
            "text": "polyneuropathy",
            "probability": 9.310245513916016e-05
        },
        {
            "start_logit": 11.640625,
            "end_logit": -6.390625,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 11.640625,
            "end_logit": -6.5859375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions other clinical features include presence of sclerotic bone lesions",
            "probability": 6.705522537231445e-05
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -0.1849365234375,
            "text": "castleman s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -0.68701171875,
            "text": "castleman s disease papilledema pleural effusion edema ascites erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 2.916015625,
            "text": "opathy monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 2.916015625,
            "text": "endocrinopathy monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 2.916015625,
            "text": "monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 2.916015625,
            "text": "opathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.8359375,
            "end_logit": 2.916015625,
            "text": "gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -4.0078125,
            "text": "castleman s disease papilledema pleural effusion edema ascites erythrocytosis and thrombocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -4.2578125,
            "text": "castleman s disease papilledema",
            "probability": 0.0
        },
        {
            "start_logit": -5.6171875,
            "end_logit": -0.68701171875,
            "text": "erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.345703125,
            "end_logit": -4.0078125,
            "text": "thrombocytosis",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_26": [
        {
            "start_logit": 11.96875,
            "end_logit": 10.0859375,
            "text": "polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 1.0
        },
        {
            "start_logit": 11.96875,
            "end_logit": -0.21826171875,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin changes",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 11.96875,
            "end_logit": -2.498046875,
            "text": "polyneuropathy organomegaly",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 11.96875,
            "end_logit": -5.875,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.96875,
            "end_logit": -5.91015625,
            "text": "polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.0546875,
            "end_logit": 10.0859375,
            "text": "protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.96875,
            "end_logit": -7.55078125,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": 11.96875,
            "end_logit": -7.77734375,
            "text": "polyneuropathy organ",
            "probability": 0.0
        },
        {
            "start_logit": 11.96875,
            "end_logit": -8.3203125,
            "text": "polyneuropathy organomegaly endocrinopathy m",
            "probability": 0.0
        },
        {
            "start_logit": 11.96875,
            "end_logit": -8.5078125,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 10.0859375,
            "text": "endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 10.0859375,
            "text": "crow fukase syndrome represents a rare multisystem syndrome characterized by polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 10.0859375,
            "text": "m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": 10.0859375,
            "text": "fukase syndrome represents a rare multisystem syndrome characterized by polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.265625,
            "end_logit": 10.0859375,
            "text": "organomegaly endocrinopathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 10.0859375,
            "text": "opathy m protein",
            "probability": 0.0
        },
        {
            "start_logit": -5.0546875,
            "end_logit": -0.21826171875,
            "text": "protein and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -0.21826171875,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -0.21826171875,
            "text": "endocrinopathy m protein and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -0.21826171875,
            "text": "crow fukase syndrome represents a rare multisystem syndrome characterized by polyneuropathy organomegaly endocrinopathy m protein and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_27": [
        {
            "start_logit": 10.5546875,
            "end_logit": 4.70703125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 0.75244140625
        },
        {
            "start_logit": 10.5546875,
            "end_logit": 3.431640625,
            "text": "polyneuropathy organomegaly",
            "probability": 0.2088623046875
        },
        {
            "start_logit": 7.13671875,
            "end_logit": 4.70703125,
            "text": "polyneuropathy",
            "probability": 0.024566650390625
        },
        {
            "start_logit": 10.5546875,
            "end_logit": 0.7255859375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes",
            "probability": 0.0139923095703125
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -2.740234375,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.0004363059997558594
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -5.875,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein",
            "probability": 1.901388168334961e-05
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -6.0078125,
            "text": "polyneuropathy",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 10.5546875,
            "end_logit": -6.55078125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 4.70703125,
            "text": "endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 4.70703125,
            "text": "features polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 4.70703125,
            "text": "monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 3.431640625,
            "text": "features polyneuropathy organomegaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 4.70703125,
            "text": "opathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 4.70703125,
            "text": "m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 4.70703125,
            "text": "organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 0.7255859375,
            "text": "endocrinopathy monoclonal protein m protein skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 0.7255859375,
            "text": "features polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 3.431640625,
            "text": "organomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -3.51953125,
            "end_logit": -1.54296875,
            "text": "polyneuropathy peripheral oedema osteosclerotic bone lesions",
            "probability": 0.0
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 0.7255859375,
            "text": "monoclonal protein m protein skin changes",
            "probability": 0.0
        }
    ],
    "571f3b320fd6f91b68000007_1": [
        {
            "start_logit": 11.109375,
            "end_logit": 11.9921875,
            "text": "obesity",
            "probability": 1.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": 11.9921875,
            "text": "hirsutism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -7.37109375,
            "text": "obesity, striae, acne",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -7.96875,
            "text": "obesity, striae, acne and hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -9.484375,
            "end_logit": 11.9921875,
            "text": ", obesity",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": 11.9921875,
            "text": "weight gain, growth retardation, hirsutism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 11.9921875,
            "text": "growth retardation, hirsutism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": 11.9921875,
            "text": "utism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -8.78125,
            "text": "obesity, striae",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": 11.9921875,
            "text": "Presenting features commonly include weight gain, growth retardation, hirsutism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": 11.9921875,
            "text": ", hirsutism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -9.3359375,
            "text": "obesity, striae, acne and",
            "probability": 0.0
        },
        {
            "start_logit": 11.109375,
            "end_logit": -10.0703125,
            "text": "obesity,",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -5.140625,
            "text": "hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": -5.140625,
            "text": "weight gain, growth retardation, hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -5.140625,
            "text": "growth retardation, hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -7.37109375,
            "text": "hirsutism, obesity, striae, acne",
            "probability": 0.0
        },
        {
            "start_logit": -9.6484375,
            "end_logit": -5.140625,
            "text": "utism",
            "probability": 0.0
        },
        {
            "start_logit": -9.78125,
            "end_logit": -5.140625,
            "text": "Presenting features commonly include weight gain, growth retardation, hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -9.9609375,
            "end_logit": -5.140625,
            "text": ", hirsutism",
            "probability": 0.0
        }
    ],
    "571f3b320fd6f91b68000007_2": [
        {
            "start_logit": 11.53125,
            "end_logit": 11.0703125,
            "text": "hirsutism",
            "probability": 1.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -3.9609375,
            "text": "hirsutism, acne",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 11.53125,
            "end_logit": -4.59375,
            "text": "hirs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 11.53125,
            "end_logit": -6.46875,
            "text": "hirsutism, acne, secondary amenorrhea and facial lentiginosis",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -6.65625,
            "text": "hirsutism, acne, secondary amenorrhea",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 11.0703125,
            "text": "ism",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -7.52734375,
            "text": "hirsut",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 11.0703125,
            "text": "utism",
            "probability": 0.0
        },
        {
            "start_logit": 11.53125,
            "end_logit": -9.09375,
            "text": "hirsutism, acne, secondary amenorrhea and",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 11.0703125,
            "text": "weight gain, hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 11.0703125,
            "text": ", hirsutism",
            "probability": 0.0
        },
        {
            "start_logit": -5.91796875,
            "end_logit": -3.9609375,
            "text": "acne",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -5.5703125,
            "text": "primary pigmented nodular adrenal disease (PPNAD)",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -3.9609375,
            "text": "ism, acne",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -5.70703125,
            "text": "primary pigmented nodular adrenal disease",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -6.6328125,
            "text": "primary pigmented nodular adrenal disease (PPNAD",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -3.9609375,
            "text": "utism, acne",
            "probability": 0.0
        },
        {
            "start_logit": -4.71875,
            "end_logit": -7.48828125,
            "text": "primary pigmented nodular adrenal",
            "probability": 0.0
        },
        {
            "start_logit": -5.91796875,
            "end_logit": -6.46875,
            "text": "acne, secondary amenorrhea and facial lentiginosis",
            "probability": 0.0
        },
        {
            "start_logit": -5.91796875,
            "end_logit": -6.65625,
            "text": "acne, secondary amenorrhea",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_1": [
        {
            "start_logit": 10.9765625,
            "end_logit": 11.828125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -4.08984375,
            "text": "bronchiectasis and sinusitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 11.828125,
            "text": "situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -7.39453125,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": 11.828125,
            "text": "inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -8.9609375,
            "text": "bronchiectasis and sinusitis is",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.34375,
            "text": "bronchiectasis and sinusitis is known as Kartagener syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.3515625,
            "text": "bronchiectasis and sinusitis is known",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 11.828125,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.609375,
            "text": "bronchiectasis and sinusitis is known as Kartagener syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.828125,
            "text": "us, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -9.984375,
            "text": "bronchiectasis and sinusitis is known as",
            "probability": 0.0
        },
        {
            "start_logit": 10.9765625,
            "end_logit": -10.0546875,
            "text": "bronchiectasis and sinusitis is known as Kartagener",
            "probability": 0.0
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -2.369140625,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -5.0234375,
            "end_logit": -4.08984375,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -4.08984375,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -2.369140625,
            "text": "inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -2.369140625,
            "text": "us",
            "probability": 0.0
        },
        {
            "start_logit": -9.6640625,
            "end_logit": -4.08984375,
            "text": "inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -7.2578125,
            "text": "situs invers",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_2": [
        {
            "start_logit": 7.5078125,
            "end_logit": 12.0859375,
            "text": "chronic rhinosinusitis",
            "probability": 0.994140625
        },
        {
            "start_logit": 2.349609375,
            "end_logit": 12.0859375,
            "text": "rhinosinusitis",
            "probability": 0.00572967529296875
        },
        {
            "start_logit": -4.6640625,
            "end_logit": 12.0859375,
            "text": "situs inversus, chronic rhinosinusitis",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -3.728515625,
            "text": "chronic rhinosinusitis, and bronchiectasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -4.64453125,
            "text": "chronic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 12.0859375,
            "text": "inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 12.0859375,
            "text": "KARTAGENER SYNDROME (KS) IS A RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 12.0859375,
            "text": ": KARTAGENER SYNDROME (KS) IS A RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.0859375,
            "text": "TAGENER SYNDROME (KS) IS A RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 12.0859375,
            "text": ": situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 12.0859375,
            "text": "KS) IS A RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 12.0859375,
            "text": "NER SYNDROME (KS) IS A RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8125,
            "end_logit": 12.0859375,
            "text": "CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus, chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -8.4921875,
            "text": "chronic rhinosinusitis, and",
            "probability": 0.0
        },
        {
            "start_logit": 2.349609375,
            "end_logit": -3.728515625,
            "text": "rhinosinusitis, and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -9.765625,
            "text": "chronic rhinosinusitis, and bronchiectasis.",
            "probability": 0.0
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -9.7890625,
            "text": "chronic rhinosinusitis,",
            "probability": 0.0
        },
        {
            "start_logit": 2.349609375,
            "end_logit": -8.4921875,
            "text": "rhinosinusitis, and",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -1.8564453125,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": 2.349609375,
            "end_logit": -9.765625,
            "text": "rhinosinusitis, and bronchiectasis.",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_3": [
        {
            "start_logit": 8.953125,
            "end_logit": 11.6875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": 11.6875,
            "text": "sinusitis, situs inversus and bronchiectasis",
            "probability": 0.00013554096221923828
        },
        {
            "start_logit": -0.70361328125,
            "end_logit": 11.6875,
            "text": "situs inversus and bronchiectasis",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 11.6875,
            "text": "inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -9.0703125,
            "end_logit": 11.6875,
            "text": "us and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": 1.685546875,
            "text": "sinusitis, situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 11.6875,
            "text": "Kartagener's syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 11.6875,
            "text": ", situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 11.6875,
            "text": "tagener's syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 11.6875,
            "text": "of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -0.70361328125,
            "end_logit": 1.685546875,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 11.6875,
            "text": "s inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 8.953125,
            "end_logit": -9.0078125,
            "text": "bronchiectasis.",
            "probability": 0.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": -0.5244140625,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": -5.16015625,
            "text": "sinusitis, situs invers",
            "probability": 0.0
        },
        {
            "start_logit": -0.70361328125,
            "end_logit": -5.16015625,
            "text": "situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": -7.20703125,
            "text": "sinusitis, situs",
            "probability": 0.0
        },
        {
            "start_logit": 0.047332763671875,
            "end_logit": -7.26171875,
            "text": "sinusitis, situs inversus and",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 1.685546875,
            "text": "inversus",
            "probability": 0.0
        },
        {
            "start_logit": -9.0703125,
            "end_logit": 1.685546875,
            "text": "us",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_4": [
        {
            "start_logit": 7.09765625,
            "end_logit": 7.6953125,
            "text": "bronchiectasis",
            "probability": 0.625
        },
        {
            "start_logit": 5.70703125,
            "end_logit": 8.046875,
            "text": "sinusitis",
            "probability": 0.2193603515625
        },
        {
            "start_logit": 5.70703125,
            "end_logit": 7.6953125,
            "text": "sinusitis, bronchiectasis",
            "probability": 0.155517578125
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -0.15185546875,
            "text": "bronchiectasis, and situs inversus",
            "probability": 0.00024306774139404297
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -0.15185546875,
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 6.0498714447021484e-05
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -4.1328125,
            "text": "bronchiectasis, and situs invers",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.046875,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 7.6953125,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis, bronchiectasis",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -4.1328125,
            "text": "sinusitis, bronchiectasis, and situs invers",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 8.046875,
            "text": "chronic sinusitis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 7.6953125,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -8.203125,
            "text": "bronchiectasis, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -8.3125,
            "text": "bronchiectasis, and situs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -8.7734375,
            "text": "bronchiectasis,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 8.046875,
            "text": "patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -9.296875,
            "text": "bronchiectasis, and situ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 7.6953125,
            "text": "patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis, bronchiectasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.4765625,
            "end_logit": 8.046875,
            "text": "comprising chronic sinusitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.70703125,
            "end_logit": -8.203125,
            "text": "sinusitis, bronchiectasis, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -10.546875,
            "end_logit": 8.046875,
            "text": "Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 5.960464477539063e-08
        }
    ],
    "56be0e4aef6e394741000008_5": [
        {
            "start_logit": 10.6484375,
            "end_logit": 11.8359375,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -3.39453125,
            "text": "bronchiectasis and sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 11.8359375,
            "text": "situs inversus, bronchiectasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -7.70703125,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 11.8359375,
            "text": "inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 11.8359375,
            "text": "Kartagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 11.8359375,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.6484375,
            "end_logit": -9.3203125,
            "text": "bronchiectasis and sinusitis.",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 11.8359375,
            "text": "KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.609375,
            "end_logit": 11.8359375,
            "text": "tagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 11.8359375,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 11.8359375,
            "text": "us, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8828125,
            "end_logit": 11.8359375,
            "text": "ner syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -4.640625,
            "end_logit": -3.39453125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -2.7421875,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -3.39453125,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -2.7421875,
            "text": "inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -2.7421875,
            "text": "Kartagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -6.75,
            "text": "situs invers",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -2.7421875,
            "text": "KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_6": [
        {
            "start_logit": 10.15625,
            "end_logit": 11.8828125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": 11.8828125,
            "text": "sinusitis, bronchiectasis",
            "probability": 0.00010889768600463867
        },
        {
            "start_logit": 10.15625,
            "end_logit": -3.88671875,
            "text": "bronchiectasis, and situs inversus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.44140625,
            "text": "bronchiectasis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": 1.15234375,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.1875,
            "text": "bronchiectasis, and situs",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 11.8828125,
            "text": "Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.421875,
            "end_logit": 11.8828125,
            "text": "Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 11.8828125,
            "text": "1933, Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 11.8828125,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.90625,
            "text": "bronchiectasis, and situ",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 11.8828125,
            "text": "pulmonary physician, reported four patients with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -9.1640625,
            "text": "bronchiectasis, and",
            "probability": 0.0
        },
        {
            "start_logit": -10.9765625,
            "end_logit": 11.8828125,
            "text": "with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -11.0234375,
            "end_logit": 11.8828125,
            "text": "four patients with the triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -9.4296875,
            "text": "bronchiectasis, and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": -3.88671875,
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": -7.44140625,
            "text": "sinusitis, bronchiectasis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": -8.1875,
            "text": "sinusitis, bronchiectasis, and situs",
            "probability": 0.0
        },
        {
            "start_logit": 1.02734375,
            "end_logit": -8.90625,
            "text": "sinusitis, bronchiectasis, and situ",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_7": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.9375,
            "text": "bronchiectasis",
            "probability": 0.87890625
        },
        {
            "start_logit": 2.76953125,
            "end_logit": 8.3046875,
            "text": "chronic maxillary sinusitis",
            "probability": 0.09637451171875
        },
        {
            "start_logit": 2.76953125,
            "end_logit": 6.9375,
            "text": "chronic maxillary sinusitis, bronchiectasis",
            "probability": 0.02435302734375
        },
        {
            "start_logit": -3.259765625,
            "end_logit": 8.3046875,
            "text": "sinusitis",
            "probability": 0.0002313852310180664
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -2.408203125,
            "text": "bronchiectasis and \"situs inversus totalis",
            "probability": 7.68899917602539e-05
        },
        {
            "start_logit": -3.259765625,
            "end_logit": 6.9375,
            "text": "sinusitis, bronchiectasis",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.3046875,
            "text": "maxillary sinusitis",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 2.76953125,
            "end_logit": -2.408203125,
            "text": "chronic maxillary sinusitis, bronchiectasis and \"situs inversus totalis",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.03125,
            "text": "bronchiectasis and \"situs inversus total",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.9375,
            "text": "maxillary sinusitis, bronchiectasis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.7109375,
            "text": "bronchiectasis and \"situs invers",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.92578125,
            "text": "bronchiectasis and \"situs inversus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.39453125,
            "text": "bronchiectasis and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.5625,
            "text": "bronchiectasis and \"situs inversus totalis\"",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -9.59375,
            "end_logit": 8.3046875,
            "text": "Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.89453125,
            "text": "bronchiectasis and \"situs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 8.3046875,
            "text": "nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -10.65625,
            "end_logit": 8.3046875,
            "text": "tagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -9.328125,
            "end_logit": 6.9375,
            "text": ", bronchiectasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.8203125,
            "end_logit": 8.3046875,
            "text": "child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56be0e4aef6e394741000008_8": [
        {
            "start_logit": 10.8515625,
            "end_logit": 12.1796875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -3.189453125,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -4.45703125,
            "text": "bronchiectasis, situs inversus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.23046875,
            "text": "bronchiectasis, situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.90625,
            "text": "bronchiectasis, situs inversus and",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.3046875,
            "text": "bronchiectasis, situs",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.4453125,
            "text": "bronchiectasis, situ",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": 12.1796875,
            "text": "Kartagener's syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.7578125,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 12.1796875,
            "text": "-bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.1015625,
            "text": "bronchiectasis, situs inversus and sinusitis--and is",
            "probability": 0.0
        },
        {
            "start_logit": -10.4296875,
            "end_logit": 12.1796875,
            "text": "tagener's syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.2109375,
            "text": "bronchiectasis,",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.265625,
            "text": "bronchiectasis, situs inversus and sinusitis--and",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.3359375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.453125,
            "text": "bronchiectasis, situs inversus and sinusitis-",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -9.5,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -3.189453125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.28515625,
            "end_logit": -3.189453125,
            "text": "situs inversus and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.28515625,
            "end_logit": -4.45703125,
            "text": "situs inversus",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_9": [
        {
            "start_logit": 11.234375,
            "end_logit": 11.7109375,
            "text": "sinusitis",
            "probability": 1.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -5.08203125,
            "text": "sinusitis, and situs inversus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 11.7109375,
            "text": "bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -7.06640625,
            "text": "sinusitis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.53125,
            "text": "sinusitis, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.640625,
            "text": "sinusitis, and situs",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.75,
            "text": "sinusitis, and situ",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -8.96875,
            "text": "sinusitis, and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": 11.234375,
            "end_logit": -9.5546875,
            "text": "sinusitis,",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 11.7109375,
            "text": ", sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.40625,
            "end_logit": 11.7109375,
            "text": "Kartagener's syndrome is characterized by the clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6484375,
            "end_logit": 11.7109375,
            "text": "tagener's syndrome is characterized by the clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -11.0078125,
            "end_logit": 11.7109375,
            "text": "of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -11.0703125,
            "end_logit": 11.7109375,
            "text": "clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -11.109375,
            "end_logit": 11.7109375,
            "text": "ner's syndrome is characterized by the clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -5.08203125,
            "text": "bronchitis, sinusitis, and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -5.08203125,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.1015625,
            "text": "bronchitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.06640625,
            "text": "bronchitis, sinusitis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -5.08203125,
            "text": ", sinusitis, and situs inversus",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_10": [
        {
            "start_logit": 10.8046875,
            "end_logit": 12.2578125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": 2.6328125,
            "text": "bronchiectasis, sinusitis",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -3.8515625,
            "text": "bronchiectasis, sinusitis and situs inversus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.52734375,
            "end_logit": 2.6328125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -7.38671875,
            "text": "bronchiectasis, sinusitis and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -7.59375,
            "text": "bronchiectasis, sinusitis and",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -8.4375,
            "text": "bronchiectasis, sinusitis and situs",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -8.4765625,
            "text": "bronchiectasis, sinusitis and situ",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -8.546875,
            "text": "bronchiectasis,",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.2578125,
            "text": "Kartagener's syndrome is a well known classical triad of presentations consisting of bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.8046875,
            "end_logit": -9.1015625,
            "text": "bronchiectasis, sinusitis and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": -10.8515625,
            "end_logit": 12.2578125,
            "text": "tagener's syndrome is a well known classical triad of presentations consisting of bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -11.0546875,
            "end_logit": 12.2578125,
            "text": "presentations consisting of bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -3.8515625,
            "text": "sinusitis and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -7.38671875,
            "text": "sinusitis and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -7.59375,
            "text": "sinusitis and",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -8.4375,
            "text": "sinusitis and situs",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -8.4765625,
            "text": "sinusitis and situ",
            "probability": 0.0
        },
        {
            "start_logit": 2.52734375,
            "end_logit": -9.1015625,
            "text": "sinusitis and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 2.6328125,
            "text": "Kartagener's syndrome is a well known classical triad of presentations consisting of bronchiectasis, sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_11": [
        {
            "start_logit": 10.609375,
            "end_logit": 11.640625,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -4.97265625,
            "text": "bronchiectasis and paranasal sinusitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 11.640625,
            "text": "situs inversus, including dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 11.640625,
            "text": "dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -7.9765625,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": 11.640625,
            "text": "ocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 11.640625,
            "text": "Kartagener's syndrome is a rare disorder characterized by the triad of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.609375,
            "end_logit": -9.140625,
            "text": "bronchiectasis and paranasal sinusitis.",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 11.640625,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.640625,
            "text": "tagener's syndrome is a rare disorder characterized by the triad of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6640625,
            "end_logit": 11.640625,
            "text": "inversus, including dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.984375,
            "end_logit": 11.640625,
            "text": "of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -3.314453125,
            "text": "situs inversus, including dextrocardia",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -3.314453125,
            "text": "dextrocardia",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -4.20703125,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -4.97265625,
            "text": "situs inversus, including dextrocardia, bronchiectasis and paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -4.97265625,
            "text": "dextrocardia, bronchiectasis and paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -4.97265625,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -9.921875,
            "end_logit": -3.314453125,
            "text": "ocardia",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": -3.314453125,
            "text": "Kartagener's syndrome is a rare disorder characterized by the triad of situs inversus, including dextrocardia",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_12": [
        {
            "start_logit": 10.7421875,
            "end_logit": 12.3359375,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -0.68798828125,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -3.904296875,
            "text": "bronchiectasis, situs inversus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -6.3515625,
            "text": "bronchiectasis, situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -7.60546875,
            "text": "bronchiectasis, situs inversus and",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -7.890625,
            "text": "bronchiectasis, situs",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.2265625,
            "text": "bronchiectasis, situ",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 12.3359375,
            "text": "Kartagener's syndrome is an inherited disease characterized by a triad of symptoms: bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.890625,
            "text": "bronchiectasis,",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -8.9609375,
            "text": "bronchiectasis, situs inversus and sinusitis resulting from defective cilial motility.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 12.3359375,
            "text": "tagener's syndrome is an inherited disease characterized by a triad of symptoms: bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.96875,
            "end_logit": 12.3359375,
            "text": "inherited disease characterized by a triad of symptoms: bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7421875,
            "end_logit": -9.4453125,
            "text": "bronchiectasis, situs inversus and sinusitis resulting",
            "probability": 0.0
        },
        {
            "start_logit": -11.0625,
            "end_logit": 12.3359375,
            "text": ": bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -0.68798828125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -0.68798828125,
            "text": "situs inversus and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -3.904296875,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -0.68798828125,
            "text": "Kartagener's syndrome is an inherited disease characterized by a triad of symptoms: bronchiectasis, situs inversus and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.9609375,
            "text": "sinusitis resulting from defective cilial motility.",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": -0.68798828125,
            "text": "inversus and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_13": [
        {
            "start_logit": 9.5546875,
            "end_logit": 13.1015625,
            "text": "rhinosinusitis",
            "probability": 1.0
        },
        {
            "start_logit": -1.697265625,
            "end_logit": 13.1015625,
            "text": "chronic rhinosinusitis",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -4.37890625,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -5.15234375,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 13.1015625,
            "text": "Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.28125,
            "end_logit": 13.1015625,
            "text": "Ear, nose and throat symptoms and signs were studied in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -6.8125,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -6.86328125,
            "text": "rhinosinusitis, chronic bronchitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.75,
            "end_logit": 13.1015625,
            "text": "and throat symptoms and signs were studied in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.2890625,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.328125,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.8203125,
            "text": "rhinosinusitis, chronic",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.9296875,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situ",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.1328125,
            "text": "rhinosinusitis, chronic bronchitis with",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.2265625,
            "text": "rhinosinusitis,",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.3671875,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis,",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -9.4921875,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": -1.697265625,
            "end_logit": -4.37890625,
            "text": "chronic rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -1.697265625,
            "end_logit": -5.15234375,
            "text": "chronic rhinosinusitis, chronic bronchitis with bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.697265625,
            "end_logit": -6.8125,
            "text": "chronic rhinosinusitis, chronic bronchitis with bronchiectasis, and situs invers",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_14": [
        {
            "start_logit": 9.5859375,
            "end_logit": 9.9921875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -0.19970703125,
            "text": "bronchiectasis and situs inversus with dextrocardia",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -1.4091796875,
            "end_logit": 9.9921875,
            "text": "sinusitis, bronchiectasis",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -5.6953125,
            "text": "bronchiectasis and situs inversus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.9921875,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.15625,
            "text": "bronchiectasis and situs invers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.71875,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.0078125,
            "text": "bronchiectasis and situs inversus with",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.5859375,
            "text": "bronchiectasis and situs inversus with dextr",
            "probability": 0.0
        },
        {
            "start_logit": -1.4091796875,
            "end_logit": 2.12890625,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.9609375,
            "text": "bronchiectasis and situs",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -9.078125,
            "text": "bronchiectasis and situs inversus with dextrocardi",
            "probability": 0.0
        },
        {
            "start_logit": -10.296875,
            "end_logit": 9.9921875,
            "text": "ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 9.9921875,
            "text": "primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.4140625,
            "end_logit": 9.9921875,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 9.9921875,
            "text": "Kartagener syndrome (a clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 9.9921875,
            "text": "tagener syndrome (a clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 9.9921875,
            "text": "omical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": 9.9921875,
            "text": "clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.4091796875,
            "end_logit": -0.19970703125,
            "text": "sinusitis, bronchiectasis and situs inversus with dextrocardia",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_15": [
        {
            "start_logit": 10.5625,
            "end_logit": 11.5625,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -1.2685546875,
            "text": "bronchiectasis and situs inversus with dextrocardia",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.58203125,
            "end_logit": 11.5625,
            "text": "sinusitis, bronchiectasis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 10.5625,
            "end_logit": -5.74609375,
            "text": "bronchiectasis and situs inversus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.5625,
            "end_logit": -7.62109375,
            "text": "bronchiectasis and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -7.64453125,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -8.2890625,
            "text": "bronchiectasis and situs inversus with",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.109375,
            "text": "bronchiectasis and situs",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.2265625,
            "text": "bronchiectasis and situs inversus with dextrocardi",
            "probability": 0.0
        },
        {
            "start_logit": 10.5625,
            "end_logit": -9.2265625,
            "text": "bronchiectasis and situ",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 11.5625,
            "text": "Kartagener Syndrome is a rare autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6796875,
            "end_logit": 11.5625,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.9921875,
            "end_logit": 11.5625,
            "text": "tagener Syndrome is a rare autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -11.1796875,
            "end_logit": 11.5625,
            "text": "rare autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -11.21875,
            "end_logit": 11.5625,
            "text": "autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.58203125,
            "end_logit": -1.2685546875,
            "text": "sinusitis, bronchiectasis and situs inversus with dextrocardia",
            "probability": 0.0
        },
        {
            "start_logit": -3.58203125,
            "end_logit": -3.642578125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -1.2685546875,
            "text": "situs inversus with dextrocardia",
            "probability": 0.0
        },
        {
            "start_logit": -3.58203125,
            "end_logit": -5.74609375,
            "text": "sinusitis, bronchiectasis and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -9.734375,
            "end_logit": -1.2685546875,
            "text": "dextrocardia",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_16": [
        {
            "start_logit": 10.3515625,
            "end_logit": 11.78125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.3515625,
            "end_logit": -1.37109375,
            "text": "bronchiectasis and sinusitis",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 11.78125,
            "text": "situs inversus, bronchiectasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.3515625,
            "end_logit": -7.6015625,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 11.78125,
            "text": "inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": 11.78125,
            "text": "Kartagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": 11.78125,
            "text": "tagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 11.78125,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": 11.78125,
            "text": "KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 11.78125,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8359375,
            "end_logit": 11.78125,
            "text": "ner syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.9609375,
            "end_logit": 11.78125,
            "text": "us, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -1.37109375,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -2.3828125,
            "text": "situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -1.37109375,
            "text": "inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.2890625,
            "end_logit": -1.37109375,
            "text": "Kartagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5859375,
            "end_logit": -1.37109375,
            "text": "tagener syndrome (KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -1.37109375,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.6875,
            "end_logit": -1.37109375,
            "text": "KS), an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.765625,
            "end_logit": -1.37109375,
            "text": "sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_17": [
        {
            "start_logit": 10.984375,
            "end_logit": 11.5546875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -2.478515625,
            "text": "bronchiectasis, situs inversus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 10.984375,
            "end_logit": -2.951171875,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 10.984375,
            "end_logit": -5.4140625,
            "text": "bronchiectasis, situs invers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.984375,
            "end_logit": -7.73828125,
            "text": "bronchiectasis, situs inversus and",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.1015625,
            "text": "bronchiectasis, situs",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.421875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.5859375,
            "text": "bronchiectasis, situ",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -8.8671875,
            "text": "bronchiectasis, situs inversus and sinusitis-",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.2734375,
            "text": "bronchiectasis, situs inversus and sinusitis--and",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.28125,
            "text": "bronchiectasis, situs inversus and sinusitis--and is",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.3046875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.34375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified",
            "probability": 0.0
        },
        {
            "start_logit": 10.984375,
            "end_logit": -9.40625,
            "text": "bronchiectasis,",
            "probability": 0.0
        },
        {
            "start_logit": -9.984375,
            "end_logit": 11.5546875,
            "text": "Kartagener&apos;s syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 11.5546875,
            "text": "apos;s syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 11.5546875,
            "text": "-bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.5546875,
            "end_logit": 11.5546875,
            "text": "tagener&apos;s syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8671875,
            "end_logit": 11.5546875,
            "text": ";s syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.544921875,
            "end_logit": -2.951171875,
            "text": "sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_18": [
        {
            "start_logit": 3.5625,
            "end_logit": 7.04296875,
            "text": "situs inversus and bronchiectasis",
            "probability": 0.92333984375
        },
        {
            "start_logit": 3.5625,
            "end_logit": 4.390625,
            "text": "situs inversus",
            "probability": 0.0648193359375
        },
        {
            "start_logit": -0.87841796875,
            "end_logit": 7.04296875,
            "text": "sinusitis, situs inversus and bronchiectasis",
            "probability": 0.010833740234375
        },
        {
            "start_logit": -0.87841796875,
            "end_logit": 4.390625,
            "text": "sinusitis, situs inversus",
            "probability": 0.0007634162902832031
        },
        {
            "start_logit": 3.5625,
            "end_logit": -4.3125,
            "text": "situs invers",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -9.453125,
            "end_logit": 7.04296875,
            "text": "us and bronchiectasis",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -9.734375,
            "end_logit": 7.04296875,
            "text": "inversus and bronchiectasis",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -0.87841796875,
            "end_logit": -1.8310546875,
            "text": "sinusitis",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -9.953125,
            "end_logit": 7.04296875,
            "text": ", situs inversus and bronchiectasis",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 7.04296875,
            "text": "bronchiectasis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -10.2421875,
            "end_logit": 7.04296875,
            "text": "Kartagener&apos;s syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 7.04296875,
            "text": "apos;s syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 3.5625,
            "end_logit": -6.90234375,
            "text": "situs inversus and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -10.578125,
            "end_logit": 7.04296875,
            "text": "tagener&apos;s syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 3.5625,
            "end_logit": -7.234375,
            "text": "situs",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -10.71875,
            "end_logit": 7.04296875,
            "text": "s inversus and bronchiectasis",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 7.04296875,
            "text": ";s syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -9.453125,
            "end_logit": 4.390625,
            "text": "us",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.5625,
            "end_logit": -8.71875,
            "text": "situ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.87841796875,
            "end_logit": -4.3125,
            "text": "sinusitis, situs invers",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56be0e4aef6e394741000008_19": [
        {
            "start_logit": 10.7734375,
            "end_logit": 12.4140625,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 12.4140625,
            "text": "Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -7.3828125,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscera",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -7.87890625,
            "text": "bronchiectasis, maldevelopment of the sinuses",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.109375,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.171875,
            "text": "bronchiectasis, maldevelopment of the sinuses and",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.3046875,
            "text": "bronchiectasis, maldevelopment",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.515625,
            "text": "bronchiectasis, maldevelopment of the",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.546875,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscera)",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.6875,
            "text": "bronchiectasis, maldevelop",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 12.4140625,
            "text": "Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -8.859375,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 12.4140625,
            "text": "comprehensive clinicomorphological examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.4140625,
            "text": "examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 12.4140625,
            "text": "24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -9.1015625,
            "text": "bronchiectasis, mal",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 12.4140625,
            "text": "children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -9.21875,
            "text": "bronchiectasis, maldevelopment of",
            "probability": 0.0
        },
        {
            "start_logit": 10.7734375,
            "end_logit": -9.2265625,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscer",
            "probability": 0.0
        },
        {
            "start_logit": -10.8671875,
            "end_logit": 12.4140625,
            "text": "clinicomorphological examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_20": [
        {
            "start_logit": 10.9140625,
            "end_logit": 11.8828125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -4.16796875,
            "text": "bronchiectasis and sinusitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -7.7734375,
            "text": "bronchiectasis and",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 11.8828125,
            "text": "situs viscerum inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -8.6484375,
            "text": "bronchiectasis and sinusitis is known as Kartagener syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -8.828125,
            "text": "bronchiectasis and sinusitis is",
            "probability": 0.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -8.953125,
            "text": "bronchiectasis and sinusitis is known",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": 11.8828125,
            "text": "triad situs viscerum inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -9.515625,
            "text": "bronchiectasis and sinusitis is known as",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 11.8828125,
            "text": "viscerum inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 10.9140625,
            "end_logit": -9.828125,
            "text": "bronchiectasis and sinusitis is known as Kartagener",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 11.8828125,
            "text": "inversus, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -10.8046875,
            "end_logit": 11.8828125,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -4.16796875,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -9.4453125,
            "end_logit": -4.16796875,
            "text": "situs viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -8.6484375,
            "text": "sinusitis is known as Kartagener syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -8.828125,
            "text": "sinusitis is",
            "probability": 0.0
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -8.953125,
            "text": "sinusitis is known",
            "probability": 0.0
        },
        {
            "start_logit": -10.4609375,
            "end_logit": -4.16796875,
            "text": "triad situs viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": -4.16796875,
            "text": "viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_21": [
        {
            "start_logit": 5.69921875,
            "end_logit": 6.3359375,
            "text": "bronchiectasis",
            "probability": 0.57275390625
        },
        {
            "start_logit": 3.953125,
            "end_logit": 7.515625,
            "text": "sinusitis",
            "probability": 0.326416015625
        },
        {
            "start_logit": 3.953125,
            "end_logit": 6.3359375,
            "text": "sinusitis, bronchiectasis",
            "probability": 0.100341796875
        },
        {
            "start_logit": -3.126953125,
            "end_logit": 7.515625,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 0.0002751350402832031
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -1.671875,
            "text": "bronchiectasis, and situs inversus",
            "probability": 0.00019216537475585938
        },
        {
            "start_logit": -3.126953125,
            "end_logit": 6.3359375,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis, bronchiectasis",
            "probability": 8.45789909362793e-05
        },
        {
            "start_logit": 3.953125,
            "end_logit": -1.671875,
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 3.337860107421875e-05
        },
        {
            "start_logit": -5.65625,
            "end_logit": 7.515625,
            "text": "chronic sinusitis",
            "probability": 2.187490463256836e-05
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -4.80078125,
            "text": "bronchiectasis, and situs invers",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -5.65625,
            "end_logit": 6.3359375,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -5.59765625,
            "text": "bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 3.953125,
            "end_logit": -4.80078125,
            "text": "sinusitis, bronchiectasis, and situs invers",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 3.953125,
            "end_logit": -5.59765625,
            "text": "sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -9.890625,
            "end_logit": 7.515625,
            "text": "patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -8.2578125,
            "text": "bronchiectasis, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -8.328125,
            "text": "bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes that are",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -8.46875,
            "text": "bronchiectasis, and situs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.484375,
            "end_logit": 7.515625,
            "text": "comprising chronic sinusitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -10.546875,
            "end_logit": 7.515625,
            "text": "Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -8.796875,
            "text": "bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_1": [
        {
            "start_logit": 13.1484375,
            "end_logit": 12.7265625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -4.36328125,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -5.87890625,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 12.7265625,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -7.69140625,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": 12.7265625,
            "text": "saxagliptin and dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": 12.7265625,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -8.5546875,
            "text": "dapagliflozin is a recently approved antidiabetic",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 12.7265625,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.1015625,
            "text": "dapagliflozin is a recently approved antidiabetic medication",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.3984375,
            "text": "dapagliflozin is",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.4140625,
            "text": "dapagliflozin is a recently approved",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.59375,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.671875,
            "text": "dapagliflozin is a",
            "probability": 0.0
        },
        {
            "start_logit": 13.1484375,
            "end_logit": -9.9453125,
            "text": "dapagliflozin is a recently",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 12.7265625,
            "text": ": The fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.3359375,
            "end_logit": 12.7265625,
            "text": "fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 12.7265625,
            "text": "agliptin and dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.71875,
            "end_logit": 12.7265625,
            "text": "Objectives: The fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -4.36328125,
            "text": "saxagliptin and dap",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_2": [
        {
            "start_logit": 13.921875,
            "end_logit": 13.3984375,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -1.9609375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.921875,
            "end_logit": -3.708984375,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 13.3984375,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -5.5078125,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.36328125,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.5,
            "text": "dapagliflozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.734375,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 13.3984375,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 13.3984375,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.453125,
            "text": "dapagliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.7890625,
            "text": "dapagliflozin/saxagliptin) tablets.",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 13.3984375,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 13.3984375,
            "text": "QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.4921875,
            "end_logit": 13.3984375,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.5625,
            "end_logit": 13.3984375,
            "text": "safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.3984375,
            "text": "efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -1.9609375,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -1.9609375,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -1.9609375,
            "text": "agliflozin/saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_3": [
        {
            "start_logit": 13.4375,
            "end_logit": 12.6796875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.4375,
            "end_logit": -3.798828125,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.046875,
            "end_logit": 12.6796875,
            "text": "Saxagliptin/dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.4375,
            "end_logit": -5.1484375,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.6484375,
            "end_logit": 12.6796875,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.4375,
            "end_logit": -7.921875,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 12.6796875,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 12.6796875,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.4375,
            "end_logit": -9.328125,
            "text": "dapagliflozin fixed-dose combination tablets (Qtern\u00ae)",
            "probability": 0.0
        },
        {
            "start_logit": 13.4375,
            "end_logit": -9.65625,
            "text": "dapagliflozin fixed-dose combination tablets (Qtern\u00ae) are indicated",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": 12.6796875,
            "text": "agliptin/dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -9.2890625,
            "end_logit": 12.6796875,
            "text": "/dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -4.046875,
            "end_logit": -1.1298828125,
            "text": "Saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -4.046875,
            "end_logit": -3.798828125,
            "text": "Saxagliptin/dap",
            "probability": 0.0
        },
        {
            "start_logit": -4.046875,
            "end_logit": -5.1484375,
            "text": "Saxagliptin/dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -1.1298828125,
            "text": "agliptin",
            "probability": 0.0
        },
        {
            "start_logit": -4.046875,
            "end_logit": -7.359375,
            "text": "Sax",
            "probability": 0.0
        },
        {
            "start_logit": -4.046875,
            "end_logit": -7.921875,
            "text": "Saxagliptin/dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": -9.0859375,
            "end_logit": -3.798828125,
            "text": "agliptin/dap",
            "probability": 0.0
        },
        {
            "start_logit": -9.2890625,
            "end_logit": -3.798828125,
            "text": "/dap",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_4": [
        {
            "start_logit": 13.125,
            "end_logit": 13.015625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -2.337890625,
            "text": "dapagliflozin and saxagliptin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.125,
            "end_logit": -4.37109375,
            "text": "dap",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -5.30078125,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.26171875,
            "end_logit": 13.015625,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -7.30078125,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 13.015625,
            "text": "brodalumab (Siliq), dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 13.015625,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -8.703125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 13.015625,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -8.96875,
            "text": "dapagliflozin and sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.0625,
            "text": "dapagliflozin and",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline",
            "probability": 0.0
        },
        {
            "start_logit": 13.125,
            "end_logit": -9.3125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent",
            "probability": 0.0
        },
        {
            "start_logit": -10.0078125,
            "end_logit": 13.015625,
            "text": ", dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 13.015625,
            "text": "Siliq), dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -5.26171875,
            "end_logit": -2.337890625,
            "text": "ozin and saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -2.337890625,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -2.337890625,
            "text": "brodalumab (Siliq), dapagliflozin and saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -2.337890625,
            "text": "iflozin and saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_5": [
        {
            "start_logit": 13.921875,
            "end_logit": 13.4296875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -2.25390625,
            "text": "dapagliflozin/saxagliptin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.921875,
            "end_logit": -3.6953125,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.93359375,
            "end_logit": 13.4296875,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -5.5234375,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.35546875,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.61328125,
            "text": "dapagliflozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.75,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.078125,
            "text": "dapagliflozin/saxagliptin) table",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 13.4296875,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.296875,
            "text": "dapagliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 13.4296875,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 13.4296875,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 13.4296875,
            "text": "QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.6171875,
            "end_logit": 13.4296875,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.625,
            "end_logit": 13.4296875,
            "text": "safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.4296875,
            "text": "C) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -4.93359375,
            "end_logit": -2.25390625,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -2.25390625,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -2.25390625,
            "text": "agliflozin/saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_6": [
        {
            "start_logit": 13.8671875,
            "end_logit": 13.375,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -2.1484375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -3.732421875,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 13.375,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -5.4765625,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -7.30859375,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -7.55078125,
            "text": "dapagliflozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.03125,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 13.375,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 13.375,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.3984375,
            "text": "dapagliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": 13.8671875,
            "end_logit": -9.5390625,
            "text": "dapagliflozin/saxagliptin) tablet",
            "probability": 0.0
        },
        {
            "start_logit": -9.6015625,
            "end_logit": 13.375,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.171875,
            "end_logit": 13.375,
            "text": "QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.375,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 13.375,
            "text": "safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 13.375,
            "text": "ERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.375,
            "text": "efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": -2.1484375,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.71875,
            "end_logit": -2.1484375,
            "text": "saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_7": [
        {
            "start_logit": 13.984375,
            "end_logit": 13.3125,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -1.9912109375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.984375,
            "end_logit": -3.544921875,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.984375,
            "end_logit": -5.71484375,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.13671875,
            "end_logit": 13.3125,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -7.58203125,
            "text": "dapagliflozin/saxagliptin) tablets are a reasonable option for patients with T2DM not controlled on metformin",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.1484375,
            "text": "dapagliflozin/saxagliptin) tablets are a reasonable option for patients with T2DM",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.171875,
            "text": "dapagliflozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.28125,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -8.53125,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 13.3125,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -9.7109375,
            "text": "dapagliflozin/saxagliptin) tablets are a reasonable option for patients with T2DM not controlled on metformin, but cost, insurance coverage, and a",
            "probability": 0.0
        },
        {
            "start_logit": 13.984375,
            "end_logit": -9.7265625,
            "text": "dapagliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": 13.3125,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.015625,
            "end_logit": 13.3125,
            "text": ": QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -5.13671875,
            "end_logit": -1.9912109375,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.67578125,
            "end_logit": -1.9912109375,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -1.9912109375,
            "text": "iflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -9.0625,
            "end_logit": -1.9912109375,
            "text": "agliflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -1.9912109375,
            "text": "/saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_8": [
        {
            "start_logit": 13.0078125,
            "end_logit": 12.875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -2.58984375,
            "text": "dapagliflozin and saxagliptin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -4.42578125,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -5.2890625,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.3828125,
            "end_logit": 12.875,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -7.15625,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": 12.875,
            "text": "brodalumab (Siliq), dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 12.875,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -8.6953125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab",
            "probability": 0.0
        },
        {
            "start_logit": -8.8359375,
            "end_logit": 12.875,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -9.0234375,
            "text": "dapagliflozin and sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -9.109375,
            "text": "dapagliflozin and",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -9.40625,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline",
            "probability": 0.0
        },
        {
            "start_logit": 13.0078125,
            "end_logit": -9.4140625,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent",
            "probability": 0.0
        },
        {
            "start_logit": -10.0625,
            "end_logit": 12.875,
            "text": ", dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.234375,
            "end_logit": 12.875,
            "text": "Siliq), dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -5.3828125,
            "end_logit": -2.58984375,
            "text": "ozin and saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -2.58984375,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -2.58984375,
            "text": "brodalumab (Siliq), dapagliflozin and saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -2.58984375,
            "text": "iflozin and saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_9": [
        {
            "start_logit": 13.7890625,
            "end_logit": 13.2265625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -2.068359375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -3.765625,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -5.71484375,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": 13.2265625,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.69921875,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -7.85546875,
            "text": "dapagliflozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -8.7578125,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 13.2265625,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 13.2265625,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.6328125,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.671875,
            "text": "dapagliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.7109375,
            "text": "dapagliflozin/saxagliptin) tablets.",
            "probability": 0.0
        },
        {
            "start_logit": 13.7890625,
            "end_logit": -9.7578125,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946 to July 1, 2017",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 13.2265625,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 13.2265625,
            "text": "QTERN (dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -2.068359375,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -2.068359375,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -2.068359375,
            "text": "agliflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -2.068359375,
            "text": "iflozin/saxagliptin",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_10": [
        {
            "start_logit": 14.1953125,
            "end_logit": 13.546875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -3.41796875,
            "text": "dap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6796875,
            "end_logit": 13.546875,
            "text": "ozin",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -6.47265625,
            "text": "dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": 13.546875,
            "text": "nd dapagliflozin",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.1875,
            "text": "dapaglifl",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.2421875,
            "text": "dapagliflozin + metformin",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.8046875,
            "text": "dapagliflozin + metformin was -0.27",
            "probability": 0.0
        },
        {
            "start_logit": 14.1953125,
            "end_logit": -8.953125,
            "text": "dapagliflozin + metformin was -0.27 (95% CI = -0.48",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 13.546875,
            "text": "iflozin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 13.546875,
            "text": "agliflozin",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -3.41796875,
            "text": "nd dap",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -4.05078125,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -4.05078125,
            "text": "dapagliflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -6.47265625,
            "text": "nd dapagl",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -8.2421875,
            "text": "ozin + metformin",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -8.8046875,
            "text": "ozin + metformin was -0.27",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": -4.05078125,
            "text": "agliptin",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -8.953125,
            "text": "ozin + metformin was -0.27 (95% CI = -0.48",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": -4.05078125,
            "text": "/saxagliptin",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_1": [
        {
            "start_logit": 8.921875,
            "end_logit": 13.171875,
            "text": "NSAIDs",
            "probability": 1.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.48046875,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.6796875,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -9.3828125,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.21875,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.2421875,
            "text": "NSAIDs is generally discouraged",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.2734375,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients.",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.4375,
            "text": "NSAIDs is generally",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.4453125,
            "text": "NSAIDs is generally discouraged because of the increased",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.5,
            "text": "NSAIDs is",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.5078125,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.5546875,
            "text": "NSAIDs is generally discouraged because of the increased risk of",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.5859375,
            "text": "NSAIDs is generally discouraged because of the",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.59375,
            "text": "NSAIDs is generally discouraged because of the increased risk",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -10.609375,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -7.48046875,
            "text": "NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -10.2421875,
            "end_logit": -7.48046875,
            "text": "patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -7.48046875,
            "text": "receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -7.48046875,
            "text": "In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": -7.48046875,
            "text": "warfarin who also require NSAIDs",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_2": [
        {
            "start_logit": 7.08984375,
            "end_logit": 11.46875,
            "text": "azole antibiotics",
            "probability": 0.9697265625
        },
        {
            "start_logit": 7.08984375,
            "end_logit": 7.9765625,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 0.0292816162109375
        },
        {
            "start_logit": 3.69921875,
            "end_logit": 7.9765625,
            "text": "nonsteroidal anti-inflammatory drugs",
            "probability": 0.0009870529174804688
        },
        {
            "start_logit": 7.08984375,
            "end_logit": 2.279296875,
            "text": "azole antibiotics, macrolides",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": 7.08984375,
            "end_logit": 2.0625,
            "text": "azole antibiotics, macrolides, quinolones",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 11.46875,
            "text": "antibiotics",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -2.734375,
            "end_logit": 7.9765625,
            "text": "macrolides, quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -3.935546875,
            "end_logit": 7.9765625,
            "text": "quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 7.9765625,
            "text": "antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 11.46875,
            "text": "While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.2578125,
            "text": "azole",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.703125,
            "end_logit": 11.46875,
            "text": "with azole antibiotics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.9765625,
            "text": "drugs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -7.14453125,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -7.34375,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors, selective serotonin reuptake inhibitors, omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": 2.279296875,
            "text": "macrolides",
            "probability": 0.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": 2.0625,
            "text": "macrolides, quinolones",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 7.9765625,
            "text": ", quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 0.0
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -8.1171875,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal",
            "probability": 0.0
        },
        {
            "start_logit": -9.3359375,
            "end_logit": 7.9765625,
            "text": ", macrolides, quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_3": [
        {
            "start_logit": 9.6953125,
            "end_logit": 12.46875,
            "text": "corticosteroids",
            "probability": 1.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 12.46875,
            "text": "oral corticosteroids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -9.8125,
            "text": "corticosteroids and warfarin, but there is limited documentation",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -9.8125,
            "text": "corticosteroids and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.109375,
            "text": "corticosteroids and warfarin, but there is limited documentation.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.203125,
            "text": "corticosteroids and warfarin, but there is limited",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.4453125,
            "text": "corticosteroids and warfarin,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.453125,
            "text": "corticosteroids and warfarin",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.5703125,
            "text": "corticosteroids and warfarin, but there is",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.7578125,
            "text": "corticosteroids and warfarin, but there",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -10.828125,
            "text": "corticosteroids and warfarin, but",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -8.40625,
            "text": "oral",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -9.8125,
            "text": "oral corticosteroids and warfarin, but there is limited documentation",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -9.8125,
            "text": "oral corticosteroids and",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.109375,
            "text": "oral corticosteroids and warfarin, but there is limited documentation.",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.203125,
            "text": "oral corticosteroids and warfarin, but there is limited",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.4453125,
            "text": "oral corticosteroids and warfarin,",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.453125,
            "text": "oral corticosteroids and warfarin",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.5703125,
            "text": "oral corticosteroids and warfarin, but there is",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -10.7578125,
            "text": "oral corticosteroids and warfarin, but there",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_4": [
        {
            "start_logit": 9.3984375,
            "end_logit": 12.90625,
            "text": "corticosteroids",
            "probability": 1.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": 12.90625,
            "text": "oral corticosteroids",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 12.90625,
            "text": "Use of oral corticosteroids",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.0234375,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.296875,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.5078125,
            "text": "corticosteroids in patients on long-term warfarin therapy may",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.53125,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.578125,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.640625,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.6640625,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.7109375,
            "text": "corticosteroids in patients on long-term warfarin",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.71875,
            "text": "corticosteroids in patients on long-term warfarin therapy",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.7578125,
            "text": "corticosteroids in patients on long-term",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.7578125,
            "text": "corticosteroids in patients on long-",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.765625,
            "text": "corticosteroids in",
            "probability": 0.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -10.78125,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -9.1796875,
            "text": "oral",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -10.0234375,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may result in a",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -10.296875,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction",
            "probability": 0.0
        },
        {
            "start_logit": -8.7421875,
            "end_logit": -10.5078125,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_5": [
        {
            "start_logit": 12.453125,
            "end_logit": 12.3984375,
            "text": "protease inhibitors",
            "probability": 1.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": 12.3984375,
            "text": "other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.453125,
            "end_logit": -4.4765625,
            "text": "protease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 12.3984375,
            "text": "inhibitors",
            "probability": 0.0
        },
        {
            "start_logit": 12.453125,
            "end_logit": -9.984375,
            "text": "protease inhibitors.",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -4.4765625,
            "text": "other protease",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -9.984375,
            "text": "other protease inhibitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -9.984375,
            "text": "inhibitors.",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_6": [
        {
            "start_logit": 9.640625,
            "end_logit": 13.0625,
            "text": "antibiotics",
            "probability": 1.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": 13.0625,
            "text": "classes of drugs, such as antibiotics",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -9.5546875,
            "text": "antibiotics,",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -9.984375,
            "text": "antibiotics, may",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.1484375,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.1640625,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.4296875,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults is not clear",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.4921875,
            "text": "antibiotics, may interact with warfarin to cause an increase",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.5,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.6328125,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -10.6953125,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -8.6171875,
            "text": "classes of drugs",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -9.390625,
            "text": "classes of drugs, such",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -9.53125,
            "text": "classes of drugs, such as",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -9.5546875,
            "text": "classes of drugs, such as antibiotics,",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -9.984375,
            "text": "classes of drugs, such as antibiotics, may",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -10.1484375,
            "text": "classes of drugs, such as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -10.1640625,
            "text": "classes of drugs, such as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -10.2890625,
            "text": "classes of",
            "probability": 0.0
        },
        {
            "start_logit": -9.8515625,
            "end_logit": -10.4921875,
            "text": "classes of drugs, such as antibiotics, may interact with warfarin to cause an increase",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_7": [
        {
            "start_logit": 12.390625,
            "end_logit": 13.1953125,
            "text": "psychotropics",
            "probability": 1.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -2.919921875,
            "text": "psychotropic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 13.1953125,
            "text": "s",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.390625,
            "end_logit": -7.76953125,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": 13.1953125,
            "text": "As the number of psychotropics",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -8.875,
            "text": "psychotropics on the market expands, the likelihood",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -9.0859375,
            "text": "psychotropics on the market expands, the likelihood increases",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -9.390625,
            "text": "psychotropics on the market",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -9.6015625,
            "text": "psychotropics on the market expands",
            "probability": 0.0
        },
        {
            "start_logit": -10.4375,
            "end_logit": 13.1953125,
            "text": "of psychotropics",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.109375,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.1953125,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.2890625,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.296875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug.",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.3359375,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.46875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent",
            "probability": 0.0
        },
        {
            "start_logit": 12.390625,
            "end_logit": -10.6015625,
            "text": "psychotropics on the",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -7.76953125,
            "text": "s on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug",
            "probability": 0.0
        },
        {
            "start_logit": -9.671875,
            "end_logit": -2.919921875,
            "text": "As the number of psychotropic",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -8.875,
            "text": "s on the market expands, the likelihood",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_8": [
        {
            "start_logit": 11.375,
            "end_logit": 11.9921875,
            "text": "fluconazole",
            "probability": 1.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -1.9287109375,
            "text": "fluconazole, amiodarone",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 11.375,
            "end_logit": -5.95703125,
            "text": "fluconazole, amiodarone, and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 11.9921875,
            "text": "36 drugs that may interact with warfarin, fluconazole",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": 11.9921875,
            "text": "Among 36 drugs that may interact with warfarin, fluconazole",
            "probability": 0.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -9.7734375,
            "text": "fluconazole, amiodarone, and",
            "probability": 0.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -9.78125,
            "text": "fluconazole, amiodarone, and omeprazole were associated with the requirement for 45.8, 16.7, and 16.7% lower median warfarin dose",
            "probability": 0.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -10.28125,
            "text": "fluconazole, amiodarone, and omeprazole were",
            "probability": 0.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -10.40625,
            "text": "fluconazole, amiodarone, and omeprazole were associated",
            "probability": 0.0
        },
        {
            "start_logit": 11.375,
            "end_logit": -10.4140625,
            "text": "fluconazole,",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -1.9287109375,
            "text": "amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -5.95703125,
            "text": "amiodarone, and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -1.9287109375,
            "text": ", amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -1.9287109375,
            "text": "36 drugs that may interact with warfarin, fluconazole, amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -10.1484375,
            "end_logit": -1.9287109375,
            "text": "Among 36 drugs that may interact with warfarin, fluconazole, amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -9.7734375,
            "text": "amiodarone, and",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -9.78125,
            "text": "amiodarone, and omeprazole were associated with the requirement for 45.8, 16.7, and 16.7% lower median warfarin dose",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -5.95703125,
            "text": "omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -10.28125,
            "text": "amiodarone, and omeprazole were",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -10.40625,
            "text": "amiodarone, and omeprazole were associated",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_9": [
        {
            "start_logit": 8.609375,
            "end_logit": 8.625,
            "text": "acetylsalicylic acid and amiodarone",
            "probability": 0.63330078125
        },
        {
            "start_logit": 8.609375,
            "end_logit": 8.0703125,
            "text": "acetylsalicylic acid",
            "probability": 0.366455078125
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.625,
            "text": "amiodarone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.33984375,
            "text": "acetyls",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.609375,
            "end_logit": -8.0234375,
            "text": "acetylsalicylic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.625,
            "text": "acid and amiodarone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.0703125,
            "text": "acid",
            "probability": 0.0
        },
        {
            "start_logit": 8.609375,
            "end_logit": -9.1015625,
            "text": "acetylsalic",
            "probability": 0.0
        },
        {
            "start_logit": -9.25,
            "end_logit": 8.625,
            "text": "and amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 8.625,
            "text": "alicylic acid and amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": 8.609375,
            "end_logit": -10.2890625,
            "text": "acetylsalicylic acid and",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 8.625,
            "text": "ylic acid and amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": 8.0703125,
            "text": "alicylic acid",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 8.0703125,
            "text": "ylic acid",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -8.0234375,
            "text": "alicylic",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": -8.0234375,
            "text": "ylic",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -10.2890625,
            "text": "acid and",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -9.1015625,
            "text": "alic",
            "probability": 0.0
        },
        {
            "start_logit": -9.25,
            "end_logit": -10.2890625,
            "text": "and",
            "probability": 0.0
        },
        {
            "start_logit": -10.09375,
            "end_logit": -10.2890625,
            "text": "alicylic acid and",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_10": [
        {
            "start_logit": 11.7734375,
            "end_logit": 11.1796875,
            "text": "amiodarone",
            "probability": 1.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -5.484375,
            "text": "amiodarone, propafenone and fibrates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -6.50390625,
            "text": "amiodarone, propafenone",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 11.1796875,
            "text": "cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.140625,
            "text": "amiodarone, propafeno",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.34375,
            "text": "amiodarone, propafenone and fibr",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.484375,
            "text": "amiodarone, propafenone and",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.5703125,
            "text": "amiodarone, propafe",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.859375,
            "text": "amiodarone, propafenone and fibrates. Cardiovascular drugs which are obviously devoid or proven to be devoid of an interaction are angiotensin converting enzyme (",
            "probability": 0.0
        },
        {
            "start_logit": 11.7734375,
            "end_logit": -9.8671875,
            "text": "amiodarone, prop",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 11.1796875,
            "text": "with cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": 11.1796875,
            "text": "coumarins: amiodarone",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -5.484375,
            "text": "cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone, propafenone and fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -8.9296875,
            "end_logit": -5.484375,
            "text": ", propafenone and fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.171875,
            "end_logit": -5.484375,
            "text": "fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -6.50390625,
            "text": "cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone, propafenone",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": -5.484375,
            "text": "with cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone, propafenone and fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.7265625,
            "end_logit": -5.484375,
            "text": "coumarins: amiodarone, propafenone and fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.765625,
            "end_logit": -5.484375,
            "text": "propafenone and fibrates",
            "probability": 0.0
        },
        {
            "start_logit": -9.8359375,
            "end_logit": -5.484375,
            "text": "ne and fibrates",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_11": [
        {
            "start_logit": 11.6953125,
            "end_logit": 11.6484375,
            "text": "trazodone",
            "probability": 1.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": 1.919921875,
            "text": "trazodone (2.2%) and carbamazepine",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -5.12890625,
            "text": "tra",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 11.6484375,
            "text": "one",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.3671875,
            "text": "trazo",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -6.5546875,
            "text": "trazod",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -7.49609375,
            "text": "trazodone (2.2%)",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -7.76953125,
            "text": "trazodone (2",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -8.5546875,
            "text": "trazodone (2.2",
            "probability": 0.0
        },
        {
            "start_logit": -8.96875,
            "end_logit": 11.6484375,
            "text": "zodone",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.140625,
            "text": "trazodone (2.2%) and carbamazepine (1",
            "probability": 0.0
        },
        {
            "start_logit": -9.359375,
            "end_logit": 11.6484375,
            "text": "done",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.4921875,
            "text": "trazodone (2.2%",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.5703125,
            "text": "trazodone (2.2%) and carbamazepine (1.1",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.7265625,
            "text": "trazodone (2.2%) and carbamazepine (1.1%). The most",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.765625,
            "text": "trazodone (2.2%) and carbamazepine (1.1%",
            "probability": 0.0
        },
        {
            "start_logit": 11.6953125,
            "end_logit": -9.8515625,
            "text": "trazodone (2.2%) and carbamazepine (1.1%). The most commonly prescribed",
            "probability": 0.0
        },
        {
            "start_logit": -0.30712890625,
            "end_logit": 1.919921875,
            "text": "carbamazepine",
            "probability": 0.0
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 1.919921875,
            "text": "one (2.2%) and carbamazepine",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": 1.919921875,
            "text": "and carbamazepine",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_1": [
        {
            "start_logit": 12.5,
            "end_logit": 12.6484375,
            "text": "CNVRanger",
            "probability": 1.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -5.16796875,
            "text": "CNV",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": 12.6484375,
            "text": "ger",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -5.7578125,
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -7.63671875,
            "text": "CNVRan",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 12.6484375,
            "text": "Ranger",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -9.421875,
            "text": "CNVRanger: association analysis of CNVs",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -9.71875,
            "text": "CNVRanger:",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -9.828125,
            "text": "CNVRanger: association analysis of CNVs with gene expression",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -9.8984375,
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -10.015625,
            "text": "CNVRanger: association analysis",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -10.1640625,
            "text": "CNVRanger: association analysis of",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -10.328125,
            "text": "CNVRanger: association analysis of CNVs with gene",
            "probability": 0.0
        },
        {
            "start_logit": 12.5,
            "end_logit": -10.3515625,
            "text": "CNVRanger: association analysis of CNVs with gene expression and",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -5.7578125,
            "text": "ger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -5.7578125,
            "text": "Ranger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -9.421875,
            "text": "ger: association analysis of CNVs",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -9.71875,
            "text": "ger:",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -9.828125,
            "text": "ger: association analysis of CNVs with gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -9.8984375,
            "text": "ger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_2": [
        {
            "start_logit": 13.859375,
            "end_logit": 14.109375,
            "text": "CNVRanger",
            "probability": 1.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": 14.109375,
            "text": "ger",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -4.0546875,
            "text": "CNV",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.66015625,
            "text": "CNVRanger R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.78515625,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.9296875,
            "text": "CNVRanger R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 14.109375,
            "text": "Ranger",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -7.984375,
            "text": "CNVRan",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.15625,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis of CNVs. This includes functionality",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.171875,
            "text": "CNVRanger R/Bioconductor package which implement",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.4140625,
            "text": "CNVRanger R/Bioconductor package which",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.421875,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.5,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive tool",
            "probability": 0.0
        },
        {
            "start_logit": 13.859375,
            "end_logit": -9.578125,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis of CNVs. This includes",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 14.109375,
            "text": "CNVs from SNP array and next-generation sequencing data are available. We present the CNVRanger",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -7.66015625,
            "text": "ger R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -7.78515625,
            "text": "ger R/Bioconductor package which implements a comprehensive toolbox",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -7.9296875,
            "text": "ger R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -9.15625,
            "text": "ger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis of CNVs. This includes functionality",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -9.171875,
            "text": "ger R/Bioconductor package which implement",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_3": [
        {
            "start_logit": 13.921875,
            "end_logit": 13.875,
            "text": "seqCNA",
            "probability": 1.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -4.01171875,
            "text": "seq",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": 13.875,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -6.61328125,
            "text": "seqCN",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -7.3046875,
            "text": "seqCNA: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 13.875,
            "text": "CNA",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -8.9375,
            "text": "seqCNA: an R",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.0,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.046875,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing.",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.6484375,
            "text": "seqCNA:",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.7734375,
            "text": "seqCNA: an",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -9.984375,
            "text": "seqCNA: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -10.0,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -10.15625,
            "text": "seqCNA: an R package for DNA copy number analysis",
            "probability": 0.0
        },
        {
            "start_logit": 13.921875,
            "end_logit": -10.1640625,
            "text": "seqCNA: an R package for DNA copy number",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -7.3046875,
            "text": "A: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -8.9375,
            "text": "A: an R",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -9.0,
            "text": "A: an R package for DNA copy number analysis in cancer using high-throughput sequencing",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -9.046875,
            "text": "A: an R package for DNA copy number analysis in cancer using high-throughput sequencing.",
            "probability": 0.0
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -9.6484375,
            "text": "A:",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_4": [
        {
            "start_logit": 14.0078125,
            "end_logit": 14.1640625,
            "text": "seqCNA",
            "probability": 1.0
        },
        {
            "start_logit": -3.55078125,
            "end_logit": 14.1640625,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -3.974609375,
            "text": "seq",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -6.609375,
            "text": "seqCN",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -7.83203125,
            "text": "seqCNA, a parallelized R package",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 14.1640625,
            "text": "CNA",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -8.9140625,
            "text": "seqCNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package",
            "probability": 0.0
        },
        {
            "start_logit": 14.0078125,
            "end_logit": -9.046875,
            "text": "seqCNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package includes novel methodology",
            "probability": 0.0
        },
        {
            "start_logit": -3.55078125,
            "end_logit": -7.83203125,
            "text": "A, a parallelized R package",
            "probability": 0.0
        },
        {
            "start_logit": -3.55078125,
            "end_logit": -8.9140625,
            "text": "A, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package",
            "probability": 0.0
        },
        {
            "start_logit": -3.55078125,
            "end_logit": -9.046875,
            "text": "A, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package includes novel methodology",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -6.66015625,
            "text": "seqCNA",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -6.609375,
            "text": "CN",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -6.66015625,
            "text": "matched normal samples and genome annotation.CONCLUSIONS: seqCNA",
            "probability": 0.0
        },
        {
            "start_logit": -8.921875,
            "end_logit": -6.66015625,
            "text": "normal samples and genome annotation.CONCLUSIONS: seqCNA",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.734375,
            "text": "seqCNA, available through Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": -6.66015625,
            "text": ", matched normal samples and genome annotation.CONCLUSIONS: seqCNA",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": -6.66015625,
            "text": "CNA",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -7.83203125,
            "text": "CNA, a parallelized R package",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -8.3671875,
            "text": "seqCNA, available through Bioconductor, provides accurate copy number predictions in tumoural data, thanks to the extensive filtering and better GC bias",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_5": [
        {
            "start_logit": 13.765625,
            "end_logit": 13.9453125,
            "text": "iGC",
            "probability": 1.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -3.94921875,
            "text": "iG",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": 13.9453125,
            "text": "C",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -8.1640625,
            "text": "iGC)",
            "probability": 0.0
        },
        {
            "start_logit": 13.765625,
            "end_logit": -8.34375,
            "text": "iGC). Multiple input formats are supported and users can define their own criteria",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 13.9453125,
            "text": "open-source R/Bioconductor package (iGC",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": 13.9453125,
            "text": "(iGC",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 13.9453125,
            "text": "package (iGC",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": -8.1640625,
            "text": "C)",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": -8.34375,
            "text": "C). Multiple input formats are supported and users can define their own criteria",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -3.94921875,
            "text": "open-source R/Bioconductor package (iG",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -3.94921875,
            "text": "(iG",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": -3.94921875,
            "text": "package (iG",
            "probability": 0.0
        },
        {
            "start_logit": -9.140625,
            "end_logit": -6.23828125,
            "text": "iGC.html",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -7.87890625,
            "text": "open-source R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -8.1640625,
            "text": "open-source R/Bioconductor package (iGC)",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -8.1640625,
            "text": "(iGC)",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -8.34375,
            "text": "open-source R/Bioconductor package (iGC). Multiple input formats are supported and users can define their own criteria",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": -8.3671875,
            "text": "open-source R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -8.75,
            "end_logit": -8.34375,
            "text": "(iGC). Multiple input formats are supported and users can define their own criteria",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_6": [
        {
            "start_logit": 13.3203125,
            "end_logit": 13.6875,
            "text": "PLRS",
            "probability": 1.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 13.6875,
            "text": "S",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -4.52734375,
            "text": "PLR",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.7890625,
            "text": "PLRS: a flexible tool",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.0078125,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression data.",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.0625,
            "text": "PLRS: a flexible",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.1953125,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression data",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.703125,
            "text": "PLRS:",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.7734375,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.8671875,
            "text": "PLRS: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.953125,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.0625,
            "text": "PLRS: a flexible tool for",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.15625,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.171875,
            "text": "PLRS: a flexible tool for the joint analysis",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.2109375,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -8.7890625,
            "text": "S: a flexible tool",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -9.0078125,
            "text": "S: a flexible tool for the joint analysis of DNA copy number and mRNA expression data.",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -9.0625,
            "text": "S: a flexible",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -9.1953125,
            "text": "S: a flexible tool for the joint analysis of DNA copy number and mRNA expression data",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -9.703125,
            "text": "S:",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_7": [
        {
            "start_logit": 13.7578125,
            "end_logit": 14.328125,
            "text": "PLRS",
            "probability": 1.0
        },
        {
            "start_logit": -3.20703125,
            "end_logit": 14.328125,
            "text": "S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -4.109375,
            "text": "PLR",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -7.734375,
            "text": "PLRS uses a wide class of interpretable models",
            "probability": 0.0
        },
        {
            "start_logit": 13.7578125,
            "end_logit": -7.90234375,
            "text": "PLRS uses a wide class of interpretable models including popular ones and incorporates prior biological knowledge",
            "probability": 0.0
        },
        {
            "start_logit": -9.1953125,
            "end_logit": 14.328125,
            "text": "flexible modelling of this association. PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": 14.328125,
            "text": "molecular levels and hence offers no opportunities for modelling it. We present a new tool for flexible modelling of this association. PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -3.20703125,
            "end_logit": -7.734375,
            "text": "S uses a wide class of interpretable models",
            "probability": 0.0
        },
        {
            "start_logit": -3.20703125,
            "end_logit": -7.90234375,
            "text": "S uses a wide class of interpretable models including popular ones and incorporates prior biological knowledge",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -4.0859375,
            "text": "Cancer Genome Atlas",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": -4.0859375,
            "text": "glioblastoma data from The Cancer Genome Atlas",
            "probability": 0.0
        },
        {
            "start_logit": -9.0234375,
            "end_logit": -4.0859375,
            "text": "PLRS using glioblastoma data from The Cancer Genome Atlas",
            "probability": 0.0
        },
        {
            "start_logit": -9.1953125,
            "end_logit": -4.109375,
            "text": "flexible modelling of this association. PLR",
            "probability": 0.0
        },
        {
            "start_logit": -9.453125,
            "end_logit": -4.0859375,
            "text": "mRNA expression. Moreover, it tests the strength of the association and provides confidence intervals. We illustrate PLRS using glioblastoma data from The Cancer Genome Atlas",
            "probability": 0.0
        },
        {
            "start_logit": -9.8125,
            "end_logit": -4.109375,
            "text": "molecular levels and hence offers no opportunities for modelling it. We present a new tool for flexible modelling of this association. PLR",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -6.47265625,
            "text": "PLRS is implemented as an R package and available from Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -6.578125,
            "text": "PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.3515625,
            "text": "PLRS is implemented as an R package and available from Bioconductor (as of version 2.12; http://bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -6.47265625,
            "text": "Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS is implemented as an R package and available from Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -6.578125,
            "text": "Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_8": [
        {
            "start_logit": 13.015625,
            "end_logit": 13.5390625,
            "text": "SomatiCA",
            "probability": 1.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 13.5390625,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -5.3671875,
            "text": "SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -8.765625,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data.",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -8.921875,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.3125,
            "text": "SomatiCA:",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.4140625,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.5390625,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -9.7734375,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -10.078125,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -10.1796875,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -10.2109375,
            "text": "SomatiCA: identifying, characterizing and quantifying",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -10.2421875,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy",
            "probability": 0.0
        },
        {
            "start_logit": 13.015625,
            "end_logit": -10.3515625,
            "text": "SomatiCA: identifying, characterizing and",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -8.765625,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data.",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -8.921875,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.3125,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.4140625,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.5390625,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -9.7734375,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_9": [
        {
            "start_logit": 13.9765625,
            "end_logit": 14.453125,
            "text": "SomatiCA",
            "probability": 1.0
        },
        {
            "start_logit": -3.14453125,
            "end_logit": 14.453125,
            "text": "A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -3.9296875,
            "text": "SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": 13.9765625,
            "end_logit": -8.25,
            "text": "SomatiCA, which explicitly accounts for tumor purity and subclonality",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": 14.453125,
            "text": "purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiCA",
            "probability": 0.0
        },
        {
            "start_logit": -3.14453125,
            "end_logit": -8.25,
            "text": "A, which explicitly accounts for tumor purity and subclonality",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -5.328125,
            "text": "LOH",
            "probability": 0.0
        },
        {
            "start_logit": -9.34375,
            "end_logit": -3.9296875,
            "text": "purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.0,
            "text": "SomatiCA.html",
            "probability": 0.0
        },
        {
            "start_logit": -9.0078125,
            "end_logit": -5.328125,
            "text": "SCNA), and 4) a list of substantial genomic aberration events including gain, loss and LOH",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -6.49609375,
            "text": "LOH. SomatiCA is available as a Bioconductor R package at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -9.234375,
            "end_logit": -5.328125,
            "text": "subclonal change in each somatic copy number aberration (SCNA), and 4) a list of substantial genomic aberration events including gain, loss and LOH",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.28125,
            "text": "LOH. SomatiCA is available as a Bioconductor R package at http://www.bioconductor.org/packages/2",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.4375,
            "text": "LOH. SomatiCA is available as a Bioconductor R package at http://www.bioconductor.org",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": -6.49609375,
            "text": "SomatiCA is available as a Bioconductor R package at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.6171875,
            "text": "LOH. SomatiCA is available",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.93359375,
            "text": "LOH. SomatiCA is available as a Bioconductor R package at http://",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.97265625,
            "text": "LOH. SomatiCA",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -8.265625,
            "text": "LOH. SomatiCA is available as a Bioconductor R package at http://www.bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -8.8828125,
            "end_logit": -7.28125,
            "text": "SomatiCA is available as a Bioconductor R package at http://www.bioconductor.org/packages/2",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_10": [
        {
            "start_logit": 13.59375,
            "end_logit": 13.78125,
            "text": "Copynumber",
            "probability": 1.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -3.783203125,
            "text": "Copy",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": 13.78125,
            "text": "er",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -6.171875,
            "text": "Copynu",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -6.2734375,
            "text": "Copynumb",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -7.40625,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number segmentation",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -8.3359375,
            "text": "Copynumber: Efficient algorithms",
            "probability": 0.0
        },
        {
            "start_logit": -8.7265625,
            "end_logit": 13.78125,
            "text": "mber",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -8.8359375,
            "text": "Copynumber: Efficient algorithms for single- and multi-track",
            "probability": 0.0
        },
        {
            "start_logit": -9.1171875,
            "end_logit": 13.78125,
            "text": "number",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.140625,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number segmentation.",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.8828125,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -9.984375,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.0546875,
            "text": "Copynumber: Efficient algorithms for single- and multi",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.0703125,
            "text": "Copynumber: Efficient algorithms for single",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.0703125,
            "text": "Copynumber:",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.1171875,
            "text": "Copynumber: Efficient algorithms for",
            "probability": 0.0
        },
        {
            "start_logit": 13.59375,
            "end_logit": -10.140625,
            "text": "Copynumber: Efficient algorithms for single- and multi-",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -7.40625,
            "text": "er: Efficient algorithms for single- and multi-track copy number segmentation",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -8.3359375,
            "text": "er: Efficient algorithms",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_11": [
        {
            "start_logit": 14.0390625,
            "end_logit": 14.3359375,
            "text": "copynumber",
            "probability": 1.0
        },
        {
            "start_logit": -3.501953125,
            "end_logit": 14.3359375,
            "text": "er",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -3.84765625,
            "text": "copy",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -6.34375,
            "text": "copynumb",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -6.734375,
            "text": "copynu",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -7.83984375,
            "text": "copynumber is",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": 14.3359375,
            "text": "R package copynumber",
            "probability": 0.0
        },
        {
            "start_logit": 14.0390625,
            "end_logit": -9.296875,
            "text": "copynumber is a software",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": 14.3359375,
            "text": "mber",
            "probability": 0.0
        },
        {
            "start_logit": -3.501953125,
            "end_logit": -7.83984375,
            "text": "er is",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -3.84765625,
            "text": "R package copy",
            "probability": 0.0
        },
        {
            "start_logit": -3.501953125,
            "end_logit": -9.296875,
            "text": "er is a software",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -6.34375,
            "text": "R package copynumb",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -7.140625,
            "text": "array-CGH",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -6.734375,
            "text": "R package copynu",
            "probability": 0.0
        },
        {
            "start_logit": -9.59375,
            "end_logit": -6.34375,
            "text": "mb",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -7.140625,
            "text": "types of array-CGH",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -8.1953125,
            "text": "array-CGH, SNP arrays and high-throughput sequencing",
            "probability": 0.0
        },
        {
            "start_logit": -8.90625,
            "end_logit": -7.83984375,
            "text": "R package copynumber is",
            "probability": 0.0
        },
        {
            "start_logit": -9.6796875,
            "end_logit": -7.140625,
            "text": "of array-CGH",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_12": [
        {
            "start_logit": 13.4296875,
            "end_logit": 13.875,
            "text": "crlmm",
            "probability": 1.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": 13.875,
            "text": "m",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -4.765625,
            "text": "cr",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -6.78515625,
            "text": "crlm",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 13.875,
            "text": "R Package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": -8.78125,
            "end_logit": 13.875,
            "text": "lmm",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.3046875,
            "text": "crlmm for Genotyping and Copy Number Estimation",
            "probability": 0.0
        },
        {
            "start_logit": -9.859375,
            "end_logit": 13.875,
            "text": "Using the R Package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.84375,
            "text": "crlmm for Genotyping and Copy Number Estimation.",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.875,
            "text": "crlmm for",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -9.9453125,
            "text": "crlmm for Genotyping",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -10.1640625,
            "text": "crlmm for Genotyping and Copy Number",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -10.484375,
            "text": "crlmm for Genotyping and",
            "probability": 0.0
        },
        {
            "start_logit": 13.4296875,
            "end_logit": -10.5078125,
            "text": "crlmm for Genotyping and Copy",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -4.765625,
            "text": "R Package cr",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -9.3046875,
            "text": "m for Genotyping and Copy Number Estimation",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -6.15625,
            "text": "R Package",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -9.84375,
            "text": "m for Genotyping and Copy Number Estimation.",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -9.875,
            "text": "m for",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -9.9453125,
            "text": "m for Genotyping",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_13": [
        {
            "start_logit": 13.890625,
            "end_logit": 14.34375,
            "text": "crlmm",
            "probability": 1.0
        },
        {
            "start_logit": -3.408203125,
            "end_logit": 14.34375,
            "text": "m",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.890625,
            "end_logit": -4.1328125,
            "text": "cr",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -6.890625,
            "text": "crlmm implements a multilevel model",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -7.015625,
            "text": "crlm",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 14.34375,
            "text": "R package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 14.34375,
            "text": "lmm",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 14.34375,
            "text": "Analysis algorithms that do not adjust for batch effects are prone to spurious measures of association. The R package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -8.8671875,
            "text": "crlmm implement",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": 14.34375,
            "text": "batch effects are prone to spurious measures of association. The R package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 14.34375,
            "text": "that do not adjust for batch effects are prone to spurious measures of association. The R package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": -9.6953125,
            "end_logit": 14.34375,
            "text": "for batch effects are prone to spurious measures of association. The R package crlmm",
            "probability": 0.0
        },
        {
            "start_logit": 13.890625,
            "end_logit": -9.2890625,
            "text": "crlmm implements a multilevel model that adjusts for batch effects and provides allele-specific estimates of copy number. This paper",
            "probability": 0.0
        },
        {
            "start_logit": -3.408203125,
            "end_logit": -6.890625,
            "text": "m implements a multilevel model",
            "probability": 0.0
        },
        {
            "start_logit": -3.408203125,
            "end_logit": -8.8671875,
            "text": "m implement",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -4.1328125,
            "text": "R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -3.408203125,
            "end_logit": -9.2890625,
            "text": "m implements a multilevel model that adjusts for batch effects and provides allele-specific estimates of copy number. This paper",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": -4.1328125,
            "text": "Analysis algorithms that do not adjust for batch effects are prone to spurious measures of association. The R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -9.5078125,
            "end_logit": -4.1328125,
            "text": "batch effects are prone to spurious measures of association. The R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": -4.1328125,
            "text": "that do not adjust for batch effects are prone to spurious measures of association. The R package cr",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_14": [
        {
            "start_logit": 13.375,
            "end_logit": 13.3046875,
            "text": "KC-SMARTR",
            "probability": 1.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -3.51171875,
            "text": "KC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.96875,
            "end_logit": 13.3046875,
            "text": "R",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -6.8984375,
            "text": "KC-SMARTR: An R package",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 13.3046875,
            "text": "SMARTR",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -8.046875,
            "text": "KC-",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -8.453125,
            "text": "KC-SMART",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -8.78125,
            "text": "KC-SMARTR: An R",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -8.8671875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.3046875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data.",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.4921875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.5859375,
            "text": "KC-SMARTR:",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.8203125,
            "text": "KC-SMARTR: An R package for",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.859375,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -9.875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment",
            "probability": 0.0
        },
        {
            "start_logit": -10.15625,
            "end_logit": 13.3046875,
            "text": "-SMARTR",
            "probability": 0.0
        },
        {
            "start_logit": 13.375,
            "end_logit": -10.25,
            "text": "KC-SMARTR: An R package for detection of statistically significant",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -6.8984375,
            "text": "R: An R package",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -8.78125,
            "text": "R: An R",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -8.8671875,
            "text": "R: An R package for detection of statistically significant aberrations in multi-experiment aCGH",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_15": [
        {
            "start_logit": 12.5546875,
            "end_logit": 10.640625,
            "text": "KC-SMART",
            "probability": 0.79296875
        },
        {
            "start_logit": 10.890625,
            "end_logit": 10.953125,
            "text": "KC-SMARTR",
            "probability": 0.20703125
        },
        {
            "start_logit": 12.5546875,
            "end_logit": -5.08203125,
            "text": "KC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.890625,
            "end_logit": -6.0,
            "text": "KC",
            "probability": 0.0
        },
        {
            "start_logit": 12.5546875,
            "end_logit": -8.6953125,
            "text": "KC-SMART, that bases its estimate of the magnitude of the CNA at a given genomic location on kernel convolution (Klijn",
            "probability": 0.0
        },
        {
            "start_logit": 10.890625,
            "end_logit": -7.5,
            "text": "KC-SMARTR offers recurrent CNA and class specific CNA detection",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 10.953125,
            "text": "R",
            "probability": 0.0
        },
        {
            "start_logit": 10.890625,
            "end_logit": -7.85546875,
            "text": "KC-SMARTR offers recurrent CNA and class specific CNA detection, at different genomic scales, in a single package without the need for additional segmentation",
            "probability": 0.0
        },
        {
            "start_logit": 10.890625,
            "end_logit": -7.984375,
            "text": "KC-SMART",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 10.640625,
            "text": "SMART",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.640625,
            "text": "algorithm, KC-SMART",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -5.08203125,
            "text": "algorithm, KC",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -7.62890625,
            "text": "t-test",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -7.5,
            "text": "R offers recurrent CNA and class specific CNA detection",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.62890625,
            "text": "VDJ regions) in addition to a number of new regions. A t-test",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -7.85546875,
            "text": "R offers recurrent CNA and class specific CNA detection, at different genomic scales, in a single package without the need for additional segmentation",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -8.203125,
            "text": "VDJ",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.3046875,
            "text": "algorithm",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -8.6953125,
            "text": "SMART, that bases its estimate of the magnitude of the CNA at a given genomic location on kernel convolution (Klijn",
            "probability": 0.0
        },
        {
            "start_logit": -8.9453125,
            "end_logit": -7.85546875,
            "text": "segmentation",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_1": [
        {
            "start_logit": 9.9453125,
            "end_logit": 7.26171875,
            "text": "neurotensin",
            "probability": 0.9951171875
        },
        {
            "start_logit": 4.65625,
            "end_logit": 7.26171875,
            "text": "Ccl4 and neurotensin",
            "probability": 0.005062103271484375
        },
        {
            "start_logit": 4.65625,
            "end_logit": 4.0390625,
            "text": "Ccl4",
            "probability": 0.0002009868621826172
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.671875,
            "text": "neurotensin (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.67578125,
            "text": "neurotensin (Nts",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.8046875,
            "text": "neurotensin (Nts) (angiocrine factors)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -8.0703125,
            "text": "neurotensin (Nts)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -9.75,
            "text": "neurotensin (Nts) (angiocrine factors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -9.8046875,
            "text": "neurotensin (Nts) (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.671875,
            "text": "Ccl4 and neurotensin (",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.67578125,
            "text": "Ccl4 and neurotensin (Nts",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.8046875,
            "text": "Ccl4 and neurotensin (Nts) (angiocrine factors)",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -8.0703125,
            "text": "Ccl4 and neurotensin (Nts)",
            "probability": 0.0
        },
        {
            "start_logit": -10.8984375,
            "end_logit": 7.26171875,
            "text": "and neurotensin",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -9.6640625,
            "text": "Ccl4 and",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -9.75,
            "text": "Ccl4 and neurotensin (Nts) (angiocrine factors",
            "probability": 0.0
        },
        {
            "start_logit": 4.65625,
            "end_logit": -9.8046875,
            "text": "Ccl4 and neurotensin (Nts) (",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": -7.67578125,
            "text": "Nts",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": -7.8046875,
            "text": "Nts) (angiocrine factors)",
            "probability": 0.0
        },
        {
            "start_logit": -9.8828125,
            "end_logit": -8.0703125,
            "text": "Nts)",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_2": [
        {
            "start_logit": 11.296875,
            "end_logit": 11.125,
            "text": "vascular endothelial growth factor",
            "probability": 1.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -0.509765625,
            "text": "vascular endothelial growth factor (VEGF",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 11.296875,
            "end_logit": -3.48046875,
            "text": "vascular endothelial growth factor (VEGF)-A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 11.296875,
            "end_logit": -6.4921875,
            "text": "vascular",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -7.328125,
            "text": "vascular endothelial growth factor (",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 11.125,
            "text": "growth factor",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 11.125,
            "text": "factor",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -8.3125,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor,",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -8.4921875,
            "text": "vascular endothelial",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.2109375,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor",
            "probability": 0.0
        },
        {
            "start_logit": -9.109375,
            "end_logit": 11.125,
            "text": "endothelial growth factor",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.3203125,
            "text": "vascular endothelial growth factor (VEGF)",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.40625,
            "text": "vascular endothelial growth",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -9.6640625,
            "text": "vascular endothelial growth factor (VEGF)-",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -10.0703125,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -10.3125,
            "text": "vascular endothelial growth factor (VEGF)-A was",
            "probability": 0.0
        },
        {
            "start_logit": 11.296875,
            "end_logit": -10.546875,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -0.509765625,
            "text": "VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -0.509765625,
            "text": "growth factor (VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -3.48046875,
            "text": "VEGF)-A",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_3": [
        {
            "start_logit": 13.21875,
            "end_logit": 13.2421875,
            "text": "tissue inhibitor of metalloproteinases-1",
            "probability": 1.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -2.87109375,
            "text": "tissue inhibitor of metalloproteinases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 13.21875,
            "end_logit": -3.451171875,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.21875,
            "end_logit": -4.11328125,
            "text": "tissue",
            "probability": 0.0
        },
        {
            "start_logit": -4.5625,
            "end_logit": 13.2421875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -5.765625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -6.36328125,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -6.41015625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -6.4765625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -6.8515625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1)",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -6.8984375,
            "text": "tissue inhibitor of metalloproteinases-",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -7.21875,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thromb",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -7.421875,
            "text": "tissue inhibitor of metalloproteinases-1 (",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -7.6015625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3)",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -8.2109375,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -8.3515625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombosp",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -8.4609375,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (TH",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -8.5390625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospond",
            "probability": 0.0
        },
        {
            "start_logit": 13.21875,
            "end_logit": -8.6328125,
            "text": "tissue inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -9.3515625,
            "end_logit": 13.2421875,
            "text": "inhibitor of metalloproteinases-1",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_4": [
        {
            "start_logit": 12.3359375,
            "end_logit": 12.484375,
            "text": "Slit2",
            "probability": 1.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -5.26953125,
            "text": "Slit",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 12.484375,
            "text": "2",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -7.3828125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -7.5703125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -8.0078125,
            "text": "Slit2, which is negatively regulated by endothelial Eph",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -8.2734375,
            "text": "Slit2,",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -8.59375,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -8.796875,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor,",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.1484375,
            "text": "Slit2, which is",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.4375,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angiocrine factor",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.5234375,
            "text": "Slit2, which is negatively regulated by endothelial",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.546875,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angiocrine factor.",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.578125,
            "text": "Slit2, which is negatively regulated by",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.5859375,
            "text": "Slit2, which",
            "probability": 0.0
        },
        {
            "start_logit": 12.3359375,
            "end_logit": -9.703125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.3828125,
            "text": "2, which is negatively regulated by endothelial EphA2",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.5703125,
            "text": "2, which is negatively regulated by endothelial EphA2 receptor",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -8.0078125,
            "text": "2, which is negatively regulated by endothelial Eph",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -8.2734375,
            "text": "2,",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_5": [
        {
            "start_logit": 13.6171875,
            "end_logit": 14.1953125,
            "text": "hepatocyte growth factor",
            "probability": 1.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -0.3486328125,
            "text": "hepatocyte growth factor (HGF",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -1.931640625,
            "text": "hepatocyte growth factor (HGF) and Wnt2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.556640625,
            "end_logit": 14.1953125,
            "text": "factor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -4.15234375,
            "text": "hepatocyte",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -5.97265625,
            "text": "hepatocyte growth factor (HGF) and Wnt",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -6.3984375,
            "text": "hepatocyte growth factor (",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 14.1953125,
            "text": "growth factor",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.9140625,
            "text": "hepatocyte growth factor (HGF)",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.6328125,
            "text": "hepatocyte growth factor (HGF) and",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.703125,
            "text": "hepatocyte growth",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -9.4609375,
            "text": "hepatocyte growth factor (HGF) and Wnt2.",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 14.1953125,
            "text": "angiocrine factors, including hepatocyte growth factor",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 14.1953125,
            "text": "ine factors, including hepatocyte growth factor",
            "probability": 0.0
        },
        {
            "start_logit": -10.9296875,
            "end_logit": 14.1953125,
            "text": "crine factors, including hepatocyte growth factor",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -0.3486328125,
            "text": "HGF",
            "probability": 0.0
        },
        {
            "start_logit": -3.556640625,
            "end_logit": -0.3486328125,
            "text": "factor (HGF",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -1.931640625,
            "text": "HGF) and Wnt2",
            "probability": 0.0
        },
        {
            "start_logit": -3.556640625,
            "end_logit": -1.931640625,
            "text": "factor (HGF) and Wnt2",
            "probability": 0.0
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -1.931640625,
            "text": "Wnt2",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_1": [
        {
            "start_logit": 12.5625,
            "end_logit": 12.171875,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 12.171875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -3.982421875,
            "text": "cataplexy, sleep paralysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -4.17578125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.015625,
            "end_logit": 12.171875,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -5.4453125,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.08984375,
            "text": "cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.13671875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.96484375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.421875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.3828125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.546875,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.75,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 12.171875,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.4375,
            "end_logit": 12.171875,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.171875,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.171875,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.171875,
            "text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -3.982421875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -4.17578125,
            "text": "excessive daytime sleepiness (EDS), cat",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_2": [
        {
            "start_logit": 10.953125,
            "end_logit": 9.1015625,
            "text": "excessive daytime sleepiness",
            "probability": 0.7119140625
        },
        {
            "start_logit": 10.953125,
            "end_logit": 7.75,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 0.182861328125
        },
        {
            "start_logit": 10.953125,
            "end_logit": 7.17578125,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 0.10260009765625
        },
        {
            "start_logit": 5.98828125,
            "end_logit": 7.75,
            "text": "cataplexy",
            "probability": 0.0012712478637695312
        },
        {
            "start_logit": 5.578125,
            "end_logit": 7.75,
            "text": "sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 0.00084686279296875
        },
        {
            "start_logit": 5.578125,
            "end_logit": 7.17578125,
            "text": "sleep paralysis",
            "probability": 0.0004749298095703125
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.08984375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and catapl",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.6953125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cat",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.71484375,
            "text": "excessive daytime sleepiness, sleep",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.7734375,
            "text": "excessive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -6.046875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -6.90234375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.953125,
            "end_logit": -7.1875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.1015625,
            "text": "sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.2734375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.5546875,
            "text": "excessive daytime sleepiness,",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.65625,
            "text": "excessive daytime",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.7421875,
            "text": "excessive daytime sleepiness, sleep paralysis,",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 0.0
        },
        {
            "start_logit": 5.98828125,
            "end_logit": -5.08984375,
            "text": "catapl",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_3": [
        {
            "start_logit": 12.5625,
            "end_logit": 12.171875,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 12.171875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -3.982421875,
            "text": "cataplexy, sleep paralysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -4.17578125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.015625,
            "end_logit": 12.171875,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -5.4453125,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.08984375,
            "text": "cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.13671875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.96484375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.421875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.3828125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.546875,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.75,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 12.171875,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.4375,
            "end_logit": 12.171875,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.171875,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.171875,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.171875,
            "text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -3.982421875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -4.17578125,
            "text": "excessive daytime sleepiness (EDS), cat",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_4": [
        {
            "start_logit": 14.8046875,
            "end_logit": 14.1640625,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": 2.95703125,
            "text": "excessive daytime sleepiness, cataplexy",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -1.37109375,
            "text": "excessive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -1.7939453125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.10546875,
            "end_logit": 14.1640625,
            "text": "sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -5.37890625,
            "text": "excessive daytime sleepiness, catapl",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -6.1328125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -6.3203125,
            "text": "excessive daytime sleepiness, cat",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -6.578125,
            "text": "excessive daytime sleepiness, cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -7.015625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted nighttime sleep",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -7.26171875,
            "text": "excessive daytime",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -8.40625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -8.75,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -8.8125,
            "text": "excessive daytime sleepiness,",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -9.1015625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagog",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -9.2578125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic",
            "probability": 0.0
        },
        {
            "start_logit": 14.8046875,
            "end_logit": -9.28125,
            "text": "excessive daytime sleepiness, cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": -9.71875,
            "end_logit": 14.1640625,
            "text": "Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 0.42236328125,
            "end_logit": 2.95703125,
            "text": "cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -2.10546875,
            "end_logit": 2.95703125,
            "text": "sleepiness, cataplexy",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_5": [
        {
            "start_logit": 10.953125,
            "end_logit": 9.1015625,
            "text": "excessive daytime sleepiness",
            "probability": 0.7119140625
        },
        {
            "start_logit": 10.953125,
            "end_logit": 7.75,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 0.182861328125
        },
        {
            "start_logit": 10.953125,
            "end_logit": 7.17578125,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 0.10260009765625
        },
        {
            "start_logit": 5.98828125,
            "end_logit": 7.75,
            "text": "cataplexy",
            "probability": 0.0012712478637695312
        },
        {
            "start_logit": 5.578125,
            "end_logit": 7.75,
            "text": "sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 0.00084686279296875
        },
        {
            "start_logit": 5.578125,
            "end_logit": 7.17578125,
            "text": "sleep paralysis",
            "probability": 0.0004749298095703125
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.08984375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and catapl",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.6953125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cat",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.71484375,
            "text": "excessive daytime sleepiness, sleep",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -5.7734375,
            "text": "excessive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -6.046875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 10.953125,
            "end_logit": -6.90234375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.953125,
            "end_logit": -7.1875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.1015625,
            "text": "sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.2734375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.5546875,
            "text": "excessive daytime sleepiness,",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.65625,
            "text": "excessive daytime",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.7421875,
            "text": "excessive daytime sleepiness, sleep paralysis,",
            "probability": 0.0
        },
        {
            "start_logit": 10.953125,
            "end_logit": -9.875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 0.0
        },
        {
            "start_logit": 5.98828125,
            "end_logit": -5.08984375,
            "text": "catapl",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_6": [
        {
            "start_logit": 12.5625,
            "end_logit": 12.171875,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 12.171875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -3.982421875,
            "text": "cataplexy, sleep paralysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -4.17578125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.015625,
            "end_logit": 12.171875,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -5.4453125,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.08984375,
            "text": "cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.13671875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.96484375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.421875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.3828125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.546875,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.75,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 12.171875,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.4375,
            "end_logit": 12.171875,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.171875,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.171875,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.171875,
            "text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -3.982421875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -4.17578125,
            "text": "excessive daytime sleepiness (EDS), cat",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_7": [
        {
            "start_logit": 12.5625,
            "end_logit": 12.171875,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 12.171875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -3.982421875,
            "text": "cataplexy, sleep paralysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.5625,
            "end_logit": -4.17578125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.015625,
            "end_logit": 12.171875,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -5.4453125,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -6.08984375,
            "text": "cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.13671875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -7.96484375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -8.421875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.3828125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.546875,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 12.5625,
            "end_logit": -9.75,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": -9.4140625,
            "end_logit": 12.171875,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.4375,
            "end_logit": 12.171875,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.8671875,
            "end_logit": 12.171875,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.9765625,
            "end_logit": 12.171875,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -10.0859375,
            "end_logit": 12.171875,
            "text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -3.982421875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": -4.17578125,
            "text": "excessive daytime sleepiness (EDS), cat",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_8": [
        {
            "start_logit": 14.8984375,
            "end_logit": 14.4296875,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": 2.01953125,
            "text": "excessive daytime sleepiness, cataplexy",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -0.900390625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -1.26171875,
            "text": "excessive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.984375,
            "end_logit": 14.4296875,
            "text": "sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -4.5703125,
            "text": "excessive daytime sleepiness, cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -4.734375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -4.9375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted nig",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -5.640625,
            "text": "excessive daytime sleepiness, catapl",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -6.67578125,
            "text": "excessive daytime sleepiness, cat",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -7.17578125,
            "text": "excessive daytime",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -7.671875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopo",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.015625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.0703125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.28125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagog",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.28125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.390625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.6015625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 14.8984375,
            "end_logit": -8.8203125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopomp",
            "probability": 0.0
        },
        {
            "start_logit": -10.0703125,
            "end_logit": 14.4296875,
            "text": "Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_9": [
        {
            "start_logit": 11.5625,
            "end_logit": 11.3046875,
            "text": "cataplexy",
            "probability": 0.94482421875
        },
        {
            "start_logit": 8.71875,
            "end_logit": 11.3046875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.054962158203125
        },
        {
            "start_logit": 8.71875,
            "end_logit": 2.88671875,
            "text": "excessive daytime sleepiness",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": 11.5625,
            "end_logit": -3.474609375,
            "text": "cataplexy, sleep paralysis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 11.5625,
            "end_logit": -4.77734375,
            "text": "cat",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 11.5625,
            "end_logit": -5.609375,
            "text": "cataplexy, sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.546875,
            "end_logit": 11.3046875,
            "text": "exy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.5625,
            "end_logit": -6.00390625,
            "text": "catapl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.71875,
            "end_logit": -3.474609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -6.41015625,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed noctur",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -7.33984375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -4.77734375,
            "text": "excessive daytime sleepiness (EDS), cat",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -7.65234375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed noct",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -8.4375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -5.609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.00390625,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -9.1875,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.41015625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed noctur",
            "probability": 0.0
        },
        {
            "start_logit": 11.5625,
            "end_logit": -9.3984375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 0.0
        },
        {
            "start_logit": -9.2265625,
            "end_logit": 11.3046875,
            "text": "EDS), cataplexy",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_10": [
        {
            "start_logit": 13.4140625,
            "end_logit": 12.8828125,
            "text": "excessive daytime sleepiness",
            "probability": 0.994140625
        },
        {
            "start_logit": 13.4140625,
            "end_logit": 7.76171875,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 0.00591278076171875
        },
        {
            "start_logit": 6.6015625,
            "end_logit": 7.76171875,
            "text": "sleep paralysis",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -3.8125,
            "text": "excessive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.203125,
            "end_logit": 12.8828125,
            "text": "sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -5.546875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -6.14453125,
            "text": "excessive daytime sleepiness, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -6.29296875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -7.59765625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, an",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.0546875,
            "text": "excessive daytime",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.2890625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations,",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.5078125,
            "text": "excessive daytime sleepiness, sleep paralysis,",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.5390625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.6171875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.7109375,
            "text": "excessive daytime sleepiness,",
            "probability": 0.0
        },
        {
            "start_logit": -4.203125,
            "end_logit": 7.76171875,
            "text": "sleepiness, sleep paralysis",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-",
            "probability": 0.0
        },
        {
            "start_logit": 13.4140625,
            "end_logit": -9.953125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation,",
            "probability": 0.0
        },
        {
            "start_logit": -9.8203125,
            "end_logit": 12.8828125,
            "text": "Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": -9.9921875,
            "end_logit": 12.8828125,
            "text": "daytime sleepiness",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_11": [
        {
            "start_logit": 12.234375,
            "end_logit": 11.78125,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": 4.0078125,
            "end_logit": 11.78125,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0002675056457519531
        },
        {
            "start_logit": 12.234375,
            "end_logit": -2.38671875,
            "text": "cataplexy, sleep paralysis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 12.234375,
            "end_logit": -4.55078125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.234375,
            "end_logit": -4.85546875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed no",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.234375,
            "end_logit": -5.01171875,
            "text": "cataplexy, sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.3671875,
            "end_logit": 11.78125,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -5.8671875,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -6.3984375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.4453125,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 4.0078125,
            "end_logit": -0.43603515625,
            "text": "excessive daytime sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.953125,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.9765625,
            "text": "cataplexy, sleep paralysis, hypnagogic",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -9.03125,
            "text": "cataplexy, sleep paralysis, hypnagog",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -9.078125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 11.78125,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 11.78125,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": 11.78125,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 11.78125,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_12": [
        {
            "start_logit": 12.234375,
            "end_logit": 11.78125,
            "text": "cataplexy",
            "probability": 1.0
        },
        {
            "start_logit": 4.0078125,
            "end_logit": 11.78125,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 0.0002675056457519531
        },
        {
            "start_logit": 12.234375,
            "end_logit": -2.38671875,
            "text": "cataplexy, sleep paralysis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 12.234375,
            "end_logit": -4.55078125,
            "text": "cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.234375,
            "end_logit": -4.85546875,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed no",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 12.234375,
            "end_logit": -5.01171875,
            "text": "cataplexy, sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.3671875,
            "end_logit": 11.78125,
            "text": "exy",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -5.8671875,
            "text": "catapl",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -6.3984375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.375,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.4453125,
            "text": "cataplexy, sleep paralysis, hypn",
            "probability": 0.0
        },
        {
            "start_logit": 4.0078125,
            "end_logit": -0.43603515625,
            "text": "excessive daytime sleepiness",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.953125,
            "text": "cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -8.9765625,
            "text": "cataplexy, sleep paralysis, hypnagogic",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -9.03125,
            "text": "cataplexy, sleep paralysis, hypnagog",
            "probability": 0.0
        },
        {
            "start_logit": 12.234375,
            "end_logit": -9.078125,
            "text": "cataplexy,",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 11.78125,
            "text": "EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 11.78125,
            "text": ", cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.65625,
            "end_logit": 11.78125,
            "text": "daytime sleepiness (EDS), cataplexy",
            "probability": 0.0
        },
        {
            "start_logit": -9.7109375,
            "end_logit": 11.78125,
            "text": "sleepiness (EDS), cataplexy",
            "probability": 0.0
        }
    ],
    "515bd543298dcd4e51000001_1": [
        {
            "start_logit": 8.0625,
            "end_logit": 5.37109375,
            "text": "H2",
            "probability": 1.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.4140625,
            "text": "H2 isochores",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -3.8359375,
            "end_logit": 5.37109375,
            "text": "GC, but attains a maximum in H2",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.83984375,
            "text": "H2 isochores, in agreement with previous experimental data",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.3828125,
            "text": "H2 isocho",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.6484375,
            "text": "H2 isochores, in",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.7265625,
            "text": "H2 isochores, in agreement",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -9.21875,
            "text": "H2 isochores,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -9.359375,
            "text": "H2 isochores, in agreement with",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 5.37109375,
            "text": "increasing GC, but attains a maximum in H2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.8359375,
            "end_logit": 1.96875,
            "text": "GC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 1.96875,
            "text": "increasing GC",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 5.37109375,
            "text": "with increasing GC, but attains a maximum in H2",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 5.37109375,
            "text": "Alu sequences also increases with increasing GC, but attains a maximum in H2",
            "probability": 0.0
        },
        {
            "start_logit": -10.953125,
            "end_logit": 5.37109375,
            "text": "but attains a maximum in H2",
            "probability": 0.0
        },
        {
            "start_logit": -10.7265625,
            "end_logit": 1.96875,
            "text": "with increasing GC",
            "probability": 0.0
        },
        {
            "start_logit": -10.796875,
            "end_logit": 1.96875,
            "text": "Alu sequences also increases with increasing GC",
            "probability": 0.0
        },
        {
            "start_logit": -3.8359375,
            "end_logit": -6.19140625,
            "text": "GC, but attains a maximum",
            "probability": 0.0
        },
        {
            "start_logit": -3.8359375,
            "end_logit": -6.4140625,
            "text": "GC, but attains a maximum in H2 isochores",
            "probability": 0.0
        },
        {
            "start_logit": -3.8359375,
            "end_logit": -7.83984375,
            "text": "GC, but attains a maximum in H2 isochores, in agreement with previous experimental data",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_1": [
        {
            "start_logit": 14.0625,
            "end_logit": 14.21875,
            "text": "antisocial personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -3.0,
            "text": "antisocial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.2109375,
            "end_logit": 14.21875,
            "text": "disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 14.0625,
            "end_logit": -6.1953125,
            "text": "antisocial personality disorder and high psychopathic",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -6.53125,
            "text": "antisocial personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": 14.21875,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -8.609375,
            "text": "antisocial personality disorder and high psychopathic traits",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -8.875,
            "text": "antisocial personality disorder and high psychopath",
            "probability": 0.0
        },
        {
            "start_logit": -9.3046875,
            "end_logit": 14.21875,
            "text": "violent offenders with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": 14.21875,
            "text": "offenders with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -9.53125,
            "text": "antisocial personality disorder and high psycho",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -9.5390625,
            "text": "antisocial personality disorder and",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -9.6953125,
            "text": "antisocial personality disorder and high psychopathic traits.",
            "probability": 0.0
        },
        {
            "start_logit": -10.0,
            "end_logit": 14.21875,
            "text": "amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.0625,
            "end_logit": -9.8828125,
            "text": "antisocial personality disorder and high",
            "probability": 0.0
        },
        {
            "start_logit": -10.1796875,
            "end_logit": 14.21875,
            "text": "monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.3671875,
            "end_logit": 14.21875,
            "text": "with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -3.2109375,
            "end_logit": -6.1953125,
            "text": "disorder and high psychopathic",
            "probability": 0.0
        },
        {
            "start_logit": -3.2109375,
            "end_logit": -8.609375,
            "text": "disorder and high psychopathic traits",
            "probability": 0.0
        },
        {
            "start_logit": -3.2109375,
            "end_logit": -8.875,
            "text": "disorder and high psychopath",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_2": [
        {
            "start_logit": 13.3125,
            "end_logit": 13.5078125,
            "text": "Borderline Personality Disorder",
            "probability": 1.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -3.63671875,
            "text": "Borderline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.484375,
            "end_logit": 13.5078125,
            "text": "Disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -7.41796875,
            "text": "Borderline Personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 13.5078125,
            "text": "Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 13.5078125,
            "text": "Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.3125,
            "end_logit": -9.3828125,
            "text": "Borderline Personality Disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": 13.5078125,
            "text": "Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": 13.5078125,
            "text": "Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": 13.5078125,
            "text": "Abuse Predict Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.5078125,
            "text": "Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": 13.5078125,
            "text": "and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -3.63671875,
            "text": "Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.1171875,
            "end_logit": -3.63671875,
            "text": "Childhood Abuse Predict Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.2109375,
            "end_logit": -3.63671875,
            "text": "Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -4.484375,
            "end_logit": -9.3828125,
            "text": "Disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.5078125,
            "end_logit": -3.63671875,
            "text": "Abuse Predict Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": -3.63671875,
            "text": "Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.828125,
            "end_logit": -3.63671875,
            "text": "and Childhood Abuse Predict Impulsiveness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.09375,
            "text": "Impulsiveness",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_3": [
        {
            "start_logit": 12.96875,
            "end_logit": 13.3359375,
            "text": "Borderline Personality Disorder",
            "probability": 1.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -3.53125,
            "text": "Borderline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.52734375,
            "end_logit": 13.3359375,
            "text": "Disorder",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -7.5,
            "text": "Borderline Personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 13.3359375,
            "text": "Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.3046875,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.515625,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.5234375,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": 13.3359375,
            "text": "Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.6640625,
            "text": "Borderline Personality Disorder Is Associated With Severity",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.71875,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.78125,
            "text": "Borderline Personality Disorder Is",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.796875,
            "text": "Borderline Personality Disorder Is Associated",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.8984375,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.9296875,
            "text": "Borderline Personality Disorder Is Associated With",
            "probability": 0.0
        },
        {
            "start_logit": 12.96875,
            "end_logit": -9.9453125,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood",
            "probability": 0.0
        },
        {
            "start_logit": -10.6015625,
            "end_logit": 13.3359375,
            "text": "Distribution Volume in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 13.3359375,
            "text": "Oxidase-A Distribution Volume in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.7421875,
            "end_logit": 13.3359375,
            "text": "Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.9296875,
            "end_logit": -3.53125,
            "text": "Monoamine Oxidase-A Distribution Volume in Borderline",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_4": [
        {
            "start_logit": 12.2734375,
            "end_logit": 12.5625,
            "text": "borderline personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -3.935546875,
            "text": "borderline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 12.5625,
            "text": "disorder",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -6.68359375,
            "text": "borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 12.5625,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 12.2734375,
            "end_logit": -9.109375,
            "text": "borderline personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": 12.5625,
            "text": "Monoamine oxidase a gene is associated with borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": 12.5625,
            "text": "oxidase a gene is associated with borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -9.109375,
            "text": "disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -3.935546875,
            "text": "Monoamine oxidase a gene is associated with borderline",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": -3.935546875,
            "text": "oxidase a gene is associated with borderline",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -6.68359375,
            "text": "personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -9.109375,
            "text": "personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -6.68359375,
            "text": "Monoamine oxidase a gene is associated with borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": -6.68359375,
            "text": "oxidase a gene is associated with borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -8.5546875,
            "text": "Monoamine oxidase a gene is associated with",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": -8.5546875,
            "text": "oxidase a gene is associated with",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -9.109375,
            "text": "Monoamine oxidase a gene is associated with borderline personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.859375,
            "end_logit": -9.203125,
            "text": "Monoamine oxidase a gene is associated",
            "probability": 0.0
        },
        {
            "start_logit": -11.0390625,
            "end_logit": -9.109375,
            "text": "oxidase a gene is associated with borderline personality disorder.",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_5": [
        {
            "start_logit": 13.1171875,
            "end_logit": 13.40625,
            "text": "borderline personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -3.75,
            "text": "borderline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.2734375,
            "end_logit": 13.40625,
            "text": "disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -7.49609375,
            "text": "borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 13.40625,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 13.40625,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 13.40625,
            "text": "impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": 13.40625,
            "text": "suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": 13.40625,
            "text": "monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 13.40625,
            "text": "mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 13.1171875,
            "end_logit": -9.921875,
            "text": "borderline personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": 13.40625,
            "text": "liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": 13.40625,
            "text": "oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -3.75,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -3.75,
            "text": "impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -9.6328125,
            "end_logit": -3.75,
            "text": "suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -9.96875,
            "end_logit": -3.75,
            "text": "monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -3.75,
            "text": "mood liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.2734375,
            "end_logit": -3.75,
            "text": "liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.328125,
            "end_logit": -3.75,
            "text": "oxidase A can be considered a functional candidate in borderline",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_6": [
        {
            "start_logit": 11.5390625,
            "end_logit": 11.5390625,
            "text": "borderline personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 11.5390625,
            "end_logit": -4.19921875,
            "text": "borderline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 11.5390625,
            "text": "disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 11.5390625,
            "end_logit": -6.68359375,
            "text": "borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 11.5390625,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 11.5390625,
            "text": "etiological development of the borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": 11.5390625,
            "text": "monoamine oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": 11.5390625,
            "text": "oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": 11.5390625,
            "text": "an important role in the etiological development of the borderline personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -4.19921875,
            "text": "etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -6.68359375,
            "text": "personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -4.19921875,
            "text": "monoamine oxidase A gene may play an important role in the etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -4.19921875,
            "text": "oxidase A gene may play an important role in the etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -4.19921875,
            "text": "an important role in the etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -6.68359375,
            "text": "etiological development of the borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -6.68359375,
            "text": "monoamine oxidase A gene may play an important role in the etiological development of the borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.7890625,
            "end_logit": -6.68359375,
            "text": "oxidase A gene may play an important role in the etiological development of the borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.890625,
            "end_logit": -6.68359375,
            "text": "an important role in the etiological development of the borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -10.3203125,
            "end_logit": -8.453125,
            "text": "monoamine oxidase A gene may",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -8.9375,
            "text": "etiological development of the",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_7": [
        {
            "start_logit": 14.125,
            "end_logit": 13.9453125,
            "text": "antisocial personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -2.708984375,
            "text": "antisocial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.77734375,
            "end_logit": 13.9453125,
            "text": "disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -6.51171875,
            "text": "antisocial personality",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 13.9453125,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -9.1953125,
            "text": "antisocial personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": 13.9453125,
            "text": "Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": 13.9453125,
            "text": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": 13.9453125,
            "text": "interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": 13.9453125,
            "text": "Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": 13.9453125,
            "text": "transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": 13.9453125,
            "text": "variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -9.1953125,
            "text": "disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -10.265625,
            "end_logit": -2.708984375,
            "text": "Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.359375,
            "end_logit": -2.708984375,
            "text": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.640625,
            "end_logit": -2.708984375,
            "text": "interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.6953125,
            "end_logit": -2.708984375,
            "text": "Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.734375,
            "end_logit": -2.708984375,
            "text": "transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.7734375,
            "end_logit": -2.708984375,
            "text": "variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -6.51171875,
            "text": "personality",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_8": [
        {
            "start_logit": 14.3203125,
            "end_logit": 14.140625,
            "text": "antisocial personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 14.3203125,
            "end_logit": -2.580078125,
            "text": "antisocial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.51171875,
            "end_logit": 14.140625,
            "text": "disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.3203125,
            "end_logit": -6.9609375,
            "text": "antisocial personality",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": 14.140625,
            "text": "personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": 14.3203125,
            "end_logit": -9.5546875,
            "text": "antisocial personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": 14.140625,
            "text": "offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": 14.140625,
            "text": "Monoamine oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": 14.140625,
            "text": "methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": 14.140625,
            "text": "an offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": 14.140625,
            "text": "promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.484375,
            "end_logit": 14.140625,
            "text": "oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.5703125,
            "end_logit": 14.140625,
            "text": "population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -10.59375,
            "end_logit": 14.140625,
            "text": "ender population with antisocial personality disorder",
            "probability": 0.0
        },
        {
            "start_logit": -9.515625,
            "end_logit": -2.580078125,
            "text": "offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -9.84375,
            "end_logit": -2.580078125,
            "text": "Monoamine oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -9.9453125,
            "end_logit": -2.580078125,
            "text": "methylation and transcriptional downregulation in an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.0390625,
            "end_logit": -2.580078125,
            "text": "an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -10.25,
            "end_logit": -2.580078125,
            "text": "promoter methylation and transcriptional downregulation in an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -3.51171875,
            "end_logit": -9.5546875,
            "text": "disorder.",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_1": [
        {
            "start_logit": 13.0625,
            "end_logit": 13.5625,
            "text": "BETAWARE",
            "probability": 1.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": 13.5625,
            "text": "WARE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.0625,
            "end_logit": -4.8671875,
            "text": "BETA",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -5.875,
            "text": "BETAWARE: a machine-learning tool",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -7.015625,
            "text": "BETAWARE: a machine-learning",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -7.515625,
            "text": "BETAWARE: a machine",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.0234375,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotes",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.4765625,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.546875,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.609375,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.8125,
            "text": "BETAWARE: a machine-",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.8515625,
            "text": "BETAWARE: a machine-learning tool to detect and predict",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.8515625,
            "text": "BETAWARE:",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.90625,
            "text": "BETAWARE: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -9.9765625,
            "text": "BETAWARE: a machine-learning tool to",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -10.078125,
            "text": "BETAWARE: a machine-learning tool to detect",
            "probability": 0.0
        },
        {
            "start_logit": 13.0625,
            "end_logit": -10.09375,
            "text": "BETAWARE: a machine-learning tool to detect and",
            "probability": 0.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": -5.875,
            "text": "WARE: a machine-learning tool",
            "probability": 0.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": -7.015625,
            "text": "WARE: a machine-learning",
            "probability": 0.0
        },
        {
            "start_logit": -4.2109375,
            "end_logit": -7.515625,
            "text": "WARE: a machine",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_2": [
        {
            "start_logit": 8.40625,
            "end_logit": 10.5859375,
            "text": "machine-learning approaches",
            "probability": 1.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -2.111328125,
            "text": "machine-learning",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 11.53125,
            "text": "methods",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 10.5859375,
            "text": "methods based on machine-learning approaches",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 10.5859375,
            "text": "based on machine-learning approaches",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.5859375,
            "text": "approaches",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.6875,
            "end_logit": 11.53125,
            "text": "top-performing methods",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.6875,
            "end_logit": 11.53125,
            "text": "performing methods",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -9.4453125,
            "end_logit": 10.5859375,
            "text": "on machine-learning approaches",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.4609375,
            "text": "machine",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 10.5859375,
            "text": "top-performing methods based on machine-learning approaches",
            "probability": 0.0
        },
        {
            "start_logit": -9.6875,
            "end_logit": 10.5859375,
            "text": "performing methods based on machine-learning approaches",
            "probability": 0.0
        },
        {
            "start_logit": -9.890625,
            "end_logit": 10.5859375,
            "text": "-learning approaches",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.8515625,
            "text": "machine-learning approaches to tackle both the detection of TMBBs in sets of proteins and the prediction of their topology. Here, we present our BETA",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -9.171875,
            "text": "machine-learning approaches to tackle both the detection of TMBBs",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -9.296875,
            "text": "machine-learning approaches to tackle both the detection of TMBBs in sets of proteins",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -9.75,
            "text": "machine-",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -9.921875,
            "text": "machine-learning approaches to tackle both the detection of TMBBs in sets of proteins and the prediction of their topology",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -10.0859375,
            "text": "machine-learning approaches to tackle both the detection of TMBBs in sets of proteins and the prediction of their topology. Here",
            "probability": 0.0
        },
        {
            "start_logit": 8.40625,
            "end_logit": -10.1875,
            "text": "machine-learning approaches to tackle both the detection of TMBB",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_3": [
        {
            "start_logit": 13.6640625,
            "end_logit": 13.609375,
            "text": "BOCTOPUS",
            "probability": 1.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -4.078125,
            "text": "BOC",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": 13.609375,
            "text": "US",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.390625,
            "text": "BOCTO",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.8046875,
            "text": "BOCTOP",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -8.6015625,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2 barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": -9.1015625,
            "end_logit": 13.609375,
            "text": "TOPUS",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.1875,
            "text": "BOCTOPUS: improved topology",
            "probability": 0.0
        },
        {
            "start_logit": -9.265625,
            "end_logit": 13.609375,
            "text": "PUS",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.359375,
            "text": "BOCTOPUS:",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.4296875,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2 barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.515625,
            "text": "BOCTOPUS: improved topology prediction",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.1640625,
            "text": "BOCTOPUS: improved topology prediction of",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.1953125,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.28125,
            "text": "BOCTOPUS: improved topology prediction of transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.3671875,
            "text": "BOCTOPUS: improved",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -8.6015625,
            "text": "US: improved topology prediction of transmembrane \u03b2 barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -9.1875,
            "text": "US: improved topology",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -9.359375,
            "text": "US:",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -9.4296875,
            "text": "US: improved topology prediction of transmembrane \u03b2 barrel",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_4": [
        {
            "start_logit": 13.625,
            "end_logit": 13.6015625,
            "text": "TMBHMM",
            "probability": 1.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -1.271484375,
            "text": "TMBHMM: a frequency profile based HMM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 13.625,
            "end_logit": -4.33203125,
            "text": "TM",
            "probability": 0.0
        },
        {
            "start_logit": -4.6796875,
            "end_logit": 13.6015625,
            "text": "MM",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -5.9921875,
            "text": "TMB",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -6.05859375,
            "text": "TMBHMM: a frequency profile based HM",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -7.890625,
            "text": "TMBHMM: a frequency",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -7.890625,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status of transmembrane residues",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.0390625,
            "text": "TMBHMM: a frequency profile",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.0625,
            "text": "TMBH",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.265625,
            "text": "TMBHMM: a frequency profile based",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 13.6015625,
            "text": "HMM",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -8.9140625,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.0859375,
            "text": "TMBHMM: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.1796875,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.3203125,
            "text": "TMBHMM: a frequency profile based HMM for",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.34375,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.359375,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.4375,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.625,
            "end_logit": -9.6640625,
            "text": "TMBHMM:",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_5": [
        {
            "start_logit": 14.046875,
            "end_logit": 13.953125,
            "text": "TMBHMM",
            "probability": 1.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -3.84375,
            "text": "TM",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -3.90234375,
            "text": "TMBHMM, a computational method based on a hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": 13.953125,
            "text": "MM",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -5.2890625,
            "text": "TMB",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -7.19140625,
            "text": "TMBHMM, a computational method based on a hidden Markov",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -7.62890625,
            "text": "TMBH",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.7578125,
            "text": "TMBHMM, a computational method",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.765625,
            "text": "TMBHMM, a computational method based on a hidden",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": 13.953125,
            "text": "HMM",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.046875,
            "text": "TMBHMM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.125,
            "text": "TMBHMM, a computational method based on a hidden Markov model for predicting the structural topology",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -3.90234375,
            "text": "MM, a computational method based on a hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -7.19140625,
            "text": "MM, a computational method based on a hidden Markov",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -3.90234375,
            "text": "hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": -3.90234375,
            "text": "HMM, a computational method based on a hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -8.703125,
            "text": "MM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence. In addition to predicting transmembrane strands",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -8.7578125,
            "text": "MM, a computational method",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -8.765625,
            "text": "MM, a computational method based on a hidden",
            "probability": 0.0
        },
        {
            "start_logit": -9.2734375,
            "end_logit": -3.90234375,
            "text": "computational method based on a hidden Markov model",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_6": [
        {
            "start_logit": 12.703125,
            "end_logit": 13.1171875,
            "text": "BTMX",
            "probability": 1.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": 13.1171875,
            "text": "X",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -5.32421875,
            "text": "BT",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -6.1640625,
            "text": "BTMX (Beta barrel TransMembrane eXposure)",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -7.26171875,
            "text": "BTM",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -7.78125,
            "text": "BTMX (",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 13.1171875,
            "text": "MX",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.03125,
            "text": "BTMX (Beta barrel",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.5,
            "text": "BTMX (Beta barrel TransMembrane eXposure",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.6796875,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.734375,
            "text": "BTMX (Beta barrel TransMembrane eXposure),",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -8.8125,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.0,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer or hidden",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.3515625,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed",
            "probability": 0.0
        },
        {
            "start_logit": 12.703125,
            "end_logit": -9.4453125,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer or",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -6.1640625,
            "text": "X (Beta barrel TransMembrane eXposure)",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -7.78125,
            "text": "X (",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -8.03125,
            "text": "X (Beta barrel",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -8.5,
            "text": "X (Beta barrel TransMembrane eXposure",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -8.6796875,
            "text": "X (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_7": [
        {
            "start_logit": 14.046875,
            "end_logit": 13.625,
            "text": "TMBETAPRED-RBF",
            "probability": 1.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -3.513671875,
            "text": "TM",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.53125,
            "end_logit": 13.625,
            "text": "RBF",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -5.828125,
            "text": "TMBETAPRED",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -7.25,
            "text": "TMBETAPRED-",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.40625,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.546875,
            "text": "TMBETA",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.765625,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.859375,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -8.9140625,
            "text": "TMBETAPRE",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.0546875,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http://rbf",
            "probability": 0.0
        },
        {
            "start_logit": -8.71875,
            "end_logit": 13.625,
            "text": "PRED-RBF",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.3203125,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.4609375,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands",
            "probability": 0.0
        },
        {
            "start_logit": 14.046875,
            "end_logit": -9.4921875,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http",
            "probability": 0.0
        },
        {
            "start_logit": -9.2890625,
            "end_logit": 13.625,
            "text": "BETAPRED-RBF",
            "probability": 0.0
        },
        {
            "start_logit": -9.90625,
            "end_logit": 13.625,
            "text": "web server, TMBETAPRED-RBF",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 13.625,
            "text": "D-RBF",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -5.95703125,
            "text": "tmrbf.html",
            "probability": 0.0
        },
        {
            "start_logit": -4.53125,
            "end_logit": -8.40625,
            "text": "RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http:/",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_8": [
        {
            "start_logit": 12.9453125,
            "end_logit": 13.4140625,
            "text": "TMBpro",
            "probability": 1.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -3.7578125,
            "text": "TMBpro: secondary structure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 13.4140625,
            "text": "ro",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -5.1875,
            "text": "TM",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -5.9609375,
            "text": "TMBpro: secondary structure, beta-contact",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -6.48046875,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -7.52734375,
            "text": "TMBp",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -7.9375,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.015625,
            "text": "TMBpro: secondary structure, beta-",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 13.4140625,
            "text": "Bpro",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.75,
            "text": "TMBpro: secondary",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.7890625,
            "text": "TMBpro: secondary structure, beta",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -8.8046875,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.140625,
            "text": "TMBpro: secondary structure, beta-contact and",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.2265625,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.3984375,
            "text": "TMBpro:",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.8515625,
            "text": "TMBpro: secondary structure, beta-contact and tertiary",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -9.9453125,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-",
            "probability": 0.0
        },
        {
            "start_logit": 12.9453125,
            "end_logit": -10.0,
            "text": "TMBpro: secondary structure,",
            "probability": 0.0
        },
        {
            "start_logit": -4.57421875,
            "end_logit": -3.7578125,
            "text": "ro: secondary structure",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_9": [
        {
            "start_logit": 10.8515625,
            "end_logit": 11.5390625,
            "text": "TMBpro",
            "probability": 1.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": 2.990234375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure",
            "probability": 0.00019419193267822266
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -3.572265625,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 2.56640625,
            "end_logit": 2.990234375,
            "text": "secondary structure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 11.5390625,
            "text": "ro",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -6.5234375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro-CON",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -6.59375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -6.83984375,
            "text": "TM",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.390625,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS)",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.48828125,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.4921875,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -7.75390625,
            "text": "TMBpro) of specialized predictors",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.09375,
            "text": "TMBp",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.609375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBp",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.7265625,
            "text": "TMBpro)",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.78125,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TM",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 11.5390625,
            "text": "Bpro",
            "probability": 0.0
        },
        {
            "start_logit": 10.8515625,
            "end_logit": -8.9609375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-",
            "probability": 0.0
        },
        {
            "start_logit": 2.56640625,
            "end_logit": -3.572265625,
            "text": "secondary structure (TMBpro-SS",
            "probability": 0.0
        },
        {
            "start_logit": 2.56640625,
            "end_logit": -3.939453125,
            "text": "secondary structure (TMBpro-SS), beta-contacts (TMBpro-CON) and tertiary structure (TMBpro-3D",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_10": [
        {
            "start_logit": 13.46875,
            "end_logit": 13.6171875,
            "text": "BOCTOPUS",
            "probability": 1.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -4.41796875,
            "text": "BOC",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 13.6171875,
            "text": "US",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -4.66015625,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVM",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -5.515625,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -6.37109375,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -6.65625,
            "text": "BOCTO",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.08203125,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs)",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.41796875,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.671875,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and Hidden Markov",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.73828125,
            "text": "BOCTOP",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -7.85546875,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector",
            "probability": 0.0
        },
        {
            "start_logit": 13.46875,
            "end_logit": -8.4765625,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs",
            "probability": 0.0
        },
        {
            "start_logit": -8.9921875,
            "end_logit": 13.6171875,
            "text": "PUS",
            "probability": 0.0
        },
        {
            "start_logit": -9.28125,
            "end_logit": 13.6171875,
            "text": "TOPUS",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -4.66015625,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVM",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -4.765625,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and Hidden Markov Models",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -4.765625,
            "text": "Hidden Markov Models",
            "probability": 0.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -4.66015625,
            "text": "support vector machines (SVM",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -5.00390625,
            "text": "Hidden Markov Models (HMMs",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_11": [
        {
            "start_logit": 13.671875,
            "end_logit": 13.375,
            "text": "PRED-TMBB",
            "probability": 1.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -3.6484375,
            "text": "PRED",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 13.375,
            "text": "BB",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -6.77734375,
            "text": "PRED-TM",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -7.87890625,
            "text": "PRED-",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.109375,
            "text": "PRED-TMBB: a web server",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -8.6171875,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 13.375,
            "text": "TMBB",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.40625,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.5546875,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.6328125,
            "text": "PRED-TMBB: a web server for predicting the topology",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.859375,
            "text": "PRED-TMBB:",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -9.9375,
            "text": "PRED-TMBB: a web",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -10.0078125,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -10.0546875,
            "text": "PRED-TMBB: a web server for",
            "probability": 0.0
        },
        {
            "start_logit": 13.671875,
            "end_logit": -10.09375,
            "text": "PRED-TMBB: a web server for predicting the topology of",
            "probability": 0.0
        },
        {
            "start_logit": -4.8515625,
            "end_logit": -8.109375,
            "text": "BB: a web server",
            "probability": 0.0
        },
        {
            "start_logit": -4.8515625,
            "end_logit": -8.6171875,
            "text": "BB: a web server for predicting the topology of beta-barrel outer membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.8515625,
            "end_logit": -9.40625,
            "text": "BB: a web server for predicting the topology of beta-barrel outer membrane",
            "probability": 0.0
        },
        {
            "start_logit": -4.8515625,
            "end_logit": -9.5546875,
            "text": "BB: a web server for predicting the topology of beta-barrel",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_12": [
        {
            "start_logit": 13.953125,
            "end_logit": 13.4609375,
            "text": "PRED-TMBB",
            "probability": 1.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -3.4921875,
            "text": "PRED",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 13.4609375,
            "text": "BB",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -7.47265625,
            "text": "PRED-TM",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -8.3203125,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa.gr/PRED-TMBB",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -8.4453125,
            "text": "PRED-",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -8.8671875,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa.gr",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.1640625,
            "text": "PRED-TMBB, http:/",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.1875,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.2578125,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa.gr/PRED-TMBB)",
            "probability": 0.0
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 13.4609375,
            "text": "TMBB",
            "probability": 0.0
        },
        {
            "start_logit": 13.953125,
            "end_logit": -9.3515625,
            "text": "PRED-TMBB,",
            "probability": 0.0
        },
        {
            "start_logit": -4.390625,
            "end_logit": -2.40234375,
            "text": "Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -4.390625,
            "end_logit": -5.84375,
            "text": "Hidden Markov Model, trained according to the Conditional Maximum Likelihood",
            "probability": 0.0
        },
        {
            "start_logit": -4.390625,
            "end_logit": -7.0859375,
            "text": "Hidden Markov Model, trained according to the Conditional Maximum Likelihood criterion",
            "probability": 0.0
        },
        {
            "start_logit": -9.2578125,
            "end_logit": -2.40234375,
            "text": "Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": -2.40234375,
            "text": "Model",
            "probability": 0.0
        },
        {
            "start_logit": -9.3984375,
            "end_logit": -2.40234375,
            "text": "outer membrane proteins of Gram-negative bacteria. The method is based on a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -9.609375,
            "end_logit": -2.40234375,
            "text": "transmembrane strands and the topology of beta-barrel outer membrane proteins of Gram-negative bacteria. The method is based on a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -9.7578125,
            "end_logit": -2.40234375,
            "text": "topology of beta-barrel outer membrane proteins of Gram-negative bacteria. The method is based on a Hidden Markov Model",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_13": [
        {
            "start_logit": 13.6640625,
            "end_logit": 13.75,
            "text": "TBBPred",
            "probability": 1.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": 13.75,
            "text": "red",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -4.484375,
            "text": "TB",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -6.88671875,
            "text": "TBBP",
            "probability": 0.0
        },
        {
            "start_logit": -8.7890625,
            "end_logit": 13.75,
            "text": "BPred",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.171875,
            "text": "TBBPred,",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.4296875,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.578125,
            "text": "TBBPred, for predicting transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -9.9140625,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions",
            "probability": 0.0
        },
        {
            "start_logit": -10.1015625,
            "end_logit": 13.75,
            "text": "Web server, TBBPred",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.109375,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.2578125,
            "text": "TBBPred, for predicting transmembrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.6640625,
            "end_logit": -10.296875,
            "text": "TBBPred, for predicting transmembrane beta-",
            "probability": 0.0
        },
        {
            "start_logit": -10.578125,
            "end_logit": 13.75,
            "text": "developed a Web server, TBBPred",
            "probability": 0.0
        },
        {
            "start_logit": -10.6328125,
            "end_logit": 13.75,
            "text": "server, TBBPred",
            "probability": 0.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -9.171875,
            "text": "red,",
            "probability": 0.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -9.4296875,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -9.578125,
            "text": "red, for predicting transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -9.9140625,
            "text": "red, for predicting transmembrane beta-barrel regions",
            "probability": 0.0
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -10.109375,
            "text": "red, for predicting transmembrane beta-barrel regions in",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_14": [
        {
            "start_logit": 14.125,
            "end_logit": 13.2109375,
            "text": "PROFtmb",
            "probability": 1.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -3.712890625,
            "text": "PROF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 13.2109375,
            "text": "mb",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -7.578125,
            "text": "PROFtmb prediction method",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -7.7265625,
            "text": "PROFt",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -8.3125,
            "text": "PROFtmb prediction method are available",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 13.2109375,
            "text": "tmb",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -10.0078125,
            "text": "PROFtmb prediction method are",
            "probability": 0.0
        },
        {
            "start_logit": 14.125,
            "end_logit": -10.0859375,
            "text": "PROFtmb prediction",
            "probability": 0.0
        },
        {
            "start_logit": -9.3828125,
            "end_logit": 13.2109375,
            "text": "proteome predictions and the PROFtmb",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": 13.2109375,
            "text": "All proteome predictions and the PROFtmb",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": 13.2109375,
            "text": "and the PROFtmb",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": 13.2109375,
            "text": "predictions and the PROFtmb",
            "probability": 0.0
        },
        {
            "start_logit": -5.02734375,
            "end_logit": -7.578125,
            "text": "mb prediction method",
            "probability": 0.0
        },
        {
            "start_logit": -9.3828125,
            "end_logit": -3.712890625,
            "text": "proteome predictions and the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -5.02734375,
            "end_logit": -8.3125,
            "text": "mb prediction method are available",
            "probability": 0.0
        },
        {
            "start_logit": -9.875,
            "end_logit": -3.712890625,
            "text": "All proteome predictions and the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -10.109375,
            "end_logit": -3.712890625,
            "text": "and the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -10.53125,
            "end_logit": -3.712890625,
            "text": "predictions and the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -5.02734375,
            "end_logit": -10.0078125,
            "text": "mb prediction method are",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_15": [
        {
            "start_logit": 13.6484375,
            "end_logit": 13.875,
            "text": "BBF",
            "probability": 1.0
        },
        {
            "start_logit": -4.09765625,
            "end_logit": 13.875,
            "text": "F",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -4.28125,
            "text": "BB",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 13.875,
            "text": "beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -7.06640625,
            "text": "BBF) program",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -8.0078125,
            "text": "BBF)",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -8.546875,
            "text": "BBF) program, allowing identification of outer membrane beta-barrel proteins encoded within prokaryotic genomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -9.1171875,
            "text": "BBF) program, allowing identification of outer membrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -9.171875,
            "text": "BBF) program,",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -9.1875,
            "text": "BBF) program, allowing identification of outer membrane beta-barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -9.3046875,
            "text": "BBF) program, allowing identification of outer membrane beta-barrel proteins encoded",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -9.40625,
            "text": "BBF) program, allowing identification of outer membrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": -10.2265625,
            "end_logit": 13.875,
            "text": "(BBF",
            "probability": 0.0
        },
        {
            "start_logit": 13.6484375,
            "end_logit": -10.03125,
            "text": "BBF) program, allowing identification of outer",
            "probability": 0.0
        },
        {
            "start_logit": -10.34375,
            "end_logit": 13.875,
            "text": "er (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -10.3828125,
            "end_logit": 13.875,
            "text": "finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -10.390625,
            "end_logit": 13.875,
            "text": "The beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -4.28125,
            "text": "beta-barrel finder (BB",
            "probability": 0.0
        },
        {
            "start_logit": -4.09765625,
            "end_logit": -7.06640625,
            "text": "F) program",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -5.390625,
            "text": "beta-barrel finder",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_16": [
        {
            "start_logit": 13.2890625,
            "end_logit": 12.3203125,
            "text": "BBF",
            "probability": 1.0
        },
        {
            "start_logit": 0.349853515625,
            "end_logit": 12.3203125,
            "text": "beta-barrel finder (BBF",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -4.53125,
            "text": "BB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -4.69140625,
            "text": "BBF) program",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 12.3203125,
            "text": "F",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -7.359375,
            "text": "BBF)",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.2421875,
            "text": "BBF) program, was used to analyze the proteins encoded within the Escherichia coli genome",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.25,
            "text": "BBF) program, was used to analyze the proteins encoded within the Escherichia coli",
            "probability": 0.0
        },
        {
            "start_logit": 13.2890625,
            "end_logit": -8.4296875,
            "text": "BBF) program,",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 12.3203125,
            "text": "the beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -8.8515625,
            "end_logit": 12.3203125,
            "text": "finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -8.96875,
            "end_logit": 12.3203125,
            "text": "This program, termed the beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": 0.349853515625,
            "end_logit": 2.294921875,
            "text": "beta-barrel finder",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": 12.3203125,
            "text": "(BBF",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 12.3203125,
            "text": "within any completely sequenced prokaryotic genome. This program, termed the beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 12.3203125,
            "text": "termed the beta-barrel finder (BBF",
            "probability": 0.0
        },
        {
            "start_logit": -9.9375,
            "end_logit": 12.3203125,
            "text": "er (BBF",
            "probability": 0.0
        },
        {
            "start_logit": 0.349853515625,
            "end_logit": -4.53125,
            "text": "beta-barrel finder (BB",
            "probability": 0.0
        },
        {
            "start_logit": 0.349853515625,
            "end_logit": -4.69140625,
            "text": "beta-barrel finder (BBF) program",
            "probability": 0.0
        },
        {
            "start_logit": 0.349853515625,
            "end_logit": -5.2890625,
            "text": "beta-barrel",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_17": [
        {
            "start_logit": 12.9765625,
            "end_logit": 13.6484375,
            "text": "transFold",
            "probability": 1.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -3.7578125,
            "text": "transFold employs a generalized hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.51171875,
            "end_logit": 13.6484375,
            "text": "old",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -5.18359375,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S-attribute grammar",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -5.2109375,
            "text": "transF",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 13.6484375,
            "text": "algorithm transFold",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -7.0859375,
            "text": "transFold employs a generalized hidden Markov",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.109375,
            "text": "transFold employs a generalized",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.1171875,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S-attribute",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.171875,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.203125,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.328125,
            "text": "transFold employs a generalized hidden",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.328125,
            "text": "transFold employs a generalized hidden Markov model (i.e., multi",
            "probability": 0.0
        },
        {
            "start_logit": 12.9765625,
            "end_logit": -8.40625,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S-attribute gramm",
            "probability": 0.0
        },
        {
            "start_logit": -9.640625,
            "end_logit": 13.6484375,
            "text": "nonouter membrane) proteins is introduced to predict the supersecondary structure of transmembrane beta-barrel proteins. The algorithm transFold",
            "probability": 0.0
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -3.7578125,
            "text": "old employs a generalized hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -5.18359375,
            "text": "old employs a generalized hidden Markov model (i.e., multitape S-attribute grammar",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -3.7578125,
            "text": "algorithm transFold employs a generalized hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": -3.7578125,
            "text": "hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -7.0859375,
            "text": "old employs a generalized hidden Markov",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_18": [
        {
            "start_logit": 13.3203125,
            "end_logit": 13.4609375,
            "text": "BOMP",
            "probability": 1.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -4.44921875,
            "text": "BOM",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 13.4609375,
            "text": "P",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.4765625,
            "text": "BOMP: a program",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.75,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -8.921875,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.0546875,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.1484375,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.234375,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.578125,
            "text": "BOMP: a program to predict integral beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.796875,
            "text": "BOMP: a program to predict",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.8984375,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.9609375,
            "text": "BOMP: a",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -9.9765625,
            "text": "BOMP: a program to predict integral beta-barrel outer",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.1484375,
            "text": "BOMP:",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.234375,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram",
            "probability": 0.0
        },
        {
            "start_logit": 13.3203125,
            "end_logit": -10.234375,
            "text": "BOMP: a program to predict integral beta-",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -8.4765625,
            "text": "P: a program",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -8.75,
            "text": "P: a program to predict integral beta-barrel outer membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -4.7109375,
            "end_logit": -8.921875,
            "text": "P: a program to predict integral beta-barrel outer membrane",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_19": [
        {
            "start_logit": 14.109375,
            "end_logit": 14.1171875,
            "text": "BOMP",
            "probability": 1.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -3.291015625,
            "text": "BOM",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": 14.1171875,
            "text": "P",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -6.99609375,
            "text": "BOMP), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal pattern",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -8.25,
            "text": "BOMP), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -8.28125,
            "text": "BOMP)",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -8.5,
            "text": "BOMP),",
            "probability": 0.0
        },
        {
            "start_logit": 14.109375,
            "end_logit": -8.640625,
            "text": "BOMP), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal pattern typical",
            "probability": 0.0
        },
        {
            "start_logit": -9.03125,
            "end_logit": 14.1171875,
            "text": "beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 0.0
        },
        {
            "start_logit": -9.4609375,
            "end_logit": 14.1171875,
            "text": "the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 0.0
        },
        {
            "start_logit": -9.5234375,
            "end_logit": 14.1171875,
            "text": "(BOMP",
            "probability": 0.0
        },
        {
            "start_logit": -9.578125,
            "end_logit": 14.1171875,
            "text": "Outer Membrane protein Predictor (BOMP",
            "probability": 0.0
        },
        {
            "start_logit": -9.8984375,
            "end_logit": 14.1171875,
            "text": "bacterium is an integral beta-barrel outer membrane protein. The program, called the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -6.99609375,
            "text": "P), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal pattern",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -8.25,
            "text": "P), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -8.28125,
            "text": "P)",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -8.5,
            "text": "P),",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -8.640625,
            "text": "P), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal pattern typical",
            "probability": 0.0
        },
        {
            "start_logit": -9.03125,
            "end_logit": -3.291015625,
            "text": "beta-barrel Outer Membrane protein Predictor (BOM",
            "probability": 0.0
        },
        {
            "start_logit": -9.4609375,
            "end_logit": -3.291015625,
            "text": "the beta-barrel Outer Membrane protein Predictor (BOM",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_20": [
        {
            "start_logit": 13.90625,
            "end_logit": 13.5625,
            "text": "OMBBpred",
            "probability": 1.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -4.109375,
            "text": "OM",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -4.18359375,
            "text": "OMBBpred, which utilizes a Support Vector Machine",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": 13.5625,
            "text": "d",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -6.08984375,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -6.44921875,
            "text": "OMBB",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -7.078125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors derived from predicted secondary structures, hydrophobicity",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -7.703125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors derived from predicted secondary structures",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -7.98046875,
            "text": "OMBBpred, which utilizes a Support Vector",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -8.375,
            "text": "OMBBpre",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -8.5078125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 13.5625,
            "text": "pred",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 13.5625,
            "text": "OMBBs, called OMBBpred",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -9.0703125,
            "text": "OMBBpred,",
            "probability": 0.0
        },
        {
            "start_logit": 13.90625,
            "end_logit": -9.234375,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors derived from predicted",
            "probability": 0.0
        },
        {
            "start_logit": -9.328125,
            "end_logit": 13.5625,
            "text": "sequence-based predictor of OMBBs, called OMBBpred",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -4.18359375,
            "text": "d, which utilizes a Support Vector Machine",
            "probability": 0.0
        },
        {
            "start_logit": -5.72265625,
            "end_logit": -4.18359375,
            "text": "Support Vector Machine",
            "probability": 0.0
        },
        {
            "start_logit": -4.78125,
            "end_logit": -6.08984375,
            "text": "d, which utilizes a Support Vector Machine classifier",
            "probability": 0.0
        },
        {
            "start_logit": -5.72265625,
            "end_logit": -6.08984375,
            "text": "Support Vector Machine classifier",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_21": [
        {
            "start_logit": 13.9296875,
            "end_logit": 14.0859375,
            "text": "TBBPred",
            "probability": 1.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": 14.0859375,
            "text": "red",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -4.09375,
            "text": "TB",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -6.3828125,
            "text": "TBBP",
            "probability": 0.0
        },
        {
            "start_logit": -8.96875,
            "end_logit": 14.0859375,
            "text": "BPred",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.90625,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res.in",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -8.9375,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.03125,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": 14.0859375,
            "text": "Web server, TBBPred",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.359375,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.3671875,
            "text": "TBBPred,",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.4140625,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.65625,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www",
            "probability": 0.0
        },
        {
            "start_logit": 13.9296875,
            "end_logit": -9.7734375,
            "text": "TBBPred, for predicting transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": -10.1328125,
            "end_logit": 14.0859375,
            "text": "this study, we have developed a Web server, TBBPred",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -8.6875,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res.in/raghava",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -8.90625,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res.in",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -8.9375,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -9.03125,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -3.62109375,
            "end_logit": -9.359375,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech",
            "probability": 0.0
        }
    ],
    "6027fcd31cb411341a0000ef_1": [
        {
            "start_logit": 13.6171875,
            "end_logit": 13.8984375,
            "text": "TreeEFM",
            "probability": 1.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -3.841796875,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver (CLP",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 13.8984375,
            "text": "M",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -4.6015625,
            "text": "Tree",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -6.00390625,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -6.9140625,
            "text": "TreeEFM is",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.05078125,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver (",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.6484375,
            "text": "TreeEF",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -7.73046875,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.03125,
            "text": "TreeEFM is implemented in C++",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.5390625,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solve",
            "probability": 0.0
        },
        {
            "start_logit": -8.875,
            "end_logit": 13.8984375,
            "text": "software TreeEFM",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.6328125,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.640625,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear",
            "probability": 0.0
        },
        {
            "start_logit": 13.6171875,
            "end_logit": -8.671875,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver",
            "probability": 0.0
        },
        {
            "start_logit": -9.390625,
            "end_logit": 13.8984375,
            "text": "when applied to large GSMNs.AVAILABILITY AND IMPLEMENTATION: The stand-alone software TreeEFM",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -3.841796875,
            "text": "M is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver (CLP",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -6.00390625,
            "text": "M is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver",
            "probability": 0.0
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -3.841796875,
            "text": "CLP",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -6.02734375,
            "text": "EFMEvolver",
            "probability": 0.0
        }
    ],
    "6027fcd31cb411341a0000ef_2": [
        {
            "start_logit": 12.8515625,
            "end_logit": 12.765625,
            "text": "EFM-Ta",
            "probability": 1.0
        },
        {
            "start_logit": 12.8515625,
            "end_logit": -3.109375,
            "text": "EFM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 12.8515625,
            "end_logit": -5.515625,
            "text": "EF",
            "probability": 0.0
        },
        {
            "start_logit": -5.53125,
            "end_logit": 12.765625,
            "text": "Ta",
            "probability": 0.0
        },
        {
            "start_logit": 12.8515625,
            "end_logit": -7.65625,
            "text": "EFM-Ta that boosts the efficiency rate by analyzing the information provided by the LP",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 12.765625,
            "text": "called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 12.765625,
            "text": "new method called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -8.8125,
            "end_logit": 12.765625,
            "text": "-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": 12.765625,
            "text": "method called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -2.486328125,
            "text": "simplex method",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -2.486328125,
            "text": "tableau of the simplex method",
            "probability": 0.0
        },
        {
            "start_logit": -8.984375,
            "end_logit": -2.486328125,
            "text": "LP solver. We base our method on a further study of the final tableau of the simplex method",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -3.109375,
            "text": "called EFM",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -3.109375,
            "text": "new method called EFM",
            "probability": 0.0
        },
        {
            "start_logit": -9.5625,
            "end_logit": -2.486328125,
            "text": "au of the simplex method",
            "probability": 0.0
        },
        {
            "start_logit": -9.625,
            "end_logit": -2.486328125,
            "text": "method",
            "probability": 0.0
        },
        {
            "start_logit": -9.7421875,
            "end_logit": -2.486328125,
            "text": "of the simplex method",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -6.3984375,
            "text": "simplex method. By performing additional elementary steps and avoiding trivial solutions consisting of two cycles",
            "probability": 0.0
        },
        {
            "start_logit": -9.1796875,
            "end_logit": -3.109375,
            "text": "method called EFM",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -7.015625,
            "text": "simplex method. By performing additional elementary steps and avoiding trivial solutions consisting of two cycles, we obtain many more EFMs for each LP",
            "probability": 0.0
        }
    ]
}
